Citrus Sinensis ID: 026299
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 240 | 2.2.26 [Sep-21-2011] | |||||||
| Q75H77 | 362 | Serine/threonine-protein | yes | no | 0.970 | 0.643 | 0.944 | 1e-130 | |
| Q7Y0B9 | 371 | Serine/threonine-protein | no | no | 0.966 | 0.625 | 0.931 | 1e-129 | |
| Q940H6 | 362 | Serine/threonine-protein | yes | no | 0.962 | 0.638 | 0.939 | 1e-128 | |
| Q39193 | 361 | Serine/threonine-protein | no | no | 0.966 | 0.642 | 0.909 | 1e-127 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.962 | 0.639 | 0.901 | 1e-123 | |
| Q39192 | 362 | Serine/threonine-protein | no | no | 0.954 | 0.632 | 0.869 | 1e-121 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.883 | 0.625 | 0.891 | 1e-114 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.883 | 0.625 | 0.886 | 1e-113 | |
| P43291 | 363 | Serine/threonine-protein | no | no | 0.887 | 0.586 | 0.868 | 1e-112 | |
| Q7XQP4 | 359 | Serine/threonine-protein | no | no | 0.883 | 0.590 | 0.867 | 1e-111 |
| >sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 465 bits (1197), Expect = e-130, Method: Compositional matrix adjust.
Identities = 220/233 (94%), Positives = 226/233 (96%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+A+TVGPGMDMPIMHD DRYELVRDIGSGNFGVARLMR + +LVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRSRADGQLVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EPKNFRKTI
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKNFRKTIQ 233
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 459 bits (1180), Expect = e-129, Method: Compositional matrix adjust.
Identities = 216/232 (93%), Positives = 226/232 (97%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
DR+A+TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRD++T ELVAVKYIERG+KID
Sbjct: 12 DRAALTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDRRTMELVAVKYIERGEKID 71
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
+NVQREIINHRSL+HPNI+RFKEVILTPTHLAIVMEYASGGELFERIC RFSEDEAR+
Sbjct: 72 DNVQREIINHRSLKHPNIIRFKEVILTPTHLAIVMEYASGGELFERICKNVRFSEDEARY 131
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 132 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 191
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
PAYIAPEVLLKKEYDGK ADVWSCGVTLYVM+VGAYPFEDPEEPKNFRKTI
Sbjct: 192 PAYIAPEVLLKKEYDGKTADVWSCGVTLYVMVVGAYPFEDPEEPKNFRKTIQ 243
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 458 bits (1179), Expect = e-128, Method: Compositional matrix adjust.
Identities = 219/233 (93%), Positives = 229/233 (98%), Gaps = 2/233 (0%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 231
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1 | Back alignment and function description |
|---|
Score = 453 bits (1166), Expect = e-127, Method: Compositional matrix adjust.
Identities = 212/233 (90%), Positives = 227/233 (97%), Gaps = 1/233 (0%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232
|
Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1136), Expect = e-123, Method: Compositional matrix adjust.
Identities = 211/234 (90%), Positives = 225/234 (96%), Gaps = 3/234 (1%)
Query: 1 MDRSAMTVGP-GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK 59
M+R+A GP GM+MPIMHD DRYELV++IGSGNFGVARLMR++ + +LVAVKYI+RG+K
Sbjct: 1 MERAA--AGPLGMEMPIMHDGDRYELVKEIGSGNFGVARLMRNRASGDLVAVKYIDRGEK 58
Query: 60 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
IDENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERIC+AGRFSEDEA
Sbjct: 59 IDENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICSAGRFSEDEA 118
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTV
Sbjct: 119 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI
Sbjct: 179 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQ 232
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1115), Expect = e-121, Method: Compositional matrix adjust.
Identities = 200/230 (86%), Positives = 223/230 (96%), Gaps = 1/230 (0%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
+D+PIMHDSDRY+ V+DIGSGNFGVARLM D+ T+ELVAVKYIERG+KIDENVQREIINH
Sbjct: 12 IDLPIMHDSDRYDFVKDIGSGNFGVARLMTDRVTKELVAVKYIERGEKIDENVQREIINH 71
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
RSLRHPNIVRFKEVILTP+HLAIVMEYA+GGEL+ERICNAGRFSEDEARFFFQQLISGVS
Sbjct: 72 RSLRHPNIVRFKEVILTPSHLAIVMEYAAGGELYERICNAGRFSEDEARFFFQQLISGVS 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
YCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE+LL
Sbjct: 132 YCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEILL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-VMYCTFS 240
++EYDGK+ADVWSCGVTLYVMLVGAYPFEDP+EP+++RKTI ++ T+S
Sbjct: 192 RQEYDGKLADVWSCGVTLYVMLVGAYPFEDPQEPRDYRKTIQRILSVTYS 241
|
Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 409 bits (1051), Expect = e-114, Method: Compositional matrix adjust.
Identities = 189/212 (89%), Positives = 207/212 (97%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+++DIGSGNFGVA+L+RD +T+EL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
DVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTI 213
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 407 bits (1047), Expect = e-113, Method: Compositional matrix adjust.
Identities = 188/212 (88%), Positives = 207/212 (97%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+++DIGSGNFGVA+L+RD +T+EL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APRLKICDFGYSKSS+LHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
DVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTI 213
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43291|SRK2A_ARATH Serine/threonine-protein kinase SRK2A OS=Arabidopsis thaliana GN=SRK2A PE=1 SV=1 | Back alignment and function description |
|---|
Score = 405 bits (1040), Expect = e-112, Method: Compositional matrix adjust.
Identities = 185/213 (86%), Positives = 205/213 (96%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YELV+DIG+GNFGVARLM+ K ++ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMKVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHLAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK+A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKMA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIQ 214
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7XQP4|SAPK7_ORYSJ Serine/threonine-protein kinase SAPK7 OS=Oryza sativa subsp. japonica GN=SAPK7 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 401 bits (1030), Expect = e-111, Method: Compositional matrix adjust.
Identities = 184/212 (86%), Positives = 205/212 (96%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYEL++DIG+GNFGVARLMR+K+T+ELVA+KYI RG KIDENV REIINHRSLRHPNI+
Sbjct: 2 ERYELLKDIGAGNFGVARLMRNKETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV++TPTHLAIVMEYA+GGELF+RICNAGRFSEDEAR+FFQQLI GVSYCH MQ+CH
Sbjct: 62 RFKEVVVTPTHLAIVMEYAAGGELFDRICNAGRFSEDEARYFFQQLICGVSYCHFMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKTA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
DVWSCGVTLYVMLVGAYPFEDP++PKNFRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTI 213
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 240 | ||||||
| 356575154 | 364 | PREDICTED: serine/threonine-protein kina | 0.970 | 0.640 | 0.987 | 1e-134 | |
| 356521207 | 364 | PREDICTED: serine/threonine-protein kina | 0.970 | 0.640 | 0.978 | 1e-134 | |
| 356519681 | 369 | PREDICTED: serine/threonine-protein kina | 0.966 | 0.628 | 0.978 | 1e-133 | |
| 255561655 | 363 | Serine/threonine-protein kinase SAPK10, | 0.970 | 0.641 | 0.961 | 1e-133 | |
| 356575156 | 373 | PREDICTED: serine/threonine-protein kina | 0.970 | 0.624 | 0.950 | 1e-132 | |
| 356521209 | 371 | PREDICTED: serine/threonine-protein kina | 0.970 | 0.628 | 0.95 | 1e-132 | |
| 449438438 | 365 | PREDICTED: serine/threonine-protein kina | 0.970 | 0.638 | 0.952 | 1e-131 | |
| 225428695 | 363 | PREDICTED: serine/threonine-protein kina | 0.970 | 0.641 | 0.957 | 1e-131 | |
| 224123434 | 363 | predicted protein [Populus trichocarpa] | 0.970 | 0.641 | 0.948 | 1e-130 | |
| 404435147 | 362 | sucrose non-fermenting 1-related protein | 0.970 | 0.643 | 0.948 | 1e-130 |
| >gi|356575154|ref|XP_003555707.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 484 bits (1245), Expect = e-134, Method: Compositional matrix adjust.
Identities = 230/233 (98%), Positives = 232/233 (99%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521207|ref|XP_003529248.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 482 bits (1241), Expect = e-134, Method: Compositional matrix adjust.
Identities = 228/233 (97%), Positives = 232/233 (99%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSD+YELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDKYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKE+ILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEIILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356519681|ref|XP_003528498.1| PREDICTED: serine/threonine-protein kinase SRK2E-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 479 bits (1232), Expect = e-133, Method: Compositional matrix adjust.
Identities = 227/232 (97%), Positives = 231/232 (99%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
DRSAM+VGPGMD+PIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERG+KID
Sbjct: 13 DRSAMSVGPGMDLPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGEKID 72
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF
Sbjct: 73 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 132
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
FFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 133 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 192
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH
Sbjct: 193 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 244
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561655|ref|XP_002521837.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538875|gb|EEF40473.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 478 bits (1231), Expect = e-133, Method: Compositional matrix adjust.
Identities = 224/233 (96%), Positives = 233/233 (100%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+T+GPGMD+PIMHDSDRYELV+DIG+GNFGVARLMRDK+T+ELVAVKYIERG+KI
Sbjct: 1 MDRSALTIGPGMDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQTDELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575156|ref|XP_003555708.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1226), Expect = e-132, Method: Compositional matrix adjust.
Identities = 230/242 (95%), Positives = 232/242 (95%), Gaps = 9/242 (3%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVL 171
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK SSVL
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKVHFLRTVISSSVL 180
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231
HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT
Sbjct: 181 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 240
Query: 232 IH 233
IH
Sbjct: 241 IH 242
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521209|ref|XP_003529249.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 475 bits (1223), Expect = e-132, Method: Compositional matrix adjust.
Identities = 228/240 (95%), Positives = 232/240 (96%), Gaps = 7/240 (2%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSD+YELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDKYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKE+ILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEIILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHS 173
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK SSVLHS
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKVYFFLHTSSVLHS 180
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH
Sbjct: 181 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 240
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449438438|ref|XP_004136995.1| PREDICTED: serine/threonine-protein kinase SRK2E-like [Cucumis sativus] gi|449495591|ref|XP_004159888.1| PREDICTED: serine/threonine-protein kinase SRK2E-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 472 bits (1214), Expect = e-131, Method: Compositional matrix adjust.
Identities = 222/233 (95%), Positives = 230/233 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+TVGPGMD+PIMHDSDRYELVRDIGSGNFG+ARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1 MDRSALTVGPGMDIPIMHDSDRYELVRDIGSGNFGIARLMRDKQTGELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
D NV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQ 233
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1213), Expect = e-131, Method: Compositional matrix adjust.
Identities = 223/233 (95%), Positives = 229/233 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+TVGP MD+PIMHDSDRYELVRDIGSGNFGVARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1 MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQ 233
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123434|ref|XP_002330314.1| predicted protein [Populus trichocarpa] gi|222871349|gb|EEF08480.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1211), Expect = e-130, Method: Compositional matrix adjust.
Identities = 221/233 (94%), Positives = 228/233 (97%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRS MTVGPGMDMPIMHD DRYELVRDIGSGNFGVARLMRDK+ +ELVAVKYIERG+KI
Sbjct: 1 MDRSVMTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRDKQADELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN+GRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNSGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP STVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPTSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EP+NFR TIH
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPRNFRSTIH 233
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|404435147|gb|AFR68940.1| sucrose non-fermenting 1-related protein kinase 2 family member [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 470 bits (1210), Expect = e-130, Method: Compositional matrix adjust.
Identities = 221/233 (94%), Positives = 231/233 (99%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+A+TVGPGMD+PIMHDSDRYELVRDIG+GNFGVARLMRD++T ELVAVKYIERG+KI
Sbjct: 1 MDRTAVTVGPGMDVPIMHDSDRYELVRDIGAGNFGVARLMRDRQTNELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVME+ASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEFASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIQ 233
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 240 | ||||||
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.962 | 0.638 | 0.939 | 3.8e-117 | |
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.962 | 0.639 | 0.913 | 1.9e-115 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.883 | 0.587 | 0.867 | 7.9e-101 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.883 | 0.588 | 0.858 | 7.1e-100 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.883 | 0.600 | 0.849 | 8.2e-99 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.883 | 0.618 | 0.844 | 1.2e-97 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.883 | 0.605 | 0.820 | 1.4e-96 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.883 | 0.625 | 0.801 | 1.6e-93 | |
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.862 | 0.458 | 0.458 | 1.5e-44 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.85 | 0.458 | 0.465 | 1.5e-44 |
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1154 (411.3 bits), Expect = 3.8e-117, P = 3.8e-117
Identities = 219/233 (93%), Positives = 229/233 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 231
|
|
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1138 (405.7 bits), Expect = 1.9e-115, P = 1.9e-115
Identities = 212/232 (91%), Positives = 227/232 (97%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI 231
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1000 (357.1 bits), Expect = 7.9e-101, P = 7.9e-101
Identities = 184/212 (86%), Positives = 203/212 (95%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YELV+DIG+GNFGVARLMR K ++ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL + EYDGK+A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
DVWSCGVTLYVMLVGAYPFED E+PKNF+KTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTI 213
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 991 (353.9 bits), Expect = 7.1e-100, P = 7.1e-100
Identities = 182/212 (85%), Positives = 202/212 (95%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YE+V+D+G+GNFGVARL+R K+T+ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE EAR+FFQQLI GV YCHS+Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
DVWSCGVTLYVMLVG YPFEDP++P+NFRKTI
Sbjct: 182 DVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTI 213
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 981 (350.4 bits), Expect = 8.2e-99, P = 8.2e-99
Identities = 180/212 (84%), Positives = 200/212 (94%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+Y++V+D+G+GNFGVARL+R K T+ELVA+KYIERG KIDENV REIINHRSL+HPNI+
Sbjct: 2 DKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEVILTPTHLAIVMEYASGGELF+RIC AGRFSE EAR+FFQQLI GV YCHS+Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
DVWSCGVTLYVMLVGAYPFEDP +PKNFRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTI 213
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 970 (346.5 bits), Expect = 1.2e-97, P = 1.2e-97
Identities = 179/212 (84%), Positives = 201/212 (94%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+V+DIGSGNFGVA+L+RDK ++EL AVK+IERG KIDE+VQREI+NHRSL HPNI+
Sbjct: 2 ERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LT THLA+VMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGV+YCHS+Q+CH
Sbjct: 62 RFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APR+KICDFGYSKS VLHSQPK+TVGTPAYIAPEVL KEYDGKIA
Sbjct: 122 RDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
DVWSCGVTLYVMLVGAYPFEDP +PK+FRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTI 213
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 960 (343.0 bits), Expect = 1.4e-96, P = 1.4e-96
Identities = 174/212 (82%), Positives = 198/212 (93%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RY+++RD+GSGNFGVA+L+R+K E AVKYIERG KIDE+VQREIINHR L+HPNI+
Sbjct: 2 ERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV +TPTHLAIVMEYA+GGELFERICNAGRFSEDE R++F+QLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSP+ LKICDFGYSKSSVLHSQPKSTVGTPAY+APEVL +KEY+GKIA
Sbjct: 122 RDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKIA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
DVWSCGVTLYVMLVGAYPFEDPE+P+N R TI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTI 213
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 931 (332.8 bits), Expect = 1.6e-93, P = 1.6e-93
Identities = 170/212 (80%), Positives = 193/212 (91%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++YE+V+D+G GNFG+ARLMR+K+T ELVAVK+I+RG KIDENV REIINHR+L HPNIV
Sbjct: 2 EKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHL IVMEYA+GGELFERI + GRFSE EAR+FFQQLI GV Y H++Q+CH
Sbjct: 62 RFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV + EYDGK
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSV 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
DVWSCGV LYVMLVGAYPFEDP++P+NFRKT+
Sbjct: 182 DVWSCGVALYVMLVGAYPFEDPKDPRNFRKTV 213
|
|
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 469 (170.2 bits), Expect = 1.5e-44, P = 1.5e-44
Identities = 99/216 (45%), Positives = 135/216 (62%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHP 77
+YE+ R IG G F + R+ +T E VA+K +++ K+ E ++REI + ++HP
Sbjct: 23 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMKLIKHP 82
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
N+V+ EV+ + T + I++EY +GGELF++I N GR EDEAR +FQQLI V YCHS
Sbjct: 83 NVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYCHSRG 142
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP--KSTVGTPAYIAPEVLLKKE 194
V HRDLK EN LLD LKI DFG S S + ++ GTP Y+APEVL +
Sbjct: 143 VYHRDLKPENLLLDSYG--NLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLNDRG 200
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
YDG AD+WSCGV LYV+L G PF+D ++K
Sbjct: 201 YDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKK 236
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 469 (170.2 bits), Expect = 1.5e-44, P = 1.5e-44
Identities = 101/217 (46%), Positives = 136/217 (62%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHP 77
+YEL R IG G F + ++ +T E VA+K ++R K+ + ++REI + +RHP
Sbjct: 8 KYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKLVRHP 67
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+VR EV+ + T + I++EY +GGELF++I GR SE EAR +F QLI GV YCHS
Sbjct: 68 CVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCHSKG 127
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLKK 193
V HRDLK EN LLD LKI DFG S L Q K+T GTP Y+APEVL K
Sbjct: 128 VYHRDLKPENLLLDSQG--NLKISDFGLS---ALPEQGVTILKTTCGTPNYVAPEVLSHK 182
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
Y+G +AD+WSCGV LYV++ G PF++ + P + K
Sbjct: 183 GYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSK 219
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| A2ZAB5 | SAPK3_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.8443 | 0.8833 | 0.6347 | N/A | no |
| Q02066 | AAIP_WHEAT | 2, ., 7, ., 1, 1, ., 1 | 0.8866 | 0.8458 | 0.6114 | N/A | no |
| Q39193 | SRK2I_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9098 | 0.9666 | 0.6426 | no | no |
| A2YNT8 | SAPK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.8915 | 0.8833 | 0.6253 | N/A | no |
| Q940H6 | SRK2E_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9399 | 0.9625 | 0.6381 | yes | no |
| Q75H77 | SAPKA_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.9442 | 0.9708 | 0.6436 | yes | no |
| Q7Y0B9 | SAPK8_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.9310 | 0.9666 | 0.6253 | no | no |
| Q75V57 | SAPK9_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.9017 | 0.9625 | 0.6398 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 240 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-86 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-75 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-65 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-60 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-53 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-50 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-44 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-44 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-43 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-43 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-42 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-41 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-41 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-40 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-39 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-39 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-39 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-39 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-39 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-39 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-38 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-37 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-37 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-37 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-37 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-36 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-36 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-36 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-36 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-35 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-35 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-35 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-35 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-35 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-35 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-35 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-34 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-34 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-34 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-34 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-34 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-34 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-34 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-33 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-33 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-33 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-33 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-33 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-33 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-33 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-33 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-32 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-32 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-31 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-31 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-31 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-31 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-30 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-30 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-29 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-29 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-29 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-29 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-29 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-29 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-28 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-28 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-28 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-28 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-28 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-27 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-27 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-27 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-27 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-27 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-27 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-27 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-27 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-26 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-26 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-26 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-26 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-26 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-26 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-25 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-25 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-24 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-24 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-24 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-23 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-23 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-23 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-23 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-22 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-22 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-22 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-21 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-21 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-21 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-21 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-20 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-20 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-20 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-20 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-20 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-20 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-19 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-19 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-18 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-16 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-16 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 256 bits (657), Expect = 1e-86
Identities = 93/212 (43%), Positives = 127/212 (59%), Gaps = 5/212 (2%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
YE++ +G G+FG L RDKKT +LVA+K I ++ K E + REI + L+HPNIV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
R +V L +VMEY GG+LF+ + GR SEDEARF+ +Q++S + Y HS + H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLK EN LLD +K+ DFG ++ + + VGTP Y+APEVLL K Y +
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV- 177
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
D+WS GV LY +L G PF ++ K I
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKI 209
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 229 bits (585), Expect = 1e-75
Identities = 91/222 (40%), Positives = 120/222 (54%), Gaps = 6/222 (2%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPNI 79
YEL+R +GSG+FG + K T ++VAVK + K D+ +REI R L HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
VR + HL +VMEY GG+LF+ + G SEDEA+ Q++ G+ Y HS +
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGK 198
HRDLK EN LLD + +KI DFG +K + S +T VGTP Y+APEVLL G
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCTFS 240
DVWS GV LY +L G PF + ++
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLE 220
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 5e-65
Identities = 86/188 (45%), Positives = 112/188 (59%), Gaps = 5/188 (2%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVI 86
+G G FG L RDKKT + VA+K I++ D E + REI + L HPNIV+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 87 LTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
HL +VMEY GG L + + N G+ SEDE Q++ G+ Y HS + HRDLK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 146 ENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
EN LLD S ++K+ DFG SK + S K+ VGTPAY+APEVLL K Y + +D+WS
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 205 CGVTLYVM 212
GV LY +
Sbjct: 180 LGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 1e-60
Identities = 75/209 (35%), Positives = 115/209 (55%), Gaps = 15/209 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
+YE+++ IG G+FG L+R K +L +K I +K E+ E+ + L HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
I+++ E L IVMEYA GG+L ++I + F E++ +F QL + Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
S ++ HRD+K +N L +K+ DFG SK S+V + K+ VGTP Y++PE+
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQ 176
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
K Y+ K +D+WS G LY + +PFE
Sbjct: 177 NKPYNYK-SDIWSLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 1e-53
Identities = 82/212 (38%), Positives = 116/212 (54%), Gaps = 12/212 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 84
+G G+FG L+R K T +L A+K +++ I + R+ + HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L +V+EYA GGELF + GRFSE+ ARF+ +++ + Y HS+ + +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 145 LENTLLD--GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
EN LLD G +K+ DFG +K S+ + GTP Y+APEVLL K Y GK D
Sbjct: 121 PENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVD 175
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
WS GV LY ML G PF + + + K +
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK 207
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 6e-53
Identities = 76/223 (34%), Positives = 111/223 (49%), Gaps = 17/223 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
+ +G G+FG L DK T EL+AVK +E +E + +REI SL+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 79 IVRFK--EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IVR+ E L I +EY SGG L + G+ E R + +Q++ G++Y HS
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ HRD+K N L+D +K+ DFG +K S GTP ++APEV+ +
Sbjct: 121 GIVHRDIKGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
EY AD+WS G T+ M G P+ + P + +Y
Sbjct: 179 EYGRA-ADIWSLGCTVIEMATGKPPWSELGNP------MAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 2e-50
Identities = 72/208 (34%), Positives = 109/208 (52%), Gaps = 9/208 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 81
+E++ IG G FG R K+T + VA+K I + E + EI + +HPNIV+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L L IVME+ SGG L + + + + +E + + ++L+ G+ Y HS + H
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
RD+K N LL DG +K+ DFG S + VGTP ++APEV+ K YD K
Sbjct: 122 RDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPK 226
AD+WS G+T + G P+ + K
Sbjct: 178 -ADIWSLGITAIELAEGKPPYSELPPMK 204
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 5e-48
Identities = 82/223 (36%), Positives = 129/223 (57%), Gaps = 23/223 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE-IINHR----SLR 75
D +E ++ +G+G+FG L+R K + + A+K + + KI + Q E ++N + S+R
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIR 59
Query: 76 HPNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
HP +V F++ ++L +VMEY GGELF + +GRF E ARF+ Q++ +
Sbjct: 60 HPFLVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y HS+ + +RDLK EN LLD G +KI DFG++K + + + GTP Y+APE+
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEI 169
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+L K Y GK D W+ G+ +Y ML G PF D + + K +
Sbjct: 170 ILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 1e-44
Identities = 83/231 (35%), Positives = 120/231 (51%), Gaps = 21/231 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHP- 77
Y ++R +G G+FG L RD+K VA+K + + + REI SL HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCH 134
NIV+ + L +VMEY GG L + + G SE EA F Q++S + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAP 187
S + HRD+K EN LLD +K+ DFG +K +S + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 188 EVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
EVLL Y +D+WS G+TLY +L G PFE + +T+ ++
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228
|
Length = 384 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 8e-44
Identities = 76/207 (36%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
YE + +G G +GV RDKKT E+VA+K I R D +E + REI + L+HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ +VI T L +V EY +L + + G S + + QL+ G++YCHS +
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK- 192
+ HRDLK +N L++ LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 ILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF 219
K Y + D+WS G M+ G F
Sbjct: 174 KHYSTAV-DIWSVGCIFAEMITGKPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-43
Identities = 72/245 (29%), Positives = 116/245 (47%), Gaps = 39/245 (15%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 76
++ + IG G+F L ++K+T + A+K + + K+ +++E++ R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL-TRLNGH 61
Query: 77 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
P I++ F++ +L V+EYA GEL + I G E RF+ +++ + Y
Sbjct: 62 PGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 171
HS + HRDLK EN LLD +KI DFG +K
Sbjct: 118 LHSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231
+ S VGT Y++PE+L +K GK +D+W+ G +Y ML G PF E F+K
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234
Query: 232 IHVMY 236
+ + Y
Sbjct: 235 LKLEY 239
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-43
Identities = 72/217 (33%), Positives = 108/217 (49%), Gaps = 16/217 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKE 84
I G +G L + K T ++ A+K I++ D I +N +++ R + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+L +VMEY GG+L + N G ED AR + +++ + Y HS + HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+N L+D + LK+ DFG SK + + K VGTP YIAPEV+L + +
Sbjct: 121 PDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
K D WS G LY LVG PF + F+ +
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL 214
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 6e-42
Identities = 80/211 (37%), Positives = 115/211 (54%), Gaps = 9/211 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL AVK +++ + D++V+ + R L +HP + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L I +GRF E ARF+ +++ G+ + H + +RDL
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N LLD +KI DFG K +L ST GTP YIAPE+L + Y G D
Sbjct: 123 KLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
W+ GV LY ML G PFE +E + F+ +
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-41
Identities = 70/199 (35%), Positives = 109/199 (54%), Gaps = 10/199 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
IG G G D+ T + VA+K + + E + EI+ + +HPNIV + + L
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 89 PTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VMEY GG L + I N R +E + + ++++ G+ Y HS V HRD+K +N
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDN 146
Query: 148 TLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DGS +K+ DFG++ + + S+ S VGTP ++APEV+ +K+Y K+ D+WS
Sbjct: 147 ILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV-DIWS 201
Query: 205 CGVTLYVMLVGAYP-FEDP 222
G+ M G P +P
Sbjct: 202 LGIMCIEMAEGEPPYLREP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 3e-41
Identities = 73/205 (35%), Positives = 112/205 (54%), Gaps = 9/205 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
D E ++ +G+G FG L+RD+ +E A+K + + I ++V E + + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P I+R L ++MEY GGELF + N+GRFS F+ +++ + Y HS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
++ +RDLK EN LLD +K+ DFG++K L + + GTP Y+APEV+ K +
Sbjct: 121 EIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175
Query: 197 GKIADVWSCGVTLYVMLVGAYPFED 221
K D W+ G+ +Y MLVG PF D
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-41
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
RY+++ IG G G+ +D++T E VA+K + I REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
+V+ +V + +VMEY +L E + + R E + + + + L+ GV+Y H+
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL-KKE 194
+ HRDLK N L+ S LKI DFG ++ S V T Y APE+L ++
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 195 YDGKIADVWSCGVTLYVMLVGA 216
YD + D+W+ G +L G+
Sbjct: 178 YDPGV-DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 3e-40
Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 20/214 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
YE++ IG G+FG R +R K +++ K I+ G + E ++++++ R L+HPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPN 60
Query: 79 IVRF--KEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSY 132
IVR+ + + + L IVMEY GG+L + I E+ QL+ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 133 CH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIA 186
CH V HRDLK N LD + +K+ DFG +K S T VGTP Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
PE L YD K +D+WS G +Y + + PF
Sbjct: 179 PEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-39
Identities = 70/207 (33%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+ + L+ IG G+FG DK+T ++VA+K I E D+I++ +Q+EI R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
I ++ L + L I+MEY GG + + G+ E F ++++ G+ Y H
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRD+K N LL +G +K+ DFG S + S+ + VGTP ++APEV+ +
Sbjct: 119 KIHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFED 221
YD K AD+WS G+T + G P D
Sbjct: 175 YDEK-ADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-39
Identities = 63/202 (31%), Positives = 107/202 (52%), Gaps = 7/202 (3%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPN 78
+EL+R IG G FG +++ + T+++ A+KY+ + +++ R ++N R L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V ++ +V++ GG+L + +FSE++ +F+ +++ + Y HS +
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRD+K +N LLD + I DF + + ST GTP Y+APEVL ++ Y
Sbjct: 122 IHRDIKPDNILLDEQ--GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SV 178
Query: 199 IADVWSCGVTLYVMLVGAYPFE 220
D WS GVT Y L G P+
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-39
Identities = 72/211 (34%), Positives = 108/211 (51%), Gaps = 16/211 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGD-KIDENVQREIINHRSLRHPN 78
R++ IG G FG + T EL+AVK I + D K + + E+ L+HPN
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA--RFFFQQLISGVSYCHSM 136
+V++ V + + I MEY SGG L E + GR DE R + QL+ G++Y HS
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSH 118
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLL 191
+ HRD+K N LD + +K+ DFG + ++ + + +S GTPAY+APEV+
Sbjct: 119 GIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 192 KKEYDGKI--ADVWSCGVTLYVMLVGAYPFE 220
+ G AD+WS G + M G P+
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 4e-39
Identities = 71/222 (31%), Positives = 109/222 (49%), Gaps = 18/222 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---VQREIINHRSLRHPN 78
Y+L IG G FGV + +T + VA+K I +E + +EI ++L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV++ I T L I++EYA G L + I G F E + Q++ G++Y H V
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K N L DG +K+ DFG + K + + S VGTP ++APEV+
Sbjct: 121 IHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYC 237
+D+WS G T+ +L G P+ D + ++
Sbjct: 177 STA-SDIWSLGCTVIELLTGNPPYYD-------LNPMAALFR 210
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-39
Identities = 79/209 (37%), Positives = 111/209 (53%), Gaps = 16/209 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSLRHPNIV 80
+G G FG L+R+K T + A+K I + + I + ++ + H ++ RHP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMK-ILKKEVI---IAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
K T L VMEYA+GGELF + FSED ARF+ +++S + Y HS V +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKI 199
RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +Y G+
Sbjct: 119 RDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRA 175
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228
D W GV +Y M+ G PF + + K F
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-39
Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 84
+G G FG L++ K A+K +++ ++ Q I + + HP IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
++ ++MEY GGEL+ + + G F E ARF+ ++ Y H+ + +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
EN LLD + +K+ DFG++K + + GTP Y+APE++L K YD D WS
Sbjct: 121 PENLLLDSN--GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWS 177
Query: 205 CGVTLYVMLVGAYPFEDPEE 224
G+ LY +L G PF + +E
Sbjct: 178 LGILLYELLTGRPPFGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 8e-39
Identities = 74/197 (37%), Positives = 104/197 (52%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-----LRHPNIVRFK 83
IG G+FG L + K + AVK +++ + + Q+ I+ R+ ++HP +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD L DFG K + HS+ ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPF 219
W G LY ML G PF
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 6e-38
Identities = 74/220 (33%), Positives = 111/220 (50%), Gaps = 15/220 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
++++ +G G +G L + K T E+VA+K +++ N R ++ R + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+ +L + MEY GG+ + N G SED ARF+ ++ V H +
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRDLK EN L+D S +K+ DFG SK V + S VG+P Y+APEVL K YD
Sbjct: 123 IHRDLKPENFLIDAS--GHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 199 IADVWSCGVTLYVMLVGAYPF--EDPEEP----KNFRKTI 232
+ D WS G LY L G PF P E K +++T+
Sbjct: 179 V-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 7e-38
Identities = 67/220 (30%), Positives = 104/220 (47%), Gaps = 11/220 (5%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
E V+ +G G+ GV +R K T ++ A+K I + Q RE+ RS P +V+
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCH 140
++IV+EY GG L + + G+ E + +Q++ G+ Y H+ + H
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K N L+ G KI DFG SK +T VGT Y++PE ++ E
Sbjct: 124 RDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYS 178
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYC 237
AD+WS G+TL +G +PF P +P F +
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG 218
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-37
Identities = 81/206 (39%), Positives = 111/206 (53%), Gaps = 14/206 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHR------SLRHPNIVR 81
+G G+FG L KKT EL A+K +++GD I + V+ + R S RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T H+ VMEYA+GG+L I + FSE A F+ ++ G+ Y H ++ +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +KI DFG K + ST GTP ++APEVL + Y +
Sbjct: 126 DLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAV 182
Query: 201 DVWSCGVTLYVMLVGAYPF--EDPEE 224
D W GV +Y MLVG PF +D EE
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-37
Identities = 77/200 (38%), Positives = 109/200 (54%), Gaps = 19/200 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ YEL++ IGSG +G RD T ELVA+K I E GD + +Q+EI + RHPN
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHPN 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV + L L IVMEY GG L + G SE + + ++ + G++Y H
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL-- 190
HRD+K N LL DG +K+ DFG S +++ ++ KS +GTP ++APEV
Sbjct: 122 KIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAV 175
Query: 191 -LKKEYDGKIADVWSCGVTL 209
K YDGK D+W+ G+T
Sbjct: 176 ERKGGYDGK-CDIWALGITA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 5e-37
Identities = 79/209 (37%), Positives = 108/209 (51%), Gaps = 7/209 (3%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDEN-VQREIINHRSLRHPN 78
+YE +R +G G FG+ L R K ++LV +K I E+ K + Q E + L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
I+ + E L L IVMEYA GG L E I ED FF Q++ + + H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK +N LLD +KI DFG SK S+ + VGTP YI+PE+ K Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
K +D+W+ G LY + FE P
Sbjct: 180 QK-SDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 6e-37
Identities = 80/205 (39%), Positives = 115/205 (56%), Gaps = 13/205 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T E A+K +++ D + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T HL VMEY +GG+L I ++GRF E ARF+ ++I G+ + H + +RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N LLD +KI DFG K ++ ST GTP YIAPE+L ++Y+ + D
Sbjct: 122 LKLDNVLLDKD--GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV-D 178
Query: 202 VWSCGVTLYVMLVGAYPF--EDPEE 224
WS GV LY ML+G PF ED +E
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 9e-37
Identities = 80/251 (31%), Positives = 114/251 (45%), Gaps = 45/251 (17%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RH 76
D +E+++ IG G FG L+RDK T ++ A+K + + D I N + R +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 77 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
P IV+ F++ HL +VMEY GG+L + F E+ ARF+ +L+ +
Sbjct: 61 PWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDS 116
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------------------------- 167
H + HRD+K +N L+D +K+ DFG K
Sbjct: 117 VHKLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 168 -SSVLHSQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
H Q + STVGTP YIAPEVL Y + D WS GV LY ML G PF
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSD 233
Query: 223 EEPKNFRKTIH 233
+ + K I+
Sbjct: 234 TLQETYNKIIN 244
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-36
Identities = 73/204 (35%), Positives = 108/204 (52%), Gaps = 15/204 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKY---IERGDKIDENVQREIINHRSLRHP 77
++YE++ +G G +GV R+K T E+VA+K E + + + RE+ R LRH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV KE L +V EY EL E + G D R + QL+ ++YCHS
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLL 191
+ HRD+K EN L+ S + LK+CDFG++++ L ++P S V T Y APE+L+
Sbjct: 119 HNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLV 174
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
GK DVW+ G + +L G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-36
Identities = 70/212 (33%), Positives = 111/212 (52%), Gaps = 9/212 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPN 78
+E+ +G+G+FG R+ + K T E A+K +++ + + + + +S L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + ++E+ GGELF + AGRF D A+F+ +L+ Y HS +
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
+RDLK EN LLD +K+ DFG++K + + + GTP Y+APEV+ K + GK
Sbjct: 140 IYRDLKPENLLLDNK--GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGH-GK 194
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D W+ GV LY + G PF D + + K
Sbjct: 195 AVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK 226
|
Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-36
Identities = 72/249 (28%), Positives = 112/249 (44%), Gaps = 39/249 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
++ ++ +G G+ G L+R K T +L A+K +++ + I N ++EI+ +L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATL 58
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 132
HP + T T+L +VM+Y GGELF + SE+ ARF+ +++ + Y
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 133 CHSMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQP 175
H + + +RDLK EN LL S P P K G +SSV
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 176 -----------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
S VGT YIAPEV+ + + D W+ G+ LY ML G PF+
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKGSNR 237
Query: 225 PKNFRKTIH 233
+ F +
Sbjct: 238 DETFSNILK 246
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 6e-36
Identities = 76/205 (37%), Positives = 109/205 (53%), Gaps = 8/205 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+R+K T A+K + + I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L VMEYA+GGELF + F+E+ ARF+ +++S + Y HS V +RD+K
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
LEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNF 228
GV +Y M+ G PF + + + F
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-35
Identities = 73/209 (34%), Positives = 112/209 (53%), Gaps = 10/209 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSLRH-PNIVR 81
IG G FG +R K T + A+K + + + + + +R I+ L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
K T + L +V +Y SGGELF + GRFSED A+F+ +L+ + + H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLK EN LLD + + +CDFG SK+++ ++ +T GT Y+APEVLL ++ K
Sbjct: 121 DLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
D WS GV ++ M G PF + + +R
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQMYR 207
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-35
Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNI 79
Y+ + IG G +GV RDK T E+VA+K I+ + I + REI + L HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
++ +V L +V E+ +L++ I + R E + + QL+ G+++CHS +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLKKEY 195
HRDLK EN L++ LK+ DFG ++S S + V T Y APE+LL +
Sbjct: 120 LHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 196 DGKIADVWSCGVTLYVMLVG 215
D+WS G +L
Sbjct: 176 YSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-35
Identities = 77/205 (37%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T+EL A+K I + D I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK-ILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T L VMEY +GG+L I G+F E A F+ ++ G+ + HS + +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N +LD +KI DFG K ++ + T GTP YIAPE++ + Y GK D
Sbjct: 127 LKLDNVMLDAE--GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 202 VWSCGVTLYVMLVGAYPF--EDPEE 224
W+ GV LY ML G PF ED +E
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-35
Identities = 76/217 (35%), Positives = 114/217 (52%), Gaps = 13/217 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T+E+ A+K +++ D I D++V + R L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T L VMEY +GG+L +I + +F E +RF+ ++ + + H V +RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N LLD K+ DFG K +L+ +T GTP YIAPE+L + EY + D
Sbjct: 122 LKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV-D 178
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH--VMY 236
W+ GV +Y M+ G PFE E F +H V+Y
Sbjct: 179 WWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY 215
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-35
Identities = 75/214 (35%), Positives = 106/214 (49%), Gaps = 17/214 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-----SLRHPNIVRFK 83
IG G+FG L + K AVK +++ + + Q I+ R +L+HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K V + ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
W G LY ML G PF + + + MY
Sbjct: 180 WCLGAVLYEMLYGLPPF--------YSRDVSQMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-35
Identities = 70/195 (35%), Positives = 105/195 (53%), Gaps = 20/195 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQ-REIINHRSLR----H 76
Y++++ +G G FG L R+K+T ELVA+K +++ +E + RE+ +SLR H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 134
PNIV+ KEV L V EY G L++ + FSE R Q++ G+++ H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 192
HRDLK EN L+ S +KI DFG ++ + S+P T V T Y APE+LL+
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172
Query: 193 -KEYDGKIADVWSCG 206
Y + D+W+ G
Sbjct: 173 STSYSSPV-DIWALG 186
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-35
Identities = 74/226 (32%), Positives = 111/226 (49%), Gaps = 21/226 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSLRHPN 78
YE + IG G +G R+KKT ELVA+K I R + E REI + LRHPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPN 59
Query: 79 IVRFKEVILTPTHLAI--VMEYA----SGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
IVR KE++ + +I V EY +G L + +F+E + + + +QL+ G+ Y
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQY 115
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRD+K N L++ LK+ DFG ++ + T V T Y PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 191 L-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235
L Y ++ D+WS G L + +G F+ E + K +
Sbjct: 174 LGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELC 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 9e-35
Identities = 79/209 (37%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIV 80
R +G G+FG L R K++ L AVK +++ D I D++V+ + R L HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ TP L VME+ +GG+L I + RF E ARF+ ++ S + + H + +
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKI 199
RDLKL+N LLD K+ DFG K + + + ST GTP YIAPE+L + Y G
Sbjct: 120 RDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPS 176
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228
D W+ GV LY ML G PFE E F
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-34
Identities = 74/210 (35%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE----------RGDKIDENVQREIINHRSLRHPN 78
IGSG+FG L + + EL+AVK +E R + + + REI + L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV++ L HL I +EY GG + + N G F E R F +Q++ G++Y H+ +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLL 191
HRD+K N L+D +KI DFG SK S+ + S G+ ++APEV+
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ Y K AD+WS G + ML G +PF D
Sbjct: 186 QTSYTRK-ADIWSLGCLVVEMLTGKHPFPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-34
Identities = 76/205 (37%), Positives = 110/205 (53%), Gaps = 8/205 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+R+K + + A+K +++ I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L VMEY +GGELF + FSED RF+ +++S + Y HS ++ +RDLK
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVW 203
LEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNF 228
GV +Y M+ G PF + + K F
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-34
Identities = 68/208 (32%), Positives = 118/208 (56%), Gaps = 15/208 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
+Y V+ IG G+FG A L++ K+ + +K I + K E ++E+ +++HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 135
IV+++E +L IVM+Y GG+L+++I NA R F ED+ +F Q+ + + H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLK 192
++ HRD+K +N L +K+ DFG ++ VL+S ++ +GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGT--IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICEN 175
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ Y+ K +D+W+ G LY M + FE
Sbjct: 176 RPYNNK-SDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-34
Identities = 72/209 (34%), Positives = 106/209 (50%), Gaps = 8/209 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVRFKE 84
IG G+FG +R + T+ + A+K I + + + + R++ P IV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+P L +V+ + +GGELF + GRF ARF+ +L+ + H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVW 203
EN LLD + +CDFG K ++ +T GTP Y+APE+LL Y K D W
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+ GV LY ML G PF D + +RK +
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKIL 206
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-34
Identities = 74/207 (35%), Positives = 113/207 (54%), Gaps = 9/207 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T + A+K +++ + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T +L VMEY +GG+L I + +F A F+ ++I G+ + HS + +RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N LLD +KI DFG K ++L T GTP YIAPE+LL ++Y+ + D
Sbjct: 123 KLDNILLDTD--GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV-DW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFR 229
WS GV LY ML+G PF +E + F+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQ 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-34
Identities = 78/216 (36%), Positives = 118/216 (54%), Gaps = 11/216 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL A+K +++ I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L +I GRF E A F+ ++ G+ + HS + +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K ++ K+ GTP YIAPE++ + Y GK D
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTI--HVMY 236
W+ GV LY ML G PFE +E + F+ + +V Y
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 220
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 7e-34
Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 8/205 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ ++++ +G G++G K+T ++VA+K + + + + + +EI + P I
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
V++ T L IVMEY G + + +I N +E+E Q + G+ Y HS +
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
HRD+K N LL+ K+ DFG S + + ++ + +GTP ++APEV+ + Y+
Sbjct: 120 KIHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 197 GKIADVWSCGVTLYVMLVGAYPFED 221
K AD+WS G+T M G P+ D
Sbjct: 178 NK-ADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 8e-34
Identities = 75/206 (36%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K E AVK +++ ID++V+ ++ R L +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T HL VME+ +GG+L I + GRF A F+ +++ G+ + HS + +RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K +V ST GTP YIAPE+L +Y + D
Sbjct: 123 KLDNVMLDRD--GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV-DW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNF 228
WS GV LY ML+G PF +E + F
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-33
Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHP 77
Y +R +G G FG A L R + + LV K + + E +R+ +N L+HP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHS 135
NI+ + + L I MEYA+GG L+++I F E+ ++ Q++S VSY H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLK 192
+ HRD+K N L + A +K+ DFG SK S ++ + VGTP Y++PE+
Sbjct: 120 AGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQG 175
Query: 193 KEYDGKIADVWSCGVTLYVML 213
+Y+ K +D+W+ G LY +L
Sbjct: 176 VKYNFK-SDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-33
Identities = 66/216 (30%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 24 ELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
L + +G G FG + E VAVK + + D ++ ++ RE R L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 134
PNIV+ V L IVMEY GG+L + R S + F Q+ G+ Y
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEV 189
S HRDL N L+ + +KI DFG Y K + ++APE
Sbjct: 121 SKNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPES 175
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
L + ++ K +DVWS GV L+ + F EEP
Sbjct: 176 LKEGKFTSK-SDVWSFGVLLWEI------FTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 73/197 (37%), Positives = 107/197 (54%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 83
IG G+FG L R K E+ AVK +++ + + ++ I++ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K ++ H+ ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQ--GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPF 219
W G LY ML G PF
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 78/206 (37%), Positives = 111/206 (53%), Gaps = 9/206 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+++K T A+K +++ + + V + +R L RHP + K
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDL 143
T L VMEYA+GGELF + FSED ARF+ +++S + Y HS V +RDL
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
KLEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D
Sbjct: 123 KLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNF 228
W GV +Y M+ G PF + + K F
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-33
Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 24 ELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
L + +G G FG + K + VAVK + + D ++ ++ RE R L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
PN+V+ V L IVMEY GG+L + N + S + F Q+ G+ Y S
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVL 190
HRDL N L+ + +KI DFG Y K + ++APE L
Sbjct: 121 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESL 175
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
+ ++ K +DVWS GV L+ + F E+P
Sbjct: 176 KEGKFTSK-SDVWSFGVLLWEI------FTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-33
Identities = 73/209 (34%), Positives = 110/209 (52%), Gaps = 14/209 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRH--- 76
R EL IG G +G + T +VA+K I D+ ++QRE+ LR
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI ++ L L I+MEYA GG + + AG +E ++++ + Y H +
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK-KE 194
V HRD+K N L+ + +K+CDFG + +S +ST VGTP ++APEV+ + K
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223
YD K AD+WS G+T+Y M G P+ D +
Sbjct: 179 YDTK-ADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-33
Identities = 77/203 (37%), Positives = 104/203 (51%), Gaps = 30/203 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ-------REIINHRS 73
D YE + I G +GV RDKKT E+VA+K + K+++ + REI
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60
Query: 74 LRHPNIVRFKEVIL--TPTHLAIVMEYASGGE-----LFERICNAGRFSEDEARFFFQQL 126
L+HPNIV KEV++ + +VMEY E L E + F + E + QL
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQL 115
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAY 184
+SGV++ H + HRDLK N LL + LKICDFG ++ S L + V T Y
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172
Query: 185 IAPEVLL-KKEYDGKIADVWSCG 206
APE+LL KEY I D+WS G
Sbjct: 173 RAPELLLGAKEYSTAI-DMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 6e-33
Identities = 73/207 (35%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL A+K +++ I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L I G+F E +A F+ ++ G+ + H + +RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K ++ T GTP YIAPE++ + Y GK D
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFR 229
W+ GV LY ML G PF+ +E + F+
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 8e-33
Identities = 75/228 (32%), Positives = 114/228 (50%), Gaps = 29/228 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
+ +E ++ I +G +G L+R K+T + A+K I + + I N V+R+I+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
+P +V T HL +VMEY GG+ + N G D AR +F + + + Y H
Sbjct: 60 -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKST 178
+ + HRDLK +N L+ + +K+ DFG SK ++ K
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEE 224
GTP YIAPEV+L++ Y GK D W+ G+ LY LVG PF + PEE
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-33
Identities = 66/202 (32%), Positives = 100/202 (49%), Gaps = 8/202 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVK---YIERGDKIDENVQ---REIINHRSLRHPNIVRF 82
+GSG+FG + + AVK + G E V+ +EI L+HPNIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
+L I +E GG L + + G F E R + +Q++ G+ Y H HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
+K N L+D + +K+ DFG +K V S KS G+P ++APEV+ ++ G AD+
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 203 WSCGVTLYVMLVGAYPFEDPEE 224
WS G T+ M G P+ E
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEG 207
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 73/216 (33%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRHPN 78
RYEL++ IGSG +GV DK+T VA+K I D ID + + REI R LRH N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 79 IVRFKEVILTPT-----HLAIVMEYA---------SGGELFERICNAGRFSEDEARFFFQ 124
I+ +++ P+ + IV E S L ++D ++F
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQYFLY 110
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VG 180
Q++ G+ Y HS V HRDLK N L++ + LKICDFG ++ K V
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 181 TPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
T Y APE+LL Y I D+WS G +L
Sbjct: 169 TRWYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 78/262 (29%), Positives = 120/262 (45%), Gaps = 58/262 (22%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLR---- 75
D +E ++ IG G FG RL++ K T + A+K + + + + ++E + H R+ R
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML----EKEQVAHVRAERDILA 56
Query: 76 ---HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+P +V+ +L ++MEY GG++ + F+E+E RF+ + I +
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 171
H + HRD+K +N LLD +K+ DFG
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAK--GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 172 HSQPK------------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
S+P STVGTP YIAPEV L+ Y K D WS GV +Y ML
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEML 233
Query: 214 VGAYPF--EDPEEPKNFRKTIH 233
VG PF ++P+E +RK I+
Sbjct: 234 VGYPPFCSDNPQE--TYRKIIN 253
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 75/207 (36%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 22 RYELVRDIGSGNFG-VARLMR--DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+++++ +G G++G V ++ R D + L V K E+ EI S+ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
I+ +KE L L IVMEYA G+L + I + E E F QL+ G+ H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKK 193
++ HRDLK N LL +KI D G SK VL K+ +GTP Y+APEV +
Sbjct: 121 EQKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE 220
Y K +D+WS G LY M A PFE
Sbjct: 177 PYSYK-SDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-32
Identities = 72/207 (34%), Positives = 115/207 (55%), Gaps = 14/207 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
+Y ++R +G G+FG A L++ +++ A+K I + E+ ++E + ++HPNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
V FKE HL IVMEY GG+L ++I G+ F ED +F Q+ GV + H +
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLKK 193
V HRD+K +N L + ++K+ DFG S+ L + P + VGTP Y+ PE+
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE 220
Y+ K +D+WS G LY + +PF+
Sbjct: 176 PYNNK-SDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-31
Identities = 72/211 (34%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-----------VQREIINHRSLRHP 77
IG G +G L + T E++AVK +E I ++ EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV++ T +L+I +EY GG + + GRF E RFF +Q++ G++Y HS
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LLK 192
+ HRDLK +N L+D KI DFG SK S + Q S G+ ++APEV
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ Y K+ D+WS G + M G P+ D E
Sbjct: 187 QGYSAKV-DIWSLGCVVLEMFAGRRPWSDEE 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-31
Identities = 75/210 (35%), Positives = 112/210 (53%), Gaps = 18/210 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
RYE+++ IG G+FG L + K E +K I + K E ++E+I ++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 135
IV F L IVMEY GG+L +RI N R FSED+ +F Q+ G+ + H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 136 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 190
++ HRD+K +N L +G A K+ DFG ++ L+ + VGTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC 174
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ Y+ K D+WS G LY + +PFE
Sbjct: 175 QNRPYNNK-TDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-31
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDEN----VQREIINHRSLRHPNIVRF 82
+G G FG L D T +AVK + + ++ EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
+ L+I MEY GG + +++ G +E R + +Q++ GV Y HS + HRD
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGK 198
+K N L D A +K+ DFG SK + S KS GTP +++PEV+ + Y G+
Sbjct: 130 IKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GR 186
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPE 223
ADVWS G T+ ML P+ + E
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEFE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLRHPN 78
E + ++G+GN GV + + T +++AVK I I+E +Q++I I H+ P
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC-NSPY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS- 135
IV F ++I MEY GG L + GR E ++ G++Y H
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ ++K+CDFG S V +S K+ VGT +Y+APE + +Y
Sbjct: 120 HKIIHRDVKPSNILVNSR--GQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDY 176
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
K +D+WS G++L + G +P+ +P
Sbjct: 177 SVK-SDIWSLGLSLIELATGRFPYPPENDP 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-31
Identities = 73/223 (32%), Positives = 115/223 (51%), Gaps = 15/223 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
+E++ IG G+FGV + K + + A+K I+ K++ + E I+ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHSM 136
I+R+ E L L IVMEYA G+L + + GR ED+ FF Q++ G+++ HS
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 193
++ HRD+K N LD +KI D G +K +L + VGTP Y++PE+ K
Sbjct: 121 KILHRDIKSLNLFLDAY--DNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
Y+ K +DVW+ GV LY G +PF+ + K I ++
Sbjct: 177 PYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF 218
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 3e-31
Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 17/214 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 83
IG G+FG L + K + AVK +++ ++ Q+ I+ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V+++ +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K + S +T GTP Y+APEV+ K+ YD + D
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV-DW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
W G LY ML G PF + + + MY
Sbjct: 180 WCLGAVLYEMLYGLPPF--------YCRDVAEMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 71/213 (33%), Positives = 113/213 (53%), Gaps = 20/213 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRS 73
++ +++++ IG G FG +L+R K ++++ A+K + + + I + +R+I+ H +
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
IV+ +L +VMEY GG+L + N E ARF+ +++ +
Sbjct: 102 --SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAI 158
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEV 189
HSM HRD+K +N LLD S LK+ DFG + ++ + VGTP YI+PEV
Sbjct: 159 HSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEV 214
Query: 190 LLKKEYD---GKIADVWSCGVTLYVMLVGAYPF 219
L + D G+ D WS GV LY MLVG PF
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-30
Identities = 65/201 (32%), Positives = 113/201 (56%), Gaps = 14/201 (6%)
Query: 29 IGSGNFGVARLMRDKKTEE---LVAVKYIERG-----DKIDENVQREIINHRSLRHPNIV 80
+G G+FG L+R + L A+K +++ D++ ++R+I+ + HP IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHPFIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ T L +++++ GG+LF R+ F+E++ +F+ +L + + HS+ + +
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKI 199
RDLK EN LLD +K+ DFG SK S+ H + S GT Y+APEV+ ++ + +
Sbjct: 122 RDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QS 178
Query: 200 ADVWSCGVTLYVMLVGAYPFE 220
AD WS GV ++ ML G+ PF+
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 6e-30
Identities = 61/211 (28%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
+G G FG +L VAVK ++ +E +E + L HPN+VR
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 84 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GVSYCH 134
V L +V+EY GG+L + R S +++ + L+S G+ Y
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLL 191
S + HRDL N L+ +KI DFG S+ + G I APE L
Sbjct: 123 SKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS GV L+ + +GA P+
Sbjct: 181 DGIFTSK-SDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 72/230 (31%), Positives = 110/230 (47%), Gaps = 42/230 (18%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---- 75
+ +ELV IG G +G R KKT +LVA+K ++ + +E ++ E LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSN 61
Query: 76 HPNIVRFKEVILTPTH------LAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQ 125
HPNI F + L +VME GG +L + + G R E+ + ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 126 LISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST----- 178
+ G++Y H +V HRD+K +N LL + +K+ DFG S +Q ST
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFGVS------AQLDSTLGRRN 171
Query: 179 --VGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
+GTP ++APEV+ E YD + +DVWS G+T + G P D
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-29
Identities = 73/253 (28%), Positives = 120/253 (47%), Gaps = 40/253 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSL 74
+++ +G G+FG +++R+K T ++ A+K +++ + + +R+I++ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 133
P I + + +L +VMEY GG+L + +F ED A+F+ +L+ +
Sbjct: 60 -SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL 191
H M HRD+K EN L+D + +K+ DFG + ++ K VGTP YIAPEVL
Sbjct: 119 HQMGYVHRDIKPENVLIDRT--GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 192 KKEYDGKIA-----DVWSCGVTLYVMLVGAYPFED-------------------PEEPK- 226
DGK D WS GV Y M+ G PF + PE+PK
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236
Query: 227 --NFRKTIHVMYC 237
+F I + C
Sbjct: 237 SSDFLDLIQSLLC 249
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-29
Identities = 74/204 (36%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRHPN 78
+E + IG G +G+ RD + E+VA+K + ER D I + REI +LRHPN
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPN 67
Query: 79 IVRFKEVILTPTHLA---IVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYC 133
IV KEV+ HL +VMEY L + + FSE + + QL+ G+ Y
Sbjct: 68 IVELKEVV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYL 124
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLL- 191
H + HRDLK+ N LL LKI DFG +++ L ++P + V T Y APE+LL
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
Y I D+W+ G L +L
Sbjct: 183 CTTYTTAI-DMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-29
Identities = 69/200 (34%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
++ V IG G +GV R+K T E+VA+K I R D E V REI + L HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ +VI T L +V E+ + F + + QL+ G+++CHS +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLKK 193
V HRDLK +N L++ A +K+ DFG +++ + P T V T Y APE+LL
Sbjct: 121 VLHRDLKPQNLLINTEGA--IKLADFGLARAFGV---PVRTYTHEVVTLWYRAPEILLGC 175
Query: 194 EYDGKIADVWSCGVTLYVML 213
+Y D+WS G M+
Sbjct: 176 KYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-29
Identities = 77/271 (28%), Positives = 113/271 (41%), Gaps = 61/271 (22%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRH 76
+ ++ IG G FG L+R T L A+K + + D + N +R+I+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--N 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ +L VM+Y GG++ + G F ED ARF+ +L + H M
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK---------------S 168
HRD+K +N L+D +K+ DFG Y K S
Sbjct: 121 GFIHRDIKPDNILIDRD--GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 169 SVLHSQPK----------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212
+ + K S VGTP YIAPEVLL+ Y ++ D WS GV LY M
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 237
Query: 213 LVGAYPFEDPE------EPKNFRKTIHVMYC 237
LVG PF + N+ T+H+
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQ 268
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-29
Identities = 71/221 (32%), Positives = 111/221 (50%), Gaps = 21/221 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + DK T VAVK ++ R + E + E++ R +HPNIV L
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +S+ H+ V HRD+K ++
Sbjct: 87 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDS 145
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y G D+WS
Sbjct: 146 ILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 200
Query: 205 CGVTLYVMLVGAYP-FEDP----------EEPKNFRKTIHV 234
G+ + M+ G P F +P P + V
Sbjct: 201 LGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKV 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-29
Identities = 69/204 (33%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKIDEN------VQREIINHRSLR 75
+ +R +G+G+FG L K + VA+K E+ I + +R+I+N+ +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY--IN 89
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HP V ++L +V+E+ GGE F + RF D F+ Q++ Y S
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ + +RDLK EN LLD +K+ DFG++K V+ ++ + GTP YIAPE+LL +
Sbjct: 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNVGH 205
Query: 196 DGKIADVWSCGVTLYVMLVGAYPF 219
GK AD W+ G+ +Y +LVG PF
Sbjct: 206 -GKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 8e-29
Identities = 66/230 (28%), Positives = 98/230 (42%), Gaps = 22/230 (9%)
Query: 24 ELVRDIGSGNFGV---ARL-MRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
EL + +G G FG L + TE VAVK ++ G ++ E E + L HP
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIVR V L IV EY GG+L F R + + + + Q+ G+ Y S
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 190
HRDL N L+ + +KI DFG S+ ++ + APE L
Sbjct: 121 KNFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED--PEEPKNFRKTIHVMYC 237
++ K +DVWS GV L+ + +G P+ EE + + +
Sbjct: 177 KDGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR 225
|
Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 16/210 (7%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGD-----KIDENV--QREIINHR 72
+EL+R +G+G +G L+R +L A+K +++ K E+ +R+++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
R P +V T T L ++++Y +GGELF + F+E E R + +++ + +
Sbjct: 62 R-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APEV+
Sbjct: 121 LHQLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 191 LKKEYD-GKIADVWSCGVTLYVMLVGAYPF 219
K D WS GV + +L GA PF
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--------HP 77
++ I G FG L + + T + A+K +++ D I +N ++ N ++ R P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN---QVTNVKAERAIMMIQGESP 57
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + + +L +VMEY +GG+ I G ED A+ + +++ GV H
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K EN L+D LK+ DFG S++ + K VGTP Y+APE +L D
Sbjct: 118 IIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DD 171
Query: 198 KIADVWSCGVTLYVMLVGAYPFE 220
K++D WS G ++ L G PF
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 81
+G+G F RD KT L+AVK + +++ E +++EI L HP+I+R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
+H + +E+ +GG + + G F E + +QL+ G+SY H Q+ HR
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLLKKE 194
D+K N L+D S RL+I DFG ++ L ++ +GT A++APEVL ++
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
Y G+ DVWS G + M P+
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-28
Identities = 70/201 (34%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 18 HDSD-RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----R 72
D + + +R+IG G+FG RD +T E+VA+K + K ++II +
Sbjct: 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV 130
LRHPN + +K L +VMEY S ++ E + E E + G+
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGL 128
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+Y HS + HRD+K N LL + +K+ DFG S+ L S S VGTP ++APEV+
Sbjct: 129 AYLHSHERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVI 183
Query: 191 L---KKEYDGKIADVWSCGVT 208
L + +YDGK DVWS G+T
Sbjct: 184 LAMDEGQYDGK-VDVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-28
Identities = 67/209 (32%), Positives = 112/209 (53%), Gaps = 15/209 (7%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERG-----DKIDENV--QREIINHR 72
+EL++ +G+G +G L+R T +L A+K +++ K E+ +R ++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ P +V T L ++++Y SGGE+F + FSEDE RF+ ++I + +
Sbjct: 62 R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APE++
Sbjct: 121 LHKLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
K GK D WS G+ ++ +L GA PF
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-28
Identities = 67/206 (32%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRSLRHPNIVRF 82
+G G FG + K T ++ A K ++ R + +++I+ S R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCH 140
T L +VM +GG+L I N G F E A F+ Q+I G+ + H ++ +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLK EN LLD R I D G + + K GTP Y+APEVL + YD
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-V 175
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPK 226
D ++ G TLY M+ G PF +E
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKV 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-28
Identities = 75/210 (35%), Positives = 105/210 (50%), Gaps = 15/210 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD-KIDENVQREIINH--RSLR 75
RY L + +G G+FG L++DKK E L +K I G+ +E VQ L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 131
HP IV+F L I+ EY G +L ++ SE++ +F QL+ GV
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
Y H ++ HRDLK +N L + LKI DFG S+ + +T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ YD K +D+WS G LY M A+ FE
Sbjct: 178 KHQGYDSK-SDIWSLGCILYEMCCLAHAFE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-28
Identities = 74/226 (32%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
D YEL+ IG G V E VA+K I+ +K +V +E+ HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCNHP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCH 134
N+V++ + L +VM Y SGG L + G E ++++ G+ Y H
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 135 SMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAP 187
S HRD+K N LL DGS +KI DFG S S K+ VGTP ++AP
Sbjct: 120 SNGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 188 EVL-LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
EV+ YD K AD+WS G+T + GA P+ K T+
Sbjct: 176 EVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTL 220
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-28
Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 9/205 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
+G G +G+ RD T+ +A+K I ER + + + EI H L+H NIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 88 TPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 145 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIAD 201
+N L++ + + +KI DFG SK + ++ ++ GT Y+APEV+ K + Y G AD
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPAD 193
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPK 226
+WS G T+ M G PF + EP+
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQ 218
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-28
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
D +E++ ++G G FG + K+T A K I+ + D V+ +I++ +HP
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKHP 62
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
NIV E L I++E+ GG L + R +E + R+ +Q++ +++ HS
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-- 191
+V HRDLK N LL DG +K+ DFG S + Q + T +GTP ++APEV+
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 192 ---KKEYDGKIADVWSCGVTLYVM 212
YD K AD+WS G+TL +
Sbjct: 179 TFKDNPYDYK-ADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-27
Identities = 70/203 (34%), Positives = 111/203 (54%), Gaps = 16/203 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D+YE V IG G +GV RD+ T E +A+K I R ++ DE V REI + ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQQLISGVSYCH 134
NIVR ++V+ + L +V EY +L + + ++ F+++ + + Q++ G++YCH
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVL 190
S +V HRDLK +N L+D LK+ DFG +++ + P T V T Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI---PVRTFTHEVVTLWYRAPEIL 175
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
L + D+WS G M+
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVK--YIERGDKIDENVQREIINHRSLRHPNIVR 81
E V IGSG G + + T L A+K Y D + + REI R + HPN+V+
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
++ + +++E+ GG L +F D AR Q++SG++Y H + HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV----LLKKEYD 196
D+K N L++ A +KI DFG S+ P S+VGT AY++PE L YD
Sbjct: 193 DIKPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250
Query: 197 GKIADVWSCGVTLYVMLVGAYPF 219
G D+WS GV++ +G +PF
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 64/200 (32%), Positives = 104/200 (52%), Gaps = 9/200 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREI-INHRSLRHPNIVR 81
R IG G++ L+ KKT + A+K I++ D+ VQ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L V+E+ SGG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++Y +
Sbjct: 121 DLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV- 177
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 66/206 (32%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSLR-- 75
YE + +IG G +G RD T VA+K + E G I + REI + L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58
Query: 76 -HPNIVRFKEVILTP-----THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLIS 128
HPNIVR +V P L +V E+ + C + + +QL+
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 129 GVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
GV + HS ++ HRDLK +N L+ DG ++KI DFG ++ S V T Y A
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLWYRA 174
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVM 212
PEVLL+ Y + D+WS G +
Sbjct: 175 PEVLLQSSYATPV-DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-27
Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKY-IERGDKIDE-NVQREIINHRSLR-HPNI 79
Y+++ IG G F + +KT + A+K + +++ N REI R L HPNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 80 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
+R EV+ LA+V E L+E I R E + + QL+ + + H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 194
+ HRD+K EN L+ LK+ DFG + ++S+P T + T Y APE LL
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 195 YDGKIADVWSCGVTLYVML 213
Y G D+W+ G + +L
Sbjct: 175 YYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-27
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLR 75
RYE + +G G + V RDK+T +VA+K I+ G++ I+ REI + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
HPNI+ +V +++ +V E+ +L E++ + + + + + G+ Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEV 189
HS + HRDLK N L+ LK+ DFG ++S P V T Y APE+
Sbjct: 119 HSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPEL 173
Query: 190 LLKKEYDGKIADVWSCGV 207
L + G D+WS G
Sbjct: 174 LFGARHYGVGVDMWSVGC 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 68/196 (34%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+++E++ +G G +GV R K+T+E+VA+K E +++ E RE+ R+L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV KE L +V EY EL E + N ++ R + QLI + +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHK 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 193
+ HRD+K EN L+ S LK+CDFG++++ S T V T Y +PE+LL
Sbjct: 119 NDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 194 EYDGKIADVWSCGVTL 209
Y GK D+WS G L
Sbjct: 177 PY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-27
Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 17/194 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
Y+ V IG G +GV RDK T E+VA+K I R + DE V REI + L HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 136
IVR +V+ + L +V E+ +L + + ++ D + QL+ G++YCHS
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK 192
+V HRDLK +N L+D A LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLG 173
Query: 193 KEYDGKIADVWSCG 206
D+WS G
Sbjct: 174 SRQYSTPVDIWSIG 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-27
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHP 77
RY+ + +IGSG +GV D ++ + VA+K I + +R E+ R +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 78 NIVRFKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
NI+ ++++ P + +VM+ +L I + +E+ R+F QL+ G+ Y
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ-PKSTVGTPAYIAPE 188
HS V HRDLK N L++ L+I DFG S S H V T Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVML 213
+LL EY I D+WS G ML
Sbjct: 182 LLLSLPEYTTAI-DMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-27
Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIIN 70
D+ + + +EL++ IGSG +G R+ T EL A+K I E G+ VQ+EII
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIM 59
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ +H NIV + L L I ME+ GG L + G SE + + ++ + G+
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEV 189
Y HS HRD+K N LL + +K+ DFG S + ++ KS +GTP ++APEV
Sbjct: 120 YYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
Query: 190 LLKKEYDG--KIADVWSCGVT 208
+ G ++ D+W+ G+T
Sbjct: 178 AAVERKGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-27
Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K + + E + EI+ R +HPNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 138
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 198 KIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHP 77
+YE + IG G +G ++++T E+VA+K + R D DE V REI + L+H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHS 135
NIVR +V+ + L +V EY + ++ ++ G + + F QL+ G+++CHS
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KK 193
V HRDLK +N L++ + LK+ DFG +++ + + V T Y P+VL K
Sbjct: 118 HNVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYP 218
Y I D+WS G + P
Sbjct: 176 LYSTSI-DMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-26
Identities = 85/257 (33%), Positives = 124/257 (48%), Gaps = 42/257 (16%)
Query: 14 MPIMHDS-----DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQR- 66
MP +D + YE+++ IG+G FG L++ K+T+E K I RG K E Q
Sbjct: 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60
Query: 67 -EIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNA----GRFSEDEA 119
E+ R L+H NIVR+ + L + L I+ME+ G+L I G+ E
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 120 RFFFQQLISGVSYCHSMQ-------VCHRDLKLENTLLDG---------------SPAPR 157
+QL+ ++YCH+++ V HRDLK +N L + P
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVG 215
KI DFG SK+ + S S VGTP Y +PE+LL K YD K +D+W+ G +Y + G
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSG 239
Query: 216 AYPFEDPEEPKNFRKTI 232
PF + NF + I
Sbjct: 240 KTPF---HKANNFSQLI 253
|
Length = 1021 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 71/215 (33%), Positives = 107/215 (49%), Gaps = 20/215 (9%)
Query: 29 IGSGNFG---VARLMRDKKTEELVAVKYIERG-------DKIDENVQREIINHRSLRHPN 78
+G G +G R + T ++ A+K +++ D +R I+ +++HP
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNIL--EAVKHPF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV T L +++EY SGGELF + G F ED A F+ ++ + + H +
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
+RDLK EN LLD +K+ DFG K S+ T GT Y+APE+L++ + G
Sbjct: 122 IYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
K D WS G +Y ML GA PF +N +KTI
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPF----TAENRKKTI 209
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + AG F E + ++++ G+ Y HS + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDGKIADVWS 204
N LL S +K+ DFG + + +Q K + VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWS 186
Query: 205 CGVTLYVMLVGAYPFED 221
G+T + G P D
Sbjct: 187 LGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-26
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
++ + +G G G R K T + A+K I + + + RE+ ++S + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 79 IVRFKEVILTP--THLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVS 131
IV++ L + + I MEY GG L + I GR E + ++ G+S
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y HS ++ HRD+K N LL +K+CDFG S V S + GT Y+APE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQ 176
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
K Y +DVWS G+TL + +PF EP
Sbjct: 177 GKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEP 209
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-26
Identities = 65/200 (32%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 81
R IG G++ L+R KKTE + A+K +++ + ID + + ++ HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L V+EY +GG+L + + E+ ARF+ ++ ++Y H + +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++Y G
Sbjct: 121 DLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 7e-26
Identities = 74/211 (35%), Positives = 109/211 (51%), Gaps = 16/211 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
++ YE+V+ IG G FG +L+R K T ++ A+K + + + I + R +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P +V+ +L +VMEY GG+L + N E ARF+ +++ + HS
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 160
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
M HRD+K +N LLD S LK+ DFG +K ++ + VGTP YI+PEVL
Sbjct: 161 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 216
Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPF 219
+ Y G+ D WS GV LY MLVG PF
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-26
Identities = 62/200 (31%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 81
R IG G++ L+R KK +++ A+K +++ + ID + + ++ +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L +V+EY +GG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +EY G
Sbjct: 121 DLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 68/211 (32%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
++ Y++V+ IG G FG +L+R K ++++ A+K + + + I + R +
Sbjct: 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P +V+ +L +VMEY GG+L + N E A+F+ +++ + HS
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 160
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
M + HRD+K +N LLD LK+ DFG ++ ++ + VGTP YI+PEVL
Sbjct: 161 MGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLK 216
Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPF 219
+ Y G+ D WS GV L+ MLVG PF
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-25
Identities = 67/191 (35%), Positives = 104/191 (54%), Gaps = 8/191 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
YEL++ +GSG +G R+ T EL AVK I E GD +Q+EI + +H NIV
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIV 69
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L+ L I MEY GG L + G SE + + ++ + G++Y HS H
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG-- 197
RD+K N LL + +K+ DFG +K + ++ KS +GTP ++APEV ++ G
Sbjct: 130 RDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 198 KIADVWSCGVT 208
++ D+W+ G+T
Sbjct: 188 QLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRHPN 78
++ + +G G + R++ T E+VA+K I E G REI + L+H N
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHEN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IVR +VI T L +V EY + + G + + F QL+ G+++CH
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KKE 194
+V HRDLK +N L++ LK+ DFG +++ + + + V T Y AP+VLL +
Sbjct: 120 RVLHRDLKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 195 YDGKIADVWSCGVTLYVMLVG 215
Y I D+WS G + M+ G
Sbjct: 178 YSTSI-DIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 5e-25
Identities = 68/196 (34%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+E+VA+K I+ + DE ++Q+EI P I R+
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + G E ++++ G+ Y HS + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSC 205
N LL S +K+ DFG + ++T VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSL 187
Query: 206 GVTLYVMLVGAYPFED 221
G+T + G P D
Sbjct: 188 GITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 5e-25
Identities = 75/209 (35%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D+++++ IG G +G RDK T ELVA+K + R D E REI R L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNH 65
Query: 77 PNIVRFKEVILTPTHLA-----------IVMEYASG---GELFERICNAGRFSEDEARFF 122
NIV KE I+T A +V EY G L + + FSED + F
Sbjct: 66 RNIVNLKE-IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSF 121
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VG 180
+QL+ G++YCH HRD+K N LL+ ++K+ DFG ++ T V
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNK--GQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTL 209
T Y PE+LL +E G DVWSCG L
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 7e-25
Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 25 LVRDIGSGNFGVARLMR----DKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
++ +G G+FG L R T E VAVK + ++ + +REI R+L H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 79 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
IV++K V P L ++MEY G L + + + + + F Q+ G+ Y S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA-YIAPEVLL 191
+ HRDL N L++ +KI DFG +K K +P + APE L
Sbjct: 128 QRYIHRDLAARNILVESE--DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
++ +DVWS GVTLY + P + P P F + I
Sbjct: 186 TSKFSSA-SDVWSFGVTLYELFTYGDPSQSP--PAEFLRMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-24
Identities = 68/225 (30%), Positives = 116/225 (51%), Gaps = 24/225 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + R+K + VAVK ++ R + E + E++ R +H N+V + L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L ++ME+ GG L + I + R +E++ + ++ + Y HS V HRD+K ++
Sbjct: 89 VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147
Query: 148 TL--LDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
L LDG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y ++ D+WS
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV-DIWS 202
Query: 205 CGVTLYVMLVGAYPF--------------EDPEEPKNFRKTIHVM 235
G+ + M+ G P+ P + KN K V+
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVL 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-24
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + G E + ++++ G+ Y HS + HRD+K
Sbjct: 72 LKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKIADVWS 204
N LL S +K+ DFG + + +Q K VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWS 186
Query: 205 CGVTLYVMLVGAYPFED 221
G+T + G P +
Sbjct: 187 LGITAIELAKGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-24
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---- 65
+ P + +YE + IG G FG R KKT+++VA+K + + EN +
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFP 55
Query: 66 ----REIINHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAG- 112
REI + L+H N+V E+ T +V E+ +L + N
Sbjct: 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNV 114
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSV 170
+F+ E + + L++G+ Y H ++ HRD+K N L+ DG LK+ DFG +++
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFS 170
Query: 171 LHSQPKST-----VGTPAYIAPEVLLKKEYDGKIADVWSCG 206
L K V T Y PE+LL + G D+W G
Sbjct: 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-24
Identities = 67/192 (34%), Positives = 102/192 (53%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
+R+IG G+FG RD +T E+VA+K + K ++II + ++HPN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+K L +VMEY S +L E + E E + G++Y HS +
Sbjct: 90 YKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL + ++K+ DFG S+ + S S VGTP ++APEV+L + +YD
Sbjct: 148 HRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYD 202
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 203 GKV-DVWSLGIT 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-24
Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
+R+IG G+FG RD + E+VA+K + K ++II + LRHPN ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
++ L +VMEY S +L E + E E + G++Y HS +
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL S +K+ DFG S+ + + VGTP ++APEV+L + +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 193 GKV-DVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-24
Identities = 70/215 (32%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 23 YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI------------ERGDKIDENVQREII 69
Y ++ +GSG FG V ++ + + L+A+K I ER I + V I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQ 125
LRHPNIVR+ + L L IVM+ G L E + RF+E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 126 LISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
++ + Y H ++ HRDL N +L ++ I DFG +K S+ S VGT Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
PE++ + Y G+ ADVW+ G LY M PF
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-24
Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 18/211 (8%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGDKIDE-------NVQREIINHR 72
+EL++ +G+G +G L+R + +L A+K +++ + + +R+++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ P +V T T L ++++Y +GGELF + RF E E + + +++ + +
Sbjct: 62 R-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + + DFG SK + S GT Y+AP+++
Sbjct: 121 LHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 191 LKKE--YDGKIADVWSCGVTLYVMLVGAYPF 219
+ +D K D WS GV +Y +L GA PF
Sbjct: 179 RGGDGGHD-KAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-24
Identities = 70/255 (27%), Positives = 116/255 (45%), Gaps = 47/255 (18%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-- 78
D +E ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ +L ++ME+ GG++ + SE+ +F+ + + + H +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK--------- 176
HRD+K +N LLD +K+ DFG ++ H+ P
Sbjct: 121 GFIHRDIKPDNLLLDAK--GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 177 ----------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF- 219
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237
Query: 220 -EDPEEPKNFRKTIH 233
E P+E +RK ++
Sbjct: 238 SETPQE--TYRKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 4e-24
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 81
+G G +G +L+AVK +E +K E +Q E+ +SL+H NIV+
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
+ L ++I ME+ GG + + G E + +Q++ GV+Y H+ V HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEVLLKKE 194
D+K N +L P +K+ DFG ++ HS KS GTP ++APEV+ +
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
Y G+ +D+WS G T++ M G P
Sbjct: 185 Y-GRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-24
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDK--IDENVQREIINHRSLRHP 77
++YE + IG G++GV R+++T ++VA+K ++E D I + REI + L+HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
N+V EV L +V EY L E N E + Q + V++CH
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLKKE 194
HRD+K EN L+ + ++K+CDFG+++ +L V T Y APE+L+
Sbjct: 121 CIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 195 YDGKIADVWSCGVTLYVMLVG 215
G DVW+ G +L G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 7e-24
Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K + + E + EI+ R ++PNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIH 138
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 198 KIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-24
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDKIDENVQ----REIINHRSLR 75
++YE + +G G++G+ + K+T ++VA+K ++E D D+ V+ REI + LR
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H N+V EV L +V E+ L E+ N E R + Q++ G+ +C
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFC 116
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 191
HS + HRD+K EN L+ S + +K+CDFG+++ ++ T V T Y APE+L+
Sbjct: 117 HSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLV 173
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
G+ D+W+ G + ML G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 8e-24
Identities = 65/207 (31%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHP 77
RY+ + IG G +G+ K T VA+K I + + REI R +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYC 133
NI+ + I+ P + EL E ++ S D ++F Q++ G+ Y
Sbjct: 64 NIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 189
HS V HRDLK N LL+ LKICDFG ++ + V T Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 190 LLK-KEYDGKIADVWSCGVTLYVMLVG 215
+L K Y I D+WS G L ML
Sbjct: 181 MLNSKGYTKAI-DIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-23
Identities = 71/209 (33%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K I + E + EI+ + L++PNIV
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQV 138
F + L L +VMEY +GG L + + DEA+ ++ + + + H+ QV
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQV 136
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 137 IHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 196 DGKIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 193 GPKV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-23
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 14/210 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRH 76
++RY ++ +G G FG+ RD+ T + VA+K I + + + RE+ + LRH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 77 PNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NI+ ++ ++P + V E G R+ + + ++F Q++ G+ Y HS
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS 126
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KE 194
V HRDLK N L++ + LKICDFG ++ + Q V T Y APE++L ++
Sbjct: 127 AGVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 195 YDGKIADVWSCGVTLYVMLVGA--YPFEDP 222
YD ++ D+WS G ML G +P +D
Sbjct: 183 YDVEV-DIWSAGCIFAEMLEGKPLFPGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-23
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
+++ + IG G F V +VA+K ++ + +D ++ +EI + L H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 132
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 187
HS ++ HRD+K N + + +K+ D G SK++ HS VGTP Y++P
Sbjct: 122 MHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSP 175
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
E + + Y+ K +D+WS G LY M PF
Sbjct: 176 ERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-23
Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNI 79
+ +E++ ++G G FG ++K+T L A K I+ + ++ E+ EI S HPNI
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
V+ + +L I++E+ +GG + + R +E + R +Q + ++Y H ++
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 139 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL---- 191
HRDLK N L LDG +K+ DFG S + Q + S +GTP ++APEV++
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 192 -KKEYDGKIADVWSCGVTLYVM 212
+ YD K ADVWS G+TL M
Sbjct: 181 KDRPYDYK-ADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-23
Identities = 67/192 (34%), Positives = 101/192 (52%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQ---REIINHRSLRHPNIVR 81
+ +IG G+FG + T E+VAVK + G + +E Q +E+ + L+HPN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+K L +VMEY S +L E + E E + G++Y HS +
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL + ++K+ DFG S+ S S VGTP ++APEV+L + +YD
Sbjct: 144 HRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 199 GKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-23
Identities = 70/207 (33%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI------ERGDKIDENVQREIINHRSLRHPNIVRF 82
+G G FG L D T +AVK + + K ++ EI ++LRH IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 83 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ P L+I +EY GG + +++ G +E+ R + +Q++ GVSY HS + H
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 196
RD+K N L D A +K+ DFG SK ++ S KS GTP +++PEV+ + Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY- 186
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPE 223
G+ ADVWS T+ ML P+ + E
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 2e-23
Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA++ + + E + EI+ R ++PNIV
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ ++ + S+ + VGTP ++APEV+ +K Y
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-23
Identities = 70/256 (27%), Positives = 117/256 (45%), Gaps = 49/256 (19%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN---- 78
+E ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+ +L ++ME+ GG++ + +E+E +F+ + + + H +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK----------- 176
HRD+K +N LLD +K+ DFG ++ HS P
Sbjct: 123 IHRDIKPDNLLLDSK--GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 177 --------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--E 220
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 221 DPEEP----KNFRKTI 232
P+E N+++T+
Sbjct: 240 TPQETYKKVMNWKETL 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-23
Identities = 68/213 (31%), Positives = 110/213 (51%), Gaps = 15/213 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR------EIINHRSLRH 76
+ L + +G G FG L D T +AVK ++ + E + EI ++L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 77 PNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
IV++ + P L+I ME+ GG + +++ + G +E+ R + +Q++ GVSY H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVL 190
S + HRD+K N L D +K+ DFG SK + + KS GTP +++PEV+
Sbjct: 124 SNMIVHRDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ Y G+ AD+WS G T+ ML P+ + E
Sbjct: 182 SGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-23
Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 15/203 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
++ +E++ ++G G FG ++K+T L A K IE + + E+ EI + HP
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV+ L I++E+ GG + + R +E + + +Q++ + Y HSM+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL--- 191
+ HRDLK N LL DG +K+ DFG S +V Q + S +GTP ++APEV++
Sbjct: 131 IIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 192 --KKEYDGKIADVWSCGVTLYVM 212
YD K AD+WS G+TL M
Sbjct: 187 MKDTPYDYK-ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 7e-23
Identities = 71/196 (36%), Positives = 103/196 (52%), Gaps = 16/196 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKID-ENVQREIINHRSLRHPN 78
+Y ++ IG G +G+ ++ +T E VA+K I ++ID + REI R L H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 79 IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++ K+ I+ P H + IV E +L + I ++ S+D ++F QL+ G+ Y
Sbjct: 66 VIAIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLL 191
HS V HRDLK N LL+ + LKICDFG ++ +S V T Y APE+LL
Sbjct: 124 IHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 192 K-KEYDGKIADVWSCG 206
EY I DVWS G
Sbjct: 182 NCSEYTTAI-DVWSVG 196
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 2e-22
Identities = 69/218 (31%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-D--ENVQ------REI 68
H +YE+++ +G G +G+ D++T+E+VA+K KI D N REI
Sbjct: 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK------KIFDAFRNATDAQRTFREI 57
Query: 69 INHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFF 123
+ + L HPNIV+ VI I + + E E + A + R+
Sbjct: 58 MFLQELGDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIM 113
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----- 178
QL+ + Y HS V HRDLK N LL+ R+K+ DFG ++S +
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 179 -VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
V T Y APE+LL K D+WS G L ML+G
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 4e-22
Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 6/150 (4%)
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+PN ++ + T ++M+Y G+LF+ + G+ SE E + +QL+ ++ H
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ H D+KLEN L D + R+ +CD+G K P GT Y +PE + Y
Sbjct: 128 HNIIHNDIKLENVLYDRA-KDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNY 183
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFE-DPEE 224
D D W+ GV Y +L G +PF+ D +E
Sbjct: 184 DVSF-DWWAVGVLTYELLTGKHPFKEDEDE 212
|
Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 5e-22
Identities = 69/215 (32%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
RY +R +G G+ G+ D ++ VAVK I D ++ REI R L H N
Sbjct: 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 79 IVRFKEVILT-----------PTHLA---IVMEYASGGELFERICNAGRFSEDEARFFFQ 124
IV+ EV+ T L IV EY + G SE+ AR F
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMY 121
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVG 180
QL+ G+ Y HS V HRDLK N ++ + LKI DFG ++ H K +
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
T Y +P +LL K D+W+ G ML G
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 5e-22
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
Y + IG G +GV R+KKT ++VA+K I R + +E V REI + L+HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++V++ + L ++ E+ S + + + + + + Q++ G+ +CHS
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVL 190
+V HRDLK +N L+D +K+ DFG +++ H V T Y APEVL
Sbjct: 121 RVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHE-----VVTLWYRAPEVL 173
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYP 218
L D+WS G T++ + P
Sbjct: 174 LGSPRYSTPVDIWSIG-TIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 6e-22
Identities = 67/199 (33%), Positives = 107/199 (53%), Gaps = 11/199 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + +K T + VAVK ++ R + E + E++ R H N+V L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +SY H+ V HRD+K ++
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y G D+WS
Sbjct: 149 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203
Query: 205 CGVTLYVMLVGAYP-FEDP 222
G+ + M+ G P F +P
Sbjct: 204 LGIMVIEMIDGEPPYFNEP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 7e-22
Identities = 55/211 (26%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-- 76
++ E + D+G+GN G ++ T ++A K + G K +V+++I+ + H
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHEC 60
Query: 77 --PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P IV F L ++ + ME+ G L G + ++ G++Y +
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 135 SM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
++ ++ HRD+K N L++ ++K+CDFG S +++S + VGT Y++PE +
Sbjct: 121 NVHRIMHRDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGG 177
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
+Y K +DVWS G+++ + +G +PF
Sbjct: 178 KYTVK-SDVWSLGISIIELALGKFPFAFSNI 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 7e-22
Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 11/208 (5%)
Query: 40 MRDKKTEELVAVKYIERGDKIDENVQR-EIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98
R +E V K++ D+ R E+ + H IV+ + + L ++MEY
Sbjct: 87 TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 99 ASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154
SGG+L ++I + F E E F Q++ + HS ++ HRDLK N L P
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MP 204
Query: 155 APRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYV 211
+K+ DFG+SK SV S GTP Y+APE+ +K Y K AD+WS GV LY
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYE 263
Query: 212 MLVGAYPFEDPEEPKNFRKTIHVMYCTF 239
+L PF+ P + + ++ ++ Y F
Sbjct: 264 LLTLHRPFKGPSQREIMQQVLYGKYDPF 291
|
Length = 478 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-21
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 82
+G G FG L D T +A K ++ + E + EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 83 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L I MEY GG + +++ G +E R + +Q++ G+SY HS + H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 196
RD+K N L D A +K+ DFG SK ++ S +S GTP +++PEV+ + Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY- 186
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPE 223
G+ ADVWS G T+ ML P+ + E
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-21
Identities = 67/192 (34%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G + R K TE LVA+K I E + RE+ ++L+H NIV ++I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
T L +V EY +L + + N G S + F QL+ G+SYCH ++ HRDLK
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKP 131
Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVW 203
+N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY I D+W
Sbjct: 132 QNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI-DMW 188
Query: 204 SCGVTLYVMLVG 215
G LY M G
Sbjct: 189 GVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-21
Identities = 75/270 (27%), Positives = 113/270 (41%), Gaps = 61/270 (22%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRH 76
+ ++ +G G FG L R T+ L A+K + + D + N +R+I+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--N 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR +L VM+Y GG++ + G F ED ARF+ +L V H M
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 137 QVCHRDLKLENTLLD--------------------------GSPAPRLKICDFGYS---- 166
HRD+K +N L+D R DF
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 167 --------------KSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
+++ H + S VGTP YIAPEVLL+ Y ++ D WS GV LY
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239
Query: 211 VMLVGAYPF--EDPEEPK----NFRKTIHV 234
MLVG PF + P E + N++ ++H+
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHI 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-21
Identities = 76/271 (28%), Positives = 112/271 (41%), Gaps = 69/271 (25%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 79
++ +G G FG L T L A+K + + D ++ N +R+I+ + +
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWV 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
V+ +L VM+Y GG++ + F E ARF+ +L + H M
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123
Query: 140 HRDLKLENTL--LDGSPAPRLKICDFG-------------YSKSSVLHS---QPK----- 176
HRD+K +N L LDG +K+ DFG Y K S + +P
Sbjct: 124 HRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 177 ---------------------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTL 209
S VGTP YIAPEVLL+K Y ++ D WS GV L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVIL 238
Query: 210 YVMLVGAYPFEDPEEPK------NFRKTIHV 234
+ MLVG PF P + N+ T+H+
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHI 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-21
Identities = 66/227 (29%), Positives = 116/227 (51%), Gaps = 19/227 (8%)
Query: 11 GMDMPIMHD-SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI- 68
+D+ + D + +ELV +G+G +G R KT +L A+K ++ + +E ++ EI
Sbjct: 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEIN 64
Query: 69 INHRSLRHPNIVRFKEVILT---PTH---LAIVMEYASGGELFERICN--AGRFSEDEAR 120
+ + H NI + + P H L +VME+ G + + + N ED
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA 124
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-V 179
+ ++++ G+++ H+ +V HRD+K +N LL + +K+ DFG S ++T +
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFI 182
Query: 180 GTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
GTP ++APEV+ E YD + +D+WS G+T M GA P D
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-21
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------REIINHRSLR 75
RY++ IG G++GV D T E VA+K I + + E+V REI R LR
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57
Query: 76 HPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
HP+IV K ++L P+ + +V E +L + I + + +FF QL+ +
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIA 186
Y H+ V HRDLK +N L + +LKICDFG ++ + + V T Y A
Sbjct: 117 KYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 187 PEVL--LKKEYDGKIADVWSCGVTLYVMLVG 215
PE+ +Y I D+WS G +L G
Sbjct: 175 PELCGSFFSKYTPAI-DIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-21
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN 78
+D +E++ IG G +G + +KK L AVK ++ +DE ++ E +SL HPN
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80
Query: 79 IVRFKEVILTPTHLA-----IVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 129
+V+F + L +V+E +GG EL + + G R E + + G
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPE 188
+ + H+ ++ HRD+K N LL +K+ DFG S + + ++VGTP ++APE
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 189 VL-LKKEYDGKI---ADVWSCGVTLYVMLVGAYPFED 221
V+ +++YD DVWS G+T + G P D
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 5e-21
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 21/219 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN 78
SD +E++ IG G +G + +KK AVK ++ IDE ++ E ++L HPN
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76
Query: 79 IVRF-----KEVILTPTHLAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 129
+V+F K+ + L +V+E +GG +L + G R E + + + G
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAP 187
+ + H + HRD+K N LL + +K+ DFG S +S + ++VGTP ++AP
Sbjct: 137 LQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAP 193
Query: 188 EVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
EV+ L YD + DVWS G+T + G P D
Sbjct: 194 EVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 6e-21
Identities = 73/227 (32%), Positives = 109/227 (48%), Gaps = 21/227 (9%)
Query: 22 RY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIER--GDKIDENVQREIINHRSL 74
RY + +R +G G+FG L + T E+VAVK ++R G + ++EI ++L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 75 RHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
H NIV++K L ++MEY G L + + + + + F QQ+ G++Y
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAY 122
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAY-IAPE 188
HS HRDL N LLD +KI DFG +K+ + + + +P + A E
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 189 VLLKKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234
L KE A DVWS GVTLY +L + P PK F + I
Sbjct: 181 CL--KENKFSYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMIGP 223
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 6e-21
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIINHRSL 74
D +E+++ IG G FG +++ K TE + A+K + + + + +R ++ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 133
+ I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 QW--ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
H + HRD+K +N LLD + R LK+ G +SSV VGTP YI+
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-------AVGTPDYIS 171
Query: 187 PEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPF 219
PE+L E G D WS GV +Y ML G PF
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 7e-21
Identities = 65/199 (32%), Positives = 107/199 (53%), Gaps = 11/199 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + K + +LVAVK ++ R + E + E++ R +H N+V L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +S H+ V HRD+K ++
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APE++ + Y G D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 205 CGVTLYVMLVGAYP-FEDP 222
G+ + M+ G P F +P
Sbjct: 202 LGIMVIEMVDGEPPYFNEP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-21
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV + K + ++A K I +I ++ +II + H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ +D+WS G++L M +G YP P+
Sbjct: 180 SVQ-SDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-20
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 23 YELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
+++ + IG G F A + D+K L V+ E D K ++ +EI + L HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
++++ + + L IV+E A G+L + I + E +F QL S V + H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 189
S +V HRD+K N + + +K+ D G SK++ H S VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ + Y+ K +D+WS G LY M PF
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-20
Identities = 69/217 (31%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK------YIERGDKIDENVQREIINHRSL 74
D +E+++ IG G FG +++ K T ++ A+K ++R + +R+++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 133
R I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAP 187
H + HRD+K +N LLD + RL DFG S L T VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172
Query: 188 EVLLKKEYDGK-----IADVWSCGVTLYVMLVGAYPF 219
E+L E DGK D WS GV +Y ML G PF
Sbjct: 173 EILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-20
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV ++ K + ++A K I +I ++ +II + H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV F + ++I ME+ GG L + + A R E+ ++ G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
Q+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ +D+WS G++L + +G YP P+
Sbjct: 180 SVQ-SDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-20
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNIVR 81
+G G FG ++ K T ++ A K +++ G+K+ +++EI+ + P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEIL--EKVNSPFIVN 57
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCHSMQVC 139
+ THL +VM +GG+L I N G + R + Q+ G+ + HSM +
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
+RD+K EN LLD RL D G + GT Y+APE+L ++ Y +
Sbjct: 118 YRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEE 224
D ++ G ++Y M+ G PF+D +E
Sbjct: 176 -DWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-20
Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 81
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
TP L +++ +GG+L + G FSE E RF+ ++I G+ + H+ V +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 142 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
DLK N LLD R+ CDF K P ++VGT Y+APEVL K
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYD 174
Query: 198 KIADVWSCGVTLYVMLVGAYPF 219
AD +S G L+ +L G PF
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 4e-20
Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN---IVRFKE 84
+G G FG + + T +L A K + + K + + ++ R L + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCH 140
T T L +VM +GG+L I N F E A F+ Q+ISG+ + H ++ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
RDLK EN LLD ++I D G + + S+ K GTP ++APE+L +EYD +
Sbjct: 121 RDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178
Query: 200 ADVWSCGVTLYVMLVGAYPF 219
D ++ GVTLY M+ PF
Sbjct: 179 -DYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 4e-20
Identities = 66/204 (32%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 81
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
TP L+ +++ +GG+L + G FSE E RF+ ++I G+ + H+ V +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 142 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYD 196
DLK N LLD R+ CDF K P ++VGT Y+APEVL K YD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 174
Query: 197 GKIADVWSCGVTLYVMLVGAYPFE 220
AD +S G L+ +L G PF
Sbjct: 175 SS-ADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-20
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 31/212 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----- 75
DRY+ + +GSG +G D KT VA+K K+ Q I R+ R
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLL 68
Query: 76 ----HPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
H N++ +V + L +V G +L I + S+D +F Q
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQ 126
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 183
++ G+ Y HS + HRDLK N ++ LKI DFG ++ H+ + T V T
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEMTGYVATRW 180
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Y APE++L + + D+WS G + +L G
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 8e-20
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 24 ELVRDIGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL+ IG + L + K T LVAVK I E++ Q+EII R L+HPN
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 79 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
I+ + + + L +V M Y S +L + G E F + +++ + Y HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPAYIAP 187
HR +K + LL G ++ + YS + V+H PKS+V +++P
Sbjct: 120 KGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 188 EVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
EVL + + Y+ K D++S G+T + G PF+D
Sbjct: 178 EVLQQNLQGYNEKS-DIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-19
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G + R K T+ LVA+K I E + RE+ + L+H NIV ++I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 87 LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
T L +V EY +L + + + G + + F QL+ G++YCH +V HRDLK
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132
Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVW 203
+N L++ LK+ DFG +++ + ++ S V T Y P++LL +Y +I D+W
Sbjct: 133 QNLLINER--GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI-DMW 189
Query: 204 SCGVTLYVMLVGA--YPFEDPEEPKNF 228
G Y M G +P EE +F
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHF 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-19
Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 19/214 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRH 76
D + E + +IGSG G MR KKT ++AVK + R +EN +R +++ H
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSH 71
Query: 77 --PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSY 132
P IV+ +T + + I ME S +L +RI G ED ++ + Y
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHY 129
Query: 133 C-HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL 190
V HRD+K N LLD S +K+CDFG S V S+ K+ + G AY+APE +
Sbjct: 130 LKEKHGVIHRDVKPSNILLDAS--GNVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERI 186
Query: 191 ----LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+YD + ADVWS G++L + G +P++
Sbjct: 187 DPPDPNPKYDIR-ADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-19
Identities = 71/268 (26%), Positives = 117/268 (43%), Gaps = 63/268 (23%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDE----NVQREIINHRSL 74
+ + V+ IG G FG RL++ K T ++ A+K + + + K D+ +R+++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P +V +L ++ME+ GG+L + FSED RF+ + + + H
Sbjct: 60 -SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK-------------- 167
+ HRD+K +N L+D +K+ DFG Y K
Sbjct: 119 KLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 168 --------SSVLHSQPK-------------STVGTPAYIAPEVLLKKEYDGKIADVWSCG 206
+ + S+ + STVGTP YIAPE+ L++ Y G+ D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLG 235
Query: 207 VTLYVMLVGAYPF--EDPEEPKNFRKTI 232
++ L+G PF E+ E +RK I
Sbjct: 236 AIMFECLIGWPPFCSENSHE--TYRKII 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-19
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 81
+ELV +G+G +G R KT +L A+K ++ +E +++EI + + H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 82 FKEVILTPT------HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 133
+ + L +VME+ G + + I N E+ + ++++ G+S+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK 192
H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 193 KE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
E YD K +D+WS G+T M GA P D
Sbjct: 186 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-19
Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 26 VRDIGSGNFGVARLMR----DKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNI 79
+RD+G G+FG L R T E VAVK + E G ++++EI R+L H NI
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 80 VRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM 136
V++K + + ++ME+ G L E + N + + + + Q+ G+ Y S
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLLK 192
Q HRDL N L++ ++KI DFG +K+ + K + +P + APE L++
Sbjct: 129 QYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 193 KEYDGKIADVWSCGVTLYVML 213
++ +DVWS GVTLY +L
Sbjct: 187 SKF-YIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-19
Identities = 68/202 (33%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRH 76
+ Y+ + +G G++ R K T +LVA+K I E G RE + L+H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKH 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHS 135
NIV ++I T L +V EY +L + + + G S R F QL+ G++YCH
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KK 193
+V HRDLK +N L+ S LK+ DFG +++ + S+ S V T Y P+VLL
Sbjct: 122 RRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179
Query: 194 EYDGKIADVWSCGVTLYVMLVG 215
EY + D+W G Y M G
Sbjct: 180 EYSTSL-DMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-19
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ Y + +G G + R K TE LVA+K I E + RE+ + L+H N
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV +++ T L +V EY +L + + + G S + F Q++ G++YCH +
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEY 195
V HRDLK +N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY
Sbjct: 125 VLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 196 DGKIADVWSCGVTLYVMLVG 215
+I D+W G + M G
Sbjct: 183 STQI-DMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-19
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
++++G+G FGV + + + + VA+K I+ G ++ E L H +V+
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 137
V + IV EY S G C E RF QL+ G++Y S Q
Sbjct: 67 VCTKQRPIYIVTEYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKE 194
HRDL N L+D +K+ DFG S+ VL + S+VG+ + PEVLL +
Sbjct: 121 FIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
+ K +DVW+ GV ++ V +G P+E
Sbjct: 178 FSSK-SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-19
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIINHRSLRH 76
+E+++ IG G FG +++ K +++ A+K + + + + +R+++ + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 135
I +L +VM+Y GG+L + R ED ARF+ +++ + H
Sbjct: 63 --ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 193
+ HRD+K +N L+D + RL DFG + +S+ VGTP YI+PE+L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 194 EYDGK-----IADVWSCGVTLYVMLVGAYPF 219
E DGK D WS GV +Y ML G PF
Sbjct: 179 E-DGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 4e-19
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDK--KTEELVAVKYIE----RGDKIDENVQREIINHRSLR 75
+YE+ IG G +G + K K + A+K + + I ++ REI R L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 76 HPNIVRFKEVILTPTHLAIVM--EYASGGEL----FERICNAGRFSEDEARFFFQQLISG 129
H N+V EV L ++ + +YA F R + Q+++G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 130 VSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS------TVGT 181
V Y HS V HRDLK N L+ +G +KI D G ++ + ++ K V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178
Query: 182 PAYIAPEVLL-KKEYDGKIADVWSCG 206
Y APE+LL + Y I D+W+ G
Sbjct: 179 IWYRAPELLLGARHYTKAI-DIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 7e-19
Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 9/205 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLR 75
+D YE + +G G++ + K +LVA+K I E G RE + L+
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLK 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
H NIV ++I T L +V EY + G + + F QL+ G+SY H
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 194
+ HRDLK +N L+ S LK+ DFG +++ + S S V T Y P+VLL
Sbjct: 122 RYILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST 179
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
D+W G M+ G F
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 8e-19
Identities = 72/223 (32%), Positives = 105/223 (47%), Gaps = 39/223 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERGDKIDENVQREIINHRSLR---- 75
RYEL++++G G +G+ R+ +T EE VA+K KI ++I+ R+LR
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKL 54
Query: 76 ------HPNIVRFKEV-ILTPTHLAIVMEYASGGELFE----RICNAG-RFSEDEARFFF 123
H NI ++ I+ P + + Y EL E +I +G ++ + F
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYE---ELMEADLHQIIRSGQPLTDAHFQSFI 111
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKS-SVLH--SQPKST 178
Q++ G+ Y HS V HRDLK N L D LKICDFG ++ S + T
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGFSENPGENAGFMT 167
Query: 179 --VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
V T Y APE++L + K DVWS G L L+G P
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL-AELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 9e-19
Identities = 54/142 (38%), Positives = 82/142 (57%), Gaps = 12/142 (8%)
Query: 92 LAIVMEYASGGELFERICN---AGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
+A+V++YA+ G+L + I + R F E EA F Q++ V + HS + HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 148 TLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL + +K+ DFG+SK ++V ++ GTP Y+APE+ +K Y K AD++S
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFS 230
Query: 205 CGVTLYVMLVGAYPF--EDPEE 224
GV LY +L PF E+ EE
Sbjct: 231 LGVLLYELLTLKRPFDGENMEE 252
|
Length = 496 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV + + + ++A K I +I ++ +II + H
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVLHECNS 58
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS- 135
P IV F + ++I ME+ GG L + + AGR E+ ++ G++Y
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
+ +D+WS G++L M +G YP P+
Sbjct: 176 TVQ-SDIWSLGLSLVEMAIGRYPIPPPDA 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 55/204 (26%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
Y +++ + G+ G + + V +K ++G + E + + +NH P+++R
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNH-----PSVIRM 122
Query: 83 KEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
K+ +++ +V+ + S +L+ + + D+A +Q++ G+ Y H+ ++ HR
Sbjct: 123 KDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
D+K EN ++ ++ I D G ++ V+ GT APEVL + +Y+ K AD
Sbjct: 182 DVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK-AD 238
Query: 202 VWSCGVTLYVMLVGAYP---FEDP 222
+WS G+ L+ ML AYP FEDP
Sbjct: 239 IWSAGIVLFEML--AYPSTIFEDP 260
|
Length = 357 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-18
Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFKE 84
+G GN G T ++AVK I I +Q++I++ + + P I+ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 85 VILTPTHLAIVMEYASGGEL--FERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCH 140
++I E+ GG L + +I GR + ++ G++Y S+++ H
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RD+K N L++ ++K+CDFG S V +S K+ VGT AY+APE + ++Y G +
Sbjct: 119 RDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQY-GIHS 174
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYC 237
DVWS G++ + +G +P+ ++ + + ++ C
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC 211
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-18
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSLRHPNI 79
Y VR +G G++G L+R + + +K + + + ++E L+HPNI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 80 VRFKEVIL-TPTHLAIVMEYASGGELFERIC-NAGRF-SEDEARFFFQQLISGVSYCHSM 136
V ++E L IVM + GG+L+ ++ G+ E++ +F Q+ + Y H
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 193
+ HRDLK +N L + +K+ D G ++ VL +Q + +GTP Y++PE+ K
Sbjct: 122 HILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNK 177
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPF 219
Y+ K +DVW+ G +Y M + F
Sbjct: 178 PYNYK-SDVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-18
Identities = 59/187 (31%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 29 IGSGNFGVARL--MRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
IG G FG L R +K VAVK ++ + E +LRHPN+V+ V+
Sbjct: 14 IGKGEFGDVMLGDYRGQK----VAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 87 LTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
L L IV EY + G L + + + GR + + F + G+ Y HRDL
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVW 203
N L+ K+ DFG +K + SQ + + P + APE L +K++ K +DVW
Sbjct: 130 ARNVLVSEDLVA--KVSDFGLAKEA---SQGQDSGKLPVKWTAPEALREKKFSTK-SDVW 183
Query: 204 SCGVTLY 210
S G+ L+
Sbjct: 184 SFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 5e-18
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D E++ ++G GN+G + + T +A+K I ++DE+ +II + H
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVS 58
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYC 133
P IV F + + MEY G +L+ ED R ++ G+ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 134 -HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
+ HRD+K N L++G+ ++K+CDFG S +++ S K+ +G +Y+APE +
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 193 KEYDGKI-----ADVWSCGVTLYVMLVGAYPFEDPE 223
+ +DVWS G+++ M +G YP+ PE
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP-PE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-18
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
+ + + IG G F VA+K ++ D +D + + I + L HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
++++ + L IV+E A G+L I + + E +F QL S + + H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 189
S +V HRD+K N + + +K+ D G SK++ H S VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ + Y+ K +D+WS G LY M PF
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-17
Identities = 68/215 (31%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D YE + IG G +G RDK T +LVA+K R + +E + REI + L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59
Query: 77 -PNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGR-----FSEDEARFFFQQ 125
IVR +V L +V EY +L + + + GR + F Q
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAY 184
L+ GV++CH V HRDLK +N L+D LKI D G ++ S+ + T Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWY 177
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
APEVLL + D+WS G M F
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-17
Identities = 65/197 (32%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 29 IGSGNFGVARLMR----DKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFK 83
+G GNFG L R T E+VAVK ++ + +REI +SL+H NIV++K
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 84 EVILTP--THLAIVMEYASGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V + +L +VMEY G L + + R + + Q+ G+ Y S + H
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPA-----YIAPEVLLKK 193
RDL N L++ R+KI DFG +K + Q K V P + APE L +
Sbjct: 132 RDLATRNILVESE--NRVKIGDFGLTK---VLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 194 EYDGKIADVWSCGVTLY 210
++ +DVWS GV LY
Sbjct: 187 KFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-17
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPN 78
RY ++ +GSG +G DK+T E VA+K + R + + RE+ + ++H N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 79 IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++ +V + +VM Y ++I SED+ ++ Q++ G+ Y
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLKY 132
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS + HRDLK N L + LKI DFG ++ + ++ V T Y APEV+L
Sbjct: 133 IHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILN 188
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + D+WS G + ML G F+
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-17
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
DRY ++ +GSG +G D++T VA+K + R + + RE+ + ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 78 NIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V L +VM + G ++ + SED +F Q++ G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y H+ + HRDLK N L + LKI DFG ++ + S+ V T Y APEV+L
Sbjct: 133 YIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVIL 188
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + D+WS G + ML G F+
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-17
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARL---MRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
LV++IGSG FG+ L + +K VA+K I G +E+ E L
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRK----VAIKTIREGAMSEEDFIEEAQVMMKLS 57
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
HP +V+ V + + +V E+ G L + + G+FS++ + G++Y
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLL 191
S V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV
Sbjct: 118 SSNVIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFS 174
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+Y K +DVWS GV ++ V G P+E+
Sbjct: 175 FSKYSSK-SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 4e-17
Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 25/201 (12%)
Query: 28 DIGSGNFGVARLMRDKKTEEL-----VAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
+G G+FGV R R + + VAVK + DK+ + + +E SL H N+
Sbjct: 2 KLGDGSFGVVR--RGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNA-GRFSEDEARFFFQQLISGVSYCHSMQ 137
+R V+LT L +V E A G L +R+ +A G F + Q+ +G+ Y S +
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTP-AYIAPEVLL 191
HRDL N LL + ++KI DFG ++ + + V P A+ APE L
Sbjct: 118 FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 192 KKEYDGKIADVWSCGVTLYVM 212
+ + +DVW GVTL+ M
Sbjct: 174 TRTFS-HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-17
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSLR--- 75
+YE V +IG G +G RD + VA+K + D + + RE+ + L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 76 HPNIVRFKEVILT-----PTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLIS 128
HPNIVR +V T T + +V E+ +++ G + + +Q +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLR 119
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
G+ + H+ + HRDLK EN L+ + ++K+ DFG ++ V T Y APE
Sbjct: 120 GLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 189 VLLKKEYDGKIADVWSCGVTLYVML 213
VLL+ Y + D+WS G M
Sbjct: 178 VLLQSTYATPV-DMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-17
Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 85
++++GSG FGV L + + + VA+K I G +E+ E L HP +V+ V
Sbjct: 9 MKELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 86 ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
L IV E+ G L + G+ S+D Q + G+ Y HRDL
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGKIAD 201
N L+ S +K+ DFG ++ VL + S+ G + PEV +Y K +D
Sbjct: 128 ARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-SD 183
Query: 202 VWSCGVTLY-VMLVGAYPFE 220
VWS GV ++ V G PFE
Sbjct: 184 VWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 9e-17
Identities = 61/179 (34%), Positives = 85/179 (47%), Gaps = 11/179 (6%)
Query: 47 ELVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102
+LVA+K I K +E V RE + L+H NIV ++I T L V EY
Sbjct: 31 QLVALKVISM--KTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTD 88
Query: 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
I + G R F QL+ G++Y H + HRDLK +N L+ S LK+ D
Sbjct: 89 LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--SYLGELKLAD 146
Query: 163 FGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
FG +++ + SQ S+ V T Y P+VLL +Y + D+W G ML G F
Sbjct: 147 FGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL-DIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-16
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
IG G FG M K + ++AVK I R ++ +R +++ RS P IV+F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 85 VILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYC--------- 133
+ I ME S + ++ + + ++++ ++
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNYLK 124
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 191
+++ HRD+K N LLD + +K+CDFG S V S K+ G Y+APE +
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDP 181
Query: 192 --KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ YD + +DVWS G+TLY + G +P+
Sbjct: 182 SARDGYDVR-SDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-16
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 10/201 (4%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
++++GSG FGV L + + + VA+K I G +++ E L HPN+V+
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 85 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
V + IV EY + G L + G+ + + + Y S HRDL
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKKEYDGKIA 200
N L+ +K+ DFG ++ VL Q S+ GT + PEV + K +
Sbjct: 127 AARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-S 182
Query: 201 DVWSCGVTLY-VMLVGAYPFE 220
DVWS GV ++ V G P+E
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-16
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 27 RDIGSGNFGVAR--LMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRS----LRHPNI 79
+++G GNFG + K +E+ VAVK +++ + I ++E + S L HP I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ-EHIAAG-KKEFLREASVMAQLDHPCI 58
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
VR V L +VME A G L + + + + Q+ G++Y S
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT--P-AYIAPEVLLKKEY 195
HRDL N LL + KI DFG S++ ++T P + APE + ++
Sbjct: 118 HRDLAARNVLLVNR--HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 196 DGKIADVWSCGVTLYVML-VGAYPFED 221
K +DVWS GVTL+ GA P+ +
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-16
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
+RY+ + +GSG +G D KT VAVK + R + + RE+ + ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 78 NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
N++ +V L ++ + G +L I + ++D +F Q++ G+ Y
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRDLK N L + LKI DFG ++ H+ + T V T Y APE++
Sbjct: 136 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
L + + D+WS G + +L G F
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-16
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLR 75
D E++ ++G G +GV MR T ++AVK I E Q+ + I+ RS+
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVD 58
Query: 76 HPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE--ARFFFQQLISGVS 131
P V F + + I ME S + ++++ + G ++ + ++ +
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV-SIVKALE 117
Query: 132 YCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE- 188
Y HS + V HRD+K N L++ ++K+CDFG S V S K+ G Y+APE
Sbjct: 118 YLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPER 174
Query: 189 ---VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
L +K YD K +DVWS G+T+ + G +P++
Sbjct: 175 INPELNQKGYDVK-SDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 6e-16
Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 6/149 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+ +V+ I G FG L R K +L AVK +++ D I++N+ ++ R + P
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + ++ +VMEY GG++ + G F E+ A + ++ + Y H +
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDLK +N L+ S +K+ DFG SK
Sbjct: 126 IHRDLKPDNMLI--SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-16
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
+RY+ + +GSG +G D + + VAVK + R + RE+ + ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 78 NIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
N++ +V T + E G +L I + S++ +F QL+ G+ Y
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS + HRDLK N ++ L+I DFG ++ + + V T Y APE++L
Sbjct: 134 IHSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLN 189
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ + D+WS G + +L G F
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ Y+L IG+G+FGV T E VA+K + + + RE++ ++L H NI
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---NRELLIMKNLNHINI 121
Query: 80 VRFKEVILTPT--------HLAIVMEYASGG-----ELFERICNAGRFSEDEARFFFQQL 126
+ K+ T L +VME+ + + R N + + QL
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQL 179
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKSTVGTPA 183
++Y HS +CHRDLK +N L+D P LK+CDFG +K+ + + S + +
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218
Y APE++L D+WS G + M++G YP
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YP 269
|
Length = 440 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-15
Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 24/219 (10%)
Query: 19 DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
D+ ++ + IG+G FG RL K E VA+K ++ G E +R+ ++ S+
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIM 59
Query: 76 ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
HPNI+ + V+ + IV EY G L F R + G+F+ + + + SG
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASG 118
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
+ Y M HRDL N L++ + K+ DFG S+ VL P++ T
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 174
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ APE + +++ +DVWS G+ ++ VM G P+ +
Sbjct: 175 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 21/226 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D VAVK + R + + +R E++ + + H N
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 79 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
I+ V TP + +VME +C D R + Q++ G
Sbjct: 82 IISLLNV-FTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCG 135
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HS + HRDLK N ++ LKI DFG ++++ + V T Y APEV
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235
+L Y + D+WS G + ++ G+ F+ + + K I +
Sbjct: 194 ILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-15
Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRD-KKTEELVAVKYI-----ERGDKIDENVQREIINH-RSL 74
+YE V +IG G +G RD K VA+K + E G + + ++ H +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 75 RHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLI 127
HPN+VR +V T L +V E+ +++ G +E FQ L+
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 120
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVML 213
EVLL+ Y + D+WS G M
Sbjct: 179 EVLLQSSYATPV-DLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-15
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRHP 77
E R IG G FGV + D + + VA+K + + +N V RE+ +H
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMP---NVFQNLVSCKRVFRELKMLCFFKHD 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSEDEARFFFQQLISGVSY 132
N++ + IL P H+ E EL + I + S D + F Q++ G+ Y
Sbjct: 60 NVLSALD-ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRD+K N L++ + LKICDFG ++ T V T Y APE+L
Sbjct: 119 LHSAGILHRDIKPGNLLVNSN--CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 191 L-KKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + Y + D+WS G +L F+
Sbjct: 177 MGSRHYTSAV-DIWSVGCIFAELLGRRILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 5e-15
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 35/218 (16%)
Query: 25 LVRDIGSGNFG---VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 79
+ + IG G FG RL K E VA+K ++ G DK + E HPNI
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 80 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLI-------SGV 130
+R + V+ + I+ EY G L F R E++ +F QL+ SG+
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGM 119
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-----PA-Y 184
Y M HRDL N L++ + K+ DFG S+ L ++T T P +
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLSR--RLED-SEATYTTKGGKIPIRW 174
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + +++ +DVWS G+ ++ VM G P+ D
Sbjct: 175 TAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-15
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 79
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQF--V 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ 137
V T L +V+ +GG+L I N G F E+ A F+ +++ G+ H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+RDLK EN LLD ++I D G + + VGT Y+APEVL + Y
Sbjct: 123 TVYRDLKPENILLDDY--GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-T 179
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEE 224
D W G +Y M+ G PF +E
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-15
Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 18/194 (9%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
R + S N G + E L+A K ++ G + ++ EI+ L H NI++ +E++
Sbjct: 180 RGVNSTNQGKPK------CERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLISGVSYCHSMQVCHR 141
+ + ++ + +L+ + + +D + R +QL+ V Y H ++ HR
Sbjct: 233 RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKI 199
D+KLEN L+ L DFG + + VGT A +PE+L Y +I
Sbjct: 292 DIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEI 348
Query: 200 ADVWSCGVTLYVML 213
D+WSCG+ L ML
Sbjct: 349 TDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-14
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 29 IGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 81
IG+G FG RL K E VA+K ++ G E +R+ ++ S+ HPNI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+ V+ + I+ E+ G L F R N G+F+ + + + +G+ Y M
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLL 191
HRDL N L++ + K+ DFG S+ L T + + APE +
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+++ +DVWS G+ ++ VM G P+ D
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-14
Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 45/228 (19%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRH 76
YE++ +G G FG R KT +VA+K I E+ D REI + L+H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKH 66
Query: 77 PNIVRFKEVIL--------TPTHLAIVMEYA----SGGELFE--RICNAGRFSEDEARFF 122
PN+V ++ + + +V Y SG L E + + +E + + +
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV----KLTESQIKCY 120
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------ 176
QL+ G++Y H + HRD+K N L+D LKI DFG ++ P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--PYDGPPPNPKGGG 176
Query: 177 --------STVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
+ V T Y PE+LL ++ Y + D+W G M
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 21/223 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D E VA+K + R + + +R E++ + + H N
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
I+ V TP + IVME +C + D R + Q++ G
Sbjct: 85 IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HS + HRDLK N ++ LKI DFG ++++ V T Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+L Y + D+WS G + M+ G F + + K I
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-14
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 79
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + R +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSRF--V 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ 137
V T L +V+ +GG+L I + G F E A F+ ++ G+ H +
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ +RDLK EN LLD ++I D G + K VGT Y+APEV+ + Y
Sbjct: 123 IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 198 KIADVWSCGVTLYVMLVGAYPFE 220
D W+ G LY M+ G PF+
Sbjct: 181 S-PDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-14
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 29 IGSGNFGVARLMR--DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G +G + D K E+ A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 87 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHSM 136
L+ + + ++ +YA F R A + + Q++ G+ Y H+
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 187
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
E+LL + K D+W+ G +L F +E
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-14
Identities = 55/199 (27%), Positives = 83/199 (41%), Gaps = 26/199 (13%)
Query: 25 LVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
L R +G+G FG V + T+ VAVK ++ G E +E + LRH +V+
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF-FQQLI-------SGVSYCHS 135
V + IV EY S G L + + E + QL+ G++Y S
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLES 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP-AYIAPEVLL 191
HRDL N L+ + KI DFG ++ ++ + P + APE
Sbjct: 122 RNYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAAN 177
Query: 192 KKEYDGKIADVWSCGVTLY 210
+ K +DVWS G+ L
Sbjct: 178 YGRFTIK-SDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-14
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 11/209 (5%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+ R +G G FG + + T ++ A K +E+ + +N + +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
+V T L +V+ +GG+L I N G F E+ A F+ ++ G+ H
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 195
++ +RDLK EN LLD ++I D G + + + + VGT Y+APEV+ + Y
Sbjct: 122 RIVYRDLKPENILLDDY--GHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERY 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
D W G +Y M+ G PF +E
Sbjct: 179 -TFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-14
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQR--EIINHRSLRHP 77
R +G G FG + + T ++ A K +E+ G+ + N +R E +N R
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF---- 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 135
+V T L +V+ +GG+L I N G F E A F+ +L G+
Sbjct: 62 -VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ +RDLK EN LLD ++I D G + + VGT Y+APEV+ ++Y
Sbjct: 121 ERIVYRDLKPENILLDDR--GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
D W G +Y M+ G PF +E
Sbjct: 179 TFS-PDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 68/248 (27%), Positives = 99/248 (39%), Gaps = 51/248 (20%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR------ 75
RY+++R IG G G L D VA+K I R D + ++ R LR
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSEN----PLLKKRFLREAKIAA 57
Query: 76 ---HPNIVRFKEVILTPTHLAIVMEYASG---GELFERICNAGRFSEDEAR------FF- 122
HP IV + + M Y G L + + S++ A F
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 123 -FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----------------Y 165
F ++ + + Y HS V HRDLK +N LL + I D+G
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 166 SKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
+ ++ +S P VGTP Y+APE LL D+++ GV LY ML ++P+
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR- 233
Query: 223 EEPKNFRK 230
K RK
Sbjct: 234 ---KKGRK 238
|
Length = 932 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-14
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 29 IGSGNFG-VAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 81
IG+G FG V R L + E VA+K ++ G E +++ ++ S+ H NI+R
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 82 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ V+ I+ EY G L + + + G FS + + + +G+ Y M H
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLKKE 194
RDL N L++ + K+ DFG S+ VL P+ T T + APE + ++
Sbjct: 131 RDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS G+ ++ VM G P+ D
Sbjct: 187 FTSA-SDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 9e-14
Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 17/207 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIV 80
+ L R +GSG FG + K VA+K ++ D + ++ Q+E+ + LRH +++
Sbjct: 8 FTLERKLGSGYFG--EVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQV 138
V + I+ E G L + + A Q+ G++Y
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYS---KSSV-LHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL N L+ K+ DFG + K V L S K + APE
Sbjct: 126 IHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASHGT 180
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
+ K +DVWS G+ LY + G P+
Sbjct: 181 FSTK-SDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-13
Identities = 66/198 (33%), Positives = 89/198 (44%), Gaps = 20/198 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
IG G FG +++ + T + VAVK I K D Q E L H N+VR V
Sbjct: 14 IGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQVCHRDL 143
IL L IVME S G L + GR + F + G+ Y S ++ HRDL
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADV 202
N L+ S K+ DFG ++ + S P + APE L K++ K +DV
Sbjct: 127 AARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSK-SDV 180
Query: 203 WSCGVTLY-VMLVGAYPF 219
WS GV L+ V G P+
Sbjct: 181 WSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------REIINHRSLR 75
RY+ ++ IGSG G+ D T + VA+K + R +NV RE++ + +
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73
Query: 76 HPNIVRFKEVILTP-------THLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQL 126
H NI+ V TP + +VME A+ ++ + + R S + Q+
Sbjct: 74 HKNIIGLLNV-FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQM 127
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
+ G+ + HS + HRDLK N ++ LKI DFG ++++ V T Y A
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRA 185
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
PEV+L Y + D+WS G + M+ G F
Sbjct: 186 PEVILGMGYKENV-DIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-13
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 29 IGSGNFG-VARLMR-DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G +G V + R D K + A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 87 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHSM 136
L+ + ++ +YA F R A + + Q++ G+ Y H+
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 187
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
E+LL + K D+W+ G +L F +E
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-13
Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 34/218 (15%)
Query: 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDE-----N 63
S+RY +G G +G D T ++VA+K + + +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 64 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 123
RE+ ++H NI+ +V + + +VM+ + +L + + R +E + +
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCIL 125
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------H 172
Q+++G++ H HRDL N ++ KI DFG ++
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDET 183
Query: 173 SQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCG 206
Q + S V T Y APE+L+ E D+WS G
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221
|
Length = 335 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-13
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 21 DRYELVRDIGSGNFGVAR--LMRDKKTEEL-VAVKY--IERGDKIDENVQREIINHRSLR 75
+ L R IG G FG + + E++ VAVK + E +E R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
HP+IV+ VI T + IVME A GEL + N + QL + ++Y
Sbjct: 66 HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-P-AYIAPEVLLK 192
S + HRD+ N L+ SP +K+ DFG S+ S K++ G P ++APE +
Sbjct: 125 SKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + +DVW GV ++ ++++G PF
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 8e-13
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 9/198 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D + VA+K + R + + +R E++ + + H N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
I+ V L + EL + +C + D R + Q++ G+ + HS
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK N ++ LKI DFG ++++ V T Y APEV+L Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 196 DGKIADVWSCGVTLYVML 213
+ D+WS G + M+
Sbjct: 196 KENV-DIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-12
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-- 73
++ L+R++G G+FG +A+ + + E VA+K + + E E +N S
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 74 --LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF-------- 121
++VR V+ T +VME + G+L + R R +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQK 120
Query: 122 FFQ---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
F Q ++ G++Y + + HRDL N ++ +KI DFG ++ +
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKG 178
Query: 179 VGT--PA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPF 219
P ++APE L + K +DVWS GV L+ M + P+
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 65/233 (27%), Positives = 93/233 (39%), Gaps = 41/233 (17%)
Query: 24 ELVRDIGSGNFGV----------------ARLMRDKKTEELVAVKYIERG--DKIDENVQ 65
V +G G FG + LVAVK + D E+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER---------ICNAGRF 114
+E+ L PNI R V L ++MEY G+L F + CN+
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
S + Q+ SG+ Y S+ HRDL N L+ +KI DFG S++ L+S
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSRN--LYSS 183
Query: 175 PKSTVG--TPAYI---APEVLLKKEYDGKIADVWSCGVTLY--VMLVGAYPFE 220
V P I A E +L ++ K +DVW+ GVTL+ + L P+E
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYE 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-12
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 24 ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL+ IG G + L R K T E V V+ I +E V Q E+ + HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++ + L +V + + G + IC SE + Q ++ + Y H M
Sbjct: 61 IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120
Query: 137 QVCHRDLKLENTL--LDGSPAPRLKICDFGY----------SKSSVLHSQPKSTVGTPAY 184
HR +K + L +DG K+ G + V+H PK +V +
Sbjct: 121 GYVHRSVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174
Query: 185 IAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++PEVL + + YD K +D++S G+T + G PF+D
Sbjct: 175 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-12
Identities = 58/200 (29%), Positives = 85/200 (42%), Gaps = 14/200 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
IG GNFG R + VAVK + + +++ + + + HPNIVR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
V + IVME GG+ + G R E + +G+ Y S HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLLKKEYDGKIA 200
N L+ LKI DFG S+ +++ P + APE L Y + +
Sbjct: 121 AARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-S 177
Query: 201 DVWSCGVTLY-VMLVGAYPF 219
DVWS G+ L+ +GA P+
Sbjct: 178 DVWSFGILLWEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-12
Identities = 59/193 (30%), Positives = 90/193 (46%), Gaps = 15/193 (7%)
Query: 28 DIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
++GSGNFG + + + KK+E+ VAVK I + D D ++ E++ + L +P IVR
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
I +VME A G L + + +E Q+ G+ Y HR
Sbjct: 61 MIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPA-YIAPEVLLKKEYDG 197
DL N LL KI DFG SK + + + K+ P + APE + ++
Sbjct: 120 DLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 198 KIADVWSCGVTLY 210
K +DVWS GV ++
Sbjct: 178 K-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-12
Identities = 63/217 (29%), Positives = 87/217 (40%), Gaps = 45/217 (20%)
Query: 27 RDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL---RHPNIV 80
IG GNFG L K VAVK R + ++ + L HPNIV
Sbjct: 1 EKIGKGNFGDVYKGVL----KGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIV 55
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYC 133
+ V + + IVME GG L + + + R ++L+ +G+ Y
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYL 109
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG---------YSKSSVLHSQP-KSTVGTPA 183
S HRDL N L+ + LKI DFG Y+ S L P K T
Sbjct: 110 ESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT----- 162
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
APE L Y + +DVWS G+ L+ +G P+
Sbjct: 163 --APEALNYGRYTSE-SDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-12
Identities = 47/161 (29%), Positives = 65/161 (40%), Gaps = 16/161 (9%)
Query: 45 TEELVAVKYIERGDKIDE-----NVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY 98
T VA+K + R D +E +RE L HPNIV P L V EY
Sbjct: 2 TGHEVAIKLL-RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APR 157
G L E + G E Q++ ++ H+ + HRDLK +N ++ + P
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 158 LKICDFGYSK-----SSVLHSQPKST---VGTPAYIAPEVL 190
K+ DFG + T +GTP Y APE L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-11
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 29 IGSGNFG------VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+GSG FG ++ VAVK + +G E ++E + L HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVS 131
IV+ V L I+ME GG+L + +A ++L+ G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPR-LKICDFGYSK---SSVLHSQPKSTVGTPAYI 185
Y M HRDL N L+ G A R +KI DFG ++ S + + + ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 186 APEVLLKKEYDGKI---ADVWSCGVTLY-VMLVGAYPF 219
APE LL DGK +DVWS GV ++ ++ +G P+
Sbjct: 181 APESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-11
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 22 RYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINH----RS 73
E ++ +GSG FG + + + ++ VA+K + ++ +EI++ S
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKEILDEAYVMAS 65
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 132
+ HP++VR + L+ ++ + G L + + + + Q+ G+SY
Sbjct: 66 VDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG-TP-AYIAPEV 189
++ HRDL N L+ +P +KI DFG +K V + + G P ++A E
Sbjct: 125 LEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 190 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+L + Y K +DVWS GVT++ +M GA P+E
Sbjct: 183 ILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 7e-11
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 19 DSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP 77
D +L+R +G+G FG V + + T VAVK ++ G ++ E + LRHP
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 130
+++ V + IV E G L E + QLI SG+
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVASGM 116
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---AP 187
+Y + HRDL N L+ + K+ DFG ++ + ++ G I AP
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLAR-VIKEDIYEAREGAKFPIKWTAP 173
Query: 188 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
E L + K +DVWS G+ L ++ G P+
Sbjct: 174 EAALYNRFSIK-SDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-10
Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 18 HDSDRYELVRDIGSGNFGV---ARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIIN 70
+ + E VRDIG G FG AR E +VAVK ++ + + QRE
Sbjct: 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------------------RICN 110
HPNIV+ V + ++ EY + G+L E R C
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 111 AGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK- 167
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRN 179
Query: 168 --SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
S+ + ++ ++ PE + Y + +DVW+ GV L+
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-10
Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 13/189 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
+G G +G KK VAVK ++ E +E + ++HPN+V+ V
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ--QLISGVSYCHSMQVCHRDLKLE 146
I+ E+ + G L + + R + + Q+ S + Y HRDL
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 133
Query: 147 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
N L+ +K+ DFG S+ + H+ K + + APE L ++ K +D
Sbjct: 134 NCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 187
Query: 202 VWSCGVTLY 210
VW+ GV L+
Sbjct: 188 VWAFGVLLW 196
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-10
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 28 DIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 81
++GSGNFG + + + +K + VA+K ++ + +++V+ E++ + H P IVR
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 82 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V L +VME ASGG L + + + Q+ G+ Y H
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLKKEYD 196
RDL N LL KI DFG SK+ + + +S P + APE + +++
Sbjct: 119 RDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 197 GKIADVWSCGVTLYVML-VGAYPFEDPEEPK 226
+ +DVWS G+T++ G P++ + P+
Sbjct: 177 SR-SDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 49/181 (27%), Positives = 73/181 (40%), Gaps = 32/181 (17%)
Query: 72 RSLRHPNIVRFKEVILTPTHLAI--------VMEYASGGEL--FERIC------NAGRFS 115
L H NI L H+ I + Y + G L F + C N S
Sbjct: 63 YGLSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLH 172
+ Q+ G+SY H V H+D+ N ++D ++KI D S+ H
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE--LQVKITDNALSRDLFPMDYH 173
Query: 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE--DPEEPKNFR 229
+ ++A E L+ KEY +DVWS GV L+ +M +G P+ DP E +
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL 232
Query: 230 K 230
K
Sbjct: 233 K 233
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-10
Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 20/216 (9%)
Query: 19 DSDRYELVRDIGSGNFG-VAR--LMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D+ ++ R +G+G FG + R L K E VA+ + G DK E +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
H NIVR + VI + IV EY S G L F R + G+ + L SG+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMK 121
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG---YSKSSVLHS--QPKSTVGTPAYIA 186
Y M H+ L L++ KI F KS +++ KS V + A
Sbjct: 122 YLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPV---LWAA 176
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
PE + + +DVWS G+ ++ VM G P+ D
Sbjct: 177 PEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-10
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 38/227 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEE--------------LVAVKYIERGDKIDENVQ- 65
+ L +G G FG L + E LVAVK + R D + + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RAD-VTKTARN 62
Query: 66 ---REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL------------FERICN 110
+EI L++PNI+R V ++ L ++ EY G+L F N
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--- 167
S + Q+ SG+ Y S+ HRDL N L+ +KI DFG S+
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLY 180
Query: 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214
S + V ++A E +L ++ +DVW+ GVTL+ M
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-10
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+ +LV+ +G+G FG M VAVK ++ G + E ++L+H +V
Sbjct: 6 ESIKLVKKLGAGQFGEV-WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 81 RFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
R V+ + I+ EY + G L F + G+ + F Q+ G++Y
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEY 195
HRDL+ N L+ S + KI DFG ++ + ++ + G + APE + +
Sbjct: 125 IHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPF 219
K +DVWS G+ LY ++ G P+
Sbjct: 182 TIK-SDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-10
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 25 LVRDIGSGNFGVARLMR-----DKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 78
L R++G G FG L ++ + LVAVK + + D ++ RE +L+H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQ 125
IV+F V + L +V EY G+L + + G ++ + QQ
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 182
+ +G+ Y S HRDL N L+ + +KI DFG S+ S+ + T+
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE ++ +++ + +DVWS GV L+ + G P+
Sbjct: 187 RWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-10
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 31/212 (14%)
Query: 25 LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
L R++G G FG L + + +ELVAVK ++ + ++ +RE + +H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI--------------CNAGRFSEDEARFFF 123
NIV+F V +V EY G+L + + G + +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
Q+ SG+ Y S HRDL N L+ +KI DFG S+ +++ VG
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--VYTTDYYRVGGHT 184
Query: 184 -----YIAPEVLLKKEYDGKIADVWSCGVTLY 210
++ PE ++ +++ + +DVWS GV L+
Sbjct: 185 MLPIRWMPPESIMYRKFTTE-SDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-10
Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 39/202 (19%)
Query: 29 IGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFK 83
+G GNFG ++DK VAVK + D E + + R L+ HPNIV+
Sbjct: 3 LGKGNFGEVFKGTLKDKTP---VAVKTCKE-DLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 136
V + IVME GG+ + R +DE + +QL+ +G++Y S
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESK 112
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 188
HRDL N L+ + LKI DFG S+ SS L P + APE
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPE 164
Query: 189 VLLKKEYDGKIADVWSCGVTLY 210
L Y + +DVWS G+ L+
Sbjct: 165 ALNYGRYSSE-SDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-10
Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 45/230 (19%)
Query: 21 DRYELVRDIGSGNFGVARL-----MRDKKTEE-----------LVAVKYIERGDKIDENV 64
R +G G FG L M ++ LVAVK + R D ++N
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDA-NKNA 62
Query: 65 Q----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC----------- 109
+ +EI L+ PNI+R V +T L ++ EY G+L + +
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 110 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
+ S F Q+ SG+ Y S+ HRDL N L+ + +KI DFG S++
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN- 179
Query: 170 VLHS------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
L+S Q ++ + +LL K +DVW+ GVTL+ +L
Sbjct: 180 -LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA--SDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-10
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 24 ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL +IG G N L R T LV V+ + + +E++ Q E++ RHPN
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60
Query: 79 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
I+ V T + L ++ M Y S L + G SE + G++Y H
Sbjct: 61 IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQ 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEV 189
HR++K + L+ G L YS K+ V++ P+ + +++PE+
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179
Query: 190 LLKKEYDGKI-ADVWSCGVTLYVMLVGAYPFED 221
L + Y + +D++S G+T + G PF+D
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 24/220 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINH 71
D L+R +G G FG + R E VAVK + D+ D ++ I++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS- 64
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERIC--NAGRFSE---DEARFFFQ 124
H NIVR V I++E +GG+L F R R S + F +
Sbjct: 65 -KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKS---SVLHSQPKSTVG 180
+ G Y HRD+ N LL R+ KI DFG ++ + + + +
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE L + K DVWS GV L+ + +G P+
Sbjct: 184 PIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-09
Identities = 65/247 (26%), Positives = 104/247 (42%), Gaps = 46/247 (18%)
Query: 29 IGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVR 81
+G G FG A ++ + VAVK ++ E ++ E + + HP++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FERIC---------------NAGRFSEDEARFFFQ 124
L +++EYA G L F R ++ + DE
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 125 QLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVL 171
LIS G+ Y M++ HRDL N L+ + ++KI DFG S+ S V
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNF 228
S+ + V ++A E L Y + +DVWS GV L+ ++ +G YP PE N
Sbjct: 186 RSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL 241
Query: 229 RKTIHVM 235
KT + M
Sbjct: 242 LKTGYRM 248
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 21 DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
D+ L + +G G FG + +DK E + VAVK ++ D E ++++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 72
Query: 74 L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEAR--- 120
+ +H NI+ L +++EYAS G L E + A R +S D AR
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPD 131
Query: 121 --FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SS 169
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ ++
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNN 189
Query: 170 VLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + + + P ++APE L + Y + +DVWS GV ++ + +G P+
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-09
Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 30/223 (13%)
Query: 24 ELVRDIGSGNFG-VAR----LMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
+ ++G G FG V + ++ + VA+K ++ K+ + ++E L+H
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFE------RICNAGRFSED-------EARFFF 123
PNIV V ++ EY + G+L E + G S D + F
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 124 Q---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKS 177
Q+ +G+ Y S HRDL N L+ +KI DFG S+ S+ +
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ ++ PE +L ++ + +D+WS GV L+ + G P+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-09
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 29/221 (13%)
Query: 25 LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
L R++G G FG L + K + LVAVK ++ ++ QRE +L+H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FER--------------ICNAGRFSEDEARFF 122
IV+F V L +V EY G+L F R G +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTV 179
Q+ SG+ Y S HRDL N L+ + +KI DFG S+ S+ + T+
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE ++ +++ + +DVWS GV L+ + G P+
Sbjct: 187 LPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-09
Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 29 IGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 81
IG GNFG V R M K ++ A+K ++ + EN R+ + HPNI+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA---------RFFFQQLI----- 127
+L I +EYA G L + + + D A QQL+
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 128 --SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
+G+ Y Q HRDL N L+ + A KI DFG S+ ++ K T+G P
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLPVR 183
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y K +DVWS GV L+ ++ +G P+
Sbjct: 184 WMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-09
Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 39/224 (17%)
Query: 25 LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREI-------INHRSL 74
L + +G G FG +L +D ++ VAVK + K+D + EI +
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDF 58
Query: 75 RHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLI- 127
HPN+++ V + L +++ + G+L + R + Q L+
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLK 117
Query: 128 ------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPK 176
G+ Y + HRDL N +L + +C DFG SK S + Q +
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGR 173
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+IA E L + Y K +DVW+ GVT++ + G P+
Sbjct: 174 IAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 45/234 (19%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDENVQREI 68
DR L + +G G FG A + + VAVK + + D + E ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 69 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF------- 121
I +H NI+ V L +V+EYA+ G L + + A R + A
Sbjct: 72 IG----KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPE 126
Query: 122 ----------FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171
F Q+ G+ + S + HRDL N L+ + +KI DFG ++ +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--I 182
Query: 172 HSQP---KSTVG-TPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
H K+T G P ++APE L + Y + +DVWS GV L+ + +G P+
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-09
Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 32/217 (14%)
Query: 29 IGSGNFGVARLMRDKKTEE-----LVAVKYIERGDKIDENVQ----REIINHRSLRHPNI 79
+G G FG L + K EE LV VK +++ DEN+Q RE+ R L H N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNV 70
Query: 80 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GV 130
VR + +++EY G+L F R + +Q ++ G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 131 SYCHSMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 185
+ + + HRDL N L+ L Y+ + ++
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SKDVYNSEYYKLRNALIPL---RWL 185
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + + ++ K +DVWS GV ++ V G PF
Sbjct: 186 APEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYG 221
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-09
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 27 RDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
R IG G+FG L+ + AVK + R ++E Q +E I + HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 82 FKEVILTPTHLA-IVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVC 139
+ L +V+ Y G+L I + + + F Q+ G+ Y S +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 140 HRDLKLENTLLDGSPAPRLKICDFG-----YSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
HRDL N +LD S +K+ DFG Y K S H+ K V ++A E L
Sbjct: 121 HRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQ 175
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+++ K +DVWS GV L+ +M GA P+ D
Sbjct: 176 TQKFTTK-SDVWSFGVLLWELMTRGAPPYPD 205
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-09
Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 29 IGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 81
IG GNFG V + K + A+K ++ + ++ R+ + HPNI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFE-----RIC-----------NAGRFSEDEARFFFQQ 125
+L + +EYA G L + R+ A S + F
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G P
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 176
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVWS GV L+ ++ +G P+
Sbjct: 177 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-08
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 29/218 (13%)
Query: 27 RDIGSGNFG------VARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPN 78
+IG+G FG R M + V VK + DE + +E+ +R L HPN
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKAR----VVVKELRASATPDEQLLFLQEVQPYRELNHPN 56
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL-----FERICNAGRFSEDEARFFFQQLISGVSYC 133
+++ + +V+E+ G+L R A +D + ++ SG+ +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTP-AYIAPEVL 190
H H DL L N L + +KI D+G + + K P ++APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 191 LKKEYDGKIAD------VWSCGVTLYVML-VGAYPFED 221
+ D D +WS GVT++ + P+ D
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 28 DIGSGNFGVARL-----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 81
++G G FG L + ++ + LVAVK + E + ++ QRE L+H +IVR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FER-------------ICNAGRFSEDEARFFFQQL 126
F V L +V EY G+L F R G+ + + Q+
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
SG+ Y S+ HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTMLP 187
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLY 210
++ PE +L +++ + +D+WS GV L+
Sbjct: 188 IRWMPPESILYRKFTTE-SDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-08
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
+LV+ +G+G FG M VA+K +++G E E + L+HP +VR
Sbjct: 9 KLVKKLGAGQFGEV-WMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLY 67
Query: 84 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
V+ T + I+ EY G L F + + + ++ Q+ G+++ HR
Sbjct: 68 AVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
DL+ N L+ S KI DFG ++ + ++ + G + APE + + K
Sbjct: 127 DLRAANILV--SETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 199 IADVWSCGVTLY-VMLVGAYPF---EDPEEPKNFRK 230
+DVWS G+ L ++ G P+ +PE +N +
Sbjct: 184 -SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-08
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ +L++ +G+G FG V + T+ VAVK ++ G E+ E + LRH +
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSE-----DEARFFFQQLISGVSYC 133
V+ V+ + + IV EY S G L + + + GR + D A Q+ +G++Y
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYI 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 188
M HRDL+ N L+ KI DFG ++ L + T A + APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 173
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPF 219
L + K +DVWS G+ L ++ G P+
Sbjct: 174 AALYGRFTIK-SDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 19/182 (10%)
Query: 49 VAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104
VA+K I+ D+ +EI +H SL H IVR + + L +V + + G L
Sbjct: 39 VAIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSL 95
Query: 105 FERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163
+ + + + Q+ G+ Y ++ HR+L N LL S + ++I DF
Sbjct: 96 LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK-SDS-IVQIADF 153
Query: 164 GYSKSSVLHSQPK----STVGTP-AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAY 217
G + +L+ K S TP ++A E +L Y + +DVWS GVT++ M+ GA
Sbjct: 154 GVA--DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAE 210
Query: 218 PF 219
P+
Sbjct: 211 PY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 42 DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM-EYAS 100
D KT E V +K +RG E I+ R++ HP+I++ K +++ Y +
Sbjct: 113 DNKTCEHVVIKAGQRGGTATE---AHIL--RAINHPSIIQLKGTFTYNKFTCLILPRYKT 167
Query: 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160
+L+ + + + + ++ + Y H ++ HRD+K EN ++ P +
Sbjct: 168 --DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN-HPG---DV 221
Query: 161 C--DFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
C DFG + V + K GT A APE+L + Y G D+WS G+ L+ M
Sbjct: 222 CLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 37/112 (33%), Positives = 51/112 (45%), Gaps = 17/112 (15%)
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQP 175
+QL+S + Y H + HRD+K EN L++G IC DFG S S+ H
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226
TV T APEVL Y + D+WS G+ ++ V A F +
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDE 370
|
Length = 461 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-07
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 23/204 (11%)
Query: 16 IMHDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL 74
I +S R E+ +G G FG V + T VA+K ++ G E +E + L
Sbjct: 3 IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL 58
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE----DEARFFFQQLISGV 130
RH +V+ V+ + + IV EY S G L + + G + + Q+ SG+
Sbjct: 59 RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGM 115
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YI 185
+Y M HRDL+ N L+ + K+ DFG ++ L + T A +
Sbjct: 116 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPIKWT 170
Query: 186 APEVLLKKEYDGKIADVWSCGVTL 209
APE L + K +DVWS G+ L
Sbjct: 171 APEAALYGRFTIK-SDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-07
Identities = 42/177 (23%), Positives = 78/177 (44%), Gaps = 9/177 (5%)
Query: 39 LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98
L+ D +T++ +K + + + + II H PN+V + I++ + +V+++
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66
Query: 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
A GG+L+ I E+ + + +++ + H + RDL N LLD +L
Sbjct: 67 AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126
Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+S+ S + Y APEV E + + D WS G L+ +L G
Sbjct: 127 TY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-07
Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 18/219 (8%)
Query: 24 ELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
+L + +G+G FG V +K T+ VAVK ++ G E E ++L+H +V+
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 83 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V+ T + I+ E+ + G L F + + + F Q+ G+++ H
Sbjct: 67 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
RDL+ N L+ S + KI DFG ++ K + + APE + +
Sbjct: 126 RDLRAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAINFGSF 180
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH 233
K +DVWS G+ L ++ G P+ P+ R
Sbjct: 181 TIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 39/231 (16%)
Query: 22 RYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL 74
R L + +G G FG + +DK + + VAVK + + D D+++ ++++ +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLS-DLVSEMEM 70
Query: 75 -----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EA 119
+H NI+ L +++EYAS G L E + A R +S D E
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEE 129
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
+ F+ L+S G+ Y S + HRDL N L+ +KI DFG ++ +
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNI 187
Query: 172 HSQPKSTVGT-PA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
K+T G P ++APE L + Y + +DVWS GV L+ + +G P+
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ R++++ +G G FG D+K +E AVK + K + + EI +R +
Sbjct: 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADP 187
Query: 80 V-RFKEVILT------PTHLAIVM-EYASGGELFERICNAGRFSEDE-ARFFFQQLISGV 130
RF + + H+ IVM +Y G L + I G FS A+ FQ ++ +
Sbjct: 188 ADRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGVA-L 244
Query: 131 SYCHS-MQVCHRDLKLENTLLDGS-------------PAP-RLKICDFGYSKSSVLHSQP 175
Y H+ + + H DLK EN L++ S P P R++ICD G HS+
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR- 302
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+ V T Y +PEV+L + D+WS G +Y + G
Sbjct: 303 TAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 11/101 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSAR 237
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
P ++APE + K Y + +DVWS GV L+ + +GA P+
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-07
Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 23 YELVRDIGSGNFG-VARLMRDKKTEEL---VAVKYIERGD--KIDENVQREIINHRSLRH 76
++ ++ +GSG FG V + + + E++ VA+K + K ++ + E S+ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHS 135
P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 69 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVL 190
++ HRDL N L+ +KI DFG +K +L + K ++A E +
Sbjct: 128 RRLVHRDLAARNVLVKT--PQHVKITDFGLAK--LLGADEKEYHAEGGKVPIKWMALESI 183
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
L + Y + +DVWS GVT++ +M G+ P++
Sbjct: 184 LHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-07
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVK----YIERGDKIDENVQREIINHRSLRHPNIVR 81
IG GNFG AR+ +D + A+K Y + D D + E++ + HPNI+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLC-KLGHHPNIIN 72
Query: 82 FKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSEDEARFFFQQ 125
+L + +EYA G L + + A S + F
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G P
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 188
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVWS GV L+ ++ +G P+
Sbjct: 189 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-07
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 26 VRDIGSGNFGVAR---LMRDKKTEEL-VAVKYIER--GDKIDENVQREIINHRSLRHPNI 79
V+ +GSG FG + + +T ++ VA+K + G K + E + S+ HP++
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
VR V L+PT + +V + G L + + + + Q+ G+ Y ++
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKK 193
HRDL N L+ SP +KI DFG ++ +L K ++A E + +
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFE 220
++ + +DVWS GVT++ +M G P++
Sbjct: 187 KFTHQ-SDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-07
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 11/182 (6%)
Query: 41 RDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100
+ + V VK + G + REI +++ H I+ + + +VM
Sbjct: 114 HGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169
Query: 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160
+LF + +G ++A ++L+ ++Y H + HRD+K EN LD L
Sbjct: 170 C-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG- 227
Query: 161 CDFGYSKSSVLHS-QPKST--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217
DFG + H P+ GT +PE+L Y K D+WS G+ L+ M V
Sbjct: 228 -DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNV 285
Query: 218 PF 219
Sbjct: 286 TL 287
|
Length = 392 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-07
Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
P ++APE + K Y + +DVWS GV L+ + +GA P+
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 9e-07
Identities = 43/209 (20%), Positives = 78/209 (37%), Gaps = 22/209 (10%)
Query: 41 RDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100
E V +K + + L H ++V+ V + ++ +V EY
Sbjct: 25 VGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVK 83
Query: 101 GGEL-----FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----- 150
G L E+ + + D A +QL S + Y ++ H ++ +N L+
Sbjct: 84 FGPLDVFLHREKNNVSLHWKLDVA----KQLASALHYLEDKKLVHGNVCGKNILVARYGL 139
Query: 151 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA-DVWSCGVTL 209
+ P +K+ D G + + + + +IAPE + + IA D WS G TL
Sbjct: 140 NEGYVPFIKLSDPGIPITVLSREERVERI---PWIAPECIRNGQASLTIAADKWSFGTTL 196
Query: 210 Y-VMLVGAYPFE--DPEEPKNFRKTIHVM 235
+ G P E + F + H +
Sbjct: 197 LEICSNGEEPLSTLSSSEKERFYQDQHRL 225
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-07
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-------ENVQREIINHRSLRHP 77
L + +G G FG +M + ++ +K + KI E+ E + + HP
Sbjct: 3 LGKTLGEGEFG--SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 78 NIVRFKEVILTPTHL------AIVMEYASGGEL-----FERICNAGRFSEDEARF-FFQQ 125
N++R V L +++ + G+L + R+ + ++ + F
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKSTVG 180
+ SG+ Y S HRDL N +L+ + + +C DFG SK + + Q +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNEN----MNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
+IA E L + Y K +DVWS GVT++
Sbjct: 177 PVKWIAIESLADRVYTTK-SDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 21 DRYELVRDIGSGNFG-VARLMR---DKKTEE---LVAVKYIERGDKIDENVQREIINHRS 73
DR L + +G G FG V R DK + VAVK + + + D+++ ++I+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLA-DLISEME 69
Query: 74 L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----E 118
L +H NI+ V L +++EYA+ G L E + A R ++ D E
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPE 128
Query: 119 ARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--S 169
+ F+ L+S G+ Y S + HRDL N L+ +KI DFG ++
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHD 186
Query: 170 VLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + + S P ++APE L + Y + +DVWS G+ ++ + +G P+
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 26 VRDIGSGNFG-VARLMRDKKTEEL---VAVKYIERGD--KIDENVQREIINHRSLRHPNI 79
V+ +GSG FG V + + E + VA+K + K ++ + E + P +
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
R + LT T + +V + G L + + N R + + Q+ G+SY +++
Sbjct: 72 CRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLLKKEY 195
HRDL N L+ SP +KI DFG ++ + G ++A E +L + +
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFE 220
+ +DVWS GVT++ +M GA P++
Sbjct: 189 THQ-SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 35/110 (31%), Positives = 54/110 (49%), Gaps = 9/110 (8%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 178
F Q+ +G+ + S HRDL N L+ +KICDFG ++ + S ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKN 227
++APE + Y ++DVWS G+ L+ + +G P+ PE P N
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPY--PELPMN 348
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 64/233 (27%), Positives = 101/233 (43%), Gaps = 41/233 (17%)
Query: 21 DRYELVRDIGSGNFGVARL-----MRDKKTEEL--VAVKYIER-------GDKIDENVQR 66
DR L + +G G FG + + +K + VAVK ++ D I E
Sbjct: 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 77
Query: 67 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED----- 117
++I +H NI+ L +++EYAS G L E R + +
Sbjct: 78 KMIG----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 118 EARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-S 169
E + F+ L+S G+ Y S + HRDL N L+ +KI DFG ++
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIH 191
Query: 170 VLHSQPKSTVGT-PA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ K+T G P ++APE L + Y + +DVWS GV L+ + +G P+
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 242
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
P ++APE + + Y + +DVWS GV L+ + +GA P+
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 23 YELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
+ L R +G G FG R L + + + VAVK ++ +++ RE + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 77 PNIVRFKEVIL---TPTHLAIVM---EYASGGELFERICNAGRFSEDEARFFFQQLI--- 127
PN+++ V L L I M + G+L + R E+ Q L+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFM 119
Query: 128 ----SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKST 178
SG+ Y S HRDL N +L+ + + +C DFG SK S + Q ++
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVW+ GVT++ +M G P+
Sbjct: 176 KLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 19/227 (8%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINH 71
+ + +G+G FG A + VAVK ++ E + +I++H
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
H NIV + ++ EY G+L F R + ++ F Q+ G
Sbjct: 95 LG-NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA-YIA 186
+++ S HRDL N LL + +KICDFG ++ + S K P ++A
Sbjct: 154 MAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTI 232
PE + Y + +DVWS G+ L+ + +G+ P+ F K I
Sbjct: 212 PESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI 257
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-06
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 27 RDIGSGNFGVARL--MRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 82
++IG+G FG L + T V VK + + E ++ E +RSL+H N+++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 83 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ---QLISGVSYCHSMQ 137
T +VME+ G+L + R C + + ++ G+ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEV 189
H DL L N LL +KI D+G S H++ K +IAPE+
Sbjct: 121 FIHSDLALRNCLLTADLT--VKIGDYGLS-----HNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 190 LLKKEYDG--------KIADVWSCGVTLYVML-VGAYPF 219
+ E G K ++VWS GVT++ + +G+ P+
Sbjct: 174 V--DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-06
Identities = 23/48 (47%), Positives = 30/48 (62%), Gaps = 2/48 (4%)
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
+GTP Y+APE+LL K + G D W+ GV L+ L G PF D E P+
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFND-ETPQ 586
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 25/202 (12%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
I G G + + K VK I + I + EI + L+HPNIV+ + +
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS---EIADMGKLQHPNIVKLIGLCRS 754
Query: 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS------YCH-SMQVCHR 141
++ EY G L E + N E R +++ G++ +C S V
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRNLSW----ERR---RKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
+L E ++DG P L++ S +L + K + + AY+APE K+ K +D
Sbjct: 808 NLSPEKIIIDGKDEPHLRL-----SLPGLLCTDTKCFISS-AYVAPETRETKDITEK-SD 860
Query: 202 VWSCGVTLYVMLVGAYPFEDPE 223
++ G+ L +L G P D E
Sbjct: 861 IYGFGLILIELLTGKSP-ADAE 881
|
Length = 968 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
F Q+ G+ + S HRDL N LL + +KICDFG ++ ++H + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298
Query: 182 P----AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++APE + Y ++DVWS G+ L+ + +G P+
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-06
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 48 LVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103
LVAVK I R D ++N + + + L+ PNI+R V + L ++ EY G+
Sbjct: 48 LVAVK-ILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 104 LFERICNAGRFSEDEAR--------------------FFFQQLISGVSYCHSMQVCHRDL 143
L + ++ + E Q+ SG+ Y S+ HRDL
Sbjct: 106 L-NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKKEYDGK 198
N L+ + +KI DFG S++ L++ + A ++A E +L ++
Sbjct: 165 ATRNCLVGENLT--IKIADFGMSRN--LYAGDYYRIQGRAVLPIRWMAWECILMGKFT-T 219
Query: 199 IADVWSCGVTLY--VMLVGAYPF 219
+DVW+ GVTL+ +ML P+
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPY 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 47/197 (23%), Positives = 89/197 (45%), Gaps = 29/197 (14%)
Query: 47 ELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102
+ VA+K ++ DK + E + E + L+HPNIV V+ L+++ Y S
Sbjct: 36 QAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93
Query: 103 ELFERIC------NAGRFSEDE--------ARFF--FQQLISGVSYCHSMQVCHRDLKLE 146
+L E + + G +D+ A F Q+ +G+ + S V H+DL
Sbjct: 94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153
Query: 147 NTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
N L+ +KI D G + ++ + +++ +++PE ++ ++ +D+W
Sbjct: 154 NVLV--FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIW 210
Query: 204 SCGVTLY-VMLVGAYPF 219
S GV L+ V G P+
Sbjct: 211 SYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 28/197 (14%)
Query: 47 ELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104
+LVA+K ++ + + Q+E L HPNIV V+ + ++ EY + G+L
Sbjct: 35 QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 105 FERI----------CNAG-----RFSEDEARFFFQ--QLISGVSYCHSMQVCHRDLKLEN 147
E + C++ + S D F Q+ +G+ Y S H+DL N
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154
Query: 148 TLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
L+ +KI D G S+ + QPKS + ++ PE ++ ++ +D+W
Sbjct: 155 ILI--GEQLHVKISDLGLSREIYSADYYRVQPKSLLPI-RWMPPEAIMYGKFSSD-SDIW 210
Query: 204 SCGVTLY-VMLVGAYPF 219
S GV L+ + G P+
Sbjct: 211 SFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-05
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
+G G FG + T + VA+K ++ G + E +E + LRH +V V+ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71
Query: 89 PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
+ IV E+ G L F + + + Q+ G++Y M HRDL+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA 131
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKKEYDGKIAD 201
N L+ + KI DFG ++ L + T A + APE L + K +D
Sbjct: 132 NILVGDNLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SD 185
Query: 202 VWSCGVTLYVMLV-GAYPF 219
VWS G+ L ++ G P+
Sbjct: 186 VWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-05
Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 25/170 (14%)
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ----QL 126
+R L+HPNI++ + +V EY G+L + + Q ++
Sbjct: 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI 108
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS----KSSVLHSQPKSTVGTP 182
+GV++ H H DL L N L +K+ D+G K + ++ V
Sbjct: 109 AAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPL- 165
Query: 183 AYIAPEVLLKKEYDG-------KIADVWSCGVTLYVMLVGAYPFEDPEEP 225
++APE L+ + + G K ++VW+ GVTL+ + FE+ +P
Sbjct: 166 RWLAPE-LVGEFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQ 174
+D RF Q + G+ + S HRD+ N LL DG A KICDFG ++ + S
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSN 267
Query: 175 --PKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPF 219
K P ++APE + Y + +DVWS G+ L+ + +G P+
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 7e-04
Identities = 38/123 (30%), Positives = 55/123 (44%), Gaps = 7/123 (5%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV 179
F Q+ G+S+ S HRDL N LL + KICDFG ++ S K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 180 GTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHVMYC 237
P ++APE + Y + +DVWS G+ L+ + +G+ P+ F K I Y
Sbjct: 277 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335
Query: 238 TFS 240
S
Sbjct: 336 MLS 338
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.001
Identities = 27/83 (32%), Positives = 39/83 (46%), Gaps = 13/83 (15%)
Query: 133 CHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+++ HR K N LL DG G SV P+ + P ++APEV+
Sbjct: 27 LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
+ Y K AD++S G+TLY L
Sbjct: 77 QGQSYTEK-ADIYSLGITLYEAL 98
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
++ L+R++G G+FG AR + + E VAVK + + E + E +N S+
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63
Query: 76 HP----NIVRFKEVILTPTHLAIVMEYASGGEL--FERIC------NAGRFSE--DEARF 121
++VR V+ +VME + G+L + R N GR E
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 178
++ G++Y ++ + HRDL N ++ +KI DFG ++ + + +
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDYYRKGGKG 181
Query: 179 VGTPAYIAPEVLLKKEYDGKI---ADVWSCGVTLY 210
+ ++APE L DG +D+WS GV L+
Sbjct: 182 LLPVRWMAPESL----KDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 240 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.64 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.55 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.45 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.31 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.3 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.28 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.12 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.11 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.11 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.08 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.92 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.84 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.73 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.6 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.53 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.48 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.47 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.34 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.32 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.28 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.27 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.27 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.16 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.15 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.13 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.12 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 98.04 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.0 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.89 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.89 | |
| PLN02236 | 344 | choline kinase | 97.65 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.65 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.61 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.61 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.6 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.58 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.58 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.45 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.28 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.17 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.12 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.11 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.01 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.99 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.88 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.6 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.58 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.49 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.07 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.42 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.85 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.52 | |
| COG3231 | 266 | Aph Aminoglycoside phosphotransferase [Translation | 94.2 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.08 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=303.43 Aligned_cols=212 Identities=40% Similarity=0.644 Sum_probs=193.4
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
...+|.+.+.||.|+|++||+|++..++..||||.+.... ...+....|+.+|+.++||||+.+++++.+++.+++|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3479999999999999999999999999999999987642 3345678999999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC-CC---CcEEEecCCccccccc
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PA---PRLKICDFGYSKSSVL 171 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~-~~---~~~~L~d~~~~~~~~~ 171 (240)
||||+||.|.+++.+.+.+++..++.++.||+.|+++||+++|||+||||.|||++.+ .. ..+|++|||+++....
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999999999999999999999999999999999999999999999999999765 22 4699999999998888
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
.....+..|++.|||||++....++.+ +|+||+|+++|+|++|..||...+..+.+..+
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~ 226 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLLYI 226 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence 888888899999999999987887666 99999999999999999999988877776644
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=296.00 Aligned_cols=215 Identities=37% Similarity=0.623 Sum_probs=196.0
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
...+++|++++.||+|+||+||+++...+++.||+|++++.. ...+...+|..+|..++||.|+++.-.|.+...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 346799999999999999999999999999999999997742 2345678999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~- 171 (240)
|+|++|+.||.|...+++++.+++..++.++.+|+.||.|||+.|||||||||+|||++.+++ ++|+|||++.....
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccC
Confidence 999999999999999999999999999999999999999999999999999999999987776 99999999974443
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
+....+..|++.|||||++.+..++.. +|+||||+++|+|++|..||.+.+....+++|++.
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~ 240 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG 240 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC
Confidence 445566789999999999999877666 99999999999999999999999999999988764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=307.90 Aligned_cols=214 Identities=39% Similarity=0.610 Sum_probs=198.4
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeec----CccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
.+|++.+.||+|+|+.+|.+++..+|+.||+|++.+ .+...+...+|+++++.++|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 789999999999999999999999999999999987 4566678899999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~ 175 (240)
|.|+.++|-.++++.+++++.++..+++||+.|+.|||+.+|+||||+..|+|++++.+ +|++|||+|...... ...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCccccc
Confidence 99999999999998899999999999999999999999999999999999999988877 999999999877755 666
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceece
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYC 237 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (240)
.+..|++.|.|||++.+....-. +||||+||++|.|+.|.+||...+..+.+++|-..-|-
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~ 236 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS 236 (592)
T ss_pred ceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc
Confidence 77889999999999987777666 99999999999999999999999999999888766554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=296.11 Aligned_cols=219 Identities=39% Similarity=0.617 Sum_probs=194.1
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--------ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (240)
-.+.|.+.+.||+|+||.|-+|....+|+.||||++..... ......+|+++|++++||||+++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 44889999999999999999999999999999999976421 1234579999999999999999999999999
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC-cEEEecCCccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSS 169 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~-~~~L~d~~~~~~~ 169 (240)
+.|+|+||++||.|.+.+..++.+.+...+.+++|++.|+.|||+.||+||||+|+|||+..+... .+|+.|||+|...
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999776332 4899999999887
Q ss_pred cccCCCCCCcCCccccCccccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCchh-hhhhhhceece
Q 026299 170 VLHSQPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-NFRKTIHVMYC 237 (240)
Q Consensus 170 ~~~~~~~~~~~~~~~~~pE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~ 237 (240)
.......+..|++.|.|||++.+.. .++.+.|+|||||++|-+++|.+||.+..... ..++|.+.-|.
T Consensus 330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA 400 (475)
T ss_pred ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence 7777778889999999999997654 44556899999999999999999999875555 77888776654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=290.26 Aligned_cols=198 Identities=33% Similarity=0.548 Sum_probs=182.4
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeec--CccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe-EEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~~ 97 (240)
.+.+.+..||.|+.|+||+++++.++..+|+|++.. ++....++.+|+++++.++||||+.+||.|.+++. ..++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 478889999999999999999999999999999944 44555788999999999999999999999999984 999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
||++|||.+++.+.+.+++..+-.++.++++||.|||+ .+|+||||||+|+|++..+. +||+|||++...... ...
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~a~ 235 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-IAN 235 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-hcc
Confidence 99999999999988889999999999999999999995 89999999999999988777 999999998766555 667
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
+..|+..|||||.+.+..++.+ +||||||..++|+..|+.||...
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred cccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCc
Confidence 7899999999999999998877 99999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=290.98 Aligned_cols=220 Identities=52% Similarity=0.826 Sum_probs=198.2
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----c--cccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCC
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----D--KIDENVQREIINHRSLR-HPNIVRFKEVILTPT 90 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 90 (240)
...++|.+.+.||.|+||.|+.+.+..++..||+|.+... . ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457999999999999999999999999999999976553 1 23456678999999999 999999999999999
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc-
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS- 169 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~- 169 (240)
.+++||||+.||.|.+++.+.+++.+.+...+++|++.|++|+|+.||+||||||+|++++.+. .++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccC
Confidence 9999999999999999999888999999999999999999999999999999999999998873 34999999999877
Q ss_pred cccCCCCCCcCCccccCccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceecee
Q 026299 170 VLHSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCT 238 (240)
Q Consensus 170 ~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (240)
..........|++.|.|||.+.+.. +...++||||+|++||.|++|..||.+.+...++++|.+.-+.-
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~ 242 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI 242 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC
Confidence 4566777889999999999999988 88888999999999999999999999999999999977765543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=273.51 Aligned_cols=213 Identities=34% Similarity=0.612 Sum_probs=194.4
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
.-++|+.++.||.|+||+|.+++.+.+|..||+|++.... ...+...+|..+|+.+.||.++++.+.+.+.+.+++
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 4478999999999999999999999999999999987753 334667899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
||||++||.|..++.+.+++++...+.++.||+.||+|||+.+|++||++|+|||++.++. +|+.|||++......
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSGR-- 197 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecCc--
Confidence 9999999999999999999999999999999999999999999999999999999988776 999999998655333
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceec
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (240)
..+..|++.|+|||.+........ +|+||||+++|||+.|..||.+.+....++||+..-+
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynka-vDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v 258 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKA-VDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV 258 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcc-hhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc
Confidence 567789999999999988877554 9999999999999999999999999999999987654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=291.65 Aligned_cols=217 Identities=33% Similarity=0.522 Sum_probs=192.0
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 92 (240)
..+.+|.+.+.||.|+|++|++|++..++..||||++.+.. ........|-..|.+| .||.|++++-.|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34579999999999999999999999999999999987642 2223456777888888 899999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
|+|++|.++|.|.+++.+.+.+++...+.++.+|+.||+|||+.|||||||+|+|||++.++. ++|.|||.+......
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPS 227 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChh
Confidence 999999999999999999999999999999999999999999999999999999999988877 999999998533221
Q ss_pred C------------CC--CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceece
Q 026299 173 S------------QP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYC 237 (240)
Q Consensus 173 ~------------~~--~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (240)
. .. .+++|+..|.+||.+.++..+.. +|+|+|||++|+|+.|..||.+.++.-.|++|++.-|-
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE 305 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence 1 11 45779999999999988887666 99999999999999999999999999999999987653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=286.77 Aligned_cols=215 Identities=34% Similarity=0.562 Sum_probs=190.1
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++++.||+|+||.||+|+...+|+.+|+|++.+.... -+..+.|-.+|....+|+||+++-.|.+.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 448999999999999999999999999999999999875433 3567788888888899999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc---
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 171 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~--- 171 (240)
||||++||.+.++|.+.+.|++...+.++.+++.|++.||+.|++|+||+|+|+|++..++ +||.|||++.....
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999987776 99999999841110
Q ss_pred --------------------cCC-----CC--------------------CCcCCccccCccccccCCCCCcccchHHHH
Q 026299 172 --------------------HSQ-----PK--------------------STVGTPAYIAPEVLLKKEYDGKIADVWSCG 206 (240)
Q Consensus 172 --------------------~~~-----~~--------------------~~~~~~~~~~pE~~~~~~~~~~~~Di~slG 206 (240)
... .. +.+|++.|+|||++.+..+... +|+||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHHHH
Confidence 000 00 1248899999999999886555 9999999
Q ss_pred HHHHHHHhCCCCCCCCCchhhhhhhhceec
Q 026299 207 VTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236 (240)
Q Consensus 207 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (240)
|++|||+.|..||.+.+...++++|+.+-.
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~ 405 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRE 405 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhh
Confidence 999999999999999999999999998753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=273.07 Aligned_cols=210 Identities=26% Similarity=0.485 Sum_probs=183.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+++|+.+..+|+|++|+|+++++..+|+.||||++...+. ..+..++|+++|++++|+|++.++++|.......+|+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 4689999999999999999999999999999999976443 3356799999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc-ccCC
Q 026299 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQ 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~-~~~~ 174 (240)
||++. ++.+-+++. ..++.+.++.+++|++.|+.|+|+.+++||||+|+||++..++. +||||||+|+... ++..
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcch
Confidence 99987 444445543 45899999999999999999999999999999999999988887 9999999998665 4455
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
....+.+.+|.|||.+.+...+.+..||||+||++.||++|+..|++..+-|++=.|.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ 215 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIR 215 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHH
Confidence 5566778899999999997777776999999999999999999999998887755443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=288.89 Aligned_cols=219 Identities=32% Similarity=0.486 Sum_probs=197.4
Q ss_pred CcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccH--HHHHHHHHHHhcC-CCCeeeeeEEEEcCC
Q 026299 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLR-HPNIVRFKEVILTPT 90 (240)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~--~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 90 (240)
+...+.+++|+++++||.|.||.||+|+...+++.||||+++..-...+ --++|+..|+++. ||||+++.+++.+.+
T Consensus 3 ~~~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 3 LTQVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred ceehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 3445567899999999999999999999999999999999977532222 3479999999998 999999999999987
Q ss_pred -eEEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 91 -HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 91 -~~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
.+++||||++. +|.+.+.. ++.+++..+..|++||++||+++|+.|+.|||+||+|||+..... +||+|||+|+.
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARe 159 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLARE 159 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEecccccccc
Confidence 89999999976 89988864 457999999999999999999999999999999999999975444 99999999999
Q ss_pred ccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
.....+....+-+.+|.|||++.+...++.+.|+||+||+++|+.+-+..|.+.++.|++-||++++
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VL 226 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVL 226 (538)
T ss_pred cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHh
Confidence 8888888888889999999999999888888999999999999999999999999999999998764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=282.26 Aligned_cols=212 Identities=31% Similarity=0.526 Sum_probs=188.5
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--CeEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAI 94 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 94 (240)
.+.|+.+++||+|.||.||+|++..+|+.||+|++..+. ....-..+|+.+|+++.||||+++.++..+. ..+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 368999999999999999999999999999999997754 2334578999999999999999999998876 68999
Q ss_pred EEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
|+||++. .|..++... -.+++.+++.++.||+.||+|+|.+|+.||||+.+|||++.++. +||+|||+|+......
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSG 272 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCC
Confidence 9999976 777777553 37999999999999999999999999999999999999988777 9999999998555443
Q ss_pred --CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 174 --~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.....+.+.+|.|||.+.+...+..+.|+||.||++.||+.|...|.+.++.+++.+|.+.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl 335 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL 335 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH
Confidence 3445667889999999999998888899999999999999999999999999999988764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=259.32 Aligned_cols=212 Identities=30% Similarity=0.482 Sum_probs=190.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|...+.+|+|.||.||+|++..+|+.||||++...... ....++|++.|+.++|+||+.+.++|.+.+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 6899999999999999999999999999999999886443 4678999999999999999999999999999999999
Q ss_pred cCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
|++. .|+..+.. ...++...++.++.++++|++|+|++.|.||||||+|++++.++. +||+|||+++...+.....
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCccc
Confidence 9976 78887754 457999999999999999999999999999999999999998887 9999999998766554443
Q ss_pred C-CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 177 S-TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 177 ~-~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
. .+.+..|.|||.+++...+....|+||.||++.||+-|..-|.+.++-+++.+|.+.+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~L 218 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRAL 218 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHc
Confidence 3 3567889999999999888888999999999999999999999999999998887754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=274.27 Aligned_cols=217 Identities=40% Similarity=0.682 Sum_probs=203.4
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc----HHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
-+|++.+.||+|.+|.|-+|.....|..|+||.+.++.-.. -.+.+|+++++.++||||+.++++|++.+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 47999999999999999999999999999999998764333 35789999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
||.++|.|.+++.+.+.+++.+...+++||..|+.|.|..+++|+||+.+||+++.+++ +|++|||++..........
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHHH
Confidence 99999999999999999999999999999999999999999999999999999998887 9999999998888888888
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceeceee
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCTF 239 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (240)
++.|++-|.+||+..+.++..+..|.||||++||.|+.|.+||.+.+....+++|-+..|-.+
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP 273 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP 273 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC
Confidence 999999999999999999988889999999999999999999999999999999988877543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=269.63 Aligned_cols=208 Identities=35% Similarity=0.528 Sum_probs=186.9
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--C---eEEEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--T---HLAIVM 96 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~---~~~lv~ 96 (240)
.|+-.+.+|.|+||.||++...++++.||||++..+.... -+|+.+++.+.||||+++.-+|... . +..+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 6889999999999999999999999999999998876543 4699999999999999998887643 2 456999
Q ss_pred ecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 97 ~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
||++- +|...+.. +..++...++-+.+||++||.|||+.||+||||||.|+++|.+. +.+||+|||.|.....+
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t-g~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT-GVLKICDFGSAKVLVKG 179 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC-CeEEeccCCcceeeccC
Confidence 99965 78777753 56789999999999999999999999999999999999998664 35999999999999999
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.+..+..++..|.|||.+.+...++.+.||||.||++.||+-|+..|.+.+..++++.|++.
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~ 241 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV 241 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH
Confidence 99999999999999999999998888899999999999999999999999999999888764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=273.39 Aligned_cols=210 Identities=35% Similarity=0.494 Sum_probs=180.2
Q ss_pred CcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCC
Q 026299 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT 90 (240)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (240)
....++....++.+.+|.|+||+||++.+..+ ..|++|.+...... .+.+.+|+.++.+++||||++++|++.+..
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 44555677888888899999999999999733 22999998765433 348999999999999999999999999887
Q ss_pred -eEEEEEecCCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCC-ceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 91 -HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 91 -~~~lv~~~~~~~~l~~~l~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~-ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
.+++||||+++|+|.+++.. ...++...+..++.+|+.|++|||+.+ |||+||||+|+|++.+. .++|++|||++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGls 191 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLS 191 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccc
Confidence 79999999999999999987 578999999999999999999999999 99999999999998776 24999999999
Q ss_pred cccccc-CCCCCCcCCccccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 167 KSSVLH-SQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 167 ~~~~~~-~~~~~~~~~~~~~~pE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
+..... .......|+..|||||.+.+ ..++. ++||||||+++|+|++|..||.+.....
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~-K~DvySFgIvlWEl~t~~~Pf~~~~~~~ 253 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTE-KSDVYSFGIVLWELLTGEIPFEDLAPVQ 253 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCc-cchhhhHHHHHHHHHHCCCCCCCCCHHH
Confidence 766554 33344678999999999984 45544 4999999999999999999999987633
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=276.80 Aligned_cols=210 Identities=29% Similarity=0.527 Sum_probs=181.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++++.||+|++|.||++++..++..|++|++.... .....+.+|..++..++|+||+++++.+.++..+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999987532 22245678999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC---
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~--- 173 (240)
||+++++|.+++.+.+.+++..+..++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987765 9999999975332110
Q ss_pred ---------------------------------CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026299 174 ---------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (240)
Q Consensus 174 ---------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (240)
......|++.|+|||.+.+...+.+ +|+||||+++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCC
Confidence 0112357889999999987776555 999999999999999999999
Q ss_pred CCCchhhhhhhhc
Q 026299 221 DPEEPKNFRKTIH 233 (240)
Q Consensus 221 ~~~~~~~~~~~~~ 233 (240)
+.+....+.+++.
T Consensus 238 ~~~~~~~~~~i~~ 250 (363)
T cd05628 238 SETPQETYKKVMN 250 (363)
T ss_pred CCCHHHHHHHHHc
Confidence 8887777777664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=281.73 Aligned_cols=210 Identities=33% Similarity=0.472 Sum_probs=190.6
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC------CCCeeeeeEEEEcCCeEEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR------HPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv 95 (240)
+|+|++.||+|.||.|.+|.+..+++.||||++++......+...|+.+|..++ .-|+++++++|...++.|+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 889999999999999999999999999999999998888888999999999986 24799999999999999999
Q ss_pred EecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
+|.++. +|.++++.+. .++...++.++.||+.+|..||+.|||||||||+|||+.+.....+|++|||.+.......
T Consensus 267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v 345 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV 345 (586)
T ss_pred ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc
Confidence 999965 9999998664 5889999999999999999999999999999999999987777789999999987443322
Q ss_pred CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
- ....+..|.|||++.+.++... .|+|||||+++||.+|...|.+.++.+++.+|++..
T Consensus 346 y--tYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 346 Y--TYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred e--eeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 2 5667889999999999999887 999999999999999999999999999999998753
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=272.75 Aligned_cols=215 Identities=38% Similarity=0.607 Sum_probs=183.2
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-----------c----ccHHHHHHHHHHHhcCCCCeeeeeE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------K----IDENVQREIINHRSLRHPNIVRFKE 84 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----------~----~~~~~~~e~~~l~~l~h~~i~~~~~ 84 (240)
.+.|++.+.||+|.+|.|-+|++..+++.||||++.+.. . ..+...+|+.++++++|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 378999999999999999999999999999999985411 1 1146889999999999999999999
Q ss_pred EEEcC--CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEec
Q 026299 85 VILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (240)
Q Consensus 85 ~~~~~--~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d 162 (240)
+..+. +.+|+|+||++.|.+.+.-.....+++.+.+.++++++.||+|||..||+||||||+|+|++.++. +||+|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIsD 253 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKISD 253 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--EEeec
Confidence 98775 679999999998888764433334999999999999999999999999999999999999988866 99999
Q ss_pred CCcccccccc------CCCCCCcCCccccCcccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 163 FGYSKSSVLH------SQPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 163 ~~~~~~~~~~------~~~~~~~~~~~~~~pE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
||++.....+ .......|++.|+|||.+.+ ......+.||||+|++||.|+.|..||-+.....++.||+.
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 9998654222 11233569999999999977 34556778999999999999999999999999999999986
Q ss_pred eec
Q 026299 234 VMY 236 (240)
Q Consensus 234 ~~~ 236 (240)
.-+
T Consensus 334 ~pL 336 (576)
T KOG0585|consen 334 DPL 336 (576)
T ss_pred Ccc
Confidence 543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=281.85 Aligned_cols=210 Identities=36% Similarity=0.631 Sum_probs=188.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc---HHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+++|-+.+.+|+|+||+||+++...+.+.||+|.+.+.-+.. ....+|+++++.++||||+..+++|+....+|+|+
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 368999999999999999999999999999999987754333 45789999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
||+.| +|..++...+.++++.+..++.+++.||.|||+.+|.|+|++|.||++..+++ +||+|||+++.........
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceee
Confidence 99988 99999999999999999999999999999999999999999999999987777 9999999998777655443
Q ss_pred -CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 177 -STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 177 -~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
+.-|++.|||||...+.+++.. +|.|||||++|||..|+.||........++.|+.
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~ 214 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYARSITQLVKSILK 214 (808)
T ss_pred eeccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc
Confidence 3458999999999998888777 9999999999999999999988777776666653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=268.39 Aligned_cols=208 Identities=35% Similarity=0.593 Sum_probs=180.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||+|++|.||++.+..+++.|++|++.... ...+.+.+|+..++.++||||+++++++.++..+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999986532 22345788999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
||+++++|.+++.+.+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~--~~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLRD--RTW 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhccC--Ccc
Confidence 99999999999988888999999999999999999999999999999999999987665 99999999864432 222
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
...+++.|+|||.+.+...+.+ +||||||+++|+|++|..||...+....+.++..
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~ 212 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA 212 (291)
T ss_pred cccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 3457889999999887776544 9999999999999999999988776665555543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=270.63 Aligned_cols=210 Identities=33% Similarity=0.569 Sum_probs=182.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++.+.||.|++|.||++++..+++.|++|.+.... ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 3489999999999999999999999999999999987542 223467899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
+|||+++++|.+.+.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+..... .
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~--~ 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPD--R 171 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCC--C
Confidence 9999999999999988888999999999999999999999999999999999999987766 99999999864422 2
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.....+++.|+|||.+.+...+.. +|+||||+++|+|++|..||.+.+....++++..
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 229 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 223467889999999987776544 9999999999999999999988776665555543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=264.99 Aligned_cols=213 Identities=32% Similarity=0.476 Sum_probs=183.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEE-cC-CeEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVIL-TP-THLAIV 95 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~-~~~~lv 95 (240)
..|++.++||.|+||.||++++..+|..+|.|.+.-+. ....+...|+.+|++++||||++++++.. .+ ..+++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 67999999999999999999999999999999987543 33356789999999999999999999443 33 348999
Q ss_pred EecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhh--CC--ceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS--MQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~--~~--ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
||++++|.|...++. .+.+++..+|.++.|++.||..+|. .. +.|+||+|.||+++.++. +||+|||+++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r 176 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGR 176 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhHh
Confidence 999999999988753 3459999999999999999999998 45 999999999999987776 9999999997
Q ss_pred ccccc-CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceec
Q 026299 168 SSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236 (240)
Q Consensus 168 ~~~~~-~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (240)
..... ....+.+|++.||+||.+.+.++..+ +|||||||++|+|..-+.||.+.+-....+||-..-+
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY 245 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence 55544 33356789999999999988888666 9999999999999999999999988777777766533
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=278.65 Aligned_cols=217 Identities=38% Similarity=0.717 Sum_probs=202.4
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
..|++.+-||.|+.|.|.+|++..+|+.+|||.+... +.....+.+|+.+++.+.|||++.+++++.+...+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 7899999999999999999999999999999998664 233456889999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
||++||.|.+++.+.+++++.+...+++||+.|+.|+|..+|+|+|++|+|++++.... +|++|||.|.....+....
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLLE 169 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCcccc
Confidence 99999999999999999999999999999999999999999999999999999987776 9999999998888888888
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceeceee
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCTF 239 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (240)
+-.|++.|.+||++.+.+++..++||||-|++++.|++|.+||.+.+-...+.|+-+..|.-|
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP 232 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP 232 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC
Confidence 899999999999999999999999999999999999999999999888888888888777544
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=274.70 Aligned_cols=210 Identities=34% Similarity=0.590 Sum_probs=180.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++++.||.|++|.||++++..++..||+|++.... .....+.+|+.++..++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999987532 22245678999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC--
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-- 174 (240)
||+++++|.+++...+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence 99999999999988888999999999999999999999999999999999999987776 99999998754321110
Q ss_pred -------------------------------------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCC
Q 026299 175 -------------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217 (240)
Q Consensus 175 -------------------------------------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 217 (240)
.....+++.|+|||.+.+...+.+ +|+|||||++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCC
Confidence 011247889999999877776555 999999999999999999
Q ss_pred CCCCCCchhhhhhhhc
Q 026299 218 PFEDPEEPKNFRKTIH 233 (240)
Q Consensus 218 pf~~~~~~~~~~~~~~ 233 (240)
||...+....+.+++.
T Consensus 238 Pf~~~~~~~~~~~i~~ 253 (364)
T cd05599 238 PFCSDNPQETYRKIIN 253 (364)
T ss_pred CCCCCCHHHHHHHHHc
Confidence 9988776666665554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=264.90 Aligned_cols=209 Identities=36% Similarity=0.548 Sum_probs=177.0
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc-cHHHHHHHHHHHhcCCCCeeeeeEEEEcCC--eEEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVM 96 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 96 (240)
..+|+..+.||+|+||.||.+.+..+|...++|.+...... .+...+|+.+|++++|||||+++|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 57899999999999999999999999999999998765322 355789999999999999999999855444 689999
Q ss_pred ecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC-CCCCcEEEecCCccccccc---
Q 026299 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL--- 171 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~-~~~~~~~L~d~~~~~~~~~--- 171 (240)
||+++|+|.+++.+.+ ++++..+..+.+|+++||.|||++|++||||+|+||+++. ++. +||+|||.+.....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGT 173 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccc
Confidence 9999999999998876 8999999999999999999999999999999999999987 455 99999998865542
Q ss_pred -cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC-CCchhhhhh
Q 026299 172 -HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED-PEEPKNFRK 230 (240)
Q Consensus 172 -~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~ 230 (240)
........+++.|||||++.......+++|||||||++.+|+||..||.. ......+.+
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ 234 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLL 234 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHH
Confidence 22334567899999999998643333459999999999999999999988 344443333
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=270.16 Aligned_cols=207 Identities=33% Similarity=0.535 Sum_probs=180.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||+|++|.||++++..+++.|++|++.... .....+.+|+..++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987642 22345788999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence 99999999999988888999999999999999999999999999999999999987765 99999999864433 233
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
...+++.|+|||.+.+...+.. +||||||+++|+|++|..||...+..+.+.++.
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 211 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211 (333)
T ss_pred CcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHH
Confidence 4567889999999987766555 999999999999999999998877666555443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=274.94 Aligned_cols=210 Identities=31% Similarity=0.541 Sum_probs=179.0
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++++.||.|++|.||++++..+++.|++|.+.... .....+.+|+.+++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999986532 12245678999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC---
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~--- 173 (240)
||+++++|.+++...+.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987665 9999999874211100
Q ss_pred ---------C------------------------------------CCCCcCCccccCccccccCCCCCcccchHHHHHH
Q 026299 174 ---------Q------------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 208 (240)
Q Consensus 174 ---------~------------------------------------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~ 208 (240)
. .....+++.|+|||.+.+..++.+ +|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchh
Confidence 0 001347889999999987776555 999999999
Q ss_pred HHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 209 LYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 209 l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
+|+|++|..||...+..+.+.+++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~ 262 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIIN 262 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHc
Confidence 9999999999988777666666554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=273.35 Aligned_cols=209 Identities=33% Similarity=0.499 Sum_probs=178.5
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
..|++++.||+|+||.||+|++..++..||+|++.... .....+.+|+.+++.++|+||+++++.+.+++.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999987532 22345788999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC---
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~--- 173 (240)
||+++++|.+++.+...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987665 9999999864211000
Q ss_pred ---------------------------------------------CCCCCcCCccccCccccccCCCCCcccchHHHHHH
Q 026299 174 ---------------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 208 (240)
Q Consensus 174 ---------------------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~ 208 (240)
......++..|+|||.+.+...+.. +|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhH
Confidence 0012357889999999987776555 999999999
Q ss_pred HHHHHhCCCCCCCCCchhhhhhhh
Q 026299 209 LYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 209 l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
+|+|++|..||...+......+++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~ 261 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVI 261 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHH
Confidence 999999999998877666555554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=268.31 Aligned_cols=213 Identities=31% Similarity=0.505 Sum_probs=182.1
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCC-cEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~-~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
....++|++.+.||.|++|.||+|.+..++ ..|++|.+.... ...+.+.+|+.+++.++||||+++++++.+++.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 345578999999999999999999976554 689999886532 223467789999999999999999999999999
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
.++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecCC
Confidence 9999999999999999988888999999999999999999999999999999999999987665 99999999864422
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
......+++.|+|||.+.+...+.. +|+||||+++|+|++|..||.+.+....+.++...
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 243 (340)
T PTZ00426 184 --RTYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG 243 (340)
T ss_pred --CcceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC
Confidence 2234567889999999987766554 99999999999999999999988776666665543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=260.06 Aligned_cols=219 Identities=29% Similarity=0.425 Sum_probs=188.6
Q ss_pred CCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEc
Q 026299 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILT 88 (240)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (240)
.+..+...+.+.|++.+.||.|..+.||.|+....++.|+||++..+... -+.+.+|+..++.++||||++++-.|..
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 34455667889999999999999999999999999999999999775433 3578899999999999999999999999
Q ss_pred CCeEEEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 89 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
+..+|+||+|+.+||+.+++... ..+++..+..+++++++||.|||++|-+|||||+.|||++.++. ++|+|||++
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvs 173 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVS 173 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceee
Confidence 99999999999999999999754 34899999999999999999999999999999999999998887 999999987
Q ss_pred ccccccCCC-----CCCcCCccccCccc-cccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 167 KSSVLHSQP-----KSTVGTPAYIAPEV-LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 167 ~~~~~~~~~-----~~~~~~~~~~~pE~-~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
......... ....+++.|||||+ ...-..+..|+||||||++..||.+|..||........+...
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t 244 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT 244 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 533322211 44578999999999 455556677799999999999999999999998876654433
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=256.12 Aligned_cols=218 Identities=31% Similarity=0.426 Sum_probs=190.7
Q ss_pred CcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcC-
Q 026299 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP- 89 (240)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 89 (240)
...+-..+.|+.+..|++|.||.||+|++..+++.||+|+++.+... .-..++|+.+|.+++||||+.+..+..-+
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 44555668999999999999999999999999999999999875422 23468999999999999999999987654
Q ss_pred -CeEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 90 -THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 90 -~~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
+.+|+||||++. .|...+.+- .++...+++.+..|+++|+.|||...|+||||+|+|++++..+. +|++|||+|+
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR 225 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAR 225 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhh
Confidence 679999999976 777777654 47999999999999999999999999999999999999987776 9999999999
Q ss_pred cccccCCC-CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 168 SSVLHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 168 ~~~~~~~~-~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.+...... .....+..|.|||.+.+...+++..|+||+||++.+|+++...|.+..+.+++.+|.+.
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~l 293 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKL 293 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHH
Confidence 77766444 34457889999999999988888799999999999999999999999999999998764
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=273.68 Aligned_cols=210 Identities=34% Similarity=0.540 Sum_probs=178.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++++.||+|++|.||++++..++..|++|.+.... .....+.+|+.+++.++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986532 22345778999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc----
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 172 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~---- 172 (240)
||+++++|.+++...+.+++..+..++.||+.||+|||+.||+||||+|+||+++.++. ++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987766 999999986421100
Q ss_pred ----------------------------------------CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHH
Q 026299 173 ----------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (240)
Q Consensus 173 ----------------------------------------~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l 212 (240)
.......+++.|+|||.+.+...+.+ +|||||||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeeh
Confidence 00012357889999999987776555 9999999999999
Q ss_pred HhCCCCCCCCCchhhhhhhhc
Q 026299 213 LVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 213 ~~g~~pf~~~~~~~~~~~~~~ 233 (240)
++|..||...+..+...++..
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~ 258 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVIN 258 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhc
Confidence 999999988876665555443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=272.42 Aligned_cols=210 Identities=34% Similarity=0.530 Sum_probs=178.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+.|++++.||+|+||.||++++..++..|++|.+.... .....+.+|+.+++.++|+||+++++.+.+++.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999987532 22345788999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC---
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~--- 173 (240)
||+++++|.+++.+.+.+++..+..++.||+.||+|||+.||+|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccc
Confidence 99999999999988788999999999999999999999999999999999999987766 9999999864211000
Q ss_pred ---------------------------------------------CCCCCcCCccccCccccccCCCCCcccchHHHHHH
Q 026299 174 ---------------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 208 (240)
Q Consensus 174 ---------------------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~ 208 (240)
......+++.|+|||++.+..++.. +|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHH
Confidence 0012357889999999987777655 999999999
Q ss_pred HHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 209 LYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 209 l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
+|+|++|..||...+......+++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~ 262 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVIN 262 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 9999999999988776666655543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=272.73 Aligned_cols=214 Identities=36% Similarity=0.573 Sum_probs=189.2
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCC
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 90 (240)
.....++|++++.||+|+||+|+++....+++.||||.++++.- .-+....|..++... +||.++.++..|..++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 35566899999999999999999999999999999999988642 234566777777766 5999999999999999
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
++|+||||+.||.+.. +...+.+++..+..++.+++.||+|||++||++||||.+||+++.++. +||+|||++....
T Consensus 443 ~l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccC
Confidence 9999999999988443 334567999999999999999999999999999999999999987776 9999999997655
Q ss_pred -ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 171 -LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 171 -~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.+....+..|++.|+|||++.+..++.. .|+||||++||+|+.|+.||++.++.+.+..|+.
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~ 582 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN 582 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 5666778899999999999998888666 9999999999999999999999999999988864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=255.74 Aligned_cols=212 Identities=31% Similarity=0.444 Sum_probs=186.3
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCC-eeeeeEEEEcCC-----
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPN-IVRFKEVILTPT----- 90 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~----- 90 (240)
...|+.++.+|+|.+|+||+|+...+|+.||+|++..... ......+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 5679999999999999999999999999999999987544 3456789999999999999 999999998876
Q ss_pred -eEEEEEecCCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCc
Q 026299 91 -HLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (240)
Q Consensus 91 -~~~lv~~~~~~~~l~~~l~~~~----~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~ 165 (240)
..++|+||.+. .|..++.... .++...++.+++||+.|++|||+.||+||||||.||+++..+. +||+|||+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGL 166 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--Eeeeccch
Confidence 78999999976 7888886544 4778899999999999999999999999999999999988666 99999999
Q ss_pred ccccccc-CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 166 SKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 166 ~~~~~~~-~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
++....+ ........+..|.|||.+.+...+....|+||+||+++||+++...|.+..+.+++.+|.+.
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~ 236 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL 236 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 9866533 33556678889999999999977766699999999999999999999999998888777654
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=260.42 Aligned_cols=204 Identities=28% Similarity=0.473 Sum_probs=171.9
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
..++|++.+.||.|++|.||++++..++..|++|.+.... .....+.+|+..++.++||||+++++++.++...++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 4578999999999999999999999999999999986543 22345788999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CC
Q 026299 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~ 174 (240)
||+++ +|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+...... ..
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCcc
Confidence 99965 67666654 356899999999999999999999999999999999999987665 999999988643222 22
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
.....++..|+|||.+.+......++|+||||+++++|++|..||.+....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 210 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 233456789999999876654455599999999999999999999876443
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=269.80 Aligned_cols=210 Identities=30% Similarity=0.537 Sum_probs=180.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++++.||+|++|.||++++..++..|++|.+.... .....+.+|..++..++|++|+++++.+.+++.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986532 22345778999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC---
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~--- 173 (240)
||+++++|.+++.+.+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987665 9999999875332110
Q ss_pred ---------------------------------CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026299 174 ---------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (240)
Q Consensus 174 ---------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (240)
......+++.|+|||++.+...+.. +|+|||||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCC
Confidence 0112357889999999987776655 999999999999999999999
Q ss_pred CCCchhhhhhhhc
Q 026299 221 DPEEPKNFRKTIH 233 (240)
Q Consensus 221 ~~~~~~~~~~~~~ 233 (240)
+.+....+.+++.
T Consensus 238 ~~~~~~~~~~i~~ 250 (360)
T cd05627 238 SETPQETYRKVMN 250 (360)
T ss_pred CCCHHHHHHHHHc
Confidence 8887777766654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=270.83 Aligned_cols=204 Identities=31% Similarity=0.554 Sum_probs=183.5
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
..|+..+.+|+|+.|.||.++...++..||||++.... .-.+-+.+|+.+++..+|+||+.+++.+..++.+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 68999999999999999999999999999999998753 33466889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCCCC
Q 026299 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 178 (240)
Q Consensus 100 ~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~~~ 178 (240)
+|++|.+.+... .+++.++..++++++.||.|||..||+|+||+.+||++..++. +||+|||++....... .....
T Consensus 353 ~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 353 EGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred CCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccccc
Confidence 999999988554 4899999999999999999999999999999999999987777 9999999997655443 56778
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
.|+++|||||+..+..+..+ .||||||++++||+.|+.||-.++....+
T Consensus 430 VGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAl 478 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRAL 478 (550)
T ss_pred cCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHH
Confidence 89999999999998888777 99999999999999999999876654443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=265.24 Aligned_cols=203 Identities=37% Similarity=0.609 Sum_probs=174.2
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (240)
+.||+|++|.||++++..+++.|++|++.... .....+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987532 22245678999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cCCCCCCcCC
Q 026299 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 181 (240)
Q Consensus 103 ~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~~~~~~~~~ 181 (240)
+|.+.+...+.+++..+..++.||+.||+|||+.||+|+||+|+||+++.++. ++|+|||++..... ........++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence 99999988888999999999999999999999999999999999999987765 99999999864322 2223345688
Q ss_pred ccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 182 ~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
+.|+|||.+.+...+.. +|+||||+++|+|++|..||.+.+....+..+.
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~ 208 (323)
T cd05571 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208 (323)
T ss_pred ccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 99999999987776555 999999999999999999998876655554443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=269.83 Aligned_cols=210 Identities=36% Similarity=0.591 Sum_probs=183.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||+|++|.||++++..++..|++|++.... .....+.+|...+..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999987532 23356788999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC---
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~--- 173 (240)
||+++++|.+++.+...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence 99999999999988788999999999999999999999999999999999999987776 9999999986443322
Q ss_pred ---------------------------CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 174 ---------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 174 ---------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
......++..|+|||.+.+...+.. +|||||||++|+|++|..||...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHHH
Confidence 1223457889999999988766555 999999999999999999999888777
Q ss_pred hhhhhhc
Q 026299 227 NFRKTIH 233 (240)
Q Consensus 227 ~~~~~~~ 233 (240)
...+++.
T Consensus 238 ~~~~i~~ 244 (350)
T cd05573 238 TYNKIIN 244 (350)
T ss_pred HHHHHhc
Confidence 6666665
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=269.94 Aligned_cols=219 Identities=33% Similarity=0.536 Sum_probs=199.1
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe-EEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l 94 (240)
..++|.+++.+|+|+||.++.++++..+..|++|.+.... ..++....|+.++++++||||+.+.+.|..++. .+|
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 3578999999999999999999999999999999987643 334568999999999999999999999998877 899
Q ss_pred EEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
||+|++||++.+.+.+.+ -++++.+..|+.|++.|++|||++.|+|+||++.|||+..+.. ++|+|||++......
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPE 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCc
Confidence 999999999999887544 5899999999999999999999999999999999999988887 899999999888777
Q ss_pred C-CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceeceeeC
Q 026299 173 S-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCTFS 240 (240)
Q Consensus 173 ~-~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (240)
. ...+..|++.|++||.+.+.++..+ +|||||||++|+|.+-..+|.+.+....+.+|++..+.+.|
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp 227 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP 227 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC
Confidence 6 6677889999999999999888776 99999999999999999999999999999999998876543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=257.74 Aligned_cols=212 Identities=30% Similarity=0.472 Sum_probs=178.5
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+.++|++.+.||.|++|.||++++..++..|++|.+.... .....+.+|+..++.++||||+++++++.++...++|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 4578999999999999999999999999999999886532 22346789999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-C
Q 026299 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~ 174 (240)
||+++ +|.+++... ..++...+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||.+....... .
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCcc
Confidence 99986 888877654 35789999999999999999999999999999999999987766 9999999986443222 2
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.....++..|+|||.+.+......++|+||||+++|+|++|..||.+.+..+.+..+.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 218 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 23345688999999987655445569999999999999999999988877666555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=257.29 Aligned_cols=200 Identities=28% Similarity=0.420 Sum_probs=172.9
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
.|++.+.||+|+||.||++.+..++..|++|.+.... .....+.+|+.+++.++|++|+++.+.+.+++..++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4889999999999999999999999999999886532 122356789999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
|+++++|.+.+... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence 99999998877542 35899999999999999999999999999999999999987665 999999998754333333
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
....++..|+|||.+.+..++.. +||||||+++|+|++|..||...+.
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCc
Confidence 44567899999999987777655 9999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=262.75 Aligned_cols=203 Identities=35% Similarity=0.602 Sum_probs=173.6
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (240)
+.||+|+||.||++++..++..|++|.+.... .....+.+|+..++.++||||+++++.+...+.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987532 22245678999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCCCcCC
Q 026299 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 181 (240)
Q Consensus 103 ~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~~~~~ 181 (240)
+|...+.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++...... .......++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence 99998888888999999999999999999999999999999999999987765 999999987643222 222334578
Q ss_pred ccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 182 ~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
..|+|||.+.+...+.+ +|+||||+++|+|++|..||...+....+.++.
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~ 208 (323)
T cd05595 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208 (323)
T ss_pred cCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 89999999987776555 999999999999999999998877665555443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=257.09 Aligned_cols=213 Identities=33% Similarity=0.499 Sum_probs=187.1
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeec---CccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC-----C
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTP-----T 90 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 90 (240)
.+.+|..++.+|.|++|.|+.+.+..+|+.||||++.. +.....+..+|+++|+.++|+||+.+.+++..+ .
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 44677778999999999999999999999999999874 234446789999999999999999999998762 4
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
..|+|+|+++. .|...+..+..+++..+..+++|++.||.|+|+.+++|||++|+|++++.+.. +|++|||+|+...
T Consensus 100 DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLD 176 (359)
T ss_pred eeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeecc
Confidence 68999999944 88888877777999999999999999999999999999999999999999888 9999999998665
Q ss_pred c---cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 171 L---HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 171 ~---~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
. .........+..|.|||.+.....++++.||||.||+++||++|...|.+.+..+++..|+..
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~ 243 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL 243 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence 3 223234556789999999988888888899999999999999999999999999998887764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=257.72 Aligned_cols=213 Identities=29% Similarity=0.464 Sum_probs=184.2
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
...+.|++++.||.|+-|.||++....++..+|+|++.+.... ..+...|-++|+.+.||.++.+|..+..+.+.|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 3447899999999999999999999999999999999875432 245778899999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc-
Q 026299 94 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 170 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~- 170 (240)
++||||+||.|...++++ +.+++..++.++.+++-||+|||-.|||.|||||+|||+.++++ +.|.||.++....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCPV 231 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCCC
Confidence 999999999999888765 46999999999999999999999999999999999999998887 9999999862100
Q ss_pred --------------------------------cc-C-----------------------CCCCCcCCccccCccccccCC
Q 026299 171 --------------------------------LH-S-----------------------QPKSTVGTPAYIAPEVLLKKE 194 (240)
Q Consensus 171 --------------------------------~~-~-----------------------~~~~~~~~~~~~~pE~~~~~~ 194 (240)
.. . ...+.+|+-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 00 0 001234667899999998888
Q ss_pred CCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 195 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.+.. .|+|+||+++|||+.|..||.+.+...++.+|+.
T Consensus 312 HgsA-VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~ 349 (459)
T KOG0610|consen 312 HGSA-VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG 349 (459)
T ss_pred CCch-hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc
Confidence 7665 9999999999999999999999999999988875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=268.07 Aligned_cols=212 Identities=32% Similarity=0.502 Sum_probs=180.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++.+.||+|+||.||++++..++..+++|.+.... .....+.+|..+++.++||||+++++.+.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4579999999999999999999999999999999986521 223457789999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
||||+++++|.+++... .+++..+..++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||.+........
T Consensus 121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCc
Confidence 99999999999988554 5889999999999999999999999999999999999987766 99999999865432221
Q ss_pred --CCCCcCCccccCccccccCC---CCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 175 --PKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 175 --~~~~~~~~~~~~pE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.....+++.|+|||.+.+.. ....++|+||||+++|+|++|..||...+....+.+++.
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 23456889999999986543 234559999999999999999999998887777777664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=266.15 Aligned_cols=214 Identities=34% Similarity=0.508 Sum_probs=181.3
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
....++|++.+.||+|++|.||++++..++..+++|++.... .....+.+|..+++.++||||+++++.+.++..+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 345589999999999999999999999999999999986422 2224467889999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||.+......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~ 195 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcC
Confidence 999999999999998854 45889999999999999999999999999999999999987765 999999998654322
Q ss_pred C--CCCCCcCCccccCccccccCC---CCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 173 S--QPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 173 ~--~~~~~~~~~~~~~pE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
. ......+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||...+....+.+++.
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 261 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 261 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 2 122456889999999986543 234559999999999999999999998887777777664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=260.64 Aligned_cols=202 Identities=35% Similarity=0.596 Sum_probs=173.8
Q ss_pred ecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCch
Q 026299 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
||+|+||.||++++..++..|++|.+.... .....+.+|+..++.++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 689999999999999999999999987532 2234567899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCCCcCCcc
Q 026299 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 183 (240)
Q Consensus 105 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~~~~~~~ 183 (240)
.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++...... .......++..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence 999988888999999999999999999999999999999999999987766 999999998643222 22233457889
Q ss_pred ccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 184 ~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
|+|||.+.+...+.+ +|+||||+++|+|++|..||.+.+....+++++.
T Consensus 159 y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~ 207 (312)
T cd05585 159 YLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207 (312)
T ss_pred cCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence 999999987766555 9999999999999999999988777666665544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=261.08 Aligned_cols=203 Identities=35% Similarity=0.605 Sum_probs=173.5
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (240)
+.||+|++|.||++++..++..|++|++.... .....+.+|+..++.++||||+++.+.+..++.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987632 22245778999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCCCcCC
Q 026299 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 181 (240)
Q Consensus 103 ~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~~~~~ 181 (240)
+|.+.+.....+++..+..++.||+.||+|||+.||+|+||+|+||+++.++. ++|+|||++...... .......++
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence 99998888888999999999999999999999999999999999999987765 999999997643222 222334578
Q ss_pred ccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 182 ~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
+.|+|||.+.+...+.. +|+||||+++|+|++|..||...+.......+.
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~ 208 (328)
T cd05593 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208 (328)
T ss_pred cCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHHHHHHHhc
Confidence 89999999987766555 999999999999999999998877665554443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=259.31 Aligned_cols=209 Identities=33% Similarity=0.564 Sum_probs=177.1
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCC-CCeeeeeEEEEcCCeEEEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 96 (240)
+|++.+.||+|++|.||+|++..++..|++|++.... ...+.+..|...+..+.| ++|+++++++.+.+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999987532 223456788888888876 56888999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~~~ 175 (240)
||+++++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence 99999999999988888999999999999999999999999999999999999987765 99999998754322 2222
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
....++..|+|||.+.+...+.. +|+||||+++|+|++|..||...+....+..+..
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~ 215 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215 (324)
T ss_pred eeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 33457889999999987776555 9999999999999999999988777666655543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=260.89 Aligned_cols=210 Identities=29% Similarity=0.505 Sum_probs=176.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++++.||+|++|.||++++..++..||+|++.... .....+.+|...+..++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999986522 22244778889999999999999999999999999999
Q ss_pred ecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
||+++++|.+++.+ ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence 99999999999875 456899999999999999999999999999999999999987765 999999997644332221
Q ss_pred --CCCcCCccccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 176 --KSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 176 --~~~~~~~~~~~pE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
....+++.|+|||.+.. ......++|+||||+++|+|++|..||.+....+.+.+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 22357889999999863 2333445999999999999999999998876655555544
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=266.60 Aligned_cols=215 Identities=28% Similarity=0.419 Sum_probs=187.1
Q ss_pred cccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
++-++.+.+++++.||+|-||.|+.+.+.. ...|++|.+.......++|.+|+.++++++|++|++++++|..+..++|
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 444556788999999999999999999984 4569999999988888999999999999999999999999999889999
Q ss_pred EEecCCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 95 VMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
||||++.|+|.+++.. ...++...+..++.||++|++||+++++|||||-..|||++.+.. +|++|||+++.....
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIGDD 356 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccCCC
Confidence 9999999999999986 456999999999999999999999999999999999999988776 999999999832211
Q ss_pred C--CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 173 S--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 173 ~--~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
. .....--..-|.|||.+....++.+ +||||||++|+||+| |+.||...+..+.++.+-+
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~ 419 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER 419 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc
Confidence 1 1111123457999999999998777 999999999999998 9999999999888877654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=255.10 Aligned_cols=206 Identities=31% Similarity=0.501 Sum_probs=175.0
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++.+.||+|++|.||++++..++..|++|++.... ...+.+.+|+..++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999999999999999987642 223567899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC--CC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~--~~ 175 (240)
|++++++..+......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence 9998777655544557899999999999999999999999999999999999987765 9999999986543222 12
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (240)
....++..|+|||.+.+...+. ++|+||||+++|+|++|..||...+..+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~-~~DiwslGvil~el~~g~~pf~~~~~~~~~~ 211 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGK-AVDMWSVGCILGELSDGQPLFPGESEIDQLF 211 (287)
T ss_pred cccccccccCCcHHHcCCCCCC-chhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2345788999999998777654 4999999999999999999998876655443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=265.16 Aligned_cols=213 Identities=32% Similarity=0.508 Sum_probs=180.7
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
...++|++.+.||+|++|.||++++..++..||+|.+.... .....+.+|+.+++.++||||+++++++.++..++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34579999999999999999999999999999999986532 22244678999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
+||||+++++|.+++.+ ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||.+.......
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCC
Confidence 99999999999998854 45889999999999999999999999999999999999987766 9999999986543322
Q ss_pred --CCCCCcCCccccCccccccCC---CCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 174 --QPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 174 --~~~~~~~~~~~~~pE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
......+++.|+|||.+.+.. ....++|+||||+++|+|++|..||.+.+....+.+++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence 123346889999999986543 234559999999999999999999998887777777654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=258.87 Aligned_cols=209 Identities=34% Similarity=0.563 Sum_probs=177.0
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+|++.+.||+|++|.||++++..++..|++|.+..... .......|...+..+ +|++|+++++++.+.+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999876421 123355666777666 5799999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~~~ 175 (240)
||+++++|.+.+.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence 99999999999988788999999999999999999999999999999999999987766 99999999864332 2223
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
....+++.|+|||.+.+...+.+ +|+||||+++|+|++|..||.+.+....+.+++.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~ 215 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 34567889999999987776555 9999999999999999999998877666665554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=258.44 Aligned_cols=206 Identities=32% Similarity=0.517 Sum_probs=174.2
Q ss_pred eeeecCCCceeEEEEEec---CCCcEEEEEEeecCc-----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 26 VRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++.||+|+||.||++++. .++..|++|++.... .....+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999874 468899999987532 222456789999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~ 176 (240)
|+++++|.+++...+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCccc
Confidence 9999999999988888899999999999999999999999999999999999987765 999999997643222 2223
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
...++..|+|||.+.+...+.+ +||||||+++|+|++|..||...+....+.++++.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~ 215 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG 215 (323)
T ss_pred ccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 3457889999999987766554 99999999999999999999888776666665543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=262.82 Aligned_cols=211 Identities=31% Similarity=0.524 Sum_probs=179.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||+|++|.||++++..++..|++|.+..... ....+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999999999999999876432 2345778899999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-
Q 026299 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~- 174 (240)
||+++++|.+++.+. ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence 999999999998765 67999999999999999999999999999999999999987765 99999999864433222
Q ss_pred -CCCCcCCccccCcccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 175 -PKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 175 -~~~~~~~~~~~~pE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.....++..|+|||.+.. ....+.++||||||+++|+|++|..||...+....+.+++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~ 223 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN 223 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 122357889999999863 22334559999999999999999999988777766666554
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=259.69 Aligned_cols=211 Identities=29% Similarity=0.487 Sum_probs=176.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||+|+||.||++++..++..|++|.+.... .....+.+|...+..++|++|+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986521 22234678888999999999999999999999999999
Q ss_pred ecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
||+++++|.+++.+ ...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence 99999999999976 457899999999999999999999999999999999999987665 999999998644332221
Q ss_pred --CCCcCCccccCccccccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 176 --KSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 --~~~~~~~~~~~pE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
....++..|+|||.+.+. .....++|+||||+++|+|++|..||...+..+.+.+++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~ 222 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc
Confidence 224578899999988652 2234459999999999999999999987766665555543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=257.13 Aligned_cols=204 Identities=35% Similarity=0.559 Sum_probs=173.4
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|++|.||++++..++..|++|.+.... ...+.+..|...+..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999987532 2224566777777766 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cCCCCCCcC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~~~~~~~~ 180 (240)
++|.+.+.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence 999999988888999999999999999999999999999999999999987766 99999998764322 222234457
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
++.|+|||.+.+...+.. +|+||||+++|+|++|..||...+....+..+..
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~ 210 (320)
T cd05590 159 TPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210 (320)
T ss_pred CccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc
Confidence 889999999987766555 9999999999999999999998887766666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=251.67 Aligned_cols=203 Identities=28% Similarity=0.418 Sum_probs=174.2
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
+|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|+.+++.++|+||+++++.+..++..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 5899999999999999999999999999999986532 112346789999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
|+.+++|.+.+... ..+++..+..++.|++.|++|||+.|++|+||+|+||++++++. ++|+|||.+.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETI 158 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCcc
Confidence 99999998877543 45899999999999999999999999999999999999987665 999999998755433333
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
....++..|+|||.+.+...+.. +|+||||+++|+|++|..||.+.+....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~ 209 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVK 209 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhH
Confidence 44567889999999987766555 9999999999999999999988665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=256.97 Aligned_cols=206 Identities=37% Similarity=0.608 Sum_probs=172.0
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHH---HhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINH---RSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
|++++.||+|++|.||++.+..++..|++|.+.... ...+.+.+|...+ +.++||||+++++++.+++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999987532 1223455555444 566899999999999999999999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CC
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~ 174 (240)
|||+++++|...+.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence 999999999887743 56899999999999999999999999999999999999987766 999999987643222 22
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
.....++..|+|||.+.+...+.. +|+||||+++|+|++|..||.+.+..+.+.++.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~ 214 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV 214 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 234567889999999987766555 999999999999999999998877666555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=265.72 Aligned_cols=210 Identities=30% Similarity=0.448 Sum_probs=174.8
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--------Ce
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--------TH 91 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~ 91 (240)
..+|++.+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++||||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 368999999999999999999999999999999886543 3345799999999999999998886432 24
Q ss_pred EEEEEecCCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 92 LAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~----~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
+++||||+++ ++.+++. ....++...++.++.|++.||+|||+.||+||||+|+||+++.++. .++|+|||++.
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccch
Confidence 6799999976 6666553 3457899999999999999999999999999999999999975432 38999999997
Q ss_pred cccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
............+++.|+|||.+.+....+.++|||||||++|+|++|..||.+....+.+.++++.
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 6555444455667889999999877655555699999999999999999999998887777776653
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=257.76 Aligned_cols=205 Identities=33% Similarity=0.579 Sum_probs=171.5
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHH-HHHhcCCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|++|.||++++..++..|++|.+..... ....+.+|.. .++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 468999999999999999999999999875321 1123444443 45778999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCCCcC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~~~~ 180 (240)
++|.+++.....+++..+..++.||+.||+|||+.|++|+||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence 999999988888999999999999999999999999999999999999987765 999999987643222 22233457
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
+..|+|||.+.+...+.+ +|+||||+++|+|++|..||...+....+.+++..
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 211 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211 (323)
T ss_pred ChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 889999999987776555 99999999999999999999988776666665543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=255.87 Aligned_cols=209 Identities=32% Similarity=0.559 Sum_probs=176.3
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+|++.+.||+|++|.||++++..+++.||+|++.... ...+.+..|...+..+. |++|+++++.+.+.+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999987532 12234667777887775 578888999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~ 175 (240)
||+++++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+...... ...
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence 99999999999988788999999999999999999999999999999999999987765 999999988643222 222
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
....++..|+|||.+.+...+.. +|+||||+++++|++|..||.+.+....+++++.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~ 215 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 33457889999999987766554 9999999999999999999988877666665544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=255.17 Aligned_cols=202 Identities=37% Similarity=0.594 Sum_probs=169.2
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHh-cCCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|+||.||++++..+++.||+|.+.... ...+....|...+.. .+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999987532 122334556666654 4899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCCCcC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~~~~ 180 (240)
++|.+++.....+++..+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence 999999988888999999999999999999999999999999999999987765 999999998643322 22234457
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
+..|+|||.+.+...+.+ +|+||||+++++|++|..||.+.+....+.++
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i 208 (316)
T cd05592 159 TPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208 (316)
T ss_pred CccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 899999999987776555 99999999999999999999887765555444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=239.65 Aligned_cols=213 Identities=35% Similarity=0.621 Sum_probs=192.3
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++.+.||+|.||.||.++...++..|++|++.+.. ....++.+|+++.+.++||||++++++|.++...|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4489999999999999999999999999999999987753 334567899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 95 VMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 95 v~~~~~~~~l~~~l~--~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
+.||.+.+++...+. ....+++.....+++|++.|+.|+|..+++||||+|+|++++..+. ++++|||-+.... .
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-S 176 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-C
Confidence 999999999999998 5567899999999999999999999999999999999999987776 9999999876444 6
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
....+..|+..|++||...+...+.. .|+|++|++.|+++.|..||.+....+++++|.+.-
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~ 238 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD 238 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc
Confidence 66677889999999999988888776 999999999999999999999999999998887653
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=257.44 Aligned_cols=211 Identities=27% Similarity=0.502 Sum_probs=176.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||+|+||.||++++..++..+++|.+.... .....+.+|...+..++|++|+++++.+.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986421 12234678888899999999999999999999999999
Q ss_pred ecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-
Q 026299 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~- 174 (240)
||+++++|.+++.+ ...+++..+..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence 99999999999976 457899999999999999999999999999999999999987665 99999998754322221
Q ss_pred -CCCCcCCccccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 175 -PKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 175 -~~~~~~~~~~~~pE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.....+++.|+|||.+.. ......++|+||||+++|+|++|..||...+....+.+++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~ 222 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence 123457889999999863 22334459999999999999999999988776666665543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=257.77 Aligned_cols=200 Identities=33% Similarity=0.572 Sum_probs=170.3
Q ss_pred CeeEeeeecCCCceeEEEEEec---CCCcEEEEEEeecCc-----cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeE
Q 026299 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 92 (240)
+|++++.||+|++|.||++++. .++..|++|++.... ...+.+.+|+.+++.+ +|++|+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999875 468899999986532 2234567899999999 489999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
++||||+++++|.+++.....+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence 999999999999999988888999999999999999999999999999999999999987765 999999998644322
Q ss_pred CC--CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 173 SQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 173 ~~--~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
.. .....++..|+|||.+.+......++||||||+++|+|++|..||....
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 211 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence 22 2234578999999999776544556999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=254.75 Aligned_cols=203 Identities=30% Similarity=0.510 Sum_probs=177.4
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
..++|++++.||+|++|.||++++..++..+++|.+.... .....+.+|+..++.++||||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 4589999999999999999999999999999999887642 22356889999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~-~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
||+++++|.+++.....+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++. ++|+|||.+..... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~ 159 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 159 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-ccc
Confidence 9999999999998878899999999999999999999986 6999999999999987766 99999998864422 222
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
....++..|+|||.+.+...+.+ +|+||||+++|+|++|..||...+..
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 34467889999999987776554 99999999999999999999766543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=258.64 Aligned_cols=202 Identities=37% Similarity=0.599 Sum_probs=171.8
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (240)
+.||+|+||.||++++..++..|++|.+.... .....+.+|+..++.++||||+++.+.+...+.+++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987632 12245678889999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cCCCCCCcC
Q 026299 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (240)
Q Consensus 103 ~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~~~~~~~~ 180 (240)
+|..++.....+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence 999988888889999999999999999999997 79999999999999987766 99999998764322 222233458
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
+..|+|||.+.+...+.+ +|+||||+++|+|++|..||...+.......+
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i 208 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208 (325)
T ss_pred CcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCHHHHHHHH
Confidence 889999999987776555 99999999999999999999877665544443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=256.38 Aligned_cols=204 Identities=33% Similarity=0.553 Sum_probs=173.2
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|++|.||++++..++..|++|++.... ...+.+..|..++..+ +||||+++++++.+++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999999999999999987632 2223456777777765 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCCCcC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~~~~ 180 (240)
++|...+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+...... .......+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence 999999888888999999999999999999999999999999999999987766 999999988643222 22233457
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
+..|+|||.+.+...+.+ +|+||||+++|+|++|..||...+....+.++..
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~ 210 (321)
T cd05591 159 TPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDDLFESILH 210 (321)
T ss_pred CccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 889999999887766555 9999999999999999999998887777666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=256.70 Aligned_cols=204 Identities=34% Similarity=0.593 Sum_probs=170.7
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHH-HHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|+||.||++++..++..|++|++..... ....+..|. ..++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 468999999999999999999999999875321 112333443 346778999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cCCCCCCcC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~~~~~~~~ 180 (240)
++|.+++.....+++..+..++.|+++||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccC
Confidence 999999988888899999999999999999999999999999999999987765 99999999864322 222334458
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
+..|+|||++.+...+.+ +||||||+++|+|++|..||.+.+....+.++..
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 210 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210 (325)
T ss_pred CccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 899999999987776555 9999999999999999999988877766666544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=260.35 Aligned_cols=210 Identities=32% Similarity=0.510 Sum_probs=186.9
Q ss_pred CcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc--HHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
.........|+..+.||+|+||.||+|.+..+++.||+|++..+.... +++..|+.+|..++++||.++++.+..+..
T Consensus 6 ~~~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 6 VLKIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred hhcCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence 344455678999999999999999999999999999999998765443 678999999999999999999999999999
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
++++|||+.||++.+.++....+.+..+..++++++.|+.|||..+.+|+||++.||++..++. ++|+|||++.....
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTN 163 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeec
Confidence 9999999999999999987777799999999999999999999999999999999999988866 99999999875554
Q ss_pred c-CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 172 H-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 172 ~-~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
. .......|++.|||||++....++.+ +||||||++.++|.+|..|+.......
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmr 218 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMR 218 (467)
T ss_pred hhhccccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcce
Confidence 3 33377899999999999996666666 999999999999999999998877633
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=264.79 Aligned_cols=211 Identities=30% Similarity=0.457 Sum_probs=177.5
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCC-CcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
...|.+.+.||+|++|.||.|.+..+ +..|++|.+..... ....+.+|+..++.++||||+++++++..++..++|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 35699999999999999999998877 78899997655432 22456789999999999999999999999999999999
Q ss_pred cCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 98 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 98 ~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
|+++++|.+.+.. ..++++.++..++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++.......
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCcc
Confidence 9999999887743 346899999999999999999999999999999999999987765 9999999986543222
Q ss_pred ---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 174 ---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 174 ---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
......+++.|+|||++.+...+.. +||||||+++++|++|..||...+....+.+++.
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~ 285 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY 285 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 1233457889999999887766554 9999999999999999999988776665555544
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=256.33 Aligned_cols=214 Identities=41% Similarity=0.658 Sum_probs=192.2
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 94 (240)
...|++.+.||.|.||.||.++...+|..+|+|.+..... ..+...+|+.+++.+. ||||+.+++.+.+...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3689999999999999999999999999999999977532 2357899999999998 9999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCC--CcEEEecCCcccccccc
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLH 172 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~--~~~~L~d~~~~~~~~~~ 172 (240)
|||++.||.|.+.+... .+++.....++.|++.++.|||+.|++|+|++|+|+++..... +.++++|||++......
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 99999999999988766 4999999999999999999999999999999999999965533 46999999999877765
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
.......|++.|+|||++....+... .|+||+|+++|.|++|..||.+.+....+.+++..-
T Consensus 193 ~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~ 254 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD 254 (382)
T ss_pred ceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC
Confidence 56677789999999999987777666 999999999999999999999999999988777654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=258.40 Aligned_cols=198 Identities=27% Similarity=0.387 Sum_probs=172.1
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc-cHHHHHHHHHHHhcCCCCeeeeeEEEEcCC-eEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~~~ 98 (240)
+.|.-...||+|+||.||++.-..+ ..|+||++...... ..+|.+|+..+.+++|||+++++|+|.+.+ ..++|+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy 153 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY 153 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence 5667778999999999999999854 88999988776654 566999999999999999999999999998 49999999
Q ss_pred CCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCC---ceeecCCCCCeEEcCCCCCcEEEecCCccccccc-c
Q 026299 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H 172 (240)
Q Consensus 99 ~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~---ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~ 172 (240)
++.|+|.+.+.... ++++.....|+.++++||+|||+.. |+|+||+++|||+|.+.. .|++|||++..... .
T Consensus 154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEGD 231 (361)
T ss_pred cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCccc
Confidence 99999999997654 8999999999999999999999753 999999999999998887 89999999965443 3
Q ss_pred CCCCCC-cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 173 SQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 173 ~~~~~~-~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
...... .++.+|++||+...+..+.+ +||||||+++.|+++|+.|....
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCC
Confidence 333333 78999999999988777666 99999999999999999887643
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=256.76 Aligned_cols=203 Identities=32% Similarity=0.481 Sum_probs=169.1
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC---ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC-----CeEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLA 93 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 93 (240)
+|++.+.||+|++|.||++++..++..|++|.+... ......+.+|+..++.++||||+++++++... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999988643 12234578999999999999999999988643 2479
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
+||||++ ++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence 9999996 588888887778999999999999999999999999999999999999987766 9999999986433221
Q ss_pred C----CCCCcCCccccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 174 Q----PKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 174 ~----~~~~~~~~~~~~pE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
. .....++..|+|||.+.+. .....++||||||+++|+|++|..||.+.+....
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~ 216 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 216 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH
Confidence 1 1234578899999988652 2334459999999999999999999987765443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=255.80 Aligned_cols=204 Identities=34% Similarity=0.585 Sum_probs=170.3
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHH-HHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|++|.||++++..++..|++|++..... ....+.+|. ..++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999999999999999865321 122344454 357788999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cCCCCCCcC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~~~~~~~~ 180 (240)
++|...+.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence 999988887788999999999999999999999999999999999999987765 99999998764322 222233457
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
+..|+|||.+.+...+.+ +|+||||+++|+|++|..||...+......+++.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 210 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210 (321)
T ss_pred CcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc
Confidence 889999999977776555 9999999999999999999988876666555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=257.43 Aligned_cols=205 Identities=33% Similarity=0.561 Sum_probs=172.6
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHH-HHHhcCCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|++|.||++++..++..+++|++.... .....+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999999999999999986532 11233444543 46778999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cCCCCCCcC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~~~~~~~~ 180 (240)
++|...+.....+++..+..++.||+.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence 999998888888999999999999999999999999999999999999987776 99999999864322 222234457
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
+..|+|||.+.+..++.+ +|+||||+++|+|++|..||...+....++++++.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~ 211 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211 (325)
T ss_pred ChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 889999999987777555 99999999999999999999988777776666543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=251.16 Aligned_cols=212 Identities=27% Similarity=0.457 Sum_probs=177.7
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+.++|++.+.||+|++|.||++++..++..|++|.+.... .....+.+|+..+++++|+||+++++++..++..++||
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 5588999999999999999999999999999999987543 22345778999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-C
Q 026299 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~ 174 (240)
||+++ +|.+.+... ..++...+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||.+....... .
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCccc
Confidence 99976 777776544 45889999999999999999999999999999999999987765 9999999986433222 2
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.....++..|+|||.+.+......++|+||||+++++|++|..||.+.+..+.+..+++
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 219 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 22345678899999987665445569999999999999999999988877666555543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=253.15 Aligned_cols=202 Identities=35% Similarity=0.547 Sum_probs=170.0
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|++|.||++++..++..|++|.+.... ........|...+... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46899999999999999999999999987632 2223456677777654 899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCCCcC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~~~~ 180 (240)
++|.+.+.....++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+...... .......+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence 999999888788999999999999999999999999999999999999987765 999999987643222 22233457
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
+..|+|||.+.+...+.. +|+||||+++|+|++|..||.+.+....++.+
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~ 208 (316)
T cd05620 159 TPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208 (316)
T ss_pred CcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 889999999987776555 99999999999999999999887765555443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=252.85 Aligned_cols=201 Identities=35% Similarity=0.574 Sum_probs=169.1
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHh-cCCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|++|.||++++..++..||+|.+.... ........|...+.. ++||||+++++++.+++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999999999999999987642 222345567777765 4899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCCCcC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~~~~ 180 (240)
++|.+.+.....++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence 999999987778999999999999999999999999999999999999987765 999999987643222 22234457
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhh
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (240)
+..|+|||.+.+...+.. +|+||||+++|+|++|..||...+....++.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (316)
T cd05619 159 TPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207 (316)
T ss_pred CccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 889999999987776555 9999999999999999999988766555443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=248.29 Aligned_cols=209 Identities=31% Similarity=0.464 Sum_probs=172.0
Q ss_pred CCeeEeeeecCCCceeEEEEEecC-CCcEEEEEEeecCcc---ccHHHHHHHHHHHhc---CCCCeeeeeEEEEc-----
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILT----- 88 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~----- 88 (240)
++|++++.||+|++|.||++++.. ++..|++|.+..... ....+.+|+..++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 578899998865432 223456677776665 69999999999853
Q ss_pred CCeEEEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 89 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
...+++++|++++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence 3568999999975 888887643 35899999999999999999999999999999999999987766 999999998
Q ss_pred ccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.............++..|+|||.+.+...+.+ +|+||||+++|+|++|..||.+.+..+.+.++++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 75544433444567889999999977766555 9999999999999999999999888777777654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=255.08 Aligned_cols=206 Identities=26% Similarity=0.422 Sum_probs=167.3
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEec-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHHhc-CCCCeeeeeEEEEcC
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 89 (240)
+..++|++.+.||.|+||.||+|.+. .++..|++|.+..... ....+.+|+.++..+ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 45579999999999999999999852 3457899998865432 234688999999999 899999999988765
Q ss_pred -CeEEEEEecCCCCchHHHHHhc---------------------------------------------------------
Q 026299 90 -THLAIVMEYASGGELFERICNA--------------------------------------------------------- 111 (240)
Q Consensus 90 -~~~~lv~~~~~~~~l~~~l~~~--------------------------------------------------------- 111 (240)
..++++|||+++++|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4588999999999999988642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC---CCCCCcCCcc
Q 026299 112 -----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPA 183 (240)
Q Consensus 112 -----~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~---~~~~~~~~~~ 183 (240)
.+++...+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||++....... ......++..
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCcc
Confidence 23777889999999999999999999999999999999987665 9999999986432221 1122234568
Q ss_pred ccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchh
Q 026299 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (240)
Q Consensus 184 ~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (240)
|+|||.+.+...+.+ +||||||+++|+|++ |..||.+.....
T Consensus 242 y~aPE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~ 284 (338)
T cd05102 242 WMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINE 284 (338)
T ss_pred ccCcHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence 999999987776555 999999999999997 999998765443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=255.94 Aligned_cols=209 Identities=27% Similarity=0.425 Sum_probs=174.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC-----
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 90 (240)
..++|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|+..++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3489999999999999999999999999999999986532 22356778999999999999999999986543
Q ss_pred -eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 91 -~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
..++||||+++ ++.+.+. ..++...+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||.+...
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCcccc
Confidence 47899999976 5555553 34789999999999999999999999999999999999987766 999999998654
Q ss_pred cccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 170 ~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
..........++..|+|||.+.+...+.+ +|+||||+++|+|++|..||.+.+..+.+.++++
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~ 236 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 43333344567889999999988777665 9999999999999999999998877666555443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=256.68 Aligned_cols=206 Identities=31% Similarity=0.541 Sum_probs=174.3
Q ss_pred eeeecCCCceeEEEEEec---CCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 26 VRDIGSGNFGVARLMRDK---KTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
++.||+|++|.||++++. .++..|++|++..... ....+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 367999999999999874 5789999999876321 2234678999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCCC
Q 026299 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (240)
Q Consensus 100 ~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~~ 178 (240)
++++|.+++.+...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+...... ......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence 99999999988788999999999999999999999999999999999999987766 999999998644333 222334
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.++..|+|||.+.+...+.+ +|+||||+++|+|++|..||...+......++...
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~ 213 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213 (318)
T ss_pred cCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence 57889999999987666554 99999999999999999999888776666655543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=253.64 Aligned_cols=192 Identities=32% Similarity=0.543 Sum_probs=165.8
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|++|.||++++..++..|++|++.... .....+.+|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999987632 1223467888888888 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc-ccCCCCCCcC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~-~~~~~~~~~~ 180 (240)
++|.+++...+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++.... .........+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence 999998888888999999999999999999999999999999999999987765 9999999886422 2222334567
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
+..|+|||.+.+...+.+ +|+||||+++|+|++|..||..
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCccc
Confidence 889999999987776555 9999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=252.11 Aligned_cols=203 Identities=37% Similarity=0.607 Sum_probs=171.5
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||.|++|.||++.+..++..|++|.+.... .....+.+|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999987632 2224456787888777 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cCCCCCCcC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~~~~~~~~ 180 (240)
++|...+.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence 999999888888999999999999999999999999999999999999987766 99999998754222 222233457
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
+..|+|||.+.+..++.+ +|+||||+++|+|++|..||...+....+..+.
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~ 209 (318)
T cd05570 159 TPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209 (318)
T ss_pred CccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 889999999988777655 999999999999999999998776655554443
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=251.47 Aligned_cols=202 Identities=31% Similarity=0.519 Sum_probs=175.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
..++|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|+||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4589999999999999999999999999999999887642 22356889999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~-~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
||+++++|.+++.+.+.+++..+..++.+++.|+.|||+. +++|+||+|+||+++.++. ++|+|||.+..... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~ 159 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 159 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hcc
Confidence 9999999999998888899999999999999999999975 7999999999999987665 99999998864422 222
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
....++..|+|||.+.+...+.+ +|+||||+++|+|++|..||.....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcch
Confidence 33457889999999977666554 9999999999999999999976554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=245.99 Aligned_cols=207 Identities=37% Similarity=0.654 Sum_probs=179.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|++.+++++||||+++++.+.++..++++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999986532 23356788999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence 99999999999988888999999999999999999999999999999999999987765 999999998654333 33
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
...++..|++||.+.+...+.. +|+||||+++++|++|..||...+......++.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 211 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL 211 (290)
T ss_pred CCCCCccccChhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 3457788999999877665444 999999999999999999998877555555444
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=244.60 Aligned_cols=197 Identities=41% Similarity=0.656 Sum_probs=173.0
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHH---HHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~---~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
|++++.||+|++|.||++++..+++.|++|.+......... ..+|+..++.++||||+++++++.+....+++|+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999876544332 345899999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc-cccCCCCCC
Q 026299 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST 178 (240)
Q Consensus 100 ~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~-~~~~~~~~~ 178 (240)
.+++|.+++.....++...+..++.|+++||.+||+.|++|+||+|+||+++.++. ++|+|||.+... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 99999999987888999999999999999999999999999999999999986665 999999998642 223333455
Q ss_pred cCCccccCccccc-cCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 179 VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 179 ~~~~~~~~pE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
.++..|.|||.+. +... ..++|+||||+++++|++|..||...
T Consensus 159 ~~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSGGGSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccc-cccccccccccccccccccccccccc
Confidence 6788999999987 4444 44599999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=243.28 Aligned_cols=217 Identities=35% Similarity=0.599 Sum_probs=191.0
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC---ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
+.|++.+.||+|.|+.|+.+.+..+|..+++|.+... ...-+.+.+|..+.+.++||||+++.+.+.+....++|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 7899999999999999999999999999999987653 3344678899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCCccccccccCCCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
+++|+.|-.-+....-+++..+--.++||+++|+|.|.+||||+|++|+|+++-... ..-+||+|||++.....+....
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~ 170 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWH 170 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccc
Confidence 999988755443445578888888999999999999999999999999999994332 2349999999998777666667
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceecee
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCT 238 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (240)
...|++.|+|||++.+.++..+ +|||+-|+++|-|+.|.+||.+++..+.+++|++.-|.-
T Consensus 171 G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~ 231 (355)
T KOG0033|consen 171 GFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDY 231 (355)
T ss_pred cccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCC
Confidence 7889999999999999988777 999999999999999999999999999999999877653
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=257.34 Aligned_cols=209 Identities=27% Similarity=0.405 Sum_probs=175.7
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC-----eEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 93 (240)
+|++.+.||+|++|.||++.+..+++.|++|.+.... .....+.+|+..++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999999999999999886432 22356789999999999999999999998776 789
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
+|+||+.+ +|.+.+.....++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE 157 (372)
T ss_pred EEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence 99999965 78887777778999999999999999999999999999999999999987766 9999999986443222
Q ss_pred C--CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 174 Q--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 174 ~--~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
. .....++..|+|||.+.+......++|+||||+++++|++|..||.+.+..+.+..+.+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 219 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1 12234678899999988766555569999999999999999999998877666655543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=244.21 Aligned_cols=201 Identities=28% Similarity=0.421 Sum_probs=172.8
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
+|+..+.||.|+||+||++.+..+++.+++|.+..... ....+.+|+.+++.++|++++++.+.+..++..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999865421 12346789999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
|+++++|.+.+... ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.+.. ++|+|||.+.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESI 158 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCCcc
Confidence 99999998877543 36899999999999999999999999999999999999987665 999999988654433333
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
....++..|+|||.+.+...+.+ +|+||||+++++|++|..||......
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~ 207 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEK 207 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 44567899999999987766555 99999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=254.67 Aligned_cols=210 Identities=28% Similarity=0.425 Sum_probs=177.0
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC------
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 89 (240)
..++|++.+.||+|++|.||.+.+..++..|++|.+.... .....+.+|+..++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3489999999999999999999999999999999986532 2234677899999999999999999987643
Q ss_pred CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
...++||||+++ ++.+.+.. .++...+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||.+...
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCcccc
Confidence 357999999976 66666643 4788999999999999999999999999999999999987765 999999998755
Q ss_pred cccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 170 ~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
..........++..|+|||.+.+...+.+ +|+||||+++|+|++|..||...+..+.+.++++.
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 240 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 44433344567889999999987776555 99999999999999999999988887777776653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=252.10 Aligned_cols=191 Identities=33% Similarity=0.566 Sum_probs=164.6
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|++|.||++++..++..|++|.+.... .....+.+|...+.++ +||||+++++++..++.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46899999999999999999999999987642 1223466788777666 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cCCCCCCcC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~~~~~~~~ 180 (240)
++|..++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence 999998888888999999999999999999999999999999999999987766 99999998864322 222234567
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (240)
+..|+|||.+.+...+.+ +|+||||+++|+|++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCc
Confidence 889999999987776555 999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=254.37 Aligned_cols=194 Identities=22% Similarity=0.328 Sum_probs=167.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
...+|++++.||.|++|.||++.+..+++.|++|... ...+.+|+.+++.++||||+++++++..+...++++++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3468999999999999999999999999999999643 24567899999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc--CCCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPK 176 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~--~~~~ 176 (240)
+. ++|.+++.....++...++.++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||.+...... ....
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccccc
Confidence 86 478888877778999999999999999999999999999999999999987766 999999998532211 1222
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
...+++.|+|||++.+..++.+ +|+||||+++|+|++|..||-.
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCC
Confidence 3468899999999987766554 9999999999999999988754
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=246.11 Aligned_cols=211 Identities=27% Similarity=0.467 Sum_probs=177.4
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
..++|++.+.||.|++|.||++++..++..|++|.+.... .....+.+|+..++.++||||+++++++..+...++|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4578999999999999999999999999999999986542 22346778999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-
Q 026299 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~- 174 (240)
||+++ +|.+++.. ...++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKT 160 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCc
Confidence 99975 78887765 356899999999999999999999999999999999999987766 99999999864332221
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
.....++..|+|||.+.+......++|+||||+++++|++|..||...+..+.+..+.
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~ 218 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF 218 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2233457889999998776555556999999999999999999998877665554443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=253.97 Aligned_cols=210 Identities=27% Similarity=0.402 Sum_probs=175.4
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC------
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 89 (240)
..++|++.+.||+|++|.||.+.+..++..|++|.+.... .....+.+|+..++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3489999999999999999999999999999999886532 2234677899999999999999999988654
Q ss_pred CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
...+++|||+++ ++.+.+.. .++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~ 169 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 169 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccC
Confidence 347899999976 56665543 4789999999999999999999999999999999999987766 999999998755
Q ss_pred cccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 170 ~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
..........++..|+|||.+.+...+.+ +|+||||+++++|++|..||.+.+..+.+.++++.
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 44433444567889999999987776555 99999999999999999999988776666555543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=239.53 Aligned_cols=205 Identities=32% Similarity=0.486 Sum_probs=174.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc------cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
+.|++.+.||.|++|.||.+.+..++..+++|.+...... ...+.+|+..+++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999989999999988654221 2357789999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
++|++++++|.+.+.....+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecccccc
Confidence 9999999999999988788999999999999999999999999999999999999987665 99999999864332211
Q ss_pred C----CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 175 P----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 175 ~----~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
. ....++..|+|||.+.+...+.+ +|+||||+++|+|++|..||.+.+.....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~ 216 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAI 216 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccchHHHH
Confidence 1 22346678999999987775444 99999999999999999999876554443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=243.48 Aligned_cols=193 Identities=33% Similarity=0.458 Sum_probs=163.9
Q ss_pred ecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCch
Q 026299 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
||+|+||.||++.+..+++.|++|.+...... .+.+..|+.+++.++|+||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 68999999999999999999999998653221 24567899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-CCCCc
Q 026299 105 FERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV 179 (240)
Q Consensus 105 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~~~~~ 179 (240)
.+.+.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+........ .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccC
Confidence 877642 346899999999999999999999999999999999999987665 99999999864433222 22345
Q ss_pred CCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 180 ~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
++..|+|||.+.+...+.+ +|+||||+++|+|++|..||.....
T Consensus 159 g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred CCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 7889999999988776555 9999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=243.61 Aligned_cols=208 Identities=29% Similarity=0.453 Sum_probs=171.4
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhc---CCCCeeeeeEEEEcC-----C
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILTP-----T 90 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~-----~ 90 (240)
+|++.+.||+|++|.||++++..++..|++|.+..... ......+|+..++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 59999999999999999999999999999998865322 223456677766655 699999999988642 4
Q ss_pred eEEEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 91 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
..++++|++++ +|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence 57899999976 788877653 34899999999999999999999999999999999999987766 99999999875
Q ss_pred ccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
...........++..|+|||.+.+...+.+ +|+||||+++++|++|..||......+.+.++..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 221 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHH
Confidence 543333344557788999999987766555 9999999999999999999988877776666554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=249.79 Aligned_cols=192 Identities=31% Similarity=0.545 Sum_probs=165.6
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|++|.||++++..++..|++|++.... ...+.+.+|...+.++ +||+|+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999999999999999987642 2224467888888777 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cCCCCCCcC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~~~~~~~~ 180 (240)
++|...+.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence 999998887788999999999999999999999999999999999999987776 99999998864222 222234557
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
+..|+|||.+.+...+.. +|+||||+++|+|++|..||..
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 159 TPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCc
Confidence 889999999987776555 9999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=241.25 Aligned_cols=211 Identities=24% Similarity=0.355 Sum_probs=173.7
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEec---CCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
+++.+|++.+.||+|+||.||++.+. ..+..|++|.+..... ....+.+|+..++.++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 45688999999999999999999865 3467899998876432 224678999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
++||||+++++|.+++... ..+++..++.++.|++.|+++||+.|++|+||+|+||+++.++. ++++|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~ 159 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKS 159 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCcccccccc
Confidence 9999999999999988764 47899999999999999999999999999999999999987665 99999998654322
Q ss_pred cCCCC--CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 172 HSQPK--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 172 ~~~~~--~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
..... ...++..|+|||.+.+...+.+ +||||||++++++++ |..||.+....+.+..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~ 221 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 21111 1223467999999887776555 999999999999775 99999877666554443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=253.65 Aligned_cols=202 Identities=35% Similarity=0.550 Sum_probs=167.6
Q ss_pred ecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhc---CCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
||+|+||.||++++..++..|++|++..... .......|...+... +||||+++++.+.+...+++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6899999999999999999999999865321 112334555555554 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCCCcC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~~~~ 180 (240)
++|.+++.....+++..+..++.||+.||+|||+.||+|+||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence 999999988888999999999999999999999999999999999999987765 999999998643222 22334567
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
+..|+|||.+.+......++|+||||+++|+|++|..||...+....+.++.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~ 210 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA 210 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH
Confidence 8899999998766544556999999999999999999998877666555443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=258.96 Aligned_cols=216 Identities=31% Similarity=0.446 Sum_probs=178.6
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC--
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT-- 90 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 90 (240)
.....++|++.+.||+|+||.||++++..++..||+|.+..... ....+.+|+..+..++|+|++++++.+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 33455899999999999999999999999999999999876432 2245778999999999999999888765432
Q ss_pred ------eEEEEEecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEE
Q 026299 91 ------HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (240)
Q Consensus 91 ------~~~lv~~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L 160 (240)
.+++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL 184 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKL 184 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEE
Confidence 36799999999999998854 246899999999999999999999999999999999999987765 999
Q ss_pred ecCCcccccccc---CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 161 CDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 161 ~d~~~~~~~~~~---~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
+|||++...... .......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+....+.+++..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~ 260 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 999998643322 12234567889999999987776555 99999999999999999999887766666655543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=237.88 Aligned_cols=210 Identities=33% Similarity=0.511 Sum_probs=179.3
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC---ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+|++.+.||+|++|.+|++.+..++..|++|.+... ......+.+|+..++.++|||++++++.+.+.+.+++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 588999999999999999999999999999988653 23345678999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-C
Q 026299 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (240)
Q Consensus 99 ~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~ 175 (240)
+++++|.+++... ..++...++.++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence 9999999988764 56899999999999999999999999999999999999987765 99999998764433222 2
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
....+...|+|||...+...+.. +|+||||+++++|++|..||...+......++.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRG 216 (256)
T ss_pred hccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 23356788999999987776555 99999999999999999999888766655555443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=238.58 Aligned_cols=211 Identities=27% Similarity=0.443 Sum_probs=176.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
++++|++.+.||+|++|.||++.+. .+..+++|.+.......+.+.+|+..+++++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 4578999999999999999999886 456799998876655567789999999999999999999999999999999999
Q ss_pred CCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC--
Q 026299 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (240)
Q Consensus 99 ~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~-- 175 (240)
+++++|.+++.. ...++...++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceecc
Confidence 999999998864 346899999999999999999999999999999999999987665 999999987643222111
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
....+...|+|||.+.+...+.+ +|+||||+++++|++ |..||...+..+.+.++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~ 216 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216 (256)
T ss_pred CCCCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence 12234457999999876665554 999999999999999 9999988877766655543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=241.35 Aligned_cols=199 Identities=28% Similarity=0.427 Sum_probs=171.7
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
+|+..+.||+|++|.||++.+..++..|++|.+...... ...+.+|+.+++.++|++++++.+.+.+++..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 478899999999999999999999999999988754221 2346789999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
|+++++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI 158 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence 99999999888543 35899999999999999999999999999999999999987665 999999998654433333
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
....++..|+|||.+.+...+.+ +|+||||+++++|++|..||....
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCC
Confidence 34567889999999987776555 999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=240.89 Aligned_cols=192 Identities=28% Similarity=0.429 Sum_probs=163.9
Q ss_pred ecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCch
Q 026299 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
||+|+||.||++++..+|+.|++|.+..... .......|+.+++.++||||+++.+.+.++...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6899999999999999999999999865321 123456789999999999999999999999999999999999999
Q ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcCCc
Q 026299 105 FERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182 (240)
Q Consensus 105 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~ 182 (240)
.+.+... ..++...+..++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|||.+.............++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence 8877543 35889999999999999999999999999999999999987766 9999999986554433333456788
Q ss_pred cccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 183 ~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
.|+|||.+.+...+.. +|+||||+++|+|++|..||....
T Consensus 159 ~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 159 GYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred CccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999987775544 999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=261.39 Aligned_cols=209 Identities=33% Similarity=0.437 Sum_probs=179.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC--ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC------
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 90 (240)
.+..|...+.||+|+||.||+++++.+|+.||||.+... ....+..-+|++++++++|+|||++.++=.+..
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 346778889999999999999999999999999998773 344467889999999999999999998855443
Q ss_pred eEEEEEecCCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC--CCCcEEEecCCc
Q 026299 91 HLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGY 165 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~---~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~--~~~~~~L~d~~~ 165 (240)
...++||||+||+|...+.+. ..|++.++..++.++..|+.+||++||+||||||.||++..+ +..-.||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 357999999999999999643 359999999999999999999999999999999999998543 333479999999
Q ss_pred cccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
|+....+..-.+..|+..|++||...+...++.-.|.||||+++|++.||..||.....+..
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~ 232 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN 232 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc
Confidence 99888888888899999999999998644444449999999999999999999977666543
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=250.31 Aligned_cols=199 Identities=31% Similarity=0.504 Sum_probs=166.6
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
....++|+.++.||.|++|.||++++..+++.|++|.+.... .....+.+|+.+++.++|+||+++++++..++.+++
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 334478999999999999999999999999999999986542 223568899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~- 173 (240)
|+||+++++|.+. ...++..+..++.||+.||+|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMD 223 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceecccccc
Confidence 9999999888542 23567888999999999999999999999999999999987765 9999999986543222
Q ss_pred CCCCCcCCccccCccccccC----CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 174 QPKSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
......++..|+|||.+... .....++||||||+++|+|++|..||..
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 22345678899999987432 2334459999999999999999999974
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=257.31 Aligned_cols=199 Identities=28% Similarity=0.441 Sum_probs=167.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
.+...+.+.||+|.||+||++++-.+ ||||++.... ...+.|++|+..+++-+|.||+-+.|++..... .+|+
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred HHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 36778899999999999999999865 9999987643 344679999999999999999999999998776 9999
Q ss_pred ecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc---c
Q 026299 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---H 172 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~---~ 172 (240)
.||.|.+|..++.-. .++.....+.|++|+++|+.|||.++|+|+||+..|||+.++.. ++|+|||++..... .
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRWSGE 544 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeeeccc
Confidence 999999999988643 46888999999999999999999999999999999999988766 99999999863322 2
Q ss_pred CCCCCCcCCccccCccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 173 SQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.......++..|||||++... ..++.++||||||+++|||++|.+||.....
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~ 598 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR 598 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh
Confidence 222334578899999998643 2345559999999999999999999984443
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=239.93 Aligned_cols=206 Identities=30% Similarity=0.483 Sum_probs=175.5
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++.+.||+|++|.||++++..+++.|++|.+.... ...+.+.+|+..++.++|+|++++++++..+...++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999999899999999886532 223557899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~ 176 (240)
|++++++..+......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCccccc
Confidence 9999888877766667999999999999999999999999999999999999987765 9999999986544332 222
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
...+...|+|||.+.+....+.++|+||||+++++|++|..||.+.+..+..
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~ 210 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL 210 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 3346678999999876554455599999999999999999999877665443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=251.64 Aligned_cols=218 Identities=35% Similarity=0.628 Sum_probs=197.1
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeec---CccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
.-|.+.+-||+|-|.+|-+|++..+|++|+||++.+ +......+..|+..++.++||||+++|++......+|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 578999999999999999999999999999999976 33444678899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
.=++|.|.+++-+. ..+++...+.+++||+.|+.|.|+.-+||+||+|+|+.+-... +-+||.|||++....++....
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl-GlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL-GLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec-CceEeeeccccccCCCcchhh
Confidence 99999999998654 4599999999999999999999999999999999998875433 239999999999888888888
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceeceee
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCTF 239 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (240)
...|+..|.|||++.+..++.++.||||||++||-|+||+.||...++-..+-.||.-.|..|
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP 239 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP 239 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc
Confidence 999999999999999999999999999999999999999999999999999888887666544
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=238.62 Aligned_cols=212 Identities=22% Similarity=0.336 Sum_probs=179.1
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
.+..+|++.+.||.|++|.||++.+..++..+++|.+..+......+.+|+..++.++|+||+++++++..++.+++++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 35578999999999999999999999999999999987665545678899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
|+++++|.+++... ..++...+..++.|++.+|.+||+.|++|+||+|+||++++++. ++|+|||.+.........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT 160 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceee
Confidence 99999999988653 35889999999999999999999999999999999999987665 999999998654432221
Q ss_pred C--CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 176 K--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 176 ~--~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
. ....+..|+|||.+.+...+.. +|+||||+++|+|++ |..||...+..+.+.++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 219 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 1 1223457999999877776555 999999999999998 999998776655555443
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=266.74 Aligned_cols=202 Identities=30% Similarity=0.424 Sum_probs=170.6
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
.++|++.+.||+|++|.||+|.+..++..|++|++..+.. ..+++.+|+..++.++||||+++++++.+++..+++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 3689999999999999999999999999999999865322 235688999999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 96 MEYASGGELFERICNA-----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~-----------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
|||++|++|.+++... ...+...+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFG 158 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWG 158 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecC
Confidence 9999999999988532 23456678899999999999999999999999999999987766 9999999
Q ss_pred ccccccccC-------------------CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 165 YSKSSVLHS-------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 165 ~~~~~~~~~-------------------~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.+....... ......+++.|+|||.+.+...+.+ +|+||||+++++|++|..||...+.
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcch
Confidence 986441110 1112357889999999987776555 9999999999999999999976543
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=237.81 Aligned_cols=211 Identities=27% Similarity=0.449 Sum_probs=175.5
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+.++|++.+.||.|++|.||.+++.. +..+++|.+.......+.+.+|+..++.++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 45789999999999999999998764 45699998876655557789999999999999999999999988889999999
Q ss_pred CCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC--
Q 026299 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (240)
Q Consensus 99 ~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~-- 175 (240)
+.+++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceeec
Confidence 9999999988653 46899999999999999999999999999999999999987665 999999987644322111
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
....+...|++||.+.+...+.+ +|+||||+++++|++ |..||...+..+...++.+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~ 216 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216 (256)
T ss_pred CCCccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc
Confidence 11234467999999977666554 999999999999998 9999987766555554443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=238.33 Aligned_cols=208 Identities=36% Similarity=0.524 Sum_probs=176.1
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----------cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
+|++.+.||.|++|.||+|.+..++..+++|.+...... .+.+.+|+..+++++||||+++++++..+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 578899999999999999999988999999988654221 1356789999999999999999999999999
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
.++++||+++++|.+++...+.++...+..++.|++.|+++||+.|++|+||+|+||++++++. ++|+|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence 9999999999999999988788999999999999999999999999999999999999987665 99999998865542
Q ss_pred cCC-------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 172 HSQ-------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 172 ~~~-------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
... .....++..|+|||.+.+...+.. +|+||||+++++|++|..||...+....+.++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 225 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG 225 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh
Confidence 111 112346778999999987766555 999999999999999999998876655544433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=266.68 Aligned_cols=214 Identities=33% Similarity=0.561 Sum_probs=175.4
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--CeE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 92 (240)
....+|++++.||.|+||.||++++..++..+++|.+.... .....+..|+.+++.++||||+++++++... ..+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34579999999999999999999999999999999887532 2235678999999999999999999988653 568
Q ss_pred EEEEecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhC-------CceeecCCCCCeEEcCC--------
Q 026299 93 AIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-------QVCHRDLKLENTLLDGS-------- 153 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~-------~ivh~~i~~~nili~~~-------- 153 (240)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+|+||+|+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999999999998864 25699999999999999999999984 49999999999999642
Q ss_pred -------CCCcEEEecCCccccccccCCCCCCcCCccccCccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 154 -------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 154 -------~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
..+.++|+|||++.............+++.|+|||++.+.. ....++|||||||++|+|++|..||...+..
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 23348999999987554443344456889999999986532 2344599999999999999999999876655
Q ss_pred hhhhhh
Q 026299 226 KNFRKT 231 (240)
Q Consensus 226 ~~~~~~ 231 (240)
..+.+.
T Consensus 250 ~qli~~ 255 (1021)
T PTZ00266 250 SQLISE 255 (1021)
T ss_pred HHHHHH
Confidence 444333
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=236.39 Aligned_cols=206 Identities=33% Similarity=0.492 Sum_probs=172.4
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc------cHHHHHHHHHHHhcCCCCeeeeeEEEEcC--Ce
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 91 (240)
+.+|++.+.||+|++|.||.+.+..++..|++|.+...... ...+.+|+..++.++||||+++++.+.+. ..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 46899999999999999999999999999999987643211 23567899999999999999999988764 46
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
+++++|++++++|.+++.+...+++..+..++.|++.+|++||+.+++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~ 158 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCcccccccc
Confidence 7899999999999999987777899999999999999999999999999999999999987665 99999998864432
Q ss_pred cC----CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 172 HS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 172 ~~----~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
.. ......++..|+|||.+.+...+.. +|+||||+++|+|++|..||...+....+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~ 218 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFEAMAAI 218 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCccchHHHH
Confidence 11 1122346778999999877666444 99999999999999999999876544443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=239.41 Aligned_cols=200 Identities=32% Similarity=0.554 Sum_probs=176.9
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
.|++.+.||.|++|.||++.+..++..|++|.+.... ...+.+.+|+..+++++||||+++++.+..+...++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999999999999987542 233578899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~ 177 (240)
|+.+++|.+++....++++..+..++.|++++|.+||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence 9999999999987778999999999999999999999999999999999999987766 99999999876554434444
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
..+...|+|||.+.+...+.+ +|+||||+++++|++|..||...+.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred cCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCc
Confidence 567788999999877775555 9999999999999999999987764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=250.65 Aligned_cols=211 Identities=25% Similarity=0.432 Sum_probs=174.8
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC----
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP---- 89 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 89 (240)
+..+++|++.+.||.|+||.||++.+..++..|++|.+..... ....+.+|+..++.++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 3456899999999999999999999999999999998865322 224567899999999999999999987643
Q ss_pred --CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 90 --THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 90 --~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
...+++++++ +++|.+++. ...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||++.
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~ 166 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLAR 166 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccce
Confidence 3468999987 668887664 456899999999999999999999999999999999999987766 9999999986
Q ss_pred cccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.... ......++..|+|||.+.+....+.++||||||+++|+|++|..||...+..+.+.+++.
T Consensus 167 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 230 (343)
T cd07878 167 QADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIME 230 (343)
T ss_pred ecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 4432 223446788999999987755455569999999999999999999988776666655543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=237.89 Aligned_cols=203 Identities=32% Similarity=0.459 Sum_probs=172.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
..++|++.+.||+|++|.||++++..++..|++|++..... ....+.+|+..++.++||||+++++.+..++..++|+|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 34789999999999999999999999999999998865432 23457789999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~ 176 (240)
|+++++|.+++....++++..+..++.|++.++++||+.|++|+|++|+||+++.++. ++|+|||.+....... ...
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRK 164 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccC
Confidence 9999999999887778999999999999999999999999999999999999987665 9999999986543222 223
Q ss_pred CCcCCccccCccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 177 STVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
...++..|+|||.+... .....++|+||||+++++|++|..||...+
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 34577889999987532 222445999999999999999999986544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=250.30 Aligned_cols=213 Identities=25% Similarity=0.371 Sum_probs=171.3
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEe-----cCCCcEEEEEEeecCc--cccHHHHHHHHHHHhc-CCCCeeeeeEEEE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL 87 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (240)
..+..++|++.+.||+|+||.||++++ ..++..|++|++.... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 334456899999999999999999974 3456789999886532 2235678999999999 8999999999999
Q ss_pred cCCeEEEEEecCCCCchHHHHHhcC-------------------------------------------------------
Q 026299 88 TPTHLAIVMEYASGGELFERICNAG------------------------------------------------------- 112 (240)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~l~~~~------------------------------------------------------- 112 (240)
.++..++||||+++++|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999998885421
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 113 --------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 113 --------------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
.++...+..++.|++.||.|||+.|++|+||+|+||+++.+.. ++|+|||++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~ 267 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRND 267 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCc
Confidence 4678889999999999999999999999999999999987665 999999998644322
Q ss_pred CCC---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 173 SQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 173 ~~~---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
... ....++..|+|||.+.+...+.+ +|+||||+++++|++ |..||........+.+.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~ 329 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH
Confidence 211 11223457999999987776555 999999999999998 89999776554443333
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=235.89 Aligned_cols=211 Identities=24% Similarity=0.344 Sum_probs=176.4
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
...++|++.+.||+|++|.||++.+.. +..|++|.+.......+.+.+|+..+++++|+|++++++++...+..++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 345789999999999999999999764 5679999987765555778899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
++++++|.+++.... .++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYE 159 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCccc
Confidence 999999999986543 6899999999999999999999999999999999999987766 999999988654422111
Q ss_pred C--CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 176 K--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 176 ~--~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
. .......|+|||.+.+...+.+ +|+||||+++++|++ |..||.+.+....+.++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218 (261)
T ss_pred ccCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 1 1122357999999877766555 999999999999999 999998877665554443
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=251.78 Aligned_cols=210 Identities=25% Similarity=0.379 Sum_probs=169.9
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHHhc-CCCCeeeeeEEEEcC
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 89 (240)
...++|++.+.||+|+||.||++++.. ++..|++|.+..... ..+.+.+|+..++.+ +|+||+++++.+...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 345789999999999999999998643 345799998865432 234678999999999 899999999999999
Q ss_pred CeEEEEEecCCCCchHHHHHhc----------------------------------------------------------
Q 026299 90 THLAIVMEYASGGELFERICNA---------------------------------------------------------- 111 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~---------------------------------------------------------- 111 (240)
...++||||+++++|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999887532
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC---C
Q 026299 112 ------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---K 176 (240)
Q Consensus 112 ------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~---~ 176 (240)
.+++...+..++.|++.||+|||+.|++|+||+|+||+++.+.. ++|+|||++......... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeecc
Confidence 23678889999999999999999999999999999999987665 999999998644322111 1
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
...++..|+|||.+.+...+.+ +|+||||+++|+|++ |..||........+.+
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~ 326 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326 (374)
T ss_pred CCCCccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHH
Confidence 1223457999999977776555 999999999999997 9999987655444333
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=236.76 Aligned_cols=210 Identities=25% Similarity=0.386 Sum_probs=175.5
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
+..++|++++.||.|++|.||++.+. ++..|++|.+.......+.+.+|+.+++.++|+||+++++.+...+..++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 45689999999999999999999976 55679999887655555778999999999999999999999999999999999
Q ss_pred cCCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-
Q 026299 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (240)
Q Consensus 98 ~~~~~~l~~~l~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~- 174 (240)
++++++|.+++.. ...++...+..++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||.+........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYT 159 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCcee
Confidence 9999999998865 345788999999999999999999999999999999999987765 99999999865432211
Q ss_pred -CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 175 -~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
.....+...|+|||.+.....+.+ +|+||||+++|+|++ |..||...+..+...++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL 217 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH
Confidence 112234567999999877766555 999999999999998 99999876655544443
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=241.60 Aligned_cols=209 Identities=28% Similarity=0.438 Sum_probs=177.1
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc------cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
+|++.+.||.|++|.||++.+..++..|++|.+...... ...+.+|+..++.++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999989999999998765322 34567899999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-
Q 026299 96 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~- 173 (240)
|||+ +++|.+++.... .+++..+..++.|+++||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc
Confidence 9999 889999987765 7999999999999999999999999999999999999987766 9999999986544332
Q ss_pred CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
......++..|+|||.+.+......++|+||||+++++|++|..||...+..+.+.++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~ 217 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFE 217 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHH
Confidence 222334567899999886655555569999999999999999888888777666655543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=243.43 Aligned_cols=211 Identities=26% Similarity=0.348 Sum_probs=171.2
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcE--EEEEEeecCc--cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~--v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 92 (240)
+..++|++.+.||+|++|.||+|.+..++.. +++|.+.... .....+.+|+..+.++ +|+||+++++++..++.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 4567999999999999999999998877654 4666655422 2234678899999999 899999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC
Q 026299 93 AIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~ 156 (240)
++++||+++++|.+++.... .++...++.++.|++.|+++||+.|++|+||+|+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~- 162 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV- 162 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc-
Confidence 99999999999999886432 4788999999999999999999999999999999999987665
Q ss_pred cEEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 157 ~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
++|+|||++.................|+|||.+.+...+. ++|+||||+++++|++ |..||...+..+...++
T Consensus 163 -~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 163 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred -EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcc-cccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 9999999985432222222223356799999887666544 4999999999999998 99999877665555444
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=242.08 Aligned_cols=206 Identities=26% Similarity=0.412 Sum_probs=167.2
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecC----------------CCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCee
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKK----------------TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIV 80 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~----------------~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~ 80 (240)
..++|++.+.||+|+||.||++.+.. ++..|++|.+..... ....+.+|+..+.+++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 34789999999999999999998643 344799998876432 234688999999999999999
Q ss_pred eeeEEEEcCCeEEEEEecCCCCchHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceee
Q 026299 81 RFKEVILTPTHLAIVMEYASGGELFERICNA-------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHR 141 (240)
Q Consensus 81 ~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~-------------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~ 141 (240)
++++++.+.+..+++|||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 9999999999999999999999999988543 135778899999999999999999999999
Q ss_pred cCCCCCeEEcCCCCCcEEEecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh--CC
Q 026299 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GA 216 (240)
Q Consensus 142 ~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~--g~ 216 (240)
||+|+||+++.++. ++|+|||.+....... ......++..|+|||.+.+...+.+ +|+||||+++++|++ +.
T Consensus 163 dlkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 163 DLATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred CcchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccCC
Confidence 99999999987765 9999999986432221 1122334668999999877766555 999999999999986 67
Q ss_pred CCCCCCCchhh
Q 026299 217 YPFEDPEEPKN 227 (240)
Q Consensus 217 ~pf~~~~~~~~ 227 (240)
.||...+....
T Consensus 240 ~p~~~~~~~~~ 250 (304)
T cd05096 240 QPYGELTDEQV 250 (304)
T ss_pred CCCCcCCHHHH
Confidence 88876654443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=233.59 Aligned_cols=209 Identities=32% Similarity=0.536 Sum_probs=179.1
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+|++++.+|.|++|.++.+++..++..+++|.+.... .....+.+|+..+++++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5999999999999999999999999999999876532 3335678999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CC
Q 026299 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (240)
Q Consensus 99 ~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~ 175 (240)
+++++|.+++... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence 9999999988764 45899999999999999999999999999999999999987765 9999999886443332 22
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
....++..|.|||.+.+...+.. +|+||||+++++|++|..||...+......++..
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~ 215 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ 215 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 34457889999999887766554 9999999999999999999988766665555543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=239.70 Aligned_cols=208 Identities=20% Similarity=0.194 Sum_probs=171.5
Q ss_pred CCCCeeEe--eeecCCCceeEEEEEecCCCcEEEEEEeecCcccc----HHHHHHHHHHHhcCCCCeeeeeEEEEc----
Q 026299 19 DSDRYELV--RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILT---- 88 (240)
Q Consensus 19 ~~~~y~~~--~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 88 (240)
+.++++.. ..+++|+++.||++.. +|..|++|.+....... +.+.+|+..+++++||||+++++++.+
T Consensus 16 ~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~ 93 (283)
T PHA02988 16 ESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93 (283)
T ss_pred CHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC
Confidence 44445555 5789999999999988 57899999987654333 456799999999999999999999876
Q ss_pred CCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
...++++|||+++++|.+++.+...++......++.+++.|+.+||+ .+++|+||+|+||+++.++. ++|+|||++.
T Consensus 94 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~ 171 (283)
T PHA02988 94 LPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEK 171 (283)
T ss_pred CCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHh
Confidence 35789999999999999999887889999999999999999999998 49999999999999987766 9999999976
Q ss_pred cccccCCCCCCcCCccccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 168 SSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
.... ......++..|+|||.+.+. ...+.++||||||+++|+|++|..||.+.+..+.+..++
T Consensus 172 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~ 235 (283)
T PHA02988 172 ILSS--PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII 235 (283)
T ss_pred hhcc--ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 4322 22334567899999998762 233445999999999999999999999887666655543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=255.22 Aligned_cols=207 Identities=26% Similarity=0.437 Sum_probs=169.7
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCC------CCeeeeeEEEEcC-CeE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTP-THL 92 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~-~~~ 92 (240)
.++|++.+.||+|+||.||++.+..++..||||++............|+.++..++| .+++.+++++..+ ..+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 478999999999999999999999999999999987644444556677777777654 4588888888765 578
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCC--------------Cc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPA--------------PR 157 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~--------------~~ 157 (240)
++|++++ +++|.+++.+.+.+++..+..++.||+.||+|||+ .||+|+||+|+||+++.++. ..
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 8999988 56888888877889999999999999999999997 59999999999999976542 14
Q ss_pred EEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhh
Q 026299 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (240)
Q Consensus 158 ~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (240)
++|+|||.+.... .......++..|+|||.+.+..++.. +|||||||++|+|++|..||...+..+.+..
T Consensus 287 vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 287 VRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred EEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 8999999875322 22234567889999999988777555 9999999999999999999988776554443
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=235.21 Aligned_cols=208 Identities=33% Similarity=0.536 Sum_probs=176.3
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
+|++.+.||.|++|.||++++..++..+++|.+.... ...+.+.+|+..++.++|+|++++.+.+.+++.+++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5899999999999999999999999999999886532 23356788999999999999999999999999999999999
Q ss_pred CCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-CC
Q 026299 100 SGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (240)
Q Consensus 100 ~~~~l~~~l~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~~ 176 (240)
++++|.+++.. ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence 99999888754 345889999999999999999999999999999999999987665 99999999864433222 22
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
...++..|+|||.+.+...+.. +|+||||+++++|++|..||...+......++.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~ 213 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNLILKVC 213 (255)
T ss_pred cccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCHHHHHHHHh
Confidence 3457788999999877766555 999999999999999999998776655544443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=233.37 Aligned_cols=202 Identities=36% Similarity=0.523 Sum_probs=174.8
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
.++|++.+.+|.|++|.||++.+..++..+++|.+..... ....+.+|+..++.++||||+++++.+.++..++++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 3789999999999999999999998899999999876433 335688999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCC
Q 026299 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (240)
Q Consensus 99 ~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~ 176 (240)
+++++|.+++... .++++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhccc
Confidence 9999999988765 68999999999999999999999999999999999999987765 9999999886443322 223
Q ss_pred CCcCCccccCccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 177 STVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
...+...|++||.+.+. ..+. ++|+||||+++++|++|..||...+.
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~-~~Di~slG~~l~~~~tg~~p~~~~~~ 209 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDG-KCDIWALGITAIELAELQPPMFDLHP 209 (262)
T ss_pred cccCCccccCchhhcccccCCcCc-hhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 34567789999998766 5544 49999999999999999999977653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=228.86 Aligned_cols=207 Identities=29% Similarity=0.448 Sum_probs=175.4
Q ss_pred CCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC-
Q 026299 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT- 90 (240)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 90 (240)
+...++++++|++.++||.|||+.|++++..++++.||+|++.... ...+...+|++..++++|||+++++++...+.
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 5567789999999999999999999999999999999999987765 44577899999999999999999998876543
Q ss_pred ----eEEEEEecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCC--ceeecCCCCCeEEcCCCCCcEEE
Q 026299 91 ----HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKI 160 (240)
Q Consensus 91 ----~~~lv~~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~--ivh~~i~~~nili~~~~~~~~~L 160 (240)
..|++++|...|+|.+.+.+ +..+++.++..|+.++++||++||+.. +.|+||+|.||++++++. ++|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl 170 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVL 170 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEE
Confidence 48999999999999988764 236999999999999999999999998 999999999999988776 999
Q ss_pred ecCCccccccccCCCC----------CCcCCccccCccccccCC--CCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 161 CDFGYSKSSVLHSQPK----------STVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 161 ~d~~~~~~~~~~~~~~----------~~~~~~~~~~pE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
.|||.++......... ....+..|.|||.+.-.. ..+.++|||||||++|.|+.|.-||..
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 9999987544333332 223688999999875432 224449999999999999999999964
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=240.28 Aligned_cols=199 Identities=31% Similarity=0.523 Sum_probs=172.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
++|++.+.||.|++|.||++.+..++..+++|.+..... ....+.+|++.+++++||||+++++.+.+++..++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 469999999999999999999999999999998865422 234578999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~ 177 (240)
+++++|.+++.....+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++. ++|+|||.+...... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-MANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCccccccc-cccc
Confidence 9999999999888889999999999999999999997 59999999999999987765 999999987644222 2234
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
..++..|+|||.+.+...+.+ +|+||||+++++|++|..||...+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred CCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcc
Confidence 467789999999877665544 999999999999999999997654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=237.78 Aligned_cols=204 Identities=30% Similarity=0.490 Sum_probs=170.7
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+|++++.||.|++|.||++.+..++..|++|.+..... ....+.+|+..++.++|||++++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58999999999999999999999999999998865422 235678899999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-
Q 026299 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (240)
Q Consensus 99 ~~~~~l~~~l~~~---~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~- 174 (240)
+++ +|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV 157 (285)
T ss_pred CCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence 975 787777532 46899999999999999999999999999999999999987766 99999998864332211
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
.....+...|+|||.+.+....+.++|+||||+++++|++|..||...+..+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~ 211 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 122345778999999876655455599999999999999999999876654443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=238.04 Aligned_cols=205 Identities=29% Similarity=0.499 Sum_probs=175.3
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
......+|++.+.+|.|++|.||++.+..++..+++|.+..... ..+.+.+|+..++.++|+|++++++.+..+...++
T Consensus 15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 34455799999999999999999999998999999998876432 23567889999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
|+||+++++|.+++.+ ..++..++..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 171 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhcccccc
Confidence 9999999999998854 45799999999999999999999999999999999999987765 99999998764432221
Q ss_pred -CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 175 -~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.....+...|+|||.+.+...+.. +|+||||+++++|++|..||...+.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCH
Confidence 223456788999999887766555 9999999999999999999977654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=274.43 Aligned_cols=215 Identities=32% Similarity=0.494 Sum_probs=188.7
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
.+.++|.+++.||+|+||.|..+++.+++..||.|++.+-. ....-|..|-.++..-..+.|+.++-.|.++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 35589999999999999999999999999999999987622 22345777888888788999999999999999999
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
+||+|++||.|...+.+...+++.-.++++..|+.||+.||+.|+|||||+|+|||++..|+ ++|+|||.+-.....+
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADG 229 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCC
Confidence 99999999999999988888999999999999999999999999999999999999987776 9999999986554332
Q ss_pred --CCCCCcCCccccCccccccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 174 --QPKSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 174 --~~~~~~~~~~~~~pE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.....+|+|.|.+||++... ..+.+.+|+||+|+++|+|+.|..||....-..++.|||.-
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence 33456799999999998522 34455599999999999999999999999999999999875
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=238.17 Aligned_cols=209 Identities=29% Similarity=0.454 Sum_probs=173.4
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
...+.|++++.||.|++|.||++++..++..+++|.+..... ....+.+|+..++.++|+|++++++.+..+..+++||
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 344789999999999999999999999999999999865432 2356788999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CC
Q 026299 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~ 174 (240)
||+++++|..++.+ ...+++..+..++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||.+...... ..
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTLQR 166 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceeccccccc
Confidence 99999999887654 456899999999999999999999999999999999999976665 999999987543222 22
Q ss_pred CCCCcCCccccCccccccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 175 PKSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
.....++..|+|||.+.+. .....++|+||||+++|+|++|..||...+....+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 224 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 224 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH
Confidence 2334567789999998532 22234599999999999999999999776544333
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=235.28 Aligned_cols=209 Identities=25% Similarity=0.423 Sum_probs=173.7
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+..+|++.+.||+|++|.||++++. ++..+++|.+.......+.+.+|+..++.++|+||+++++++...+..++++|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 3467999999999999999999886 466799998876555556788999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC-
Q 026299 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 176 (240)
Q Consensus 99 ~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~- 176 (240)
+++++|.+++... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceeccccccccc
Confidence 9999999988653 46899999999999999999999999999999999999987766 9999999876443221111
Q ss_pred -CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 177 -STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 177 -~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
.......|+|||.+.+...+.+ +|+||||+++|+|++ |..||...+..+...++
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214 (256)
T ss_pred CCCCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 1122347999999887776555 999999999999998 89999776655544443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=237.26 Aligned_cols=204 Identities=32% Similarity=0.476 Sum_probs=173.4
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc-cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
...++|++.+.||.|++|.||++++..++..|++|.+...... ...+.+|+..++.++||||+++++.+...+..++++
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 3446899999999999999999999999999999988765322 245778999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~ 175 (240)
||+++++|.+++...+.+++..+..++.|++.++.|||+.|++|+||+|+||+++.++. ++|+|||.+...... ...
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKR 163 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCccccc
Confidence 99999999999988888999999999999999999999999999999999999986665 999999987543322 222
Q ss_pred CCCcCCccccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 176 KSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
....++..|+|||.+.. ......++|+||||+++++|++|..||....
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 34467889999998742 2223445999999999999999999986544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=240.43 Aligned_cols=209 Identities=33% Similarity=0.523 Sum_probs=177.1
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||.|++|.||++.+..++..|++|.+..... ....+.+|++.++.++|+||+++++.+.++...+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 479999999999999999999999999999999876532 2245788999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
||+.+++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhccccccc
Confidence 999999999988653 46899999999999999999999999999999999999987665 99999998753322111
Q ss_pred ------------------------------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 175 ------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 175 ------------------------------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.....++..|+|||.+.+...+.. +|+||||+++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCch-HHHHHHHHHHHHHhhCCCCCCCCch
Confidence 112245678999999987766554 9999999999999999999988776
Q ss_pred hhhhhhhh
Q 026299 225 PKNFRKTI 232 (240)
Q Consensus 225 ~~~~~~~~ 232 (240)
...+.+++
T Consensus 238 ~~~~~~~~ 245 (316)
T cd05574 238 DETFSNIL 245 (316)
T ss_pred HHHHHHHh
Confidence 66655544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=234.89 Aligned_cols=208 Identities=25% Similarity=0.359 Sum_probs=171.9
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
..++|++.+.||+|++|.||++++..+ ..|++|.+.......+.+.+|+..++.++|+||+++++.+. ....+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 457899999999999999999998755 45999988765555567899999999999999999999874 4567899999
Q ss_pred CCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC-
Q 026299 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (240)
Q Consensus 99 ~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~- 175 (240)
+++++|.+++... ..++...+..++.|++.||++||+.+++|+||+|+||++++++. ++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeecccccccc
Confidence 9999999998653 35788999999999999999999999999999999999987665 999999998644322211
Q ss_pred -CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 176 -~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
....++..|+|||...+...+.. +|+||||+++++|++ |..||.+........++
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~ 216 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216 (262)
T ss_pred ccCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH
Confidence 12234567999999877776555 999999999999999 88899877665554443
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=250.83 Aligned_cols=217 Identities=41% Similarity=0.663 Sum_probs=198.8
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
...|.+.+.||+|.|++|..+++.-++..|+||.+.+... ......+|+.+++.+.||||++++++...+..+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 3689999999999999999999999999999999877432 2245789999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
||..++.+.+++.+.+...+.+....+.|++.|++|+|+++|||+||+.+|++++.+.. ++|+|||++..........
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lq 212 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLMLQ 212 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeeccccccc
Confidence 99999999999999998889999999999999999999999999999999999988776 9999999998888888888
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceecee
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCT 238 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (240)
+..+++-|.|||.+.+..+..++.|+||||+++|.|++|.+||.+.+-...-.+.+...|..
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rI 274 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRI 274 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecc
Confidence 99999999999999999998888999999999999999999999988887777776665543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=237.31 Aligned_cols=202 Identities=29% Similarity=0.450 Sum_probs=168.1
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
.++|++++.||+|++|.||++.+..++..|++|.+..... ....+.+|+..++.++|+||+++++++.++...++++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 4789999999999999999999999999999999865432 22457889999999999999999999999999999999
Q ss_pred cCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CC
Q 026299 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~ 175 (240)
|+.+ ++.+.+.. ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus 84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 84 YMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQTY 160 (291)
T ss_pred cccC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCCC
Confidence 9965 66655543 356788899999999999999999999999999999999987765 9999999886433221 12
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
....+...|+|||.+.+......++|+||||+++++|++|..||...+.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 2334577899999987655444459999999999999999999976543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=239.98 Aligned_cols=210 Identities=26% Similarity=0.351 Sum_probs=171.1
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCc--EEEEEEeecCc--cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~--~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 95 (240)
++|++.+.||.|++|.||++.+..++. .+++|.+.... ...+.+.+|+..+.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 689999999999999999999876654 46788776422 2235678899999999 799999999999998999999
Q ss_pred EecCCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEE
Q 026299 96 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~ 159 (240)
+||+++++|.+++.+.. .++...+..++.|++.|+++||+.|++|+||+|+||+++.+.. ++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~k 159 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SK 159 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EE
Confidence 99999999999986532 4788899999999999999999999999999999999987665 99
Q ss_pred EecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 160 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 160 L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
|+|||++.................|+|||.+.+...+.+ +||||||+++++|++ |..||...+..+.+.++.+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 999998764332222222223457999999877766555 999999999999997 9999988776665555543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=240.23 Aligned_cols=211 Identities=34% Similarity=0.469 Sum_probs=178.0
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--CeEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAI 94 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 94 (240)
.++|++.+.||.|++|.||+|.+..++..+++|.+..... ....+.+|+..+++++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 4689999999999999999999999999999999875432 223567899999999999999999998877 88999
Q ss_pred EEecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-
Q 026299 95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~- 172 (240)
++||+++ +|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCc
Confidence 9999975 8888876543 5899999999999999999999999999999999999987765 999999988755443
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.......+...|+|||.+.+......++|+||||+++++|++|..||...+..+.+.++..
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK 221 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 2222344677899999987665545559999999999999999999998887777666554
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=239.61 Aligned_cols=206 Identities=29% Similarity=0.520 Sum_probs=170.0
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+|++.+.||.|++|.||++++..+|..+++|.+.... .....+.+|+..++.++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5899999999999999999999999999999986532 2234577899999999999999999999999999999999
Q ss_pred CCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-CC
Q 026299 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (240)
Q Consensus 99 ~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~~ 176 (240)
+++ +|.+++.. ...+++..+..++.||++||.|||+.|++|+||+|+||+++.++. ++|+|||.+........ ..
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence 976 67776654 467899999999999999999999999999999999999987765 99999999864432221 22
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCC-CCCCchhhhhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRK 230 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~ 230 (240)
...++..|+|||.+.+....+.++|+||||+++++|++|..|| ...+....+.+
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~ 212 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 212 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHH
Confidence 3346778999999877665555699999999999999988885 44443333333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=233.58 Aligned_cols=209 Identities=33% Similarity=0.495 Sum_probs=174.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc------cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--Ce
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 91 (240)
+.+|++.+.||+|++|.+|++.+..++..|++|.+.... .....+.+|+..+++++|+||+++++.+.+. ..
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CCceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 368999999999999999999999999999999875421 1224678899999999999999999998764 46
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
+++++|++++++|.+++.+...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~ 158 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcccccccccc
Confidence 8899999999999999887777899999999999999999999999999999999999987665 99999999865432
Q ss_pred cC----CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 172 HS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 172 ~~----~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
.. ......++..|+|||.+.+...+.. +|+||||+++++|++|..||.+.+....+.++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 221 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI 221 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH
Confidence 11 1122346778999999887666554 99999999999999999999877655554443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=237.02 Aligned_cols=202 Identities=31% Similarity=0.502 Sum_probs=170.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
..++|++.+.||.|++|.||++.+..+++.|++|.+..... ....+.+|+.+++.++|+||+++++++.++...++|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 34789999999999999999999998999999999865432 2245678999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-
Q 026299 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~- 174 (240)
||+++ +|.+++... ..+++..++.++.|+++||.|||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCcc
Confidence 99986 888887654 46899999999999999999999999999999999999987765 99999998764332211
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
.....++..|+|||.+.+......++|+||||+++++|++|..||...+
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1222356789999998765544555999999999999999999997765
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=231.71 Aligned_cols=210 Identities=37% Similarity=0.559 Sum_probs=179.0
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+|++.+.||.|++|.+|++.+..++..+++|.+.... .....+.+|+..++.++|||++++++.+..++..++|+|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 6999999999999999999999999999999986542 2235678999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 99 ~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
+++++|.+++... ..+++..+..++.+++.++++||+.|++|+||+|+||+++.+.. .++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCcccc
Confidence 9999999998653 35899999999999999999999999999999999999975442 47999999987655444444
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
...++..|+|||.+.+...+.+ +|+||||+++++|++|..||...+......++..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 215 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIMS 215 (256)
T ss_pred ccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh
Confidence 4567889999999987666554 9999999999999999999988766555555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=239.67 Aligned_cols=210 Identities=29% Similarity=0.508 Sum_probs=176.5
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++.+.||.|++|.||++.+..+++.|++|.+..... ..+.+.+|++.++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 479999999999999999999998899999998765322 23567889999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-CC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~~ 176 (240)
|++++++..+......++...+..++.|++.++.|||+.|++|+||+|+||+++.++. ++|+|||.+........ ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence 9999888887766666899999999999999999999999999999999999987765 99999998864433222 12
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
...+...|+|||.+.+......++|+||||+++++|++|..||...+..+.+.++.
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 33467789999998765544556999999999999999999998776555444433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=237.76 Aligned_cols=209 Identities=23% Similarity=0.396 Sum_probs=173.2
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCC-----cEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTE-----ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
.++|++.+.||.|++|.||++.+...+ ..+++|.+.... .....+.+|+..++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468999999999999999999987555 679999886543 2234678999999999999999999999998899
Q ss_pred EEEEecCCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC
Q 026299 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~ 156 (240)
++++||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||++++++.
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~- 162 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT- 162 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc-
Confidence 9999999999999998654 34788899999999999999999999999999999999987765
Q ss_pred cEEEecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 157 RLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 157 ~~~L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
++|+|||.+....... ......++..|+|||.+.+...+.+ +|+||||+++++|++ |..||.+....+....+
T Consensus 163 -~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 163 -VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred -EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999986433221 1122344678999999877776554 999999999999998 99999877665555443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=236.45 Aligned_cols=209 Identities=28% Similarity=0.452 Sum_probs=177.8
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+|++.+.||.|++|.||+|.+..++..|++|.+.... .....+.+|+..+++++|+||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5899999999999999999999899999999987643 2235788999999999999999999999999999999999
Q ss_pred CCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC--C
Q 026299 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (240)
Q Consensus 99 ~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~--~ 175 (240)
+ +++|.+++.. ..++++..++.++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCcc
Confidence 9 8899998854 456899999999999999999999999999999999999987665 99999998865543321 2
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
....++..|+|||.+.+....+.++|+||||+++++|++|..||...+....+.++++
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~ 215 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFR 215 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHH
Confidence 3345778899999987666555669999999999999999988887766655555443
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=236.07 Aligned_cols=206 Identities=30% Similarity=0.504 Sum_probs=175.8
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
....+|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++|+|++++++.+..+..+++|+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 34478999999999999999999999999999999886543 23356788999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-C
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~ 175 (240)
||+++++|.+++.. ..+++..+..++.+++.++++||+.|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccC
Confidence 99999999988754 46899999999999999999999999999999999999987665 99999998764433222 2
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
....+...|+|||.+.+...+.. +|+||||+++|+|++|..||...+....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~ 223 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (296)
T ss_pred CCcCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 23456778999999887766555 9999999999999999999987655433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=237.87 Aligned_cols=212 Identities=27% Similarity=0.402 Sum_probs=175.7
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
..++|++.+.||+|++|.||++.+.. ++..|++|.+...... ...+.+|++.++.++|+||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 34789999999999999999998753 3678999988764333 3578899999999999999999999999999
Q ss_pred EEEEEecCCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCc
Q 026299 92 LAIVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~--------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~ 157 (240)
.+++|||+++++|.+++... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~-- 160 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV-- 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--
Confidence 99999999999999998653 23788899999999999999999999999999999999987765
Q ss_pred EEEecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 158 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 158 ~~L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
++|+|||.+....... ..........|+|||.+.+...+.. +|+||||+++++|++ |..||...+..+.+..+.+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 9999999886432221 1122334578999999987776555 999999999999998 9999987766665555443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=235.75 Aligned_cols=202 Identities=33% Similarity=0.548 Sum_probs=174.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
++|++.+.||.|++|.||++++..++..+++|.+..... ....+.+|+..++.++|+|++++.+.+.++...++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 478999999999999999999999999999999876432 224578899999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~ 177 (240)
+++++|.+++... ++++..+..++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+...... .....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence 9999999988654 7899999999999999999999999999999999999987766 999999998655433 22234
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
..++..|+|||.+.+...+.. +|+||||+++|+|++|..||...+...
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~~ 205 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMR 205 (274)
T ss_pred ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchHH
Confidence 456778999999987775544 999999999999999999997655433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=234.34 Aligned_cols=214 Identities=33% Similarity=0.524 Sum_probs=190.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---------cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 90 (240)
.+|.-.+.+|.|..+.|..+.+..++..+++|++.... ...+.-..|+.+|+++ .||+|+++.+++..+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 57888899999999999999999999999999986521 1113457899999988 5999999999999999
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
..++|++.++.|.|.|++.+.-.+++.+...+++|++++++|||.++|||+||+|+||+++++.. ++|.|||++....
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccC
Confidence 99999999999999999988888999999999999999999999999999999999999987776 9999999999888
Q ss_pred ccCCCCCCcCCccccCcccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceec
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (240)
.+.......|+++|+|||.+.. .+.+....|.|++|+++|.|+.|..||......-.++-|++..|
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky 245 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY 245 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence 8888888899999999998853 34556669999999999999999999999888888888887655
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=237.16 Aligned_cols=209 Identities=33% Similarity=0.545 Sum_probs=175.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
.+|++++.++.|++|.||++.+..++..|++|.+..... ....+.+|+..++.++||||+++++.+..++..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 479999999999999999999999999999998876432 2245678999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC---
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~--- 173 (240)
||++|++|.+++...+.+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCcccc
Confidence 99999999999988888999999999999999999999999999999999999987665 9999999875311100
Q ss_pred -------------CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 174 -------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 174 -------------~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
......++..|+|||.+.+...+.+ +|+||||+++++|++|..||.+.+....+.++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 0011235668999999887766555 999999999999999999998766555444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=237.44 Aligned_cols=209 Identities=29% Similarity=0.438 Sum_probs=174.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
++|++++.||.|++|.||++.+..++..+++|.+..... ..+.+.+|+..+++++|+|++++++.+..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 679999999999999999999998999999999876432 2356788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCCC
Q 026299 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (240)
Q Consensus 100 ~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~~ 177 (240)
++++|.+++... ..+++..++.++.|++.++.|||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccce
Confidence 999999988653 56899999999999999999999999999999999999987765 9999999875443222 1223
Q ss_pred CcCCccccCccccccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 178 TVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
..++..|++||.+... .....++|+||||+++|+|++|..||...+....+.++
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~ 220 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI 220 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH
Confidence 3567889999987532 22234599999999999999999999876654444333
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=231.88 Aligned_cols=207 Identities=31% Similarity=0.464 Sum_probs=173.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc------ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--CeE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 92 (240)
.+|++.+.+|+|++|.||++.+..++..|++|.+..... ....+.+|+..++.++||||+++++.+... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 579999999999999999999999999999998865321 123577899999999999999999988753 568
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
++++|++++++|.+++.....++....+.++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccc
Confidence 899999999999999987778999999999999999999999999999999999999987665 999999988644321
Q ss_pred C----CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhh
Q 026299 173 S----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (240)
Q Consensus 173 ~----~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (240)
. ......+...|+|||.+.+...+.. +|+||||+++++|++|..||.+.+....+.+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~ 220 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK 220 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccchHHHHHH
Confidence 1 1122346778999999987766554 9999999999999999999987755544443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=230.12 Aligned_cols=209 Identities=27% Similarity=0.491 Sum_probs=174.2
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEc-CCeEEEEEe
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME 97 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~~ 97 (240)
.|++.+.+|.|++|.||.+++..+++.+++|.+..... ..+.+.+|+..+++++|+|++++.+.+.. +..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 58999999999999999999999999999999865432 23457889999999999999999988764 446899999
Q ss_pred cCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CC
Q 026299 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (240)
Q Consensus 98 ~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~ 174 (240)
++++++|.+++... ..+++.+++.++.+++.++++||+.|++|+||+|+||+++.++. ++|+|||.+...... ..
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCc
Confidence 99999999988653 45899999999999999999999999999999999999987665 999999998644322 22
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.....+.+.|+|||.+.+...+.+ +|+||||+++++|++|..||...+......++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~ 216 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE 216 (257)
T ss_pred cccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 233456788999999988776655 9999999999999999999987765555444433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=236.15 Aligned_cols=213 Identities=26% Similarity=0.427 Sum_probs=174.5
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEe-----cCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
++..+|++.+.+|.|++|.||++.+ ..++..+++|.+.... .....+.+|+..+++++||||+++++++...+.
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 3567899999999999999999985 3346678999876543 233568899999999999999999999999999
Q ss_pred EEEEEecCCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcE
Q 026299 92 LAIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~-------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~ 158 (240)
.++++||+++++|.+++...+ .+++..+..++.|++.||++||+.|++|+||+|+||+++.++. +
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~ 159 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--V 159 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--E
Confidence 999999999999999886443 3899999999999999999999999999999999999987765 9
Q ss_pred EEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 159 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 159 ~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
+|+|||.+........ .....++..|+|||.+.+...+.. +|+||||+++++|++ |..||......+.+.++..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 9999999864432211 122234568999999877666554 999999999999998 9999987766555544443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=232.24 Aligned_cols=211 Identities=25% Similarity=0.341 Sum_probs=177.4
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
...++|++.+.||.|++|.||++.+. ++..+++|.+.......+++.+|+..++.++|+||+++++++......++++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 35589999999999999999999976 45779999988766666789999999999999999999999998889999999
Q ss_pred cCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
++++++|.+++... ..++...+..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYT 159 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhh
Confidence 99999999998654 36899999999999999999999999999999999999987765 999999987644321111
Q ss_pred --CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 176 --~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
........|+|||.+.+...+.. +|+||||+++++|++ |..||.+.+....+.++.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE 218 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 11223457999999887666555 999999999999998 999998776665555544
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=234.92 Aligned_cols=193 Identities=27% Similarity=0.457 Sum_probs=166.5
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
++|++++.||.|++|.||++.+..++..|++|.+..+.. ....+.+|+..+++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 468899999999999999999999999999998866422 234678999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~ 178 (240)
+++++|..+ ..+++..+..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||.+...... .....
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecccc-cccCC
Confidence 999888653 34688899999999999999999999999999999999987766 999999998644322 22334
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
.++..|+|||.+.+...+.+ +|+||||+++++|++|..||..
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred CCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchh
Confidence 67789999999987776555 9999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=231.48 Aligned_cols=209 Identities=32% Similarity=0.469 Sum_probs=177.0
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
++|++.+.+|.|++|.||++....++..+++|++.... .....+.+|+..++.++|+|++++++.+..+..+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999999899999999886543 2335688999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 99 ~~~~~l~~~l~~~---~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
+++++|.+++... ..+++..+..++.|++.|+.+||+.|++|+||+|+||++++++. ++|+|||.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR 158 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence 9999999998754 35899999999999999999999999999999999999987665 999999988644433222
Q ss_pred -----CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 176 -----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 176 -----~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
....++..|++||.+......+.++|+||||+++++|++|..||...+....+.+.
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 219 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT 219 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH
Confidence 23346778999999877744455599999999999999999999877655444443
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=236.49 Aligned_cols=205 Identities=30% Similarity=0.493 Sum_probs=175.1
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
.....++|++++.||.|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++|+|++++++.+..+...++
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 3445589999999999999999999999899999999987643 233567889999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
|+||+++++|.+++.+ ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 170 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCcc
Confidence 9999999999998854 45789999999999999999999999999999999999987665 99999998864433222
Q ss_pred -CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 175 -~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.....+...|++||.+.+...+.. +|+||||+++++|++|..||...+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 223456778999999987766554 9999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=235.37 Aligned_cols=207 Identities=33% Similarity=0.545 Sum_probs=175.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC---ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++.+.||.|++|.+|++.+..+++.|++|.+... ....+.+.+|+..++.++|+||+++.+++..++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4799999999999999999999999999999988653 2233578899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC--CC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~--~~ 175 (240)
|++++.+..+......++...++.++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence 9998777666655567999999999999999999999999999999999999987665 9999999986554433 22
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (240)
....++..|+|||.+.+....+.++|+||||+++++|++|..||...+..+.+.
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~ 212 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY 212 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 334567789999999877444556999999999999999999998766554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=231.38 Aligned_cols=203 Identities=29% Similarity=0.497 Sum_probs=176.0
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
.++|++.+.++.|++|.+|++++..++..+++|.+..... .+.+.+|+..++.++|+|++++++.+.++...++++|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 3689999999999999999999998899999998876543 567899999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCCC
Q 026299 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (240)
Q Consensus 100 ~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~~ 177 (240)
++++|.+++.. ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcccccc
Confidence 99999998865 456899999999999999999999999999999999999987766 9999999986544332 2233
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
..+...|+|||++.+...+.+ +|+||||+++++|++|..||.......
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~ 206 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMR 206 (256)
T ss_pred ccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 446778999999877766544 999999999999999999997654433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=232.30 Aligned_cols=209 Identities=25% Similarity=0.383 Sum_probs=172.5
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
...++|++.+.||.|++|.||++.+. ++..+++|.+.......+.+.+|+.++++++|+|++++++++. ....+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 34578999999999999999999877 5566999998876555677899999999999999999999875 456789999
Q ss_pred cCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
++++++|.+++... ..++...+..++.+++.||.|||+.|++|+||+|+||++++++. ++|+|||.+.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYT 158 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCcccc
Confidence 99999999988653 35899999999999999999999999999999999999987665 999999998644322211
Q ss_pred --CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 176 --~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
....++..|+|||.+.+...+.+ +|+||||+++++|++ |..||.+.+..+...++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 11223457999999877666555 999999999999999 89999876655544443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=244.83 Aligned_cols=210 Identities=26% Similarity=0.364 Sum_probs=170.2
Q ss_pred cccCCCCCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHHhcC-CCCeeeeeEEE
Q 026299 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVI 86 (240)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 86 (240)
....+.++|++.+.||.|+||.||++.+.. .+..|++|++..... ..+.+.+|+.+++.+. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 344456899999999999999999998753 245799998865432 2356889999999996 99999999999
Q ss_pred EcCCeEEEEEecCCCCchHHHHHhc-------------------------------------------------------
Q 026299 87 LTPTHLAIVMEYASGGELFERICNA------------------------------------------------------- 111 (240)
Q Consensus 87 ~~~~~~~lv~~~~~~~~l~~~l~~~------------------------------------------------------- 111 (240)
...+..++||||+++++|.+++...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999999998887532
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEE
Q 026299 112 -----------------------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (240)
Q Consensus 112 -----------------------------------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili 150 (240)
..++...+..++.|++.|++|||+.+++|+||+|+||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 136778889999999999999999999999999999999
Q ss_pred cCCCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchh
Q 026299 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (240)
Q Consensus 151 ~~~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (240)
+.+.. ++|+|||.+........ .....++..|+|||.+.+...+.+ +||||||+++++|++ |..||.......
T Consensus 271 ~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 271 AQGKI--VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred eCCCE--EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 87665 99999999864432221 122235568999999987766555 999999999999997 999997765443
Q ss_pred h
Q 026299 227 N 227 (240)
Q Consensus 227 ~ 227 (240)
.
T Consensus 348 ~ 348 (400)
T cd05105 348 T 348 (400)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=231.28 Aligned_cols=204 Identities=32% Similarity=0.492 Sum_probs=175.3
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc------ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
+|+..+.||.|++|.||++.+..++..|++|.+..... ..+.+.+|+..++.++|+||+++++++.++..++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 57888999999999999999998899999998866431 234678899999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
+||+++++|.+++.+..+++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence 999999999999988778999999999999999999999999999999999999987665 999999988655444333
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
....++..|++||.+........++|+||||+++++|++|..||......+.
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~ 210 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA 210 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH
Confidence 4456778899999987666234459999999999999999999977654333
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=242.45 Aligned_cols=210 Identities=28% Similarity=0.420 Sum_probs=175.9
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC------
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 89 (240)
..++|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|+..+++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3488999999999999999999999999999999886432 2234567899999999999999999988644
Q ss_pred CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
...++|+||+.+ +|.+.+... ++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeC
Confidence 357999999976 777777544 899999999999999999999999999999999999987765 999999998755
Q ss_pred cccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 170 ~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
..........++..|+|||.+.+...+.+ +|+||||+++++|++|..||...+..+.+.++++.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 232 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQ 232 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 43333333456788999999988777655 99999999999999999999988877776666543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=249.96 Aligned_cols=190 Identities=35% Similarity=0.528 Sum_probs=170.2
Q ss_pred EeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCch
Q 026299 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
=++=||.|+.|-||.++.. ++.||||++. +....+++-|++|+||||+.+.|+|...-.+|||||||..|.|
T Consensus 128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc--CceehhHHHh------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3556899999999999875 6789999763 3445788999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcCCccc
Q 026299 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184 (240)
Q Consensus 105 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~ 184 (240)
.++|....+++...+..|..+|+.+++|||...|+|+|||.-||||.-+.. +||+|||-+...........+.|+..|
T Consensus 200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGTVaW 277 (904)
T KOG4721|consen 200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGTVAW 277 (904)
T ss_pred HHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhhHhh
Confidence 999999999999999999999999999999999999999999999987766 999999998766555556678899999
Q ss_pred cCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 185 ~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
||||++.+.+...+ .||||||++||+|+||..||.+-+..
T Consensus 278 MAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdss 317 (904)
T KOG4721|consen 278 MAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSS 317 (904)
T ss_pred hCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccchh
Confidence 99999988888776 99999999999999999999876543
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=230.10 Aligned_cols=209 Identities=31% Similarity=0.553 Sum_probs=176.8
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+|++.+.||.|++|.+|++++..++..|++|.+.... .....+.+|+..++.++|+||+++.+++...+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 6999999999999999999999999999999986532 2234688999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-C
Q 026299 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (240)
Q Consensus 99 ~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~ 175 (240)
+++++|.+.+.... .+++..+..++.|++.++.+||+.|++|+||+|+||+++.+.. ++++|||.+........ .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence 99999999886543 5789999999999999999999999999999999999987665 99999998864433221 1
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
....+...|+|||.+.+...+.+ +|+||||+++++|++|..||...+..+.+.+++.
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~ 215 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc
Confidence 22346778999999887776554 9999999999999999999987766665555544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=244.19 Aligned_cols=196 Identities=24% Similarity=0.359 Sum_probs=167.3
Q ss_pred CCeeEeeeecCCCceeEEEEEec--CCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
.+|++++.||.|++|.||++... .++..|++|.+... ....+|+.+++.++||||+++++++......+++|++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 57999999999999999999764 35678999987543 3456899999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC---C
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---P 175 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~---~ 175 (240)
+.+ +|.+++.....++...++.++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++........ .
T Consensus 168 ~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~~ 244 (392)
T PHA03207 168 YKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQC 244 (392)
T ss_pred cCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCcccccccc
Confidence 864 78888877778999999999999999999999999999999999999987766 99999999864433221 1
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
....++..|+|||.+.+..++.+ +|+||||+++|+|++|..||.+...
T Consensus 245 ~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 245 YGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred cccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 23467899999999987776555 9999999999999999999977543
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=236.88 Aligned_cols=203 Identities=27% Similarity=0.431 Sum_probs=170.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
++|++++.||.|++|.||++++..++..|++|.+.... .....+.+|+..+++++|+||+++++.+...+.+++++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47899999999999999999999999999999886532 2235678899999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 99 ~~~~~l~~~l~~~---~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
+++++|..++... ..+++..+..++.+++.|+.|||+ .|++|+||+|+||+++.++. ++|+|||.+..... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVA-SL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC--EEEeecCCcccccC-Cc
Confidence 9999998888653 368999999999999999999996 59999999999999987655 99999998764322 22
Q ss_pred CCCCcCCccccCccccccCCC-----CCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 175 PKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
.....+...|+|||.+.+... ...++|+||||+++++|++|..||...+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 214 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN 214 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence 233456778999998855432 2445999999999999999999997655443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=232.65 Aligned_cols=211 Identities=31% Similarity=0.496 Sum_probs=174.8
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCC------
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPT------ 90 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------ 90 (240)
...++|++.+.||.|++|.+|++.+..++..+++|.+.......+.+.+|+..++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 345899999999999999999999998899999999887666567789999999998 6999999999997644
Q ss_pred eEEEEEecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 91 HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
.+++++||+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~ 160 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVS 160 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCccc
Confidence 48999999999999988764 346899999999999999999999999999999999999987665 999999987
Q ss_pred cccccc-CCCCCCcCCccccCccccccCC----CCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhh
Q 026299 167 KSSVLH-SQPKSTVGTPAYIAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (240)
Q Consensus 167 ~~~~~~-~~~~~~~~~~~~~~pE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (240)
...... .......++..|+|||.+.... ....++|+||||+++++|++|..||..........+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 229 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH
Confidence 643322 2223345678899999875432 223459999999999999999999986654444333
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=233.24 Aligned_cols=209 Identities=30% Similarity=0.490 Sum_probs=176.3
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
+|++.+.||.|++|.||++++..++..|++|.+..... ..+.+.+|+..++.++|+||+++++.+.+.+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58999999999999999999999999999999876432 2356778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-C
Q 026299 100 SGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (240)
Q Consensus 100 ~~~~l~~~l~~~---~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~ 175 (240)
++ +|.+++... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF 157 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence 86 787777543 35899999999999999999999999999999999999987765 99999998864332211 1
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
....++..|++||.+.+......++|+||||+++++|++|..||.+.+..+.+.++++
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 215 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 2234567899999987665545569999999999999999999998887777666554
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=235.26 Aligned_cols=205 Identities=34% Similarity=0.517 Sum_probs=168.6
Q ss_pred eEeeeecCCCceeEEEEEec----CCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 24 ELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++.+.||.|.||.||+|... ..+..|+||.+..... ..+.+.+|+..+++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 56789999999999999998 4577899999865332 24678999999999999999999999998888999999
Q ss_pred cCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc---
Q 026299 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 172 (240)
Q Consensus 98 ~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~--- 172 (240)
|+++++|.+++... ..++...+..++.|++.||.|||+.+++|++|+++||+++.++. +||+|||.+......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence 99999999999876 67999999999999999999999999999999999999987775 999999998654211
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
...........|+|||.+.+...+.+ +||||||++++++++ |..||.+.+..+...++
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~ 218 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL 218 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH
T ss_pred cccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccc
Confidence 12233345678999999877776444 999999999999999 78999888666655554
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=232.77 Aligned_cols=199 Identities=29% Similarity=0.464 Sum_probs=169.5
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||.|++|.||++++..++..|++|.+.... .....+.+|+..++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999999999999999876422 22245788999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 97 ~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccch
Confidence 99999999887752 345889999999999999999999999999999999999987766 999999987644322
Q ss_pred CC-CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 173 ~~-~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
.. .....+...|+|||.+.+...+.+ +|+||||+++++|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCccc
Confidence 21 122356778999999987776555 99999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=232.48 Aligned_cols=198 Identities=30% Similarity=0.484 Sum_probs=170.2
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCccc-cHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEEEecCCCCch
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
+.||+|+++.|-.+..-.++..|+||++.+.+.- +.+..+|++.+..++ |+||++++++|+++..+|+|||.+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 4689999999999999999999999999876433 367899999999995 99999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCCcccccccc--------CCC
Q 026299 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH--------SQP 175 (240)
Q Consensus 105 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~~~~~~--------~~~ 175 (240)
...+++..-+++.+..++.++|+.||++||.+||.|+|++|+||+..... ..-+||+||.+....... ...
T Consensus 164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L 243 (463)
T KOG0607|consen 164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPEL 243 (463)
T ss_pred HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccc
Confidence 99999988999999999999999999999999999999999999995433 334899999987543322 122
Q ss_pred CCCcCCccccCccccc----cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 176 KSTVGTPAYIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.+..|+..|||||+.. ...++.++.|.||||+++|-|++|..||.+...
T Consensus 244 ~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 244 LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 3446889999999853 345667789999999999999999999987654
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=233.37 Aligned_cols=206 Identities=30% Similarity=0.457 Sum_probs=170.5
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcC-CCCeeeeeEEEEcC--CeEEEEEe
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIVME 97 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~~ 97 (240)
|++++.+|.|++|.||++.+..++..|++|.+..... ......+|+..+.++. |+|++++++++.++ +.+++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999999999999998866422 2233457888888885 99999999999987 88999999
Q ss_pred cCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
|+++ ++.+.+.+ ...+++..+..++.|++.||++||+.|++|+||+|+||+++. +.++|+|||.+..........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEecccccccccCCCcC
Confidence 9976 77777755 356899999999999999999999999999999999999987 459999999987554444434
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
...++..|+|||.+......+.++|+||||+++++|++|..||...+..+.+.++.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~ 212 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIH 212 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHH
Confidence 44567889999987655544556999999999999999999998887666555443
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=238.12 Aligned_cols=204 Identities=23% Similarity=0.380 Sum_probs=167.9
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcE----EEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~----v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
....+|++.+.||+|++|.||++++..++.. |++|.+.... .....+.+|+..++.++||||+++++++... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 3557899999999999999999998665553 8999886532 2335688899999999999999999998764 5
Q ss_pred EEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
.+++++++++++|.+++... ..++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~ 160 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLG 160 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEcccccccccc
Confidence 67999999999999988764 45889999999999999999999999999999999999987766 9999999987544
Q ss_pred ccCCCC---CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCch
Q 026299 171 LHSQPK---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (240)
Q Consensus 171 ~~~~~~---~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (240)
...... ....+..|++||.+.+...+.+ +|+||||+++|+|++ |..||.+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~ 218 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPAS 218 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 322211 1223457999999987776555 999999999999997 99999775543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=231.45 Aligned_cols=201 Identities=32% Similarity=0.560 Sum_probs=172.5
Q ss_pred ecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCch
Q 026299 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
||.|++|.||++++..++..+++|.+.... .....+.+|+..++.++||||+++++.+.++...++++||.++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999999889999999987643 2235688999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcCCccc
Q 026299 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184 (240)
Q Consensus 105 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~ 184 (240)
.+++.+...++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.............+...|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence 999988778999999999999999999999999999999999999987765 999999998755444333344577889
Q ss_pred cCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC--chhhhhhhh
Q 026299 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--EPKNFRKTI 232 (240)
Q Consensus 185 ~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~ 232 (240)
++||.+.+...+.+ +|+||||+++|+|++|..||...+ ..+...+++
T Consensus 159 ~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 207 (262)
T cd05572 159 VAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207 (262)
T ss_pred cChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh
Confidence 99999877666555 999999999999999999998776 444444443
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=230.34 Aligned_cols=200 Identities=31% Similarity=0.531 Sum_probs=176.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
.+|++.+.||.|++|.+|++.+..++..|++|.+..... ....+.+|+..+++++|+|++++++.+..+...++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368999999999999999999999999999999876542 346788999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC-
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 176 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~- 176 (240)
+++++|.+++....++++..+..++.|+++++++||+ .|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN 158 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence 9999999999877889999999999999999999999 99999999999999987766 9999999987554433332
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
...+...|+|||.+.+...+.. +|+||||+++|+|++|..||....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ceeecccccCHhhhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccc
Confidence 3456788999999877765544 999999999999999999997774
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=232.88 Aligned_cols=210 Identities=25% Similarity=0.367 Sum_probs=172.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
..++|++.+.||+|++|.||++.+.. ++..|++|.+..... ....+.+|+..++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34789999999999999999999987 678899998765432 23468889999999999999999999998888
Q ss_pred EEEEEecCCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecC
Q 026299 92 LAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDF 163 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~-------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~ 163 (240)
.++++||+++++|.+++...+ .+++..+..++.|++.+++|||+.+++|+||+|+||+++.++ ...++|+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999999886543 488899999999999999999999999999999999997654 234899999
Q ss_pred CccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 026299 164 GYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (240)
Q Consensus 164 ~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (240)
|.+........ .........|+|||.+.+...+.+ +||||||+++++|++ |..||...+......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~~ 232 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99865422111 112223457999999987776555 999999999999997 999998776555443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=232.92 Aligned_cols=193 Identities=33% Similarity=0.482 Sum_probs=166.1
Q ss_pred ecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCch
Q 026299 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
||+|++|.||++.+..+++.|++|.+.... .....+.+|++.++.++|||++++++++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999999999999999886532 2234567899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcCCc
Q 026299 105 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182 (240)
Q Consensus 105 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~ 182 (240)
.+++.+.. .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+.............+..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence 99887655 6899999999999999999999999999999999999987765 9999999886544333334455677
Q ss_pred cccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 183 ~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.|++||.+.+...+.. +|+||||+++++|++|..||.....
T Consensus 159 ~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 159 GYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 8999999877775444 9999999999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=230.63 Aligned_cols=197 Identities=29% Similarity=0.416 Sum_probs=163.9
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCch
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
+.||+|++|.||++++..++..+++|.+.... .....+.+|+..++.++||||+++++++..+...++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999999899999999876432 2235688999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC---CCcC
Q 026299 105 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 180 (240)
Q Consensus 105 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~---~~~~ 180 (240)
.+++.+. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.......... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCC
Confidence 9988654 35899999999999999999999999999999999999987665 9999999986433211111 1122
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchh
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (240)
...|+|||.+.+...+.. +|+||||+++|+|++ |..||.......
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~ 204 (252)
T cd05084 159 PVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQ 204 (252)
T ss_pred ceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHH
Confidence 356999999877776555 999999999999997 899987655443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=236.45 Aligned_cols=211 Identities=36% Similarity=0.611 Sum_probs=189.3
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
+++|..++.||+|.||+|-+++-..+++.||+|++++.-- .-..-+.|-..|+..+||.+..+.-.|...+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4789999999999999999999999999999999877532 223457888999999999999998899999999999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc-ccCC
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQ 174 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~-~~~~ 174 (240)
|||..||.|...+.+.+-+++.....+-..|+.||.|||+++||.+|++.+|.+++.+++ +|+.|||++.... .+..
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccce
Confidence 999999999888888888999999999999999999999999999999999999988887 9999999996443 4455
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.....|++.|+|||++.+..+... .|+|.+|+++|+|+||++||.+.+....+.-|+.
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ 382 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM 382 (516)
T ss_pred eccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccchhHHHHHHHh
Confidence 677889999999999988888655 9999999999999999999999999999887764
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=232.77 Aligned_cols=209 Identities=21% Similarity=0.329 Sum_probs=169.3
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
..++|++.+.||+|++|.||.+.+.. ++..|++|.+..... ....+.+|+..++.++|+||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 44789999999999999999998652 356799998755332 23457889999999999999999999999899
Q ss_pred EEEEEecCCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEe
Q 026299 92 LAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~----------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~ 161 (240)
.+++|||+++++|.+++.+.. .++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~ 161 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIG 161 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEEC
Confidence 999999999999999886422 2567889999999999999999999999999999999987665 9999
Q ss_pred cCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 162 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 162 d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
|||.+....... ......++..|+|||.+.+...+.. +|+||||+++++|++ |..||...+....+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~ 233 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999875432211 1112234568999999987776555 999999999999998 7899987665554443
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=232.15 Aligned_cols=201 Identities=31% Similarity=0.510 Sum_probs=171.7
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-------ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
+|+..+.||+|++|.+|.+.+..+++.+++|.+..... ....+.+|+..++.++|+||+++++++.+++.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 48888999999999999999999999999998865321 23567899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
+++|+.+++|.+++.+.+++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence 9999999999999988888999999999999999999999999999999999999975542 389999999865443221
Q ss_pred -----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 175 -----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 175 -----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.....++..|+|||.+.+...+. ++|+||||+++++|++|..||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGR-SCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 12234677899999987666544 49999999999999999999976544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=229.41 Aligned_cols=202 Identities=29% Similarity=0.436 Sum_probs=173.2
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+.++|++.+.+|.|++|.||++... +..|++|.+........++.+|+..++.++|+||+++++++.+....++++|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 4678999999999999999999875 77899999877655456788999999999999999999999988999999999
Q ss_pred CCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 99 ~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
+++++|.+++.... .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEcccccccccccccc--
Confidence 99999999987655 6899999999999999999999999999999999999987665 99999999865532221
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (240)
.......|+|||.+.......+ +|+||||++++++++ |..||...+..+.
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~ 208 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDV 208 (256)
T ss_pred cCCCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 2334567999999877766554 999999999999997 9999977655443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=230.35 Aligned_cols=210 Identities=26% Similarity=0.419 Sum_probs=172.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCC---CcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
.+++|++.+.||+|+||.||+|.+..+ ...+++|.+..... ....+.+|+..++.++||||+++++.+..++..+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 457899999999999999999998644 45789998765432 2346788999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
+++|++++++|.+++... +.++...+..++.|++.|+++||+.+++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccc
Confidence 999999999999998654 46899999999999999999999999999999999999987766 999999998755311
Q ss_pred CCC---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 173 SQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 173 ~~~---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
... ........|+|||.+.+...+.+ +|+||||+++++|++ |..||..........++
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 221 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Confidence 111 11223467999999887766555 999999999999997 99999776655544443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=230.03 Aligned_cols=207 Identities=24% Similarity=0.393 Sum_probs=172.2
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
+..++|++++.||.|++|.||+|... ++..|++|.+.......+.+.+|+..+++++|+|++++++++. .+..++++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 45689999999999999999999876 5677999998876665678899999999999999999999874 456899999
Q ss_pred cCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
++.+++|.+++... ..++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCcc
Confidence 99999999987643 36889999999999999999999999999999999999987766 999999998644322111
Q ss_pred --CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 026299 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (240)
Q Consensus 176 --~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (240)
....+...|+|||.+.....+.. +|+||||++++++++ |..||.+.+......
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 214 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ 214 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHH
Confidence 12234568999999877666544 999999999999998 999998776554443
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=230.35 Aligned_cols=202 Identities=30% Similarity=0.479 Sum_probs=170.6
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc-------cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
+|++.+.||.|++|.||++.+. ++..+++|.+...... ...+.+|+..++.++|+||+++.+++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5889999999999999999875 7888999988654321 1457889999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc---
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 171 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~--- 171 (240)
++||+++++|.+++.+..++++..+..++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence 9999999999999987778899999999999999999999999999999999999987665 99999998764321
Q ss_pred ----cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 172 ----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 172 ----~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
........++..|+|||.+.+...+.. +|+||||+++++|++|..||...+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~ 216 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAA 216 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHH
Confidence 111123346778999999877766555 9999999999999999999977554433
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=229.09 Aligned_cols=200 Identities=34% Similarity=0.543 Sum_probs=173.3
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+|++.+.||+|++|.+|++.+..++..|++|.+..... ....+.+|+..++.++|+||+++++.+...+.+++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 68999999999999999999998999999999876544 345788999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC--
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-- 176 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~-- 176 (240)
+++++|.+++.....+++..+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccc
Confidence 999999999987777899999999999999999999999999999999999987665 9999999986544332221
Q ss_pred ---CCcCCccccCccccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 177 ---STVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 177 ---~~~~~~~~~~pE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
...+...|+|||.+.+.. ....++|+||||++++++++|..||...+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 234667899999987665 23445999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=231.81 Aligned_cols=209 Identities=24% Similarity=0.404 Sum_probs=171.1
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCc---EEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
+..+|++.+.||+|++|.||+|.+..++. .|++|.+.... .....+..|+..++.++||||+++.+++.++...+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 34679999999999999999999886654 69999886532 22357889999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
+++||+++++|.+++.. .+.++...+..++.|++.|+++||+.|++|+||+|+||+++.+.. ++|+|||.+......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~ 159 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc--EEECCCccccccccC
Confidence 99999999999998865 346899999999999999999999999999999999999976665 999999987543322
Q ss_pred CCCCCC---c---CCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 173 SQPKST---V---GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 173 ~~~~~~---~---~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
...... . ....|++||.+.+...+.+ +|+||||++++++++ |..||...+..+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~ 223 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINA 223 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 211111 1 1347999999987776555 999999999999886 9999987665544443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=235.56 Aligned_cols=212 Identities=33% Similarity=0.496 Sum_probs=176.1
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcC--CeEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 93 (240)
..++|++.+.||.|++|.||++.+..+++.|++|.+...... .....+|+..+++++|+|++++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 568999999999999999999999999999999998754322 23456899999999999999999998765 5689
Q ss_pred EEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
+|+||+++ +|.+++.. ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCCc
Confidence 99999975 78777764 356899999999999999999999999999999999999987665 999999998655433
Q ss_pred CCC-CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 173 SQP-KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 173 ~~~-~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
... ........|+|||.+.+....+.++|+||||+++|+|++|..||.+.+....+.++..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 223 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 211 2223466799999987765555669999999999999999999998887776665554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=232.90 Aligned_cols=203 Identities=22% Similarity=0.362 Sum_probs=167.2
Q ss_pred CCCeeEeeeecCCCceeEEEEEec----CCCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~----~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
.+.|++.+.||+|+||.||++.+. .++..+++|.+...... ...+.+|+..++.++||||+++++++..+...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 478999999999999999999853 45678999988753322 246788999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC
Q 026299 94 IVMEYASGGELFERICNA-----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~-----------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~ 156 (240)
++|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+..
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~- 162 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH- 162 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc-
Confidence 999999999999988532 23778889999999999999999999999999999999987765
Q ss_pred cEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCch
Q 026299 157 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (240)
Q Consensus 157 ~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (240)
++|+|||++........ .....++..|+|||.+.+...+.. +|+||||+++++|++ |..||.+....
T Consensus 163 -~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05090 163 -VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQ 233 (283)
T ss_pred -EEeccccccccccCCcceecccCCCccceecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999865432211 122234567999999877766554 999999999999998 99999765543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=232.35 Aligned_cols=211 Identities=22% Similarity=0.352 Sum_probs=172.9
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCC-----CcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCC
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPT 90 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (240)
+..++|++.+.||.|++|.||++.+... +..|++|.+...... ...+.+|+..++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 4568999999999999999999998743 478999987654322 246788999999999999999999999999
Q ss_pred eEEEEEecCCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEE
Q 026299 91 HLAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~----------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L 160 (240)
..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl 160 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEE
Confidence 9999999999999999886422 3677889999999999999999999999999999999987776 999
Q ss_pred ecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 161 CDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 161 ~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
+|||.+....... ......++..|+|||.+.+...+.+ +|+||||++++++++ |..||...+.....+.+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 234 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence 9999876443221 1122334568999999877766555 999999999999998 99999876655544443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=242.09 Aligned_cols=193 Identities=26% Similarity=0.452 Sum_probs=163.2
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
..+|++++.||+|++|.||++++..++..|++|.... .....|+.+++.++|+||+++++++..+...++|++++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 3579999999999999999999999999999997433 23457899999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCC
Q 026299 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (240)
Q Consensus 100 ~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~ 178 (240)
.+ +|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||.+............
T Consensus 140 ~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 140 SS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred CC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCcccccc
Confidence 65 77777654 467899999999999999999999999999999999999987766 999999998643333333345
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCC-CCCCC
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFED 221 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~ 221 (240)
.++..|+|||.+.+..++.+ +|+||||+++|+|+++. .+|..
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred cccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccC
Confidence 67889999999988776555 99999999999999854 44443
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=232.70 Aligned_cols=208 Identities=29% Similarity=0.441 Sum_probs=172.7
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCC
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (240)
-|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++|+|++++++.+..+...++++||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 4789999999999999999999999999999886543 233567889999999999999999999999999999999999
Q ss_pred CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCCC
Q 026299 101 GGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (240)
Q Consensus 101 ~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~~ 178 (240)
+++|..++.+ ..++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...... ......
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEccccccccccccccccccc
Confidence 9999887754 457899999999999999999999999999999999999987765 999999987643322 122334
Q ss_pred cCCccccCccccccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 179 VGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
.++..|+|||.+... ...+.++|+||||+++++|++|..||...+......++
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 220 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI 220 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH
Confidence 577889999987422 22234599999999999999999999876655444443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=232.39 Aligned_cols=209 Identities=32% Similarity=0.484 Sum_probs=172.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++|+||+++++++.++...++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999999999999999886532 223567889999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-
Q 026299 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~- 174 (240)
|+++ ++.+.+.... .+++..++.++.|++.||++||+.|++|+||+|+||+++..+. .++|+|||.+........
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCccc
Confidence 9975 7777665433 3578889999999999999999999999999999999975432 489999999864433221
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
.....++..|+|||.+.+......++|+||||+++++|++|..||...+..+.+.++
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~ 216 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 122345678999999876554455599999999999999999999887766665554
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=229.42 Aligned_cols=208 Identities=24% Similarity=0.357 Sum_probs=170.9
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
..++|++.+.||.|++|.||++.+..+ ..+++|.+.......+.+.+|+.+++.++|+|++++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 346899999999999999999998755 45899988766555677899999999999999999998875 4567899999
Q ss_pred CCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC-
Q 026299 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (240)
Q Consensus 99 ~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~- 175 (240)
+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCcccc
Confidence 9999999988653 34789999999999999999999999999999999999987765 999999998644322211
Q ss_pred -CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 176 -~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
....++..|+|||...+...+.. +|+||||+++|+|++ |..||.+........++
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 12234567999998877666555 999999999999999 99999887665544443
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=233.34 Aligned_cols=208 Identities=31% Similarity=0.483 Sum_probs=173.5
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
.|+.++.||.|++|.||++++..++..|++|.+..... ....+.+|+..+++++||||+++++++.++...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48999999999999999999999999999998865322 224688999999999999999999999999999999999
Q ss_pred CCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-C
Q 026299 99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (240)
Q Consensus 99 ~~~~~l~~~l~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~ 175 (240)
+.+ +|.+++.. ...+++..+..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 157 (284)
T ss_pred ccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence 964 78877754 346899999999999999999999999999999999999987776 99999998764433221 1
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
....+...|+|||.+.+....+.++|+||||+++++|++|..||...+..+...+++
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~ 214 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 214 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 223456789999988776654556999999999999999999998876655554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=231.09 Aligned_cols=210 Identities=30% Similarity=0.486 Sum_probs=173.4
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcC-----CeE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP-----THL 92 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~ 92 (240)
..++|++.+.||+|++|.||++.+..+++.+++|.+.........+.+|+..++++ +|||++++++++... +.+
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 45889999999999999999999999999999999876544456677899999888 799999999998753 358
Q ss_pred EEEEecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 93 AIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
++|+||+++++|.+++.. ...+++..++.++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|||.+..
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~ 177 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQ 177 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchh
Confidence 999999999999987752 456899999999999999999999999999999999999987765 99999998865
Q ss_pred ccccC-CCCCCcCCccccCccccccCCC----CCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhh
Q 026299 169 SVLHS-QPKSTVGTPAYIAPEVLLKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (240)
Q Consensus 169 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (240)
..... ......+...|+|||.+..... .+.++|+||||+++++|++|..||...+....+.+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~ 244 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Confidence 43322 1223456778999998764431 24459999999999999999999987665444443
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=228.07 Aligned_cols=208 Identities=27% Similarity=0.450 Sum_probs=174.1
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
++.+|++.+.||.|++|.||++.+. ++..+++|.+.........+.+|+..++.++|||++++++++......++++||
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 4678999999999999999999886 466799998877665567789999999999999999999999998999999999
Q ss_pred CCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC--C
Q 026299 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (240)
Q Consensus 99 ~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~--~ 175 (240)
+++++|.+++... .++++..++.++.+++.++++||+.+++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCccccc
Confidence 9999999988653 46899999999999999999999999999999999999986665 99999998764432211 1
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
.....+..|+|||.+.+...+.+ +|+||||+++|+|++ |..||........+.+
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 213 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYENRSNSEVVET 213 (256)
T ss_pred CCCccchhhcCHhHhccCCcChH-HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 12234568999999877666554 999999999999998 9999977665444433
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=240.00 Aligned_cols=205 Identities=26% Similarity=0.419 Sum_probs=166.3
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCccc--cHHHHHHHHHHHhc-CCCCeeeeeEEEEc
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVILT 88 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 88 (240)
....++|++.+.||.|+||.||+|.+.. +++.|++|++...... ...+.+|+..++++ +|+||+++++++..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 3455799999999999999999997543 3578999988653222 24567899999999 79999999998865
Q ss_pred C-CeEEEEEecCCCCchHHHHHhc--------------------------------------------------------
Q 026299 89 P-THLAIVMEYASGGELFERICNA-------------------------------------------------------- 111 (240)
Q Consensus 89 ~-~~~~lv~~~~~~~~l~~~l~~~-------------------------------------------------------- 111 (240)
. ..++++++|+++++|.+++...
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 5688999999999999887532
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC---CCCCcCCcc
Q 026299 112 -----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 183 (240)
Q Consensus 112 -----~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~ 183 (240)
.+++...+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||++........ .....+...
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCcc
Confidence 25788899999999999999999999999999999999987665 99999999865432221 112234567
Q ss_pred ccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCc
Q 026299 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE 224 (240)
Q Consensus 184 ~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 224 (240)
|+|||.+.+..++.+ +|+|||||++++|++ |..||.+...
T Consensus 241 y~aPE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~ 281 (337)
T cd05054 241 WMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQI 281 (337)
T ss_pred ccCcHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999988877666 999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=232.47 Aligned_cols=208 Identities=33% Similarity=0.531 Sum_probs=175.7
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--CeEEEEEe
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVME 97 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~~ 97 (240)
|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|+|++++++++.+. ...+++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 788999999999999999999999999999987652 2335678899999999999999999999988 78999999
Q ss_pred cCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC--
Q 026299 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (240)
Q Consensus 98 ~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-- 174 (240)
|+++ +|.+++... ..+++..++.++.|+++|+++||+.|++|+||+|+||++++++. ++|+|||.+........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence 9976 888877654 57899999999999999999999999999999999999987766 99999999865543321
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.....++..|+|||.+.+....+.++|+||||+++++|++|..||...+....+.++.+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~ 216 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 22234567899999887655445569999999999999999999988887666655543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=231.69 Aligned_cols=200 Identities=32% Similarity=0.525 Sum_probs=171.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
..|+..+.||.|++|.||.+.+..++..+++|.+..... ....+.+|+..++.+.|+||+++++.+.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 568899999999999999999998999999998875432 235678899999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-CCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~~~ 177 (240)
+++++|.+++.. .++++..+..++.+++.++++||+.+++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCcccccc
Confidence 999999998854 56899999999999999999999999999999999999987665 99999999865433221 122
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
..+...|+|||.+.+...+.. +|+||||+++++|++|..||...+.
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHP 206 (277)
T ss_pred ccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcCh
Confidence 346678999999887766555 9999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=232.90 Aligned_cols=207 Identities=33% Similarity=0.491 Sum_probs=173.4
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
|++.+.||.|++|.||++.+..+|..|++|.+..... ..+.+.+|+..++.++|+|++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 6889999999999999999999999999998875432 2356788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCC
Q 026299 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (240)
Q Consensus 100 ~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~ 176 (240)
+ ++|.+++.... .+++..+..++.|++++|++||+.+++|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc--EEEeecccccccCCCccccC
Confidence 6 58988887655 6899999999999999999999999999999999999987665 9999999986443222 112
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
...++..|+|||.+.+......++|+||||+++|+|++|..||...+..+.+.+++
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 213 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIF 213 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 23457789999988766544555999999999999999999998877655554443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=228.46 Aligned_cols=208 Identities=24% Similarity=0.385 Sum_probs=171.5
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
...++|++.+.||+|++|.||++.+. .+..+++|.+.......+.+.+|+.+++.++|+||+++.+.+.. ...++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 34589999999999999999999866 45669999887665555678899999999999999999999887 77899999
Q ss_pred cCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-
Q 026299 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (240)
Q Consensus 98 ~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~- 174 (240)
|+++++|.+++.+. ..++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYT 158 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCCcc
Confidence 99999999998653 35788899999999999999999999999999999999987665 99999998864332211
Q ss_pred -CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 175 -~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
.....+...|+|||.+.....+.. +|+||||++++++++ |..||...+..+....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~ 215 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 215 (260)
T ss_pred cccCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 112234567999999877666555 999999999999998 9999987766554443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=229.02 Aligned_cols=203 Identities=28% Similarity=0.435 Sum_probs=172.7
Q ss_pred eeecCCCceeEEEEEecCC---CcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||.|++|.||++.+... +..+++|.+...... .+.+.+|+..++.++|+|++++++++.++...++++||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4689999999999999866 899999998775443 46788999999999999999999999999999999999999
Q ss_pred CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 102 ~~l~~~l~~~---------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccc
Confidence 9999999775 67999999999999999999999999999999999999987765 999999998755433
Q ss_pred C---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 173 S---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 173 ~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
. ......+...|+|||.+.....+.+ +|+||||+++++|++ |..||..........++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 221 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR 221 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 2 2233446778999999877765444 999999999999999 699998876655544443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=232.33 Aligned_cols=199 Identities=29% Similarity=0.451 Sum_probs=169.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||.|++|.||++++..++..+++|.+.... .....+.+|+..++.++|+||+++++.+..++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999999899999999876532 22346788999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 97 ~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
|++++++|.+++.. ...+++..++.++.|+++++.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhccccC
Confidence 99999999988753 345899999999999999999999999999999999999987665 999999987644332
Q ss_pred CC-CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 173 ~~-~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
.. .....+...|+|||.+.+...+.. +|+||||+++++|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccc
Confidence 22 123356778999999877766555 99999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=233.63 Aligned_cols=211 Identities=28% Similarity=0.453 Sum_probs=172.4
Q ss_pred CCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEc
Q 026299 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT 88 (240)
Q Consensus 12 ~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (240)
.+++.....++|++.+.||.|++|.||++.+..++..|++|.+..... ....+.+|+..++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 3 YEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred ccCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 345566677899999999999999999999999999999998865322 22345789999999999999999999875
Q ss_pred CC--------eEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEE
Q 026299 89 PT--------HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (240)
Q Consensus 89 ~~--------~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~ 159 (240)
.. ..++|+||+.+ ++.+.+... ..+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++. ++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~k 159 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LK 159 (310)
T ss_pred ccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EE
Confidence 43 45999999975 777776544 36899999999999999999999999999999999999987765 99
Q ss_pred EecCCccccccccCCC-----CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 160 ICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 160 L~d~~~~~~~~~~~~~-----~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
|+|||.+......... ....++..|+|||.+.+......++|+||||+++++|++|..||...+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~ 230 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ 230 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998644332221 12345678999998876654455699999999999999999999776544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=237.48 Aligned_cols=202 Identities=26% Similarity=0.416 Sum_probs=164.5
Q ss_pred EeeeecCC--CceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 25 LVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 25 ~~~~l~~g--~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
+++.||+| ++++||++.+..+++.|++|.+.... ...+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789998 77899999999999999999987542 22345678999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC---
Q 026299 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (240)
Q Consensus 100 ~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~--- 174 (240)
++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. +++.||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhcccccccccc
Confidence 999999988643 45899999999999999999999999999999999999987765 89999976432211111
Q ss_pred -----CCCCcCCccccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 175 -----PKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 175 -----~~~~~~~~~~~~pE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
.....+...|+|||.+.+. ...+.++|+||||+++++|++|..||.........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 219 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 219 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH
Confidence 1122345679999998764 23345599999999999999999999876554443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=233.32 Aligned_cols=210 Identities=27% Similarity=0.426 Sum_probs=173.4
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCC----------------cEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCee
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTE----------------ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIV 80 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~----------------~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~ 80 (240)
+.++|++++.||+|++|.||++.+...+ ..|++|.+..... ..+.+.+|+..++.++|||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4579999999999999999999877543 4579998876432 235678899999999999999
Q ss_pred eeeEEEEcCCeEEEEEecCCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeE
Q 026299 81 RFKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (240)
Q Consensus 81 ~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~-----------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nil 149 (240)
++++++..++..++++|++++++|.+++.+.. .+++..++.++.|++.||.+||+.|++|+||+|+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99999999999999999999999999987655 6899999999999999999999999999999999999
Q ss_pred EcCCCCCcEEEecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh--CCCCCCCCCc
Q 026299 150 LDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEE 224 (240)
Q Consensus 150 i~~~~~~~~~L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~ 224 (240)
++.++. ++|+|||.+....... ......++..|+|||.+.+...+.. +|+||||+++|+|++ +..||...+.
T Consensus 163 i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 163 VGKNYT--IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ecCCCc--eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 987755 9999999886433221 1222334568999999887666555 999999999999997 7888877665
Q ss_pred hhhhhhh
Q 026299 225 PKNFRKT 231 (240)
Q Consensus 225 ~~~~~~~ 231 (240)
...+...
T Consensus 240 ~~~~~~~ 246 (296)
T cd05051 240 QQVIENA 246 (296)
T ss_pred HHHHHHH
Confidence 5544433
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=230.19 Aligned_cols=210 Identities=24% Similarity=0.394 Sum_probs=171.7
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCC---cEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
+..+|++.+.||.|++|.||++.+..++ ..+++|.+..... ..+.+.+|+..++.++||||+++++++..++..+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 4578999999999999999999986444 3789998765432 2356789999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
++|||+++++|.+++... ..++..++..++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCcccccccc
Confidence 999999999999998654 46899999999999999999999999999999999999987665 999999988654332
Q ss_pred CCCC----CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 173 SQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 173 ~~~~----~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
.... .......|++||.+.+...+.+ +|+||||++++++++ |..||...+..+....+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~ 222 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH
Confidence 2111 1112457999999987766555 999999999999886 99999877655444433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=231.31 Aligned_cols=202 Identities=32% Similarity=0.540 Sum_probs=171.6
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcC---CCCeeeeeEEEEcCCeEEEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~ 96 (240)
.|++.+.||.|++|.+|++.+..++..+++|.+.... ...+.+.+|+..++.++ |||++++++++..+...++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5888999999999999999999899999999886542 22356788999998886 999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-C
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~ 175 (240)
||+++++|.+++.. ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCCcccc
Confidence 99999999998855 47899999999999999999999999999999999999987665 99999998865443322 2
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
....+...|+|||.+.+......++|+||||+++|+|++|..||...+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 234577789999998765554556999999999999999999997665443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=230.83 Aligned_cols=203 Identities=29% Similarity=0.469 Sum_probs=170.3
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcC------Ce
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP------TH 91 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~ 91 (240)
..+.|++.+.||.|++|.||++.+..+++.+++|.+.........+.+|+..++++ +|+|++++.+++... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 34679999999999999999999999999999999877655556788999999888 699999999998753 45
Q ss_pred EEEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 92 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
+++++||+++++|.+++... ..+++..+..++.|++.|++|||+.+++|+||+|+||+++.++. ++|+|||.+...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~ 161 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL 161 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceec
Confidence 89999999999999988753 35889999999999999999999999999999999999987766 999999998644
Q ss_pred ccc-CCCCCCcCCccccCccccccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 170 VLH-SQPKSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 170 ~~~-~~~~~~~~~~~~~~pE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
... .......++..|+|||.+... .....++|+||||+++++|++|..||...+
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 322 222334577889999998632 123445999999999999999999997544
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=231.05 Aligned_cols=206 Identities=29% Similarity=0.474 Sum_probs=170.5
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEE-----cCCeE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVIL-----TPTHL 92 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~ 92 (240)
..++|++.+.||+|++|.||++.+..++..+++|...........+.+|+..++.+ +|+|++++++++. .+..+
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 45899999999999999999999999999999998766444446678899999998 6999999999874 34568
Q ss_pred EEEEecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 93 AIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
+++|||+++++|.+++.. ...+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+|||.+..
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~ 173 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQ 173 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceee
Confidence 999999999999987642 346888999999999999999999999999999999999987766 99999999865
Q ss_pred ccccC-CCCCCcCCccccCccccccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 169 SVLHS-QPKSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 169 ~~~~~-~~~~~~~~~~~~~pE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
..... ......++..|+|||.+... ...+.++|+||||+++++|++|..||...+...
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~ 236 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH
Confidence 43322 22334577889999987532 223445999999999999999999997665433
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=227.41 Aligned_cols=199 Identities=29% Similarity=0.465 Sum_probs=170.4
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||.|++|.||++.+..++..|++|.+.... ...+.+.+|+..+++++|++++++++.+..++..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999999899999999886422 22456889999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 97 ~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
||+++++|.+++.. ...++...++.++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCC
Confidence 99999999988753 245899999999999999999999999999999999999987665 999999987643322
Q ss_pred C-CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 173 S-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 173 ~-~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
. ......+...|.|||.+.+...+.. +|+||||+++++|++|..||...
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccC
Confidence 2 1223456778999999877766555 99999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=231.46 Aligned_cols=198 Identities=32% Similarity=0.486 Sum_probs=163.0
Q ss_pred CCe-eEeeeecCCCceeEEEEE----ecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--Ce
Q 026299 21 DRY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (240)
Q Consensus 21 ~~y-~~~~~l~~g~~g~v~~~~----~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 91 (240)
++| ++++.||+|++|.||.+. ...++..|++|.+..... ....+.+|+..++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 999999999999998765 335678899998876432 345678999999999999999999987653 46
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
.+++|||+++++|.+++.. ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCC
Confidence 8899999999999998865 45899999999999999999999999999999999999987765 99999999864433
Q ss_pred cCC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 172 ~~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
... .....+...|+|||.+.+...+.+ +|+||||+++++|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCC
Confidence 221 112234557999999877666554 99999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=232.29 Aligned_cols=209 Identities=27% Similarity=0.406 Sum_probs=171.3
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCccc-cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
...+|.+.+.||+|++|.||++++.. ++..+++|.+...... ...+.+|+..++.++|+||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 44689999999999999999998642 4556888887654322 24688999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC
Q 026299 93 AIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~ 156 (240)
++||||+++++|.+++.... .+++..++.++.|++.|+++||++|++|+||+|+||+++.++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~- 161 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL- 161 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc-
Confidence 99999999999999986532 3788999999999999999999999999999999999987765
Q ss_pred cEEEecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 157 RLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 157 ~~~L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
++|+|||.+....... ......+...|+|||.+.+...+.+ +|+||||+++++|++ |..||...+....+..
T Consensus 162 -~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 162 -VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred -EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999986443221 1222345678999999877766555 999999999999998 9999977665544433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=229.50 Aligned_cols=211 Identities=24% Similarity=0.370 Sum_probs=173.3
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCc---EEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
..++|+..+.||+|++|.||++.+..++. .+++|.+.... .....+.+|++.++.++|+|++++.+++...+..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 45689999999999999999999876544 78999886542 22356788999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
++||++++++|.+++... ..++...+..++.|++.|+++||+.|++|+||+|+||+++.+.. ++|+|||.+......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~ 160 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceecccc
Confidence 999999999999988653 56899999999999999999999999999999999999987665 999999998644322
Q ss_pred CCCC----CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 173 SQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 173 ~~~~----~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
.... .......|+|||.+.....+.. +|+||||+++|+|++ |..||...+..+....+.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~ 224 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN 224 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh
Confidence 2111 1112346999999877666554 999999999999997 999998776655555443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=244.46 Aligned_cols=192 Identities=22% Similarity=0.300 Sum_probs=163.2
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
....|.+.+.||+|++|.||++.+..++..|++|... ...+.+|+.++++++|+||+++++++..++..++++++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4568999999999999999999999999999999532 23467899999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC---
Q 026299 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (240)
Q Consensus 99 ~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~--- 174 (240)
+.+ +|.+++... ..++...+..++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++........
T Consensus 242 ~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 242 YRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceeccccccccc
Confidence 964 777777543 56999999999999999999999999999999999999987665 99999999864322211
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 219 (240)
.....++..|+|||++.+...+.+ +||||||+++|+|++|..|+
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCc
Confidence 123457889999999988776555 99999999999999877654
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=233.82 Aligned_cols=213 Identities=24% Similarity=0.374 Sum_probs=173.7
Q ss_pred cccCCCCCeeEeeeecCCCceeEEEEEec-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHHhc-CCCCeeeeeEEE
Q 026299 15 PIMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 86 (240)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 86 (240)
......++|++.+.||.|++|.||++.+. ..+..+++|.+..... ..+.+.+|+..++++ +|+||+++++.+
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 34455679999999999999999999853 3456899998765432 234688999999999 799999999999
Q ss_pred EcCCeEEEEEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 87 LTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 87 ~~~~~~~lv~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
...+..++++||+++++|.+++.... .++..++..++.+++.+++|||+.+++|+||+|+||+++.+.. ++|+|||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~dfg 186 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI--VKICDFG 186 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe--EEECCCc
Confidence 99999999999999999999986533 3899999999999999999999999999999999999976665 9999999
Q ss_pred ccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 165 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 165 ~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
.+........ .....++..|+|||.+.+...+.. +|+||||+++++|++ |..||........+.+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~ 255 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH
Confidence 9864432221 112234567999999987776555 999999999999998 9999987665544433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=231.22 Aligned_cols=211 Identities=27% Similarity=0.419 Sum_probs=172.0
Q ss_pred CCCCeeEeeeecCCCceeEEEEEec-----CCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
+.++|++.+.||+|++|.||++... .++..+++|.+.... .....+.+|+..++.++|+||+++++++.++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 5678999999999999999999743 346688888775432 2335688999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCc
Q 026299 93 AIVMEYASGGELFERICNAG---------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~---------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~ 157 (240)
++++||+++++|.+++.... .+++..+..++.|++.|++|||+.|++|+||+|+||++++++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~-- 160 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV-- 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC--
Confidence 99999999999999886543 3788999999999999999999999999999999999987665
Q ss_pred EEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 158 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 158 ~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
++|+|||.+........ .....++..|+|||.+.+...+.. +|+||||+++++|++ |..||......+.+..+.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 99999998754322211 112223567999999877776555 999999999999998 999997766655544443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=230.98 Aligned_cols=208 Identities=24% Similarity=0.356 Sum_probs=175.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
.+|++.+.||.|++|.||++.+.. +..+++|.+..... ....+.+|+..++.++|+||+++++++.+....+++|||+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 579999999999999999999987 88899999876544 3467889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC-C
Q 026299 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K 176 (240)
Q Consensus 100 ~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~-~ 176 (240)
++++|.+++... ..++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+......... .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCcccccc
Confidence 999999998653 46899999999999999999999999999999999999987766 999999998644322111 1
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
...+...|++||.+.+...... +|+||||+++++|++ |..||...+....+.++.
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218 (261)
T ss_pred CCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 2234457999999877766555 999999999999998 899998877666655554
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=233.49 Aligned_cols=202 Identities=26% Similarity=0.481 Sum_probs=175.2
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+.++|++++.||+|++|.||++.+..++..|++|.+.... .....+.+|+..++.++||||+++++.+.....+++|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 4578999999999999999999999999999999876543 23457889999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
||+++++|.+++.+.++++...+..++.+++.++.|||+ .+++|+||+|+||+++.++. ++|+|||.+...... ..
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~~-~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELINS-IA 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchhhh-cc
Confidence 999999999988877789999999999999999999997 59999999999999987665 999999987543222 22
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
....++..|+|||.+.+...+.+ +|+||||+++++|++|..||.....
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred CccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccch
Confidence 33467889999999877766555 9999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=225.25 Aligned_cols=204 Identities=33% Similarity=0.502 Sum_probs=176.4
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+|++.+.||+|++|.+|++.+..++..|++|.+..... ..+.+.+|++.+++++|+|++++.+++.+++..++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999998999999999877542 345688999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-CCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~~~ 177 (240)
+++++|.+++.+...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC--EEEeccccceecCCCcccccc
Confidence 999999999988788999999999999999999999999999999999999987655 99999999865543332 123
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
..+...|++||...+... ..++|+||||+++++|++|..||...+.....
T Consensus 159 ~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~ 208 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAAL 208 (254)
T ss_pred cccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 456778999999877664 44599999999999999999999876544333
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=231.26 Aligned_cols=209 Identities=31% Similarity=0.407 Sum_probs=170.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCe-----
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR-HPNIVRFKEVILTPTH----- 91 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----- 91 (240)
++|++.+.||.|++|.||++.+..++..|++|.+..... ....+.+|+..++.++ |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999998765422 2356788999999995 6999999999887655
Q ss_pred EEEEEecCCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC-CCCCcEEEecCCc
Q 026299 92 LAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGY 165 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~-~~~~~~~L~d~~~ 165 (240)
.++++||+++ +|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++. ++. ++|+|||.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~--~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe--EEEeeccc
Confidence 8999999986 777776532 35799999999999999999999999999999999999986 444 99999998
Q ss_pred ccccccc-CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 166 SKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 166 ~~~~~~~-~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
+...... .......+.+.|+|||.+.+....+.++|+||||+++++|++|..||...+......++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 225 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 7644322 112223456789999988765544556999999999999999999998877666555443
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=233.92 Aligned_cols=213 Identities=20% Similarity=0.345 Sum_probs=173.3
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
+..+|++.+.||.|++|.||++.+.. .+..|++|++...... .+.+.+|...++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 44678999999999999999998754 3578999998754322 3557889999999999999999999999999
Q ss_pred EEEEEecCCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCC
Q 026299 92 LAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~ 155 (240)
.+++++|+++++|.+++... ..++...+..++.|++.||+|||+.|++|+||+|+||+++.+..
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 99999999999999887532 24788889999999999999999999999999999999987665
Q ss_pred CcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 156 PRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 156 ~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
++|+|||++........ .....+++.|+|||.+.+...+.. +|+||||+++++|++ |..||.+....+.+..+
T Consensus 163 --~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 163 --VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred --eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999998764432211 122234568999999877776555 999999999999998 88899877666665555
Q ss_pred hce
Q 026299 232 IHV 234 (240)
Q Consensus 232 ~~~ 234 (240)
...
T Consensus 240 ~~~ 242 (283)
T cd05091 240 RNR 242 (283)
T ss_pred HcC
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=234.63 Aligned_cols=215 Identities=26% Similarity=0.404 Sum_probs=173.2
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC---
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--- 89 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 89 (240)
.+...++|++.+.||.|++|.||++.+..++..+++|.+..... ....+.+|++.++.++|+||+++++++...
T Consensus 3 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred CCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 44456899999999999999999999999999999998865432 224567899999999999999999987543
Q ss_pred -----CeEEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecC
Q 026299 90 -----THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (240)
Q Consensus 90 -----~~~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~ 163 (240)
..++++++|+.+ ++...+.. ...+++..+..++.|+++||++||+.|++|+||+|+||+++.++. ++|+||
T Consensus 83 ~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~df 159 (311)
T cd07866 83 SKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADF 159 (311)
T ss_pred ccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcC
Confidence 346899999876 56665543 457999999999999999999999999999999999999987776 999999
Q ss_pred CccccccccCCCC------------CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 164 GYSKSSVLHSQPK------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 164 ~~~~~~~~~~~~~------------~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
|.+.......... ...++..|+|||.+.+......++|+||||+++++|++|..||.+.+......++
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9886433222111 1134667999998876554455599999999999999999999887776665554
Q ss_pred hc
Q 026299 232 IH 233 (240)
Q Consensus 232 ~~ 233 (240)
..
T Consensus 240 ~~ 241 (311)
T cd07866 240 FK 241 (311)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=232.27 Aligned_cols=213 Identities=25% Similarity=0.385 Sum_probs=173.1
Q ss_pred cccCCCCCeeEeeeecCCCceeEEEEEecCC-----CcEEEEEEeecCcc--ccHHHHHHHHHHHhc-CCCCeeeeeEEE
Q 026299 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 86 (240)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 86 (240)
......++|++.+.||+|++|.||++.+... ...+++|.+..... ....+.+|+..++++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3445668999999999999999999998643 37899998865432 224577899999999 799999999999
Q ss_pred EcCCeEEEEEecCCCCchHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEE
Q 026299 87 LTPTHLAIVMEYASGGELFERICN----------------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (240)
Q Consensus 87 ~~~~~~~lv~~~~~~~~l~~~l~~----------------~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili 150 (240)
..++.++++|||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||++
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 999999999999999999998854 2358889999999999999999999999999999999999
Q ss_pred cCCCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchh
Q 026299 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (240)
Q Consensus 151 ~~~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (240)
+.++. ++|+|||.+........ .........|+|||.+.+...+.. +|+||||+++|+|++ |..||......+
T Consensus 166 ~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 166 TEDHV--MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred cCCCe--EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 87665 99999999865433211 111223457999999877666555 999999999999997 999998766555
Q ss_pred hhhh
Q 026299 227 NFRK 230 (240)
Q Consensus 227 ~~~~ 230 (240)
.+..
T Consensus 243 ~~~~ 246 (293)
T cd05053 243 LFKL 246 (293)
T ss_pred HHHH
Confidence 4443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=227.46 Aligned_cols=205 Identities=36% Similarity=0.570 Sum_probs=172.3
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEc--CCeEEEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVM 96 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 96 (240)
+|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++|+|++++++++.. +...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999886532 223457789999999999999999998764 35689999
Q ss_pred ecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHh-----hCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 97 ~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH-----~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
||+++++|.+++.. ..++++..++.++.|++.||.+|| +.+++|+||+|+||+++.++. ++|+|||.+.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccccc
Confidence 99999999998865 357899999999999999999999 889999999999999987665 9999999987
Q ss_pred cccccCC-CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 026299 168 SSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (240)
Q Consensus 168 ~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (240)
....... .....+...|+|||.+.+...+.. +|+||||+++++|++|..||...+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 220 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQLQLAS 220 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccCcCHHHHHH
Confidence 5544332 233457889999999877765544 999999999999999999998776444333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=223.81 Aligned_cols=200 Identities=35% Similarity=0.572 Sum_probs=175.7
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCC
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (240)
.|++.+.+|.|++|.+|++.+..++..+++|++..... ....+.+|+..++.++|++++++.+.+..+...++++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 48899999999999999999998999999999876543 44678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCc
Q 026299 101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179 (240)
Q Consensus 101 ~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~ 179 (240)
+++|.+++... ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccccccee
Confidence 99999988765 57899999999999999999999999999999999999987665 9999999987655443334456
Q ss_pred CCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 180 ~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
+...|++||.+.+...+.+ +|+||||+++++|++|..||...+.
T Consensus 159 ~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~ 202 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPP 202 (253)
T ss_pred cCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCch
Confidence 7788999999877765444 9999999999999999999987643
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=229.27 Aligned_cols=210 Identities=25% Similarity=0.377 Sum_probs=172.0
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCc----EEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
....+|++.+.||+|++|.||++.+..+++ .+++|....... ....+.+|+..++.++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 355899999999999999999999876554 588887765432 23567889999999999999999999887 77
Q ss_pred EEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
.++++||+++++|.+++.+. ..+++..+..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~ 160 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLD 160 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCccccccc
Confidence 89999999999999988764 46899999999999999999999999999999999999987665 9999999986544
Q ss_pred ccCCCCC---CcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 171 LHSQPKS---TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 171 ~~~~~~~---~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
....... ......|+|||.+.....+.. +|+||||++++++++ |..||......+....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 224 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 3222111 112457999999876666555 999999999999998 99999887655544433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=229.86 Aligned_cols=207 Identities=31% Similarity=0.539 Sum_probs=178.4
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
...+.|++.+.++.|++|.+|++.+..++..+++|++.......+.+.+|+..++.++|+|++++++.+..+...++++|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 34578999999999999999999999889999999987765445678899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CC
Q 026299 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~ 175 (240)
|+++++|.+++.... .++...+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhh
Confidence 999999999998766 8999999999999999999999999999999999999987766 9999999875443222 11
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
....+...|++||.+.+...+.+ +|+||||+++|+|++|..||...+....
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~ 224 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRA 224 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 23346678999999887766555 9999999999999999999987654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=229.18 Aligned_cols=204 Identities=23% Similarity=0.395 Sum_probs=167.2
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCc----EEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
...++|++.+.||.|++|.||+|.+..++. .|++|.+..... ....+.+|...++.++|+||+++++++... .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 355899999999999999999999876666 478998765332 235678899999999999999999998754 4
Q ss_pred EEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
.+++++++++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||++....
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~ 160 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLD 160 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeecc
Confidence 67899999999999988653 46899999999999999999999999999999999999976665 9999999986543
Q ss_pred ccCCC---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCch
Q 026299 171 LHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (240)
Q Consensus 171 ~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (240)
..... ........|+|||.+.+...+.+ +|+||||+++|+|++ |..||......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~ 218 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPAR 218 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 32221 11234567999999977766555 999999999999998 99999765443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=225.25 Aligned_cols=209 Identities=35% Similarity=0.580 Sum_probs=178.3
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+|++.+.||.|++|.+|++.+..++..+++|.+.... .....+.+|++.++.++|+|++++.+.+..+...++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5899999999999999999999999999999987643 2335678999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-
Q 026299 99 ASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (240)
Q Consensus 99 ~~~~~l~~~l~~~----~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~- 173 (240)
+++++|.+.+.+. ..++...+..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence 9999999988763 67899999999999999999999999999999999999987665 9999999986443332
Q ss_pred CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
......++..|+|||...+...+.. +|+||||+++++|++|..||...+..+...+..+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 217 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELALKILK 217 (258)
T ss_pred eecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc
Confidence 2233456778999999877766555 9999999999999999999988766555554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=233.68 Aligned_cols=206 Identities=26% Similarity=0.380 Sum_probs=167.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecC-------CCcEEEEEEeecCcc--ccHHHHHHHHHHHhc-CCCCeeeeeEEEEc
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 88 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 88 (240)
..++|.+.+.||+|+||.||.+++.. +...+++|.+..... ....+.+|+..++.+ +|+||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 34789999999999999999998753 234699998875432 224577899999999 79999999999999
Q ss_pred CCeEEEEEecCCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC
Q 026299 89 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (240)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~ 152 (240)
.+..++++||+++++|.+++.... .++..++..++.|++.||++||+.|++|+||+|+||+++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 999999999999999999986532 3788899999999999999999999999999999999987
Q ss_pred CCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026299 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (240)
Q Consensus 153 ~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (240)
++. ++|+|||.+........ .........|+|||.+.+...+.. +|+||||+++|+|++ |..||...+..+.
T Consensus 176 ~~~--~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 176 DNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred CCc--EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 765 99999999864432111 111223467999999877766555 999999999999998 8889876554433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=226.44 Aligned_cols=198 Identities=28% Similarity=0.400 Sum_probs=161.8
Q ss_pred eecCCCceeEEEEEe--cCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCC
Q 026299 28 DIGSGNFGVARLMRD--KKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (240)
Q Consensus 28 ~l~~g~~g~v~~~~~--~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (240)
.||+|++|.||++.+ ..++..+++|++..... ..+.+.+|+..++.++||||+++++++. ....++++|+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 35678899998765432 2356788999999999999999999875 45678999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC----CCC
Q 026299 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KST 178 (240)
Q Consensus 103 ~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~----~~~ 178 (240)
+|.+++.....+++..+..++.|++.|+++||+.|++|+||+|.||+++.++. ++|+|||.+......... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCCC
Confidence 99999987778999999999999999999999999999999999999987665 999999998654332221 112
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (240)
.++..|+|||.+.....+. ++|+||||+++|+|++ |..||.+.+..+...
T Consensus 159 ~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 209 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSS-KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ 209 (257)
T ss_pred CCCccccCHhHhccCCcCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 2346899999887665544 4999999999999998 999998765544433
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=236.26 Aligned_cols=210 Identities=24% Similarity=0.374 Sum_probs=174.7
Q ss_pred CCeeE-eeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc---------------HHHHHHHHHHHhcCCCCeeeeeE
Q 026299 21 DRYEL-VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---------------ENVQREIINHRSLRHPNIVRFKE 84 (240)
Q Consensus 21 ~~y~~-~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---------------~~~~~e~~~l~~l~h~~i~~~~~ 84 (240)
++|.. .+.||.|++|.||++.+..+++.|++|.+....... ..+.+|+..++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 67764 577999999999999999999999999986543222 14678999999999999999999
Q ss_pred EEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 85 ~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
++..++..+++||++++ +|.+++.....++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFG 164 (335)
T ss_pred EEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCcc
Confidence 99999999999999975 88888877778999999999999999999999999999999999999987765 9999999
Q ss_pred cccccccc---------------CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 026299 165 YSKSSVLH---------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (240)
Q Consensus 165 ~~~~~~~~---------------~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (240)
.+...... .......++..|+|||.+.+....+.++|+||||+++++|++|..||.+.+..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 88644311 111122346689999998776554566999999999999999999999888766665
Q ss_pred hhhc
Q 026299 230 KTIH 233 (240)
Q Consensus 230 ~~~~ 233 (240)
++..
T Consensus 245 ~i~~ 248 (335)
T PTZ00024 245 RIFE 248 (335)
T ss_pred HHHH
Confidence 5543
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=231.36 Aligned_cols=198 Identities=31% Similarity=0.532 Sum_probs=172.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
++|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+|+..++.++||||+++++.+..+..+++++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46888999999999999999999999999999887653 2335678999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 99 ~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
+++++|.+++... .++++..+..++.|++.++++||+ .|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHHhh-
Confidence 9999999998765 778999999999999999999999 99999999999999987665 999999987644332222
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
...+...|+|||.+.+...+.. +|+||||+++++|++|..||...
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred cccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcc
Confidence 2567788999999877766555 99999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=229.71 Aligned_cols=209 Identities=21% Similarity=0.351 Sum_probs=168.5
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCC
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPT 90 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (240)
.+.++|++.+.||+|++|.||++.+.. .+..|++|.+...... ...+.+|+..++.++|+||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 356899999999999999999997652 3557999987654322 235678999999999999999999999989
Q ss_pred eEEEEEecCCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEE
Q 026299 91 HLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L 160 (240)
..+++|||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L 160 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKI 160 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEE
Confidence 999999999999999998642 23466788999999999999999999999999999999987665 999
Q ss_pred ecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 026299 161 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (240)
Q Consensus 161 ~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (240)
+|||.+........ .....++..|+|||.+.+...+.. +|+||||+++++|++ |..||......+...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~~~~ 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99998764322111 112234567999999887776555 999999999999998 788997765544433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=227.95 Aligned_cols=202 Identities=34% Similarity=0.498 Sum_probs=170.5
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-----------ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (240)
+|.+.+.||.|++|.||++.+..++..+++|.+..... ..+.+.+|+..++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 68899999999999999999998999999998764211 1134678999999999999999999999999
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
..++|+||+++++|.+++.+...++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccc
Confidence 99999999999999999988788999999999999999999999999999999999999987665 9999999986443
Q ss_pred ccCC---CCCCcCCccccCccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 171 LHSQ---PKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 171 ~~~~---~~~~~~~~~~~~pE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
.... .....++..|+|||.+.... ..+.++|+||||++++++++|..||...+..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 218 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH
Confidence 2211 12234677899999987654 2345599999999999999999999765443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=225.79 Aligned_cols=202 Identities=28% Similarity=0.418 Sum_probs=167.3
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEE-cCCeEEEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVM 96 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~ 96 (240)
.+.++|++.+.||+|++|.||++... +..+++|.+..+. ..+.+.+|+..+++++|+|++++++++. .++..++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 45689999999999999999999765 6778999876543 3456889999999999999999999765 446789999
Q ss_pred ecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 97 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
||+++++|.+++.+.. .+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQ- 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceeccccC-
Confidence 9999999999886543 4788999999999999999999999999999999999987765 9999999876433222
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (240)
........|+|||.+.+...+.. +|+||||+++|+|++ |..||...+..+.
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~~~ 208 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDV 208 (256)
T ss_pred -CCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 22334567999999877666554 999999999999997 9999977655443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=234.18 Aligned_cols=196 Identities=29% Similarity=0.423 Sum_probs=157.7
Q ss_pred eeeecCCCceeEEEEEec--CCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEc--CCeEEEEEecCCC
Q 026299 26 VRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 101 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~~~~~~ 101 (240)
.+.||+|+||.||+|++. .++..|++|.+.... ....+.+|+.+++.++||||+++++++.. +...+++++++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 357999999999999965 367889999886542 34567899999999999999999999865 3568899999865
Q ss_pred CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC--CCCcEEEecCCcccccc
Q 026299 102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 170 (240)
Q Consensus 102 ~~l~~~l~~~---------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~--~~~~~~L~d~~~~~~~~ 170 (240)
+|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||++..+ ..+.++|+|||.+....
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 777766421 248899999999999999999999999999999999999432 23459999999986543
Q ss_pred ccC----CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 171 ~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
... ......++..|+|||.+.+....+.++|+||||+++++|++|..||....
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 221 12234568889999999876655666999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=231.10 Aligned_cols=208 Identities=32% Similarity=0.493 Sum_probs=176.0
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEEEecC
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
|++.+.||.|++|.||+|....++..|++|.+..... ......+|+..+++++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999998899999998865432 2234567889999998 999999999999999999999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCC
Q 026299 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (240)
Q Consensus 100 ~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~ 177 (240)
+++|.+.+.... .++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence 668888886654 6899999999999999999999999999999999999987665 99999999875544333344
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
..++..|+|||.+.+....+.++|+||||+++++|++|..||......+.+.++.+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~ 213 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICS 213 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHH
Confidence 55677899999887665555669999999999999999999988887777666554
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=236.55 Aligned_cols=206 Identities=32% Similarity=0.491 Sum_probs=171.1
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC---ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC-----Ce
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 91 (240)
..+|++.+.||.|++|.||++++..++..|++|.+... ......+.+|+..++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46899999999999999999999999999999988653 22234567899999999999999999987654 34
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
.++++||++ ++|.+++...+.+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCC
Confidence 799999996 488888877788999999999999999999999999999999999999987765 99999999865433
Q ss_pred c-CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 172 H-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 172 ~-~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
. .......++..|+|||.+.+......++|+||||+++++|++|..||.+.+....+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 218 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL 218 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence 2 12223356778999998876443455599999999999999999999876544333
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=225.68 Aligned_cols=197 Identities=29% Similarity=0.382 Sum_probs=163.3
Q ss_pred eeecCCCceeEEEEEecCCC---cEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTE---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|++|.||++.+...+ ..+++|.+..... ..+.+.+|+..++.+.|+|++++++++. .+..+++++++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46899999999999876554 7899998876544 3456889999999999999999999876 4567999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCC----
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---- 177 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~---- 177 (240)
++|.+++.....+++..+..++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence 999999988778999999999999999999999999999999999999987765 99999999865433322111
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (240)
..+...|+|||.+.+...+.. +|+||||+++++|++ |..||...+..+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~~ 207 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAEV 207 (257)
T ss_pred ccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 112357999999877766554 999999999999998 9999987665443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=236.48 Aligned_cols=204 Identities=32% Similarity=0.489 Sum_probs=167.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC--ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC-----CeE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----THL 92 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 92 (240)
.++|++.+.||.|++|.||++.+..++..|++|.+... ......+.+|+..++.++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 37899999999999999999999999999999998643 22335678899999999999999999987654 357
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
+++++++++ ++.+.+ ....+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~ 159 (336)
T cd07849 84 YIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPE 159 (336)
T ss_pred EEEehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeecccc
Confidence 899999975 777666 4456899999999999999999999999999999999999987766 999999988644322
Q ss_pred CCC----CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 173 SQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 173 ~~~----~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
... ....++..|+|||.+.+....+.++|+||||+++++|++|..||.+.+....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~ 218 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ 218 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 211 2234677899999876654445569999999999999999999987655443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=249.21 Aligned_cols=200 Identities=30% Similarity=0.490 Sum_probs=165.0
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC-ccccHHHHHHHHHHHhcC-CCCeeeeeEEE-EcC------Ce
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLR-HPNIVRFKEVI-LTP------TH 91 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~------~~ 91 (240)
-+++|.+.|.+|||+.||+|++...+..||+|++... ....+...+|+.++++|+ |+|||.+++.. ... ..
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 5778999999999999999999988799999997654 333467899999999997 99999999932 211 24
Q ss_pred EEEEEecCCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCC--ceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 92 LAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~--ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
+.++||||.|+.|.+++.. +..|++.++..|++++++|+.+||... |+|||||-+|||++.++. .||||||.+.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCcccccc
Confidence 6799999999999999974 345999999999999999999999887 999999999999988876 9999999986
Q ss_pred cccccCCCC----------CCcCCccccCccccc--cCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 168 SSVLHSQPK----------STVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 168 ~~~~~~~~~----------~~~~~~~~~~pE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
......... ....++-|++||++. ++-....|+|||+|||+||.|+....||...
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 443333111 123678999999973 2333345599999999999999999999876
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=226.10 Aligned_cols=207 Identities=35% Similarity=0.526 Sum_probs=176.3
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+|++.+.++.|++|.+|++++..++..+++|.+.... .....+.+|+..++.++|+||+++.+++.+....++++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999999999999987532 2234567899999999999999999999999999999999
Q ss_pred CCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 99 ASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 99 ~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
+++++|.+++.+ ...+++..++.++.+++.|+++||+.|++|+||+|+||+++.++. ++|+|||.+...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKN-M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhccC-C
Confidence 999999998865 356899999999999999999999999999999999999987655 999999998655444 3
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
.....+...|++||.+.+...+.. +|+||||+++++|++|..||...+......++.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 214 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ 214 (256)
T ss_pred cccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 333457788999999977766555 999999999999999999998777654444433
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=221.95 Aligned_cols=213 Identities=23% Similarity=0.460 Sum_probs=186.8
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC-CCCeeeeeEEEEcC--CeE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTP--THL 92 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~ 92 (240)
.+.+.++|++++.+|+|.+++||.+.+..++++++||.+++-. ...+.+|+.+|..++ ||||++++++..+. ..+
T Consensus 33 ~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 33 DWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred eccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4557799999999999999999999999999999999887643 367899999999997 99999999999876 457
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
.+++|++.......+. +.++..++..++.++++||.|+|+.||.|+|++|.|++++.... +++|+|+|+|....++
T Consensus 111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCC
Confidence 8999999875555433 45899999999999999999999999999999999999985543 5999999999999998
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCC-CCCCchhhhhhhhce
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRKTIHV 234 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~ 234 (240)
..-.....+..|.-||.+.+.+.+...-|+|||||++..|++...|| .+.++.+++.+|-++
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 88888888999999999999988887789999999999999988775 777888888877553
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=243.48 Aligned_cols=215 Identities=29% Similarity=0.382 Sum_probs=180.3
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCc---E-EEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEE---L-VAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVIL 87 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~-v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 87 (240)
+.+..++-.+.+.||+|+||.||+++....+. . ||+|...... .....+.+|.++++.++||||++++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 33344555666999999999999999885422 3 8999887522 22246889999999999999999999999
Q ss_pred cCCeEEEEEecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 88 TPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
.+..+++|||+++||+|.++|...+ .++..+...++.+.+.||+|||+++++||||-.+|.|++.+.. +|++|||++
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs 309 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLS 309 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccc
Confidence 9999999999999999999998877 4999999999999999999999999999999999999987776 899999998
Q ss_pred ccccccCCCC-CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 167 KSSVLHSQPK-STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 167 ~~~~~~~~~~-~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
+......... .......|+|||.+....++.+ +||||||+++||+++ |..||.+....+.-.++..
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred cCCcceeeccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 7554222222 2234578999999988866565 999999999999998 8889999998888777744
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=231.89 Aligned_cols=210 Identities=25% Similarity=0.377 Sum_probs=169.3
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEec-------CCCcEEEEEEeecCcc--ccHHHHHHHHHHHhc-CCCCeeeeeEEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (240)
...++|++.+.||+|++|.||++++. .....+++|.+..... ....+.+|+..++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34479999999999999999999863 2355789998765322 224578899999999 6999999999999
Q ss_pred cCCeEEEEEecCCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEc
Q 026299 88 TPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (240)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~ 151 (240)
++..+++++||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 988999999999999999998653 2478889999999999999999999999999999999998
Q ss_pred CCCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026299 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (240)
Q Consensus 152 ~~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (240)
.++. ++|+|||.+........ ......+..|+|||.+.+...+.+ +|+||||+++++|++ |..||...+..+.
T Consensus 169 ~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 169 EDNV--MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred CCCc--EEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 7665 99999999864432111 111223457999999877666554 999999999999999 8999977655444
Q ss_pred hhh
Q 026299 228 FRK 230 (240)
Q Consensus 228 ~~~ 230 (240)
+..
T Consensus 246 ~~~ 248 (314)
T cd05099 246 FKL 248 (314)
T ss_pred HHH
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=236.78 Aligned_cols=210 Identities=33% Similarity=0.497 Sum_probs=179.7
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC-----eEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 93 (240)
+|++.+.||.|++|.||++++..++..+++|.+.... ...+.+.+|+..++.++|+||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6899999999999999999999889999999887642 23357889999999999999999999988775 789
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
++++|+++ +|.+++.+..++++..+..++.+++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccc
Confidence 99999975 78888877778999999999999999999999999999999999999987755 9999999987554443
Q ss_pred ----CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 174 ----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 174 ----~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
......++..|+|||.+.+......++|+||||+++++|++|..||.+.+....++++++.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 222 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHh
Confidence 1233456778999999988744455599999999999999999999998877777666554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=223.86 Aligned_cols=199 Identities=37% Similarity=0.550 Sum_probs=175.7
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--CeEEEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 96 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 96 (240)
+|++.+.|++|++|.+|++.+..++..+++|.+.... ...+.+.+|+..+++++|+||+++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5889999999999999999999999999999987654 2346788999999999999999999999988 8899999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC--
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-- 174 (240)
|++++++|.+++.+...+++..++.++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEecccccccc
Confidence 99999999999988778999999999999999999999999999999999999987665 99999999875554443
Q ss_pred -CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 175 -~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
.....+...|++||.+.+...+.+ +|+||||+++++|++|..||...+
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC
Confidence 344567789999999877765444 999999999999999999997765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=228.12 Aligned_cols=202 Identities=27% Similarity=0.367 Sum_probs=163.1
Q ss_pred eeecCCCceeEEEEEecCCCc--EEEEEEeecC--ccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~--~v~iK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|++|.||++++..++. .+++|.+... ....+.+.+|+..++++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 358999999999999987765 4678877642 22335678899999999 799999999999999999999999999
Q ss_pred CchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCc
Q 026299 102 GELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (240)
Q Consensus 102 ~~l~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~ 165 (240)
++|.+++.... .++...+..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCC
Confidence 99999886532 3788999999999999999999999999999999999987665 99999998
Q ss_pred cccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
+.................|+|||.+.....+.. +|+||||+++++|++ |..||...+..+.+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~ 224 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH
Confidence 753322222222223457999999876665444 999999999999997 99999877665555444
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=231.85 Aligned_cols=211 Identities=33% Similarity=0.529 Sum_probs=173.4
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC------
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 90 (240)
.++|++.+.||.|++|.||++.+..+++.|++|.+.... .....+.+|+..++.++|||++++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 368999999999999999999999999999999987542 22346778999999999999999999987654
Q ss_pred ----eEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCc
Q 026299 91 ----HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (240)
Q Consensus 91 ----~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~ 165 (240)
.+++++||+++ ++...+... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||.
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~ 162 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGL 162 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccc
Confidence 78999999987 666666543 46899999999999999999999999999999999999987765 99999998
Q ss_pred cccccccCC--CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 166 SKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 166 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
+........ .........|++||.+.+....+.++|+||||+++++|++|..||...+....++++.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 865433321 12234566899999887655445559999999999999999999988776666555544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=228.81 Aligned_cols=201 Identities=31% Similarity=0.547 Sum_probs=168.7
Q ss_pred CeeEeeeecCCCceeEEEEEec---CCCcEEEEEEeecCc-----cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeE
Q 026299 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 92 (240)
.|++.+.||.|++|.||.+++. .+|..|++|++.... ...+.+.+|+.+++.+ +|++|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999985 478899999986532 2235678899999999 589999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
++|+||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccc
Confidence 999999999999999988788999999999999999999999999999999999999987765 999999988654332
Q ss_pred C--CCCCCcCCccccCccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 173 S--QPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 173 ~--~~~~~~~~~~~~~pE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
. ......+...|++||.+.+.. ....++|+||||+++++|++|..||.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 213 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc
Confidence 1 112344678899999987543 234459999999999999999999975433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=236.00 Aligned_cols=216 Identities=27% Similarity=0.442 Sum_probs=176.6
Q ss_pred CCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEc
Q 026299 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT 88 (240)
Q Consensus 12 ~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (240)
++-.+....++|++++.||.|++|.||++.+..++..|++|.+..... ....+.+|+..++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07880 6 VNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred hhhhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence 344455567899999999999999999999999999999998864322 23457789999999999999999999876
Q ss_pred CC------eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEec
Q 026299 89 PT------HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (240)
Q Consensus 89 ~~------~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d 162 (240)
+. .+++|++++ +++|.+++. ...+++..+..++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~d 161 (343)
T cd07880 86 DLSLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILD 161 (343)
T ss_pred CccccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEee
Confidence 53 458999998 668887775 456899999999999999999999999999999999999987665 99999
Q ss_pred CCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
||.+..... ......++..|++||.+.+....+.++|+||||+++++|++|..||...+....+.+++.
T Consensus 162 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~ 230 (343)
T cd07880 162 FGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK 230 (343)
T ss_pred ccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999864432 222335677899999987644445569999999999999999999988776666555443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=227.64 Aligned_cols=193 Identities=32% Similarity=0.470 Sum_probs=158.9
Q ss_pred eecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHh---cCCCCeeeeeEEEEcCCeEEEEEecCC
Q 026299 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRS---LRHPNIVRFKEVILTPTHLAIVMEYAS 100 (240)
Q Consensus 28 ~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~---l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (240)
.||+|++|.||++.+..++..+++|.+...... ...+.++...++. .+|++++.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 479999999999999999999999988654211 1223444443433 468999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcC
Q 026299 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (240)
Q Consensus 101 ~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~ 180 (240)
+++|.+++...+.+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+...... ......+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCC
Confidence 9999999887788999999999999999999999999999999999999987765 999999987543322 2223457
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
+..|+|||.+.+......++|+||||+++++|++|..||....
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 8899999998754444455999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=228.99 Aligned_cols=205 Identities=28% Similarity=0.469 Sum_probs=170.1
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEc------CC
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------PT 90 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~ 90 (240)
...+.|++.+.+|.|++|.||++.+..+++.+++|.+.........+..|+..++++ +|+|++++++++.. ..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 455899999999999999999999999999999999876655556678888888888 69999999999853 45
Q ss_pred eEEEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 91 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
.++++|||+++++|.+++... ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++. ++|+|||.+..
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~ 170 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhh
Confidence 789999999999999988653 35788889999999999999999999999999999999987766 99999998764
Q ss_pred cccc-CCCCCCcCCccccCccccccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 169 SVLH-SQPKSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 169 ~~~~-~~~~~~~~~~~~~~pE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.... .......++..|+|||.+... .....++|+||||+++++|++|..||.....
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 4321 222334577889999987532 2224459999999999999999999976544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=231.24 Aligned_cols=208 Identities=26% Similarity=0.423 Sum_probs=168.2
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCC--------------CcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeee
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKT--------------EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRF 82 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~--------------~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~ 82 (240)
..++|++.+.||+|++|.||.+++..+ ...|++|.+..... ....+.+|+..+++++|+|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 346899999999999999999987543 23589998865422 23468899999999999999999
Q ss_pred eEEEEcCCeEEEEEecCCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEE
Q 026299 83 KEVILTPTHLAIVMEYASGGELFERICNAG------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (240)
Q Consensus 83 ~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili 150 (240)
++++...+..++||||+++++|.+++.... .++...+..++.|++.|++|||+.|++|+||+|+||++
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 999999999999999999999999885431 36788899999999999999999999999999999999
Q ss_pred cCCCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh--CCCCCCCCCch
Q 026299 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEP 225 (240)
Q Consensus 151 ~~~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~ 225 (240)
+.++. ++|+|||.+........ .....+...|+|||.+.+...+.+ +|+||||+++++|++ +..||......
T Consensus 163 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 163 GNHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred cCCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 87665 99999999864432211 112234568999999877776554 999999999999987 77888776554
Q ss_pred hhhh
Q 026299 226 KNFR 229 (240)
Q Consensus 226 ~~~~ 229 (240)
..+.
T Consensus 240 ~~~~ 243 (295)
T cd05097 240 QVIE 243 (295)
T ss_pred HHHH
Confidence 4433
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=224.77 Aligned_cols=206 Identities=30% Similarity=0.416 Sum_probs=172.3
Q ss_pred eeEeeeecCCCceeEEEEEecCCC----cEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+++.+.||.|++|.||++.+...+ ..+++|.+..... ....+.+|+..++.++|+|++++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 467889999999999999998766 8999999876544 3467889999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 97 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~--l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
+++++++|.+++..... +++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDY 158 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccc
Confidence 99999999999876544 899999999999999999999999999999999999987765 99999999865443322
Q ss_pred CC--CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 175 PK--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 175 ~~--~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
.. ...+...|++||.+.+...+. ++|+||||+++++|++ |..||...+.......+
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~-~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~ 217 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTS-KSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL 217 (258)
T ss_pred cccccCCCcccccChHHhccCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 11 122557899999986655544 4999999999999998 88998876655544443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=231.43 Aligned_cols=199 Identities=33% Similarity=0.517 Sum_probs=169.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+.|+..+.||.|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++|+||+++++.+..+...++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 46888899999999999999999899999999876543 2234678999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-CCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~~~ 177 (240)
+++++|.+++.. ..+++..+..++.+++.|+.|||+.|++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhc
Confidence 999999988754 56899999999999999999999999999999999999987766 99999998864432221 122
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
..+...|+|||++.+...+.+ +|+||||+++++|++|..||.+..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred ccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccc
Confidence 346778999999987766554 999999999999999999987543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=231.50 Aligned_cols=203 Identities=29% Similarity=0.392 Sum_probs=166.9
Q ss_pred CeeEeeeecCCCceeEEEEEecC--CCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--CeEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKK--TEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~--~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 93 (240)
+|++.+.||+|++|.||++.+.. ++..|++|.+.... ...+...+|+..++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999998 89999999987632 3345678899999999999999999999988 7899
Q ss_pred EEEecCCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC--CCcEEEecCCcc
Q 026299 94 IVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYS 166 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~--~~~~~L~d~~~~ 166 (240)
+|+|++++ ++.+.+... ..+++..++.++.|++.|++|||+.+++|+||+|+||+++.++ .+.++|+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999976 566655321 2689999999999999999999999999999999999997611 334999999988
Q ss_pred ccccccCC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 167 KSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 167 ~~~~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
........ .....++..|+|||.+.+......++|+||||+++++|++|..||...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 64433222 122345678999998876654455599999999999999999999876554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=225.32 Aligned_cols=199 Identities=32% Similarity=0.516 Sum_probs=164.8
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCcccc----HHHHHHHH-HHHhcCCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||.|++|.||+|.+..++..|++|.+....... ..+..|.. .....+|+|++++++.+..++.+++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57899999999999999999999999886532111 22333433 33455899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcCC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~ 181 (240)
++|.+++....++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..... .....+.
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCCC
Confidence 999999988788999999999999999999999999999999999999987665 99999998764322 2334567
Q ss_pred ccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 182 ~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
..|++||.+.+... ..++|+||||+++++|++|..||...+....+.++
T Consensus 157 ~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 205 (260)
T cd05611 157 PDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI 205 (260)
T ss_pred cCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 78999999887764 44599999999999999999999877666555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=225.74 Aligned_cols=205 Identities=22% Similarity=0.359 Sum_probs=165.2
Q ss_pred eeEeeeecCCCceeEEEEEecCC---CcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe-----
Q 026299 23 YELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 91 (240)
|++.+.||+|++|.||.|....+ +..|++|.+...... ...+.+|+..++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999997653 478999988754322 2467889999999999999999998876543
Q ss_pred -EEEEEecCCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 92 -LAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 92 -~~lv~~~~~~~~l~~~l~~~------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
.++++||+++++|..++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCcc
Confidence 78999999999998887432 25899999999999999999999999999999999999987665 9999999
Q ss_pred ccccccccCCC---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 165 YSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 165 ~~~~~~~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
.+......... .....+..|++||.+.+...+.. +|+||||+++|+|++ |..||.+.+..+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~ 227 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDY 227 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 98644332211 11223457999999876666555 999999999999999 9999977665554443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=229.47 Aligned_cols=201 Identities=31% Similarity=0.515 Sum_probs=171.7
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC-ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
.++|++.+.||+|++|.||++.+..++..|++|.+... ....+.+.+|+..++.++|||++++++.+..++..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 47999999999999999999999888999999988643 23345678899999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~~ 177 (240)
+++++|.+++.+ ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 98 ~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred CCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceeccccccccccc
Confidence 999999998854 35789999999999999999999999999999999999987665 9999999875433222 1223
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
..+...|++||.+.+...+.. +|+||||++++++++|..||...+.
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~ 220 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENP 220 (293)
T ss_pred ccCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 346778999999887766554 9999999999999999999976654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=227.56 Aligned_cols=208 Identities=23% Similarity=0.395 Sum_probs=171.2
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
+.++|++++.||.|++|.||+++... +...+++|.+...... ...+.+|+.++++++|+||+++++++.+.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 45789999999999999999999753 3567889987654322 3568899999999999999999999999889
Q ss_pred EEEEEecCCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEec
Q 026299 92 LAIVMEYASGGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d 162 (240)
.++|+||+++++|.+++.... .++...+..++.|++.+|.|||+.|++|+||+|+||+++.++. ++++|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~ 160 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSL 160 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcc
Confidence 999999999999999987655 6899999999999999999999999999999999999987765 99999
Q ss_pred CCccccccccC--CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 026299 163 FGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (240)
Q Consensus 163 ~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (240)
||++....... ......++..|+|||.+.+...... +|+||||+++++|++ |..||........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~ 229 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEEVLN 229 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccchHHHHH
Confidence 99875332211 1222344567999999877766544 999999999999998 888997655544333
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=227.08 Aligned_cols=204 Identities=23% Similarity=0.360 Sum_probs=164.5
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCc----EEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
...++|++.+.||.|++|.||++.+..++. .+++|.+..... ....+..|+..++.+.||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 345789999999999999999999876665 477777654322 12456677778889999999999998754 55
Q ss_pred EEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 92 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
.+++++++++++|.+++.. ...+++..+..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~ 160 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLY 160 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceecc
Confidence 7789999999999999865 456899999999999999999999999999999999999987665 9999999986443
Q ss_pred ccCCC---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCch
Q 026299 171 LHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (240)
Q Consensus 171 ~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (240)
..... ....++..|++||.+.+...+.+ +|+||||+++|+|++ |..||.+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 22211 12234567999999877766554 999999999999998 99999776543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=226.67 Aligned_cols=198 Identities=31% Similarity=0.503 Sum_probs=168.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--CeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 96 (240)
++|+..+.||.|++|.||.+.+..++..+++|.+..... ....+.+|++.++.++||||+++++++.+. +.++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 478999999999999999999999999999999876433 345688999999999999999999988654 4689999
Q ss_pred ecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 97 ~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
||+++++|.+++.. ...++...+..++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence 99999999887643 345889999999999999999999999999999999999987765 999999997644322
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
.. ....+...|++||.+.+...+.. +|+||||+++|+|++|..||...
T Consensus 159 ~~-~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 159 LA-GTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc-ccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcc
Confidence 22 23346778999999877766555 99999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=244.74 Aligned_cols=212 Identities=27% Similarity=0.472 Sum_probs=174.8
Q ss_pred CCCCe-eEeeeecCCCceeEEEEEecCCCcEEE---EEE--eecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe-
Q 026299 19 DSDRY-ELVRDIGSGNFGVARLMRDKKTEELVA---VKY--IERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTH- 91 (240)
Q Consensus 19 ~~~~y-~~~~~l~~g~~g~v~~~~~~~~~~~v~---iK~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 91 (240)
...+| +..+.||+|+|.+||+|.|..+|-.|| +|. +...+...+++..|+.+|+.|+|+||++++..+.+...
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~ 116 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK 116 (632)
T ss_pred CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence 33555 667789999999999999998888776 221 22234445789999999999999999999999987654
Q ss_pred -EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--CceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 92 -LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 92 -~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~--~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
+.+|+|.+..|+|..++.+.+..+...++.|++||++||.|||+. .|+||||+-+|||++.+ .+.+||+|+|+|..
T Consensus 117 ~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 117 TINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-LGEVKIGDLGLATL 195 (632)
T ss_pred eeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC-cCceeecchhHHHH
Confidence 889999999999999999999999999999999999999999987 49999999999999844 45699999999964
Q ss_pred ccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc-hhhhhhhhce
Q 026299 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHV 234 (240)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~ 234 (240)
.... ....-.|++.|||||... ..+... .||||||++++||+|+..||..... ...++|.+..
T Consensus 196 ~r~s-~aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SG 259 (632)
T KOG0584|consen 196 LRKS-HAKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSG 259 (632)
T ss_pred hhcc-ccceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcC
Confidence 4333 333468999999999886 334344 9999999999999999999988755 4455665543
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=229.39 Aligned_cols=208 Identities=32% Similarity=0.483 Sum_probs=175.5
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
|++.+.||.|++|.+|++.+..+++.+++|.+..... ....+.+|+..+++++|+||+++++++.++...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 6788999999999999999999999999998866432 2356788999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCCC
Q 026299 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (240)
Q Consensus 100 ~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~~ 177 (240)
++ ++.+++.. ..+++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccC
Confidence 76 77777755 457899999999999999999999999999999999999987665 9999999886554333 2223
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
..+...|+|||.+.+....+.++|+||||+++++|++|..||...+..+.+.++.+
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~ 213 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFR 213 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 44667899999988764445569999999999999999999988877666655543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=235.14 Aligned_cols=205 Identities=29% Similarity=0.463 Sum_probs=171.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEc----CCeEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHLA 93 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 93 (240)
++|++.+.||.|++|.||++.+..++..|++|++.... .....+.+|+..++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 78999999999999999999999999999999987642 233567789999999999999999988763 35689
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
+|+||+.+ +|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 85 lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 85 VVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccC
Confidence 99999965 88888877777999999999999999999999999999999999999987766 9999999986543322
Q ss_pred CC-----CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 174 QP-----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 174 ~~-----~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
.. ....++..|+|||.+.+......++|+||||+++++|++|..||.+.+....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~ 221 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL 221 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH
Confidence 11 22356778999999876544556699999999999999999999877654433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=240.80 Aligned_cols=202 Identities=37% Similarity=0.640 Sum_probs=177.3
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeec---CccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCc
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~ 103 (240)
+.||+|.||+||-++++.+|+.||||++.+ ....++...+|+.+|..++||.|+.+.-.|+..+..++|||.+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 579999999999999999999999999876 34556788999999999999999999999999999999999998866
Q ss_pred hHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC-CCCCcEEEecCCccccccccCCCCCCcCC
Q 026299 104 LFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGT 181 (240)
Q Consensus 104 l~~~l~-~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~-~~~~~~~L~d~~~~~~~~~~~~~~~~~~~ 181 (240)
|.-++. +.+.+++..-+.++.||+.||+|||-++|+|+||+|+||++.. +.-+.+||+|||+++...-.....+-.|+
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGT 729 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGT 729 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCC
Confidence 666664 3467999999999999999999999999999999999999953 33446999999999988888888888999
Q ss_pred ccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC-Cchhhhh
Q 026299 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFR 229 (240)
Q Consensus 182 ~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~ 229 (240)
+.|+|||++.++.+... -|+||.|+++|--++|+.||... +..++++
T Consensus 730 PAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ 777 (888)
T KOG4236|consen 730 PAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ 777 (888)
T ss_pred ccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccchhHHhh
Confidence 99999999988887666 99999999999999999999654 3344433
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=226.21 Aligned_cols=208 Identities=32% Similarity=0.485 Sum_probs=173.6
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhc---CCCCeeeeeEEEEcCCe-----
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILTPTH----- 91 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----- 91 (240)
|++.+.||.|++|.||++++..++..|++|.+..... ....+.+|+..++++ .|+|++++.+++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7889999999999999999998899999999875322 223456777766655 59999999999988766
Q ss_pred EEEEEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
.++++|++++ +|.+++.... .+++..++.++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC--EEEeccCcceec
Confidence 8999999976 7888776543 4899999999999999999999999999999999999987755 999999998665
Q ss_pred cccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 170 ~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
..........+...|+|||.+.+...+.+ +|+||||+++++|++|..||......+.+.+++..
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDV 221 (287)
T ss_pred cCCcccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHH
Confidence 44433334456778999999987776555 99999999999999999999988887777776553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=226.15 Aligned_cols=201 Identities=30% Similarity=0.522 Sum_probs=170.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+-|++.+.||.|++|.||++.+..++..+++|....... ....+.+|+..++.++||||+++++.+..+...++|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 458889999999999999999998999999998765432 224678899999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~~ 177 (240)
+++++|.+++.+ ..++...+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhcc
Confidence 999999988754 56899999999999999999999999999999999999987765 9999999875443221 1122
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
..+...|+|||.+.+...+.. +|+||||+++++|++|..||...+..
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~ 207 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPM 207 (277)
T ss_pred ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchH
Confidence 346778999999877666544 99999999999999999999765543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=226.65 Aligned_cols=199 Identities=27% Similarity=0.403 Sum_probs=162.5
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHH-HHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++++.||.|++|.||++++..++..|++|.+..... ....+..|... ++..+|||++++++++..++..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999999876432 22345556554 566789999999999999999999999
Q ss_pred cCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhC-CceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 98 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 98 ~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~-~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
|+++ +|.+++.. +..+++..++.++.|++.|++|||+. +++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS 157 (283)
T ss_pred hhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence 9975 77776643 34689999999999999999999997 9999999999999987765 999999998654333
Q ss_pred CCCCCCcCCccccCccccccCC---CCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
.......++..|+|||.+.+.. ..+.++|+||||+++++|++|..||...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 2223345677899999886532 2244599999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=229.30 Aligned_cols=206 Identities=27% Similarity=0.454 Sum_probs=166.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecC----------------CCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeee
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKK----------------TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVR 81 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~----------------~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~ 81 (240)
.++|++.+.||+|++|.||++.+.. ++..+++|.+..... ...++.+|+..++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4679999999999999999986432 345789998865432 2356889999999999999999
Q ss_pred eeEEEEcCCeEEEEEecCCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEE
Q 026299 82 FKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (240)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~-----------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili 150 (240)
+++++..++..+++|||+++++|.+++.... .++...+..++.|++.|+++||+.|++|+||+|+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999999999999886532 36677899999999999999999999999999999999
Q ss_pred cCCCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh--CCCCCCCCCch
Q 026299 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEP 225 (240)
Q Consensus 151 ~~~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~ 225 (240)
+.++. ++|+|||.+........ .........|++||...+...+.+ +|+||||+++|+|++ |..||...+..
T Consensus 164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 164 GKNYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred cCCCC--EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 87665 99999999864432211 111223567999998877766554 999999999999998 78999766554
Q ss_pred hhh
Q 026299 226 KNF 228 (240)
Q Consensus 226 ~~~ 228 (240)
+.+
T Consensus 241 ~~~ 243 (296)
T cd05095 241 QVI 243 (296)
T ss_pred HHH
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=209.00 Aligned_cols=210 Identities=29% Similarity=0.503 Sum_probs=183.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
.+|.-.++||+|.+|+||++++.++++.|++|++..++.. ....++|+.+++.++|.||++++++...+..+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 4677788999999999999999999999999999876433 3678999999999999999999999999999999999
Q ss_pred cCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CC
Q 026299 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~ 175 (240)
|++. .|..+... ++.++.+.++.++.|++++|.+.|+.++.|+|++|.|.+++.+++ ++|.|||+++...... -.
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEee
Confidence 9976 55555533 467899999999999999999999999999999999999988887 9999999997554433 23
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
.....+..|.+|.++++...+++..|+||-||++.++.. |...|.+.+..+++.+|..
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~ 217 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH
Confidence 344567899999999999988887999999999999997 8888999999998888765
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=225.34 Aligned_cols=192 Identities=32% Similarity=0.471 Sum_probs=159.0
Q ss_pred eecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHH---HHHhcCCCCeeeeeEEEEcCCeEEEEEecCC
Q 026299 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREII---NHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (240)
Q Consensus 28 ~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (240)
.||+|++|.||++.+..+++.|++|.+...... ...+..|.. .++...||+|+++.+.+.+++..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 379999999999999999999999988653211 112333433 3344579999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcC
Q 026299 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (240)
Q Consensus 101 ~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~ 180 (240)
|++|..++...+.+++..++.++.|++.|++|||+.+++|+||+|+||+++.++. ++|+|||.+...... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~~-~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCcc-CCcCcCC
Confidence 9999998887788999999999999999999999999999999999999987765 999999987644322 2233467
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
+..|+|||.+.+....+.++|+||+|+++++|++|..||.+.
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 889999999876543445599999999999999999999776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=228.36 Aligned_cols=203 Identities=24% Similarity=0.376 Sum_probs=165.3
Q ss_pred CeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
+|++.+.||+|+||.||++.+.. ....+++|.+...... ...+.+|+..++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 2356888877654322 2467889999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEE
Q 026299 95 VMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~------------------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili 150 (240)
++||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999987542 247788999999999999999999999999999999999
Q ss_pred cCCCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchh
Q 026299 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (240)
Q Consensus 151 ~~~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (240)
++++. ++|+|||.+........ ......+..|+|||.+.+...+.. +|+||||+++++|++ |..||.+.....
T Consensus 161 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 161 AEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred cCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH-hHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 87765 99999999864322211 112234567999999876666554 999999999999998 999997765444
Q ss_pred h
Q 026299 227 N 227 (240)
Q Consensus 227 ~ 227 (240)
.
T Consensus 238 ~ 238 (290)
T cd05045 238 L 238 (290)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=246.27 Aligned_cols=197 Identities=33% Similarity=0.534 Sum_probs=171.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+.|+-++.||.|+||-||.+++..+.+.|+||.+.-.-. ...+++.|+.+|++++|||++.+.|+|..+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 468889999999999999999999999999999865322 2246899999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
|||-| |..|++.- .+++.+.++..|..+.+.||.|||+.+.+|+||+..||++.+++. +||+|||.+. ...+.
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAs---i~~PA 179 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSAS---IMAPA 179 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchh---hcCch
Confidence 99955 88887753 467999999999999999999999999999999999999998887 9999999876 34556
Q ss_pred CCCcCCccccCccccc---cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.+++|+++|||||++. .+.++.+ .||||||++.++|..+.+|+-+.+.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred hcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchH
Confidence 6789999999999974 4456666 9999999999999998888654443
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=226.11 Aligned_cols=201 Identities=35% Similarity=0.580 Sum_probs=171.2
Q ss_pred ecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCch
Q 026299 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+..+++++|+||+++++.+..+...+++++++++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5889999999999998899999998865432 335678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC---------CC
Q 026299 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------QP 175 (240)
Q Consensus 105 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~---------~~ 175 (240)
.+++.+.+.+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence 999987778999999999999999999999999999999999999987776 9999999876443332 11
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
....+...|++||...+...+ .++|+||||+++++|++|..||...+....+.++.
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 214 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGHS-KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL 214 (265)
T ss_pred cCcccCccccCHHHhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 233467789999998777654 44999999999999999999998777666555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=225.70 Aligned_cols=201 Identities=30% Similarity=0.503 Sum_probs=171.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
..|+..+.||.|++|.+|++.+..++..+++|.+..... ..+.+.+|+..++.++|+|++++++++..++..+++++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 567778899999999999999998999999998865432 2345788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCCCC
Q 026299 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 178 (240)
Q Consensus 100 ~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~~~ 178 (240)
++++|.+++.. .+++...+..++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||.+....... .....
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCcccccc
Confidence 99999998866 67899999999999999999999999999999999999987665 9999999875433222 12234
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
.++..|+|||.+.+...+.+ +|+||||+++++|++|..||...+..
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~ 221 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPL 221 (285)
T ss_pred cCCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHH
Confidence 57788999999877766554 99999999999999999999765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=231.19 Aligned_cols=203 Identities=29% Similarity=0.492 Sum_probs=171.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
+.|.....||.|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++|+|++++++.+..++..++++||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 56677888999999999999999899999999886533 22356789999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-CCCC
Q 026299 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST 178 (240)
Q Consensus 100 ~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~~~~ 178 (240)
++++|.+++.. ..+++..+..++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||.+........ ....
T Consensus 102 ~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 102 EGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCcee
Confidence 99999988744 46899999999999999999999999999999999999987765 99999998754322221 1234
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
.++..|+|||.+.+...+.. +|+||||+++++|++|..||...+....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~ 226 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQA 226 (292)
T ss_pred ecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56788999999877666554 9999999999999999999987665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=225.70 Aligned_cols=204 Identities=22% Similarity=0.371 Sum_probs=159.9
Q ss_pred eeecCCCceeEEEEEecC--CCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCC
Q 026299 27 RDIGSGNFGVARLMRDKK--TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (240)
+.||+|+||.||++.... ....+++|.+...... ...+.+|+..++.++|+||+++++.+......+++|||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999996543 3557888876543222 245788999999999999999999999999999999999999
Q ss_pred chHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC---C
Q 026299 103 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 174 (240)
Q Consensus 103 ~l~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~---~ 174 (240)
+|.+++.... ..+...+..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||.+....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence 9999986543 2456778899999999999999999999999999999987766 9999999875432211 1
Q ss_pred CCCCcCCccccCccccccC------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 175 PKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
.....+...|+|||.+... ...+.++|+||||+++++|++ |..||......+.+.+.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 223 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV 223 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh
Confidence 1223345679999987532 223455999999999999998 888998776655554443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=224.39 Aligned_cols=201 Identities=30% Similarity=0.451 Sum_probs=166.2
Q ss_pred eeecCCCceeEEEEEecC-CCc--EEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSGNFGVARLMRDKK-TEE--LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~-~~~--~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+.||+|++|.||++.+.. ++. .+++|.+..... ..+.+.+|+..+++++|+||+++++.+.. ...++++|++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 333 689998877544 34578899999999999999999999988 889999999999
Q ss_pred CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC----C
Q 026299 102 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----P 175 (240)
Q Consensus 102 ~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~----~ 175 (240)
++|.+++.+.. .++...++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccccceecc
Confidence 99999987654 6899999999999999999999999999999999999987765 99999999865433211 1
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
....++..|+|||.+.+...+.. +|+||||+++++|++ |..||...+..+...++
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred cCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 12335668999999877776555 999999999999998 99999776655544443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=227.85 Aligned_cols=198 Identities=30% Similarity=0.455 Sum_probs=164.5
Q ss_pred CCCCeeEeeeecCCCceeEEEEEe----cCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--C
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRD----KKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--T 90 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~----~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 90 (240)
+.+.|++++.||+|++|.||.++. ..++..|++|.+.... ...+.+.+|+..++.++|||++++.+++.+. .
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 446789999999999999999984 4568899999986542 2235688999999999999999999998875 5
Q ss_pred eEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
..++++||+++++|.+++.+. ..++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~ 159 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAI 159 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCcccccc
Confidence 689999999999999998654 35899999999999999999999999999999999999987665 999999998754
Q ss_pred cccCC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 026299 170 VLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219 (240)
Q Consensus 170 ~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 219 (240)
..... .....+...|+|||.+.+...+.+ +|+||||+++++|+++..|+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCC
Confidence 33222 122345567999999877766555 99999999999999976654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=228.61 Aligned_cols=212 Identities=25% Similarity=0.389 Sum_probs=171.1
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEec-------CCCcEEEEEEeecCc--cccHHHHHHHHHHHhc-CCCCeeeeeEEE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVI 86 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 86 (240)
.....+|++.+.||+|++|.||.+++. ..+..+++|...... .....+.+|+..++.+ +||||+++++.+
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 345689999999999999999999753 234579999876532 2235688999999999 899999999999
Q ss_pred EcCCeEEEEEecCCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEE
Q 026299 87 LTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (240)
Q Consensus 87 ~~~~~~~lv~~~~~~~~l~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili 150 (240)
......+++|||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 9999999999999999999998653 236778899999999999999999999999999999999
Q ss_pred cCCCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchh
Q 026299 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (240)
Q Consensus 151 ~~~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (240)
+.++. ++|+|||.+........ .....+...|+|||.+.+..++.. +|+||||+++++|++ |..||...+..+
T Consensus 171 ~~~~~--~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 171 TENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred cCCCc--EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 87665 99999999864432221 112234567999999877666555 999999999999998 888987766655
Q ss_pred hhhhh
Q 026299 227 NFRKT 231 (240)
Q Consensus 227 ~~~~~ 231 (240)
.+.++
T Consensus 248 ~~~~~ 252 (304)
T cd05101 248 LFKLL 252 (304)
T ss_pred HHHHH
Confidence 54443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=224.20 Aligned_cols=199 Identities=25% Similarity=0.350 Sum_probs=158.7
Q ss_pred eeecCCCceeEEEEEec--CCCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCC
Q 026299 27 RDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (240)
+.||+|++|.||++... .++..+++|.+...... ...+.+|+..++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999865 34567899987654322 246788999999999999999999999888899999999999
Q ss_pred chHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC---C
Q 026299 103 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 174 (240)
Q Consensus 103 ~l~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~---~ 174 (240)
+|.+++.... .++...+..++.|++.|++|||+.|++|+||+|+||+++.+.. ++|+|||.+....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCccccccccCcceeec
Confidence 9999886422 3566778889999999999999999999999999999987665 9999999875332211 1
Q ss_pred CCCCcCCccccCccccccCC------CCCcccchHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026299 175 PKSTVGTPAYIAPEVLLKKE------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (240)
.....++..|+|||.+.+.. ..+.++|+||||+++++|++ |..||...+..+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 218 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 12234567899999886432 12445999999999999996 9999987665544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=227.86 Aligned_cols=209 Identities=34% Similarity=0.548 Sum_probs=177.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 95 (240)
++|++.+.||+|++|.||++.+..++..|++|++.... .....+.+|...+++++ |+||+++++++.+++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999886532 22356788899999998 99999999999999999999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~- 174 (240)
||++++++|.+++...+.++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence 999999999999988878999999999999999999999999999999999999987665 99999998764432221
Q ss_pred --------------------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 175 --------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 175 --------------------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
.....+...|++||...+...+.. +|+||||++++++++|..||...+....++++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 112335678999998877665444 999999999999999999998877655555544
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=236.37 Aligned_cols=213 Identities=26% Similarity=0.389 Sum_probs=171.7
Q ss_pred CCCCcccCCCCCeeEeeeecCCCceeEEEEEec-----CCCcEEEEEEeecCccc--cHHHHHHHHHHHhcC-CCCeeee
Q 026299 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRF 82 (240)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~ 82 (240)
..+.......++|.+.+.||+|+||.||++++. .++..|++|++...... ...+.+|+.++.++. ||||+++
T Consensus 27 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 27 PYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred CCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 344445556688999999999999999999964 34568999998764322 246788999999997 9999999
Q ss_pred eEEEEcCCeEEEEEecCCCCchHHHHHhcC--------------------------------------------------
Q 026299 83 KEVILTPTHLAIVMEYASGGELFERICNAG-------------------------------------------------- 112 (240)
Q Consensus 83 ~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~-------------------------------------------------- 112 (240)
++.+..+...++|+||+++++|.+++...+
T Consensus 107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 999999899999999999999999885431
Q ss_pred ------------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCC
Q 026299 113 ------------------------------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144 (240)
Q Consensus 113 ------------------------------------------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~ 144 (240)
.++...+..++.|++.||+|||+.+++|+||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk 266 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA 266 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence 25666788899999999999999999999999
Q ss_pred CCCeEEcCCCCCcEEEecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCC
Q 026299 145 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFE 220 (240)
Q Consensus 145 ~~nili~~~~~~~~~L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~ 220 (240)
|+||+++.+.. ++|+|||.+....... ......++..|+|||.+.+.....+ +|+||||+++++|++ |..||.
T Consensus 267 p~NiLl~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 267 ARNVLICEGKL--VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred cceEEEeCCCE--EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH-hHHHHHHHHHHHHHHcCCCCCC
Confidence 99999987655 9999999986433221 1122345678999999987766554 999999999999998 899997
Q ss_pred CCCchh
Q 026299 221 DPEEPK 226 (240)
Q Consensus 221 ~~~~~~ 226 (240)
.....+
T Consensus 344 ~~~~~~ 349 (401)
T cd05107 344 ELPMNE 349 (401)
T ss_pred CCCchH
Confidence 655433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=222.81 Aligned_cols=198 Identities=29% Similarity=0.448 Sum_probs=159.7
Q ss_pred eecCCCceeEEEEEec--CCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCc
Q 026299 28 DIGSGNFGVARLMRDK--KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103 (240)
Q Consensus 28 ~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~ 103 (240)
.||+|++|.||.+.+. .++..|++|....... ..+.+.+|+..++.++|+||+++++++.. ...++|+||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999775 4456799998866432 23457899999999999999999998754 57899999999999
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC----CCC
Q 026299 104 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KST 178 (240)
Q Consensus 104 l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~----~~~ 178 (240)
|.+++.. ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.+.. ++|+|||.+......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence 9998864 456899999999999999999999999999999999999987765 999999988643322111 111
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (240)
.....|+|||.+.....+.. +|+||||+++|++++ |..||.+....+...
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 209 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVMS 209 (257)
T ss_pred CCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 12457999999876666544 999999999999996 999998776554443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=223.33 Aligned_cols=209 Identities=34% Similarity=0.554 Sum_probs=175.5
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++|+|++++++.+.+....++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5899999999999999999999999999999986642 3345678999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC-
Q 026299 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (240)
Q Consensus 99 ~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~- 175 (240)
+++++|.+++.... .+++..+..++.+++.|+.+||+.+++|+||+|+||+++.++. .++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence 99999999886543 4789999999999999999999999999999999999976643 3699999988644332221
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
....++..|+|||.+.+...+.. +|+||||+++++|++|..||...+..+.+.++.
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 215 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC 215 (257)
T ss_pred cccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 22346778999999877766555 999999999999999999998776655555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=232.53 Aligned_cols=211 Identities=26% Similarity=0.437 Sum_probs=172.0
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC----
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP---- 89 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 89 (240)
....++|++.+.||+|++|.||++.+..++..|++|++..... ..+.+.+|+..+++++|+||+++.+++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 3455899999999999999999999998999999998865321 234577899999999999999999988643
Q ss_pred --CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 90 --THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 90 --~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
...+++++++ +++|.+++.. ..+++..++.++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||.+.
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~ 168 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR 168 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecccccc
Confidence 3467888876 6688877644 46899999999999999999999999999999999999987765 9999999976
Q ss_pred cccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
... .......++..|+|||.+.+......++|+||||+++++|++|..||...+....+.++++
T Consensus 169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 169 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred ccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 432 2223345677899999987644445559999999999999999999988776665555433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=230.21 Aligned_cols=202 Identities=29% Similarity=0.493 Sum_probs=170.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
..|+....||.|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++|||++++++.+..++..++++||+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 56677778999999999999999899999999986533 23356788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-CCCC
Q 026299 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST 178 (240)
Q Consensus 100 ~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~~~~ 178 (240)
++++|.+++.. ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........ ....
T Consensus 101 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 101 QGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccce
Confidence 99999887644 56899999999999999999999999999999999999987766 99999998754332221 2234
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
.++..|+|||.+.+...+.+ +|+||||+++++|++|..||...+...
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~ 224 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQ 224 (297)
T ss_pred ecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56789999999987766554 999999999999999999997655433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=227.70 Aligned_cols=198 Identities=31% Similarity=0.471 Sum_probs=165.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+.|+..+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+..++.++|||++++.+++.+++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 679999999999999999999998999999998864322 1245788999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
||+.+ ++.+.+.. ..++++..+..++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||.+.... ..
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~---~~ 168 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVS---PA 168 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecC---CC
Confidence 99975 66666643 456899999999999999999999999999999999999987766 9999999875432 22
Q ss_pred CCCcCCccccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 176 KSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
....+...|+|||.+.+ ......++|+||||+++++|++|..||...+.
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 23456778999998742 22234459999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=225.69 Aligned_cols=200 Identities=30% Similarity=0.479 Sum_probs=163.3
Q ss_pred CCCCeeEeeeecCCCceeEEEEE----ecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--Ce
Q 026299 19 DSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 91 (240)
+..+|++++.||+|++|.||.+. +..++..|++|.+..... ..+.+.+|+..++.++||||+++.+++... ..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 34689999999999999999997 345788999998865432 234678999999999999999999987543 46
Q ss_pred EEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
+++++||+++++|.+++.+. ..++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCccccccc
Confidence 89999999999999998654 46899999999999999999999999999999999999987765 9999999987543
Q ss_pred ccCCC----CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 171 LHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 171 ~~~~~----~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
..... ........|+|||.+.+...+.+ +|+||||+++++|+++..|+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChH-HHHHHHHHHHHHHhhcCCcCCC
Confidence 32211 11123346999999877666554 9999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=231.51 Aligned_cols=210 Identities=25% Similarity=0.384 Sum_probs=169.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecC-------CCcEEEEEEeecCc--cccHHHHHHHHHHHhc-CCCCeeeeeEEEEc
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILT 88 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 88 (240)
...+|++.+.||+|+||.||.+++.. .+..+++|.+.... .....+.+|+..++++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 44689999999999999999998643 22368999876532 2235678999999999 79999999999999
Q ss_pred CCeEEEEEecCCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC
Q 026299 89 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (240)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~ 152 (240)
++..++++||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 999999999999999999886432 3677889999999999999999999999999999999987
Q ss_pred CCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 026299 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (240)
Q Consensus 153 ~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 228 (240)
++. ++|+|||.+........ .........|+|||.+.+...+.. +|+||||+++++|++ |..||...+..+.+
T Consensus 170 ~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 170 DNV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred CCc--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 765 99999999864432211 111223457999999987776555 999999999999998 89999877665555
Q ss_pred hhh
Q 026299 229 RKT 231 (240)
Q Consensus 229 ~~~ 231 (240)
..+
T Consensus 247 ~~~ 249 (334)
T cd05100 247 KLL 249 (334)
T ss_pred HHH
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=223.63 Aligned_cols=193 Identities=20% Similarity=0.194 Sum_probs=161.0
Q ss_pred eeecCCCceeEEEEEecCCC----------cEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 27 RDIGSGNFGVARLMRDKKTE----------ELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~----------~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+.||+|++|.||++.+..++ ..+++|.+.........+.+|+..++.++||||+++++++.. ...++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999998766 357888776654445678899999999999999999999988 7789999
Q ss_pred ecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC-----cEEEecCCcccccc
Q 026299 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSKSSV 170 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~-----~~~L~d~~~~~~~~ 170 (240)
||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.. .++|+|||.+....
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 9999999999987655 78999999999999999999999999999999999999866522 49999999986543
Q ss_pred ccCCCCCCcCCccccCccccccC-CCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 223 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 223 (240)
. .....+...|+|||.+.+. ...+.++|+||||+++++|++ |..||...+
T Consensus 160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 160 S---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred c---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 2 2233456679999998776 233455999999999999999 688886664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=225.40 Aligned_cols=206 Identities=24% Similarity=0.296 Sum_probs=169.1
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecC----CCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEc-CC
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PT 90 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~----~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 90 (240)
.+.++|++.+.||+|++|.||++.+.. ++..|++|.+.... ...+.+.+|+..++.++|+||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 466899999999999999999999875 36788999876542 223567889999999999999999998776 46
Q ss_pred eEEEEEecCCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEec
Q 026299 91 HLAIVMEYASGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~--------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d 162 (240)
..+++++++++++|.+++... ..++...++.++.+++.||+|||+.+++|+||+|+||+++.+.. ++++|
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~d 160 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITD 160 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEECC
Confidence 788999999999999988653 35889999999999999999999999999999999999987665 99999
Q ss_pred CCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchh
Q 026299 163 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (240)
Q Consensus 163 ~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (240)
||++........ .....+...|+|||.+.+...+.+ +||||||++++++++ |..||...+..+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~ 227 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFE 227 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHHH
Confidence 999864432211 112234567999999877766555 999999999999998 999997665433
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=229.65 Aligned_cols=195 Identities=29% Similarity=0.434 Sum_probs=156.2
Q ss_pred eeecCCCceeEEEEEecC--CCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEc--CCeEEEEEecCCCC
Q 026299 27 RDIGSGNFGVARLMRDKK--TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGG 102 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~~~~~~~ 102 (240)
..||+|+||.||+|++.. ++..|++|.+.... ....+.+|+.+++.++||||+++++++.. +...++++||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 579999999999999764 56789999876543 34567889999999999999999999854 4678999999876
Q ss_pred chHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC--CCCcEEEecCCccccccc
Q 026299 103 ELFERICN---------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 103 ~l~~~l~~---------~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~--~~~~~~L~d~~~~~~~~~ 171 (240)
+|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||++..+ ..+.++|+|||++.....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence 66666532 1247889999999999999999999999999999999999432 233599999999864432
Q ss_pred cCC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 172 ~~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
... .....++..|+|||.+.+....+.++||||||+++++|++|..||....
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 221 1233567889999998776555566999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=225.28 Aligned_cols=202 Identities=25% Similarity=0.392 Sum_probs=161.8
Q ss_pred eeEeeeecCCCceeEEEEEecCCCc--EEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC------Ce
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------TH 91 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~--~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 91 (240)
+.+.+.||+|++|.||++.+..++. .+++|.+.... ...+.+.+|+..++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999887665 68999876542 2235678899999999999999999987532 24
Q ss_pred EEEEEecCCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCc
Q 026299 92 LAIVMEYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~------~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~ 165 (240)
.+++++|+.+++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence 6899999999999887742 234789999999999999999999999999999999999987665 99999999
Q ss_pred cccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026299 166 SKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (240)
Q Consensus 166 ~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (240)
+........ ......+..|++||.+.+...+.. +|+||||+++|+|++ |..||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~ 223 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEI 223 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 865433221 122234567999999887766555 999999999999999 8899977555443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=234.73 Aligned_cols=210 Identities=30% Similarity=0.455 Sum_probs=185.0
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..+.|++-+.||+|+||.|+-++...+|+-||.|.+.+- ...+.-.++|-.+|.++..+.||.+--.|...+.+|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 347889999999999999999999999999999987542 1223456899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
|+..+.||.|.-.+.+.+ -+++..+..++.+|+.+|+.||+.+||.||++|+||++|+.++ ++|+|+|+|....-+
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g 340 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEG 340 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCC
Confidence 999999999976665443 6999999999999999999999999999999999999987776 999999999988888
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
.+.....|+.+|||||++.+..++.. .|+|||||++|+|+.|+.||....+....+++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv 398 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV 398 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHH
Confidence 88888899999999999988886555 99999999999999999999987776655443
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=232.60 Aligned_cols=200 Identities=27% Similarity=0.493 Sum_probs=177.4
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (240)
.-|.++.+||+|++|.||++.++.+|+.++||.+..+.. ...+..|+.++++++.|+++++||.+.....+|+|||||.
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 457889999999999999999999999999999877543 4567899999999999999999999999999999999999
Q ss_pred CCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cCCCCCC
Q 026299 101 GGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKST 178 (240)
Q Consensus 101 ~~~l~~~l~-~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~~~~~~ 178 (240)
.|++.+++. +++++++.++..+++.-+++|+|||...-+|+||+..||+++-++. .+|+|||++..... -.....-
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhCcc
Confidence 999999885 5678999999999999999999999999999999999999976665 89999999854332 2344566
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.|++.|||||++..-.+.+. +||||||++.++|..|..||.+-..
T Consensus 190 IGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHP 234 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHP 234 (502)
T ss_pred ccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccc
Confidence 79999999999988888777 9999999999999999999987544
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=223.75 Aligned_cols=208 Identities=26% Similarity=0.365 Sum_probs=168.5
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCC---CcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
..++|++.+.||.|++|.||++.+... ...+++|...... ...+.+.+|+..++.++||||+++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 457899999999999999999987643 4568999876543 233568899999999999999999999876 4567
Q ss_pred EEEecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
+++||+++++|.+++.+.. .++...+..++.+++.|+++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~ 160 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeecccc
Confidence 9999999999999987643 5899999999999999999999999999999999999987665 999999987644322
Q ss_pred CCC--CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 173 SQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 173 ~~~--~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
... ........|+|||.+.....+.. +|+||||++++++++ |..||...+......+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~ 220 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR 220 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 111 11223457999998876666554 999999999999986 9999987765554433
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=226.55 Aligned_cols=208 Identities=35% Similarity=0.538 Sum_probs=176.0
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC---ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
|++.+.||+|++|.+|++++..+++.+++|.+... ....+.+.+|+..++.++|+|++++.+++.+....++++|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67889999999999999999999999999998764 233456778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCCC
Q 026299 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (240)
Q Consensus 100 ~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~~ 177 (240)
++ +|.+++.+. ..++...+..++.+++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCc
Confidence 75 899988765 57999999999999999999999999999999999999987665 9999999886443322 1122
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
......|+|||.+.+....+.++|+||||++++++++|..||...+..+.+.++.+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 213 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH
Confidence 33466799999987764445559999999999999999999988887766665543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=232.96 Aligned_cols=208 Identities=32% Similarity=0.486 Sum_probs=171.5
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC---ccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcC--CeEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTP--THLA 93 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 93 (240)
.++|++.+.||.|++|.||++.+..++..+++|.+... ......+.+|+..++++ +|+||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 37899999999999999999999988999999987542 22234567899999999 999999999998654 4689
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
+|+|++++ +|.+++.+. .+++.....++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 86 lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELE 161 (337)
T ss_pred EEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhcccccc
Confidence 99999975 888877655 7788999999999999999999999999999999999987776 9999999886443322
Q ss_pred C------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 174 Q------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 174 ~------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
. .....++..|+|||.+.+......++|+||||+++++|++|..||......+...++
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~ 225 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI 225 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 1 122346778999998876655556699999999999999999999877666554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=222.32 Aligned_cols=195 Identities=30% Similarity=0.557 Sum_probs=161.8
Q ss_pred CCeeEeeee--cCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDI--GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l--~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++.+.+ |.|++|.||++.+..++..+++|.+....... .|......+ +|+|++++++.+...+..++|||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 466676666 99999999999999999999999886543211 122222222 69999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~ 177 (240)
|+++++|.+++.+...+++..+..++.|+++|+.+||+.|++|+||+|+||+++.++. .++|+|||.+.... ....
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~~l~dfg~~~~~~---~~~~ 165 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD-RIYLCDYGLCKIIG---TPSC 165 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC-eEEEecCccceecC---CCcc
Confidence 9999999999987778999999999999999999999999999999999999987661 39999999876432 2223
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
..++..|+|||.+.+...+.+ +|+||||+++++|++|..||.....
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~ 211 (267)
T PHA03390 166 YDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDED 211 (267)
T ss_pred CCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCc
Confidence 456788999999987776554 9999999999999999999976543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=223.57 Aligned_cols=206 Identities=33% Similarity=0.530 Sum_probs=169.2
Q ss_pred CeeEeeeecCCCceeEEEEEecC-CCcEEEEEEeecCc-----------cccHHHHHHHHHHHh-cCCCCeeeeeEEEEc
Q 026299 22 RYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD-----------KIDENVQREIINHRS-LRHPNIVRFKEVILT 88 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~-~~~~v~iK~~~~~~-----------~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 88 (240)
.|++.+.||.|++|.||++.+.. ++..+++|.+.... ....++.+|+..+.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 68889999875421 111345677776754 689999999999999
Q ss_pred CCeEEEEEecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcEEEecC
Q 026299 89 PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDF 163 (240)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~~L~d~ 163 (240)
++..++++||+++++|.+++.. ...+++..++.++.|++.++.+||+ .|++|+||+|+||+++.++. ++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence 9999999999999999887743 3468999999999999999999995 78999999999999987765 999999
Q ss_pred CccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhh
Q 026299 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (240)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (240)
|.+.............++..|++||.+.+...+.. +|+||||+++|+|++|..||...+.......
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~ 224 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSLATK 224 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcccccCHHHHHHH
Confidence 99875544433344557788999999987666444 9999999999999999999977655444333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=219.86 Aligned_cols=199 Identities=27% Similarity=0.366 Sum_probs=163.1
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCch
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
+.||+|++|.||++... ++..+++|.+..... ....+.+|+..++.++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999865 678899998765432 234678999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC--CCCcCC
Q 026299 105 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGT 181 (240)
Q Consensus 105 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~--~~~~~~ 181 (240)
.+++... ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+......... ......
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence 9988653 45789999999999999999999999999999999999987665 999999987543222111 112234
Q ss_pred ccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 026299 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (240)
Q Consensus 182 ~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (240)
..|+|||.+.+...+.+ +|+||||++++++++ |..||..........
T Consensus 158 ~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~ 205 (250)
T cd05085 158 IKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQARE 205 (250)
T ss_pred ccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 57999999877666555 999999999999998 999997765544433
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=221.14 Aligned_cols=200 Identities=30% Similarity=0.411 Sum_probs=165.9
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
..++|++.+.||.|++|.||.+.. ++..+++|.+..+. ..+.+.+|+..++.++|||++++++++..+ ..++++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 447899999999999999998864 67789999876543 346788999999999999999999998764 57899999
Q ss_pred CCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 99 ~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
+++++|.+++.... .++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+...... ..
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~--~~ 155 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG--VD 155 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc--CC
Confidence 99999999986543 4789999999999999999999999999999999999987665 999999988643221 12
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (240)
.......|+|||.+.+...+.. +|+||||+++++|++ |..||...+....
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 206 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEV 206 (254)
T ss_pred CCCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHHH
Confidence 2334567999999877666554 999999999999997 9999977665443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=225.96 Aligned_cols=205 Identities=27% Similarity=0.445 Sum_probs=167.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
+.++|++.+.||.|++|.||++.+.. ++..+++|.+..... ....+.+|+..++.++||||+++++++.++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 34789999999999999999999753 578899998865432 23567889999999999999999999999899
Q ss_pred EEEEEecCCCCchHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeE
Q 026299 92 LAIVMEYASGGELFERICNA----------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~----------------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nil 149 (240)
.++++||+++++|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 99999999999999988643 23678889999999999999999999999999999999
Q ss_pred EcCCCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCch
Q 026299 150 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (240)
Q Consensus 150 i~~~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (240)
++.++. ++|+|||.+........ .........|+|||.+.+...+.. +|+||||+++++|++ |..||.+....
T Consensus 163 ~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 163 VGENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred ecCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 987665 99999998764332211 112233557999999877766554 999999999999997 88898665443
Q ss_pred h
Q 026299 226 K 226 (240)
Q Consensus 226 ~ 226 (240)
+
T Consensus 240 ~ 240 (288)
T cd05050 240 E 240 (288)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=231.27 Aligned_cols=204 Identities=25% Similarity=0.418 Sum_probs=163.8
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEec-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHHhc-CCCCeeeeeEEEEcC
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 89 (240)
...++|++.+.||.|+||.||+|++. .++..|++|.+..... ....+.+|+..+..+ +|+||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 45578999999999999999999853 4578899999875432 224578899999999 689999999988654
Q ss_pred -CeEEEEEecCCCCchHHHHHhc---------------------------------------------------------
Q 026299 90 -THLAIVMEYASGGELFERICNA--------------------------------------------------------- 111 (240)
Q Consensus 90 -~~~~lv~~~~~~~~l~~~l~~~--------------------------------------------------------- 111 (240)
...++++||+++++|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 5678999999999999887532
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC---CCCC
Q 026299 112 ----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 178 (240)
Q Consensus 112 ----------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~---~~~~ 178 (240)
..++...+..++.|+++||+|||+.|++|+||+|+||+++.++. ++|+|||.+........ ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCC
Confidence 13567788889999999999999999999999999999987665 99999998864322211 1112
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCc
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE 224 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 224 (240)
.++..|+|||.+.+...+.+ +|+||||+++++|++ |..||.....
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~ 287 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKI 287 (343)
T ss_pred CCCcceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccc
Confidence 23457999999877766555 999999999999997 9999976544
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=251.45 Aligned_cols=209 Identities=27% Similarity=0.417 Sum_probs=179.9
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCc-----EEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (240)
.+.+.-++.+.||+|+||.||.+....... .|++|.+.... ....+|++|..+++.++||||++++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 456888999999999999999999885543 38999887753 33467999999999999999999999999999
Q ss_pred eEEEEEecCCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecC
Q 026299 91 HLAIVMEYASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~ 163 (240)
..++++|||.||.|..++.+. ..++..++..++.+|++|..||+++.+||+||..+|.|++.... +|++||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKIaDF 846 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKIADF 846 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEEccc
Confidence 999999999999999999866 24899999999999999999999999999999999999987765 999999
Q ss_pred CccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 026299 164 GYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (240)
Q Consensus 164 ~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (240)
|+|+...... ..........|||||.+.+..++++ +||||||+++||+++ |..||.+.+..+.+.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~ 915 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLL 915 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHH
Confidence 9998332211 1111223468999999999888777 999999999999999 999999998887765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=220.00 Aligned_cols=201 Identities=39% Similarity=0.649 Sum_probs=172.1
Q ss_pred ecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCch
Q 026299 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
||.|++|.+|.+.+..+++.+++|.+..... ....+.+|+..++.++|+|++++++.+..+...+++||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999998899999999876533 234678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCCCcCCcc
Q 026299 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 183 (240)
Q Consensus 105 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~~~~~~~ 183 (240)
.+++.....+++..+..++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+...... .......+...
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence 999988778999999999999999999999999999999999999987765 999999998654433 22334456778
Q ss_pred ccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 184 ~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
|++||...+...+.. +|+||||++++++++|..||...+......++.
T Consensus 159 ~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 206 (250)
T cd05123 159 YLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL 206 (250)
T ss_pred ccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 999999877766554 999999999999999999998776555444443
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=236.35 Aligned_cols=206 Identities=27% Similarity=0.388 Sum_probs=167.9
Q ss_pred CCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeec---CccccHHHHHHHHHHHhcC-CCCeeeeeEEEEc
Q 026299 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLR-HPNIVRFKEVILT 88 (240)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 88 (240)
+.-+..+...|+++++||+||.+.||++.....+. |++|++.. ++.....+.+|+..|.+++ |.+|+++++|-..
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~i-yalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQI-YALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcc-hhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 34455677899999999999999999999885544 56665544 3344467899999999995 7999999999999
Q ss_pred CCeEEEEEecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 89 PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
++++|+|||+= ...|..++.... ..+...++.++.|++.|+.++|+.||||.||+|.|+++-.+ .+||+|||+|.
T Consensus 432 d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG---~LKLIDFGIA~ 507 (677)
T KOG0596|consen 432 DGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG---RLKLIDFGIAN 507 (677)
T ss_pred CceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee---eEEeeeechhc
Confidence 99999999973 458888886554 35556999999999999999999999999999999999533 49999999997
Q ss_pred cccccC---CCCCCcCCccccCccccccCCCC----------CcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 168 SSVLHS---QPKSTVGTPAYIAPEVLLKKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 168 ~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~----------~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
...... -..+..|+..||+||.+.....+ .+++|||||||+||+|+.|..||..-.
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 655443 33567899999999998644322 344999999999999999999997643
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=226.50 Aligned_cols=200 Identities=26% Similarity=0.368 Sum_probs=164.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|+..+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..+.++. |+||+++++++..+...+++++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 56778889999999999999999999999999887543 22346788999998886 9999999999999888999999
Q ss_pred cCCCCchHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHhhC-CceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 98 YASGGELFERI---C--NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 98 ~~~~~~l~~~l---~--~~~~l~~~~~~~~~~~i~~~l~~LH~~-~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
++.. ++.++. . ....+++..+..++.+++.||+|||+. +++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhcc
Confidence 9864 554432 1 235689999999999999999999975 9999999999999987665 99999999865444
Q ss_pred cCCCCCCcCCccccCccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
........++..|+|||.+.+. ...+.++|+||||+++++|++|..||....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 4333444567889999998776 234455999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=230.67 Aligned_cols=210 Identities=33% Similarity=0.452 Sum_probs=169.7
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC---------
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP--------- 89 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------- 89 (240)
..+|++.+.||.|++|.||++.+..++..|++|.+..... ..+.+.+|+..++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 4899999999999999999999999999999998866433 235678899999999999999999876543
Q ss_pred -----CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 90 -----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 90 -----~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
...++++||+++ +|.+++. ...+++..++.++.|++.|+++||+.|++|+||+|+||+++.++. .++|+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFG 160 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcc
Confidence 357899999975 8887774 346899999999999999999999999999999999999974432 38999999
Q ss_pred ccccccccCC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 165 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 165 ~~~~~~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
.+........ .....++..|+|||.+.+......++|+||||+++++|++|..||...+......+++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 8864322111 1223456789999987665545556999999999999999999998776655554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=232.26 Aligned_cols=213 Identities=26% Similarity=0.430 Sum_probs=175.6
Q ss_pred cccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
......++|++.+.||.|++|.||++++..++..|++|.+.... .....+.+|+..++.++|+|++++.+++.....
T Consensus 9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 34445688999999999999999999999999999999876532 223456789999999999999999988776554
Q ss_pred ------EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCc
Q 026299 92 ------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (240)
Q Consensus 92 ------~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~ 165 (240)
.++|++++ +++|.+++.. ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|||.
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~ 164 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGL 164 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEccccc
Confidence 89999998 5588887754 56899999999999999999999999999999999999987665 99999999
Q ss_pred cccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
+...... .....++..|+|||.+.+....+.++|+||||+++++|++|..||.+.+....+.++++
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 230 (343)
T cd07851 165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230 (343)
T ss_pred ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 8654322 23345677899999986644445559999999999999999999988877666665554
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=224.92 Aligned_cols=201 Identities=30% Similarity=0.490 Sum_probs=168.5
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecC----CCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEc--CC
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILT--PT 90 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 90 (240)
..+.|++.+.||+|++|.||+++... ++..+++|.+...... ...+.+|+..++.++|+||+++++++.. ..
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 34688999999999999999999653 4789999998766543 5678999999999999999999999887 55
Q ss_pred eEEEEEecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 91 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
..++++||+++++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~ 159 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVL 159 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEccccccccc
Confidence 7899999999999999987654 5899999999999999999999999999999999999987765 999999998655
Q ss_pred cccCCC----CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 170 VLHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 170 ~~~~~~----~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
...... ........|++||.+.+...+.. +|+||||+++++|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccc
Confidence 422111 11233456999999877766555 99999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=247.45 Aligned_cols=210 Identities=28% Similarity=0.416 Sum_probs=179.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
.+-++.+.||+|+||+||+++... ....|+||.++..... ..+|++|++.+..++|||||+++|+|..++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 566888999999999999999763 3568999988775433 468999999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEE
Q 026299 94 IVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~--------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~ 159 (240)
+|+||+..|.|.++|... .+|+..+...++.||+.|++||-+..+||+||-++|.+|+++.. +|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VK 643 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VK 643 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--EE
Confidence 999999999999998532 12888999999999999999999999999999999999988777 99
Q ss_pred EecCCccccccccCCC---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 160 ICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 160 L~d~~~~~~~~~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
++|||+++..-...=. ....-..+|||||.+..+.+++. +||||+|++|||+++ |..||.+..+.+.++.+-+
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 9999998744322111 11224568999999999999888 999999999999998 9999999999888776543
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=245.75 Aligned_cols=210 Identities=29% Similarity=0.429 Sum_probs=181.4
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
+.|.++..||.|+||.||+|.+..++-..+-|++.-.. ...++++-|+++|..+.||+|+++++.|..++.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 56788999999999999999999998888888876533 33367899999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc-ccCCCCC
Q 026299 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKS 177 (240)
Q Consensus 100 ~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~-~~~~~~~ 177 (240)
.||-+..++.+ ...|++..+.-+++|+++||.|||+.+|+|+||+..||++..++. ++|+|||++.... ......+
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhcc
Confidence 99999887765 467999999999999999999999999999999999999998888 9999999975322 2344567
Q ss_pred CcCCccccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 178 TVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
+.|+++|||||+... ...+..++||||||++|++|..+..|-+..+....+.+|-
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia 248 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 248 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh
Confidence 889999999998742 2334445999999999999999999998888887777664
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=221.23 Aligned_cols=202 Identities=37% Similarity=0.563 Sum_probs=172.1
Q ss_pred CCCCCeeEee-eecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcC----Ce
Q 026299 18 HDSDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP----TH 91 (240)
Q Consensus 18 ~~~~~y~~~~-~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~ 91 (240)
...++|++-. .||-|-.|.|-.+.++.+++++|+|++.. .....+|++.+... .||||+.+++++.+. ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 3446776654 68999999999999999999999997643 35577899888766 599999999998764 46
Q ss_pred EEEEEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCCcccc
Q 026299 92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKS 168 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~~ 168 (240)
+.+|||.++||.|...++..+ .+++.++-.|+.||..|++|||+.+|.||||+|+|+|+.... +..+||+|||++..
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 789999999999999887665 599999999999999999999999999999999999995332 23499999999987
Q ss_pred ccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
........+...+++|.|||++....++ +..|+||||+++|-|++|..||.+...
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred cCCCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCC
Confidence 7777777778889999999999766654 449999999999999999999988654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=227.32 Aligned_cols=227 Identities=26% Similarity=0.370 Sum_probs=185.4
Q ss_pred CCCCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhc-CCCCeeeeeEE
Q 026299 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEV 85 (240)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~ 85 (240)
.|..+....+..+..+-+..||.|+||.|++..+..+|...|||++..... ...+++.|++...+. .+|||++++|.
T Consensus 52 ~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 52 LPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cCCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 455555555666777888899999999999999999999999999977543 335677888666555 68999999999
Q ss_pred EEcCCeEEEEEecCCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcEE
Q 026299 86 ILTPTHLAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLK 159 (240)
Q Consensus 86 ~~~~~~~~lv~~~~~~~~l~~~l~-----~~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~~ 159 (240)
+..++..|+.||.++- |+..+.. ....++++.+-.+.-..+.||+||-+ ..|+|+|++|+||+++..+. +|
T Consensus 132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VK 208 (361)
T ss_pred hhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--Ee
Confidence 9999999999999965 6655432 34568999999999999999999985 58999999999999987766 99
Q ss_pred EecCCccccccccCCCCCCcCCccccCccccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceecee
Q 026299 160 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCT 238 (240)
Q Consensus 160 L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (240)
|+|||.+.............|..-|+|||.+..... +.-++|+||||+++||+.||..||...+. .++++..+++|-
T Consensus 209 LCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gd 286 (361)
T KOG1006|consen 209 LCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGD 286 (361)
T ss_pred eecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCC
Confidence 999999876655555566678888999999965543 34449999999999999999999876554 888888888887
Q ss_pred eC
Q 026299 239 FS 240 (240)
Q Consensus 239 ~~ 240 (240)
||
T Consensus 287 pp 288 (361)
T KOG1006|consen 287 PP 288 (361)
T ss_pred CC
Confidence 65
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=228.09 Aligned_cols=209 Identities=30% Similarity=0.453 Sum_probs=169.6
Q ss_pred CeeEeeeecCCCceeEEEEEecCC--CcEEEEEEeecCc---cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcC----Ce
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTP----TH 91 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~--~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~ 91 (240)
+|++.+.||.|++|.||++++..+ +..|++|.+.... .....+.+|+..++++ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999987 8999999876532 1234677899999988 599999999875432 45
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
.+++++++. ++|.+++.....+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence 788899886 488888877788999999999999999999999999999999999999987765 99999999864432
Q ss_pred cCC-----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 172 HSQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 172 ~~~-----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
... .....++..|+|||.+.+......++|+||||+++++|++|..||...+....+.+++.
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~ 224 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHH
Confidence 211 12235678899999887654445559999999999999999999988776555554443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=218.42 Aligned_cols=196 Identities=28% Similarity=0.381 Sum_probs=163.3
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCch
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
+.||.|++|.||++.+.. +..|++|.+..... ....+.+|+..+++++|+||+++++++.+....++++|++++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 468999999999999987 89999998876433 345788999999999999999999999999999999999999999
Q ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC---CCCcC
Q 026299 105 FERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 180 (240)
Q Consensus 105 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~---~~~~~ 180 (240)
.+++.. ...++...+..++.+++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+......... .....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcc
Confidence 998865 346889999999999999999999999999999999999987665 999999988644321111 11223
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchh
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (240)
...|+|||.+.+...+.. +|+||||+++++|++ |..||.......
T Consensus 158 ~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~ 203 (251)
T cd05041 158 PIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQ 203 (251)
T ss_pred eeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCHHH
Confidence 456999999877766544 999999999999998 889987765443
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=225.72 Aligned_cols=202 Identities=30% Similarity=0.480 Sum_probs=167.8
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC---ccccHHHHHHHHHHHhcCCCCeeeeeEEEEc-CCeEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLA 93 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 93 (240)
...++|++.+.||.|++|.||++.+..++..|++|.+... ......+.+|+..++.++|||++++.+++.. +...+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3457899999999999999999999999999999987542 2234567889999999999999999999875 46788
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
+++++++ ++|.+++.. ..++...+..++.|+++||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 87 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~~-- 160 (328)
T cd07856 87 FVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQDP-- 160 (328)
T ss_pred EEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCccccccccCC--
Confidence 9999985 588877753 45788889999999999999999999999999999999987665 99999998764322
Q ss_pred CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
......+...|+|||.+.+....+.++|+||||+++++|++|..||...+..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~ 212 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 2223456778999998866444455699999999999999999999876543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=223.31 Aligned_cols=202 Identities=17% Similarity=0.184 Sum_probs=154.3
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCC---CcEEEEEEeecCcccc--H----------HHHHHHHHHHhcCCCCeeeee
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKID--E----------NVQREIINHRSLRHPNIVRFK 83 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~--~----------~~~~e~~~l~~l~h~~i~~~~ 83 (240)
..++|++.+.||+|+||.||++.+..+ +..+++|......... + ....++..+..+.|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 447999999999999999999998877 6677777543322110 0 112233444566899999999
Q ss_pred EEEEcCC----eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEE
Q 026299 84 EVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (240)
Q Consensus 84 ~~~~~~~----~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~ 159 (240)
+.+.... ..+++++++.. ++.+.+......++..+..++.|++.|++|||+.+++||||+|+||+++.+.. ++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~~ 166 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GY 166 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--EE
Confidence 8766543 34677777643 66666665555688899999999999999999999999999999999976665 99
Q ss_pred EecCCccccccccC--------CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 160 ICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 160 L~d~~~~~~~~~~~--------~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
|+|||++....... ......+++.|+|||...+...+.+ +||||||+++++|++|..||.....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99999986443211 1122357889999999887776554 9999999999999999999987743
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=243.65 Aligned_cols=196 Identities=25% Similarity=0.422 Sum_probs=152.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCC-cEE------------------EEEEeecCccccHHHHHHHHHHHhcCCCCeee
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTE-ELV------------------AVKYIERGDKIDENVQREIINHRSLRHPNIVR 81 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~-~~v------------------~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 81 (240)
++|++++.||+|+||.||++...... ... +.|.+.........+.+|+.+++.++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 58999999999999999998765322 111 12222222233345789999999999999999
Q ss_pred eeEEEEcCCeEEEEEecCCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC
Q 026299 82 FKEVILTPTHLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (240)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~ 156 (240)
+++++.+.+..+++++++.+ .+.+++... .......+..++.|++.||+|||+.||+|+||+|+||+++.++.
T Consensus 228 l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~- 305 (501)
T PHA03210 228 IEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK- 305 (501)
T ss_pred EeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-
Confidence 99999999999999999865 666665432 12345678889999999999999999999999999999987765
Q ss_pred cEEEecCCccccccccCC--CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026299 157 RLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (240)
Q Consensus 157 ~~~L~d~~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (240)
++|+|||++........ .....++..|+|||.+.+..++.. +||||||+++|+|++|..++.
T Consensus 306 -vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 306 -IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred -EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCc
Confidence 99999999865433222 223467899999999988776555 999999999999999876543
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=222.63 Aligned_cols=200 Identities=27% Similarity=0.409 Sum_probs=162.2
Q ss_pred eeecCCCceeEEEEEecCCC------cEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 27 RDIGSGNFGVARLMRDKKTE------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~------~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+.||.|++|.||++++.... ..+++|.+.... .....+.+|+..++.++||||+++++++......++++|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999986443 679999876543 2345688999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC---CCcEEEecCCcccc
Q 026299 99 ASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKS 168 (240)
Q Consensus 99 ~~~~~l~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~---~~~~~L~d~~~~~~ 168 (240)
+++++|.+++... ..++...+..++.|++.++.|||+.+++|+||+|+||+++.+. ...++|+|||.+..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999988642 2377899999999999999999999999999999999998655 12499999998864
Q ss_pred ccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026299 169 SVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (240)
Q Consensus 169 ~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (240)
..... .......+..|+|||.+.+...+.+ +|+||||+++++|++ |..||...+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~~ 222 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQEV 222 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHHHHHcCCCCCcccCHHHH
Confidence 32221 1122234568999999987776554 999999999999998 9999976654443
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=218.36 Aligned_cols=202 Identities=32% Similarity=0.468 Sum_probs=166.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
+.......||+|++|.||++.+..++..|++|.+..... ..+.+.+|+..++.++|+||+++++++..++..++++||+
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 344445689999999999999998999999998765432 3356889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-C
Q 026299 100 SGGELFERICNA-GRF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (240)
Q Consensus 100 ~~~~l~~~l~~~-~~l--~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~ 175 (240)
++++|.+++... .++ +...+..++.|++.|+.+||+.|++|+||+|+||+++.+. ..++|+|||.+........ .
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCCcc
Confidence 999999988754 445 7888999999999999999999999999999999997533 2499999998864432221 2
Q ss_pred CCCcCCccccCccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 176 KSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
....++..|+|||.+.+.. ....++|+||||+++++|++|..||....
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 2334678899999986543 23455999999999999999999997543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=224.79 Aligned_cols=202 Identities=23% Similarity=0.383 Sum_probs=164.6
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCc----EEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
+..++|+..+.||+|++|.||++.+..++. .+++|.+...... ...+.+|+..++.++||||+++++++... .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 355789999999999999999999877665 4688877654321 23577899999999999999999998754 4
Q ss_pred EEEEEecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
.+++++++++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~ 160 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLE 160 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEcccccccccc
Confidence 678999999999999886543 6889999999999999999999999999999999999977665 9999999986543
Q ss_pred ccCCC---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 026299 171 LHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 223 (240)
Q Consensus 171 ~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 223 (240)
..... .....+..|++||.+.+...+.+ +|+||||+++|+|++ |..||.+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22211 12234568999999877666555 999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=223.39 Aligned_cols=202 Identities=29% Similarity=0.458 Sum_probs=167.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
..|+..+.||+|++|.+|++++..++..+++|.+...... ...+.+|+..++.++|+|++++++++.++...++|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4588999999999999999999989999999988653221 235778999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
||+.+ ++.+.+.. ..++++..+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+.... ..
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~---~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIAS---PA 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccC---Cc
Confidence 99976 67666643 456899999999999999999999999999999999999987665 9999999875332 22
Q ss_pred CCCcCCccccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 176 KSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
....++..|+|||.+.. ......++|+||||+++++|++|..||...+....+
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~ 233 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 233 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 33456778999999742 222344599999999999999999999776544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=219.14 Aligned_cols=194 Identities=22% Similarity=0.248 Sum_probs=156.0
Q ss_pred eeecCCCceeEEEEEecC------------CCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 27 RDIGSGNFGVARLMRDKK------------TEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~------------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
+.||.|++|.||+++... ....+++|.+..... ....+.+|...++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998643 233588887655332 2246778889999999999999999999988899
Q ss_pred EEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCC-----CcEEEecCCccc
Q 026299 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-----PRLKICDFGYSK 167 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~-----~~~~L~d~~~~~ 167 (240)
+++||+++++|..++.. ..++++..++.++.|++.|++|||+.|++|+||+|+||+++.++. ..++++|||.+.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 99999999999888765 356899999999999999999999999999999999999975442 138999999875
Q ss_pred cccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHH-hCCCCCCCCC
Q 026299 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPE 223 (240)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~ 223 (240)
.... .....++..|+|||.+.+....+.++||||||+++|+|+ .|..||....
T Consensus 161 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 161 TVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred cccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 4322 122345678999998875554455599999999999998 5888886544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=228.14 Aligned_cols=207 Identities=29% Similarity=0.469 Sum_probs=169.4
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC------C
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 90 (240)
..+|.+.+.||.|++|.||+|++..+++.|++|.+.... .....+.+|+..++.++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999999899999999886532 2234578899999999999999999998754 2
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
.++++++++.. ++..+. ...++...+..++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 94 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHAD 168 (342)
T ss_pred eEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCC
Confidence 46899999864 666544 335899999999999999999999999999999999999987665 9999999976432
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
. ......++..|+|||.+.+....+.++|+||||+++++|++|..||...+....+.+++.
T Consensus 169 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~ 229 (342)
T cd07879 169 A--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229 (342)
T ss_pred C--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2 222334567899999987654445559999999999999999999998776666555544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=223.57 Aligned_cols=200 Identities=28% Similarity=0.460 Sum_probs=168.1
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCC
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (240)
.|+....||.|++|.||++.+..++..+++|.+..... ....+.+|+..++.++|+|++++++.+..++..+++|||++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 34445789999999999999999999999998754332 23467889999999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCCCCc
Q 026299 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 179 (240)
Q Consensus 101 ~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~~~~ 179 (240)
+++|.+++. ...+++..+..++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||.+....... ......
T Consensus 101 ~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 101 GGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccccccc
Confidence 999998774 446899999999999999999999999999999999999987765 9999999876443222 122344
Q ss_pred CCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 180 ~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
++..|++||.+.+...+. ++|+||||+++++|++|..||......
T Consensus 178 ~~~~y~~pE~~~~~~~~~-~~Dv~slGvil~el~tg~~p~~~~~~~ 222 (292)
T cd06657 178 GTPYWMAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPYFNEPPL 222 (292)
T ss_pred cCccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 677899999987766654 499999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=241.33 Aligned_cols=198 Identities=33% Similarity=0.543 Sum_probs=170.8
Q ss_pred eecCCCceeEEEEEecCCCcEEEEEEeecC-ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCchHH
Q 026299 28 DIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 106 (240)
Q Consensus 28 ~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~ 106 (240)
.||+|.+|+||-+++..+...++||-+... +....-..+|+..++.++|.||++++|.+..++++-+.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 589999999999999999999999987654 3334557899999999999999999999999999999999999999999
Q ss_pred HHHhc-CCC--CHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc-cccCCCCCCcCCc
Q 026299 107 RICNA-GRF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVGTP 182 (240)
Q Consensus 107 ~l~~~-~~l--~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~-~~~~~~~~~~~~~ 182 (240)
.+... +|+ ++..+-.+.+||++||.|||+..|||+||+-+|++++ ...+.+|+.|||-+.+. .......++.|+.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN-TySGvlKISDFGTsKRLAginP~TETFTGTL 740 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN-TYSGVLKISDFGTSKRLAGINPCTETFTGTL 740 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe-eccceEEecccccchhhccCCccccccccch
Confidence 88644 466 8899999999999999999999999999999999996 33345999999988543 3445556788999
Q ss_pred cccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 183 AYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 183 ~~~~pE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
-|||||++..+ ..+.+++|||||||++.+|.||+.||.....+.
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq 785 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ 785 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh
Confidence 99999999655 456777999999999999999999998776543
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=220.97 Aligned_cols=194 Identities=23% Similarity=0.252 Sum_probs=155.8
Q ss_pred eecCCCceeEEEEEecC------------------------CCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeee
Q 026299 28 DIGSGNFGVARLMRDKK------------------------TEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRF 82 (240)
Q Consensus 28 ~l~~g~~g~v~~~~~~~------------------------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~ 82 (240)
.||+|+||.||++.... ....|++|.+..... ....+.+|..+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 68999999999997532 234688888765322 23467788899999999999999
Q ss_pred eEEEEcCCeEEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-----CC
Q 026299 83 KEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-----AP 156 (240)
Q Consensus 83 ~~~~~~~~~~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-----~~ 156 (240)
++++..+...++||||+++++|..++.. .+.++...+..++.|++.|++|||+.|++|+||+|+||+++..+ .+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 9999999999999999999999988865 45689999999999999999999999999999999999997543 22
Q ss_pred cEEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHH-hCCCCCCCCCc
Q 026299 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEE 224 (240)
Q Consensus 157 ~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~ 224 (240)
.+++.|||.+..... .....++..|+|||.+.+......++|+||||+++++|+ +|..||.....
T Consensus 162 ~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 162 FIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred eeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 479999998643321 122345677999998876544455599999999999985 69999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=239.28 Aligned_cols=212 Identities=29% Similarity=0.496 Sum_probs=194.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeec----CccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++++++.-||-|+||.|=+++..+....+|+|.+++ +....+....|-.++..++.|.|+++|..|.++.+.|.+|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 677888899999999999999887777789998876 3455577888999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
|-|=||.+...+...+.+++...+.++.++++|++|||++|||.+||+|+|.+++.++- +||.|||++.....+....
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KTw 577 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKTW 577 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCcee
Confidence 99999999999998899999999999999999999999999999999999999987766 9999999999999999999
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
++.|++.|.|||++.+...+.. .|.||||+++|+|++|..||.+.+...++..|++.+
T Consensus 578 TFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi 635 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI 635 (732)
T ss_pred eecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh
Confidence 9999999999999988887666 999999999999999999999999999998888754
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=221.44 Aligned_cols=203 Identities=30% Similarity=0.449 Sum_probs=167.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+.|...+.||.|++|.||++++..++..|++|.+...... ...+.+|+..++.++|||++++++++.+....++++
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 3477788899999999999999999999999998653221 235678999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
||+.+ ++.+.+.. ..++++..+..++.|++.++.|||+.|++|+||+|+||+++.++. ++|+|||.+... ...
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~---~~~ 174 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKS---SPA 174 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCccc---CCC
Confidence 99965 66666654 457899999999999999999999999999999999999987665 999999987532 222
Q ss_pred CCCcCCccccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 026299 176 KSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (240)
....++..|+|||.+.. ......++|+||||+++++|++|..||...+......
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~ 230 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 34457788999999853 2223445999999999999999999997766544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=233.80 Aligned_cols=209 Identities=34% Similarity=0.536 Sum_probs=178.0
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+-|..++.||-|+||+|.+++...+...|+.|.+.+.+-. ....+.|-.+|..-..+.+|+++-.|.+++++|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 5688999999999999999999999999999998764322 245677888888889999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc----
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 172 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~---- 172 (240)
+|++||.+-.+|.+-+-+.+....+++.++..|+++.|..|++|+||+|+|||||.+++ +||.|||+++..-..
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceeccccc
Confidence 99999999999988888999999999999999999999999999999999999988877 999999998421100
Q ss_pred ----CCC-----------------------------------CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHH
Q 026299 173 ----SQP-----------------------------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213 (240)
Q Consensus 173 ----~~~-----------------------------------~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~ 213 (240)
..+ ...+|+..|+|||++.+..++.. +|+||.|++|++|+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHHh
Confidence 000 01237789999999998887666 99999999999999
Q ss_pred hCCCCCCCCCchhhhhhhh
Q 026299 214 VGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 214 ~g~~pf~~~~~~~~~~~~~ 232 (240)
.|+.||.+.+......+++
T Consensus 866 ~g~~pf~~~tp~~tq~kv~ 884 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVI 884 (1034)
T ss_pred hCCCCccCCCCCcceeeee
Confidence 9999999887766544443
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=221.69 Aligned_cols=195 Identities=18% Similarity=0.222 Sum_probs=158.6
Q ss_pred eeecCCCceeEEEEEecCCCc-------EEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 27 RDIGSGNFGVARLMRDKKTEE-------LVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~-------~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+.||.|+||.||++.+...+. .+++|.+.... ...+.+.+|...++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999999865443 48888775433 2235678899999999999999999999998899999999
Q ss_pred CCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC------cEEEecCCccccccc
Q 026299 99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKSSVL 171 (240)
Q Consensus 99 ~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~------~~~L~d~~~~~~~~~ 171 (240)
+++++|.+++...+ .+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.. .++++|||.+.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 99999999987544 58999999999999999999999999999999999999766542 379999998754332
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhC-CCCCCCCCc
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEE 224 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~ 224 (240)
.....++..|+|||.+.+....+.++|+||||+++|+|++| ..||...+.
T Consensus 161 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~ 211 (258)
T cd05078 161 ---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211 (258)
T ss_pred ---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH
Confidence 22344667899999997755445559999999999999998 466655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=217.06 Aligned_cols=204 Identities=23% Similarity=0.320 Sum_probs=158.8
Q ss_pred eeecCCCceeEEEEEecCC--CcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCC
Q 026299 27 RDIGSGNFGVARLMRDKKT--EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (240)
+.||+|++|.||++....+ ...+++|.+..... ..+.+.+|+..++.++||||+++++.+.+....+++|||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3689999999999975433 34566776655432 2357889999999999999999999999999999999999999
Q ss_pred chHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc---CCC
Q 026299 103 ELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP 175 (240)
Q Consensus 103 ~l~~~l~~~----~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~---~~~ 175 (240)
+|.+++.+. ...+...+..++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||.+...... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence 999988653 23566778899999999999999999999999999999987665 999999987532211 112
Q ss_pred CCCcCCccccCccccccCC------CCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 176 KSTVGTPAYIAPEVLLKKE------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
....++..|+|||.+.... ..+.++|+||||+++++|++ +..||...+..+.+.+++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 222 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI 222 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 2344677899999875321 12345999999999999997 677887766655555443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=219.04 Aligned_cols=204 Identities=25% Similarity=0.395 Sum_probs=162.5
Q ss_pred eeEeeeecCCCceeEEEEEec---CCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC------
Q 026299 23 YELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 90 (240)
|++.+.||+|++|.||++.+. .++..+++|.+.... ...+.+.+|+..++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999865 357889999886542 22346788999999999999999999886542
Q ss_pred eEEEEEecCCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 91 HLAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
..+++++|..+++|.+++... ..++...+..++.|++.|++|||+.|++|+||+|+||+++.+.. ++|+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECccc
Confidence 247889999999998876432 24788999999999999999999999999999999999987665 9999999
Q ss_pred ccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 026299 165 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (240)
Q Consensus 165 ~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (240)
.+........ .........|++||.+.....+.. +|+||||+++++|++ |..||...+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~~~ 226 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH
Confidence 8865432221 112234567999999877766554 999999999999999 889987766544433
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=227.21 Aligned_cols=216 Identities=30% Similarity=0.459 Sum_probs=184.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC--CCC----eeeeeEEEEcCCeEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--HPN----IVRFKEVILTPTHLA 93 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~--h~~----i~~~~~~~~~~~~~~ 93 (240)
..+|+++..+|+|.||.|-.+.+..++..||||+++.-....+..+-|++.|.++. .|+ ++.+.++|...+..|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 47999999999999999999999999999999999887777788899999999993 233 677788899999999
Q ss_pred EEEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC---------C--------
Q 026299 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---------P-------- 154 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~---------~-------- 154 (240)
+|+|.+ |.|+.+++.++. +++...+..+++|+++++.+||+.+++|.||+|+||++.+. .
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 999988 569999997654 68899999999999999999999999999999999998311 0
Q ss_pred -CCcEEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 155 -APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 155 -~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
...++++|||.++... ......+-+..|.|||++.+-.|+.+ +||||+||+|.||.+|...|...++...+ .+|+
T Consensus 247 ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-aMMe 322 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-AMME 322 (415)
T ss_pred CCcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-HHHH
Confidence 1148999999876332 22344566789999999999999888 99999999999999999999988866655 8888
Q ss_pred eeceeeC
Q 026299 234 VMYCTFS 240 (240)
Q Consensus 234 ~~~~~~~ 240 (240)
.++|++|
T Consensus 323 rIlGp~P 329 (415)
T KOG0671|consen 323 RILGPIP 329 (415)
T ss_pred HhhCCCc
Confidence 8888875
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=224.68 Aligned_cols=204 Identities=22% Similarity=0.313 Sum_probs=163.3
Q ss_pred eeecCC--CceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 27 RDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 27 ~~l~~g--~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
..||.| +++.||.+++..+++.|++|.+...... .+.+.+|+..++.++||||+++++++..++..++++|++.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 8999999999999999999998754322 24578888989999999999999999999999999999999
Q ss_pred CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC----
Q 026299 102 GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---- 175 (240)
Q Consensus 102 ~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~---- 175 (240)
+++.+++.+. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. +++.||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCcccccc
Confidence 9999988754 34889999999999999999999999999999999999987765 999999764322111111
Q ss_pred ----CCCcCCccccCccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 176 ----KSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 176 ----~~~~~~~~~~~pE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
........|++||.+.+.. ....++|+||||+++++|++|..||.+........+.+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 223 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKL 223 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHh
Confidence 1112345699999987642 23455999999999999999999998876655544443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=220.32 Aligned_cols=200 Identities=32% Similarity=0.550 Sum_probs=166.8
Q ss_pred CeeEeeeecCCCceeEEEEEec---CCCcEEEEEEeecCc-----cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeE
Q 026299 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 92 (240)
.|++.+.||.|++|.||++++. .++..|++|.+.... ...+.+.+|+..+.++ +|+||+++.+.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999865 457889999886532 2234577899999999 589999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
++||||+++++|.+++.....+++..+..++.|++++|++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccccccc
Confidence 999999999999999877778899999999999999999999999999999999999987665 999999987644332
Q ss_pred CCC--CCCcCCccccCccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 173 SQP--KSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 173 ~~~--~~~~~~~~~~~pE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
... ....+...|++||.+.+.. ....++|+||||+++++|++|..||...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 212 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 211 2234678899999986654 23445999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=216.82 Aligned_cols=196 Identities=28% Similarity=0.386 Sum_probs=155.0
Q ss_pred eeecCCCceeEEEEEecC---CCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEc-CCeEEEEEecCC
Q 026299 27 RDIGSGNFGVARLMRDKK---TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVMEYAS 100 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~---~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~~~~~ 100 (240)
+.||+|++|.||++.+.. .+..+++|.+.... ...+.+.+|+..++.++|||++++++++.. ++..+++++|+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 35679999875432 223567789999999999999999998764 556789999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-----C
Q 026299 101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----Q 174 (240)
Q Consensus 101 ~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-----~ 174 (240)
+++|.+++.+. ..++...+..++.|++.|++|||+.+++|+||+|+||++++++. ++|+|||.+....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence 99999998653 35678888999999999999999999999999999999987765 9999999886432211 1
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCch
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (240)
.....++..|+|||.+.+...+.+ +||||||+++++|++ |..||...+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~ 209 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSF 209 (262)
T ss_pred cccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 112234567999999877766555 999999999999999 56677654443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=233.47 Aligned_cols=199 Identities=29% Similarity=0.463 Sum_probs=175.2
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---------cccHHHHHHHHHHHhcC---CCCeeeeeEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSLR---HPNIVRFKEVIL 87 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~ 87 (240)
...|+.++.+|.|+||.|+.+.+..+...|+||.+.+.. ......-.|+.++..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 367999999999999999999999999999999986632 11223457888998886 999999999999
Q ss_pred cCCeEEEEEecC-CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 88 TPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 88 ~~~~~~lv~~~~-~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
++++++++||.- +|..|.+++...+.+++.+.+.+++|++.+++.||+.|||||||+.+|+.++.++- ++|+|||.+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsa 717 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSA 717 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccch
Confidence 999999999976 46788999988889999999999999999999999999999999999999977665 999999987
Q ss_pred ccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
. .....+.....|+..|.|||.+.+..+-.+..|||+||+++|.++....||.+
T Consensus 718 a-~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 A-YTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred h-hhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 5 33445556788999999999999998887779999999999999999999864
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=219.28 Aligned_cols=203 Identities=30% Similarity=0.416 Sum_probs=165.4
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 93 (240)
..+.++|++.+.||+|++|.||++.+..++..|++|.+..... ....+..|+..+.+.. |+||+++++++.++...+
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3456899999999999999999999998899999999875432 2234566776666664 999999999999999999
Q ss_pred EEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
++||++.+ ++.+.... ...+++..+..++.+++.++.|||+ .|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~ 167 (296)
T cd06618 91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGRLVD 167 (296)
T ss_pred EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchhccC
Confidence 99999865 66666654 4578999999999999999999997 59999999999999987665 99999999865443
Q ss_pred cCCCCCCcCCccccCccccccCC---CCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
........++..|+|||.+.+.. ..+.++|+||||+++++|++|..||...
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 33333345677899999986553 2344599999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=222.25 Aligned_cols=198 Identities=29% Similarity=0.461 Sum_probs=164.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
..|+..+.||.|++|.||++++..++..+++|.+..... ...++.+|+..++.++|+|++++.+++..+...++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 568899999999999999999999999999998864321 1235678999999999999999999999999999999
Q ss_pred ecCCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~-~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
||+.+ ++.+.+. ...++++..+..++.+++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+..... .
T Consensus 95 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~---~ 168 (308)
T cd06634 95 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---A 168 (308)
T ss_pred EccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeecC---c
Confidence 99975 7766664 3456899999999999999999999999999999999999987665 99999998754322 2
Q ss_pred CCCcCCccccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 176 KSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
....++..|+|||.+.+ ....+.++|+||||+++++|++|..||...+.
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 219 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence 23456778999999753 22234459999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=216.86 Aligned_cols=206 Identities=33% Similarity=0.513 Sum_probs=167.6
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC------ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
+|++.+.||+|++|.||++.+...+..+++|..... ......+..|...++.++|||++++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 689999999999999999999877776777765432 12223466788899999999999999999998899999
Q ss_pred EecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
+||+++++|.+++.. ...+++..++.++.|++.|+++||+.|++|+||+|+||+++.+ .++|+|||.+.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCC
Confidence 999999999887753 3568999999999999999999999999999999999999753 389999998765433
Q ss_pred cC-CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 172 HS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 172 ~~-~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
.. ......++..|+|||.+.+...+.+ +|+||||+++++|++|..||..........++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~ 217 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI 217 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 22 2223446778999999876666555 99999999999999999999766554444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=220.72 Aligned_cols=193 Identities=27% Similarity=0.437 Sum_probs=157.8
Q ss_pred CceeEEEEEecCCCcEEEEEEeecC---ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCchHHHHH
Q 026299 33 NFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 109 (240)
Q Consensus 33 ~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~ 109 (240)
+.+.++.+++..++..|++|++... ......+.+|+..++.++|+||+++++++.+++..++++||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4456777777878999999998764 2223578899999999999999999999999999999999999999999887
Q ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC--------CCCCc
Q 026299 110 NA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTV 179 (240)
Q Consensus 110 ~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~--------~~~~~ 179 (240)
+. ..+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++. ++|.||+.+........ .....
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccccccccccccccccc
Confidence 53 45889999999999999999999999999999999999987665 99999998754332211 12233
Q ss_pred CCccccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 180 GTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 180 ~~~~~~~pE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
+...|+|||.+.+. .....++|+||||+++++|++|..||.+......
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~ 218 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM 218 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 55679999998764 2234459999999999999999999987655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=223.16 Aligned_cols=215 Identities=33% Similarity=0.551 Sum_probs=182.8
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCe
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 91 (240)
+++-.+|..+..||+|+||.|-++....+.+.||||+++++--. -+--..|-.+|... +-|.+++++..|..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 33447899999999999999999999999999999998775211 12223455555544 45788888888888899
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
+|+||||+.||.|--.++.-+.+-+.....++.+|+-+|-+||++||+.+||+.+||+++.+++ ++|.|||.+.....
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeeccccccccc
Confidence 9999999999999877877788889999999999999999999999999999999999987776 99999999864443
Q ss_pred -cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 172 -HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 172 -~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
+....+..|++.|+|||++...++... .|+||+|++||+|+.|+.||.++++...++.|++-
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgks-vDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh 565 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH 565 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc
Confidence 445567889999999999987777555 99999999999999999999999999999998863
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=212.58 Aligned_cols=212 Identities=28% Similarity=0.388 Sum_probs=174.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc--HHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 95 (240)
+.++.+.+..||.|.-|.|++++..++|...|||.+......+ ++++..+.+....+ +|+|++.+|+|..+...++.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 4456678889999999999999999999999999998754332 46677776666665 89999999999999889999
Q ss_pred EecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
||.+.. -+..++.+ .+++++..+-.+...+++||.||-+ .|++|+|++|+||+++..+. +||+|||++.+.....
T Consensus 170 MelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 170 MELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeeccc
Confidence 998853 44544543 3578999999999999999999995 59999999999999987776 9999999998888778
Q ss_pred CCCCCcCCccccCccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCC-Cchhhhhhhhc
Q 026299 174 QPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIH 233 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~ 233 (240)
.+....|.+.|||||.+.-. ..+.-++||||||++++||.||..||.+. ++.+.+-+++.
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln 309 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN 309 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence 88888899999999998644 23344499999999999999999999885 44555555543
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=254.71 Aligned_cols=204 Identities=32% Similarity=0.485 Sum_probs=175.6
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc---HHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+++....+|.|.||.||.+.+.++|+..|+|-+.-.+... ..+.+|..++..+.|||+++++|+=.+.+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 5666778999999999999999999999999876644332 4568999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-----C
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----S 173 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-----~ 173 (240)
|++|+|.+.+...+..++.-...+..|++.|+.|||+.||||+||||.||+++.++. +|++|||.|.-.... .
T Consensus 1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCCH
Confidence 999999999987777777778888899999999999999999999999999988876 999999998644433 2
Q ss_pred CCCCCcCCccccCccccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 174 QPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
......|++.|||||++.+.. ....+.|||||||++.||+||..||...+.+=.
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a 1449 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA 1449 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH
Confidence 334567999999999998765 234458999999999999999999988776533
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=234.73 Aligned_cols=146 Identities=31% Similarity=0.473 Sum_probs=132.7
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
.++|++++.||.|+||.||++.+..++..|++|++...... ...+.+|+..+..++|+||+++++.+.....+++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999998764322 24678899999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
|||+.+++|.+++...+.+++..++.++.||+.||+|||+.||+|+||+|+||+++.++. ++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~--vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH--IKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC--EEEEeCCCCc
Confidence 999999999999987778899999999999999999999999999999999999987665 9999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=210.27 Aligned_cols=181 Identities=23% Similarity=0.309 Sum_probs=151.9
Q ss_pred CCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCchHHHHHhc
Q 026299 32 GNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 111 (240)
Q Consensus 32 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~ 111 (240)
|.++.||++++..+++.|++|.+..... ...|...+....||||+++++++.+++..+++|||+++++|.+++.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 8899999999999999999999866432 233444445567999999999999999999999999999999998877
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcCCccccCccccc
Q 026299 112 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191 (240)
Q Consensus 112 ~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~ 191 (240)
..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++++|||.+...... ......+..|+|||.+.
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG 155 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccccc--cccCCcCccccCCcccC
Confidence 78999999999999999999999999999999999999987766 999999976543322 12233456799999987
Q ss_pred cCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 192 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
+...+.. +|+||+|+++++|++|..||..
T Consensus 156 ~~~~~~~-~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 156 ISEETEA-CDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred CCCCCch-hhHHHHHHHHHHHHHCcchhhc
Confidence 6666554 9999999999999999977654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=201.12 Aligned_cols=202 Identities=26% Similarity=0.370 Sum_probs=166.5
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC--ccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
....+..||+|++|.|-+.++..+|...|+|.+... .....+.++|+.+..+. .+|.++.++|....+...++.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 344566899999999999999999999999998653 33345677888766555 689999999999999999999999
Q ss_pred CCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHhhC-CceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 99 ASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 99 ~~~~~l~~~l----~~~~~l~~~~~~~~~~~i~~~l~~LH~~-~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
++. ||..+. ..++.+++.-+-+++..++.||.+||++ .++|||++|+|||++.++. +|+||||.+.......
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISGYLVDSI 203 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccceeehhhh
Confidence 965 775543 4567799999999999999999999965 8999999999999977766 9999999987666555
Q ss_pred CCCCCcCCccccCccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 174 QPKSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
......|..-|+|||.+... ..+.-++||||||++++||.+++.||.....+-
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence 55557788899999998533 233444999999999999999999998765443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=226.71 Aligned_cols=210 Identities=27% Similarity=0.409 Sum_probs=180.8
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
.+...++++||+|-||.|..+.-. ++.+||+|..+.+... ..+|.+|+++|.+++||||+.++++|..++.+++++|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 377899999999999999999877 4789999999886533 3679999999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
|++.|.|.+++.++. .+..+...+++.||+.|++||.+.++|||||.++|++++.+.+ +|++|||.++..-.+.-.
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCce
Confidence 999999999998773 3456778889999999999999999999999999999987776 999999998744333222
Q ss_pred ---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHH--hCCCCCCCCCchhhhhhhhc
Q 026299 176 ---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML--VGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 ---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~--~g~~pf~~~~~~~~~~~~~~ 233 (240)
.......+|||+|.+..+.+++. +|+|+||+++||++ +...||.+.++.+.+++.-.
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~ 755 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE 755 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh
Confidence 23345679999999999999777 99999999999964 69999999998887776543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=213.20 Aligned_cols=203 Identities=32% Similarity=0.443 Sum_probs=170.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCc----EEEEEEeecC---ccccHHHHHHHHHHHhcCCCCeeeeeEEEEc-CCeE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHL 92 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~----~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 92 (240)
..|+++..||+|.+|.||+|....++. .+|||.++-. ...+...-+|+..++.++|+|++.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 579999999999999999996554432 6899988654 3445678899999999999999999999987 7789
Q ss_pred EEEEecCCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC--CCCcEEEecCCc
Q 026299 93 AIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGY 165 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~-----~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~--~~~~~~L~d~~~ 165 (240)
++++||.+. .|.+++. +.+.++...++.+++||+.++.|||++=+.|+||+|.||++..+ ..+++|++|+|+
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999999876 7777764 23469999999999999999999999999999999999999655 235699999999
Q ss_pred cccccccCCC----CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 166 SKSSVLHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 166 ~~~~~~~~~~----~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
++.....-.+ ..-+.+..|.|||.+.+...++++.|+|+.||+..||++-...|.....
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 9865443322 2234577899999999999999999999999999999999999977543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-31 Score=203.47 Aligned_cols=209 Identities=42% Similarity=0.641 Sum_probs=175.5
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCC
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (240)
|++.+.++.|+++.+|++.+..++..+++|.+..... ..+.+.+|+..++.++|+|++++++.+......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 6788999999999999999998899999999876543 35678899999999999999999999998899999999999
Q ss_pred CCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC--CCCC
Q 026299 101 GGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKS 177 (240)
Q Consensus 101 ~~~l~~~l~~~~~-l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~--~~~~ 177 (240)
+++|.+++..... ++...+..++.+++.++.+||+.+++|+|++|+||+++.+.. ++|+|||.+....... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL--VKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeCceeeEecCcccccccc
Confidence 9999999987666 899999999999999999999999999999999999987654 9999999886554432 2234
Q ss_pred CcCCccccCcccc-ccCCCCCcccchHHHHHHHHHHHhCCCCCCC-CCch-hhhhhhhce
Q 026299 178 TVGTPAYIAPEVL-LKKEYDGKIADVWSCGVTLYVMLVGAYPFED-PEEP-KNFRKTIHV 234 (240)
Q Consensus 178 ~~~~~~~~~pE~~-~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~-~~~~~~~~~ 234 (240)
..+...|++||.. ....... ++|+|+||+++++|++|..||.. .+.. ...+.+...
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 4567789999988 4444444 59999999999999999999977 3333 444444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=222.83 Aligned_cols=200 Identities=35% Similarity=0.520 Sum_probs=165.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEec
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
...|++...+|.|+|+.+-.+.+..++...++|++.... .+..+|..++... .||||++..+++.++...++|||.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 478999999999999999999999999999999987763 2334566555444 799999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEc-CCCCCcEEEecCCccccccccCCCCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKS 177 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~-~~~~~~~~L~d~~~~~~~~~~~~~~~ 177 (240)
+.|+.+.+.+-..+... .++..|+++|+.|++|||+.|+||||++|+|||+. +.+. ++|+|||.+...... ...
T Consensus 398 l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~--~~t 472 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGH--LRLTYFGFWSELERS--CDT 472 (612)
T ss_pred ccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCc--EEEEEechhhhCchh--hcc
Confidence 99988877665544433 77788999999999999999999999999999995 4444 999999998654443 233
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
...+..|.|||++....++.. +|+||||++||+|++|..||........+
T Consensus 473 p~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~~ei 522 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAGIEI 522 (612)
T ss_pred cchhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCchHHH
Confidence 345778999999986666555 99999999999999999999887776333
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=207.47 Aligned_cols=213 Identities=31% Similarity=0.528 Sum_probs=180.5
Q ss_pred CCcCCCCCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHH-hcCCCCe
Q 026299 5 AMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHR-SLRHPNI 79 (240)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~-~l~h~~i 79 (240)
+++...+.......--.+|.+++.||+|++.+|.+++...+.+.|++|++++. +..-+..+.|-.... ..+||.+
T Consensus 234 a~~~m~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pfl 313 (593)
T KOG0695|consen 234 AIDGMDGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFL 313 (593)
T ss_pred hhhhccccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeE
Confidence 34444444455555558999999999999999999999999999999998763 222234455555444 3479999
Q ss_pred eeeeEEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEE
Q 026299 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (240)
Q Consensus 80 ~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~ 159 (240)
+-+...|..+..+++|.||++||.|--.++++++++++....+...|.-||.|||++||+.+|++.+|++++..+. +|
T Consensus 314 vglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ik 391 (593)
T KOG0695|consen 314 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IK 391 (593)
T ss_pred EehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--ee
Confidence 9999999999999999999999999877888899999999999999999999999999999999999999987776 99
Q ss_pred EecCCccccc-cccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026299 160 ICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (240)
Q Consensus 160 L~d~~~~~~~-~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (240)
|.|+|.+... .++....+..+++.|.|||++.+..+.-. .|+|+||+++++|+.|+-||.
T Consensus 392 ltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 392 LTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred ecccchhhcCCCCCcccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcc
Confidence 9999998643 44556677889999999999988887665 999999999999999999994
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-33 Score=210.06 Aligned_cols=217 Identities=27% Similarity=0.412 Sum_probs=181.8
Q ss_pred CCCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC---ccccHHHHHHHHHHHhcCCCCeeeeeEEE
Q 026299 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVI 86 (240)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 86 (240)
..+..|.+...++|+-+.++|+|.||+||+|+...+++.|++|.+--+ .......++|+.+|..++|+|++.++++|
T Consensus 6 ~s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic 85 (376)
T KOG0669|consen 6 DSMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC 85 (376)
T ss_pred hcccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHH
Confidence 456678888999999999999999999999999999999998875432 23346789999999999999999998887
Q ss_pred EcC--------CeEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCc
Q 026299 87 LTP--------THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (240)
Q Consensus 87 ~~~--------~~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~ 157 (240)
... ..+++||++++. .|..++.+. ..++..+++.++.+++.+|.|+|...|+|+|+++.|++++.++.
T Consensus 86 ~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi-- 162 (376)
T KOG0669|consen 86 RTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI-- 162 (376)
T ss_pred hhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--
Confidence 642 348999999976 677777554 46899999999999999999999999999999999999988777
Q ss_pred EEEecCCccccccccCCCC-----CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 026299 158 LKICDFGYSKSSVLHSQPK-----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (240)
Q Consensus 158 ~~L~d~~~~~~~~~~~~~~-----~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (240)
++|+|||+++......... ....+..|++||.+.+...+.+..|+|.-||++.+|+++...+.+.++...+.
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~ 239 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLH 239 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHH
Confidence 9999999996443332221 22347789999999999888777999999999999999999998887766543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=236.02 Aligned_cols=204 Identities=32% Similarity=0.471 Sum_probs=161.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC--ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC---------
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP--------- 89 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------- 89 (240)
.+|+.++.||+||||.||++++.-+|..||||++... ......+.+|+..|.+++|||+++++..+.++
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4578889999999999999999999999999999876 34446789999999999999999987643200
Q ss_pred --------------------------------------------------------------------------------
Q 026299 90 -------------------------------------------------------------------------------- 89 (240)
Q Consensus 90 -------------------------------------------------------------------------------- 89 (240)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ------------------------------CeEEEEEecCCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHhhCCc
Q 026299 90 ------------------------------THLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQV 138 (240)
Q Consensus 90 ------------------------------~~~~lv~~~~~~~~l~~~l~~~~~l-~~~~~~~~~~~i~~~l~~LH~~~i 138 (240)
..+||.||||+..++.+++.++... .....|+++++|++||.|+|+.||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 0157888999887777777655443 578899999999999999999999
Q ss_pred eeecCCCCCeEEcCCCCCcEEEecCCcccccc-------------------ccCCCCCCcCCccccCccccccCC--CCC
Q 026299 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-------------------LHSQPKSTVGTPAYIAPEVLLKKE--YDG 197 (240)
Q Consensus 139 vh~~i~~~nili~~~~~~~~~L~d~~~~~~~~-------------------~~~~~~~~~~~~~~~~pE~~~~~~--~~~ 197 (240)
|||||||.|||++.++. +||+|||++.... .........|+.-|.|||.+.+.. .+.
T Consensus 719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999997776 9999999986411 011123446788999999998776 466
Q ss_pred cccchHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 026299 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (240)
Q Consensus 198 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (240)
.|.|+||||++++||+. ||.-..+.-.+.
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL 825 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTSMERASIL 825 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCchHHHHHHH
Confidence 66999999999999984 354444433333
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=219.67 Aligned_cols=204 Identities=25% Similarity=0.374 Sum_probs=170.4
Q ss_pred eEeeeecCCCceeEEEEEecCC----CcEEEEEEeecC--ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 24 ELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~~~----~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++.++||.|-||.||++....- +--||||..+.+ +...+.|+.|..+++.++||||++++|+|.+ ...|+|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence 4556799999999999997643 346889988774 3445789999999999999999999999986 67899999
Q ss_pred cCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC--
Q 026299 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (240)
Q Consensus 98 ~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-- 174 (240)
..+.|.|+.+++.+ ..++-..+..++.||..||.|||+.++|||||-..||++..+.- +||+|||+++......-
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccchhh
Confidence 99999999999865 47999999999999999999999999999999999999987765 99999999975433221
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
........-|||||.+.-..+++. +|||.||+++||+++ |..||.+-++.|.+-++
T Consensus 549 aS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i 605 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI 605 (974)
T ss_pred ccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceEEEe
Confidence 122223457999999977777665 999999999999886 99999998888776544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=200.04 Aligned_cols=189 Identities=46% Similarity=0.737 Sum_probs=165.1
Q ss_pred CceeEEEEEecCCCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCchHHHHHh
Q 026299 33 NFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 110 (240)
Q Consensus 33 ~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~ 110 (240)
++|.+|++.+..+++.+++|++...... .+.+.+|+..+++++|+|++++.+.+......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5789999999988999999998765432 46788999999999999999999999999999999999999999999877
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcCCccccCcccc
Q 026299 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190 (240)
Q Consensus 111 ~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 190 (240)
...++...++.++.+++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+.............+...|++||..
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH--VKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc--EEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 666899999999999999999999999999999999999987755 999999998766554444455677889999998
Q ss_pred ccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 191 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.+...+. ++|+||||++++++++|..||.....
T Consensus 159 ~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~ 191 (244)
T smart00220 159 LGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQ 191 (244)
T ss_pred ccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 8766656 59999999999999999999977333
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=219.98 Aligned_cols=215 Identities=27% Similarity=0.383 Sum_probs=184.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC------CCCeeeeeEEEEcCCeEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR------HPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~l 94 (240)
++|.|....|+|-|++|..|.++..|..||||++.++......-+.|+++|++|. ..|++.++..|...+++|+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl 511 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL 511 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence 6899999999999999999999999999999999998777777789999999995 3579999999999999999
Q ss_pred EEecCCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 95 VMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~---~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
|||.+.- +|.+++...+ .|....+..+++|++-||..|-..|++|+||+|+|||++.... .++|||||.|....-
T Consensus 512 VFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~e 589 (752)
T KOG0670|consen 512 VFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFASE 589 (752)
T ss_pred Eehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCcccccccc
Confidence 9998854 8999998655 4888999999999999999999999999999999999986655 489999998854322
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceeceeeC
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCTFS 240 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (240)
........+..|.|||++.+-+++.. .|+||.||+||+|.||...|++.++++.++-.|. +=|+||
T Consensus 590 -neitPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me-~KGk~p 655 (752)
T KOG0670|consen 590 -NEITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME-LKGKFP 655 (752)
T ss_pred -ccccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHH-hcCCCc
Confidence 22222345678999999999999888 9999999999999999999999999888765554 334443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=226.64 Aligned_cols=213 Identities=25% Similarity=0.397 Sum_probs=183.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCC---cEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~---~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
+.+.-++.+.||.|.||+|+.++.+-.+ ..||||.++... +...+|+.|..++-+..||||+++.|+........
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 3355688899999999999999988544 589999998864 44568999999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
+|+|||+.|+|..+|..+ ++++.-++..+++.|+.++.||-+.|+|||||...|||++.+-. +|+.|||+++....+
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd 784 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDD 784 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccC
Confidence 999999999999999654 57899999999999999999999999999999999999987776 999999999755443
Q ss_pred CCCC--CCc--CCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhce
Q 026299 173 SQPK--STV--GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 173 ~~~~--~~~--~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 234 (240)
.+.. +.- -..+|.|||.+.-..+++. +||||+|+++||.++ |+.||.+..+.+.++.|.+.
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g 850 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG 850 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHHHHHhc
Confidence 3221 111 2368999999998888777 999999999999776 99999999999998887654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=221.83 Aligned_cols=220 Identities=26% Similarity=0.419 Sum_probs=184.6
Q ss_pred CCCCCCCcccCCCCCeeEeeeecCCCceeEEEEEecCC---CcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeee
Q 026299 8 VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRF 82 (240)
Q Consensus 8 ~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~ 82 (240)
.+|..+..-.+..++.++.++||+|.||.|+.+.|..- --.|+||.+..+.. ...+|++|+..+.+++|+|++++
T Consensus 97 ~~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRL 176 (1039)
T KOG0199|consen 97 ANPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRL 176 (1039)
T ss_pred CCcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEE
Confidence 45566666666668889999999999999999998843 23688998877643 34789999999999999999999
Q ss_pred eEEEEcCCeEEEEEecCCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEE
Q 026299 83 KEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (240)
Q Consensus 83 ~~~~~~~~~~~lv~~~~~~~~l~~~l~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L 160 (240)
||+..+ ....+|||..+.|||.+.|.. ...+-...+..++.||+.|+.||..+++||+|+-..|+++-.... +|+
T Consensus 177 yGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI 253 (1039)
T KOG0199|consen 177 YGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKI 253 (1039)
T ss_pred eeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eee
Confidence 999988 778899999999999999865 345778889999999999999999999999999999999977665 999
Q ss_pred ecCCccccccccCCCCC----CcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 161 CDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 161 ~d~~~~~~~~~~~~~~~----~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
+|||+.+........-. ......|.|||.+....++.. +|+|++|++||||++ |+.||.+....+.+++|
T Consensus 254 ~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i 328 (1039)
T KOG0199|consen 254 CDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI 328 (1039)
T ss_pred ecccceeccCCCCcceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc
Confidence 99999986654433322 123457999999998888777 999999999999998 99999998877766654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=218.19 Aligned_cols=211 Identities=29% Similarity=0.511 Sum_probs=182.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEc-----CCeE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT-----PTHL 92 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~~~~ 92 (240)
..+.|++.+.+|.|.+|.||++++..++...++|+...+....+.+..|.++|+.. .|||++.+++++.- ++.+
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 34789999999999999999999999999999999988888888899999999888 58999999999864 3679
Q ss_pred EEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 93 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
|+|||||.|||..|.+++. ..+.++.+..|++.++.|+.+||+..++|+||+=.||++..++. +||+|||++....
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQld 174 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLD 174 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeee
Confidence 9999999999999998753 46888999999999999999999999999999999999987776 9999999985333
Q ss_pred -ccCCCCCCcCCccccCccccccCC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 171 -LHSQPKSTVGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 171 -~~~~~~~~~~~~~~~~pE~~~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
......+..|++.|||||++.... ++.. +|+||||++.++|-.|.+|+-+......+-+|.
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip 241 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 241 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchhhhhccCC
Confidence 345556778999999999996553 3344 899999999999999999998887766554443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=235.90 Aligned_cols=188 Identities=24% Similarity=0.331 Sum_probs=154.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (240)
..++....+|+|++|.||+|++..++..|++|.+..... ...+|+..+++++||||+++++++.++...++||||++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 345667789999999999999988999999998865432 22356888999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---hCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCC
Q 026299 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (240)
Q Consensus 101 ~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH---~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~ 177 (240)
+++|.+++.. +++.....++.++++|++||| +.+++|+||+|+||+++.+...++. ++...... ....
T Consensus 767 ~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~---~~~~~~~~---~~~~ 837 (968)
T PLN00113 767 GKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLC---TDTK 837 (968)
T ss_pred CCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE---eccccccc---cCCC
Confidence 9999999853 788999999999999999999 6699999999999999877763333 33322111 1122
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
..++..|+|||.+.+...+.+ +||||||+++|||++|..||..
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ccccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCc
Confidence 356789999999887776555 9999999999999999999853
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=210.95 Aligned_cols=208 Identities=31% Similarity=0.453 Sum_probs=171.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccH--------HHHHHHHHHHhcCCCCeeeeeEEEEc-CC
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHRSLRHPNIVRFKEVILT-PT 90 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~--------~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 90 (240)
+++|-++.+||+|+|+.||+|.+-.....|++|+-..+..+.+ ..-+|..+++.+.||.|+++|+++.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 4799999999999999999999998899999997655443332 35689999999999999999999874 57
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--CceeecCCCCCeEEc-CCCCCcEEEecCCccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--QVCHRDLKLENTLLD-GSPAPRLKICDFGYSK 167 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~--~ivh~~i~~~nili~-~~~~~~~~L~d~~~~~ 167 (240)
.+|-|.||++|..|.-++..++.+++.+...|+.||+.||.||.+. .|+|-||+|.||++. ....+.+++.|||++.
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 8899999999999999998889999999999999999999999975 599999999999984 3445569999999986
Q ss_pred cccccCCC--------CCCcCCccccCccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 168 SSVLHSQP--------KSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 168 ~~~~~~~~--------~~~~~~~~~~~pE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
......-. ....|+-+|++||.+.-. +..+.+.||||.|++.|+++.|..||...-....
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 54332211 234577889999987544 3335559999999999999999999977654443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=208.38 Aligned_cols=215 Identities=27% Similarity=0.416 Sum_probs=176.5
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeec---CccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC-----eEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 93 (240)
+-+-.+.||.|+||.||.+.+-.+|+.|++|++.+ +-...+++.+|++.|...+|.|++..+++..... .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34456789999999999999999999999999865 2233467889999999999999999998876542 356
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
+++|.+.. .|..++.....++...++-+++||+++|.|||+.||.|+||+|.|.+++.+.. +|++|||+++-.....
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhh
Confidence 78887754 67777777788999999999999999999999999999999999999999988 9999999997554433
Q ss_pred CCC--CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceeceeeC
Q 026299 174 QPK--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCTFS 240 (240)
Q Consensus 174 ~~~--~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (240)
... ....+.+|.|||.+.+...++.+.||||.||+..||+.++..|.....-..++ .+.-++|++|
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~-lItdLLGTPs 278 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQ-MIIDLLGTPS 278 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHH-HHHHHhCCCc
Confidence 322 22456789999999999888888999999999999999999998776655544 4444555554
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=199.48 Aligned_cols=212 Identities=26% Similarity=0.412 Sum_probs=181.7
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC---ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC---
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT--- 90 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 90 (240)
.+.+.+|.-++.++.|+. .|..+-+.-.+..|++|..... ....++..+|...+..+.|+||++.+.++....
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 345689999999999999 7778888889999999997653 233467889999999999999999999997653
Q ss_pred ---eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 91 ---HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 91 ---~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
..|+|||+++. +|...+. -.++-+.+..++.|++.|+.+||+.||+||||+|+||++..+.. +|+.|||+++
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar 166 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLAR 166 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhc
Confidence 47899999966 7777665 33688899999999999999999999999999999999988887 9999999998
Q ss_pred cccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
.....-.......+..|.|||.+.+..+... .||||+||++.+|+.|...|.+.+.-+.+-|+++.+
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~l 233 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQL 233 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHh
Confidence 6666545555667889999999998886666 999999999999999999999999999998887643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=205.72 Aligned_cols=193 Identities=27% Similarity=0.342 Sum_probs=159.2
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHH--hcCCCCeeeeeEEEEcCC----eEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRHPNIVRFKEVILTPT----HLA 93 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~--~l~h~~i~~~~~~~~~~~----~~~ 93 (240)
-...++.+.+|+|.||.||+|+.. ++.||||++...+. ..+++|-++.+ .++|+||+++++.-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 367889999999999999999886 48899999866543 55667766665 457999999998866544 789
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC---------CceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------QVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~---------~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
+|++|.+.|+|.++|..+ .++..+..+++..+++||+|||+. .|+||||+..|||+..|.+ ..|+|||
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFG 361 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFG 361 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccc
Confidence 999999999999999654 479999999999999999999962 4999999999999988887 9999999
Q ss_pred ccccccccCCC---CCCcCCccccCccccccCCCCC-----cccchHHHHHHHHHHHhCCCCC
Q 026299 165 YSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDG-----KIADVWSCGVTLYVMLVGAYPF 219 (240)
Q Consensus 165 ~~~~~~~~~~~---~~~~~~~~~~~pE~~~~~~~~~-----~~~Di~slG~~l~~l~~g~~pf 219 (240)
++-....+.+. ...+|+.+|||||++.+...-. ++.||||+|.++||++++...+
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 99655543333 3357899999999998765433 3479999999999999876544
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=198.72 Aligned_cols=208 Identities=26% Similarity=0.445 Sum_probs=166.5
Q ss_pred CCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEE-EEcC
Q 026299 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEV-ILTP 89 (240)
Q Consensus 12 ~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~ 89 (240)
..++-+.--+.|++.+.||.|.||.+-++.++.++..+++|-+..+.....+|.+|..---.| .|.||+..|++ |...
T Consensus 15 ~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 15 EELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred ccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 334444444899999999999999999999999999999999888777778899988654444 58999988776 5566
Q ss_pred CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
+.+++++||++.|+|..-+... .+.+...+.++.|++.|++|+|++++|||||+.+|||+-.....++||+|||..+..
T Consensus 95 d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 8889999999999998877543 378999999999999999999999999999999999996655558999999987643
Q ss_pred cccCCCCCCcCCccccCccccccCCC----CCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 170 VLHSQPKSTVGTPAYIAPEVLLKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 170 ~~~~~~~~~~~~~~~~~pE~~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
..... ..-....|.+||.+..... ..+.+|+|.||++++.+++|..||...
T Consensus 174 g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 174 GTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred Cceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 32222 2223456788887643321 233489999999999999999999743
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=210.77 Aligned_cols=203 Identities=23% Similarity=0.348 Sum_probs=177.2
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
..+.+...+||.|.+|.||.+.+......|+||.++.+....+.|+.|..+++.++|||+++++|+|..+..+|||+||+
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 34556778999999999999999999999999999999888899999999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC--CC
Q 026299 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 175 (240)
Q Consensus 100 ~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~--~~ 175 (240)
..|+|.+++.+. ..++.--+..++.||..|++||..++++|+||-..|.|+..+.. +|++|||+++...-+. .+
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCceecc
Confidence 999999999654 34677778889999999999999999999999999999987776 9999999998654332 22
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCch
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (240)
...-...-|.|||.+.-+.+..+ +|||+||++||++.| |-.||.+-+.-
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlS 473 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLS 473 (1157)
T ss_pred cCccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence 22334567999999999998777 999999999999998 88888876543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=199.45 Aligned_cols=202 Identities=28% Similarity=0.361 Sum_probs=163.2
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHh--cCCCCeeeeeEEEEcCC----eE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTPT----HL 92 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~ 92 (240)
.-++-++.+.+|+|.||+||+++++ |+.||||++...+ +..+.+|.++.+. ++|+||+.+++.-..+. .+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3478899999999999999999997 7889999987643 3567777777764 49999999988754332 47
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--------CceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~--------~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
++|++|-+.|||.|+|.+ ..++.+....++..++.||++||.. .|.|||||..||++-.++. +.++|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLG 361 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLG 361 (513)
T ss_pred EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeece
Confidence 999999999999999977 6689999999999999999999952 2999999999999988887 9999999
Q ss_pred ccccccc-----cCCCCCCcCCccccCccccccCCC-----CCcccchHHHHHHHHHHHhC----------CCCCCCCCc
Q 026299 165 YSKSSVL-----HSQPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVG----------AYPFEDPEE 224 (240)
Q Consensus 165 ~~~~~~~-----~~~~~~~~~~~~~~~pE~~~~~~~-----~~~~~Di~slG~~l~~l~~g----------~~pf~~~~~ 224 (240)
+|..... ........|+.+|||||++...-. .-+.+||||||.++||+..+ .+||.+.-.
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9964433 344456679999999999865532 12338999999999998643 378877644
Q ss_pred hhh
Q 026299 225 PKN 227 (240)
Q Consensus 225 ~~~ 227 (240)
.|-
T Consensus 442 ~DP 444 (513)
T KOG2052|consen 442 SDP 444 (513)
T ss_pred CCC
Confidence 443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=217.22 Aligned_cols=200 Identities=26% Similarity=0.386 Sum_probs=167.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCc----EEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
...+.++.||+|+||+||++.+-..|+ +|++|++...+. ....+++|.-.+.+++|||++++++++..+. +.+
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 445566789999999999999987655 667777665443 3567899999999999999999999998765 789
Q ss_pred EEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
|++|+++|+|.+++..+ .++.......|..||++|+.|||+.++|||||-.+|||+..... +|+.|||++.......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCccc
Confidence 99999999999999754 57999999999999999999999999999999999999987766 9999999997665544
Q ss_pred CCCCCc---CCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCc
Q 026299 174 QPKSTV---GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE 224 (240)
Q Consensus 174 ~~~~~~---~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 224 (240)
..-... ..+-|+|-|.+....++.. +||||+|+++||++| |..|+.+...
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 333222 2456899998877777666 999999999999998 9999876543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=198.91 Aligned_cols=132 Identities=26% Similarity=0.423 Sum_probs=117.1
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC--------CCCeeeeeEEEEc-
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--------HPNIVRFKEVILT- 88 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~~- 88 (240)
++..+|.+.++||.|-|++||++.|..++..||+|+.+...-..+..++|+++|++++ ..+|+++++.|..
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 3457999999999999999999999999999999999888777788999999999884 2469999999975
Q ss_pred ---CCeEEEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEE
Q 026299 89 ---PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLL 150 (240)
Q Consensus 89 ---~~~~~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili 150 (240)
+.+.|+|+|++ |.+|..++..+ +-++...++.|++|++.||.|||. .||+|.||+|+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 46799999999 55888877654 469999999999999999999995 699999999999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=205.15 Aligned_cols=202 Identities=21% Similarity=0.283 Sum_probs=148.7
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEec----------------CCCcEEEEEEeecCccc---------------cHHHHH
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDK----------------KTEELVAVKYIERGDKI---------------DENVQR 66 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~----------------~~~~~v~iK~~~~~~~~---------------~~~~~~ 66 (240)
...++|++.++||+|+||.||++... ..+..|+||++...... .+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 46789999999999999999999752 34567999998653211 122334
Q ss_pred HHHHHHhcCCCCe-----eeeeEEEEc--------CCeEEEEEecCCCCchHHHHHhcC---------------------
Q 026299 67 EIINHRSLRHPNI-----VRFKEVILT--------PTHLAIVMEYASGGELFERICNAG--------------------- 112 (240)
Q Consensus 67 e~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~~~~~~~~l~~~l~~~~--------------------- 112 (240)
|+..+.+++|.++ +.+++++.. .+..++|+||+++++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6666667765543 566666643 346899999999999998875321
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC--CCcCCccccCc
Q 026299 113 ---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAP 187 (240)
Q Consensus 113 ---~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~--~~~~~~~~~~p 187 (240)
.++...++.++.|++.+|.|||+.+++|+||+|+||+++.+.. ++|+|||.+.......... ....++.|++|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1345678889999999999999999999999999999987765 9999999986443322221 22346789999
Q ss_pred cccccCCCC---------------------CcccchHHHHHHHHHHHhCCC-CCCC
Q 026299 188 EVLLKKEYD---------------------GKIADVWSCGVTLYVMLVGAY-PFED 221 (240)
Q Consensus 188 E~~~~~~~~---------------------~~~~Di~slG~~l~~l~~g~~-pf~~ 221 (240)
|.+...... ..+.|+||+|+++++|+++.. ||.+
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 987543211 123699999999999999886 7654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=210.76 Aligned_cols=199 Identities=20% Similarity=0.223 Sum_probs=140.0
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCC----CcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEE------EE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV------IL 87 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~----~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~ 87 (240)
...++|++.+.||+|+||.||++++..+ +..|++|.+..... .+....+ .+....+.++..+... ..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3558999999999999999999999988 89999998754321 1111111 1111112222221111 23
Q ss_pred cCCeEEEEEecCCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCC
Q 026299 88 TPTHLAIVMEYASGGELFERICNAGR--------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147 (240)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~l~~~~~--------------------l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~n 147 (240)
.+...++|++|.++++|.+++..... .....+..++.|++.||+|||+.||+|+||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 45678999999999999988864321 1233466799999999999999999999999999
Q ss_pred eEEcCCCCCcEEEecCCcccccccc--CCCCCCcCCccccCccccccCCCC---------------------CcccchHH
Q 026299 148 TLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLKKEYD---------------------GKIADVWS 204 (240)
Q Consensus 148 ili~~~~~~~~~L~d~~~~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~---------------------~~~~Di~s 204 (240)
|+++.+. +.++|+|||++...... .......+++.|+|||.+...... +.++||||
T Consensus 286 ILl~~~~-~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 286 IIFSEGS-GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEEeCCC-CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 9997532 24999999998643322 223345678899999976433221 22369999
Q ss_pred HHHHHHHHHhCCCCCC
Q 026299 205 CGVTLYVMLVGAYPFE 220 (240)
Q Consensus 205 lG~~l~~l~~g~~pf~ 220 (240)
|||++|+|+++..++.
T Consensus 365 lGviL~el~~~~~~~~ 380 (566)
T PLN03225 365 AGLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHHhCcCCCc
Confidence 9999999998776643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-28 Score=209.59 Aligned_cols=210 Identities=25% Similarity=0.418 Sum_probs=172.5
Q ss_pred CCCCCcccCCCCCeeEeeeecCCCceeEEEEEecC-------CCcEEEEEEeecCccc--cHHHHHHHHHHHhc-CCCCe
Q 026299 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKI--DENVQREIINHRSL-RHPNI 79 (240)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i 79 (240)
|..+ .+....++.++.+.||.|.||.|+++.... ....|++|..+..... .+.+..|++.++.+ +|+||
T Consensus 286 ~~~~-~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~ni 364 (609)
T KOG0200|consen 286 PEDP-KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNI 364 (609)
T ss_pred CcCC-ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcch
Confidence 3344 455555666888899999999999998541 2567999988765433 46788999999988 59999
Q ss_pred eeeeEEEEcCCeEEEEEecCCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecC
Q 026299 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143 (240)
Q Consensus 80 ~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i 143 (240)
+.++|.+..++..++|.||+..|.|.+++...+ .++..++..+++||+.|++||++..+|||||
T Consensus 365 v~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDL 444 (609)
T KOG0200|consen 365 VNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDL 444 (609)
T ss_pred hhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhh
Confidence 999999999999999999999999999997655 4899999999999999999999999999999
Q ss_pred CCCCeEEcCCCCCcEEEecCCccccccccCCCCCC--c--CCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCC
Q 026299 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--V--GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYP 218 (240)
Q Consensus 144 ~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~--~--~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p 218 (240)
-.+||++..+.. +|++|||+++........... . ....|||||.+....++.+ +||||+|+++||+++ |..|
T Consensus 445 AaRNVLi~~~~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~P 521 (609)
T KOG0200|consen 445 AARNVLITKNKV--IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTP 521 (609)
T ss_pred hhhhEEecCCCE--EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCC
Confidence 999999987765 999999999754332222111 1 3456999999998666665 999999999999998 9999
Q ss_pred CCCCC
Q 026299 219 FEDPE 223 (240)
Q Consensus 219 f~~~~ 223 (240)
|.+-.
T Consensus 522 Yp~~~ 526 (609)
T KOG0200|consen 522 YPGIP 526 (609)
T ss_pred CCCCC
Confidence 98744
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-27 Score=179.25 Aligned_cols=182 Identities=46% Similarity=0.701 Sum_probs=155.6
Q ss_pred ecCCCceeEEEEEecCCCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCchHH
Q 026299 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 106 (240)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~ 106 (240)
||.|++|.+|++.+..+++.+++|.+...... .+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 58899999999999988999999998776542 4678999999999999999999999999999999999999899999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC-CCCCcEEEecCCccccccccC-CCCCCcCCcc
Q 026299 107 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA 183 (240)
Q Consensus 107 ~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~-~~~~~~~L~d~~~~~~~~~~~-~~~~~~~~~~ 183 (240)
++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. +.. ++|+||+.+....... ..........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc--EEEecCCceEEccCCcchhhcccCCCC
Confidence 98765 47899999999999999999999999999999999999987 444 9999999886443322 1333556778
Q ss_pred ccCccccccCCCCCcccchHHHHHHHHHH
Q 026299 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (240)
Q Consensus 184 ~~~pE~~~~~~~~~~~~Di~slG~~l~~l 212 (240)
|.+||........+.+.|+|+||++++++
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 99999987763444559999999999988
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=210.06 Aligned_cols=211 Identities=35% Similarity=0.510 Sum_probs=180.9
Q ss_pred CCCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc-HHHHHHHHHHHhcCCCCeeeeeEEEEc
Q 026299 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVILT 88 (240)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (240)
|+.++......++|.++..+|+|.+|.||++++..+++..++|+++..+... .-...|+-.++.++||||+.+++.+..
T Consensus 4 ~~~disrrnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 4 PKSDISRRNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred ccchhhhcCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh
Confidence 3445555545589999999999999999999999999999999998865443 456789999999999999999999999
Q ss_pred CCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
.+..+++|||+.|++|.++..-.+++++.++....+..++++.|||+.|-+||||+=.||++++.++ ++|.|||.+..
T Consensus 84 ~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaq 161 (829)
T KOG0576|consen 84 RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQ 161 (829)
T ss_pred hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhh
Confidence 9999999999999999999988899999999999999999999999999999999999999988887 99999999864
Q ss_pred ccc-cCCCCCCcCCccccCccccc--cCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 169 SVL-HSQPKSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 169 ~~~-~~~~~~~~~~~~~~~pE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
+.. -....++.|++.|||||+.. +...+...+|+|++|++.+++-.-+.|--+.
T Consensus 162 itati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl 218 (829)
T KOG0576|consen 162 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL 218 (829)
T ss_pred hhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc
Confidence 443 35557789999999999863 3344455699999999998886655554333
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=175.60 Aligned_cols=217 Identities=24% Similarity=0.301 Sum_probs=173.0
Q ss_pred CcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCC-CCeeeeeEEEEcCCeE
Q 026299 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHL 92 (240)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 92 (240)
.+-.+...+|++++.||.|+||.+|.+..-.+|+.||||+-... .......-|..+.+.+++ ..|+.+..+..+..+-
T Consensus 8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 34455678999999999999999999999999999999965443 333456778888888875 7888888888888999
Q ss_pred EEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC-cEEEecCCcccccc
Q 026299 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSV 170 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~-~~~L~d~~~~~~~~ 170 (240)
.+||+.+ |.||++...- ++.++..++.-++-|++.-++|+|.++++|+||+|+|.+..-+.+. ++.|+|||++...-
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998 5699987753 3568999999999999999999999999999999999998644322 58999999985332
Q ss_pred c--------cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh---hhhhhc
Q 026299 171 L--------HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN---FRKTIH 233 (240)
Q Consensus 171 ~--------~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~ 233 (240)
. ........|+.+|.+-....+...+.. .|+-|+|.+++++.-|.+||.+...... .++|.+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence 2 223334457888887766665555455 9999999999999999999998766544 444443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-25 Score=180.46 Aligned_cols=204 Identities=27% Similarity=0.288 Sum_probs=165.3
Q ss_pred CeeEeeeecCCCceeEEEEEecCCC-cEEEEEEeecCcccc-HHHHHHHHHHHhcC----CCCeeeeeEEE-EcCCeEEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKID-ENVQREIINHRSLR----HPNIVRFKEVI-LTPTHLAI 94 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~-~~v~iK~~~~~~~~~-~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~l 94 (240)
+|++.+.||+|+||.||.+.+..++ ..+|+|......... ..+..|+.++..+. .+++..+++.. ..+.+.++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999998774 678888766542221 25778888888876 36899999998 47788899
Q ss_pred EEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-C--CcEEEecCCccc--
Q 026299 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-A--PRLKICDFGYSK-- 167 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~--~~~~L~d~~~~~-- 167 (240)
||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.|++||||+|.|+++.... . ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99987 66999987544 4799999999999999999999999999999999999997653 1 359999999997
Q ss_pred cccccC--------C-CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 168 SSVLHS--------Q-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 168 ~~~~~~--------~-~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
...... . .....|+..|.++....+...... .|+||+++++.++..|.+||........
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~ 245 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDL 245 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccch
Confidence 321111 1 122348899999999888888666 9999999999999999999977665433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=185.96 Aligned_cols=210 Identities=26% Similarity=0.420 Sum_probs=173.4
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecC---CCcEEEEEEeecCccccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 94 (240)
..+.|.++.++|.|.|+.||++.+.. ..+.|++|.+..-. ...++.+|++.|..+. +.||+++.+.+..++...+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 34689999999999999999999998 78999999887643 3466899999999995 7899999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc----
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---- 170 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~---- 170 (240)
|+||++.....++... ++..++..+++.++.||.++|..||||+||+|+|++.+... ++-.|.|||++....
T Consensus 113 vlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t-~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT-QRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred EecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccccc-CCceEEechhHHHHHhhhh
Confidence 9999999888887744 67999999999999999999999999999999999997544 357999999974100
Q ss_pred ----------ccCC-------------------------------CCCCcCCccccCccccccCCCCCcccchHHHHHHH
Q 026299 171 ----------LHSQ-------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTL 209 (240)
Q Consensus 171 ----------~~~~-------------------------------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l 209 (240)
.... .....|+++|.|||++.+-+..+++.|+||-|+++
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0000 00123788999999999888777779999999999
Q ss_pred HHHHhCCCCCC-CCCchhhhhhhhc
Q 026299 210 YVMLVGAYPFE-DPEEPKNFRKTIH 233 (240)
Q Consensus 210 ~~l~~g~~pf~-~~~~~~~~~~~~~ 233 (240)
..++++..||- ..++.+.+.++..
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~t 293 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIAT 293 (418)
T ss_pred ehhhccccccccCccccchHHHHHH
Confidence 99999999974 4466665555543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=200.02 Aligned_cols=193 Identities=31% Similarity=0.375 Sum_probs=155.7
Q ss_pred eeeecCCCce-eEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEecCCCCc
Q 026299 26 VRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGE 103 (240)
Q Consensus 26 ~~~l~~g~~g-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~~~ 103 (240)
.+.+|.|+.| .||++... |+.||||++.... ...+.+|+..|+.. .||||+++++.=.+.+..|+..|.|.. +
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence 3457788876 67877765 6789999886543 24578999999888 599999999998888999999999966 9
Q ss_pred hHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC---CCCCcEEEecCCccccccccCCC-
Q 026299 104 LFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQP- 175 (240)
Q Consensus 104 l~~~l~~~~----~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~---~~~~~~~L~d~~~~~~~~~~~~~- 175 (240)
|.++++... .......+....|+++||++||+.+||||||+|.||+|.. ++..+.+|.|||++.....+...
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~ 668 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF 668 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence 999997641 1222456889999999999999999999999999999976 45567999999999755544333
Q ss_pred ---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCc
Q 026299 176 ---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE 224 (240)
Q Consensus 176 ---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 224 (240)
....|+.+|.|||++........ .||+||||++|+.++ |..||.+.-.
T Consensus 669 ~r~s~~sGt~GW~APE~L~~~~~~~a-vDiFslGCvfyYvltgG~HpFGd~~~ 720 (903)
T KOG1027|consen 669 SRLSGGSGTSGWQAPEQLREDRKTQA-VDIFSLGCVFYYVLTGGSHPFGDSLE 720 (903)
T ss_pred hcccCCCCcccccCHHHHhccccCcc-cchhhcCceEEEEecCCccCCCchHH
Confidence 34468899999999988877555 999999999999888 5999977543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-25 Score=172.91 Aligned_cols=203 Identities=24% Similarity=0.324 Sum_probs=174.4
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
-.|+|.++||.|+||+.+.+.+--+++.|||| +++..+.......|....+.|. .++|...+-+...+-+-.+|+|.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIK-fEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIK-FEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEE-eccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68999999999999999999999999999999 6666666677889999999885 699999888877777788999998
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC---cEEEecCCcccccc-----
Q 026299 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP---RLKICDFGYSKSSV----- 170 (240)
Q Consensus 100 ~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~---~~~L~d~~~~~~~~----- 170 (240)
|.||+|+..-. +.++..++..++.|++.-++++|++.+|.+||+|+|+||...+.. .+.++|||.+....
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence 66999988754 469999999999999999999999999999999999999654433 48999999996443
Q ss_pred ---ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 171 ---LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 171 ---~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
+..+..+..|+.+||+-....+...+.+ .|.-|||-+.++.+-|.+||.+.....
T Consensus 186 qHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 186 QHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred ccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccCcc
Confidence 3344456678999999998888888666 999999999999999999999875543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=176.61 Aligned_cols=167 Identities=16% Similarity=0.116 Sum_probs=125.6
Q ss_pred CcccCCCCCeeEeeeecCCCceeEEEEEecC-CCcEEEEEEeecC------ccccHHHHHHHHHHHhcCCCCeee-eeEE
Q 026299 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVR-FKEV 85 (240)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~-~~~~ 85 (240)
.++..-..+|++.+.||+|+||.||+|++.. ++..+++|+.... +.....+.+|+.+++.++|+|+++ +++.
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 3344456899999999999999999999876 6788899986532 112346889999999999999885 4332
Q ss_pred EEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecC-CCCCeEEcCCCCCcEEEecCC
Q 026299 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 86 ~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i-~~~nili~~~~~~~~~L~d~~ 164 (240)
+..++||||++|++|.. .. +.. ...++.+++++|.+||+.||+|||| +|+||+++.++. ++|+|||
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFG 157 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQ 157 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECc
Confidence 45799999999988863 21 111 1467889999999999999999999 899999976654 9999999
Q ss_pred ccccccccCCC---------CCCcCCccccCccccccC
Q 026299 165 YSKSSVLHSQP---------KSTVGTPAYIAPEVLLKK 193 (240)
Q Consensus 165 ~~~~~~~~~~~---------~~~~~~~~~~~pE~~~~~ 193 (240)
++......... ....+...|.+||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 98744332211 122345668889887544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=159.75 Aligned_cols=169 Identities=15% Similarity=0.172 Sum_probs=126.5
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHH----------HHHHHHHHHhcCCCCeeeeeEEEEcC
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----------VQREIINHRSLRHPNIVRFKEVILTP 89 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~----------~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (240)
..+|++++.++.|++|.||.+.. ++..+++|.+.+.....+. +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 37999999999999999999766 3557999998764332222 47888899999999999999886643
Q ss_pred --------CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEe
Q 026299 90 --------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (240)
Q Consensus 90 --------~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~ 161 (240)
...+++|||++|.+|.++.. +++ ....+++.++..+|+.|++|||++|+|+++++++ ++|+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~li 176 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRII 176 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEE
Confidence 34789999999999987632 233 2456999999999999999999999999997655 9999
Q ss_pred cCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHH
Q 026299 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213 (240)
Q Consensus 162 d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~ 213 (240)
|||............ .......+. .++|+|+||+++..+.
T Consensus 177 Dfg~~~~~~e~~a~d-----------~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAKD-----------RIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhHH-----------HHHHHhHhc-ccccccceeEeehHHH
Confidence 999865331111100 012223333 3599999999887653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=155.41 Aligned_cols=137 Identities=20% Similarity=0.191 Sum_probs=107.9
Q ss_pred eeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----------cH-----------------HHHHHHHHHHhcCCCC
Q 026299 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DE-----------------NVQREIINHRSLRHPN 78 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----------~~-----------------~~~~e~~~l~~l~h~~ 78 (240)
...||+|++|.||.|.+. +|+.||+|++..+... .. ....|+..+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 8999999998764211 01 1234889999998777
Q ss_pred eeeeeEEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhCCceeecCCCCCeEEcCCCCCc
Q 026299 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPAPR 157 (240)
Q Consensus 79 i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~L-H~~~ivh~~i~~~nili~~~~~~~ 157 (240)
+.....+... ..++||||++|+++........+++...+..++.|++.+|.++ |+.|++|+||+|+||+++. + .
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--~ 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--K 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--c
Confidence 6444333222 2379999999877765544556789999999999999999999 6999999999999999973 3 4
Q ss_pred EEEecCCcccc
Q 026299 158 LKICDFGYSKS 168 (240)
Q Consensus 158 ~~L~d~~~~~~ 168 (240)
++|+|||++..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-24 Score=166.69 Aligned_cols=204 Identities=19% Similarity=0.234 Sum_probs=161.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcC-CeE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTP-THL 92 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~ 92 (240)
.++++...+-+|.||.+|.+.+.+ +.+.|.+|.++...+. -..++.|-..+....|||++++.+++... ...
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 356666778899999999997663 2445667777665432 24678888888899999999999998654 678
Q ss_pred EEEEecCCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 93 AIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~--------~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
++++++...++|..++.. .+.++..++..++.|++.|+++||+.|+||.||-.+|-++++.-. +||+|-.
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq--VkltDsa 441 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ--VKLTDSA 441 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee--EEeccch
Confidence 899999998999999861 124778889999999999999999999999999999999976644 9999999
Q ss_pred ccccccccCCCC---CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026299 165 YSKSSVLHSQPK---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (240)
Q Consensus 165 ~~~~~~~~~~~~---~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (240)
+++...+..=+. ..-+...||+||.+....+... +|+||||+++|||++ |..|+..-+..+.
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 987554332221 1224557999999998888766 999999999999998 9999876655443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-21 Score=157.86 Aligned_cols=198 Identities=41% Similarity=0.676 Sum_probs=167.0
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhcCCC-CeeeeeEEEEcCCeEEEEEe
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~~ 97 (240)
|++.+.||.|+++.||.+.+. ..+++|.+..... ....+.+|...+..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999998 6788998876433 245788999999999987 79999999977777899999
Q ss_pred cCCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-
Q 026299 98 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~---~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~- 173 (240)
++.++++.+++.... .++......++.|++.++.++|+.+++|+|++|+||+++.... .+++.|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence 999999997776654 7899999999999999999999999999999999999986652 38999999986333322
Q ss_pred ------CCCCCcCCccccCccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 174 ------QPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 174 ------~~~~~~~~~~~~~pE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
......++..|++||.+.+. .......|+|++|+++++++.|..||.....
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 23556788999999999874 3445459999999999999999999877764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=181.74 Aligned_cols=194 Identities=24% Similarity=0.330 Sum_probs=158.9
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC---CCCeeeeeEEEEcCCeEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv 95 (240)
-..+|.+-+.+|+|++|.||.|.... |+.||+|+-.+...++-.+ ...++.+|+ -+.|+.+...+.-.+...+|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI--~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI--CLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee--hHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 34799999999999999999999996 9999999877665544322 223334443 35566666666667778899
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEc-----CCCCCcEEEecCCcccccc
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-----GSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~-----~~~~~~~~L~d~~~~~~~~ 170 (240)
++|.+.|+|.++++.++-+++..+..++.|++..++.||..+||||||||+|.++. +.....++|+|||.+....
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 99999999999999888899999999999999999999999999999999999983 2223359999999987665
Q ss_pred ccCCC---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCC
Q 026299 171 LHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA 216 (240)
Q Consensus 171 ~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 216 (240)
..... ....++-.|-++|+..+.+|+.. .|.|.|+.+++.|++|.
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGK 900 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHH
Confidence 54444 33456778999999999999766 99999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-22 Score=150.02 Aligned_cols=138 Identities=18% Similarity=0.147 Sum_probs=109.2
Q ss_pred eeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---------------------------cHHHHHHHHHHHhcCCCC
Q 026299 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------------------------DENVQREIINHRSLRHPN 78 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~~ 78 (240)
...||+|++|.||+|.+. +|+.|++|++...... ......|...+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999988 8999999998764211 112357888899999988
Q ss_pred eeeeeEEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCc
Q 026299 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPR 157 (240)
Q Consensus 79 i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~ 157 (240)
+.....+.... .++||||++|+++.........++......++.+++.++.++|+ .|++|+||+|.||+++ ++ .
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~--~ 155 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG--K 155 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC--C
Confidence 75554444332 47999999987554433344567889999999999999999999 9999999999999997 43 4
Q ss_pred EEEecCCccccc
Q 026299 158 LKICDFGYSKSS 169 (240)
Q Consensus 158 ~~L~d~~~~~~~ 169 (240)
++|+|||++...
T Consensus 156 ~~liDFG~a~~~ 167 (190)
T cd05145 156 PYIIDVSQAVEL 167 (190)
T ss_pred EEEEEcccceec
Confidence 999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=188.44 Aligned_cols=148 Identities=18% Similarity=0.201 Sum_probs=109.9
Q ss_pred HhcCC-CCeeeeeEEE-------EcCCeEEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeec
Q 026299 72 RSLRH-PNIVRFKEVI-------LTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142 (240)
Q Consensus 72 ~~l~h-~~i~~~~~~~-------~~~~~~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~ 142 (240)
+.++| .||+.+++++ .....++.++|+. +++|.+++.. ...++..++..++.||+.||+|||++||+|+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 34445 4677777766 2234567888887 4599999965 35689999999999999999999999999999
Q ss_pred CCCCCeEEcCCC-----------------CCcEEEecCCccccccccC-----------------CCCCCcCCccccCcc
Q 026299 143 LKLENTLLDGSP-----------------APRLKICDFGYSKSSVLHS-----------------QPKSTVGTPAYIAPE 188 (240)
Q Consensus 143 i~~~nili~~~~-----------------~~~~~L~d~~~~~~~~~~~-----------------~~~~~~~~~~~~~pE 188 (240)
|||+|||++..+ ...++++|||.++...... ......+++.|+|||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 999999995422 2336777777764321100 001124577799999
Q ss_pred ccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 189 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
.+.+..++.+ +|||||||++|||+++..|+..
T Consensus 186 ~~~~~~~~~~-sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 186 EDNGSSSNCA-SDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hhccCCCCch-hhhhhHHHHHHHHhhCCCchhh
Confidence 9988777555 9999999999999999888764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=148.05 Aligned_cols=187 Identities=17% Similarity=0.156 Sum_probs=136.4
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccH-----HHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEEE
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-----NVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-----~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 96 (240)
.-+...|++|+||+|+.+.. .+.+++.+.+...+...+ .+.+|+++++++. ++++++++++ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 45678999999999996655 677888887777665444 5789999999995 4889999886 4468999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecC-CCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i-~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
+|+.|.+|...... ....++.|++.++.++|+.|++|+|| +|+||+++.++. ++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCCcchH
Confidence 99999888654321 12357789999999999999999999 799999986665 999999998633322210
Q ss_pred ----C----------CCcCCccccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 176 ----K----------STVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 176 ----~----------~~~~~~~~~~pE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
. -...++.+++|+...-- ...-...++++.|.-+|.++|+..++.+.++
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 00135556666543211 1221226999999999999999988755443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-22 Score=151.04 Aligned_cols=196 Identities=22% Similarity=0.373 Sum_probs=161.0
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeec---CccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
+...+..+|.....|+.|+++++.+ .++.|++.. ....+++|..|.-.|+...||||+++++.|.....+.++..
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 4566777888999999999999844 456666544 34556789999999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhCC--ceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 98 YASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~--l~~~~~~~~~~~i~~~l~~LH~~~--ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
|++.+||...+.+... .+..+..+++.+++.++.|||+.. |.--.++...++++++-+.++.++|--++.
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf------ 341 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------ 341 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee------
Confidence 9999999999976543 677889999999999999999864 444578999999999998888887766543
Q ss_pred CCCCCcCCccccCccccccCCCC--CcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 174 QPKSTVGTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~~~--~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.......++.|++||.+++.+.+ ..++|+|||++++++|.|++.||.+...
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp 394 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP 394 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence 22234567899999999888754 3348999999999999999999988654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.6e-21 Score=141.20 Aligned_cols=108 Identities=27% Similarity=0.336 Sum_probs=90.0
Q ss_pred CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcC
Q 026299 102 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (240)
Q Consensus 102 ~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~ 180 (240)
|+|.+++.. ..++++..++.++.|++.||+|||+.+ +|+||+++.++. +++ ||.+...... ...+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc----cCCC
Confidence 578888876 456999999999999999999999998 999999987765 777 9987644322 2256
Q ss_pred CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 181 ~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
+..|+|||.+.+..++.+ +||||||+++|+|++|..||.....
T Consensus 67 ~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~ 109 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERE 109 (176)
T ss_pred cccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccch
Confidence 789999999988777555 9999999999999999999976544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=147.06 Aligned_cols=199 Identities=23% Similarity=0.243 Sum_probs=127.5
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHhcC----------CCCeeeeeEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLR----------HPNIVRFKEVI 86 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~----------h~~i~~~~~~~ 86 (240)
..+...+.||.|+++.||.+.+.++++.+++|.+...... .+.+++|......+. |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 4667788999999999999999999999999998654321 234555554444432 21233333332
Q ss_pred Ec------------CC-----eEEEEEecCCCCchHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHhhCCceeec
Q 026299 87 LT------------PT-----HLAIVMEYASGGELFERIC---NAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRD 142 (240)
Q Consensus 87 ~~------------~~-----~~~lv~~~~~~~~l~~~l~---~~~~----l~~~~~~~~~~~i~~~l~~LH~~~ivh~~ 142 (240)
.- .. +.+++|+-+.+ +|.+++. .... +.......+..|+++.+++||..|+||+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 21 11 23678887755 7766643 2222 12223344558999999999999999999
Q ss_pred CCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcCCccccCccccccC-------CCCCcccchHHHHHHHHHHHhC
Q 026299 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-------EYDGKIADVWSCGVTLYVMLVG 215 (240)
Q Consensus 143 i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-------~~~~~~~Di~slG~~l~~l~~g 215 (240)
|+|+|++++.++. +.|+||+........... ......|.+||..... ...+.+.|.|+||+++|+|+|+
T Consensus 171 i~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGG--VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS---EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCC--EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999988776 999999987654443332 3334678899976442 2234448999999999999999
Q ss_pred CCCCCCCCc
Q 026299 216 AYPFEDPEE 224 (240)
Q Consensus 216 ~~pf~~~~~ 224 (240)
..||.....
T Consensus 247 ~lPf~~~~~ 255 (288)
T PF14531_consen 247 RLPFGLSSP 255 (288)
T ss_dssp S-STCCCGG
T ss_pred cCCCCCCCc
Confidence 999976543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-20 Score=139.02 Aligned_cols=136 Identities=18% Similarity=0.230 Sum_probs=105.9
Q ss_pred eEeeeecCCCceeEEEEEecCCCcEEEEEEeecC-ccccHHHHHHHHHHHhc-----CCCCeeeeeEEEEcCC---e-EE
Q 026299 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSL-----RHPNIVRFKEVILTPT---H-LA 93 (240)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~~ 93 (240)
.-.+.||+|+++.||. +..++.. +||++... ....+.+.+|+..++.+ .||||+++++++.++. . +.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999995 6666665 68887664 22346789999999999 5799999999999873 3 33
Q ss_pred EEEec--CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHhhCCceeecCCCCCeEEcCC--CCCcEEEecCCc
Q 026299 94 IVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGY 165 (240)
Q Consensus 94 lv~~~--~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l-~~LH~~~ivh~~i~~~nili~~~--~~~~~~L~d~~~ 165 (240)
+|+|| ..+++|.+++.+. .+++. ..++.+++.++ +|||+.+|+|+||+|+||+++.. +...++|+|++-
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 4478999999664 45555 45678888777 99999999999999999999743 233699999443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-20 Score=142.28 Aligned_cols=140 Identities=17% Similarity=0.101 Sum_probs=110.5
Q ss_pred CCeeEeeeecCCCceeEEEEE-ecCCCcEEEEEEeecCccc-------------------------cHHHHHHHHHHHhc
Q 026299 21 DRYELVRDIGSGNFGVARLMR-DKKTEELVAVKYIERGDKI-------------------------DENVQREIINHRSL 74 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~-~~~~~~~v~iK~~~~~~~~-------------------------~~~~~~e~~~l~~l 74 (240)
.-|++.+.||.|++|.||.|. +..+|..|++|.+...... ...+.+|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 468899999999999999999 6678999999998754210 01246799999888
Q ss_pred CCCC--eeeeeEEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC-ceeecCCCCCeEEc
Q 026299 75 RHPN--IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLD 151 (240)
Q Consensus 75 ~h~~--i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~-ivh~~i~~~nili~ 151 (240)
.+.+ +.++++. ...++|||+++|.++.........+....+..++.|++.++.+||+.| ++|+||+|+||+++
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 7533 4444433 234799999999887765544455677778899999999999999999 99999999999998
Q ss_pred CCCCCcEEEecCCccc
Q 026299 152 GSPAPRLKICDFGYSK 167 (240)
Q Consensus 152 ~~~~~~~~L~d~~~~~ 167 (240)
++ .++|+|||.+.
T Consensus 184 -~~--~i~LiDFg~a~ 196 (237)
T smart00090 184 -DG--KVVIIDVSQSV 196 (237)
T ss_pred -CC--CEEEEEChhhh
Confidence 43 49999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.9e-21 Score=164.82 Aligned_cols=201 Identities=35% Similarity=0.590 Sum_probs=158.3
Q ss_pred eEeeeecCCCceeEEEEEecCCCcEEEEEEee----cCcccc---HHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIE----RGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~----~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
.....+|.|++|.++.+......+.+..|.+. ...... ..+..|+.+-..++|+|++.....+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45667888999988888877666656666443 211111 11445666667889999988777766655544459
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC-
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~- 175 (240)
||+++ .|..++.....++..++..++.|++.|++|+|+.|+.|+|++++|+++..++. ++++|||.+.-...+...
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCcchh
Confidence 99999 89888877778999999999999999999999999999999999999988876 999999998633333222
Q ss_pred ----CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 176 ----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 176 ----~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
....++..|+|||.+.+..+.+...||||.|++++.|.+|+.||......+.
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 2345788999999999999999989999999999999999999987655543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.1e-21 Score=166.90 Aligned_cols=194 Identities=24% Similarity=0.381 Sum_probs=148.5
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHH--HHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIIN--HRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
.|..++.||++.|=+|.++++.+ |. |++|++-+.. ...+.+.+.++- ....++||.+++.-+.......|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 78999999999999999998884 44 8999986543 222344433333 445589999999888777777888989
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC-
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~- 176 (240)
|... +|.|.+...+-+..-+.+.++.|++.|+...|+.||+|||||.+|||+..... +.|.||......-......
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCCCCCcc
Confidence 8854 89999987777899999999999999999999999999999999999987776 9999998753222221111
Q ss_pred C-------CcCCccccCccccccCC---------C-CCcccchHHHHHHHHHHHh-CCCCCC
Q 026299 177 S-------TVGTPAYIAPEVLLKKE---------Y-DGKIADVWSCGVTLYVMLV-GAYPFE 220 (240)
Q Consensus 177 ~-------~~~~~~~~~pE~~~~~~---------~-~~~~~Di~slG~~l~~l~~-g~~pf~ 220 (240)
. ......|.|||.+.... . -.++=||||+||+++||++ |..||.
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 1 11344699999886522 1 1334699999999999998 688874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.2e-19 Score=134.44 Aligned_cols=133 Identities=23% Similarity=0.218 Sum_probs=109.9
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCccc---------cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
+.||+|++|.||++.+ .+..+++|........ ...+.+|+..+..++|+++.....++......+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999987 5667889975542211 1346788999999999998887777777778899999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
|++|.+|.+++..... ....++.+++.++.++|+.|++|+|++|.||+++ ++ .++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~--~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG--KIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC--CEEEEECCcccC
Confidence 9999999998865322 8888999999999999999999999999999998 33 389999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-18 Score=129.77 Aligned_cols=129 Identities=21% Similarity=0.187 Sum_probs=102.7
Q ss_pred eecCCCceeEEEEEecCCCcEEEEEEeecCcc-c--------cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDK-I--------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 28 ~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
.||+|++|.||++.. ++..+++|....... . ..++.+|+..++.++++++.....++......+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 479999999999985 467789998554211 0 14466899999999888766665566666677899999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
++|++|.+.+..... .++.+++.++.+||+.|++|+|++|.||+++ ++ .++++|||.+..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~--~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD--KLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC--cEEEEECCCCcC
Confidence 999999887754321 7899999999999999999999999999998 33 499999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.8e-20 Score=152.48 Aligned_cols=193 Identities=28% Similarity=0.499 Sum_probs=155.6
Q ss_pred ecCCCceeEEEEEec---CCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 29 IGSGNFGVARLMRDK---KTEELVAVKYIERGDK---IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 29 l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
+|.|.+|.|+.++.. ..+..+++|+.+.... .......|-.++..++ ||.++++.-.+..+...+++.++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 688999988877644 3477788887765321 1123455667777776 99999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcCC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~ 181 (240)
+.+...+......++.....+...++-+++.+|+.|++++|+|++||+++.+++ +++.|||.+......... .++
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cgt 156 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CGT 156 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---ccc
Confidence 888888877788889999999999999999999999999999999999988776 999999998644333222 678
Q ss_pred ccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 182 ~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
..|+|||++. .. ..++|+||||++.++|++|..||.. +...+|+.
T Consensus 157 ~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~ 201 (612)
T KOG0603|consen 157 YEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK 201 (612)
T ss_pred hhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh
Confidence 8999999987 22 3348999999999999999999988 44444444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.5e-18 Score=127.91 Aligned_cols=133 Identities=22% Similarity=0.253 Sum_probs=103.9
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-----------------------ccHHHHHHHHHHHhcCCCC
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------------------IDENVQREIINHRSLRHPN 78 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~~ 78 (240)
.|.+.+.|++|++|.||++... ++..+++|++..+.. .......|+..+..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888999999999999999886 789999998764321 0113567788888887764
Q ss_pred --eeeeeEEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC
Q 026299 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (240)
Q Consensus 79 --i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~ 156 (240)
++..++ ....+++|||++|.+|..... ......++.+++.++.++|+.|++|+||+|.||+++.++.
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~- 163 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK- 163 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc-
Confidence 444433 234589999999988876432 1345678899999999999999999999999999987655
Q ss_pred cEEEecCCccc
Q 026299 157 RLKICDFGYSK 167 (240)
Q Consensus 157 ~~~L~d~~~~~ 167 (240)
++|+|||.+.
T Consensus 164 -~~liDfg~~~ 173 (198)
T cd05144 164 -IYIIDWPQMV 173 (198)
T ss_pred -EEEEECCccc
Confidence 9999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=143.56 Aligned_cols=135 Identities=22% Similarity=0.198 Sum_probs=107.2
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEee-cCc--------cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGD--------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~-~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
.|...+.||+|++|.||++.+.... +++|+.. ... ...+++.+|+..++.++|++++....+.......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3456789999999999999876443 3333321 110 1124578999999999999998887777777778
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
++||||++|++|.+++. ....++.+++.++.+||+.|++|+|++|+||+++ ++ .++|+|||.+...
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCcccccC
Confidence 89999999999998774 3467899999999999999999999999999994 33 3899999998643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.7e-16 Score=120.24 Aligned_cols=133 Identities=20% Similarity=0.233 Sum_probs=100.3
Q ss_pred eeec-CCCceeEEEEEecCCCcEEEEEEeecCc--------------cccHHHHHHHHHHHhcCCCCe--eeeeEEEEcC
Q 026299 27 RDIG-SGNFGVARLMRDKKTEELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNI--VRFKEVILTP 89 (240)
Q Consensus 27 ~~l~-~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~ 89 (240)
..+| .|+.|++|.+... +..+++|.+.... .....+.+|+..+..++|+++ +..+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3465 7888888888775 6678999875311 122457889999999998875 5666654332
Q ss_pred C----eEEEEEecCCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 90 T----HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 90 ~----~~~lv~~~~~~-~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
. ..++|+|+++| .+|.+++.. .+++... +.+++.++.+||+.||+|+||+|.||+++.++. ++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECC
Confidence 2 23599999997 688887754 4455543 568999999999999999999999999987654 9999999
Q ss_pred cccc
Q 026299 165 YSKS 168 (240)
Q Consensus 165 ~~~~ 168 (240)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.3e-16 Score=118.32 Aligned_cols=132 Identities=22% Similarity=0.281 Sum_probs=93.8
Q ss_pred eeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHH-------------------------HHHHHHHHhcCCCC--
Q 026299 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV-------------------------QREIINHRSLRHPN-- 78 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~-------------------------~~e~~~l~~l~h~~-- 78 (240)
.+.||+|++|.||.+.+. ++..|++|++.+........ ..|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999987 78899999887643221111 24455555554332
Q ss_pred eeeeeEEEEcCCeEEEEEecCCCCchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCC
Q 026299 79 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAP 156 (240)
Q Consensus 79 i~~~~~~~~~~~~~~lv~~~~~~~~l~~-~l~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~ 156 (240)
+.+.++. ...+++|||++++.+.. .+... .. ......++.+++.++.++|. .|++|+||+|+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-- 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-- 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC--
Confidence 3444433 23589999999844321 11111 11 16678899999999999999 9999999999999998 44
Q ss_pred cEEEecCCccc
Q 026299 157 RLKICDFGYSK 167 (240)
Q Consensus 157 ~~~L~d~~~~~ 167 (240)
.++|+|||.+.
T Consensus 152 ~~~liDfg~a~ 162 (187)
T cd05119 152 KVYIIDVPQAV 162 (187)
T ss_pred cEEEEECcccc
Confidence 49999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.7e-16 Score=112.14 Aligned_cols=131 Identities=24% Similarity=0.272 Sum_probs=108.8
Q ss_pred EeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCC--CCeeeeeEEEEcCCeEEEEEecCCCC
Q 026299 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG 102 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (240)
+++.++.|.++.+|++.... ..+++|....... ...+.+|...++.+++ .++++++.+....+..+++++|+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46789999999999999864 6799998766543 4578899999999976 58899988888778899999999887
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC---CceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 103 ~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~---~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
++... +......++.+++.++..+|.. +++|+|++|+||+++..+ .+++.||+.+.
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~--~~~l~Df~~~~ 137 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAG 137 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc--EEEEEeccccc
Confidence 66543 5566677889999999999974 799999999999998644 49999999764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.7e-17 Score=141.91 Aligned_cols=175 Identities=34% Similarity=0.582 Sum_probs=127.7
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
..+|..++.+..|++|.||.+++..+.+.+++| +.+.. .+++. ++.....|.++
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc----hhhhc--cccccCCccee-------------------
Confidence 478999999999999999999999999999996 43322 12221 22222233322
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC------
Q 026299 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS------ 173 (240)
Q Consensus 100 ~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~------ 173 (240)
+.-.+.++..++++..- +.+++|||+.||+|+|++|+|.+|..-+. +|+.|||++.......
T Consensus 136 --gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 136 --GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred --chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhh
Confidence 12233344444443332 78899999999999999999999976665 9999999974221111
Q ss_pred ----------CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 174 ----------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 174 ----------~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
....-.+++.|.|||++....+..+ .|+|++|+++|+.+-|..||-+.+...+|-+.+.
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 1112247899999999988888777 9999999999999999999999888887776654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=121.67 Aligned_cols=147 Identities=30% Similarity=0.435 Sum_probs=112.0
Q ss_pred CCCCeeeeeEEEEcC---------------------------CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHH
Q 026299 75 RHPNIVRFKEVILTP---------------------------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127 (240)
Q Consensus 75 ~h~~i~~~~~~~~~~---------------------------~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~ 127 (240)
+||||+.+.+.|.++ ..+|+||...+. +|.+++-.+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence 599999999887642 137899988755 8998885443 47777888899999
Q ss_pred HHHHHHhhCCceeecCCCCCeEE--cCCCCCcEEEecCCccccccc-----c--CCCCCCcCCccccCccccccCCC---
Q 026299 128 SGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL-----H--SQPKSTVGTPAYIAPEVLLKKEY--- 195 (240)
Q Consensus 128 ~~l~~LH~~~ivh~~i~~~nili--~~~~~~~~~L~d~~~~~~~~~-----~--~~~~~~~~~~~~~~pE~~~~~~~--- 195 (240)
+|+.+||+.|+.|+|+|.+||++ ++|..+.+.+.|||.+-.... . ......-|....+|||+....+.
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999998 455566799999998742221 1 11122335667899998754331
Q ss_pred --CCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 196 --DGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 196 --~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
...++|.|+.|.+.||++....||....
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rG 461 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRG 461 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccc
Confidence 2233899999999999999999998743
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.4e-16 Score=129.09 Aligned_cols=153 Identities=24% Similarity=0.360 Sum_probs=125.0
Q ss_pred HHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCc-eeecCCCCCe
Q 026299 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQV-CHRDLKLENT 148 (240)
Q Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~i-vh~~i~~~ni 148 (240)
++.+.|.|+.+++|.+.++...+.|.++++.|+|.+.+.. ...++......++++++++++|||+..| .||.++..|-
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3567899999999999999999999999999999999976 4568888899999999999999998765 9999999999
Q ss_pred EEcCCCCCcEEEecCCcccccccc---CCCCCCcCCccccCccccccCCC------CCcccchHHHHHHHHHHHhCCCCC
Q 026299 149 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEY------DGKIADVWSCGVTLYVMLVGAYPF 219 (240)
Q Consensus 149 li~~~~~~~~~L~d~~~~~~~~~~---~~~~~~~~~~~~~~pE~~~~~~~------~~~~~Di~slG~~l~~l~~g~~pf 219 (240)
+++.... +||.|||+....... ..........-|.|||.+..... .+++.|+||||++++++++...||
T Consensus 81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9988887 999999997644321 11111223557899999876421 245599999999999999999999
Q ss_pred CCCCch
Q 026299 220 EDPEEP 225 (240)
Q Consensus 220 ~~~~~~ 225 (240)
......
T Consensus 159 ~~~~~~ 164 (484)
T KOG1023|consen 159 DLRNLV 164 (484)
T ss_pred cccccc
Confidence 885443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.8e-14 Score=121.76 Aligned_cols=166 Identities=19% Similarity=0.280 Sum_probs=129.4
Q ss_pred EEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHH
Q 026299 40 MRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 118 (240)
Q Consensus 40 ~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~ 118 (240)
+....++.+|.+..+...+. ..+...+.++.++.+|||||+++++.+..+...|+|+|.+. .|..++.+ ++...
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---l~~~~ 105 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---LGKEE 105 (690)
T ss_pred cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---hHHHH
Confidence 44556788888887776554 23457888999999999999999999999999999999875 56667765 35788
Q ss_pred HHHHHHHHHHHHHHHh-hCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC-CCCCcCCccccCccccccCCCC
Q 026299 119 ARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYD 196 (240)
Q Consensus 119 ~~~~~~~i~~~l~~LH-~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~ 196 (240)
+...++||+.||-+|| +.+++|+++..+.|+++..++ .+|++|..+........ .....-...|..|+.+....+
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~- 182 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEW- 182 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCcccc-
Confidence 8888999999999998 678999999999999988877 99999998754433332 222223335666766544432
Q ss_pred CcccchHHHHHHHHHHHhC
Q 026299 197 GKIADVWSCGVTLYVMLVG 215 (240)
Q Consensus 197 ~~~~Di~slG~~l~~l~~g 215 (240)
..|.|.||+++++++.|
T Consensus 183 --s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 --SIDSWGLGCLIEELFNG 199 (690)
T ss_pred --chhhhhHHHHHHHHhCc
Confidence 26999999999999999
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.6e-16 Score=128.44 Aligned_cols=119 Identities=29% Similarity=0.401 Sum_probs=101.9
Q ss_pred CeEEEEEecCCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 90 THLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~~---~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
.++++.|+++.-.+|.+++.+.+ ..+......++.|+..+++| +|.+|+|++|.||+...+.. ++++|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhhe
Confidence 35789999999999999997543 36677889999999999999 99999999999999987775 899999998
Q ss_pred ccccccC-------CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh
Q 026299 167 KSSVLHS-------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214 (240)
Q Consensus 167 ~~~~~~~-------~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~ 214 (240)
....... ......++..|++||++.+..+..+ +||||||.++++|+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHH
Confidence 6554444 4445678999999999998888776 999999999999987
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.2e-16 Score=133.92 Aligned_cols=207 Identities=35% Similarity=0.557 Sum_probs=164.5
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCC-CcEEEEEEeecCc---cccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 93 (240)
....|.+.+.+|.|+++.+..+....+ ...++.|.+.... ........|......+. |.|++..++...+.+..+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 357899999999999999988887644 4456666554433 22234445777777776 999999999999999999
Q ss_pred EEEecCCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHh-hCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 94 IVMEYASGGELFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 94 lv~~~~~~~~l~~~l-~~~~-~l~~~~~~~~~~~i~~~l~~LH-~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
+.+++.+|+++.+.. .... ..+.......+.|+..++.|+| ..++.|+|++|+|.+++..+. .+++.|||++....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYR 176 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccc
Confidence 999999998888777 4443 5777888899999999999999 999999999999999987772 38999999997554
Q ss_pred c-cCCC---CCCcC-CccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 171 L-HSQP---KSTVG-TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 171 ~-~~~~---~~~~~-~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
. .... ....+ ++.|.|||...+.....+..|+||.|+++.-+++|..||......+
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 4 2111 23346 8899999999886665666999999999999999999997765544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-13 Score=103.26 Aligned_cols=136 Identities=14% Similarity=0.170 Sum_probs=98.0
Q ss_pred eeecCCCceeEEEEEecC------CCcEEEEEEeec--------------Ccc---------ccHH----HHHHHHHHHh
Q 026299 27 RDIGSGNFGVARLMRDKK------TEELVAVKYIER--------------GDK---------IDEN----VQREIINHRS 73 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~------~~~~v~iK~~~~--------------~~~---------~~~~----~~~e~~~l~~ 73 (240)
..++.|..+.||.|.... .+..+|+|++.- +.. .... ..+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468899999999998764 357899998642 111 0112 2488889988
Q ss_pred cCC--CCeeeeeEEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhCCceeecCCCCCeEE
Q 026299 74 LRH--PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLL 150 (240)
Q Consensus 74 l~h--~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~L-H~~~ivh~~i~~~nili 150 (240)
+.. -.++.++++ ..-++||||+.+..+.........++...+..+..+++.++..| |+.|+||||+++.||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 864 455666654 34579999997643322222233456667778889999999988 89999999999999999
Q ss_pred cCCCCCcEEEecCCccccc
Q 026299 151 DGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 151 ~~~~~~~~~L~d~~~~~~~ 169 (240)
.++ .+.++||+.+...
T Consensus 159 ~~~---~v~iIDF~qav~~ 174 (197)
T cd05146 159 HDG---KVWFIDVSQSVEP 174 (197)
T ss_pred ECC---cEEEEECCCceeC
Confidence 643 3899999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.9e-14 Score=103.11 Aligned_cols=127 Identities=20% Similarity=0.253 Sum_probs=94.1
Q ss_pred eeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCee-eeeEEEEcCCeEEEEEecCCCCch
Q 026299 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
++.++.|..+.+|.++.. +..|++|..............|+..++.+.+.+++ +++... ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467888999999999865 67899998765543334567889999888655543 444443 2334799999999877
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCc-----eeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQV-----CHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 105 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~i-----vh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
.+. . ......+.++++++..||+.++ +|||++|.||+++ ++ .++++||+.+.
T Consensus 79 ~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~ 135 (170)
T cd05151 79 LTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAG 135 (170)
T ss_pred ccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEeccccc
Confidence 643 0 1113456789999999999885 9999999999998 33 38999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.7e-13 Score=112.06 Aligned_cols=137 Identities=17% Similarity=0.156 Sum_probs=92.3
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCcccc-----------------------------------------HHHH
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----------------------------------------ENVQ 65 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-----------------------------------------~~~~ 65 (240)
+.++.|+.|.||+|+.. +|+.||||+..++-... -++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999986 68899999976532100 0123
Q ss_pred HHHHHHHhcC-----CCCeeeeeEEEEcCCeEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHhhCCc
Q 026299 66 REIINHRSLR-----HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLIS-GVSYCHSMQV 138 (240)
Q Consensus 66 ~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~-~l~~LH~~~i 138 (240)
+|...+.+++ ++++.-..-+.......++||||++|.++.+..... ...+ ...++..++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 3444443332 233322222222234568999999999998876432 1222 3445566655 4678999999
Q ss_pred eeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 139 vh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
+|+|++|.||++..++. ++++|||.+...
T Consensus 279 ~H~D~hPgNilv~~~g~--i~liDfG~~~~l 307 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGK--IIALDFGIVGRL 307 (437)
T ss_pred eeCCCCcccEEECCCCc--EEEEeCCCeeEC
Confidence 99999999999976665 999999998544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.3e-12 Score=94.53 Aligned_cols=143 Identities=17% Similarity=0.119 Sum_probs=109.2
Q ss_pred EeeeecCCCceeEEEEEecCCCcEEEEEEe-ec---Cc-----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYI-ER---GD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~-~~---~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
-+..+.+|+.+.|+.+.+. |+.++||.= .+ .+ -...+.++|...|.+++-..|.-..-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5778899999998888775 777777742 11 11 1224568899999998877877777778787778899
Q ss_pred EecCCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCc-EEEecCCccccc
Q 026299 96 MEYASG-GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR-LKICDFGYSKSS 169 (240)
Q Consensus 96 ~~~~~~-~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~-~~L~d~~~~~~~ 169 (240)
|||++| .++.+++... .+...+....+++++-+.+.-||..+|+||||.++||++.+++... +.|+|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999988 4677777543 2334444578889999999999999999999999999997766543 599999997533
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.1e-12 Score=93.75 Aligned_cols=129 Identities=22% Similarity=0.217 Sum_probs=99.1
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEe-ec---Cccc-----cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYI-ER---GDKI-----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~-~~---~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
..+++|+.+.++.+.. -|..+++|.= .+ .+.. .++-.+|..++.+++...+....-+..+.+...++||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3578899999998855 3445777742 21 1111 1346789999999988788777777788888899999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
|++|..|.+.+... ...++..+-..+.-||..||+|||+.++|+++..+. +.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCccc
Confidence 99999999888655 144566666667779999999999999999997555 8999999975
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.7e-13 Score=114.14 Aligned_cols=140 Identities=24% Similarity=0.347 Sum_probs=90.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc-----------------------------------cH---
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-----------------------------------DE--- 62 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----------------------------------~~--- 62 (240)
..|+. +.+++|+.|.||.|+...+|+.||||+..++-.. .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 7899999999999999977999999998754100 01
Q ss_pred ---HHHHHHHHHHhcC----CCCeeeeeEEEEc-CCeEEEEEecCCCCchHHHH--HhcC----CCCHHHHHHHHHHHHH
Q 026299 63 ---NVQREIINHRSLR----HPNIVRFKEVILT-PTHLAIVMEYASGGELFERI--CNAG----RFSEDEARFFFQQLIS 128 (240)
Q Consensus 63 ---~~~~e~~~l~~l~----h~~i~~~~~~~~~-~~~~~lv~~~~~~~~l~~~l--~~~~----~l~~~~~~~~~~~i~~ 128 (240)
++.+|.....+++ +...+.+=.++.+ ....++||||++|+.+.++. ...+ .+.+..+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 1233443343332 3222222222222 34567999999999997742 2222 13333344444444
Q ss_pred HHHHHhhCCceeecCCCCCeEEcCCC--CCcEEEecCCcccc
Q 026299 129 GVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKS 168 (240)
Q Consensus 129 ~l~~LH~~~ivh~~i~~~nili~~~~--~~~~~L~d~~~~~~ 168 (240)
...|++|+|++|.||+++.++ .++++++|||.+..
T Consensus 277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 468999999999999997665 23599999999753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.4e-12 Score=107.83 Aligned_cols=198 Identities=21% Similarity=0.196 Sum_probs=155.8
Q ss_pred CCeeEeeeecC--CCceeEEEEEe--cCCCcEEEEEEeecC---ccccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeE
Q 026299 21 DRYELVRDIGS--GNFGVARLMRD--KKTEELVAVKYIERG---DKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHL 92 (240)
Q Consensus 21 ~~y~~~~~l~~--g~~g~v~~~~~--~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 92 (240)
..+...+.+|. |.+|.+|.+.. ..++..+++|.-+.. +....+..+|+....+++ |++.++.+..+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 46677888999 99999999999 888999999984332 234455678888887775 89999988899999999
Q ss_pred EEEEecCCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 93 AIVMEYASGGELFERICNAGR-FSEDEARFFFQQLIS----GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~-l~~~~~~~~~~~i~~----~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
++-+|.+. .++..+...-.+ ++...++..+.+... |+..+|..+++|.+++|.||+...+.. ..+++||+...
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~-s~~~~df~~v~ 271 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWT-SCKLTDFGLVS 271 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccc-eeecCCcceeE
Confidence 99999885 577776655444 888999999999999 999999999999999999999987742 48999999987
Q ss_pred cccccCCCC------CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 168 SSVLHSQPK------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 168 ~~~~~~~~~------~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
......... ...+...|++||...+.. ....|+++||.++.+-..+..++...
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCC
Confidence 555444222 224677899999875544 34489999999999887776655433
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.5e-11 Score=91.84 Aligned_cols=139 Identities=20% Similarity=0.267 Sum_probs=101.0
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCC--CeeeeeEEEEcC---CeEEEEEecC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHP--NIVRFKEVILTP---THLAIVMEYA 99 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~---~~~~lv~~~~ 99 (240)
+.++.|..+.+|++.... |..+++|....... ....+..|...++.+++. .+++++.+.... +..+++|+++
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 678899999999998753 67899998765443 345688999999998764 456677766553 2568999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------------
Q 026299 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------- 135 (240)
Q Consensus 100 ~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~-------------------------------------------- 135 (240)
+|.++.+.+.. ..++......++.++++++..||+
T Consensus 83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 99877664421 345666666666677666666663
Q ss_pred ------------CCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 136 ------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 136 ------------~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
..++|||+.+.||+++.+....+.++||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999987422337899998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.6e-10 Score=90.98 Aligned_cols=129 Identities=13% Similarity=0.037 Sum_probs=92.9
Q ss_pred EEEEEecCCCcEEEEEEeecCccc------------cHHHHHHHHHHHhcCCCCee--eeeEEEEc-----CCeEEEEEe
Q 026299 37 ARLMRDKKTEELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIV--RFKEVILT-----PTHLAIVME 97 (240)
Q Consensus 37 v~~~~~~~~~~~v~iK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~--~~~~~~~~-----~~~~~lv~~ 97 (240)
|+.+.. +|+.|.+|........ ...+.+|+..+.++...+|. .+..+... ....++|||
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 444433 4667899976432210 01477899999888654443 33445543 234689999
Q ss_pred cCCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC-----CCCCcEEEecCCccc
Q 026299 98 YASGG-ELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSK 167 (240)
Q Consensus 98 ~~~~~-~l~~~l~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~-----~~~~~~~L~d~~~~~ 167 (240)
++++. +|.+++.. ..+.+......++.+++..+.-||+.|++|+|++++||+++. ++...+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99885 78888753 344567778899999999999999999999999999999975 234569999999774
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.28 E-value=9.8e-11 Score=97.02 Aligned_cols=179 Identities=18% Similarity=0.226 Sum_probs=129.5
Q ss_pred CCeeEeeeecC-C--CceeEEEEEecCCCcEEEEEEeecCcccc-HHHHHHHHHHHhcCCCCeeeeeEEEEc----CCeE
Q 026299 21 DRYELVRDIGS-G--NFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVILT----PTHL 92 (240)
Q Consensus 21 ~~y~~~~~l~~-g--~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 92 (240)
..|.-+..+.. + ...+.|++...-+|..|++|+++-+.... ...-.-++.++++.|.|++++.+++.. +..+
T Consensus 273 ~~~~~L~pl~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~Sl 352 (655)
T KOG3741|consen 273 ESFVNLYPLELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSL 352 (655)
T ss_pred hhhhceeecccccccccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceE
Confidence 44444444432 2 34688999999999999999994322111 223355788899999999999998873 3578
Q ss_pred EEEEecCCC-CchHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC
Q 026299 93 AIVMEYASG-GELFERICN---------------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (240)
Q Consensus 93 ~lv~~~~~~-~~l~~~l~~---------------~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~ 156 (240)
++|++|.++ .+|.+.... +...+++.+|.++.|+..||.++|+.|+..+-+.|.+|++..+.
T Consensus 353 vlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-- 430 (655)
T KOG3741|consen 353 VLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-- 430 (655)
T ss_pred EEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--
Confidence 999999975 567665422 22477899999999999999999999999999999999997554
Q ss_pred cEEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCC
Q 026299 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218 (240)
Q Consensus 157 ~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 218 (240)
++++...|......... . +-+.. ..+.|.-.||.++..|.+|..-
T Consensus 431 RIriS~C~i~Dvl~~d~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 431 RIRISGCGIMDVLQEDP-----------T--EPLES----QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eEEEecccceeeecCCC-----------C--cchhH----HhhhhHHHHHHHHHHHhhcccc
Confidence 48888777654332222 0 11211 1237999999999999998644
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.26 E-value=9.8e-11 Score=87.12 Aligned_cols=124 Identities=26% Similarity=0.299 Sum_probs=79.7
Q ss_pred eEEEEEecCCCcEEEEEEeecC--------------cc--------c-----cHHHHHHHHHHHhcCCC--CeeeeeEEE
Q 026299 36 VARLMRDKKTEELVAVKYIERG--------------DK--------I-----DENVQREIINHRSLRHP--NIVRFKEVI 86 (240)
Q Consensus 36 ~v~~~~~~~~~~~v~iK~~~~~--------------~~--------~-----~~~~~~e~~~l~~l~h~--~i~~~~~~~ 86 (240)
.||.|... ++..+|+|..... .. . .....+|+..|.++... ++++++.+.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 37888875 6778999986421 01 0 12457899999999765 456666442
Q ss_pred EcCCeEEEEEecCC--CCchHHHHHhcCCCCHHHHHHHHHHHHHH-HHHHhhCCceeecCCCCCeEEcCCCCCcEEEecC
Q 026299 87 LTPTHLAIVMEYAS--GGELFERICNAGRFSEDEARFFFQQLISG-VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (240)
Q Consensus 87 ~~~~~~~lv~~~~~--~~~l~~~l~~~~~l~~~~~~~~~~~i~~~-l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~ 163 (240)
.-++||||++ |..+..+.... ++..+...++.+++.. ...+|+.|++|||+++.||+++++ ++.++||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEEEEec
Confidence 2369999998 76665433221 2245566677777774 444689999999999999999866 3999999
Q ss_pred Cccccc
Q 026299 164 GYSKSS 169 (240)
Q Consensus 164 ~~~~~~ 169 (240)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 987533
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.5e-11 Score=96.45 Aligned_cols=153 Identities=20% Similarity=0.311 Sum_probs=111.6
Q ss_pred HHHHhcCCCCeeeeeEEEEcCC-----eEEEEEecCCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhC--C
Q 026299 69 INHRSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSM--Q 137 (240)
Q Consensus 69 ~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~~~~~~~~l~~~l~~~----~~l~~~~~~~~~~~i~~~l~~LH~~--~ 137 (240)
..+.++-|.||++++.++.+.. ...++++|++.+++..+|.+. ..+.....++|+-||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 4455667999999999987653 467899999999999999753 3588899999999999999999987 4
Q ss_pred ceeecCCCCCeEEcCCCCCcEEEecCCccccc-----cccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHH
Q 026299 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-----VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (240)
Q Consensus 138 ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~-----~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l 212 (240)
|+|+++..+.|++..++- ++++........ ........+.+-++|.+||.=.....+.. +|||+||+...+|
T Consensus 199 iihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAlem 275 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALEM 275 (458)
T ss_pred cccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHHH
Confidence 999999999999986664 555432211100 01111223345678899987555555455 9999999999999
Q ss_pred HhCCCCCCCCCc
Q 026299 213 LVGAYPFEDPEE 224 (240)
Q Consensus 213 ~~g~~pf~~~~~ 224 (240)
..+...-.....
T Consensus 276 ailEiq~tnseS 287 (458)
T KOG1266|consen 276 AILEIQSTNSES 287 (458)
T ss_pred HHheeccCCCcc
Confidence 887765444333
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-10 Score=89.81 Aligned_cols=133 Identities=20% Similarity=0.229 Sum_probs=100.2
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC-------------------c----cccHHHHHHHHHHHhcCCC--
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-------------------D----KIDENVQREIINHRSLRHP-- 77 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~-------------------~----~~~~~~~~e~~~l~~l~h~-- 77 (240)
+.+...||-|..+.||.+.+. .|.++++|.-..+ - -......+|.+.|.++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 345678999999999999998 7888999963211 0 0112467899999988654
Q ss_pred CeeeeeEEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCc
Q 026299 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (240)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~ 157 (240)
.+++.+++ +.-.+|||+++|..|...- ++.+....++..|++-+.-+-..|+||||+++-||+++.++.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-- 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-- 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence 67777665 5668999999997775432 245556666667776666666899999999999999998877
Q ss_pred EEEecCCccc
Q 026299 158 LKICDFGYSK 167 (240)
Q Consensus 158 ~~L~d~~~~~ 167 (240)
+.++||-.+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.5e-11 Score=103.14 Aligned_cols=194 Identities=21% Similarity=0.195 Sum_probs=142.4
Q ss_pred CCeeEeeeecCCCceeEEEEEec-CCCcEEEEEEeecCcccc---HHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDKID---ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 95 (240)
.+|..+..++.+.++.++.+..+ .++..|++|-..+..... ..-..|+.....+ .|.+.+.+...+......++-
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 67899999999999998887766 788899999776643221 2235666666655 477877776666666666799
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
-||+.++++.....-...+.+...+.+..|++.++.++|+..++|.|++|+||++..++ ...+++|++..... ....
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~--~~~~ 421 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRL--AFSS 421 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhcccccccccc--ceec
Confidence 99999888766554445578889999999999999999999999999999999998754 34799999987641 1122
Q ss_pred CCCcCCcccc-CccccccCCCCCcccchHHHHHHHHHHHhCCC
Q 026299 176 KSTVGTPAYI-APEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217 (240)
Q Consensus 176 ~~~~~~~~~~-~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 217 (240)
.......++. ..|.+........+.|+++||..+.+..++..
T Consensus 422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 2222333444 25555555555666999999998888877653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.12 E-value=2e-09 Score=81.83 Aligned_cols=107 Identities=18% Similarity=0.188 Sum_probs=84.4
Q ss_pred cHHHHHHHHHHHhcCCCC--eeeeeEEEEcC----CeEEEEEecCCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 026299 61 DENVQREIINHRSLRHPN--IVRFKEVILTP----THLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYC 133 (240)
Q Consensus 61 ~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~----~~~~lv~~~~~~-~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~L 133 (240)
.....+|+..+..+...+ .++++.+.... ...++|++++++ .+|.+++.....++......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 356788998888886444 34455555542 235899999987 47888887655567888889999999999999
Q ss_pred hhCCceeecCCCCCeEEcCCC-CCcEEEecCCccc
Q 026299 134 HSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 167 (240)
Q Consensus 134 H~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~ 167 (240)
|+.|++|+|+++.|||++.+. ...+.|+||+.+.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 999999999999999998765 4459999999765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.2e-11 Score=105.59 Aligned_cols=216 Identities=26% Similarity=0.358 Sum_probs=157.5
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccH----HHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
...++.+.+.+.+.++.++.++.+.-..++.....|+....+.... ....+-..+-..++|-++...--+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 3455778888888999999999998888887666666544332211 111111111112334444433333445667
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc--
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-- 170 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~-- 170 (240)
.+++++..++.|...+.+.++.+.+........+..++++||...+.|++++|.|.+...++. ..+.|++......
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLI 957 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccc
Confidence 899999998999998988888888888888899999999999999999999999999976665 7888887321000
Q ss_pred -----c---------------------c----CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026299 171 -----L---------------------H----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (240)
Q Consensus 171 -----~---------------------~----~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (240)
. . .......+++.|.+||.+.+...... +|+|++|+++++.++|..||.
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCC
Confidence 0 0 00111235778999999988887666 899999999999999999999
Q ss_pred CCCchhhhhhhhcee
Q 026299 221 DPEEPKNFRKTIHVM 235 (240)
Q Consensus 221 ~~~~~~~~~~~~~~~ 235 (240)
+....+.++.|+...
T Consensus 1037 a~tpq~~f~ni~~~~ 1051 (1205)
T KOG0606|consen 1037 AETPQQIFENILNRD 1051 (1205)
T ss_pred CcchhhhhhccccCC
Confidence 999999998887654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.6e-09 Score=79.41 Aligned_cols=141 Identities=11% Similarity=0.095 Sum_probs=102.8
Q ss_pred eEeeeecC--CCceeEEEEEecCCCcEEEEEEeec-------CccccHHHHHHHHHHHhcCCCC--eeeeeEEEE---cC
Q 026299 24 ELVRDIGS--GNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPN--IVRFKEVIL---TP 89 (240)
Q Consensus 24 ~~~~~l~~--g~~g~v~~~~~~~~~~~v~iK~~~~-------~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~---~~ 89 (240)
+.++.-+. ||.+.|+..... |..+-+|+-.. .+.....+.+|+..+..+...+ ++++. ++. .+
T Consensus 19 ~wve~pN~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~ 95 (216)
T PRK09902 19 DWVEEPNYRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIE 95 (216)
T ss_pred ceecCCCcCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccC
Confidence 34555555 888888887655 33688888652 1345578999999999886433 44443 222 11
Q ss_pred --CeEEEEEecCCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 90 --THLAIVMEYASG-GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 90 --~~~~lv~~~~~~-~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
...++|++-++| .+|.+++.+. .+++......++.+++.++.-||+.|+.|+|+.+.||+++.++...+.++||.
T Consensus 96 ~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 96 GEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred CceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 235799997764 5788877552 34577878899999999999999999999999999999975555569999998
Q ss_pred ccc
Q 026299 165 YSK 167 (240)
Q Consensus 165 ~~~ 167 (240)
-++
T Consensus 176 k~r 178 (216)
T PRK09902 176 KSR 178 (216)
T ss_pred ccc
Confidence 764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.6e-09 Score=86.90 Aligned_cols=189 Identities=13% Similarity=0.114 Sum_probs=129.2
Q ss_pred EeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeE------EEEcC-CeEEEEE
Q 026299 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKE------VILTP-THLAIVM 96 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~------~~~~~-~~~~lv~ 96 (240)
....||+|+.+.+|......+ .+-|++...+.-.. ...+..|... .||-+-.-+. +..+. ..+.++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchhhc---hhheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 456789999999987765532 35666654432111 1222333333 3443222111 11122 2377899
Q ss_pred ecCCCC-chHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 97 EYASGG-ELFERIC------NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 97 ~~~~~~-~l~~~l~------~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
+.++|. ....++. ..+......+.+.++.++.+...||+.|.+-||++++|++++++.. ++|.|-+.....
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~ 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQIN 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeec
Confidence 988774 2333331 1123667788999999999999999999999999999999987776 999998876655
Q ss_pred cccCCCCCCcCCccccCccccc-----cCCCCCcccchHHHHHHHHHHHhC-CCCCCC
Q 026299 170 VLHSQPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVG-AYPFED 221 (240)
Q Consensus 170 ~~~~~~~~~~~~~~~~~pE~~~-----~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~ 221 (240)
..+....+..+...|.+||... +...+.+ .|-|.||+++++++.| +.||.+
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCc
Confidence 5666667788999999999754 2233445 8999999999999885 999976
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.4e-08 Score=73.93 Aligned_cols=135 Identities=16% Similarity=0.187 Sum_probs=88.7
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHH----------HHHHHHHHHhcCC---CCeeeeeEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----------VQREIINHRSLRH---PNIVRFKEVI 86 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~----------~~~e~~~l~~l~h---~~i~~~~~~~ 86 (240)
..+|+..+.+.......|.+..- ++..+++|...+...-.++ ..+.+....+++. .....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 36888999998887766665544 4678999987653322111 1233333334432 2222322222
Q ss_pred E-----cCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEe
Q 026299 87 L-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (240)
Q Consensus 87 ~-----~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~ 161 (240)
. -....++++||++|..|.+... +++ .+...+.+++.-||+.|+.|||.+|.|+++..++ ++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iI 176 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRII 176 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEE
Confidence 2 1245678999999988866432 222 2445677788999999999999999999998555 8999
Q ss_pred cCCccc
Q 026299 162 DFGYSK 167 (240)
Q Consensus 162 d~~~~~ 167 (240)
|++...
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.84 E-value=7.3e-08 Score=73.65 Aligned_cols=133 Identities=17% Similarity=0.157 Sum_probs=89.6
Q ss_pred eecCCCceeEEEEEecCCCcEEEEEEeecCcc--------------------cc-----HHHHHHHHHHHhcCCC--Cee
Q 026299 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDK--------------------ID-----ENVQREIINHRSLRHP--NIV 80 (240)
Q Consensus 28 ~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------------------~~-----~~~~~e~~~l~~l~h~--~i~ 80 (240)
.|+.|..+.||.|... ++..+++|++..... .. .....|+..|+++... .++
T Consensus 55 ~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 6778888899999874 688899999754211 11 1235677777777533 344
Q ss_pred eeeEEEEcCCeEEEEEecCCCCch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcE
Q 026299 81 RFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRL 158 (240)
Q Consensus 81 ~~~~~~~~~~~~~lv~~~~~~~~l-~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~ 158 (240)
+.+.+. .-.+||||+..... .-.| +.-++...+...+..++++.+.-|-. .|+||+|||.=||++. ++. +
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~--p 205 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE--P 205 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe--E
Confidence 444443 23699999965311 1111 11123444677788888888887776 8999999999999997 333 8
Q ss_pred EEecCCccccc
Q 026299 159 KICDFGYSKSS 169 (240)
Q Consensus 159 ~L~d~~~~~~~ 169 (240)
.++|++.+...
T Consensus 206 ~iID~~QaV~~ 216 (268)
T COG1718 206 YIIDVSQAVTI 216 (268)
T ss_pred EEEECcccccc
Confidence 99999987643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.5e-07 Score=69.94 Aligned_cols=72 Identities=17% Similarity=0.168 Sum_probs=54.3
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCC--eeeeeEEEEcCCeEEEEEecCCCCc
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGE 103 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~~~~~~~~ 103 (240)
+++++|..+.+|+. .+..+++|...... ......+|...++.+.... +.+++.+..+++...++|++++|..
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999973 24468889776533 3456789999998886543 4677888777777889999999963
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=9.8e-09 Score=87.97 Aligned_cols=91 Identities=21% Similarity=0.384 Sum_probs=69.9
Q ss_pred HHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC----------CCCcCCccccCccccccC
Q 026299 125 QLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----------KSTVGTPAYIAPEVLLKK 193 (240)
Q Consensus 125 ~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~----------~~~~~~~~~~~pE~~~~~ 193 (240)
+.+.|+.++|+ .++||++|.|++|.++..+. .||+.|+++......... ........|.+||.+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44489999995 59999999999999987777 999999998655442221 122346689999999886
Q ss_pred CCCCcccchHHHHHHHHHHHhCCCC
Q 026299 194 EYDGKIADVWSCGVTLYVMLVGAYP 218 (240)
Q Consensus 194 ~~~~~~~Di~slG~~l~~l~~g~~p 218 (240)
..... +|++|||+++|.+..+..+
T Consensus 185 ~~~~~-sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 185 TNTPA-SDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred ccccc-ccceeeeeEEEEEecCCcc
Confidence 66555 9999999999998854433
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.5e-07 Score=78.15 Aligned_cols=136 Identities=21% Similarity=0.226 Sum_probs=87.4
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCcc----------------------c-------------cH------HHH
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----------------------I-------------DE------NVQ 65 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----------------------~-------------~~------~~~ 65 (240)
+.++.++-|.||.|+..+ |+.||||+..++-. . .+ ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 567889999999999994 99999999754210 0 00 122
Q ss_pred HHHHHHHhcC-----CCCeeeeeEEEEcCCeEEEEEecCCCCchHHHHH-hcCCCCHHHHHHHHHHHHHH-HHHHhhCCc
Q 026299 66 REIINHRSLR-----HPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISG-VSYCHSMQV 138 (240)
Q Consensus 66 ~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~-~~~~l~~~~~~~~~~~i~~~-l~~LH~~~i 138 (240)
+|.....+++ .+++.-..=+......-.++|||++|..+.++.. +....+... ++..++.+ ++.+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhcCc
Confidence 3333333331 3443333333333456689999999998888742 223345333 33333333 233445899
Q ss_pred eeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 139 vh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
+|+|.+|.||+++.++. +.+.|||....
T Consensus 287 fHaDpHpGNi~v~~~g~--i~~lDfGi~g~ 314 (517)
T COG0661 287 FHADPHPGNILVRSDGR--IVLLDFGIVGR 314 (517)
T ss_pred cccCCCccceEEecCCc--EEEEcCcceec
Confidence 99999999999987765 99999999753
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.5e-06 Score=62.77 Aligned_cols=129 Identities=21% Similarity=0.222 Sum_probs=89.9
Q ss_pred eeeecCCCceeEEEEEecCCCcEEEEEEeecCc-----------------cccHHHHHHHHHHHhcC------CCCeeee
Q 026299 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------------KIDENVQREIINHRSLR------HPNIVRF 82 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----------------~~~~~~~~e~~~l~~l~------h~~i~~~ 82 (240)
...|++|+.-.+|.--+.. ..+||+..+.. .......+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~dp---~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPDDP---NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCCCC---CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3568889888877554443 36788876654 22345667776666555 7889999
Q ss_pred eEEEEcCCeEEEEEecCCC------CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC
Q 026299 83 KEVILTPTHLAIVMEYASG------GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (240)
Q Consensus 83 ~~~~~~~~~~~lv~~~~~~------~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~ 156 (240)
+|+..++-...+|+|.+.. .+|.+++.+ +.++. .+...+. +-.++|-+..|+.+|++|.||++.....+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999987742 367777743 34555 4444343 44567888999999999999999755544
Q ss_pred --cEEEec
Q 026299 157 --RLKICD 162 (240)
Q Consensus 157 --~~~L~d 162 (240)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 366665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.50 E-value=3e-06 Score=77.31 Aligned_cols=79 Identities=19% Similarity=0.226 Sum_probs=57.7
Q ss_pred EeeeecCCCceeEEEEEecCCC--cEEEEEEeecCc--cccHHHHHHHHHHHhcC-CCCe--eeeeEEEEcC---CeEEE
Q 026299 25 LVRDIGSGNFGVARLMRDKKTE--ELVAVKYIERGD--KIDENVQREIINHRSLR-HPNI--VRFKEVILTP---THLAI 94 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~--~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~l 94 (240)
-++.++.|..+.+|......++ ..+++|+..... .....+.+|...++.+. |.++ ++++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3677888999999998876443 468888765433 22346889999999985 6664 7777777664 45789
Q ss_pred EEecCCCCc
Q 026299 95 VMEYASGGE 103 (240)
Q Consensus 95 v~~~~~~~~ 103 (240)
|||+++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999999864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.4e-06 Score=65.94 Aligned_cols=78 Identities=18% Similarity=0.215 Sum_probs=54.7
Q ss_pred eeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCC--eeeeeEEEEc---CCeEEEEEecCC
Q 026299 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILT---PTHLAIVMEYAS 100 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~---~~~~~lv~~~~~ 100 (240)
++.++.|..+.+|.+.... ..+++|..... .......+|...++.+.... ++.++..... ....+.++++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 5678889999999999885 47999976554 34456778888887775332 4555554322 245789999999
Q ss_pred CCchHH
Q 026299 101 GGELFE 106 (240)
Q Consensus 101 ~~~l~~ 106 (240)
|.++..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 987766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.47 E-value=4.4e-06 Score=65.26 Aligned_cols=75 Identities=12% Similarity=0.050 Sum_probs=52.0
Q ss_pred eecCCCc-eeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEEEecCCCCchH
Q 026299 28 DIGSGNF-GVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELF 105 (240)
Q Consensus 28 ~l~~g~~-g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~~~~~l~ 105 (240)
.|..|.. ..||++... +..+++|...... .....+|+..++.+. +--+++++++...++..++||++++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4455555 678888654 3678899765443 345677888887774 344666777777666788999999997765
Q ss_pred H
Q 026299 106 E 106 (240)
Q Consensus 106 ~ 106 (240)
+
T Consensus 81 ~ 81 (244)
T cd05150 81 A 81 (244)
T ss_pred H
Confidence 4
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=7.5e-06 Score=59.58 Aligned_cols=129 Identities=19% Similarity=0.186 Sum_probs=91.0
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeee-eeEEEEcCCeEEEEEecCC
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIVMEYAS 100 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~~~~~ 100 (240)
.-++.+.|++|..|.||++.+. +..+++| +...++....+..|.++|..+...++.+ ++.+..+ ++.|||++
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~K-vrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~ 95 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWR--GGEVALK-VRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID 95 (201)
T ss_pred hhhhhhhhhcccccEEEEeecc--CceEEEE-EecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence 4467788999999999999887 4478888 4455556678899999999998766544 5555433 35599999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCC-C-CeEEcCCCCCcEEEecCCccc
Q 026299 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL-E-NTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 101 ~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~-~-nili~~~~~~~~~L~d~~~~~ 167 (240)
|.+|.+..... +...+ ..+++..--|-..||-|+.|+- . ||+++ +.. +.|+||..|+
T Consensus 96 G~~L~~~~~~~---~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~~--~~iIDFd~At 154 (201)
T COG2112 96 GRPLGKLEIGG---DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DRD--VYIIDFDSAT 154 (201)
T ss_pred Ccchhhhhhcc---cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEec-CCc--EEEEEccchh
Confidence 98887755322 33333 3444455557778999999864 3 55554 323 8999999875
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.32 E-value=9.5e-05 Score=55.43 Aligned_cols=124 Identities=19% Similarity=0.264 Sum_probs=87.1
Q ss_pred CCeeEeeeecCCCc-eeEEEEEecCCCcEEEEEEeec---C-c------------------cccHHHHHHHHHHHhcC--
Q 026299 21 DRYELVRDIGSGNF-GVARLMRDKKTEELVAVKYIER---G-D------------------KIDENVQREIINHRSLR-- 75 (240)
Q Consensus 21 ~~y~~~~~l~~g~~-g~v~~~~~~~~~~~v~iK~~~~---~-~------------------~~~~~~~~e~~~l~~l~-- 75 (240)
.+++.++.||.|.. |.||+++-. |..||+|++.. . + ...+.|..|.....+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 79999999999999 999999886 66999999321 0 0 11123567776666664
Q ss_pred -CCCe--eeeeEEEEcC------------------CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 026299 76 -HPNI--VRFKEVILTP------------------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134 (240)
Q Consensus 76 -h~~i--~~~~~~~~~~------------------~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH 134 (240)
+.++ ++.+||..-. ....||.||.+... .++...+ .+|++-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~----~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDI----PQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHH----HHHHHHHHHHH
Confidence 4456 8899987422 12457888776533 2344444 44555556799
Q ss_pred hCCceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 135 ~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
..||+-+|+++.|..= -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~-------G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRG-------GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccC-------CEEEecccC
Confidence 9999999999999882 389999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.9e-07 Score=79.87 Aligned_cols=189 Identities=22% Similarity=0.251 Sum_probs=134.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCC-eeeeeEEEEcCCeEEEEEe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~~ 97 (240)
..+.|.....+++++++.+++.+....+... .+.+... ....-+++.|.+++||| .+..++-+..+.+.++.++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 3456777888999999999999888666644 5555433 33445778899999999 5555555666678899999
Q ss_pred cCCCC-chH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 98 YASGG-ELF-ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 98 ~~~~~-~l~-~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
+++++ +.. ......-.+...+...+.+.-.++++++|+.--+|+| ||+..+.. .++.+++...........
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~ 387 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKP 387 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCccccc
Confidence 99876 222 1111112244445555666777889999988768887 77765543 689999988766665566
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (240)
....+.+.+++||....+..... .|.|++|.--.++--|-.|-.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCC
Confidence 77788999999999888887666 899999976666666665543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.1e-05 Score=69.16 Aligned_cols=137 Identities=18% Similarity=0.192 Sum_probs=85.9
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCcc-----------------------c---------cH------HHHHHH
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------------------I---------DE------NVQREI 68 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----------------------~---------~~------~~~~e~ 68 (240)
+.|+..+.+.|++|+..+ |+.|+||+-+++-. . .+ +|..|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 568889999999999995 99999998543100 0 00 122333
Q ss_pred HHHHhc----CCCC------eeeeeEEEEcCCeEEEEEecCCCCchHHHHH-hcCCCCHHHHHHHHHHHHHH-HHHHhhC
Q 026299 69 INHRSL----RHPN------IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISG-VSYCHSM 136 (240)
Q Consensus 69 ~~l~~l----~h~~------i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~-~~~~l~~~~~~~~~~~i~~~-l~~LH~~ 136 (240)
+.-.+. +|-+ |++++-- ......++|||++|..+.+.-. ....++...+. ..+.++ ++.+=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~---~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDIL---NKLVEAYLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHH---HHHHHHHHHHHHhc
Confidence 222222 2333 3333222 2345789999999987766532 22335555433 333333 2334467
Q ss_pred CceeecCCCCCeEEcCC--CCCcEEEecCCccccc
Q 026299 137 QVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSS 169 (240)
Q Consensus 137 ~ivh~~i~~~nili~~~--~~~~~~L~d~~~~~~~ 169 (240)
|++|+|=+|-||++..+ +...+.+.|+|+....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 89999999999999854 3556999999997533
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.6e-05 Score=60.49 Aligned_cols=75 Identities=15% Similarity=0.264 Sum_probs=48.6
Q ss_pred eeeecCCCceeEEEEEecC-CCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCe-eeeeEEEEcCCeEEEEEecCCCCc
Q 026299 26 VRDIGSGNFGVARLMRDKK-TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGE 103 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~~~~~ 103 (240)
++.|..|-...+|++.... .+..|++|.........-+..+|...++.+...++ ++++... . + .+++||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-~-~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-Q-N--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-C-C--cEEEEeeCCCc
Confidence 4667778888999987553 35679999776543322234578888888854444 3444332 2 2 37999999866
Q ss_pred h
Q 026299 104 L 104 (240)
Q Consensus 104 l 104 (240)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.2e-05 Score=60.94 Aligned_cols=73 Identities=11% Similarity=0.003 Sum_probs=44.9
Q ss_pred eeeecCCCce-eEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCC---CeeeeeEEEEcC---CeEEEEEec
Q 026299 26 VRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVILTP---THLAIVMEY 98 (240)
Q Consensus 26 ~~~l~~g~~g-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~~~ 98 (240)
++.++.|+.. .||.+. ..+++|.... ........+|...+..+... -+..++...... ...+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 3556766665 588762 2478886544 22345788899998877532 244444433322 235789999
Q ss_pred CCCCch
Q 026299 99 ASGGEL 104 (240)
Q Consensus 99 ~~~~~l 104 (240)
++|.++
T Consensus 76 i~G~~l 81 (235)
T cd05155 76 LEGETA 81 (235)
T ss_pred ecCCCC
Confidence 998766
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.6e-05 Score=63.26 Aligned_cols=138 Identities=19% Similarity=0.210 Sum_probs=94.3
Q ss_pred EeeeecCCCceeEEEEEecCCCcEEEEEEeec-------------------------Ccc--ccHHHHHHHHHHHhcCCC
Q 026299 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIER-------------------------GDK--IDENVQREIINHRSLRHP 77 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~-------------------------~~~--~~~~~~~e~~~l~~l~h~ 77 (240)
+-.+|+-|..+.||.|... +|..+|||+++- ++. ..-....|+..|.+++..
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4457788999999999887 566699998642 111 011245778888888766
Q ss_pred CeeeeeEEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hCCceeecCCCCCeEEcCCCCC
Q 026299 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAP 156 (240)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH-~~~ivh~~i~~~nili~~~~~~ 156 (240)
.|+-.--+..- .-.|||+|+.......-.....+++...+..+-.+++..+.-|= ..++||.||+--|+++..+.
T Consensus 227 GIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~-- 302 (520)
T KOG2270|consen 227 GIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGK-- 302 (520)
T ss_pred CCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCE--
Confidence 65543333322 23689999964332222223445777777777778877777664 67999999999999996443
Q ss_pred cEEEecCCcccc
Q 026299 157 RLKICDFGYSKS 168 (240)
Q Consensus 157 ~~~L~d~~~~~~ 168 (240)
+.++|.+.+..
T Consensus 303 -lyiIDVSQSVE 313 (520)
T KOG2270|consen 303 -LYIIDVSQSVE 313 (520)
T ss_pred -EEEEEcccccc
Confidence 89999998753
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.2e-05 Score=60.85 Aligned_cols=131 Identities=15% Similarity=0.101 Sum_probs=75.1
Q ss_pred eecCCCceeEEEEEecCCCcEEEEEEeecCcccc-HHHHHHHHHHHhcCCCCe-eeeeEEEEcCCeEEEEEecCCCCchH
Q 026299 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGELF 105 (240)
Q Consensus 28 ~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~~~~~l~ 105 (240)
.+..|-.+.+|++. .++..+++|......... -+..+|...++.+....+ ++++... . -++|++|++|.++.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence 45567778888886 356678999755432221 235778888888864433 3344332 2 25899999986643
Q ss_pred H--------------HHH---hcC----CCCHH-HHHHHHHHH---------HHHHHHHhh--------CCceeecCCCC
Q 026299 106 E--------------RIC---NAG----RFSED-EARFFFQQL---------ISGVSYCHS--------MQVCHRDLKLE 146 (240)
Q Consensus 106 ~--------------~l~---~~~----~l~~~-~~~~~~~~i---------~~~l~~LH~--------~~ivh~~i~~~ 146 (240)
. .+. ... +++.. .+..+..++ ...++.+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 1 111 111 11111 111221111 111222221 24899999999
Q ss_pred CeEEcCCCCCcEEEecCCccc
Q 026299 147 NTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 147 nili~~~~~~~~~L~d~~~~~ 167 (240)
||++++++ +.++||..+.
T Consensus 157 Nil~~~~~---~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVTPQG---LKLIDWEYAS 174 (256)
T ss_pred cEEEeCCC---CEEEeccccC
Confidence 99998655 6899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.12 E-value=0.0002 Score=59.67 Aligned_cols=75 Identities=19% Similarity=0.106 Sum_probs=53.1
Q ss_pred eeeecCCCceeEEEEEecCCCcEEEEEEeecC--------ccccHHHHHHHHHHHhcC---CCCeeeeeEEEEcCCeEEE
Q 026299 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG--------DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 94 (240)
.+.++.|..+.||.+.+..+++.++||.-.+. +...++...|.+.|+.+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 57899999999999999755468999985321 123356677888887763 2456667666 4455789
Q ss_pred EEecCCCC
Q 026299 95 VMEYASGG 102 (240)
Q Consensus 95 v~~~~~~~ 102 (240)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.04 E-value=8.6e-05 Score=59.91 Aligned_cols=76 Identities=13% Similarity=0.153 Sum_probs=49.3
Q ss_pred eeeecCCCceeEEEEEecC------CCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCe-eeeeEEEEcCCeEEEEEec
Q 026299 26 VRDIGSGNFGVARLMRDKK------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~ 98 (240)
++.+..|-...+|++.... .+..+++|+............+|...+..+...++ .+++..+. + ..|++|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 4556667777888887653 25789999876654433456788888888754443 34444443 2 258899
Q ss_pred CCCCchH
Q 026299 99 ASGGELF 105 (240)
Q Consensus 99 ~~~~~l~ 105 (240)
++|.++.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 8886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.7e-06 Score=64.94 Aligned_cols=135 Identities=15% Similarity=0.144 Sum_probs=92.0
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-------------------cc----cHHHHHHHHHHHhcCCC-
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-------------------KI----DENVQREIINHRSLRHP- 77 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-------------------~~----~~~~~~e~~~l~~l~h~- 77 (240)
-+.+..++|-|..+.+|.+-+. .|.+.++|.-..+. ++ +=...+|+..++.+...
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4567788999999999999887 57778888632210 00 01235677777777432
Q ss_pred -CeeeeeEEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC
Q 026299 78 -NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (240)
Q Consensus 78 -~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~ 156 (240)
-+++.+++ +.-++||+++.|-+|.....- .+.. .+...++..+--|.+.|+||||++--||++..+..
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~- 240 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV---EDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK- 240 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeec---CChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCCC-
Confidence 24444443 456899999998777654321 1223 34445555566788999999999999999987665
Q ss_pred cEEEecCCccccc
Q 026299 157 RLKICDFGYSKSS 169 (240)
Q Consensus 157 ~~~L~d~~~~~~~ 169 (240)
++++||-.....
T Consensus 241 -i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 241 -IVVIDFPQMVST 252 (465)
T ss_pred -EEEeechHhhcc
Confidence 999999876543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=7.4e-05 Score=55.90 Aligned_cols=97 Identities=14% Similarity=0.071 Sum_probs=76.1
Q ss_pred HHHHHHHHhcCC-CCeeeeeEEEEcCCeEEEEEecCCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHhh---CC
Q 026299 65 QREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHS---MQ 137 (240)
Q Consensus 65 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~---l~~~~~l~~~~~~~~~~~i~~~l~~LH~---~~ 137 (240)
..|..+++.+++ +++++++|.|.. +++.|+...+++.+. +..-...++.....++.++++.++.|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457888888876 699999999843 678899876555321 1111235789999999999999999997 45
Q ss_pred ceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 138 ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
+.-+|++++|+-++.++. ++++|++.+.
T Consensus 83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v~ 110 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGR--LKLIDLDDVF 110 (188)
T ss_pred EEEeecchHHeEEeCCCc--EEEEechhcc
Confidence 888999999999987766 9999999874
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00023 Score=57.25 Aligned_cols=136 Identities=17% Similarity=0.137 Sum_probs=78.3
Q ss_pred eeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCC--eeeeeEE------EEcCCeEEEEEe
Q 026299 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAIVME 97 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~~ 97 (240)
++.+..|....+|.+... +..+++|.... ........|+..+..+...+ +++++.. ...++..+.+++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 566777877889988654 34689997754 23345667777777774332 3343331 122345689999
Q ss_pred cCCCCchHH-----------HH---Hh-cCCCCH--------H--HH----------HHHHHHHHHHHHHHhh-------
Q 026299 98 YASGGELFE-----------RI---CN-AGRFSE--------D--EA----------RFFFQQLISGVSYCHS------- 135 (240)
Q Consensus 98 ~~~~~~l~~-----------~l---~~-~~~l~~--------~--~~----------~~~~~~i~~~l~~LH~------- 135 (240)
|++|.++.. .+ +. ...+.. . .. ......+..++.++.+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999866421 01 10 000000 0 00 0011112233344432
Q ss_pred CCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 136 ~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
.+++|||+.|.|++++.+.. +.++||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDEL--SGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence 47999999999999986543 5799998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.0014 Score=54.73 Aligned_cols=73 Identities=16% Similarity=0.186 Sum_probs=50.1
Q ss_pred EeeeecCCCceeEEEEEecCCCcEEEEEEeec-----Cc---cccHHHHHHHHHHHhcC---CCCeeeeeEEEEcCCeEE
Q 026299 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GD---KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~-----~~---~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~ 93 (240)
-.+.+|.|....||++.+. +..++||.-.+ .. ....+...|...|+.+. ...+++++.++.+ ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 4778899999999999874 34699998652 11 12344455666666553 2467778877763 456
Q ss_pred EEEecCCC
Q 026299 94 IVMEYASG 101 (240)
Q Consensus 94 lv~~~~~~ 101 (240)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.001 Score=54.69 Aligned_cols=138 Identities=15% Similarity=0.182 Sum_probs=79.0
Q ss_pred EeeeecCCCceeEEEEEecC----CCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCee-eeeEEEEcCCeEEEEEecC
Q 026299 25 LVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~~~~ 99 (240)
-++.+..|-...+|++.... .+..|++|.........-+-.+|...++.+...++. ++++.+.. + .|.+|+
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi 115 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI 115 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence 34456668888999987532 246899998766543222336788888888654443 44555432 2 478888
Q ss_pred CCCchHHH--------------H---HhcC------CCCHHHHHHHHHHH-----------------HHHHHHH----h-
Q 026299 100 SGGELFER--------------I---CNAG------RFSEDEARFFFQQL-----------------ISGVSYC----H- 134 (240)
Q Consensus 100 ~~~~l~~~--------------l---~~~~------~l~~~~~~~~~~~i-----------------~~~l~~L----H- 134 (240)
++.++... + +... +.....+..+..++ ...+..| .
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 77665311 0 1101 01112222332111 1111111 1
Q ss_pred ---hCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 135 ---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 135 ---~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
...++|+|+.+.||+++++. ..+.++||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence 23589999999999997532 249999999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0002 Score=65.74 Aligned_cols=154 Identities=21% Similarity=0.277 Sum_probs=106.1
Q ss_pred HHHHHHHHhcCCCCeeeeeEEEEcCCeEE----EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCcee
Q 026299 65 QREIINHRSLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140 (240)
Q Consensus 65 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~----lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh 140 (240)
..|.+.+.+..|+|+..++.|........ +..++++..++...++.-...+.+....+..+.++++.++|+....|
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~ 309 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEH 309 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence 35566677889999999999988764433 34567777788888888888999999999999999999999886666
Q ss_pred ecCCCC---CeEEcCCCCCcEEEecCCccccccccCCCCCCcCCccccCccccccCCCCC-cccchHHHHHHHHHHHhCC
Q 026299 141 RDLKLE---NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG-KIADVWSCGVTLYVMLVGA 216 (240)
Q Consensus 141 ~~i~~~---nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~-~~~Di~slG~~l~~l~~g~ 216 (240)
.-+.-+ +-..+..+.....+.||+...................+.++|....+.... ...|+|++|.....+..+.
T Consensus 310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~ 389 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGE 389 (1351)
T ss_pred eEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcC
Confidence 655555 333333333223333777765544444444444455566676654444322 2269999999999998876
Q ss_pred CC
Q 026299 217 YP 218 (240)
Q Consensus 217 ~p 218 (240)
.+
T Consensus 390 ~i 391 (1351)
T KOG1035|consen 390 DI 391 (1351)
T ss_pred cc
Confidence 44
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0032 Score=51.17 Aligned_cols=74 Identities=11% Similarity=0.030 Sum_probs=42.1
Q ss_pred eeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCC--eeeeeE------EEEcCCeEEEEEe
Q 026299 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKE------VILTPTHLAIVME 97 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~------~~~~~~~~~lv~~ 97 (240)
++.+..|....+|.+... +| .+++|++... ..+....+...+..+...+ +.+++. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~~--~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFERL--TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEeccC--ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 445666777788988765 33 6899987521 2233334455554442111 233332 1122456789999
Q ss_pred cCCCCc
Q 026299 98 YASGGE 103 (240)
Q Consensus 98 ~~~~~~ 103 (240)
|++|..
T Consensus 103 ~l~G~~ 108 (319)
T PRK05231 103 FLEGKW 108 (319)
T ss_pred ecCCCC
Confidence 999864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0017 Score=52.61 Aligned_cols=140 Identities=16% Similarity=0.163 Sum_probs=78.4
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCC--eeeeeEE------EEcCCeEEE
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAI 94 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~l 94 (240)
.+-++.++.|....+|.+... ++ .+++|...... ..+....+...+..+...+ +++++.. ....+..++
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred ceeccccCCccccceEEEEeC-CC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 334666777777889988754 33 58889765532 2334556666666664222 3333331 112355789
Q ss_pred EEecCCCCchH-----------HHH---Hh-cCCC--------CHHH---H--H----------HHHHHHHHHHHHHh--
Q 026299 95 VMEYASGGELF-----------ERI---CN-AGRF--------SEDE---A--R----------FFFQQLISGVSYCH-- 134 (240)
Q Consensus 95 v~~~~~~~~l~-----------~~l---~~-~~~l--------~~~~---~--~----------~~~~~i~~~l~~LH-- 134 (240)
+++|++|.++. ..+ +. ...+ .... . . .....+.+.++++.
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 99999885431 111 10 0000 0000 0 0 00111223444443
Q ss_pred -----hCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 135 -----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 135 -----~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
..+++|||+.+.|++++.+.. ..++||+.+.
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~ 216 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSV--KGVIDFYFAC 216 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence 268999999999999987653 5899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0098 Score=48.92 Aligned_cols=72 Identities=19% Similarity=0.197 Sum_probs=47.6
Q ss_pred eecCCCceeEEEEEecCCCcEEEEEEeec-----C---ccccHHHHHHHHHHHhcC--CCC-eeeeeEEEEcCCeEEEEE
Q 026299 28 DIGSGNFGVARLMRDKKTEELVAVKYIER-----G---DKIDENVQREIINHRSLR--HPN-IVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 28 ~l~~g~~g~v~~~~~~~~~~~v~iK~~~~-----~---~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~~~~~~~~~lv~ 96 (240)
.+|.|....||++.+..++..++||.-.+ + +...++..-|...|+... .|. +++++. .++....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 57999999999999864446899998532 1 223355667777776653 353 444433 3445566899
Q ss_pred ecCCC
Q 026299 97 EYASG 101 (240)
Q Consensus 97 ~~~~~ 101 (240)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0013 Score=53.74 Aligned_cols=79 Identities=14% Similarity=0.188 Sum_probs=48.4
Q ss_pred CCeeEeeeecCCCceeEEEEEecCC---CcEEEEEEeecCccccHHHHHHHHHHHhcCCCCee-eeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~ 96 (240)
+..++ +.+..|-...+|++..... +..|++|+........-+-.+|...++.+...++. ++++++ .++ ++.
T Consensus 15 ~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~ 89 (330)
T PLN02421 15 SDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQ 89 (330)
T ss_pred CceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe-CCc---Eee
Confidence 34444 4444477778898875432 34799998766543222346788888888655553 455554 222 588
Q ss_pred ecCCCCch
Q 026299 97 EYASGGEL 104 (240)
Q Consensus 97 ~~~~~~~l 104 (240)
+|++|.++
T Consensus 90 ~fi~g~~l 97 (330)
T PLN02421 90 SFINARTL 97 (330)
T ss_pred hhhcCCCC
Confidence 88887655
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0015 Score=52.63 Aligned_cols=105 Identities=11% Similarity=0.038 Sum_probs=69.5
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCC---CCeeeeeEEEEcC---CeEEEEE
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---PNIVRFKEVILTP---THLAIVM 96 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~---~~~~lv~ 96 (240)
-.-.+.|+.|..+.+|...... + .+++|..+. ......+.+|...++.+.. ..++++++++..+ +..++||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCC-C-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 3446789999999999997653 3 477786433 2233578899999988853 3578888877543 5689999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~ 135 (240)
|+++|.++.+. ..+......+..++++++..||+
T Consensus 93 E~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~ 126 (297)
T PRK10593 93 ERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHR 126 (297)
T ss_pred eccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhC
Confidence 99999776541 12233334444555555555554
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0027 Score=52.75 Aligned_cols=78 Identities=18% Similarity=0.142 Sum_probs=51.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeec----C---ccccHHHHHHHHHHHhcC--CC-CeeeeeEEEEcCC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----G---DKIDENVQREIINHRSLR--HP-NIVRFKEVILTPT 90 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~----~---~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~ 90 (240)
+.++ .+.||.|....||++.+..++..++||.-.+ . +...++..-|.+.|+... .| ++++++.+ ++.
T Consensus 30 ~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e 106 (409)
T PRK12396 30 KGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSV 106 (409)
T ss_pred ccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcH
Confidence 3444 7788999999999999854456799998533 1 223356677888887663 35 44445443 445
Q ss_pred eEEEEEecCCC
Q 026299 91 HLAIVMEYASG 101 (240)
Q Consensus 91 ~~~lv~~~~~~ 101 (240)
...+|||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 55688888854
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0046 Score=49.97 Aligned_cols=81 Identities=15% Similarity=0.057 Sum_probs=50.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEee--cCccccHHHHHHHHHHHhcCCCC--eeeeeEEEEcCC--eEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPT--HLAI 94 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~--~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~--~~~l 94 (240)
....+++....|-...+|...+. ++++++.... .......+..+|+..++.+.--- ....+++|.++. ..+.
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 34456666666666677777665 7778888321 11223345677888887775322 334455665554 6699
Q ss_pred EEecCCCCc
Q 026299 95 VMEYASGGE 103 (240)
Q Consensus 95 v~~~~~~~~ 103 (240)
||+|+.|..
T Consensus 103 v~~~veGe~ 111 (321)
T COG3173 103 VMEWVEGEV 111 (321)
T ss_pred EEEEeccee
Confidence 999998843
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0071 Score=48.21 Aligned_cols=30 Identities=23% Similarity=0.325 Sum_probs=23.6
Q ss_pred CceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 137 ~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
.++|||+++.|+++++++. -.-++||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhcc
Confidence 4899999999999986432 24599999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0025 Score=48.58 Aligned_cols=55 Identities=16% Similarity=0.095 Sum_probs=32.7
Q ss_pred CcEEEEEEeecCccccHHHHHHHHHHHhcCCCCe-eeeeEEEEcCCeEEEEEecCCCCch
Q 026299 46 EELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 46 ~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
++.|++++.......--.-..|...++.+...++ .++++.+. ++ .|.+|++|.+|
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~-~g---~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFE-NG---RVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEET-TE---EEEE--SSEE-
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcC-CC---cEEEEeccccc
Confidence 4678999887775444556778888888865555 44444443 22 46688876553
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.016 Score=46.46 Aligned_cols=76 Identities=11% Similarity=0.069 Sum_probs=48.6
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC---CCCeeeeeEEEEcCCeEEEEEecC
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
-+-.+.++.|....+|.+. .++..+.+|.-. ......+..|..-|+.+. .-.+++++++....+..++++||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3456778889999999887 567789999765 233456788888888884 345788888888777779999999
Q ss_pred CCC
Q 026299 100 SGG 102 (240)
Q Consensus 100 ~~~ 102 (240)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.041 Score=45.00 Aligned_cols=71 Identities=11% Similarity=0.007 Sum_probs=42.8
Q ss_pred CCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCC--eeeee---E--EEEcCCeEEEEEecCCCCc
Q 026299 32 GNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFK---E--VILTPTHLAIVMEYASGGE 103 (240)
Q Consensus 32 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~---~--~~~~~~~~~lv~~~~~~~~ 103 (240)
+....||.+... ++..+++|+..+..........|+..+..+.... ++... | +...++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 344678888765 4667999977654444556677887777663221 12211 1 1223456788999998754
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.016 Score=48.42 Aligned_cols=77 Identities=9% Similarity=0.034 Sum_probs=45.1
Q ss_pred EeeeecCCCceeEEEEEecCC-CcE-----EEEEEeecCccccHHHHHHHHHHHhcCCCCe-eeeeEEEEcCCeEEEEEe
Q 026299 25 LVRDIGSGNFGVARLMRDKKT-EEL-----VAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVME 97 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~-~~~-----v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~ 97 (240)
-++.+..|-...+|++..... +.. |+++........--+-.+|..+++.+...++ .++++.+.. +++.+
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 344565688889999875533 222 3333322222212233578888888876555 445555532 48999
Q ss_pred cCCCCchH
Q 026299 98 YASGGELF 105 (240)
Q Consensus 98 ~~~~~~l~ 105 (240)
|++|.++.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99887653
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.026 Score=48.08 Aligned_cols=76 Identities=16% Similarity=0.051 Sum_probs=47.8
Q ss_pred EeeeecCCCceeEEEEEecCC--------CcEEEEEEeecCccccHHHHHHHHHHHhcCCCCee-eeeEEEEcCCeEEEE
Q 026299 25 LVRDIGSGNFGVARLMRDKKT--------EELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIV 95 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv 95 (240)
-++.|..|-...+|++..... +..|++++...+...--.-.+|...++.+...+|. ++++.+. + +.+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS-G---GRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---CEE
Confidence 566677677788888875421 46799998766543323345677777777655544 3444432 2 357
Q ss_pred EecCCCCch
Q 026299 96 MEYASGGEL 104 (240)
Q Consensus 96 ~~~~~~~~l 104 (240)
.+|++|.++
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 888887644
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.098 Score=42.40 Aligned_cols=29 Identities=21% Similarity=0.266 Sum_probs=25.3
Q ss_pred CceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 137 ~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
+++|+|+.++|++++.++. +.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence 7999999999999976655 8899998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.054 Score=44.24 Aligned_cols=131 Identities=16% Similarity=0.183 Sum_probs=75.6
Q ss_pred CceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCC---CC---eeeeeEEEE--cCC--eEEEEEecCCCC
Q 026299 33 NFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---PN---IVRFKEVIL--TPT--HLAIVMEYASGG 102 (240)
Q Consensus 33 ~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h---~~---i~~~~~~~~--~~~--~~~lv~~~~~~~ 102 (240)
....+|++.... |. +++|+...+ ........|...+..+.- +- +...-|-.. -.. +.+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~-g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTED-GR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecC-CC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 556788888774 33 399988777 556677778888876632 21 222222111 123 778899999987
Q ss_pred chHH------------HH---H---hcCC---------CCHH----H---------HHHHHHHHHHHHHHHhh-------
Q 026299 103 ELFE------------RI---C---NAGR---------FSED----E---------ARFFFQQLISGVSYCHS------- 135 (240)
Q Consensus 103 ~l~~------------~l---~---~~~~---------l~~~----~---------~~~~~~~i~~~l~~LH~------- 135 (240)
.+.. .+ . ++.+ .... . -.....++...++.+.+
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7661 11 0 0000 0010 0 00022233333333332
Q ss_pred -CC--ceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 136 -MQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 136 -~~--ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
.+ +||+|+.|.||+++.+.. -+-++||+.+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 33 999999999999987653 26889999874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.031 Score=45.92 Aligned_cols=116 Identities=20% Similarity=0.200 Sum_probs=71.2
Q ss_pred CCeeeeeEEEEcC-CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CceeecCCCCCeEEcCCC
Q 026299 77 PNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSP 154 (240)
Q Consensus 77 ~~i~~~~~~~~~~-~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~-~ivh~~i~~~nili~~~~ 154 (240)
++..+.+-+-.++ .+.|++|++- |+++.- + .....+++..++++++..++-+... ..-|+++...||+++ ++
T Consensus 285 ~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G 358 (488)
T COG5072 285 VFLETLKVVSLDETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG 358 (488)
T ss_pred hhhhcceEEecCCceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC
Confidence 3444433333333 4567777764 445532 1 2235788899999999988888854 789999999999998 44
Q ss_pred CCcEEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHH
Q 026299 155 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCG 206 (240)
Q Consensus 155 ~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG 206 (240)
. +.|+||.+++....+.. .-...+..|..+.|.. ..+.+||-+.
T Consensus 359 n--vtLIDfklsRl~~~q~~----isy~rldhp~lF~G~d--d~QFeIYrlM 402 (488)
T COG5072 359 N--VTLIDFKLSRLSYSQGI----ISYNRLDHPDLFNGVD--DYQFEIYRLM 402 (488)
T ss_pred c--eEEEEeeeeecccCCce----eeccccCchhhhcCcc--ceeeeHHHHH
Confidence 4 99999999873322221 1122334455454333 3336666653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.28 Score=46.50 Aligned_cols=32 Identities=34% Similarity=0.484 Sum_probs=25.8
Q ss_pred CCceeecCCCCCeEEcCCCCCcEE-EecCCccc
Q 026299 136 MQVCHRDLKLENTLLDGSPAPRLK-ICDFGYSK 167 (240)
Q Consensus 136 ~~ivh~~i~~~nili~~~~~~~~~-L~d~~~~~ 167 (240)
.++||+|+++.||+++.+...++. ++|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 579999999999999876532355 99999874
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.12 Score=43.30 Aligned_cols=63 Identities=16% Similarity=0.112 Sum_probs=44.7
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hCCceeecCCCCCeEEcCCCC
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPA 155 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH-~~~ivh~~i~~~nili~~~~~ 155 (240)
..++-+|..|.++..++.... .+++....++.-...|+.-+- -.+++|.|++|.||++....+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~t 383 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNKT 383 (565)
T ss_pred ceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecCC
Confidence 346667888888888886543 355666677766666655544 568999999999999954443
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.11 Score=44.77 Aligned_cols=49 Identities=16% Similarity=0.186 Sum_probs=38.6
Q ss_pred HHHHHHHHHHHhcCCCCeeeeeEEEEcC-CeEEEEEecCCCCchHHHHHhc
Q 026299 62 ENVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNA 111 (240)
Q Consensus 62 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~~~~~~~~l~~~l~~~ 111 (240)
..++-....++.+.|+|.+.++++.... ....+|+|++ +.|+++.+..+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 4566777888999999999999887654 4577899988 55999988654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.098 Score=42.27 Aligned_cols=29 Identities=31% Similarity=0.620 Sum_probs=24.3
Q ss_pred CCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 136 ~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
.+++|||+.+.|++++. + .+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~--~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N--EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C--cEEEEECcccc
Confidence 57899999999999976 3 38999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3231 Aph Aminoglycoside phosphotransferase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=94.20 E-value=1.1 Score=34.64 Aligned_cols=98 Identities=13% Similarity=0.078 Sum_probs=50.1
Q ss_pred CCCcCCCCCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCC--CCeee
Q 026299 4 SAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVR 81 (240)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~ 81 (240)
..+.++-+...+......+++-+..=.+| +.||...... +--+.+|.....+. ..+..|...++=+.- -...+
T Consensus 4 ~~~~~~lp~~~~~l~~g~~w~~v~~geS~--~~v~rl~a~~-r~g~~~k~~~~~~~--a~L~~Ea~RlrWla~~~l~~P~ 78 (266)
T COG3231 4 RSLPPGLPPALRRLLSGRRWRRVTEGESG--AGVFRLFADS-RPGLYLKIASSGPA--AELEGEAARLRWLAGQGLGCPR 78 (266)
T ss_pred CcCCCCCchhHHHhccCCccceeeccCCC--CeEEEEeccC-CCceEEEEecCcch--hhhhhHHHHHHHhcccCCCCCc
Confidence 33333333333333333444433322222 3566655553 33355665433222 446667776654432 22344
Q ss_pred eeEEEEcCCeEEEEEecCCCCchHH
Q 026299 82 FKEVILTPTHLAIVMEYASGGELFE 106 (240)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~~l~~ 106 (240)
+.++..+.+.-|++|.-++|.++..
T Consensus 79 V~~~~~~~~~~wLl~salpG~~~s~ 103 (266)
T COG3231 79 VLGLEDDADQAWLLMSALPGEDASH 103 (266)
T ss_pred eEeeccCcchhHHhhhhcCCCcccc
Confidence 4555555677789999999877644
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.08 E-value=0.0071 Score=58.01 Aligned_cols=151 Identities=17% Similarity=0.142 Sum_probs=101.3
Q ss_pred HHHHHHHhcCCCCeeeeeEEEEcC--CeEEEEEecCCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhC-C-
Q 026299 66 REIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSM-Q- 137 (240)
Q Consensus 66 ~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~~~~~~~~l~~~l~~~----~~l~~~~~~~~~~~i~~~l~~LH~~-~- 137 (240)
.|...++...|+++.....-..+. ..-+..++++.+|.+.+.+-++ +.+.+.-+.....+.+....-.|.. +
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 333344556788877766555443 2346778888888888877543 3344444544444445555555532 2
Q ss_pred ---ceeecCCCCCeEEcCCCCCcEEEecCCccc-cccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHH
Q 026299 138 ---VCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213 (240)
Q Consensus 138 ---ivh~~i~~~nili~~~~~~~~~L~d~~~~~-~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~ 213 (240)
-+|.++++-|.++..+.. ++++++|+.. ............+++.|+.|+....-..+.+ +|+|.+|+-+|.+-
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRS 1434 (2724)
T ss_pred CccchhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHh
Confidence 578899999999976655 8999999987 3333333445567778888887665566555 99999999999888
Q ss_pred hCCCCC
Q 026299 214 VGAYPF 219 (240)
Q Consensus 214 ~g~~pf 219 (240)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 240 | ||||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-129 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-128 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-128 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-128 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-127 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-126 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-45 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-43 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-43 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-42 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-42 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-42 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-42 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-42 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-42 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-42 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-41 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-41 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-41 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-41 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-40 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-40 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-40 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-40 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-35 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-35 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-35 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-35 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-34 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-34 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-34 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-34 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-34 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-34 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-34 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-34 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-34 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-34 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-34 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-34 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-34 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-34 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-34 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-34 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-34 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-34 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-34 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-34 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-34 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-34 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-34 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-34 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-34 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-34 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-34 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-34 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-34 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-34 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-34 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-34 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-34 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-34 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-34 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-34 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-34 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-34 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-34 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-33 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-33 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-33 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-33 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-33 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-33 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-33 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-33 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-33 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-33 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-33 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-33 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-33 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-33 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-32 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-32 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-31 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-31 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-31 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-31 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-30 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-30 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-30 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-30 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-30 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-30 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-30 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-30 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-30 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-30 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-30 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-30 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-30 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-30 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-30 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-30 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-30 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-30 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-30 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-30 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-30 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-30 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-30 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-30 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-30 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-30 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-30 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-30 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-29 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-29 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-29 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-29 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-29 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-29 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-29 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-29 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-29 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-29 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-29 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-29 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-29 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-29 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-28 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-28 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-28 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-28 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-28 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-28 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-28 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-28 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-28 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-28 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-28 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-28 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-28 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-28 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-28 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-28 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-28 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-28 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-28 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-28 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-28 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-28 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-28 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-28 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-28 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-28 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-28 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-28 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-28 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-28 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-28 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-28 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-28 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-28 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-28 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-28 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-28 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-28 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-28 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-28 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-28 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-28 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-28 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-28 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-28 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-28 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-28 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-28 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-28 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-28 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-28 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-28 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-28 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-28 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-28 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-28 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-28 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-28 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-28 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-28 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-28 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-28 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-28 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-28 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-27 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-27 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-27 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-27 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-27 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-27 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-27 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-27 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-27 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-27 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-27 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-27 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-27 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-27 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-27 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-27 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-27 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-27 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-27 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-27 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-27 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-27 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-27 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-26 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-26 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-26 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-26 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-26 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-26 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-26 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-26 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-26 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-26 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-25 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-25 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-25 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-25 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-25 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-25 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-25 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-25 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-25 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-25 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-25 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-25 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-25 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-25 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-25 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-25 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-24 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-24 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-24 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-24 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-24 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-24 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-24 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-24 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-24 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-23 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-23 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-23 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-23 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-23 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-23 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-23 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-23 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-23 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-22 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-22 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-22 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-22 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-22 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-22 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-22 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-22 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-22 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-22 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-22 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-22 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-22 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-21 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-21 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-20 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-20 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-20 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-20 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-20 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-19 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-19 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-19 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-19 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-19 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-19 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-19 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-19 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-19 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-19 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-19 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-19 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-19 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-19 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-19 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-18 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-18 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-18 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-18 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-18 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-18 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-18 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-18 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-18 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-18 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-18 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-18 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-18 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-18 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-18 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-18 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-18 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-18 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-18 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-18 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-18 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-18 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-18 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-18 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-18 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-18 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-18 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-18 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-17 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-17 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-17 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-17 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-17 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-17 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-17 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-17 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-16 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-15 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-14 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-13 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-13 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-12 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-08 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-08 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 4e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-08 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-08 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 5e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 6e-08 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-07 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 4e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 6e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 9e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-06 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 4e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 9e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-06 |
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 427 bits (1099), Expect = e-152
Identities = 210/233 (90%), Positives = 225/233 (96%), Gaps = 1/233 (0%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERG I
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 350 bits (901), Expect = e-123
Identities = 80/227 (35%), Positives = 127/227 (55%), Gaps = 11/227 (4%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
M +P + + ++LV+ +G G +G +L ++ TEE VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 186
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTI 232
PE+L ++E+ + DVWSCG+ L ML G P++ P + + +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 346 bits (891), Expect = e-122
Identities = 80/227 (35%), Positives = 127/227 (55%), Gaps = 11/227 (4%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
M +P + + ++LV+ +G G +G +L ++ TEE VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 186
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTI 232
PE+L ++E+ + DVWSCG+ L ML G P++ P + + +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 4e-94
Identities = 95/214 (44%), Positives = 121/214 (56%), Gaps = 8/214 (3%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y L +G G FG ++ + T VAVK + R KI ++REI N + RH
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TPT +VMEY SGGELF+ IC GR E EAR FQQ++S V YCH
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ + Y
Sbjct: 131 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
G D+WSCGV LY +L G PF+D P F+K
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK 222
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 3e-92
Identities = 73/221 (33%), Positives = 104/221 (47%), Gaps = 8/221 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
RY R +G G F + D T+E+ A K + + E + EI HRSL H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 195
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL KK +
Sbjct: 135 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
+ DVWS G +Y +LVG PFE + + + Y
Sbjct: 193 SFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 232
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 4e-92
Identities = 86/213 (40%), Positives = 123/213 (57%), Gaps = 7/213 (3%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
Y L++ IG GNF +L R T VA+K I++ +++ + + RE+ + L HP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHP 74
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV+ EVI T L ++MEYASGGE+F+ + GR E EAR F+Q++S V YCH +
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRDLK EN LLD +KI DFG+S + + + G P Y APE+ K+YDG
Sbjct: 135 IVHRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
DVWS GV LY ++ G+ PF+ + +
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 3e-91
Identities = 93/214 (43%), Positives = 123/214 (57%), Gaps = 8/214 (3%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y L +G G FG ++ + + T VAVK + R KI ++REI N + RH
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRH 75
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TP+ + +VMEY SGGELF+ IC GR E E+R FQQ++SGV YCH
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ + Y
Sbjct: 136 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
G D+WS GV LY +L G PF+D P F+K
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK 227
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 9e-91
Identities = 73/221 (33%), Positives = 104/221 (47%), Gaps = 8/221 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
RY R +G G F + D T+E+ A K + + E + EI HRSL H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 195
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL KK +
Sbjct: 161 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
+ DVWS G +Y +LVG PFE + + + Y
Sbjct: 219 SFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 258
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 3e-90
Identities = 96/214 (44%), Positives = 130/214 (60%), Gaps = 9/214 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y + +G G+FG +L KT++ VA+K+I R + V+REI + LRH
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLKLLRH 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TPT + +V+EYA GGELF+ I R +EDE R FFQQ+I + YCH
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
++ HRDLK EN LLD + +KI DFG S + K++ G+P Y APEV+ K Y
Sbjct: 128 KIVHRDLKPENLLLDDN--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
G DVWSCG+ LYVMLVG PF+D P F+K
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 4e-89
Identities = 68/223 (30%), Positives = 112/223 (50%), Gaps = 18/223 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLR 75
+Y + +G G++G + + D +T AVK +++ K+ + NV++EI R LR
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLR 64
Query: 76 HPNIVRFKEVIL--TPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVS 131
H N+++ +V+ + +VMEY G E+ + + RF +A +F QLI G+
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPE 188
Y HS + H+D+K N LL LKI G +++ + +++ G+PA+ PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG--GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 189 VLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ + G D+WS GVTLY + G YPFE K F
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN 224
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 3e-88
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 9/222 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
+ +++ +G G+F T VA+K I++ + + VQ E+ H L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 135
P+I+ ++ +V+E GE+ + N FSE+EAR F Q+I+G+ Y HS
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 194
+ HRDL L N LL + +KI DFG + + + T+ GTP YI+PE+ +
Sbjct: 131 HGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
+ + +DVWS G Y +L+G PF+ K + Y
Sbjct: 189 HGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 1e-86
Identities = 71/220 (32%), Positives = 118/220 (53%), Gaps = 8/220 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76
D +++ R +G G FG L R+K+ + ++A+K + + ++ ++REI LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R + +++E+A GEL++ + GRF E + F ++L + YCH
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN L+ LKI DFG+S + + ++ GT Y+ PE++ K +D
Sbjct: 134 KVIHRDIKPENLLMGYK--GELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
K D+W GV Y LVG PF+ P + R+ ++V
Sbjct: 191 EK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 4e-86
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--------VQREIINHR 72
+Y++ +GSG FG VA+K++E+ D+I + V E++ +
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLK 101
Query: 73 SLRH--PNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISG 129
+ ++R + P +++E +LF+ I G E+ AR FF Q++
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIA 186
V +CH+ V HRD+K EN L+D + LK+ DFG K +V GT Y
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSP 216
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
PE + Y G+ A VWS G+ LY M+ G PFE EE
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 5e-86
Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 12/213 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIINHR 72
+Y + +GSG FG DK+ + V VK+I++ D V EI
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 73 SLRHPNIVRFKEVILTPTHLAIVME-YASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ H NI++ ++ +VME + SG +LF I R E A + F+QL+S V
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y + HRD+K EN ++ +K+ DFG + + GT Y APEVL+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAED--FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
Y G ++WS GVTLY ++ PF + EE
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 7e-86
Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 8/220 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76
+ +E+ R +G G FG L R+K+++ ++A+K + + ++ ++RE+ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R T + +++EYA G ++ + +F E + +L + +SYCHS
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN LL + LKI DFG+S S+ GT Y+ PE++ + +D
Sbjct: 129 RVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
K D+WS GV Y LVG PFE + +++ V +
Sbjct: 186 EK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 224
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 7e-86
Identities = 80/245 (32%), Positives = 116/245 (47%), Gaps = 43/245 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER------------------------- 56
+Y L +IG G++GV +L ++ A+K + +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 57 --GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAG 112
E V +EI + L HPN+V+ EV+ P HL +V E + G + E +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----K 167
SED+ARF+FQ LI G+ Y H ++ HRD+K N L+ +KI DFG S
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED--GHIKIADFGVSNEFKGS 190
Query: 168 SSVLHSQPKSTVGTPAYIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
++L +TVGTPA++APE L +K + GK DVW+ GVTLY + G PF D
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 226 KNFRK 230
K
Sbjct: 247 CLHSK 251
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 5e-85
Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 22/220 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHR 72
Y L +G G FG VA+K I R +++ E+
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLW 89
Query: 73 SLR----HPNIVRFKEVILTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLI 127
+ HP ++R + T +V+E +LF+ I G E +R FF Q++
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAY 184
+ + +CHS V HRD+K EN L+D K+ DFG GT Y
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVY 204
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
PE + + +Y A VWS G+ LY M+ G PFE +E
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE 244
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 1e-81
Identities = 56/231 (24%), Positives = 97/231 (41%), Gaps = 18/231 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ + L +G G R KKT +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 78 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 132
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 191 --------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+K+Y D+WS GVT Y G+ PF E P+ ++ ++
Sbjct: 188 ERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-81
Identities = 68/224 (30%), Positives = 97/224 (43%), Gaps = 13/224 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
+E+ +G+G FG + T E VA+K + K E EI + L HPN
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 79 IVRFKEVILTPTHLA------IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISG 129
+V +EV LA + MEY GG+L + + N E R + S
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 130 VSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
+ Y H ++ HRDLK EN +L G KI D GY+K VGT Y+APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+L +K+Y D WS G + + G PF +P + +
Sbjct: 194 LLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 3e-81
Identities = 77/215 (35%), Positives = 114/215 (53%), Gaps = 5/215 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
SD Y++ ++G G F V R K T A K I + + ++RE R L+H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCHS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL K Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
K D+W+CGV LY++LVG PF D ++ + + +
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 218
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 3e-81
Identities = 79/220 (35%), Positives = 116/220 (52%), Gaps = 6/220 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHP 77
+ Y L IG G++G ++ K T A K I + ++ + ++EI +SL HP
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHP 66
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NI+R E T + +VME +GGELFER+ + F E +A + ++S V+YCH +
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 138 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN L SP LK+ DFG + ++ VGTP Y++P+V L+ Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV-LEGLY- 184
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
G D WS GV +YV+L G PF P + + K +
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF 224
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 3e-81
Identities = 56/231 (24%), Positives = 97/231 (41%), Gaps = 18/231 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ + L +G G R KKT +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 78 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 132
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 191 --------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+K+Y D+WS GVT Y G+ PF E P+ ++ ++
Sbjct: 188 ERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 2e-80
Identities = 78/220 (35%), Positives = 118/220 (53%), Gaps = 6/220 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-NVQREIINHRSLRHPN 78
+ + +GSG F L++ + T +L A+K I++ + +++ EI + ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV +++ + TH +VM+ SGGELF+RI G ++E +A QQ++S V Y H +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 139 CHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYD 196
HRDLK EN L ++ I DFG SK + + + GTP Y+APEVL +K Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY- 184
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
K D WS GV Y++L G PF + E K F K Y
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY 224
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 8e-80
Identities = 74/225 (32%), Positives = 109/225 (48%), Gaps = 13/225 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIIN 70
D Y + + +GSG G +L ++KT + VA+K I + NV+ EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 131 SYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 190 LLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
L+ + D WS GV L++ L G PF + + + I
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 232
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 7e-79
Identities = 79/226 (34%), Positives = 121/226 (53%), Gaps = 10/226 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D YE+ ++GSG F + R R K T + A K+I R E ++RE+ R
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+RHPNI+ ++ T + +++E SGGELF+ + +EDEA F +Q++ GV Y
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS ++ H DLK EN +L P PR+K+ DFG + ++ K+ GTP ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
+ G AD+WS GV Y++L GA PF + + V Y
Sbjct: 184 NYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY 228
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-78
Identities = 73/224 (32%), Positives = 109/224 (48%), Gaps = 9/224 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKID-ENVQREIINHRSLRHP 77
D + R +GSG FG L+ ++ + +K I ++ E ++ EI +SL HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYC 133
NI++ EV ++ IVME GGEL ERI SE +Q+++ ++Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 134 HSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS V H+DLK EN L SP +KI DFG ++ + GT Y+APEV K
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV-FK 199
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
++ K D+WS GV +Y +L G PF + +K +
Sbjct: 200 RDVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 1e-78
Identities = 73/225 (32%), Positives = 109/225 (48%), Gaps = 13/225 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIIN 70
D Y + + +GSG G +L ++KT + VA++ I + NV+ EI
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 131 SYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
Query: 190 LLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
L+ + D WS GV L++ L G PF + + + I
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 357
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-78
Identities = 48/243 (19%), Positives = 90/243 (37%), Gaps = 39/243 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER------------------GDKIDE 62
+ Y ++R + G F L K + A+K E+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 63 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------RF 114
+ + E+ +++ + + +I + I+ EY + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 115 SEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 170
+ + +++ SY H+ +CHRD+K N L+D + R+K+ DFG S+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMVDKK 206
Query: 171 LHSQPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
+ + GT ++ PE + Y+G D+WS G+ LYVM PF
Sbjct: 207 IK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 230 KTI 232
I
Sbjct: 263 NNI 265
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 2e-78
Identities = 82/215 (38%), Positives = 120/215 (55%), Gaps = 6/215 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
++RY +V +G G+FG +D+ T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEV L+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D K DVWS GV LY++L G PF E ++
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR 233
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 3e-78
Identities = 76/204 (37%), Positives = 102/204 (50%), Gaps = 8/204 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPN 78
+D YE+ DIG G++ V + K T AVK I DK + EI I R +HPN
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQHPN 77
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
I+ K+V ++ +V E GGEL ++I FSE EA + V Y H+ V
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 139 CHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
HRDLK N L ++ICDFG++K + T T ++APEVL ++ Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 196 DGKIADVWSCGVTLYVMLVGAYPF 219
D D+WS GV LY ML G PF
Sbjct: 198 D-AACDIWSLGVLLYTMLTGYTPF 220
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 5e-78
Identities = 78/215 (36%), Positives = 115/215 (53%), Gaps = 5/215 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKID-ENVQREIINHRSLRH 76
SD Y++ ++G G F V R K T A K I + D + ++RE R L+H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCHS
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL K Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
K D+W+CGV LY++LVG PF D ++ + + +
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 241
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 2e-77
Identities = 70/227 (30%), Positives = 105/227 (46%), Gaps = 18/227 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREI- 68
+ YE +G G V R K T + AVK I E ++ E +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 69 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
I + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 189 VLLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
++ D GK D+WS GV +Y +L G+ PF ++ R
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 3e-77
Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 17/226 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREI-I 69
+Y+ IG G V R + T AVK +E +++ E +RE I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
+ HP+I+ + + + + +V + GELF+ + SE E R + L+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
VS+ H+ + HRDLK EN LLD + +++ DFG+S + + GTP Y+APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDN-MQ-IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
L + GK D+W+CGV L+ +L G+ PF + R
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 3e-77
Identities = 77/226 (34%), Positives = 123/226 (54%), Gaps = 10/226 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y+ ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 133 CHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS+Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
+ G AD+WS GV Y++L GA PF + + V Y
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 8e-77
Identities = 80/219 (36%), Positives = 121/219 (55%), Gaps = 4/219 (1%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
SD +E+ ++G G + + K T++ A+K +++ + V+ EI L HPNI
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRLSHPNI 110
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
++ KE+ TPT +++V+E +GGELF+RI G +SE +A +Q++ V+Y H +
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 140 HRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRDLK EN L +P LKI DFG SK K+ GTP Y APE+L Y G
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GP 229
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHVMY 236
D+WS G+ Y++L G PF D + FR+ ++ Y
Sbjct: 230 EVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY 268
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 9e-77
Identities = 75/226 (33%), Positives = 119/226 (52%), Gaps = 10/226 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y++ ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ HPNI+ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
H+ ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
+ G AD+WS GV Y++L GA PF + + V Y
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY 235
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-76
Identities = 73/226 (32%), Positives = 118/226 (52%), Gaps = 10/226 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y++ ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ H N++ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
H+ ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
+ G AD+WS GV Y++L GA PF + + V Y
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY 235
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 5e-76
Identities = 83/211 (39%), Positives = 117/211 (55%), Gaps = 9/211 (4%)
Query: 20 SDRYEL---VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLR 75
Y+L + +G G+F + R KK+ + AVK I + +++ N Q+EI
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEG 64
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HPNIV+ EV H +VME +GGELFERI FSE EA + ++L+S VS+ H
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 136 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKK 193
+ V HRDLK EN L D + +KI DFG+++ +QP K+ T Y APE+L +
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
YD + D+WS GV LY ML G PF+ +
Sbjct: 185 GYD-ESCDLWSLGVILYTMLSGQVPFQSHDR 214
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 5e-76
Identities = 82/215 (38%), Positives = 120/215 (55%), Gaps = 6/215 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
++RY +V +G G+FG +D+ T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEV L+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D K DVWS GV LY++L G PF E ++
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR 233
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 6e-76
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 2/212 (0%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
++Y + D+G G FG+ + +++ K+++ V++EI RH NI
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
+ E + L ++ E+ SG ++FERI + +E E + Q+ + + HS +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-ST 182
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D+WS G +YV+L G PF +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIEN 214
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 7e-76
Identities = 78/219 (35%), Positives = 115/219 (52%), Gaps = 12/219 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
++ Y+L ++G G F V R + A I D + ++RE R L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I H ++ + +GGELFE I +SE +A QQ++ V +CH M
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 137 QVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 191
V HR+LK EN LL G+ +K+ DFG + Q GTP Y++PEVL
Sbjct: 130 GVVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
K Y GK D+W+CGV LY++LVG PF D ++ + +++
Sbjct: 187 KDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ 224
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 1e-75
Identities = 91/235 (38%), Positives = 125/235 (53%), Gaps = 9/235 (3%)
Query: 3 RSAMTVGPGM--DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---G 57
+ PGM SDRY+ R +G G+FG L +DK T + AVK I +
Sbjct: 6 MDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK 65
Query: 58 DKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 116
K D E++ RE+ + L HPNI++ E + +V E +GGELF+ I + RFSE
Sbjct: 66 QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP 175
+A +Q++SG++Y H ++ HRDLK EN LL+ S ++I DFG S +
Sbjct: 126 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
K +GT YIAPEV L YD K DVWS GV LY++L G PF E +K
Sbjct: 186 KDKIGTAYYIAPEV-LHGTYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKK 238
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-75
Identities = 64/242 (26%), Positives = 100/242 (41%), Gaps = 34/242 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ +E + +G G FG R+ A+K I ++ + E++ SL H +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 80 VRFKEVIL-------------TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQ 125
VR+ L + L I MEY G L++ I + DE F+Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SV 170
++ +SY HS + HRDLK N +D S +KI DFG +K+
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
S +GT Y+A EVL + + D++S G+ + M+ YPF E N K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILK 239
Query: 231 TI 232
+
Sbjct: 240 KL 241
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-75
Identities = 81/215 (37%), Positives = 117/215 (54%), Gaps = 6/215 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
S+ Y+ V+ +GSG +G L RDK T A+K I + + + E+ + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ + + +VME GGELF+ I + +F+E +A +Q++SGV+Y H
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL +KI DFG S + K +GT YIAPEV L+K+Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-LRKKY 214
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D K DVWS GV L+++L G PF + + RK
Sbjct: 215 DEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRK 248
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 9e-75
Identities = 67/263 (25%), Positives = 108/263 (41%), Gaps = 52/263 (19%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKID-ENVQREIINHRS 73
+Y L IG G++GV R+ + +T + A+K + + + D E ++ E+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 113
L HPNI R EV ++ +VME GG L +++
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 114 --------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153
E +Q+ S + Y H+ +CHRD+K EN L +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 154 PAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYD-GKIADVWSCGV 207
+ +K+ DFG SK + + GTP ++APEVL G D WS GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 208 TLYVMLVGAYPFEDPEEPKNFRK 230
L+++L+GA PF + +
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQ 287
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-74
Identities = 81/226 (35%), Positives = 120/226 (53%), Gaps = 17/226 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--------------GDKIDENVQ 65
+ Y VR +GSG +G L ++K A+K I++ +K E +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
EI +SL HPNI++ +V + +V E+ GGELFE+I N +F E +A +Q
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 126 LISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
++SG+ Y H + HRD+K EN LL + + +KI DFG S + + +GT Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
IAPEV LKK+Y+ K DVWSCGV +Y++L G PF + +K
Sbjct: 215 IAPEV-LKKKYNEK-CDVWSCGVIMYILLCGYPPFGGQNDQDIIKK 258
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-74
Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 3/219 (1%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D Y+++ ++GSG FGV +K T + K+I +D V+ EI L HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQ 137
++ + + +++E+ SGGELF+RI + SE E + +Q G+ + H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ H D+K EN + + A +KI DFG + K T T + APE++ ++ G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-G 228
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
D+W+ GV YV+L G PF ++ + + +
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 267
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-74
Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 9/225 (4%)
Query: 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREI-INHRSL 74
++ Y L +++G G F V R K T + A K+++ RG + EI + +
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSY 132
P ++ EV + + +++EYA+GGE+F A SE++ +Q++ GV Y
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 133 CHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
H + H DLK +N LL P +KI DFG S+ + + +GTP Y+APE+L
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
D+W+ G+ Y++L PF + + + V
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV 250
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-73
Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 13/217 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRS 73
D YEL IG G F V R +++T + AVK ++ E+++RE
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISG 129
L+HP+IV E + L +V E+ G +L I +SE A + +Q++
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 130 VSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAP 187
+ YCH + HRD+K LL + +K+ FG + VGTP ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
EV+ ++ Y GK DVW CGV L+++L G PF +E
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE 238
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 4e-73
Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 5/221 (2%)
Query: 20 SDRYELVR--DIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRH 76
+ Y + + +G G FG + T +A K I+ RG K E V+ EI L H
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHS 135
N+++ + + + +VMEY GGELF+RI + +E + F +Q+ G+ + H
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
M + H DLK EN L A ++KI DFG ++ + K GTP ++APEV + ++
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDF 264
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
D+WS GV Y++L G PF + + + +
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 6e-73
Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 23/222 (10%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++K + + A+KY+ + + ++ + EI L+ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 147 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
+DVWS G LY M G PF+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 7e-73
Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 3/219 (1%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D Y++ ++G+G FGV + ++ T A K++ + D E V++EI LRHP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 137
+V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G+ + H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
H DLK EN + + LK+ DFG + K T GT + APEV K G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
D+WS GV Y++L G PF + + R +
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 373
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 4e-72
Identities = 76/226 (33%), Positives = 118/226 (52%), Gaps = 14/226 (6%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
V G+ + D Y++ + +G G G + +K+T+E A+K ++
Sbjct: 43 FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----C 98
Query: 62 ENVQREI-INHRSLRHPNIVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RF 114
+RE+ ++ R+ + P+IVR +V L IVME GGELF RI + G F
Sbjct: 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 173
+E EA + + + Y HS+ + HRD+K EN L P LK+ DFG++K + H+
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ TP Y+APEVL ++YD K D+WS GV +Y++L G PF
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPF 263
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 5e-72
Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 23/222 (10%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++K + + A+KY+ + + ++ + EI L+ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 128 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
+DVWS G LY M G PF+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-71
Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 18/217 (8%)
Query: 20 SDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREI-INHRSLRH 76
D Y+L D +G G + + T + AVK IE + I V RE+ + ++ H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
N++ E +V E GG + I F+E EA Q + S + + H+
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 137 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 186
+ HRDLK EN L + +P +KICDF S + + + G+ Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 187 PEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPF 219
PEV+ + K D+WS GV LY++L G PF
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-71
Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 23/222 (10%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++ +++ A+KY+ + + ++ + EI L+ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + + S VG Y+ PE +
Sbjct: 175 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
+DVWS G LY M G PF+
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 5e-70
Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 20 SDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHP 77
+D Y+L + +G G G ++T + A+K + ++E+ + ++ P
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGP 82
Query: 78 NIVRFKEVILTPTHLA----IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVS 131
+IV +V H I+ME GGELF RI G F+E EA + + + +
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 132 YCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV 189
+ HS + HRD+K EN L LK+ DFG++K ++ TP Y+APEV
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEV 200
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228
L ++YD K D+WS GV +Y++L G PF
Sbjct: 201 LGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAIS 238
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 4e-69
Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 9/216 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHP 77
++Y ++ IG G+FG A L++ + +K I E +RE+ +++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV+++E L IVM+Y GG+LF+RI F ED+ +F Q+ + + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ HRD+K +N L +++ DFG ++ + ++ +GTP Y++PE+ K
Sbjct: 144 RKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
Y+ K +D+W+ G LY + + FE K
Sbjct: 202 YNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLK 236
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-68
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 24/219 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++ + IGSG FG + + + +K + +E +RE+ L H NIV
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIV 67
Query: 81 RFKEVILTPTH----------------LAIVMEYASGGELFERI--CNAGRFSEDEARFF 122
+ + L I ME+ G L + I + + A
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
F+Q+ GV Y HS ++ +RDLK N L + ++KI DFG S + + GT
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDT--KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
Y++PE + ++Y + D+++ G+ L +L +
Sbjct: 186 RYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFE 223
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 6e-68
Identities = 69/215 (32%), Positives = 108/215 (50%), Gaps = 18/215 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHP 77
+ YE++ IG+G++G + +R K +++ K ++ G + + + E+ R L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 78 NIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
NIVR+ + I+ T L IVMEY GG+L I + E+ QL +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 132 YCHSM-----QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYI 185
CH V HRDLK N LDG +K+ DFG ++ + S K+ VGTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+PE + + Y+ K +D+WS G LY + PF
Sbjct: 184 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFT 217
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-65
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
+ + + IG G F VA+K ++ D +D + +EI + L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 132
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL 191
HS +V HRD+K N + + +K+ D G + S + S VGTP Y++PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ Y+ K +D+WS G LY M PF
Sbjct: 210 ENGYNFK-SDIWSLGCLLYEMAALQSPFY 237
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-65
Identities = 55/235 (23%), Positives = 90/235 (38%), Gaps = 23/235 (9%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHP 77
D+ Y ++ +G G F L+ A+K I ++ D E QRE HR HP
Sbjct: 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86
Query: 78 NIVRFKEVILTPT----HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISG 129
NI+R L +++ + G L+ I +ED+ + + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----------V 179
+ H+ HRDLK N LL + + D G + +H +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 180 GTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
T +Y APE+ + + + DVWS G LY M+ G P++ + +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-64
Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 10/217 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSL-RH 76
++ + +G G++G +R K+ L AVK RG K E+ +H + +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHS 135
P VR ++ L + E G L + G E + + + + +++ HS
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ H D+K N L P R K+ DFG + G P Y+APE+ L+ Y
Sbjct: 176 QGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-LQGSY 232
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
ADV+S G+T+ + E + R+
Sbjct: 233 GTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGY 268
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-62
Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPN 78
D + +G G G + +K+T+E A+K ++ +RE+ ++ R+ + P+
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 72
Query: 79 IVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 132
IVR +V L IVME GGELF RI + G F+E EA + + + Y
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 133 CHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
HS+ + HRD+K EN L P LK+ DFG A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKET-T 171
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++YD K D+WS GV +Y++L G PF
Sbjct: 172 GEKYD-KSCDMWSLGVIMYILLCGYPPFYS 200
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-60
Identities = 58/242 (23%), Positives = 90/242 (37%), Gaps = 36/242 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+E ++ +G G FGV ++K + A+K I + E V RE+ L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 79 IVRFKEVILT------------PTHLAIVMEYASGGELFERI---CNAGRFSEDEARFFF 123
IVR+ L +L I M+ L + + C F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SSV 170
Q+ V + HS + HRDLK N +K+ DFG
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+++ VGT Y++PE + Y K D++S G+ L+ +L YPF E
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERVRTLT 238
Query: 231 TI 232
+
Sbjct: 239 DV 240
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 3e-60
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSLR-HPNI 79
R + R + G F +D + A+K + ++ + +E+ + L HPNI
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 80 VRF-------KEVILTPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISG 129
V+F KE T +++ G+L E + G S D F Q
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 130 VSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------- 178
V + H + + HRDLK+EN LL +K+CDFG + + + +
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 179 ----VGTPAYIAPEV--LLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
TP Y PE+ L G+ D+W+ G LY++ +PFED
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-60
Identities = 42/239 (17%), Positives = 83/239 (34%), Gaps = 28/239 (11%)
Query: 19 DSDRYELVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGDKIDENVQREIIN-HR 72
S + +G G F + D K ++ +K + + + + +++ +
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLI 127
++F L +V E S G L I + F +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSVLHSQPKST 178
+ H ++ H D+K +N +L + L + D G S + PK T
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGT 240
Query: 179 V-----GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+ T + E+L K ++ +I D + T+Y ML G Y E + + +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-58
Identities = 55/237 (23%), Positives = 91/237 (38%), Gaps = 35/237 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNI 79
+ + +G G+ G + VAVK + + EI + S HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-------EARFFFQQLISGVSY 132
+R+ T L I +E L + + + E+ +Q+ SGV++
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 133 CHSMQVCHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSVLHSQPK 176
HS+++ HRDLK +N L+ S R+ I DFG K S +
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 177 STVGTPAYIAPEVLLKKEYD------GKIADVWSCGVTLYVMLVGAY-PFEDPEEPK 226
+ GT + APE+L + + D++S G Y +L PF D +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-57
Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 14/220 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 76
++ + +G G+F L R+ T A+K +I + +K+ +R++++ L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS--RLDH 89
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 193
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L +K
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
K +D+W+ G +Y ++ G PF E F+K I
Sbjct: 208 SA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 7e-57
Identities = 54/218 (24%), Positives = 82/218 (37%), Gaps = 18/218 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIV 80
+ +G G G R VAVK I + RE+ + S HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVC 139
R+ I +E L E + E QQ SG+++ HS+ +
Sbjct: 82 RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140
Query: 140 HRDLKLENTLL---DGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL-- 190
HRDLK N L+ + + I DFG K S+ GT +IAPE+L
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 191 -LKKEYDGKIADVWSCGVTLYVMLVGAY-PFEDPEEPK 226
K+ D++S G Y ++ PF + +
Sbjct: 201 DCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQRQ 237
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-56
Identities = 56/237 (23%), Positives = 93/237 (39%), Gaps = 30/237 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSL-R 75
+ + + IGSG FG + + A+K + G ++N RE+ H L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
H ++VR+ H+ I EY +GG L + I R F E E + Q+ G+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 132 YCHSMQVCHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSVLHSQ 174
Y HSM + H D+K N + S KI D G+ S
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISS 186
Query: 175 PKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
P+ G ++A EVL + K AD+++ +T+ + ++ R+
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQWHEIRQ 242
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-53
Identities = 63/220 (28%), Positives = 114/220 (51%), Gaps = 16/220 (7%)
Query: 21 DRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----S 73
++EL++ +G G+FG + + + +L A+K + + + + R
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVE 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
+ HP IV+ T L +++++ GG+LF R+ F+E++ +F+ +L + +
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 134 HSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 190
HS+ + +RDLK EN LLD G +K+ DFG SK S+ H + + GT Y+APEV+
Sbjct: 143 HSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
++ + + AD WS GV ++ ML G PF+ + +
Sbjct: 199 NRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM 237
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 4e-53
Identities = 79/223 (35%), Positives = 114/223 (51%), Gaps = 17/223 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
D +E +R +G G+FG L R K+T +L AVK + + D I +Q + +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL-KKDVI---LQDDDVECTMTEKRILS 78
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ HP + + TP L VME+ +GG+L I + RF E ARF+ ++IS +
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
+ H + +RDLKL+N LLD K+ DFG K + + +T GTP YIAPE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+ Y G D W+ GV LY ML G PFE E F ++
Sbjct: 197 QEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-53
Identities = 75/222 (33%), Positives = 116/222 (52%), Gaps = 16/222 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------R 72
+ ++ ++ +G G FG L+R+K T A+K + R + I + ++ + H +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL-RKEVI---IAKDEVAHTVTESRVLQ 60
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ RHP + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLL 191
HS V +RD+KLEN +LD +KI DFG K + T GTP Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+Y G+ D W GV +Y M+ G PF + + + F +
Sbjct: 179 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-53
Identities = 71/218 (32%), Positives = 110/218 (50%), Gaps = 21/218 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
++++R +G+G+FG L+R + A+K + K + V+ + + H +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLMLSIV 63
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
HP I+R + ++M+Y GGELF + + RF A+F+ ++ + Y H
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 135 SMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
S + +RDLK EN LLD G +KI DFG++K + + GTP YIAPEV+
Sbjct: 124 SKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
K Y K D WS G+ +Y ML G PF D K + K
Sbjct: 178 KPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 214
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-52
Identities = 75/225 (33%), Positives = 111/225 (49%), Gaps = 21/225 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ + L + +G G+FG L KKT + A+K + K D + + +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLS 72
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ HP + T +L VMEY +GG+L I + +F A F+ ++I G+
Sbjct: 73 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
+ HS + +RDLKL+N LLD G +KI DFG K ++L +T GTP YIAPE
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+LL ++Y D WS GV LY ML+G PF +E + F
Sbjct: 189 ILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-52
Identities = 66/219 (30%), Positives = 120/219 (54%), Gaps = 13/219 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
D+++ ++ +G+G+FG L++ K++ A+K +++ + +N + ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ +RDLK EN L+D G +++ DFG++K + + + GTP +APE++L K
Sbjct: 161 DLIYRDLKPENLLIDQQG----YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKG 214
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
Y K D W+ GV +Y M G PF + + + K +
Sbjct: 215 Y-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-52
Identities = 73/225 (32%), Positives = 111/225 (49%), Gaps = 21/225 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ ++ IG G+FG L R K E AVK + + I ++++ H
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL-QKKAI---LKKKEEKHIMSERNVLL 93
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++++HP +V T L V++Y +GGELF + F E ARF+ ++ S +
Sbjct: 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y HS+ + +RDLK EN LLD G + + DFG K ++ H+ ST GTP Y+APE
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
VL K+ Y + D W G LY ML G PF + + ++
Sbjct: 210 VLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 3e-52
Identities = 75/225 (33%), Positives = 109/225 (48%), Gaps = 21/225 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ + +G G+FG L K T+EL AVK + K D +Q + +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL----KKDVVIQDDDVECTMVEKRVLA 75
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
+ S + +RDLKL+N +LD G +KI DFG K ++ T GTP YIAPE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
++ + Y GK D W+ GV LY ML G PFE +E + F+ +
Sbjct: 192 IIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (436), Expect = 4e-52
Identities = 30/256 (11%), Positives = 64/256 (25%), Gaps = 52/256 (20%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR-- 75
+G + D++T E V ++ + ++ E++ R LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 76 -----------------------HPNIVRFKEVILTPTHLAIVMEY--------ASGGEL 104
++R + L+ Y G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
Q+I ++ H + H L+ + +LD + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFE 251
Query: 165 YSKSSVLHSQPKSTVGTPAYIAPEVL----------LKKEYDGKIADVWSCGVTLYVMLV 214
V + + + PE+ ++ D W+ G+ +Y +
Sbjct: 252 ---HLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 215 GAYPFEDPEEPKNFRK 230
P
Sbjct: 309 ADLPITKDAALGGSEW 324
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-52
Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 16/224 (7%)
Query: 21 DRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQRE-IINHR---- 72
+ +EL+R +G G +G R + T ++ A+K +++ + R
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HP IV T L +++EY SGGELF ++ G F ED A F+ ++ + +
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 189
H + +RDLK EN +L+ G +K+ DFG K S+ T GT Y+APE+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
L++ + + D WS G +Y ML GA PF K K +
Sbjct: 193 LMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-51
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 12/214 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +G G+FG M+DK+T AVK + ++ E++ L P
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPR 111
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + I ME GG L + I G ED A ++ Q + G+ Y H+ ++
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLK 192
H D+K +N LL R +CDFG++ GT ++APEV++
Sbjct: 172 LHGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
K D K D+WS + ML G +P+
Sbjct: 231 KPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGP 263
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-51
Identities = 68/229 (29%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
++L+R IG G++ L+R KKT+ + A+K + + + + E I+
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV-KKELV---NDDEDIDWVQTEKHVFE 64
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR-KTIHVMY 236
+L ++Y G D W+ GV ++ M+ G PF+ N T ++
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 8e-51
Identities = 67/229 (29%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
++L+R IG G++ L+R KKT+ + A++ + + + + E I+
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV-KKELV---NDDEDIDWVQTEKHVFE 107
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR-KTIHVMY 236
+L ++Y G D W+ GV ++ M+ G PF+ N T ++
Sbjct: 224 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 271
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-50
Identities = 76/219 (34%), Positives = 114/219 (52%), Gaps = 9/219 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
+ +E ++ +G G FG L+++K T A+K +++ + ++ + + RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + K T L VMEYA+GGELF + FSED ARF+ +++S + Y HS
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 137 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 194
+ V +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +
Sbjct: 268 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
Y G+ D W GV +Y M+ G PF + + K F +
Sbjct: 326 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-50
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPNI 79
E++R IG G+FG +++ T+++ A+KY+ + ++ N R + L HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
V + +V++ GG+L + F E+ + F +L+ + Y + ++
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 140 HRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
HRD+K +N LLD G + I DF + +Q + GT Y+APE+ ++ G
Sbjct: 138 HRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 198 --KIADVWSCGVTLYVMLVGAYPFED 221
D WS GVT Y +L G P+
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHI 219
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-49
Identities = 73/220 (33%), Positives = 112/220 (50%), Gaps = 11/220 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
+ + +G G+FG L K T+EL AVK +++ I ++ V++ ++
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPG 399
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+ +
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKK 193
S + +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++ +
Sbjct: 460 SKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
Y GK D W+ GV LY ML G PFE +E + F+ +
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-49
Identities = 36/241 (14%), Positives = 62/241 (25%), Gaps = 43/241 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
+ +LV + G+ V L+RD + E A+K G + E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 78 NIVRFKEVI--------------------------LTPTHLAIVMEYASG------GELF 105
+ ++ + ++M AS L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 106 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165
G QLI + S + H +N + RL + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD--GRLMLGDVS- 239
Query: 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ P AP L + W G+++Y + PF
Sbjct: 240 --ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 224 E 224
Sbjct: 298 P 298
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-49
Identities = 73/224 (32%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
YE+V+ IG G FG +L+R K T ++ A+K + E ++R
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIMAFA 126
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P +V+ +L +VMEY GG+L + + E ARF+ +++ + H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 192
SM HRD+K +N LLD S LK+ DFG + VGTP YI+PEVL
Sbjct: 186 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 193 KEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+ D G+ D WS GV LY MLVG PF + K ++
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 287
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-48
Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 26/228 (11%)
Query: 24 ELVRDIGSGNFG---VARLMRDKKTEELVAVK-----YIERGDKIDENVQRE-----IIN 70
EL++ +G+G +G + R + T +L A+K I + K E+ + E I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 117 Q----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 131 SYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 186
+ H + + +RD+KLEN LLD G + + DFG SK V ++ GT Y+A
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 187 PEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
P+++ + K D WS GV +Y +L GA PF E + +
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-48
Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 23/230 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------R 72
D +E+++ IG G F +++ K+T ++ A+K + + ++R ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM----NKWDMLKRGEVSCFREERDVLV 116
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVS 131
+ I + +L +VMEY GG+L + G R + ARF+ +++ +
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 189
H + HRD+K +N LLD +++ DFG +S VGTP Y++PE+
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 190 LLKKEYD------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
L G D W+ GV Y M G PF + + K +H
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-48
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 13/220 (5%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-------SLRH 76
+ R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ + H+
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL K
Sbjct: 312 FVVYRDLKPANILLDEH--GHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKN---FRKTIH 233
AD +S G L+ +L G PF + R T+
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 408
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 8e-48
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 21/226 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
+E+++ IG G FG +++ K +++ A+K + E ++R +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL----NKWEMLKRAETACFREERDVLVNG 131
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYC 133
I +L +VM+Y GG+L + R E+ ARF+ +++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 191
H + HRD+K +N L+D + +++ DFG + +S+ VGTP YI+PE+L
Sbjct: 192 HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 192 KKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
E G D WS GV +Y ML G PF + + K ++
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-47
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 7/223 (3%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDK 59
+ PGM + + + IG G+FG D +T+++VA+K I E +
Sbjct: 3 HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED 62
Query: 60 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
E++Q+EI P + ++ L T L I+MEY GG + + G E +
Sbjct: 63 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQI 121
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 178
++++ G+ Y HS + HRD+K N LL +K+ DFG + ++T
Sbjct: 122 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTF 179
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
VGTP ++APEV+ + YD K AD+WS G+T + G P +
Sbjct: 180 VGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSE 221
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-47
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVIL 87
+G G +G+ RD + +A+K I D + + EI H+ L+H NIV++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 88 TPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+ I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 145 LENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKE--YDGKIAD 201
+N L++ + + LKI DFG SK + ++ ++ GT Y+APE++ K Y AD
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-AD 207
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEP 225
+WS G T+ M G PF + EP
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEP 231
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-47
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 10/206 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ ++++ +G G++G K+T ++VA+K + + E + +EI + P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHV 86
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
V++ T L IVMEY G + + I +EDE Q + G+ Y H M+
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K N LL +G K+ DFG + + + ++ + +GTP ++APEV+ + Y
Sbjct: 147 IHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFED 221
+ AD+WS G+T M G P+ D
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYAD 227
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-46
Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 9/215 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREI-INHRSLR 75
D +E + ++G+GN GV + K + ++A K I K + RE+ + H
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-N 89
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ HRD+K N L++ +K+CDFG S + S S VGT +Y++PE L
Sbjct: 150 KHKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 206
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
Y + +D+WS G++L M VG YP P+ +
Sbjct: 207 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-46
Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 20/228 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
D + R +G G FG + K T +L A K + + + + + +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSY 132
IV T T L +VM +GG++ I N F E A F+ Q++SG+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 189
H + +RDLK EN LLD G ++I D G + GTP ++APE+
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN----FRKTIH 233
LL +EY D ++ GVTLY M+ PF E ++ +
Sbjct: 361 LLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE 407
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-46
Identities = 32/252 (12%), Positives = 67/252 (26%), Gaps = 45/252 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR-- 75
+G + D++T E V ++ + ++ E++ R LR
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 76 --------------------HPNIVRFKEVILTPTHLAIVMEYAS-----------GGEL 104
P + V L + ++ + G L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
Q+I ++ H + H L+ + +LD + + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFE 256
Query: 165 YSKS--SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI----ADVWSCGVTLYVMLVGAYP 218
+ + S P A +L ++ + D W+ G+ +Y + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 219 FEDPEEPKNFRK 230
D
Sbjct: 317 NTDDAALGGSEW 328
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-46
Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 9/216 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRH 76
+ + R +G G FG + + T ++ A K +E+ + +N + +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 134
+V T L +V+ +GG+L I + G+ F E A F+ ++ G+ H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ +RDLK EN LLD ++I D G + K VGT Y+APEV+ +
Sbjct: 304 RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
Y D W+ G LY M+ G PF+ ++ +
Sbjct: 362 Y-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 396
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-45
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 13/211 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
+Y IG G G D T + VA++ + ++ K + + EI+ R ++P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV + + L L +VMEY +GG L + + E + ++ + + + HS Q
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
V HRD+K +N LL DG +K+ DFG+ + + S+ + VGTP ++APEV+ +K
Sbjct: 137 VIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
Y K D+WS G+ M+ G P+ + E P
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLN-ENP 221
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-45
Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D E+ +G G FGV + + K + VA+K I + + E+ + HPN
Sbjct: 6 DYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSRVNHPN 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI---SGVSYCHS 135
IV+ L P + +VMEYA GG L+ + A A + GV+Y HS
Sbjct: 63 IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 136 MQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
MQ + HRDLK N LL LKICDFG + + + + G+ A++APEV
Sbjct: 121 MQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
Y K DV+S G+ L+ ++ PF++
Sbjct: 178 SNYSEK-CDVFSWGIILWEVITRRKPFDE 205
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-45
Identities = 64/210 (30%), Positives = 111/210 (52%), Gaps = 11/210 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPN 78
+ IG G+ G+ L R+K + VAVK ++ R + E + E++ R +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V + L L ++ME+ GG L + I + R +E++ + ++ ++Y H+ V
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K ++ LL DG R+K+ DFG+ + S + KS VGTP ++APEV+ + Y
Sbjct: 163 IHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
+ D+WS G+ + M+ G P+ + P
Sbjct: 219 ATE-VDIWSLGIMVIEMVDGEPPYFS-DSP 246
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-45
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 12/216 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREI-INHRSLR 75
+ + E + ++GSG G MR +KT ++AVK + + ++ + ++ + +S
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P IV+ +T T + I ME + G E ++ + Y
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL---- 190
V HRD+K N LLD ++K+CDFG S V + G AY+APE +
Sbjct: 143 KHGVIHRDVKPSNILLDER--GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 191 -LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
K +YD + ADVWS G++L + G +P+++ +
Sbjct: 201 PTKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTD 235
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-44
Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREI-INHRSLR 75
+D E + ++G G +GV MR + +++AVK I E + ++ I+ R++
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICN-AGRFSEDEARFFFQQLISGVSY 132
P V F + + I ME + ++++ + ED ++ + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 133 CHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
HS + V HRD+K N L++ ++K+CDFG S V K G Y+APE +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL--GQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERI 181
Query: 191 L----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
+K Y K +D+WS G+T+ + + +P++ P
Sbjct: 182 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP 219
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-43
Identities = 60/213 (28%), Positives = 108/213 (50%), Gaps = 17/213 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
++ +E+V ++G G FG ++K+T L A K I + +++++ EI + HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSM 136
IV+ L I++E+ GG + + +E + + +Q++ +++ HS
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLL-- 191
++ HRDLK N L+ +G +++ DFG S K+ + S +GTP ++APEV++
Sbjct: 137 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 192 ---KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
YD K AD+WS G+TL M P +
Sbjct: 193 TMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-43
Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRH 76
+ D YEL IGSG V + +E VA+K I E+ + + +EI H
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELF--------ERICNAGRFSEDEARFFFQQLIS 128
PNIV + + L +VM+ SGG + + +G E ++++
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTP 182
G+ Y H HRD+K N LL + ++I DFG S + K+ VGTP
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++APEV+ + + YD K AD+WS G+T + GA P+
Sbjct: 191 CWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHK 229
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-43
Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 17/232 (7%)
Query: 6 MTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDEN 63
+ + P ++ + + +IG G +G M K + +++AVK I +K +
Sbjct: 9 LKISPEQHWDF--TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 64 VQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNA--GRFSEDE 118
+ ++ + RS P IV+F + I ME S + ++ + + E+
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126
Query: 119 ARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ +++ +++ HRD+K N LLD S +K+CDFG S V
Sbjct: 127 LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS--GNIKLCDFGISGQLVDSIAKTR 184
Query: 178 TVGTPAYIAPEVL----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
G Y+APE + ++ YD + +DVWS G+TLY + G +P+
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSV 235
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-43
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 20/220 (9%)
Query: 19 DSDRYELVRDIGSG--NFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRS 73
+ YEL+ IG G + L R K T E V V+ I +++ +Q E+ +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVS 131
HPNIV ++ + L +V + + G + IC +E + Q ++ +
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPA 183
Y H M HR +K + L+ + + + + V+H PK +V
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 184 YIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+++PEVL + YD K +D++S G+T + G PF+D
Sbjct: 201 WLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-43
Identities = 69/209 (33%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIV 80
+ IG+G+FG + R + VAVK + D E V RE+ + LRHPNIV
Sbjct: 40 NIKEKIGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSM- 136
F + P +L+IV EY S G L+ + +G E + G++Y H+
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLK 192
+ HR+LK N L+D +K+CDFG S+ + S KS GTP ++APEVL
Sbjct: 158 PPIVHRNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ + K +DV+S GV L+ + P+ +
Sbjct: 214 EPSNEK-SDVYSFGVILWELATLQQPWGN 241
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-42
Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 22/219 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN 78
+ +ELV +G+G +G R KT +L A+K ++ +E +++EI + H N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 79 IVRF------KEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGV 130
I + K L +VME+ G + + + E+ + ++++ G+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 131 SYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAP 187
S+ H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++AP
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 188 EVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
EV+ E YD K +D+WS G+T M GA P D
Sbjct: 199 EVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 236
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-42
Identities = 68/212 (32%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRHPN 78
L IG G FG ++ R + VAVK D ENV++E L+HPN
Sbjct: 10 TLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-- 136
I+ + V L +L +VME+A GG L + R D + Q+ G++Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 137 -QVCHRDLKLENTLLDGSPAPR------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ HRDLK N L+ LKI DFG ++ + S G A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ + +DVWS GV L+ +L G PF
Sbjct: 186 IRASMFSKG-SDVWSYGVLLWELLTGEVPFRG 216
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-42
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSL 74
+ +R+IG G+FG RD + E+VA+K + + +K + + +E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKL 111
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
RHPN ++++ L +VMEY G + E E + G++Y H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 135 SMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL- 191
S + HRD+K N LL G +K+ DFG + + S VGTP ++APEV+L
Sbjct: 172 SHNMIHRDVKAGNILLSEPG----LVKLGDFGSASI---MAPANSFVGTPYWMAPEVILA 224
Query: 192 --KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ +YDGK DVWS G+T + P +
Sbjct: 225 MDEGQYDGK-VDVWSLGITCIELAERKPPLFN 255
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-41
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 21/214 (9%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV--------QREIINHRSLR 75
E + IG G FG+ R K + +VA+K + GD E QRE+ +L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 134
HPNIV+ ++ P +VME+ G+L+ R+ + + G+ Y
Sbjct: 82 HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 135 SM--QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HRDL+ N L + K+ DFG S+ +G ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 190 LL--KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ ++ Y K AD +S + LY +L G PF++
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDE 230
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-41
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPNIVRF--- 82
IG G+F D +T VA ++ QR E + L+HPNIVRF
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 83 -KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VC 139
+ + + +V E + G L + R + +Q++ G+ + H+ +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ +++YD
Sbjct: 154 HRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEM-YEEKYDES- 209
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPK 226
DV++ G+ + M YP+ + +
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAA 236
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-40
Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
E+ IG G FG R + VA++ I+ ++ ++ RE++ +R RH
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
N+V F ++P HLAI+ G L+ + +A ++ R Q+++ G+ Y H+
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL 190
+ H+DLK +N D ++ I DFG + + + G ++APE++
Sbjct: 150 GILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 191 ---------LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
K + +DV++ G Y + +PF+
Sbjct: 207 RQLSPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKT 245
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-40
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 12/204 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
DRY + +G G +G D T E VA+K I R + +E V RE+ + L+H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
NI+ K VI L ++ EYA +L + + S + F QLI+GV++CHS
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 137 QVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 191
+ HRDLK +N LL S A LKI DFG +++ + + + + T Y PE+LL
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
+ Y + D+WS ML+
Sbjct: 212 SRHYSTSV-DIWSIACIWAEMLMK 234
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-40
Identities = 42/209 (20%), Positives = 82/209 (39%), Gaps = 19/209 (9%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIV 80
+ + + G R + + + VK ++ D + + E R HPN++
Sbjct: 13 NFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 81 RFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 136
+P H ++ + G L+ + F D+++ F + G+++ H++
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 137 Q--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ + L + ++D +I S Q + PA++APE L KK
Sbjct: 131 EPLIPRHALNSRSVMIDEDM--TARISMADVKFSF----QSPGRMYAPAWVAPEALQKKP 184
Query: 195 YDGKI--ADVWSCGVTLYVMLVGAYPFED 221
D AD+WS V L+ ++ PF D
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 66/212 (31%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
T G G D P Y + IG+G+FGV + + ELVA+K + DK +N R
Sbjct: 43 TPGQGPDRPQ---EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--R 96
Query: 67 EIINHRSLRHPNIVRFKEVILTPT------HLAIVMEYASG---GELFERICNAGRFSED 117
E+ R L H NIVR + + +L +V++Y
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ + QL ++Y HS +CHRD+K +N LLD A LK+CDFG +K L +
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPN 213
Query: 178 T--VGTPAYIAPEVLLK-KEYDGKIADVWSCG 206
+ + Y APE++ +Y I DVWS G
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSI-DVWSAG 244
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-38
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
M S +++ + +G+G + +K T VA+K + + + REI + L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISG 129
+H NIVR +VI T L +V E+ + + ++F QL+ G
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 188
+++CH ++ HRDLK +N L++ +LK+ DFG +++ + S+ V T Y AP+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 189 VLL-KKEYDGKIADVWSCGVTLYVMLVG 215
VL+ + Y I D+WSCG L M+ G
Sbjct: 179 VLMGSRTYSTSI-DIWSCGCILAEMITG 205
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-38
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 24 ELVRDIGSGNFG-VAR-LMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPN 78
+ + IGSG+FG V + VAVK + + +Q E+ R RH N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
I+ F T LAIV ++ G L+ + + +F + +Q G+ Y H+
Sbjct: 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ HRDLK N L +KI DFG + Q + G+ ++APEV+ ++
Sbjct: 141 IIHRDLKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 195 ---YDGKIADVWSCGVTLYVMLVGAYPFED 221
Y + +DV++ G+ LY ++ G P+ +
Sbjct: 199 SNPYSFQ-SDVYAFGIVLYELMTGQLPYSN 227
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-38
Identities = 39/183 (21%), Positives = 64/183 (34%), Gaps = 22/183 (12%)
Query: 58 DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---CNAGRF 114
+ +I N V + +L I M+ L + + C+
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F Q+ V + HS + HRDLK N +K+ DFG + +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEE 219
Query: 175 PKST-------------VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++ VGT Y++PE + Y K D++S G+ L+ +L Y F
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFST 275
Query: 222 PEE 224
E
Sbjct: 276 QME 278
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 6e-10
Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPN 78
+E ++ +G G FGV ++K + A+K I ++ E V RE+ L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 79 IVRFKE 84
IVR+
Sbjct: 66 IVRYFN 71
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-38
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE 62
+ V G + ++YE + +G G++G+ R+K T +VA+K D+
Sbjct: 7 HHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK 65
Query: 63 NV----QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSE 116
V REI + LRH N+V EV +V E+ + E N
Sbjct: 66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDY 123
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176
+ + Q+I+G+ +CHS + HRD+K EN L+ S +K+CDFG++++ +
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVY 181
Query: 177 ST-VGTPAYIAPEVLL-KKEYDGKIADVWSCG 206
V T Y APE+L+ +Y + DVW+ G
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAV-DVWAIG 212
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-38
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
+YE + IG G +G ++++T E+VA+K + R D DE V REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
NIVR +V+ + L +V E+ + F+ G + + F QL+ G+ +CH
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 192
S V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF 219
K Y I D+WS G + P
Sbjct: 177 KLYSTSI-DMWSAGCIFAELANAGRPL 202
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-38
Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 18/196 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
++YE + IG G++GV R++ T ++VA+K + D ++ REI + L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
PN+V EV L +V EY +R E + Q + V++CH
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-T--VGTPAYIAPEVLL 191
HRD+K EN L+ +K+CDFG+++ L V T Y +PE+L+
Sbjct: 120 KHNCIHRDVKPENILITKH--SVIKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELLV 175
Query: 192 K-KEYDGKIADVWSCG 206
+Y + DVW+ G
Sbjct: 176 GDTQYGPPV-DVWAIG 190
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-37
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------ 65
M + + + RYE + +G G F RDK T ++VA+K I + E
Sbjct: 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTA 59
Query: 66 -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFF 122
REI + L HPNI+ + +++++V ++ + + N+ + + +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAY 117
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-V 179
+ G+ Y H + HRDLK N LLD G LK+ DFG +KS ++ + V
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQV 173
Query: 180 GTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
T Y APE+L + Y + D+W+ G L +L+
Sbjct: 174 VTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLR 209
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-37
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
Y + IG+G+FGV + +++E VA+K + DK +N RE+ R ++HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV-LQDKRFKN--RELQIMRIVKHPNV 94
Query: 80 VRFKEVILTPTH------LAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLISGV 130
V K + L +V+EY + + QL+ +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
+Y HS+ +CHRD+K +N LLD LK+ DFG +K +L + + + + Y APE
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRAPE 211
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
++ Y I D+WS G + ++ G
Sbjct: 212 LIFGATNYTTNI-DIWSTGCVMAELMQG 238
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-37
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ Y + +G G + + K T+ LVA+K I E + RE+ + L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 79 IVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++I T L +V EY + + + + F QL+ G++YCH
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKE 194
+V HRDLK +N L++ LK+ DFG +++ + ++ V T Y P++LL +
Sbjct: 120 KVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 195 YDGKIADVWSCGVTLYVMLVG 215
Y +I D+W G Y M G
Sbjct: 178 YSTQI-DMWGVGCIFYEMATG 197
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-37
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN 78
D Y+LVR +G G + + E V VK ++ K + ++REI +LR PN
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 92
Query: 79 IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+ +++ P A+V E+ + + + ++ + RF+ +++ + YCHSM
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK-K 193
+ HRD+K N ++D +L++ D+G ++ H + V + + PE+L+ +
Sbjct: 150 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPF 219
YD + D+WS G L M+ PF
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPF 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-37
Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
++Y + IG G +GV ++ E A+K I R +K DE + REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
NIV+ +VI T L +V E+ +L + G A+ F QL++G++YCH
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 192
+V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 193 KEYDGKIADVWSCGVTLYVMLVG 215
K+Y I D+WS G M+ G
Sbjct: 176 KKYSTTI-DIWSVGCIFAEMVNG 197
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-36
Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 15/223 (6%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
M ++ ++Y+ + +G G +GV +D +VA+K I R D
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAE 58
Query: 61 DENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRF 114
DE + REI + L HPNIV +VI + L +V E+ ++ + N
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGL 116
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
+ + + + QL+ GV++CH ++ HRDLK +N L++ LK+ DFG +++ + +
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVR 174
Query: 175 PKST-VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
+ V T Y AP+VL+ K+Y + D+WS G M+ G
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITG 216
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-36
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
+G G FG A + ++T E++ +K + R ++ +E+ R L HPN+++F V+
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 88 TPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L + EY GG L I + + + F + + SG++Y HSM + HRDL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 147 NTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGTPAYIAPEVLL 191
N L+ + + + DFG ++ + + VG P ++APE++
Sbjct: 138 NCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
+ YD K DV+S G+ L ++ D
Sbjct: 196 GRSYDEK-VDVFSFGIVLCEIIGRVNADPDY 225
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-36
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----Q 65
++ P + +YE + IG G FG R +KT + VA+K + + E
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL 64
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLA--------IVMEYASG--GELFERICNAGRFS 115
REI + L+H N+V E+ T +V ++ L + +F+
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFT 122
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVL 171
E + Q L++G+ Y H ++ HRD+K N L+ LK+ DFG +S +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNS 180
Query: 172 HSQP-KSTVGTPAYIAPEVLL-KKEYDGKIADVWSCG 206
+ V T Y PE+LL +++Y I D+W G
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPI-DLWGAG 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-36
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 21 DRYELVRD-IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH 76
D +E +G G +G A+ +D K ++ A+K IE I + REI R L+H
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLRELKH 77
Query: 77 PNIVRFKEVILTPTHLAI--VMEYAS--------GGELFERICNAGRFSEDEARFFFQQL 126
PN++ ++V L+ + + +YA + + + Q+
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPR--LKICDFG----YSKSSVLHSQPKSTVG 180
+ G+ Y H+ V HRDLK N L+ G R +KI D G ++ + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 181 TPAYIAPEVLL-KKEYDGKIADVWSCG 206
T Y APE+LL + Y I D+W+ G
Sbjct: 198 TFWYRAPELLLGARHYTKAI-DIWAIG 223
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-36
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 29/226 (12%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF- 82
L+ +G G +G + R E VAVK D+ + E+ N LRH NI+ F
Sbjct: 11 TLLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 83 ---KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-- 137
+ T L ++ Y G L++ + + SG+++ H
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 138 ------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 186
+ HRDLK +N L+ + + I D G + ++ L VGT Y+A
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 187 PEVL------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
PEVL + + D+W+ G+ L+ + E+ K
Sbjct: 186 PEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-35
Identities = 71/207 (34%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLR 75
++RY++V +G G L D VA+K I + E +RE+ N L
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
H NIV +V +VMEY G L E I + G S D A F Q++ G+ + H
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKK 193
M++ HRD+K +N L+D LKI DFG +K S +Q +GT Y +PE +
Sbjct: 130 MRIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE 220
D D++S G+ LY MLVG PF
Sbjct: 188 ATDEC-TDIYSIGIVLYEMLVGEPPFN 213
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-35
Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 19/228 (8%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE 62
++ D + DR+++ R G G FG +L ++K T VA+K + D
Sbjct: 5 MMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFR 63
Query: 63 N-VQREIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGR- 113
N + + + L HPNIV+ + T L +VMEY L N R
Sbjct: 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRR 122
Query: 114 ---FSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168
+ F QLI + H S+ VCHRD+K N L++ + LK+CDFG +K
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKK 181
Query: 169 SVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
+ + + Y APE++ + Y + D+WS G M++G
Sbjct: 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLG 228
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-35
Identities = 55/246 (22%), Positives = 101/246 (41%), Gaps = 32/246 (13%)
Query: 7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
+ G G +P++ + + ++V+ IG G +G + K E VAVK ++
Sbjct: 20 SSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWF 77
Query: 64 VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
+ EI +RH NI+ F + + T L ++ +Y G L++ + +
Sbjct: 78 RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSM 136
Query: 120 RFFFQQLISGVSYCHSMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 167
+SG+ + H+ + HRDLK +N L+ + I D G +
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKFIS 194
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
++ + P + VGT Y+ PEVL + AD++S G+ L+ +
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM-ADMYSFGLILWEVARRCVSGG 253
Query: 221 DPEEPK 226
EE +
Sbjct: 254 IVEEYQ 259
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 9e-35
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 28/206 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ-------REIINHRS 73
RYE V +IG G +G RD + VA+K + R RE+ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRR 67
Query: 74 LR---HPNIVRFKEVILTPTH-----LAIVMEYASG--GELFERICNAGRFSEDEARFFF 123
L HPN+VR +V T + +V E+ ++ + +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 180
+Q + G+ + H+ + HRDLK EN L+ +K+ DFG ++ +S V
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARI---YSYQMALTPVVV 181
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCG 206
T Y APEVLL+ Y + D+WS G
Sbjct: 182 TLWYRAPEVLLQSTYATPV-DMWSVG 206
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-34
Identities = 62/246 (25%), Positives = 98/246 (39%), Gaps = 32/246 (13%)
Query: 7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
T G G +P++ + L IG G FG + R K E VAVK ++
Sbjct: 25 TSGSGSGLPLLVQRTIARTIVLQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWF 82
Query: 64 VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
+ EI LRH NI+ F + T T L +V +Y G LF+ + N + +
Sbjct: 83 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM 141
Query: 120 RFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 167
SG+++ H + HRDLK +N L+ + I D G +
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDS 199
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + P VGT Y+APEVL E + AD+++ G+ + +
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGG 258
Query: 221 DPEEPK 226
E+ +
Sbjct: 259 IHEDYQ 264
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-33
Identities = 62/214 (28%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
RY ++ +G G G+ D ++ VA+K I D ++ REI R L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--------ELFE----RICNAGRFSEDEARFFFQQL 126
IV+ E++ + E E + G E+ AR F QL
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 182
+ G+ Y HS V HRDLK N ++ + LKI DFG ++ H K + T
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
Y +P +LL Y I D+W+ G ML G
Sbjct: 189 WYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTG 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-33
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 9/205 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLRHP 77
Y L R +G G G D E +VA+K + D QRE L+ P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
++V + L + M +G +L + G + A +Q+ S + H+
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K EN L+ S + DFG + + +Q +TVGT Y+APE +
Sbjct: 155 ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFE 220
+ AD+++ LY L G+ P++
Sbjct: 213 TYR-ADIYALTCVLYECLTGSPPYQ 236
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-33
Identities = 68/250 (27%), Positives = 99/250 (39%), Gaps = 30/250 (12%)
Query: 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV---- 64
G M P DRYEL +G G L RD + VAVK + D +
Sbjct: 1 GSHMTTPSHLS-DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF 59
Query: 65 QREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
+RE N +L HP IV + IVMEY G L + + G + A
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPK 176
+++ H + HRD+K N ++ S +K+ DFG + S +Q
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--------------EDP 222
+ +GT Y++PE D + +DV+S G LY +L G PF EDP
Sbjct: 178 AVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236
Query: 223 EEPKNFRKTI 232
P + +
Sbjct: 237 IPPSARHEGL 246
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-33
Identities = 51/226 (22%), Positives = 84/226 (37%), Gaps = 28/226 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEE-LVAVKYIERGDKIDENVQ----REIINHRSL 74
+ +YE+ I G G L D+ V +K + D Q E +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV 136
Query: 75 RHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
HP+IV+ + IVMEY G L + EA + +++
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPA 194
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+SY HS+ + + DLK EN +L +LK+ D G + GTP + APE+
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEI 248
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFED------PEEPKNFR 229
+ D+++ G TL + + PE+ +
Sbjct: 249 VRTGPTVA--TDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK 292
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-32
Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRD-KKTEELVAVKYIERGDKIDENVQ----REI---INHR 72
+YE V +IG G +G RD K VA+K + R +E + RE+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 73 SLRHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQ 125
+ HPN+VR +V T L +V E+ ++ + + Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQ 128
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 183
L+ G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ Q T V T
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARI--YSFQMALTSVVVTLW 184
Query: 184 YIAPEVLLKKEYDGKIADVWSCG 206
Y APEVLL+ Y + D+WS G
Sbjct: 185 YRAPEVLLQSSYATPV-DLWSVG 206
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
+RY+ + +GSG +G D KT VAVK + R I + RE+ + ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V L +V G +L I + ++D +F Q++ G+
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y HS + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTGYVATRWYRAPE 199
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
++L Y+ + D+WS G + +L G
Sbjct: 200 IMLNWMHYNQTV-DIWSVGCIMAELLTG 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
Y ++ +GSG +G D +T VA+K + R ++ + RE+ + +RH
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V L +VM + G +L ++ + ED +F Q++ G+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y H+ + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTGYVVTRWYRAPE 195
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V+L Y + D+WS G + M+ G
Sbjct: 196 VILNWMRYTQTV-DIWSVGCIMAEMITG 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-31
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
Y +GSG +G DK++ E VA+K + R +I + RE++ + ++H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V + L +VM + +L + + +FSE++ ++ Q++ G+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y HS V HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTGYVVTRWYRAPE 193
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V+L Y+ + D+WS G + ML G
Sbjct: 194 VILSWMHYNQTV-DIWSVGCIMAEMLTG 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-31
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
RY+ ++ IGSG G+ D E VA+K + R ++ + RE++ + + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
NI+ V L IVME L ++ + + Q++ G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HS + HRDLK N ++ LKI DFG ++++ V T Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG 215
L Y + D+WS G + M+ G
Sbjct: 199 LGMGYKENV-DIWSVGCIMGEMIKG 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-31
Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 47/238 (19%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
S +Y L + +G+G+FG+ + D ++ + A+K + + D +N RE+ + L H NI
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN--RELDIMKVLDHVNI 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG--------------------------- 112
++ + T N G
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 113 --------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
+ + QL V + HS+ +CHRD+K +N L++ L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TL 181
Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
K+CDFG +K + + + + Y APE++L EY I D+WS G +++G
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILG 238
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-31
Identities = 67/214 (31%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQ------REIINH 71
RY + IG G +G+ D + VA+K KI E+ REI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKIL 79
Query: 72 RSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 126
RH NI+ ++I PT + IV + +L ++ S D +F Q+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQI 137
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 182
+ G+ Y HS V HRDLK N LL+ + LKICDFG ++ + V T
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
Y APE++L K Y I D+WS G L ML
Sbjct: 196 WYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSN 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-31
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQ------REII 69
+ S ++L +G G +GV K T E+VA+K KI+ + REI
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIK 61
Query: 70 NHRSLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQ 124
+ +H NI+ + + I+ E +L R+ + S+D ++F
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIY 119
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKST-- 178
Q + V H V HRDLK N L++ + LK+CDFG +S+ +S+P
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 179 -----VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V T Y APEV+L +Y + DVWSCG L + +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLR 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-31
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
RY+ ++ IGSG G+ D + VA+K + R ++ + RE++ + + H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
NI+ V L +VME L + I + + Q++ G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGI 177
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
+ HS + HRDLK N ++ LKI DFG +++ + T V T Y APE
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 233
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVG 215
V+L Y + D+WS G + M+
Sbjct: 234 VILGMGYKENV-DIWSVGCIMGEMVRH 259
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-31
Identities = 53/240 (22%), Positives = 95/240 (39%), Gaps = 29/240 (12%)
Query: 9 GPGMDMP-IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE 67
G + + S +L+ G FG + + + E VAVK DK + E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGC--VWKAQLLNEYVAVKIFPIQDKQSWQNEYE 68
Query: 68 IINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 123
+ + ++H NI++F K L ++ + G L + + A S +E
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIA 127
Query: 124 QQLISGVSYCHSMQ----------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
+ + G++Y H + HRD+K +N LL + I DFG +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGK 185
Query: 174 QPKST---VGTPAYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
T VGT Y+APEVL +++ + D+++ G+ L+ + + P +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDE 244
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 50/217 (23%), Positives = 82/217 (37%), Gaps = 24/217 (11%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------------ 65
Y + R I SG++G D + VA+K + V
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 66 REIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERI-CNAGRFSEDEA 119
REI HPNI+ +++ + L +V E +L + I S
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
++F ++ G+ H V HRDL N LL + + ICDF ++ + V
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYV 194
Query: 180 GTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
Y APE++++ K + + D+WS G + M
Sbjct: 195 THRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNR 230
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-30
Identities = 55/238 (23%), Positives = 87/238 (36%), Gaps = 37/238 (15%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D D +L+ IG G +G + + E VAVK ++ + ++ I + H N
Sbjct: 11 DLDNLKLLELIGRGRYG--AVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDN 68
Query: 79 IVRF-----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
I RF + +VMEY G L + + + + + G++Y
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 134 HSM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVLHSQP 175
H+ + HRDL N L+ I DFG S +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKND--GTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 176 KSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVML---VGAYPFEDPEE 224
S VGT Y+APEVL E K D+++ G+ + + +P E E
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-30
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSL 74
DRYE+ IG+G++G DK + +VA+K I R D ID + + REI L
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 75 RHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
H ++V+ ++++ L +V+E A + + +E + L+ G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
V Y HS + HRDLK N L++ +K+CDFG +++ S +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 184 ----------------------YIAPEVLL-KKEYDGKIADVWSCG 206
Y APE++L ++ Y I DVWS G
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIG 271
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-29
Identities = 54/238 (22%), Positives = 92/238 (38%), Gaps = 26/238 (10%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHR 72
+ RY LVR +G G+F L +D VA+K + E + EI +N
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 75
Query: 73 SLRHP------NIVRFKEV----ILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEAR 120
+I++ + H+ +V E G L + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134
Query: 121 FFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPR----LKICDFGYSKSSVLHSQP 175
+QL+ G+ Y H + H D+K EN L++ +P +KI D G +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHY 192
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+++ T Y +PEVLL + D+WS ++ ++ G + FE E + H
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 60/239 (25%), Positives = 96/239 (40%), Gaps = 36/239 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
D Y + IG G++G L DK TE+ VA+K + R D ID + + REI L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 77 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
I+R ++I+ L IV+E A +L + +E+ + L+ G +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-------- 183
+ H + HRDLK N LL+ +K+CDFG +++
Sbjct: 144 FIHESGIIHRDLKPANCLLNQD--CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 184 ---------------YIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
Y APE++L + Y I D+WS G +L + +
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTNR 259
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLR- 75
+YELV+ +G G +G+ D++T E+VAVK I + D + REI+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 76 HPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
H NIV V+ + +V +Y +L + A ++ QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------------- 178
HS + HRD+K N LL+ +K+ DFG S+S V + +
Sbjct: 126 HSGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 179 -------VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V T Y APE+LL +Y I D+WS G L +L G
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCG 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 18 HDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH 76
H + RYE+++ IG G+FG V + D K + VA+K + + EI R L H
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEH 149
Query: 77 ---------PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQ 125
N++ E H+ + E S L+E I FS R F
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAY 184
++ + H ++ H DLK EN LL +K+ DFG SS Q T + + Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFY 265
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
APEV+L Y I D+WS G L +L G
Sbjct: 266 RAPEVILGARYGMPI-DMWSLGCILAELLTG 295
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-27
Identities = 64/206 (31%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP--- 77
DRYE+ IG G+FG D+ +E VA+K I+ Q E+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 78 ---NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 132
IV K + HL +V E S L++ + N S + R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 133 CHS--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 189
+ + + H DLK EN LL +KI DFG SS Q + + Y +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVG 215
LL YD I D+WS G L M G
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTG 254
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + ++ +G GNFG + T E+VAVK + ++ + +REI +S
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 67
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L+H NIV++K V + L ++MEY G L + + + R + + Q+ G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y + + HRDL N L+ + R+KI DFG +K + + V P
Sbjct: 128 EYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWY 184
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY 210
APE L + ++ +DVWS GV LY
Sbjct: 185 APESLTESKFSVA-SDVWSFGVVLY 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-26
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + ++ +G GNFG + T E+VAVK + ++ + +REI +S
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 98
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L+H NIV++K V + L ++MEY G L + + + R + + Q+ G+
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y + + HRDL N L+ + R+KI DFG +K + + V P
Sbjct: 159 EYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWY 215
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY 210
APE L + ++ +DVWS GV LY
Sbjct: 216 APESLTESKFSVA-SDVWSFGVVLY 239
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-26
Identities = 33/209 (15%), Positives = 59/209 (28%), Gaps = 35/209 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRH 76
RY L+ G D + VA+ +++ + ++ + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + R +V+ T +V E+ GG L E S A Q L + H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V + S + + PA +
Sbjct: 149 GVALSIDHPSRVRV--SIDGDVV-------------------LAYPATMPDA-------- 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
D+ G +LY +LV +P +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVR 208
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 60/207 (28%), Positives = 80/207 (38%), Gaps = 14/207 (6%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
L IG GNFG R + LVAVK D + +E + HPNIVR
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 82 FKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V + IVME GG+ + R +G+ Y S H
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEY 195
RDL N L+ LKI DFG S+ + G + APE L Y
Sbjct: 237 RDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS G+ L+ +GA P+ +
Sbjct: 293 SSE-SDVWSFGILLWETFSLGASPYPN 318
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-25
Identities = 57/213 (26%), Positives = 84/213 (39%), Gaps = 21/213 (9%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
L+ +G G+FGV VAVK ++ + I SL H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
N++R V+LTP + +V E A G L +R+ + G F + Q+ G+ Y S
Sbjct: 81 RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEV 189
+ HRDL N LL + +KI DFG + L APE
Sbjct: 140 KRFIHRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 190 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
L + + +D W GVTL+ + G P+
Sbjct: 196 LKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-25
Identities = 63/223 (28%), Positives = 91/223 (40%), Gaps = 18/223 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + + +G GNFG L T LVAVK + G + QREI ++
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA 80
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L IV+++ V P L +VMEY G L + + + R + Q+ G+
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y S + HRDL N L+ S A +KI DFG +K + + V P
Sbjct: 141 EYLGSRRCVHRDLAARNILV-ESEA-HVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWY 197
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKN 227
APE L + + +DVWS GV LY + E
Sbjct: 198 APESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLR 239
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-24
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 19 DSDRYELVRDIGSGNFGV---ARL-MRDKKTEELVAVKYI--ERGDKIDENVQREIINHR 72
+ + +RD+G G+FG R T E VAVK + E G ++++EI R
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78
Query: 73 SLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISG 129
+L H NIV++K + + ++ME+ G L E + N + + + + Q+ G
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYI--- 185
+ Y S Q HRDL N L+ S ++KI DFG +K + + + TV
Sbjct: 139 MDYLGSRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVF 194
Query: 186 --APEVLLKKEYDGKIADVWSCGVTLY 210
APE L++ ++ +DVWS GVTL+
Sbjct: 195 WYAPECLMQSKFYIA-SDVWSFGVTLH 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 8/208 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HR+L N L+ + +K+ DFG S+ + APE L +
Sbjct: 338 NFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVW+ GV L+ + G P+
Sbjct: 396 FSIK-SDVWAFGVLLWEIATYGMSPYPG 422
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-23
Identities = 50/211 (23%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINH----RSLR 75
+ ++ +GSG FG + + + ++ VA+K + +EI++ S+
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD 75
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
+P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 76 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLL 191
++ HRDL N L+ +P +KI DFG +K + G P ++A E +L
Sbjct: 135 DRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ Y + +DVWS GVT++ +M G+ P++
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-23
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 21 DRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
+ +RD+G G+FG L + T E+VAVK + + G + ++EI R+L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 75 RHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
H +I+++K L +VMEY G L + + + F QQ+ G++Y
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAY 149
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----AP 187
H+ HRDL N LL + +KI DFG +K +V V AP
Sbjct: 150 LHAQHYIHRDLAARNVLL-DNDR-LVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAP 206
Query: 188 EVLLKKEYDGKIADVWSCGVTLY 210
E L + ++ +DVWS GVTLY
Sbjct: 207 ECLKEYKFYYA-SDVWSFGVTLY 228
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-23
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 10/209 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLKK 193
HRDL N L+ + +K+ DFG S+ + + G P + APE L
Sbjct: 131 NFIHRDLAARNCLVGENHL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
++ K +DVW+ GV L+ + G P+
Sbjct: 188 KFSIK-SDVWAFGVLLWEIATYGMSPYPG 215
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-23
Identities = 56/222 (25%), Positives = 85/222 (38%), Gaps = 32/222 (14%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP-- 77
+RYE+V ++G G FG V + + + VA+K I K E + EI + ++
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 78 ----NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 131
V + H+ I E G FE + + R QL +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 132 YCHSMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQ 174
+ H Q+ H DLK EN L S +++ DFG S+ +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194
Query: 175 PKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+T V T Y PEV+L+ + DVWS G L+ G
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-23
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 38/227 (16%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSL 74
+ + ++R +G G FG V + ++ AVK + K + + E I + +
Sbjct: 35 NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 132
+ NIV++ + H+ ++ E G L+E I F ++ + + +++ ++Y
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 133 CHSMQVCHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSKSS 169
M + H DLK EN LLD +K+ DFG +
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209
Query: 170 VLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
S + + T Y APEV+L +D D+WS G L + G
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTG 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 9e-23
Identities = 57/276 (20%), Positives = 99/276 (35%), Gaps = 66/276 (23%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLR 75
RY ++R +G G+F L D + ++ VA+K ++ + E EI + +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 76 HPN---IVR----FKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQL 126
PN +V+ FK + TH+ +V E + + N + QQ+
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK-SNYQGLPLPCVKKIIQQV 155
Query: 127 ISGVSYCHS-MQVCHRDLKLENTLLD---------------------------------- 151
+ G+ Y H+ ++ H D+K EN LL
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 152 -------------GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
+ ++KI D G + +H + T Y + EVL+ Y+
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234
AD+WS + + G Y FE + R H+
Sbjct: 274 -ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-22
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 10/208 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 300 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L + G P+
Sbjct: 358 FTIK-SDVWSFGILLTELTTKGRVPYPG 384
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 2e-22
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 10/208 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 383 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L + G P+
Sbjct: 441 FTIK-SDVWSFGILLTELTTKGRVPYPG 467
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-22
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
++ R + + IGSG+ G RL + + VA+K ++ G ++ + E
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HPNI+R + V+ IV EY G L F R + G+F+ + + + +G+
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMR 165
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---AP 187
Y + HRDL N L+D + K+ DFG S+ +T G I AP
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 188 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
E + + + +DVWS GV ++ V+ G P+ +
Sbjct: 224 EAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-22
Identities = 66/223 (29%), Positives = 91/223 (40%), Gaps = 34/223 (15%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHR-- 72
RYE+V +G G FG V + K VAVK ++ D+ E + EI +N
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 130
+ V+ E H+ IV E G ++ I G F D R Q+ V
Sbjct: 74 NSTF-RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHS 173
++ HS ++ H DLK EN L S P +K+ DFG S+
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188
Query: 174 QPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+ ST V T Y APEV+L + DVWS G L +G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLG 230
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-22
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D V++IGSG FG+ L ++ VA+K I G +E+ E L HP
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPK 64
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V L + +V E+ G L + R G F+ + + G++Y
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV
Sbjct: 124 CVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
Y K +DVWS GV ++ V G P+E+
Sbjct: 181 RYSSK-SDVWSFGVLMWEVFSEGKIPYEN 208
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-22
Identities = 61/222 (27%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 21 DRYELVRD--------IGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQRE 67
+ L RD +G GNFG KK + VA+K +++G E + RE
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMRE 60
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
L +P IVR V + +VME A GG L + + Q+
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT-- 181
G+ Y HRDL N LL + KI DFG SK L + +
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKW 175
Query: 182 P-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
P + APE + +++ + +DVWS GVT++ + G P++
Sbjct: 176 PLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 216
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-22
Identities = 50/209 (23%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ ++ +GSG FG + + + ++ VA+K + K ++ + E S+ +P
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSM 136
++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 78 HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLKK 193
++ HRDL N L+ +P +KI DFG +K + G P ++A E +L +
Sbjct: 137 RLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
Y + +DVWS GVT++ +M G+ P++
Sbjct: 195 IYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-22
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D+ + + +G+G FG RL K E VA+K ++ G +K + E
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HPNI+R + V+ + IV EY G L F R + +F+ + + + SG+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMK 161
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI--- 185
Y M HRDL N L++ + K+ DFG + VL P +T G I
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWT 217
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+PE + +++ +DVWS G+ L+ VM G P+ +
Sbjct: 218 SPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-22
Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYI--ERGDKIDENVQREIINHR 72
++ +GSG FG + + ++ ++ V +K I + G + + V ++
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 131
SL H +IVR + + L +V +Y G L + + + G + Q+ G+
Sbjct: 71 SLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----A 186
Y + HR+L N LL SP+ ++++ DFG + +L K + + A A
Sbjct: 130 YLEEHGMVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMA 185
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
E + +Y + +DVWS GVT++ +M GA P+
Sbjct: 186 LESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-21
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 21 DRYELV---RDIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINH---- 71
DR L +++GSGNFG + + KK + VAVK + + + D ++ E++
Sbjct: 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVM 72
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ L +P IVR + + + +VME A G L + + + Q+ G+
Sbjct: 73 QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYI 185
Y HRDL N LL + KI DFG SK L + K+ P +
Sbjct: 132 YLEESNFVHRDLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWY 187
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + ++ K +DVWS GV ++ G P+
Sbjct: 188 APECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-21
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L + +G+G FG + K + VAVK ++ G E E ++L+H
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDK 244
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ T + I+ E+ + G L F + + + F Q+ G+++
Sbjct: 245 LVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
HRDL+ N L+ S KI DFG ++ + ++ + G I APE +
Sbjct: 304 NYIHRDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L ++ G P+
Sbjct: 361 SFTIK-SDVWSFGILLMEIVTYGRIPYPG 388
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-21
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
+ L++++GSG FGV + K + VAVK I+ G ++ +E L
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKW----KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
HP +V+F V + IV EY S G L + R + + + G+++
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVL 190
S Q HRDL N L+D +K+ DFG ++ VL Q S+VGT + APEV
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVF 177
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+Y K +DVW+ G+ ++ V +G P++
Sbjct: 178 HYFKYSSK-SDVWAFGILMWEVFSLGKMPYDL 208
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 8e-21
Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 20/206 (9%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 83
+G GNFG KK + VA+K +++G E + RE L +P IVR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 84 EVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
V + +VME A GG L + + Q+ G+ Y HR+
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLLKKEYD 196
L N LL + KI DFG SK L + + + APE + +++
Sbjct: 462 LAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS GVT++ + G P++
Sbjct: 518 SR-SDVWSYGVTMWEALSYGQKPYKK 542
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-20
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +LV +G+G FG + + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR V+ T + I+ EY G L F + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
HRDL+ N L+ + + KI DFG ++ + ++ + G I APE +
Sbjct: 129 NYIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L ++ G P+
Sbjct: 186 TFTIK-SDVWSFGILLTEIVTHGRIPYPG 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-20
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
D ++++G+G FGV + + + VA+K I+ G ++ E +L
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYGKW----RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS 77
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H +V+ V + I+ EY + G L + R RF + + + + Y
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVL 190
S Q HRDL N L++ +K+ DFG S+ VL + S+VG+ + PEVL
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVL 193
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ ++ K +D+W+ GV ++ + +G P+E
Sbjct: 194 MYSKFSSK-SDIWAFGVLMWEIYSLGKMPYER 224
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 18/210 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 247
Query: 79 IVRFKEVILT-PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLK 192
HRDL N L+ K+ DFG +K + + + APE L +
Sbjct: 308 NNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 360
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
K++ K +DVWS G+ L+ + G P+
Sbjct: 361 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 389
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-20
Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 18/210 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 75
Query: 79 IVRFKEVILTPT-HLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLK 192
HRDL N L+ S K+ DFG +K + + + APE L +
Sbjct: 136 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 188
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
K++ K +DVWS G+ L+ + G P+
Sbjct: 189 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 217
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-20
Identities = 51/219 (23%), Positives = 85/219 (38%), Gaps = 22/219 (10%)
Query: 20 SDRYE-------LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQRE 67
+Y L R +G G FG K + VAVK ++ E E
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
+ ++L HP+IV+ +I I+ME GEL + N + Q+
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI- 185
++Y S+ HRD+ + N L+ +K+ DFG S+ + T I
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSR-YIEDEDYYKASVTRLPIK 179
Query: 186 --APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+PE + + + +DVW V ++ ++ G PF
Sbjct: 180 WMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFW 217
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-20
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERG--DKIDENVQREIINHR 72
+ IG+G FG L +E+ VA+K ++ G +K + E
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 101
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGV 130
H NI+R + VI + I+ EY G L F R G FS + + + +G+
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGM 160
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---A 186
Y +M HRDL N L++ + K+ DFG S+ + +T G I A
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
PE + +++ +DVWS G+ ++ VM G P+ +
Sbjct: 219 PEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-20
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 17/214 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+R EL R IG G FG M + VA+K + D + E +E + R
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 72
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HP+IV+ VI I+ME + GEL F + + QL + ++
Sbjct: 73 FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALA 130
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPE 188
Y S + HRD+ N L+ + +K+ DFG S+ + S P ++APE
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPE 187
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ + + +DVW GV ++ +++ G PF+
Sbjct: 188 SINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 220
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-20
Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 35/228 (15%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHR 72
++ L R +G G FG A+L ++ + VAVK ++ +++ RE +
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 73 SLRHPNIVRF------KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
HP++ + +++ + G+L F A R E+ Q
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQ 137
Query: 125 QLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
L+ G+ Y S HRDL N +L + + DFG S+ ++S
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYY 193
Query: 178 TVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
G + + A E L Y +DVW+ GVT++ +M G P+
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-20
Identities = 53/220 (24%), Positives = 81/220 (36%), Gaps = 24/220 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
L+R +G G FG M + + VAVK + + + E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 127
H NIVR V L I+ME +GG+L + + L+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 128 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI 185
G Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAML 207
Query: 186 -----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
PE ++ + K D WS GV L+ + +G P+
Sbjct: 208 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-19
Identities = 53/250 (21%), Positives = 90/250 (36%), Gaps = 43/250 (17%)
Query: 10 PGMDMPIMHDSDRYE-------LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDK 59
P + + + L + +G G FG L ++ T VAVK ++ +
Sbjct: 16 PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS 75
Query: 60 IDENVQ---REIINHRSLRHPNIVR-----FKEVILTPTHLAIVMEYASGGEL--FERIC 109
++ E + HPN++R + +++ + G+L +
Sbjct: 76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 110 NAGRFSEDEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
R Q L+ G+ Y + HRDL N +L + + D
Sbjct: 136 ---RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVAD 190
Query: 163 FGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA 216
FG SK ++S G A + A E L + Y K +DVW+ GVT++ + G
Sbjct: 191 FGLSK--KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGM 247
Query: 217 --YPFEDPEE 224
YP E
Sbjct: 248 TPYPGVQNHE 257
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 1e-19
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPN 78
EL R IG G FG M + VA+K + D + E +E + R HP+
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ VI I+ME + GEL + + QL + ++Y S +
Sbjct: 453 IVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVG-TPA-YIAPEVLLKK 193
HRD+ N L+ + +K+ DFG S+ + K++ G P ++APE + +
Sbjct: 512 FVHRDIAARNVLVSSNDC--VKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVW GV ++ +++ G PF+
Sbjct: 568 RFTSA-SDVWMFGVCMWEILMHGVKPFQG 595
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-19
Identities = 52/220 (23%), Positives = 81/220 (36%), Gaps = 24/220 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
L+R +G G FG M + + VAVK + + + E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 127
H NIVR V L I++E +GG+L + + L+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 128 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI 185
G Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAML 248
Query: 186 -----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
PE ++ + K D WS GV L+ + +G P+
Sbjct: 249 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-19
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
+ I S IG G+FG L+ + + AVK + R I E Q E
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 68 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 135
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 183
Q+ G+ Y S + HRDL N +LD +K+ DFG ++ + + S
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR-DMYDKEYYSVHNKTGA 192
Query: 184 -----YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L +++ K +DVWS GV L+ +M GA P+
Sbjct: 193 KLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 233
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-19
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL 74
L R++G G FG + K + LVAVK ++ QRE +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE---------RICNAGRFSEDEARFFFQQ 125
+H +IV+F V L +V EY G+L + I G+ + + Q
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 126 LI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
++ SG+ Y S HRDL N L+ +KI DFG S+ ++S
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYR 190
Query: 179 VGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
VG + PE ++ +++ + +DVWS GV L+
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILW 226
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-18
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 18/221 (8%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
+ I S IG G+FG L+ + + AVK + R I E Q E
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 68 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 199
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
Q+ G+ + S + HRDL N +LD +K+ DFG ++ T A
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 185 I-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ A E L +++ K +DVWS GV L+ +M GA P+
Sbjct: 258 LPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-18
Identities = 37/219 (16%), Positives = 72/219 (32%), Gaps = 29/219 (13%)
Query: 24 ELVRDIGSGNFGV-------ARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR 75
+G G F + E V +K +++ E+ L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H ++V V + +V E+ G L + + N + +QL + + +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL 129
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRL------KICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
+ H ++ +N LL + K+ D G S + + + + ++ P
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWVPP 186
Query: 188 EVLLKKEYDGKI----ADVWSCGVTLY-VMLVGAYPFED 221
E + + K D WS G TL+ + G P
Sbjct: 187 ECIE----NPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-18
Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 32/226 (14%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL 74
L ++G G FG + ++ + LVAVK ++ + QRE L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------RICNAGRFSEDEARFFFQQL 126
+H +IVRF V L +V EY G+L AG QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 127 I-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
+ +G+ Y + HRDL N L+ +KI DFG S+ ++S V
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSR--DIYSTDYYRV 216
Query: 180 GTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
G + PE +L +++ + +DVWS GV L+ + G P+
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-17
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 22/229 (9%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
D+ I H+ R IG G+FGV + + A+K + R ++ + RE
Sbjct: 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72
Query: 68 IINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 123
+ R L HPN++ ++L +++ Y G+L F R + + F
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIR-SPQRNPTVKDLISFG 130
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 180
Q+ G+ Y + HRDL N +LD S +K+ DFG ++ +S +
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHA 188
Query: 181 T-PA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEE 224
P + A E L + K +DVWS GV L+ ++ GA Y DP +
Sbjct: 189 RLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFD 236
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-17
Identities = 45/222 (20%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
++ + R++G G+FG VA+ + + E VA+K + + E + E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEAR--------FFF 123
++VR V+ ++ME + G+L + R +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
++ G++Y ++ + HRDL N ++ + +KI DFG ++ ++ G
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKG 200
Query: 184 YI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ +PE L + +DVWS GV L+ + + P+
Sbjct: 201 LLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 241
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-17
Identities = 44/230 (19%), Positives = 87/230 (37%), Gaps = 34/230 (14%)
Query: 19 DSDRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINH 71
+ ++G FG + + VA+K ++ + E + E +
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR 66
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFF 122
L+HPN+V V+ L+++ Y S G+L + + ++
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 123 FQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175
+ +G+ Y S V H+DL N L+ +KI D G + +++
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAAD 182
Query: 176 KSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + + APE ++ ++ +D+WS GV L+ V G P+
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-16
Identities = 55/235 (23%), Positives = 86/235 (36%), Gaps = 47/235 (20%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
+R + +G+G FG A + VAVK + ER + E V
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------FERICNAGRFSE 116
+ H NIV ++ EY G+L + +
Sbjct: 83 L-----GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
DE + L+S G+++ S HRDL N LL KICDFG ++
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR-- 193
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
+ + V A + APE + Y + +DVWS G+ L+ + +G+ P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 79
+++ L R IGSG+FG L + +T E VA+K E + E +R L+ I
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + + +VM+ S +LF C+ + S Q+I+ V + HS
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 138 VCHRDLKLENTLLD-GSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 188
HRD+K +N L+ G A ++ I DFG +K S+ H + K+ GT Y +
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 189 VLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L E D D+ S G L L G+ P
Sbjct: 184 THLGIEQSRRD----DLESLGYVLMYFLRGSLP 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-16
Identities = 55/236 (23%), Positives = 90/236 (38%), Gaps = 42/236 (17%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+ E VRDIG G FG A + + +VAVK ++ + + QRE
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 116
+PNIV+ V + ++ EY + G+L + A S
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 117 DEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
+ + +G++Y + HRDL N L+ +KI DFG S++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN- 223
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++S I PE + Y + +DVW+ GV L+ + G P+
Sbjct: 224 -IYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-16
Identities = 58/233 (24%), Positives = 87/233 (37%), Gaps = 47/233 (20%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
D + + IG GNFG AR+ +D + A+K + + D E V +
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCK 81
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDE 118
+ HPNI+ +L + +EYA G L E +
Sbjct: 82 L-----GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 119 ARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171
+ QQL+ G+ Y Q HRDL N L+ + KI DFG S+ +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEV 194
Query: 172 HSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
+ T + A E L Y +DVWS GV L+ ++ +G P
Sbjct: 195 Y-----VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-16
Identities = 50/232 (21%), Positives = 93/232 (40%), Gaps = 24/232 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
Y++ R IG G+FGV + + VA+K+ E ++ E ++ L I
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
H +V++ S +L +C +FS +Q+++ V H
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 138 VCHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIA 186
+ +RD+K +N L+ + A + + DFG K + H + K+ GT Y++
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 187 PEVLLKKEY---DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235
L +E D D+ + G L G+ P++ + N +K +
Sbjct: 187 INTHLGREQSRRD----DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-15
Identities = 53/236 (22%), Positives = 90/236 (38%), Gaps = 42/236 (17%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
L + +G G FG A ++ + VAVK ++ ++ E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 116
+ HP++++ L +++EYA G L ++
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
DE LIS G+ Y M++ HRDL N L+ +KI DFG S+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRD- 199
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ + + I A E L Y + +DVWS GV L+ ++ +G P+
Sbjct: 200 -VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 46/222 (20%), Positives = 82/222 (36%), Gaps = 42/222 (18%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVK-------YIERGDKIDE-NVQRE 67
+ + + +G+G FG A + + VAVK E+ + E +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEAR 120
+ +H NIV + ++ EY G+L + F+ +
Sbjct: 106 L-----GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 121 FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
+ L+ G+++ S HRD+ N LL + KI DFG ++ + +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLARD--IMN 216
Query: 174 QPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
V A + APE + Y + +DVWS G+ L+
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLW 257
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-15
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIV 80
+ + + IG GNFG RL ++ T E VA+K +E + E ++ L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 81 RFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+ + A+V+E S +LF +C+ FS QLIS + Y HS +
Sbjct: 69 QVYYFGPCGKYNAMVLELLGPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 139 CHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSVLH---SQPKSTVGTPAYIAP 187
+RD+K EN L+ ++ DF +K + H + KS GT Y++
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 188 EVLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L KE D D+ + G L G+ P
Sbjct: 187 NTHLGKEQSRRD----DLEALGHMFMYFLRGSLP 216
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-15
Identities = 57/249 (22%), Positives = 92/249 (36%), Gaps = 53/249 (21%)
Query: 14 MPIMHDSDRYE-------LVRDIGSGNFG-----VARLMRDKKTEELVAVKYI------- 54
+ +D+ ++E L + +G G FG A + T VAVK +
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 55 ERGDKIDE-NVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGEL-------- 104
E + E + I H N+V P L +++E+ G L
Sbjct: 73 EHRALMSELKILIHI-----GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127
Query: 105 -FERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAP 156
+ + LI G+ + S + HRDL N LL
Sbjct: 128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV- 186
Query: 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY- 210
+KICDFG ++ ++ P A + APE + + Y + +DVWS GV L+
Sbjct: 187 -VKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWE 242
Query: 211 VMLVGAYPF 219
+ +GA P+
Sbjct: 243 IFSLGASPY 251
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-15
Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 22/213 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
+RY L R IGSG+FG L D E VA+K E + E ++ ++ I
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + +VME S +LF C+ +FS Q+IS + Y HS
Sbjct: 68 PTIRWCGAEGDYNVMVMELLGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 138 VCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 188
HRD+K +N L+ G + I DFG +K + H + K+ GT Y +
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 189 VLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L E D D+ S G L +G+ P
Sbjct: 186 THLGIEQSRRD----DLESLGYVLMYFNLGSLP 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 37/230 (16%)
Query: 21 DRYELVRDIGSGNFG------VARLMRDKKTEEL-VAVKYIERGDKIDENV--QREIINH 71
D+ L + +G G FG + +DK E + VAVK ++ + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARF 121
+ + +H NI+ L +++EYAS G L + E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 122 FFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ +++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNI 210
Query: 175 PKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
T + APE L + Y + +DVWS GV ++ + +G P
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSP 259
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 37/231 (16%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEE--LVAVKYIERGDKIDENV--QREIINH 71
D+ L + +G G FG A + K +E VAVK ++ + E+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARF 121
+ + +H NI+ L +++EYAS G L + E +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 122 FFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ +++
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNI 256
Query: 175 PKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
T + APE L + Y + +DVWS GV ++ + +G P+
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 306
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-14
Identities = 54/231 (23%), Positives = 81/231 (35%), Gaps = 51/231 (22%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
+ E + +GSG FG A + VAVK + ER + E + +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL----------------FERICNA 111
+ H NIV + ++ EY G+L
Sbjct: 105 L-----GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 112 GRFSEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
ED F+ L+ G+ + HRDL N L+ +KICDFG
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFG 217
Query: 165 YSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
++ + S V A + APE L + Y K +DVWS G+ L+
Sbjct: 218 LARD--IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLW 265
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-14
Identities = 58/226 (25%), Positives = 87/226 (38%), Gaps = 46/226 (20%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEE--LVAVKYI-------ERGDKIDE-NVQ 65
DR L + +G G FG A + K VAVK + + D I E +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSE 116
+ I +H NI+ L +++EYAS G L +
Sbjct: 129 KMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
E + + L+S G+ Y S + HRDL N L+ + +KI DFG ++
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR-- 239
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
+H T + APE L + Y + +DVWS GV L+
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLW 284
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 4e-12
Identities = 39/196 (19%), Positives = 59/196 (30%), Gaps = 52/196 (26%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---------VQREIIN 70
+++ + IG G FG T VA+K I N + EII
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 71 HRSL---------RHPNIVRFKEVIL------------------------------TPTH 91
+ L R + V
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLL 150
L IV+E+ GG E++ S A+ QL + ++ S++ HRDL N LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 151 DGSPAPRLKICDFGYS 166
+ +L G S
Sbjct: 196 KKTSLKKLHYTLNGKS 211
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 1e-09
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 15/106 (14%)
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST--VGTPAYI 185
G+++ H HRD+K N LLD + KI DFG ++ S ++ VGT AY+
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYM 202
Query: 186 APEVLLKKEY-DGKI---ADVWSCGVTLYVMLVGAYPFEDPEEPKN 227
AP E G+I +D++S GV L ++ G ++ EP+
Sbjct: 203 AP------EALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-09
Identities = 63/215 (29%), Positives = 88/215 (40%), Gaps = 52/215 (24%)
Query: 29 IGSGNFG-VAR-LMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRF-- 82
IG G FG V + ++RD VA+K I+E + EI RHP++V
Sbjct: 47 IGHGVFGKVYKGVLRDGAK---VALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSLIG 102
Query: 83 --KEVILTPTHLAIVMEYASGGELFERICNAGRFSE------------DEARFFFQQLIS 128
E + ++ +Y G L + + + AR
Sbjct: 103 FCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR-------- 150
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GTPAYI 185
G+ Y H+ + HRD+K N LLD + P KI DFG SK Q STV GT YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 186 APE-----VLLKKEYDGKIADVWSCGVTLYVMLVG 215
PE L +K +DV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK------SDVYSFGVVLFEVLCA 237
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 30/167 (17%), Positives = 60/167 (35%), Gaps = 24/167 (14%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 81
++ L + IGSG FG+ L E A ++ + + + E+ ++ + + ++
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 82 FKEVILTPTHLAI-------------------VMEY--ASGGELFERICNAGRFSEDEAR 120
+L I VME ++ N G F +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG--QN-GTFKKSTVL 154
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+++ + Y H + H D+K N LL ++ + D+G S
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 22/171 (12%), Positives = 57/171 (33%), Gaps = 29/171 (16%)
Query: 22 RYELVRDIGSGNFGV--------ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
+++L N G+ ++ ++K ++ D N Q R+
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQN--FFQRA 99
Query: 74 LRHPNIVRFKEVILTPT---------------HLAIVMEY--ASGGELFERICNAGRFSE 116
+ + ++K++ TP + +V+ S + SE
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV-SPKHVLSE 158
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+L+ + + H + H ++ EN +D ++ + +G++
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-08
Identities = 27/169 (15%), Positives = 54/169 (31%), Gaps = 25/169 (14%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEEL-----VAVK---------------YIERGDKID 61
+++ IG G FG L +E + VK Y
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 62 ENVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE 118
+ L P ++ ++M+ + +++E RFS
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NA-KRFSRKT 153
Query: 119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+++ + Y H + H D+K N LL+ ++ + D+G +
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 5e-08
Identities = 56/215 (26%), Positives = 82/215 (38%), Gaps = 61/215 (28%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQRE------IINHRSLRHPNI 79
+G G FG RL D LVAVK ++ + + + +I+ H N+
Sbjct: 38 LGRGGFGKVYKGRL-ADGT---LVAVKRLKEERT--QGGELQFQTEVEMISM--AVHRNL 89
Query: 80 VRFKEVILTPTHLAIVMEYASGG----ELFERICNAGRFS--------EDEARFFFQQLI 127
+R + +TPT +V Y + G L ER + AR
Sbjct: 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR------- 142
Query: 128 SGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----- 179
G++Y H ++ HRD+K N LLD + DFG +K L + V
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVR 196
Query: 180 GTPAYIAPE-----VLLKKEYDGKIADVWSCGVTL 209
GT +IAPE +K DV+ GV L
Sbjct: 197 GTIGHIAPEYLSTGKSSEK------TDVFGYGVML 225
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-07
Identities = 33/117 (28%), Positives = 56/117 (47%), Gaps = 11/117 (9%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
+ Q+ G+ + S + HRDL N LL +KICDFG ++ ++ P
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253
Query: 182 PAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTI 232
A + APE + + Y + +DVWS GV L+ + +GA P+ + + F + +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 4e-04
Identities = 31/153 (20%), Positives = 55/153 (35%), Gaps = 22/153 (14%)
Query: 18 HDSDRYE-------LVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG----DKID 61
+D+ ++E L + +G G FG A + T VAVK ++ G +
Sbjct: 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 71
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEAR 120
+ +I+ H H N+V P L +++E+ G L + + R +
Sbjct: 72 LMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYK 129
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153
+ G Y + DLK + S
Sbjct: 130 TKGARFRQGKDYVGA---IPVDLKRRLDSITSS 159
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 1e-05
Identities = 28/202 (13%), Positives = 76/202 (37%), Gaps = 46/202 (22%)
Query: 23 YELVRDIGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+ V ++ N+ ++ + +++ ++ YIE+ D++ + Q + S R +
Sbjct: 80 QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYL 138
Query: 81 RFKEVI--LTPTHLAIV--MEYASGGE----LFERICNAGRFSEDEARFFFQQL-ISGVS 131
+ ++ + L P ++ + G + +C + + + + F+ ++ +
Sbjct: 139 KLRQALLELRPAKNVLIDGV----LGSGKTWVALDVCLSYKV---QCKMDFKIFWLN-LK 190
Query: 132 YCHS-------MQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
C+S +Q + ++ + D S +L+I +L S+P
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-------- 242
Query: 184 YIAPEVLLKKEYDGKI-ADVWS 204
Y LL + +V +
Sbjct: 243 Y--ENCLL-------VLLNVQN 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 240 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.52 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.31 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.06 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.93 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.84 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.8 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.57 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.48 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.35 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.16 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.92 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.89 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.76 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.72 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.7 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.63 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.52 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.44 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.35 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.26 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.14 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.05 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.98 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.32 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.66 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.15 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 87.51 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=333.31 Aligned_cols=214 Identities=43% Similarity=0.723 Sum_probs=176.0
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3478999999999999999999999999999999987542 223568899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
||||+ +++|.+.+.+.+++++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++........
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC--------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCc
Confidence 99999 5699999988889999999999999999999999999999999999999987766 99999999976655555
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
.....|++.|+|||++.+..++..++|||||||++|+|++|..||.+.+....++++.+..
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~ 228 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV 228 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence 5667899999999999888877666999999999999999999999988877777766543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=338.37 Aligned_cols=214 Identities=30% Similarity=0.494 Sum_probs=191.2
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
.+++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 446799999999999999999999999999999999753 2334678999999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc--
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 172 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-- 172 (240)
||||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESK 187 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTT
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCC
Confidence 9999999999999998889999999999999999999999999999999999999987776 999999999754322
Q ss_pred -CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 173 -~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
.......|++.|+|||++.+..++. ++|||||||++|+|++|..||.+.+....+.++++.-
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~-~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~ 250 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE 250 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cccccCcccCcccCCHHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 2234567999999999998877654 4999999999999999999999999888888887643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=337.27 Aligned_cols=214 Identities=29% Similarity=0.499 Sum_probs=181.9
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
..++|++++.||+|+||.||+|++..+|+.||||++..... ..+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 45899999999999999999999999999999999976432 235688999999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 96 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
|||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTV 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCCc
Confidence 9999999999999654 35789999999999999999999999999999999999987776 9999999997543322
Q ss_pred -CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 174 -~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
......|++.|+|||++.+..++. ++|||||||++|+|++|..||.+.+..+.+.++++.-
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~-~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~ 241 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNN-KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS 241 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred ccccccCCCccccCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence 122346899999999998877655 4999999999999999999999998888888877644
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=331.82 Aligned_cols=215 Identities=30% Similarity=0.542 Sum_probs=183.3
Q ss_pred CCCCeeEeeeecCCCceeEEEEEec---CCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
++++|++++.||+|+||+||+|++. .+++.||+|++.... .....+.+|+.++++++||||+++++++.+++.+
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 4578999999999999999999874 457899999987532 2234678899999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~- 171 (240)
++||||++|++|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC----
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCC
Confidence 999999999999999998899999999999999999999999999999999999999987776 99999999975433
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceec
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (240)
........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+.+.++++...
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~ 243 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL 243 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred CccccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC
Confidence 333455679999999999988777655 9999999999999999999999998888888776543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=331.97 Aligned_cols=209 Identities=27% Similarity=0.457 Sum_probs=185.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
+.|++++.||+|+||.||+|++..+|+.||||++.... ...+.+.+|+.+++.++||||+++++++.+++.+|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999997643 33456889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCCC
Q 026299 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (240)
Q Consensus 100 ~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~~ 178 (240)
+|++|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++...... ......
T Consensus 154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCC
T ss_pred CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCccccc
Confidence 99999998865 56999999999999999999999999999999999999987776 999999998755433 334567
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+.+.++..
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~ 284 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 284 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence 89999999999987777555 9999999999999999999999887777766654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=328.74 Aligned_cols=213 Identities=28% Similarity=0.404 Sum_probs=184.0
Q ss_pred cccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
+.......|++.+.||+|+||.||+|++..+|..||||++..... ..+|+.+++.++||||+++++++.+++.+++
T Consensus 52 ~~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp BCCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 334455779999999999999999999999999999999976432 3479999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
||||++|++|.+++.+.+++++..+..++.|++.||+|||++||+||||||+|||++.++. ++||+|||++........
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGL 206 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC-----
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCc
Confidence 9999999999999998889999999999999999999999999999999999999987652 399999999975433221
Q ss_pred ------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 175 ------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 175 ------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.....|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....+.++..
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 270 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc
Confidence 223468999999999988777655 9999999999999999999998877777666654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=333.55 Aligned_cols=210 Identities=27% Similarity=0.451 Sum_probs=186.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
+.|++++.||+|+||.||+|++..+|+.||||++.... ...+.+.+|+.+++.++||||+++++++.+++.+|+||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57999999999999999999999999999999997643 33467899999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCCC
Q 026299 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (240)
Q Consensus 100 ~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~~ 178 (240)
+|++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++...... ......
T Consensus 231 ~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 231 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCC
T ss_pred CCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCcccccc
Confidence 99999998854 56999999999999999999999999999999999999987776 999999998755433 334566
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~ 362 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 362 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 79999999999987777555 99999999999999999999988877777666543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=315.75 Aligned_cols=205 Identities=25% Similarity=0.438 Sum_probs=174.7
Q ss_pred CCCe-eEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEc----CCe
Q 026299 20 SDRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTH 91 (240)
Q Consensus 20 ~~~y-~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 91 (240)
..+| ++.+.||+|+||.||+|.+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+ +..
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 3455 78889999999999999999999999999987643 223568899999999999999999999865 356
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC--ceeecCCCCCeEEcC-CCCCcEEEecCCcccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKS 168 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~--ivh~~i~~~nili~~-~~~~~~~L~d~~~~~~ 168 (240)
+++||||++|++|.+++.+.+.+++..+..++.||+.||+|||++| |+||||||+|||++. ++. +||+|||+|..
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC--EEEEeCcCCEe
Confidence 8999999999999999998889999999999999999999999998 999999999999974 444 99999999864
Q ss_pred ccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 026299 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (240)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (240)
.. ........|++.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+....+.
T Consensus 182 ~~-~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~ 239 (290)
T 3fpq_A 182 KR-ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 239 (290)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred CC-CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH
Confidence 32 223344579999999998864 44 455999999999999999999998766554443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=317.86 Aligned_cols=214 Identities=26% Similarity=0.403 Sum_probs=181.1
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEec-----CCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
++.++|++.+.||+|+||.||+|++. .++..||||++..... ..+.+.+|+.++++++||||+++++++.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 45578999999999999999999875 3578899999876432 23578999999999999999999999999999
Q ss_pred EEEEEecCCCCchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcE
Q 026299 92 LAIVMEYASGGELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~-------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~ 158 (240)
+++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||+|+|||++.++. +
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~ 167 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--V 167 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--E
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--E
Confidence 99999999999999999653 36999999999999999999999999999999999999987776 9
Q ss_pred EEecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhce
Q 026299 159 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 159 ~L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 234 (240)
||+|||+++...... ......+++.|+|||.+.+..++.+ +||||||+++|||+| |..||.+.+..+.+.++.+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999996443322 1223457889999999988877555 999999999999998 89999998887777666543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=310.95 Aligned_cols=212 Identities=21% Similarity=0.372 Sum_probs=180.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEec-----CCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
..+++++.+.||+|+||+||+|+.. .++..||||++.... ...+.|.+|+.++++++||||++++|++.+++.
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 4478999999999999999999864 457889999986543 234679999999999999999999999999999
Q ss_pred EEEEEecCCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCC
Q 026299 92 LAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~ 155 (240)
+++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||+|+|||++.++.
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence 99999999999999999642 35899999999999999999999999999999999999987776
Q ss_pred CcEEEecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 156 PRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 156 ~~~~L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
+||+|||+++...... ......+++.|+|||.+.+..++.+ +||||||+++|||+| |..||.+.+..+.+..+
T Consensus 184 --~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 184 --VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp --EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred --EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999987543322 2234568899999999988877555 999999999999998 89999998877776665
Q ss_pred hc
Q 026299 232 IH 233 (240)
Q Consensus 232 ~~ 233 (240)
..
T Consensus 261 ~~ 262 (308)
T 4gt4_A 261 RN 262 (308)
T ss_dssp HT
T ss_pred Hc
Confidence 54
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=319.62 Aligned_cols=212 Identities=29% Similarity=0.461 Sum_probs=185.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC------Ce
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP------TH 91 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 91 (240)
++|++++.||+|+||.||+|++..+|+.||||++..... ..+.+.+|+.+|+.++||||+++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 689999999999999999999999999999999865432 234678999999999999999999997643 57
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
+|+||||++| +|.+++.+.+++++..++.+++||+.||+|||+.||+||||||+|||++.++. +||+|||++.....
T Consensus 134 ~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 134 VYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC--
T ss_pred EEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeeccc
Confidence 8999999975 79999988889999999999999999999999999999999999999987776 99999999975432
Q ss_pred -----cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 172 -----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 172 -----~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
........|++.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+.+|+...
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 2233456799999999999887776666999999999999999999999999998888887643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=313.61 Aligned_cols=212 Identities=26% Similarity=0.404 Sum_probs=175.5
Q ss_pred CCCCeeEeeeecCCCceeEEEEEec-----CCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
..++|++.+.||+|+||.||+|++. .++..||||++..... ..+.|.+|+.++++++||||+++++++.++..+
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4468999999999999999999865 3688999999876432 235789999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCc
Q 026299 93 AIVMEYASGGELFERICNA---------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~---------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~ 157 (240)
++||||+++|+|.+++... .++++.++..++.|++.||+|||+.+|+||||||+|||++.+..
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~-- 196 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV-- 196 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--
Confidence 9999999999999998653 35899999999999999999999999999999999999987776
Q ss_pred EEEecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 158 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 158 ~~L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
+||+|||+++...... ......+++.|+|||.+.+..++.+ +||||||+++|||++ |..||.+.+..+.+..+.+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999987543322 2233468899999999988777555 999999999999998 8999998887777666654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=307.75 Aligned_cols=211 Identities=26% Similarity=0.385 Sum_probs=173.4
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
+.++.+++++.+.||+|+||+||+|++.. .||||+++.... ..+.+.+|+.++++++||||+++++++.+ +.+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 34567899999999999999999998753 489998865432 23568999999999999999999998765 568
Q ss_pred EEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
++||||+++++|.+++... .++++..+..++.|++.||+|||+.+|+||||||+|||++.++. +||+|||+|.....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSR 184 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC---
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceeccc
Confidence 9999999999999999654 57999999999999999999999999999999999999987765 99999999864432
Q ss_pred c---CCCCCCcCCccccCccccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 172 H---SQPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 172 ~---~~~~~~~~~~~~~~pE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
. .......|++.|+|||++.+.. .++.++||||||+++|+|++|..||.+.+....+..++
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~ 250 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 2 2223457899999999986442 34556999999999999999999998877666555444
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=300.87 Aligned_cols=196 Identities=28% Similarity=0.440 Sum_probs=159.5
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC--------
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 90 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 90 (240)
++|++++.||+|+||.||+|++..++..||+|++..... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 369999999999999999999999999999999876432 2356889999999999999999999987543
Q ss_pred ----eEEEEEecCCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecC
Q 026299 91 ----HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (240)
Q Consensus 91 ----~~~lv~~~~~~~~l~~~l~~~~~---l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~ 163 (240)
.+++||||+++++|.+++..... .+...++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccC
Confidence 37899999999999999976554 455668899999999999999999999999999999987776 999999
Q ss_pred CccccccccCC-------------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 164 GYSKSSVLHSQ-------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 164 ~~~~~~~~~~~-------------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
|++........ .....|++.|+|||++.+..++.+ +|||||||++|+|++ ||...
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCc
Confidence 99865433221 123468999999999988776554 999999999999996 88654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=306.31 Aligned_cols=231 Identities=91% Similarity=1.464 Sum_probs=186.5
Q ss_pred CCCCCCcCCCCCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCee
Q 026299 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80 (240)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 80 (240)
|++..+...| .+.++....++|++++.||+|+||.||++++..+++.||+|++.......+.+.+|+..++.++||||+
T Consensus 1 m~~~~~~~~p-~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv 79 (361)
T 3uc3_A 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79 (361)
T ss_dssp -----------CCCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCCCC-CCccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCC
Confidence 6666666655 667788888999999999999999999999999999999999988777778899999999999999999
Q ss_pred eeeEEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEE
Q 026299 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (240)
Q Consensus 81 ~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L 160 (240)
++++++.++...++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++++|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred cEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEE
Confidence 99999999999999999999999999998888899999999999999999999999999999999999998777667999
Q ss_pred ecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 161 ~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
+|||++.............+++.|+|||.+.+...+.+++||||||+++|+|++|..||........+.+++
T Consensus 160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~ 231 (361)
T 3uc3_A 160 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI 231 (361)
T ss_dssp CCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH
T ss_pred eecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence 999998755555555566789999999999888777666899999999999999999998876655444433
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=322.57 Aligned_cols=202 Identities=30% Similarity=0.465 Sum_probs=175.4
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHH---HHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQRE---IINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
.++|++++.||+|+||.||+|++..+|+.||+|++.... .......+| +.+++.++||||+++++++.+++.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999999999999999987532 122233344 5566677899999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||+|.....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~~- 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK- 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS-
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecCC-
Confidence 999999999999999998899999999999999999999999999999999999999987776 99999999975433
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.......|++.|+|||++.++..++.++|+|||||++|+|++|..||.+.+.
T Consensus 345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 3345578999999999997665555669999999999999999999977544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=304.63 Aligned_cols=207 Identities=24% Similarity=0.408 Sum_probs=173.0
Q ss_pred CCeeEeeeecCCCceeEEEEEec---CCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||+|+||.||+|++. .+++.||+|.+.... ...++.+|+..++.+ +||||+++++++.+++.+++||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 68999999999999999999875 457899999886643 345678999999988 6999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC---
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~--- 173 (240)
||++|++|.+++. .+++.+++.++.||+.||+|||+.||+||||||+|||++.+. +.++|+|||+|.......
T Consensus 100 E~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~~ 175 (361)
T 4f9c_A 100 PYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIEL 175 (361)
T ss_dssp ECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCGG
T ss_pred eCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCccccc
Confidence 9999999999883 489999999999999999999999999999999999997653 249999999986332111
Q ss_pred --------------------------CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC-Cchh
Q 026299 174 --------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPK 226 (240)
Q Consensus 174 --------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~ 226 (240)
......|++.|+|||++.+...++.++||||+||++|+|++|..||... ++.+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~ 255 (361)
T 4f9c_A 176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLT 255 (361)
T ss_dssp GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHH
Confidence 1123468999999999988776666699999999999999999999655 4444
Q ss_pred hhhhhh
Q 026299 227 NFRKTI 232 (240)
Q Consensus 227 ~~~~~~ 232 (240)
.+.+|+
T Consensus 256 ~l~~I~ 261 (361)
T 4f9c_A 256 ALAQIM 261 (361)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 444443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=322.53 Aligned_cols=214 Identities=31% Similarity=0.542 Sum_probs=190.1
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
++|++.+.||+|+||.||+|++..+|+.||+|.+.... ...+.+.+|+.+|+.++||||+++++++.++..+++||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999999999999999987643 23456889999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCC
Q 026299 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (240)
Q Consensus 100 ~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~ 178 (240)
+|++|.+++.. ...+++.++..+++||+.||+|||++||+||||+|+||+++.+..+.+||+|||++............
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~ 316 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 316 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEE
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeee
Confidence 99999998864 45799999999999999999999999999999999999998765556999999999766544444456
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
.|++.|+|||++.+..++.. +|||||||++|+|++|..||.+.+..+.+.++.+.-
T Consensus 317 ~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~ 372 (573)
T 3uto_A 317 TGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 372 (573)
T ss_dssp CSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred EECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC
Confidence 78999999999988777544 999999999999999999999999888888876643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=305.34 Aligned_cols=212 Identities=25% Similarity=0.406 Sum_probs=176.8
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCC-----CcEEEEEEeecCccc--cHHHHHHHHHHHhcCC-CCeeeeeEEEEcC
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDKI--DENVQREIINHRSLRH-PNIVRFKEVILTP 89 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~ 89 (240)
+..++|++.+.||+|+||+||+|.+... ++.||+|.+...... .+.+.+|+.++++++| |||++++++|...
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 4567999999999999999999997654 367999998765332 3568899999999965 9999999998764
Q ss_pred -CeEEEEEecCCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC
Q 026299 90 -THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (240)
Q Consensus 90 -~~~~lv~~~~~~~~l~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~ 152 (240)
+.+++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+|+||||+|+|||++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 5689999999999999999642 34899999999999999999999999999999999999987
Q ss_pred CCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 026299 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (240)
Q Consensus 153 ~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 228 (240)
++. +||+|||+++....... .....+++.|+|||.+.+..++.+ +|||||||++|||++ |..||.+.+....+
T Consensus 221 ~~~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 221 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp GGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CCC--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 776 99999999975433222 123457889999999988777555 999999999999998 99999987766555
Q ss_pred hhhh
Q 026299 229 RKTI 232 (240)
Q Consensus 229 ~~~~ 232 (240)
.+++
T Consensus 298 ~~~i 301 (353)
T 4ase_A 298 CRRL 301 (353)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=294.91 Aligned_cols=195 Identities=27% Similarity=0.307 Sum_probs=159.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC----eEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~ 96 (240)
++|.+.+.||+|+||.||+|++ +|+.||||++.........+..|+..+.+++||||+++++++.+++ .+++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5799999999999999999987 5889999998765443333455666677889999999999998653 579999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--------CceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~--------~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
||+++++|.+++.+ .+++++.+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++..
T Consensus 81 Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred cCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence 99999999999965 4689999999999999999999976 9999999999999987776 99999999864
Q ss_pred ccccC-----CCCCCcCCccccCccccccCCC-----CCcccchHHHHHHHHHHHhCCCCCC
Q 026299 169 SVLHS-----QPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFE 220 (240)
Q Consensus 169 ~~~~~-----~~~~~~~~~~~~~pE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~ 220 (240)
..... ......|++.|+|||++.+... ++.++||||||+++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 43322 2233568999999999876531 2345999999999999999976553
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=292.85 Aligned_cols=214 Identities=40% Similarity=0.679 Sum_probs=190.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4789999999999999999999999999999999876432 2346789999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
||+++++|.+++...+.+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..........
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGG
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCccc
Confidence 99999999999988888999999999999999999999999999999999999987766 9999999987655554455
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
...+++.|+|||.+.+...++.++||||||+++++|++|..||.+.+......++....
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 230 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 56789999999999888877667999999999999999999999888777766665543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=285.98 Aligned_cols=212 Identities=34% Similarity=0.593 Sum_probs=186.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++++.||+|+||.||++++..+++.||+|++... ......+.+|..+++.++||||+++++++.+.+.+++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 347999999999999999999999999999999998763 2234567899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 173 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~ 173 (240)
||||++|++|.+++.+.+.+++..++.++.||+.||+|||+.||+||||+|+||+++.++. ++|+|||++..... ..
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCC
Confidence 9999999999999988888999999999999999999999999999999999999987765 99999999865332 23
Q ss_pred CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
......+++.|+|||.+.+...+.. +|+||||+++|+|++|..||.+.+....+.+++.
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 219 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 3345678999999999987776555 9999999999999999999998877776666554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=289.24 Aligned_cols=214 Identities=36% Similarity=0.568 Sum_probs=182.9
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 92 (240)
...++|++++.||+|+||.||++++..+++.||+|++... ....+.+.+|..+++.+ +||||+++++++.+.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 3458999999999999999999999999999999998763 22335577899999888 699999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~- 171 (240)
++||||++|++|.+++.+.+.+++..++.++.||+.||+|||+.||+||||+|+||+++.++. ++|+|||++.....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccC
Confidence 999999999999999988889999999999999999999999999999999999999987766 99999999864332
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
........+++.|+|||.+.+..++.. +|+||||+++|+|++|..||.+.+..+.+.+++..
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 239 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CccccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 233345568999999999987776555 99999999999999999999999888887777654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=287.15 Aligned_cols=215 Identities=33% Similarity=0.590 Sum_probs=190.0
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-------ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
.+.|++.+.||+|+||.||++++..+|..|++|.+..... ..+.+.+|+.+++.++||||+++++++.++..+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4789999999999999999999999999999999876432 235688999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCC--CcEEEecCCcccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV 170 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~--~~~~L~d~~~~~~~~ 170 (240)
++||||++|++|.+++.....+++..+..++.|++.||+|||+.||+|+||+|+||+++.++. ..++|+|||++....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 999999999999999988888999999999999999999999999999999999999976552 259999999997665
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
.........+++.|+|||.+.+..++.. +|+||||+++|+|++|..||.+.+....+.++....
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 234 (361)
T 2yab_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234 (361)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred CCCccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence 5555556678999999999987766554 999999999999999999999988877777766543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=284.74 Aligned_cols=210 Identities=46% Similarity=0.786 Sum_probs=185.6
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
.++|++.+.||+|+||.||+|.+..++..||+|++... ......+.+|+..++.++||||+++++++.++...++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 37999999999999999999999999999999998653 22345788999999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
|||+ +++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTT
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCccc
Confidence 9999 5689888888888999999999999999999999999999999999999987765 999999998766655555
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
....+++.|+|||.+.+......++||||||+++|+|++|..||.+......+.++.
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~ 221 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN 221 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 667789999999999888776666999999999999999999998876655544443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=285.17 Aligned_cols=214 Identities=24% Similarity=0.438 Sum_probs=187.8
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
.++|++.+.||+|+||.||++.+..++..+++|.+.........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 47999999999999999999999999999999998776555567889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCC
Q 026299 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (240)
Q Consensus 100 ~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~ 178 (240)
++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.+..+.++|+|||.+............
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 163 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence 999999998765 3799999999999999999999999999999999999998744456999999998755444333445
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.+++.|+|||.+.+...+. ++|+||||+++|+|++|..||...+....+.+++..
T Consensus 164 ~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 218 (321)
T 1tki_A 164 FTAPEYYAPEVHQHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA 218 (321)
T ss_dssp ESCGGGSCHHHHTTCEECH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred cCChhhcCcHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcC
Confidence 6889999999998776544 499999999999999999999988877776666543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=283.66 Aligned_cols=215 Identities=35% Similarity=0.562 Sum_probs=185.2
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCC
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 90 (240)
.....++|++.+.||+|+||.||+|++..+++.||+|++... ....+....|..++..+ +||||+++++++.+..
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 344668999999999999999999999999999999998764 22335577888888876 8999999999999999
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
.+++||||++|++|.+++.+.+.+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENM 169 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhcc
Confidence 99999999999999999988888999999999999999999999999999999999999987765 9999999986433
Q ss_pred c-cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 171 L-HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 171 ~-~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
. ........+++.|+|||.+.+..++.. +|+||||+++|+|++|..||.+.+....+.++..
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 232 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 2 223345678999999999988776555 9999999999999999999998887777666544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=287.77 Aligned_cols=214 Identities=29% Similarity=0.500 Sum_probs=178.0
Q ss_pred CcCCCCCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhc-CCCCee
Q 026299 6 MTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIV 80 (240)
Q Consensus 6 ~~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~ 80 (240)
++.............++|++++.||+|+||.||++++..+++.||+|++.... ...+.+.+|..++.++ +||||+
T Consensus 37 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv 116 (396)
T 4dc2_A 37 MNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116 (396)
T ss_dssp ------------CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBC
T ss_pred hccccccccccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcC
Confidence 33333333344455689999999999999999999999999999999987642 2224577888888876 899999
Q ss_pred eeeEEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEE
Q 026299 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (240)
Q Consensus 81 ~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L 160 (240)
++++++.++..+++||||+++++|.+++.+.+.+++..++.++.||+.||+|||+.||+||||+|+||+++.++. ++|
T Consensus 117 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL 194 (396)
T 4dc2_A 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKL 194 (396)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEE
T ss_pred eeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEE
Confidence 999999999999999999999999999988889999999999999999999999999999999999999987776 999
Q ss_pred ecCCccccc-cccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 161 CDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 161 ~d~~~~~~~-~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
+|||++... ..........+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...
T Consensus 195 ~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 195 TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTT
T ss_pred eecceeeecccCCCccccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccc
Confidence 999998753 23334455678999999999988777555 99999999999999999999643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=277.36 Aligned_cols=212 Identities=33% Similarity=0.474 Sum_probs=179.4
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc----HHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
....++|++++.||+|++|.||++++..++..|++|.+....... +.+.+|+..++.++||||+++++++.+++.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 334589999999999999999999999999999999986543322 4678999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
++||||+++++|.+++...+++++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC---
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCccccccc
Confidence 999999999999999988889999999999999999999999999999999999999987765 999999998654332
Q ss_pred C--CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 173 S--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 173 ~--~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
. ......+++.|+|||.+.+...+.. +|+||||+++|+|++|..||.+.+......+.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~ 224 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH
T ss_pred cccccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 2 2223457899999999988776555 99999999999999999999887765544333
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=279.56 Aligned_cols=211 Identities=33% Similarity=0.585 Sum_probs=186.7
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++.+.||+|++|.||++++..+++.||+|++.... ...+.+.+|..+++.++||||+++++++.+...+++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 3478999999999999999999999999999999987632 233567889999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
||||+++++|.+++.....+++..++.++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||++..... .
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~--~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--V 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--C
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecCC--c
Confidence 9999999999999988888999999999999999999999999999999999999987765 99999999864332 2
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.....+++.|+|||.+.+...+.. +|+||||+++|+|++|..||.+.+....+.+++..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 218 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC
T ss_pred cccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 334568999999999987776555 99999999999999999999988887777776654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=283.95 Aligned_cols=214 Identities=33% Similarity=0.539 Sum_probs=186.1
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 92 (240)
...++|++++.||+|+||.||++++..+++.||+|++.... ...+.+.+|..++..+ +||+|+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 45589999999999999999999999999999999987632 2335677888888877 799999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~- 171 (240)
++||||++|++|.+++...+.+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++.....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccC
Confidence 999999999999999988888999999999999999999999999999999999999987765 99999999864322
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
........+++.|+|||.+.+...+.. +|+||||+++|+|++|..||.+.+....+++++..
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 236 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CcccccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC
Confidence 233445678999999999987776555 99999999999999999999988887777776653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=280.47 Aligned_cols=212 Identities=34% Similarity=0.619 Sum_probs=186.1
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-------ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
.++|++.+.||+|+||.||++++..++..|++|.+..... ..+.+.+|+.+++.++||||+++++++.++...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3689999999999999999999999999999999876432 235688999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC--CCcEEEecCCcccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSV 170 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~--~~~~~L~d~~~~~~~~ 170 (240)
++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ ...++|+|||.+....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888899999999999999999999999999999999999997665 2249999999987665
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
.........+++.|+|||.+.+...+.. +|+||||+++|+|++|..||.+.+....+.++.
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 230 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVS 230 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CCCccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence 5555556678999999999977766555 999999999999999999998877666555443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=282.23 Aligned_cols=213 Identities=35% Similarity=0.602 Sum_probs=186.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++.+.||+|+||.||++.+..++..|++|.+...... .+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4799999999999999999999999999999998764322 2467899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCCccccccccCCCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
|+++++|.+.+.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.+. ...++|+|||++..........
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~ 188 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccc
Confidence 999999999998888899999999999999999999999999999999999997643 2459999999987665444445
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
...+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.+.+....+.++...
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~ 245 (362)
T 2bdw_A 189 GFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 245 (362)
T ss_dssp CSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 5678999999999987766554 99999999999999999999888776666655543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=283.07 Aligned_cols=204 Identities=27% Similarity=0.483 Sum_probs=180.5
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
...++|++++.||+|+||.||++++..++..||+|++.... .....+.+|+.+++.++||||+++++++.+....+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34589999999999999999999999999999999986532 23356789999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
+||||+.|++|.+++.....+++..++.++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++.......
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRET 169 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCCC
Confidence 99999999999999988888999999999999999999999999999999999999987776 9999999997665555
Q ss_pred CCCCCcCCccccCccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 174 QPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
......+++.|+|||.+.+. ...+.++|+||||+++|+|++|..||....
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 55667799999999998643 223445999999999999999999997543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=280.75 Aligned_cols=211 Identities=31% Similarity=0.562 Sum_probs=186.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++++.||+|++|.||++++..++..|++|++.... ...+.+.+|+.+++.++||||+++++++.++..+++
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 4589999999999999999999999999999999986532 233567899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
||||+++++|.+++.+.+.+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++..... .
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~--~ 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--R 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--C
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccC--C
Confidence 9999999999999988888999999999999999999999999999999999999987765 99999999864432 2
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.....+++.|+|||.+.+...+.. +|+||||+++|+|++|..||...+....+.++...
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 253 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 334568999999999987776555 99999999999999999999988877777766553
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=282.95 Aligned_cols=214 Identities=33% Similarity=0.569 Sum_probs=180.3
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHH-HHhcCCCCeeeeeEEEEcCCeE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIIN-HRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
...++|++++.||+|+||.||++++..++..|++|++..... ....+.+|... ++.++||||+++++++.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 345799999999999999999999999999999999876432 22345566655 4678999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc-c
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-L 171 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~-~ 171 (240)
++||||++|++|.+++.+.+.+++..++.++.||+.||+|||+.||+||||+|+||+++.++. ++|+|||++.... .
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCccccccccC
Confidence 999999999999999988888999999999999999999999999999999999999987765 9999999987533 2
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
........+++.|+|||.+.+..++.. +|+||||+++|+|++|..||.+.+....+.+++..
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 254 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS
T ss_pred CCccccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 334455678999999999987776554 99999999999999999999998888877777654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=287.28 Aligned_cols=214 Identities=34% Similarity=0.484 Sum_probs=185.7
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
...++|++++.||+|+||.||++++..++..||+|++... ....+.+.+|..+++.++||||+++++++.++..++
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 3557999999999999999999999999999999998752 223356889999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
+||||++|++|.+++.+ ..+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++.......
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCC
Confidence 99999999999998865 56899999999999999999999999999999999999987776 9999999986443322
Q ss_pred --CCCCCcCCccccCccccccCCC---CCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 174 --QPKSTVGTPAYIAPEVLLKKEY---DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 174 --~~~~~~~~~~~~~pE~~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
......+++.|+|||.+.+... .+.++|+||||+++|+|++|..||.+.+....+.+++..
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 288 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 288 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhc
Confidence 2335678999999999976542 344599999999999999999999999888888887753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=273.92 Aligned_cols=207 Identities=29% Similarity=0.496 Sum_probs=180.5
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
..++|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++++++..++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 4478999999999999999999999999999999987643 334568899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~ 176 (240)
|+++++|.+++.+. .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBC
T ss_pred CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccccC
Confidence 99999999988654 6899999999999999999999999999999999999987766 9999999986544332 233
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (240)
...+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+......
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~ 226 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 4568999999999988777555 999999999999999999998776554433
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=291.17 Aligned_cols=215 Identities=42% Similarity=0.741 Sum_probs=191.7
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... ...+.+.+|+..++.++||||+++++++.+.+..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4489999999999999999999999999999999987542 223568899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
||||+++++|.+++.+.+.+++..++.++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||++........
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhcccccc
Confidence 9999999999999988888999999999999999999999999999999999999987766 99999999876554444
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
.....+++.|+|||.+.+......++||||||+++|+|++|..||.+.+....+.++....
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 232 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI 232 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC
Confidence 4556789999999999887776667999999999999999999999988887777776544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=289.16 Aligned_cols=214 Identities=27% Similarity=0.486 Sum_probs=184.6
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
...++|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|..++..++||||+++++++.+++.++
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 34579999999999999999999999999999999987522 22344789999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
+||||+++++|.+++.+ ...+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++......
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMED 228 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccC
Confidence 99999999999999976 467999999999999999999999999999999999999987776 999999998644332
Q ss_pred CC--CCCCcCCccccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 173 SQ--PKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 173 ~~--~~~~~~~~~~~~pE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.. .....+++.|+|||.+.. ....+.++|+||||+++|+|++|..||.+.+..+.+.+++.
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 295 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhh
Confidence 22 233568999999999862 23334459999999999999999999999888888877765
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=272.35 Aligned_cols=210 Identities=27% Similarity=0.462 Sum_probs=176.4
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++++.||+|++|.||++++..+++.|++|++...... ...+.+|+..++.++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999999999999999998764332 2567899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~ 176 (240)
|+++..+..+....+.+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+...... ....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCCC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCcccccc
Confidence 9987444444444678999999999999999999999999999999999999987766 999999998654322 2334
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCC-CCCCchhhhhhhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRKTI 232 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~ 232 (240)
...++..|+|||.+.+....+.++||||||+++++|++|..|| ...+..+.+.++.
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~ 216 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 4567889999999987775566699999999999999888774 5555555444443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=287.34 Aligned_cols=214 Identities=35% Similarity=0.579 Sum_probs=184.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++.+.||+|+||.||++.+..++..+++|.+..... ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 689999999999999999999999999999999876432 23457899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC-CCCcEEEecCCccccccccCC-C
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ-P 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~-~~~~~~L~d~~~~~~~~~~~~-~ 175 (240)
|++|++|.+.+.....+++..+..++.||+.||+|||+.||+|+||+|+||+++.+ ..+.++|+|||++........ .
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~ 170 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCcee
Confidence 99999999999888889999999999999999999999999999999999999753 234599999999865443322 2
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.+.+....+.++....
T Consensus 171 ~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 229 (444)
T 3soa_A 171 FGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 229 (444)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred ecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC
Confidence 34568999999999987777555 999999999999999999999888777777665543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=277.25 Aligned_cols=215 Identities=31% Similarity=0.510 Sum_probs=178.1
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEec---CCCcEEEEEEeecCc-----cccHHHHHHHHHHHhcCCCCeeeeeEEEEc
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILT 88 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (240)
....++|++.+.||+|++|.||++++. .++..|++|++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 345689999999999999999999985 578999999987642 223457789999999999999999999999
Q ss_pred CCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
++..++||||+++++|.+++...+.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||.+..
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKE 170 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC--
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCcccc
Confidence 9999999999999999999988888999999999999999999999999999999999999987765 99999999864
Q ss_pred cccc-CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 169 SVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 169 ~~~~-~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.... .......+++.|+|||.+.+...+.. +|+||||+++|+|++|..||...+....+.+++..
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 236 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCc-ccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 3322 22344568899999999987766554 99999999999999999999988877777666553
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=284.74 Aligned_cols=214 Identities=27% Similarity=0.452 Sum_probs=184.6
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
...++|++++.||+|+||.||++++..+++.||+|++.... ...+.+.+|..++..++||||+++++++.+++.++
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 34589999999999999999999999999999999987532 22345788999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
+||||++|++|.+++.+. ..+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++......
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRAD 215 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCC
Confidence 999999999999999765 47999999999999999999999999999999999999987766 999999998654333
Q ss_pred CC--CCCCcCCccccCcccccc------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 173 SQ--PKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 173 ~~--~~~~~~~~~~~~pE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.. .....+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...+....+.++++
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 22 234568999999999873 22334559999999999999999999999888887777765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=276.38 Aligned_cols=200 Identities=32% Similarity=0.550 Sum_probs=176.5
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 93 (240)
..++|++++.||+|+||.||++++..+++.||+|++...... .+.+.+|..+++++ +||||+++++++.++...+
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 347899999999999999999999999999999999764322 24567899999887 8999999999999999999
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc-cc
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LH 172 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~-~~ 172 (240)
+||||+++++|.+++.+.+.+++..++.++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||++.... ..
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCCC
Confidence 99999999999999988888999999999999999999999999999999999999987765 9999999986432 22
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
.......+++.|+|||.+.+...+.. +|+||||+++|+|++|..||..
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcccccCCCccccCccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCC
Confidence 33445678999999999987776554 9999999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=273.60 Aligned_cols=212 Identities=28% Similarity=0.478 Sum_probs=178.3
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
-.++|++++.||+|++|.||++++. +++.||+|++...... ...+.+|+..++.++||||+++++++.++...++|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 4489999999999999999999996 5889999998754322 35678999999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-C
Q 026299 96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 173 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~ 173 (240)
|||+++ +|.+.+... ..+++..++.++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||.+...... .
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVR 174 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCCC
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCcc
Confidence 999986 777777554 45999999999999999999999999999999999999987766 999999998754322 2
Q ss_pred CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
......+++.|+|||.+.+....+.++||||||+++++|++|..||.+.+..+.+.++...
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 235 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI 235 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 2334467899999999887655566699999999999999999999998888877776553
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=276.11 Aligned_cols=214 Identities=26% Similarity=0.408 Sum_probs=178.9
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC--eEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLA 93 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 93 (240)
...++|++.+.||+|++|.||++++..+++.||+|++.... ...+.+.+|+..++.++||||+++++++.... ..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 34589999999999999999999999999999999987643 22356789999999999999999999998764 789
Q ss_pred EEEecCCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEc--CCCCCcEEEecCCcccc
Q 026299 94 IVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKS 168 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~---~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~--~~~~~~~~L~d~~~~~~ 168 (240)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||++. .+....++|+|||.+..
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999999997643 389999999999999999999999999999999999982 12333499999999976
Q ss_pred ccccCCCCCCcCCccccCcccccc--------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 169 SVLHSQPKSTVGTPAYIAPEVLLK--------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~pE~~~~--------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
...........++..|+|||.+.. ..+ +.++||||||+++|+|++|..||..........+++
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred cCCCCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 655555556678999999998862 344 444999999999999999999998765544444433
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=281.61 Aligned_cols=213 Identities=28% Similarity=0.493 Sum_probs=184.3
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
.++|++.+.||+|++|.||+|.+..++..|++|.+..... ....+.+|+.+++.++||||+++++++.++...++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 3689999999999999999999999999999999876532 335688999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCC
Q 026299 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (240)
Q Consensus 99 ~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~ 177 (240)
+++++|.+++... ..+++..++.++.|++.||+|||+.||+|+||+|+||+++.+..+.++|+|||++...........
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~ 209 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 209 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence 9999999988654 369999999999999999999999999999999999999865555699999999875544433334
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
..+++.|+|||.+.+...+.. +||||||+++|+|++|..||.+.+....+.++..
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~ 264 (387)
T 1kob_A 210 TTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 264 (387)
T ss_dssp ECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred eccCCCccCchhccCCCCCCc-ccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 568899999999987766554 9999999999999999999998776666555443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=276.82 Aligned_cols=204 Identities=38% Similarity=0.668 Sum_probs=177.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
.++|++++.||+|++|.||++++..+++.|++|++..... ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 3799999999999999999999999999999999865432 23568899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc---CC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQ 174 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~---~~ 174 (240)
|+++++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+...... ..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCcccc
Confidence 9999999999987778999999999999999999999999999999999999987765 999999998643322 22
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
.....+++.|+|||.+.+....+.++||||||+++++|++|..||......
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 214 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 234568899999999988777666699999999999999999999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=279.04 Aligned_cols=224 Identities=23% Similarity=0.361 Sum_probs=188.5
Q ss_pred CCCCCCCcccCCCCCeeEeeeecCC--CceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeee
Q 026299 8 VGPGMDMPIMHDSDRYELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRF 82 (240)
Q Consensus 8 ~~~~~~~~~~~~~~~y~~~~~l~~g--~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~ 82 (240)
..+.....+..+.++|++++.||+| ++|.||++++..++..||+|++...... .+.+.+|+.+++.++||||+++
T Consensus 12 ~~~~~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 91 (389)
T 3gni_B 12 LYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91 (389)
T ss_dssp SCCC--CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhhhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 4566777788889999999999999 9999999999999999999999765322 2457789999999999999999
Q ss_pred eEEEEcCCeEEEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEE
Q 026299 83 KEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (240)
Q Consensus 83 ~~~~~~~~~~~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L 160 (240)
++++.+++..++||||+++++|.+++... ..+++..+..++.||+.||+|||+.||+|+||+|+||+++.++. ++|
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl 169 (389)
T 3gni_B 92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYL 169 (389)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEE
T ss_pred eEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEE
Confidence 99999999999999999999999999765 67999999999999999999999999999999999999987765 999
Q ss_pred ecCCcccccccc--------CCCCCCcCCccccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 161 CDFGYSKSSVLH--------SQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 161 ~d~~~~~~~~~~--------~~~~~~~~~~~~~~pE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
+|||.+...... .......++..|+|||.+.+. ...+.++||||||+++|+|++|..||.+.+....+.++
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred cccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999987533211 122234678889999999874 23344599999999999999999999988877776665
Q ss_pred hc
Q 026299 232 IH 233 (240)
Q Consensus 232 ~~ 233 (240)
+.
T Consensus 250 ~~ 251 (389)
T 3gni_B 250 LN 251 (389)
T ss_dssp --
T ss_pred hc
Confidence 54
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=274.00 Aligned_cols=213 Identities=32% Similarity=0.577 Sum_probs=186.8
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-------ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
.++|++.+.||+|++|.||++++..++..|++|.+..... ..+.+.+|+..++.++||||+++++++.++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3689999999999999999999999999999999876432 235688999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC--cEEEecCCcccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP--RLKICDFGYSKSSV 170 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~--~~~L~d~~~~~~~~ 170 (240)
++|||++++++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.. .++|+|||.+....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 9999999999999999888889999999999999999999999999999999999999766521 49999999987665
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.........+++.|+|||.+.+...+.. +|+||||+++++|++|..||...+..+.+.++..
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 232 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITS 232 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred ccccccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 5555555678999999999977766555 9999999999999999999988776666555544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=272.41 Aligned_cols=212 Identities=28% Similarity=0.470 Sum_probs=168.2
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
..++|++++.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3578999999999999999999999999999999987643 23467889999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 97 EYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
||+++ +|.+++... ..++...++.++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||.+....
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFG 159 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETT
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecC
Confidence 99985 888887643 35899999999999999999999999999999999999987766 9999999987543
Q ss_pred cc-CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 171 LH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 171 ~~-~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.. .......+++.|+|||.+.+....+.++||||||+++++|++|..||.+.+..+.+.++.+
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 223 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFD 223 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 32 2233456789999999997765555569999999999999999999998887777666654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=265.76 Aligned_cols=209 Identities=37% Similarity=0.599 Sum_probs=184.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
++|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++||||+++++++.++...++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 68999999999999999999999999999999987643 33467889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEE---cCCCCCcEEEecCCccccccccCCCC
Q 026299 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 100 ~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili---~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
++++|.+++.....+++..++.++.|++.||++||+.|++|+||+|+||++ +.++ .++|+|||.+..........
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~--~~~l~Dfg~~~~~~~~~~~~ 166 (277)
T 3f3z_A 89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS--PLKLIDFGLAARFKPGKMMR 166 (277)
T ss_dssp CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC--CEEECCCTTCEECCTTSCBC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC--cEEEEecccceeccCccchh
Confidence 999999999888889999999999999999999999999999999999999 4444 49999999987665555556
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
...+++.|+|||.+.+. . +.++|+||||+++++|++|..||...+......++..
T Consensus 167 ~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 221 (277)
T 3f3z_A 167 TKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221 (277)
T ss_dssp CCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 66789999999988654 4 4449999999999999999999998877666655544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=276.44 Aligned_cols=204 Identities=37% Similarity=0.604 Sum_probs=164.1
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (240)
++|++.+.||+|++|.||++++..++..|++|++.... ..+.+.+|+..+++++||||+++++++.++...++||||++
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 57999999999999999999999999999999987643 34567889999999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC-CCCCcEEEecCCccccccccCCCCCCc
Q 026299 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTV 179 (240)
Q Consensus 101 ~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~-~~~~~~~L~d~~~~~~~~~~~~~~~~~ 179 (240)
+++|.+++...+.+++..++.++.|++.||+|||+.|++|+||+|+||+++. +..+.++|+|||.+.............
T Consensus 132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 211 (349)
T 2w4o_A 132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC 211 (349)
T ss_dssp SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccccc
Confidence 9999999988888999999999999999999999999999999999999975 224459999999987554444444566
Q ss_pred CCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 180 ~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
+++.|+|||.+.+...+.+ +||||||+++|+|++|..||.......
T Consensus 212 gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~ 257 (349)
T 2w4o_A 212 GTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQ 257 (349)
T ss_dssp -CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCHH
T ss_pred CCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCcccH
Confidence 8899999999987776555 999999999999999999998766544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=269.08 Aligned_cols=209 Identities=30% Similarity=0.485 Sum_probs=176.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++++.||+|++|.||++++ .+++.|++|.+..... ..+.+.+|+..++.++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 6899999999999999999999 5788999999865432 23678899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCC
Q 026299 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~ 175 (240)
++++ +|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+...... ...
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCcccccc
Confidence 9987 888888653 67999999999999999999999999999999999999987766 999999998644322 222
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
....+++.|+|||.+.+....+.++|+||||+++++|++|..||...+..+.+.++.+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 215 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 3346788999999997765555669999999999999999999998887777666654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=265.33 Aligned_cols=213 Identities=36% Similarity=0.609 Sum_probs=186.5
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
.++|++.+.||+|++|.||++.+..++..|++|++...... .+.+.+|+..+++++||||+++++++.+++..+++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 48999999999999999999999999999999998764322 245789999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCC-CcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~-~~~~L~d~~~~~~~~~~~~~ 175 (240)
|++++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ..++|+|||.+.........
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence 99999999999988888999999999999999999999999999999999999975443 34999999998766555555
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
....+++.|+|||.+.+...+.+ +|+||||+++++|++|..||.+.+......++..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 221 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221 (284)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh
Confidence 55678999999999988777555 9999999999999999999988776665555443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=269.22 Aligned_cols=202 Identities=28% Similarity=0.463 Sum_probs=176.0
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
..+++|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++++++.++...++||
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 46789999999999999999999999999999999875532 33467889999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC-----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceeccccccc
Confidence 99999999999976 467999999999999999999999999999999999999987766 999999998644322211
Q ss_pred ---------------CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 176 ---------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 176 ---------------~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
....+++.|+|||.+.+...+.+ +||||||+++++|++|..||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTT
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcch
Confidence 14468889999999988776555 99999999999999999998764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=265.57 Aligned_cols=214 Identities=43% Similarity=0.735 Sum_probs=177.6
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
.....++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++||||+++++++.+.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 3345589999999999999999999999999999999986532 223568899999999999999999999999999
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
.++|||++++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCC
Confidence 9999999999999999988888999999999999999999999999999999999999987765 99999999876544
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
........+++.|+|||.+.+....+.++|+||||+++++|++|..||...+....+.++
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 223 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI 223 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence 444445567889999999987766556699999999999999999999887665554443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=269.72 Aligned_cols=210 Identities=28% Similarity=0.443 Sum_probs=177.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++++.||+|++|.||++++..++..|++|++...... .+.+.+|+..++.++||||+++++++.+++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 6899999999999999999999999999999988664332 3457789999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~ 176 (240)
|+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+...... ....
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC-------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCcccccC
Confidence 9999999998887888999999999999999999999999999999999999987765 999999998654422 2223
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
...++..|+|||.+.+....+.++|+||||+++++|++|..||.+.+..+....+.
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 45678899999999875555566999999999999999999999887776655443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=269.21 Aligned_cols=211 Identities=29% Similarity=0.463 Sum_probs=179.5
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc------cccHHHHHHHHHHHhc---CCCCeeeeeEEEEcCC
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSL---RHPNIVRFKEVILTPT 90 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~ 90 (240)
.++|++++.||+|++|.||++++..+++.||+|++.... .......+|+..++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 579999999999999999999999999999999987432 2234567777777766 4999999999998754
Q ss_pred -----eEEEEEecCCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecC
Q 026299 91 -----HLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (240)
Q Consensus 91 -----~~~lv~~~~~~~~l~~~l~~~~~--l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~ 163 (240)
..++++|++++ +|.+++..... +++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+||
T Consensus 88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Df 164 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADF 164 (308)
T ss_dssp SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSC
T ss_pred CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeC
Confidence 57999999975 99998876554 899999999999999999999999999999999999987765 999999
Q ss_pred CccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
|.+.............+++.|+|||.+.+...+.+ +||||||+++++|++|..||.+.+..+.+.++++.
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99876554444455678999999999988777555 99999999999999999999998888887776653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=285.48 Aligned_cols=212 Identities=36% Similarity=0.597 Sum_probs=176.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++++.||+|+||.||++++..++..||+|++... ......+.+|+..++.++||||+++++++.+.+.+++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 347899999999999999999999999999999998753 2223456789999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-c
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H 172 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~ 172 (240)
||||+++++|.+++.....+++..+..++.|++.||+|||+ .||+|+||+|+||+++.++. ++|+|||++..... .
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDG 303 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC--
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCC
Confidence 99999999999999888899999999999999999999998 99999999999999987765 99999999864322 2
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.......+++.|+|||.+.+..++.. +||||||+++++|++|..||.+.+....+..+..
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 363 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh
Confidence 33345678999999999987776555 9999999999999999999998887766665543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=274.62 Aligned_cols=200 Identities=32% Similarity=0.499 Sum_probs=178.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---------ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
++|++.+.||+|++|.||++++..++..|++|.+..... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 689999999999999999999999999999999876432 22356789999999999999999999999999
Q ss_pred EEEEEecCCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 92 LAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 92 ~~lv~~~~~~~-~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
.++|||++.++ +|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceECC
Confidence 99999998665 99999988888999999999999999999999999999999999999987765 9999999987655
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
.........+++.|+|||.+.+......++||||||+++|+|++|..||...
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 5544455668999999999988877666699999999999999999999753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=264.53 Aligned_cols=214 Identities=26% Similarity=0.440 Sum_probs=184.1
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
...+.++|++.+.||+|++|.||++.+. ++..|++|++.......+.+.+|+..+++++||||+++++++.++...++|
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 4456789999999999999999999988 567799999988776678899999999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc--
Q 026299 96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 172 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-- 172 (240)
|||+++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEecccccccccccccc
Confidence 9999999999999654 46899999999999999999999999999999999999977665 999999998644322
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
.......++..|+|||.+.+...+.+ +|+||||+++++|++ |..||...+..+...++..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~ 222 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 222 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred ccccCcccccccCCHHHhcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Confidence 22233445678999999977776554 999999999999999 9999988877666655543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=273.42 Aligned_cols=209 Identities=29% Similarity=0.427 Sum_probs=173.1
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc----HHHHHHHHHHHhcCCCCeeeeeEEEEcCC----e
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPT----H 91 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 91 (240)
.++|++.+.||+|++|.||++++..++..|++|++....... ..+.+|+..++.++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 378999999999999999999999999999999987653222 35789999999999999999999987653 3
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
.++||||+++++|.+++...+++++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC-----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcccccc
Confidence 5999999999999999988888999999999999999999999999999999999999987766 99999999864433
Q ss_pred cCC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 172 ~~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
... .....+++.|+|||.+.+...+.+ +||||||+++|+|++|..||...+......++
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~ 231 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 231 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 221 223457899999999987766554 99999999999999999999887765554433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=264.15 Aligned_cols=211 Identities=35% Similarity=0.634 Sum_probs=180.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-------ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
++|++.+.||+|++|.||++++..+++.|++|.+..... ..+.+.+|+..++.++||||+++++++.++...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999876421 2456889999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC--CCcEEEecCCccccccc
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVL 171 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~--~~~~~L~d~~~~~~~~~ 171 (240)
+|||++++++|.+++.+...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ ...++|+|||.+.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888899999999999999999999999999999999999997655 22599999999876554
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
........+++.|+|||.+.+...+.+ +|+||||+++++|++|..||...+....+.++.
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 224 (283)
T 3bhy_A 165 GNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETLTNIS 224 (283)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CCcccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH
Confidence 444445568899999999877766555 999999999999999999998877665555443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=283.30 Aligned_cols=212 Identities=38% Similarity=0.616 Sum_probs=183.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC---ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++++.||+|++|.||++++..++..||+|++... ......+.+|+.+++.++||||+++++++.+...+++|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 7899999999999999999999999999999998653 2334678899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCCccccccccCCCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
++++++|.+.+.....+++..+..++.|++.||.|||+.||+|+||+|+||+++... ...++|+|||++..........
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 181 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccC
Confidence 999999999998888899999999999999999999999999999999999996432 3359999999987665555555
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
...+++.|+|||.+.+. + +.++||||||+++|+|++|..||.+.+..+.+.++...
T Consensus 182 ~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 237 (486)
T 3mwu_A 182 DRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237 (486)
T ss_dssp CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 66789999999998753 4 55599999999999999999999988877776665543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=283.96 Aligned_cols=212 Identities=37% Similarity=0.637 Sum_probs=184.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--------------cccHHHHHHHHHHHhcCCCCeeeeeEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNIVRFKEVI 86 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 86 (240)
++|++++.||+|+||.||+|++..++..||+|++.... ...+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 78999999999999999999999999999999987643 2235688999999999999999999999
Q ss_pred EcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCC-CcEEEecCCc
Q 026299 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGY 165 (240)
Q Consensus 87 ~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~-~~~~L~d~~~ 165 (240)
.++..+++||||+++++|.+.+.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++. ..++|+|||+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 195 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence 999999999999999999999988888999999999999999999999999999999999999976653 2599999999
Q ss_pred cccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
+.............+++.|+|||.+.+ .+ +.++||||||+++|+|++|..||.+.+....+.++...
T Consensus 196 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 196 SSFFSKDYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp CEECCTTSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CEEcCCCCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 976655555556678999999999864 44 44599999999999999999999998887777666554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=276.04 Aligned_cols=212 Identities=31% Similarity=0.510 Sum_probs=177.9
Q ss_pred CeeE--eeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 22 RYEL--VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 22 ~y~~--~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
.|++ .+.||+|+||.||++++..++..|++|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 4555 678999999999999999999999999987654 3346788999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCC
Q 026299 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (240)
Q Consensus 99 ~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~ 177 (240)
+++++|.+++... ..+++..++.++.|++.||+|||+.||+|+||+|+||++..+..+.++|+|||++...........
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 9999999888653 468999999999999999999999999999999999999655555699999999976655555555
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
..+++.|+|||.+.+...+. ++||||||+++++|++|..||...+..+.+.+++..
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 303 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSF-PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC 303 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred ccCCCcEeChhhccCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 67899999999987666544 499999999999999999999988877777666543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=267.34 Aligned_cols=209 Identities=37% Similarity=0.593 Sum_probs=173.1
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---------------------------ccHHHHHHHHHH
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------------------------IDENVQREIINH 71 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------------------------~~~~~~~e~~~l 71 (240)
..++|++.+.||+|++|.||++++..++..|++|++..... ..+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 34799999999999999999999999999999999865421 124578999999
Q ss_pred HhcCCCCeeeeeEEEEc--CCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeE
Q 026299 72 RSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (240)
Q Consensus 72 ~~l~h~~i~~~~~~~~~--~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nil 149 (240)
+.++||||+++++++.+ +...++||||+++++|.+++ ...++++..++.++.|++.||+|||+.|++|+||+|+||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99999999999999987 56899999999999998765 4457999999999999999999999999999999999999
Q ss_pred EcCCCCCcEEEecCCccccccccC-CCCCCcCCccccCccccccCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 150 LDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 150 i~~~~~~~~~L~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
++.++. ++|+|||.+....... ......+++.|+|||.+.+... ...++||||||+++|+|++|..||...+...
T Consensus 170 ~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 170 VGEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp ECTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ECCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 987765 9999999986543322 1234568899999999876553 3555899999999999999999998766544
Q ss_pred hhhh
Q 026299 227 NFRK 230 (240)
Q Consensus 227 ~~~~ 230 (240)
...+
T Consensus 248 ~~~~ 251 (298)
T 2zv2_A 248 LHSK 251 (298)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4333
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=277.04 Aligned_cols=209 Identities=32% Similarity=0.432 Sum_probs=169.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCC--eEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HLAI 94 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~l 94 (240)
++|++++.||+|+||.||+|.+..+++.||+|++.... .......+|+..++.+. ||||+++++++..++ .+++
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 78999999999999999999999999999999986532 22345778999999997 999999999997543 7899
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc--
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 172 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-- 172 (240)
||||+++ +|.+++.. ..+++..+..++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++......
T Consensus 89 v~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 89 VFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCCC
T ss_pred EecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCccccccccccc
Confidence 9999985 88887754 57899999999999999999999999999999999999987776 999999998643221
Q ss_pred --------------------CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 173 --------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 173 --------------------~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
.......+++.|+|||.+.+....+.++|||||||++++|++|..||.+.+..+.+.+++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 111234578899999999875555666999999999999999999999999888888776
Q ss_pred c
Q 026299 233 H 233 (240)
Q Consensus 233 ~ 233 (240)
.
T Consensus 245 ~ 245 (388)
T 3oz6_A 245 G 245 (388)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=292.07 Aligned_cols=214 Identities=34% Similarity=0.544 Sum_probs=188.1
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 93 (240)
..++|++++.||+|+||.||++++..+++.||+|++... ....+.+..|..++..+ +||+|+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457899999999999999999999999999999998753 23345678888888877 6899999999999999999
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc-cc
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LH 172 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~-~~ 172 (240)
+||||+++++|.+++...+.+++..++.++.||+.||+|||+.||+||||+|+||+++.++. ++|+|||++.... ..
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCC
Confidence 99999999999999988888999999999999999999999999999999999999987776 9999999987432 23
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
.......+++.|+|||++.+..++.. +|+||||+++|+|++|..||.+.+..+.++++++..
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 558 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC
T ss_pred cccccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC
Confidence 33445678999999999987777555 999999999999999999999998888888877643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=283.72 Aligned_cols=209 Identities=27% Similarity=0.414 Sum_probs=175.2
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC---ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC------C
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 90 (240)
.++|++++.||+|+||.||++++..+++.||+|++... ......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999999999999999998753 22335678999999999999999999999754 4
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
..++||||++++ +.+.+. ..+++..+..++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++....
T Consensus 141 ~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 215 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC----
T ss_pred eEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecC
Confidence 579999999874 555553 34899999999999999999999999999999999999987776 9999999997665
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.........+++.|+|||.+.+..++.. +||||||+++++|++|..||.+.+..+.+.++++.
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~ 278 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCcccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 5545556678999999999988776555 99999999999999999999999988888877654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=274.61 Aligned_cols=210 Identities=25% Similarity=0.466 Sum_probs=178.7
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEc----------
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT---------- 88 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------- 88 (240)
..++|++.+.||+|+||.||+|++..+++.||+|++..+... ..+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 457999999999999999999999999999999998765432 3479999999999999999999843
Q ss_pred ----------------------------CCeEEEEEecCCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 026299 89 ----------------------------PTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSM 136 (240)
Q Consensus 89 ----------------------------~~~~~lv~~~~~~~~l~~~l~----~~~~l~~~~~~~~~~~i~~~l~~LH~~ 136 (240)
....++||||+++ +|.+.+. ....+++..++.++.|++.||.|||+.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3348899999986 6666553 456799999999999999999999999
Q ss_pred CceeecCCCCCeEEcC-CCCCcEEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhC
Q 026299 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215 (240)
Q Consensus 137 ~ivh~~i~~~nili~~-~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g 215 (240)
||+|+||+|+||+++. ++ .++|+|||.+.............++..|+|||.+.+....+.++||||||+++++|++|
T Consensus 161 gi~H~Dikp~Nil~~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 238 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDN--TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238 (383)
T ss_dssp TEECSCCCGGGEEEETTTT--EEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred cCccCccCHHHEEEcCCCC--cEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence 9999999999999973 44 49999999997666566666677899999999988776556669999999999999999
Q ss_pred CCCCCCCCchhhhhhhhce
Q 026299 216 AYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 216 ~~pf~~~~~~~~~~~~~~~ 234 (240)
..||.+.+..+.+.++++.
T Consensus 239 ~~pf~~~~~~~~~~~i~~~ 257 (383)
T 3eb0_A 239 KPLFSGETSIDQLVRIIQI 257 (383)
T ss_dssp SCSSCCSSHHHHHHHHHHH
T ss_pred CCCCCCCChHHHHHHHHHH
Confidence 9999999888888877653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=272.31 Aligned_cols=215 Identities=32% Similarity=0.439 Sum_probs=177.7
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
...++|++++.||+|++|.||++++..+++.|++|++...... .+.+.+|+.+++.++||||+++++++.++...++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3447999999999999999999999999999999998654322 2456799999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC---CCcEEEecCCccccccc
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKSSVL 171 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~---~~~~~L~d~~~~~~~~~ 171 (240)
||||+++ +|.+++.....+++..++.++.|++.||+|||+.||+|+||+|+||+++.++ ...++|+|||.+.....
T Consensus 111 v~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 9999986 9999998888899999999999999999999999999999999999995322 23499999999865432
Q ss_pred c-CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 172 H-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 172 ~-~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
. .......++..|+|||.+.+....+.++||||||+++++|++|..||...+..+.+.++++
T Consensus 190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 252 (329)
T 3gbz_A 190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFE 252 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHH
Confidence 2 2223445688999999998766556669999999999999999999999888777776654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=270.91 Aligned_cols=217 Identities=27% Similarity=0.414 Sum_probs=180.9
Q ss_pred CcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC-
Q 026299 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP- 89 (240)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 89 (240)
.+.....++|++++.||+|++|.||++++..+++.|++|++.... .....+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 10 CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp CTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred ccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 344556689999999999999999999999999999999886543 2235678999999999999999999999873
Q ss_pred -------CeEEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEe
Q 026299 90 -------THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (240)
Q Consensus 90 -------~~~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~ 161 (240)
+..++||||+++ ++.+.+.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~ 166 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLA 166 (351)
T ss_dssp -------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEEC
T ss_pred cccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEc
Confidence 468999999987 66666654 357999999999999999999999999999999999999987765 9999
Q ss_pred cCCcccccccc-----CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 162 DFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 162 d~~~~~~~~~~-----~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
|||.+...... .......+++.|+|||.+.+....+.++||||||+++++|++|..||...+....+..+.+
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99998644321 2223445788999999998766556669999999999999999999998877766655543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=267.67 Aligned_cols=211 Identities=31% Similarity=0.479 Sum_probs=171.3
Q ss_pred cccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc---HHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
.+.....+|++.+.||+|++|.||++++ ++..|++|++....... +.+.+|+..+++++||||+++++++.+...
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 3344568999999999999999999987 57889999987654322 467899999999999999999999999999
Q ss_pred EEEEEecCCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhCC--ceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 92 LAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~---l~~~~~~~~~~~i~~~l~~LH~~~--ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
.++||||+++++|.+++..... +++..++.++.|++.||+|||+.| ++|+||+|+||+++.++. ++|+|||.+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a 186 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLS 186 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC--
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCC
Confidence 9999999999999999976543 899999999999999999999999 999999999999987765 999999998
Q ss_pred cccccc-CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhh
Q 026299 167 KSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (240)
Q Consensus 167 ~~~~~~-~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (240)
...... .......+++.|+|||.+.+...+.+ +||||||+++|+|++|..||...+.......
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~~ 250 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAA 250 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 643332 22334568899999999988777555 9999999999999999999988766555443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=262.69 Aligned_cols=210 Identities=33% Similarity=0.610 Sum_probs=180.2
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++.+.||+|++|.||++.+..++..|++|++.... .....+.+|+..++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4589999999999999999999999999999999986532 223568899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
||||+++++|.+++.....+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+..... ..
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~-~~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SR 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC-----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCc-cc
Confidence 9999999999999988888999999999999999999999999999999999999987766 99999998753322 22
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
.....++..|+|||.+.+...+.. +|+||||+++++|++|..||...+......++.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 220 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred ccccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 334567889999999987766555 999999999999999999998877666555443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=261.93 Aligned_cols=212 Identities=27% Similarity=0.434 Sum_probs=181.5
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
....++|++.+.||+|++|.||++++. ++..|++|++.......+.+.+|+..++.++||||+++++++.++...++||
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 346689999999999999999999887 5677999999887766778999999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC--
Q 026299 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-- 173 (240)
|++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhh
Confidence 9999999999987654 5999999999999999999999999999999999999987765 9999999986443221
Q ss_pred CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
......++..|+|||.+.+...+.+ +|+||||+++++|++ |..||...+......++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 219 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cccCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH
Confidence 1122334567999999987776555 999999999999998 999998777665554443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=286.89 Aligned_cols=204 Identities=28% Similarity=0.432 Sum_probs=179.4
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
...++|++.+.||+|+||.||++++..+|+.||+|++... ......+.+|+.+++.++||||+++++++.+.+.++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 3457899999999999999999999999999999998653 223356789999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
+||||++|++|.+++...+ .+++..++.++.||+.||+|||+.||+|+||+|+||+++.++. ++|+|||++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~ 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPE 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceeccc
Confidence 9999999999999887654 4999999999999999999999999999999999999987765 99999999875544
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
........+++.|+|||++.+..++.. +|+||||+++|+|++|..||...+.
T Consensus 339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 339 GQTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp TCCEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred CccccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCccccc
Confidence 443345578999999999987766554 9999999999999999999987654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=282.40 Aligned_cols=212 Identities=37% Similarity=0.597 Sum_probs=182.5
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++++.||+|+||.||++++..++..|++|++.... .....+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 47999999999999999999999999999999987642 334678899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCCccccccccCCCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
|+++++|.+.+....++++..++.++.|++.||.|||+.||+|+||+|+||+++... ...++|+|||++..........
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~ 196 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBC
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcccc
Confidence 999999999998888899999999999999999999999999999999999997533 3459999999987665555556
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
...+++.|+|||.+.+ .+ +.++||||||+++|+|++|..||.+.+....+.++...
T Consensus 197 ~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 252 (494)
T 3lij_A 197 ERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG 252 (494)
T ss_dssp CCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 6678999999998853 44 44599999999999999999999988877776666544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=263.18 Aligned_cols=215 Identities=22% Similarity=0.404 Sum_probs=181.7
Q ss_pred cccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
......++|++++.||+|++|.||++.+. ++..|++|++.......+.+.+|+..++.++||||+++++++.++...++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 34456789999999999999999999887 67789999998877667889999999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-
Q 026299 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~- 172 (240)
||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEccccccccccccc
Confidence 9999999999999976 457999999999999999999999999999999999999987765 999999998644322
Q ss_pred -CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 173 -~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
.......++..|+|||.+.+...+. ++|+||||+++++|++ |..||...+......++..
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~ 236 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSS-KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred cccccCCccCcccCCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc
Confidence 2223334567899999998776644 4999999999999998 9999988777666555543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=271.92 Aligned_cols=201 Identities=32% Similarity=0.571 Sum_probs=173.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc------cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
++|++.+.||+|+||.||++.+..+++.|++|++.... ...+.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 68999999999999999999999999999999986421 134678899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCCccccc
Q 026299 95 VMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 169 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~----~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~~~ 169 (240)
||||+++++|.+.+... ..+++..++.++.|++.||+|||+.||+|+||+|+||+++.++ ...++|+|||.+...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999998877542 3589999999999999999999999999999999999997543 235999999998654
Q ss_pred cccCC-CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 170 VLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 170 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
..... .....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.+.
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCc
Confidence 43322 334568999999999987776555 99999999999999999999774
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=269.87 Aligned_cols=214 Identities=28% Similarity=0.457 Sum_probs=181.3
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
...++|++.+.||+|++|.||++++..++..|++|++...... .+.+.+|+..++.++||||+++++++.++...++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 3558999999999999999999999999999999998664332 2456789999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-C
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 173 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~ 173 (240)
||||+++++|.++......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...... .
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC--------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCCcc
Confidence 9999999999888777778999999999999999999999999999999999999987765 999999998644332 2
Q ss_pred CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
......++..|+|||.+.+....+.++||||||+++++|++|..||...+..+.+.+++.
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 239 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 233456788999999998765555669999999999999999999999888777666553
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=270.49 Aligned_cols=210 Identities=25% Similarity=0.456 Sum_probs=181.5
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC-----CCCeeeeeEEEEcCCeEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~l 94 (240)
.++|++++.||+|++|.||++++..++..||+|++.........+..|..+++.++ ||||+++++++...+..++
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 47999999999999999999999999999999998765555567788999999886 9999999999999999999
Q ss_pred EEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC-------------------
Q 026299 95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS------------------- 153 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~------------------- 153 (240)
|||++ +++|.+++.... .++...++.++.||+.||+|||+.||+|+||+|+||+++.+
T Consensus 114 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 114 IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp EECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence 99999 889999987654 58999999999999999999999999999999999999751
Q ss_pred ----CCCcEEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 026299 154 ----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (240)
Q Consensus 154 ----~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (240)
....++|+|||.+.... .......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+..+.+.
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~ 269 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269 (360)
T ss_dssp EEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCcHHHHHH
Confidence 23459999999986432 23345568899999999988877655 999999999999999999999887766655
Q ss_pred hhhc
Q 026299 230 KTIH 233 (240)
Q Consensus 230 ~~~~ 233 (240)
.+..
T Consensus 270 ~~~~ 273 (360)
T 3llt_A 270 MMES 273 (360)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=287.07 Aligned_cols=212 Identities=39% Similarity=0.602 Sum_probs=184.5
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||+|++|.||++++..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++|+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 68999999999999999999999999999999986542 23467889999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC-CCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~-~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
|++.+++|.+.+.....+++..++.++.|++.||.|||+.||+|+||+|+||+++.. ..+.++|+|||++.........
T Consensus 106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 185 (484)
T 3nyv_A 106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185 (484)
T ss_dssp CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSH
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccccc
Confidence 999999999999888889999999999999999999999999999999999999532 2345999999998755444433
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
....+++.|+|||.+.+ .+ +.++||||||+++|+|++|..||.+.+..+.+.++...
T Consensus 186 ~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 242 (484)
T 3nyv_A 186 KDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG 242 (484)
T ss_dssp HHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 44568899999999866 34 44599999999999999999999998877776666543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=264.61 Aligned_cols=210 Identities=33% Similarity=0.556 Sum_probs=174.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
..++|++.+.||+|++|.||++++..++..+++|.+..... ..+.+.+|+..++.++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 44899999999999999999999999999999999876532 2367889999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC-CCCcEEEecCCccccccc
Q 026299 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 97 ~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~-~~~~~~L~d~~~~~~~~~ 171 (240)
|++++++|.+.+.. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.+ ..+.++|+|||.+.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 99999999988854 3679999999999999999999999999999999999999542 234599999999976555
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhh
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (240)
........+++.|+|||.+.+ .. +.++|+||||+++++|++|..||...+......+
T Consensus 180 ~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~ 236 (285)
T 3is5_A 180 DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236 (285)
T ss_dssp -------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh
Confidence 555556678999999998753 34 4559999999999999999999987765554433
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=275.57 Aligned_cols=202 Identities=19% Similarity=0.222 Sum_probs=168.7
Q ss_pred CCCCCeeEeeeecCCCceeEEEE-----EecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC---CCCeeeeeEEEEcC
Q 026299 18 HDSDRYELVRDIGSGNFGVARLM-----RDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTP 89 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~ 89 (240)
...++|++.+.||+|+||.||+| .+..++..||+|++.... ...+.+|...+..++ |+||+++++++..+
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34578999999999999999999 466789999999986543 356778888888886 89999999999999
Q ss_pred CeEEEEEecCCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC---------CCC
Q 026299 90 THLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---------SPA 155 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~---------~~~ 155 (240)
+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.||+||||+|+||+++. +..
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999999973 456999999999999999999999999999999999999976 113
Q ss_pred CcEEEecCCccccccc---cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 156 PRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 156 ~~~~L~d~~~~~~~~~---~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
+.++|+|||++..... ........++..|+|||.+.+..++.+ +||||||+++|+|++|..||...
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEEE
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCccccC
Confidence 3499999999964332 222344568999999999988876555 99999999999999999998543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=270.20 Aligned_cols=218 Identities=29% Similarity=0.437 Sum_probs=183.4
Q ss_pred CCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC
Q 026299 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (240)
Q Consensus 12 ~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (240)
..-......++|++++.||+|++|.||++++..++..|++|++..... ....+.+|+.+++.++||||+++++++...
T Consensus 18 ~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 97 (364)
T 3qyz_A 18 VRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP 97 (364)
T ss_dssp CC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred EccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence 333444456799999999999999999999999999999999875432 225688999999999999999999999765
Q ss_pred -----CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 90 -----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 90 -----~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
...++|+|++++ +|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 98 ~~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg 173 (364)
T 3qyz_A 98 TIEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFG 173 (364)
T ss_dssp STTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCT
T ss_pred CccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCc
Confidence 368999999976 88888754 56899999999999999999999999999999999999987766 9999999
Q ss_pred ccccccccCC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 165 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 165 ~~~~~~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.+........ .....+++.|+|||.+.+....+.++||||||+++++|++|..||.+.+..+.+.+++.
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 246 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH
Confidence 9875443322 23446889999999887666555669999999999999999999999988888777654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=261.13 Aligned_cols=210 Identities=33% Similarity=0.647 Sum_probs=183.3
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++.+.||+|++|.||++++..++..|++|.+.... .....+.+|+..++.++||||+++++++.+++..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 4489999999999999999999999999999999986532 223568899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
|||++++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..... ..
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~~ 168 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-LR 168 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-SC
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-cc
Confidence 9999999999999988888999999999999999999999999999999999999987765 99999998754332 22
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
.....++..|+|||.+.+...+.. +|+||||+++++|++|..||...+......++.
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 225 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh
Confidence 334568899999999987777555 999999999999999999998877666555444
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=271.25 Aligned_cols=210 Identities=27% Similarity=0.466 Sum_probs=173.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
++|++++.||+|++|.||++++..++..|++|.+...... ...+.+|+..++.++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 6899999999999999999999999999999998654322 22456799999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCC
Q 026299 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (240)
Q Consensus 99 ~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~ 176 (240)
+++ +|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+...... ....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC--------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccccc
Confidence 986 888877654 45899999999999999999999999999999999999987765 999999998644322 2223
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
...++..|+|||.+.+....+.++||||||+++++|++|..||.+.+..+....+.+
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 215 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 346788999999998765556669999999999999999999999887777666654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=262.41 Aligned_cols=211 Identities=34% Similarity=0.521 Sum_probs=183.2
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
...++|++.+.||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+..++.++||||+++++++.+++..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34579999999999999999999999999999999987643 22356788999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~- 172 (240)
++||++++++|.+++.....+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCc
Confidence 99999999999999988888999999999999999999999999999999999999987765 999999998654422
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
.......++..|+|||.+.+...+.. +|+||||+++++|++|..||......+.+.++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 227 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 227 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 22334567889999999987766555 99999999999999999999887665554444
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=262.21 Aligned_cols=212 Identities=32% Similarity=0.487 Sum_probs=182.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----------cccHHHHHHHHHHHhcC-CCCeeeeeEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----------KIDENVQREIINHRSLR-HPNIVRFKEVIL 87 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----------~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 87 (240)
-.++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..+++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3589999999999999999999999999999999987643 11245778999999996 999999999999
Q ss_pred cCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
.+...++|||++++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~ 172 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSC 172 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCE
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchh
Confidence 99999999999999999999988888999999999999999999999999999999999999987766 9999999987
Q ss_pred cccccCCCCCCcCCccccCcccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 168 SSVLHSQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~pE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
............++..|+|||.+.+ ....+.++|+||||+++++|++|..||...+.......+.
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 242 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence 6555444555678899999998852 2223445999999999999999999998876655554443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=270.10 Aligned_cols=215 Identities=24% Similarity=0.362 Sum_probs=178.3
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCc---EEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (240)
.....++|++.+.||+|+||.||++++..++. .|++|.+.... ...+.+.+|+.+++.++||||+++++++.+++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34456899999999999999999999985544 59999987643 22356889999999999999999999999999
Q ss_pred eEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
..++||||+++++|.+++... ..++...++.++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||.+...
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~ 201 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVL 201 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEEC
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCccccc
Confidence 999999999999999999654 57999999999999999999999999999999999999987765 999999998654
Q ss_pred cccCCC----CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 170 VLHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 170 ~~~~~~----~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
...... ....++..|+|||.+.+...+.+ +||||||+++++|++ |..||.+.+..+....+..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 269 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 332211 12234567999999977766554 999999999999999 9999988777666555443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=267.84 Aligned_cols=204 Identities=26% Similarity=0.287 Sum_probs=175.3
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
..++|++.+.||+|+||.||++++..+++.||+|++.... ..+.+.+|+.+++.+ +||||+++++++..+...++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 3479999999999999999999999999999999886543 345688999999999 89999999999999999999999
Q ss_pred cCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCC---CcEEEecCCccccccccC
Q 026299 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 98 ~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~---~~~~L~d~~~~~~~~~~~ 173 (240)
++ +++|.+++.. ...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++. ..++|+|||.+.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99 8899999876 467999999999999999999999999999999999999975543 129999999987543322
Q ss_pred C--------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 174 Q--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 174 ~--------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
. .....+++.|+|||.+.+...+. ++||||||+++++|++|..||.+.+..
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~g~~Pf~~~~~~ 223 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSR-RDDLEALGHMFMYFLRGSLPWQGLKAD 223 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCc-hhHHHHHHHHHHHHhcCCCCccccccc
Confidence 2 23456889999999998877644 499999999999999999999886443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=267.18 Aligned_cols=210 Identities=34% Similarity=0.523 Sum_probs=182.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++.+.||+|+||.||++++..+++.|++|.+.... ...+.+.+|+..++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3478999999999999999999999999999999987643 233567899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-C
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 173 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~ 173 (240)
||||+++++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+...... .
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGE 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTC
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCcc
Confidence 9999999999999988888999999999999999999999999999999999999987765 999999998754422 2
Q ss_pred CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
......++..|+|||.+.+...+.. +|+||||+++++|++|..||......+.+.++
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 253 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cccccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 2334567889999999987776555 99999999999999999999887665554443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=282.71 Aligned_cols=203 Identities=33% Similarity=0.446 Sum_probs=177.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|..+++.++||||+++++++.+...+++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 4478999999999999999999999999999999987532 223567899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 95 VMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~----~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
||||++|++|.+++... ..+++..++.++.||+.||+|||+.||+|+||+|+||+++.++. ++|+|||++....
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~ 340 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELK 340 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeecc
Confidence 99999999999988653 36999999999999999999999999999999999999987766 9999999987554
Q ss_pred ccCC-CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 171 LHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 171 ~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.... .....+++.|+|||.+.+..++.. +|+||||+++|+|++|..||.....
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~ 394 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGE 394 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTC
T ss_pred CCCcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCcc
Confidence 3332 233478999999999988766555 9999999999999999999987643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=261.61 Aligned_cols=209 Identities=31% Similarity=0.527 Sum_probs=159.7
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++.+.||+|++|.||++++..++..|++|.+.... ...+.+.+|+..++.++||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 4478999999999999999999999899999999986532 223568899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-
Q 026299 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~- 172 (240)
|+|++++++|.+++... .++++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPH 166 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCC
Confidence 99999999999998765 57999999999999999999999999999999999999987765 999999998654322
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhh
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (240)
.......+++.|+|||.+.+...+.. +|+||||+++++|++|..||...+....+.+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 223 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK 223 (278)
T ss_dssp -------------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC-----
T ss_pred CcceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHHHHH
Confidence 22233457889999999887766555 9999999999999999999987665544443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=269.93 Aligned_cols=211 Identities=25% Similarity=0.389 Sum_probs=176.7
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEec-------CCCcEEEEEEeecCcc--ccHHHHHHHHHHHhc-CCCCeeeeeEEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (240)
...++|++.+.||+|+||.||+|++. .++..|++|.+..... ..+.+.+|+.+++.+ +||||+++++++.
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 34579999999999999999999874 3456799999876532 234688999999999 8999999999999
Q ss_pred cCCeEEEEEecCCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEc
Q 026299 88 TPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (240)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~ 151 (240)
+++.+++||||+++++|.+++.... .++...++.++.|++.||+|||+.||+|+||+|+||+++
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 9999999999999999999997643 478999999999999999999999999999999999998
Q ss_pred CCCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026299 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (240)
Q Consensus 152 ~~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (240)
.++. ++|+|||++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.+.+....
T Consensus 238 ~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 238 ENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp TTCC--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CCCC--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 7766 99999999864433221 222345678999999987766544 999999999999999 9999988776655
Q ss_pred hhhh
Q 026299 228 FRKT 231 (240)
Q Consensus 228 ~~~~ 231 (240)
+..+
T Consensus 315 ~~~~ 318 (370)
T 2psq_A 315 FKLL 318 (370)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=268.83 Aligned_cols=211 Identities=31% Similarity=0.513 Sum_probs=182.0
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---------cHHHHHHHHHHHhc-CCCCeeeeeEEEEcCC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------DENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 90 (240)
++|++.+.||.|++|.||+|++..+|+.|+||++...... .+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 4799999999999999999999989999999998765321 24567899999998 7999999999999999
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
..++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccC
Confidence 99999999999999999988888999999999999999999999999999999999999987765 9999999987655
Q ss_pred ccCCCCCCcCCccccCccccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.........+++.|+|||.+.+. ...+.++||||||+++|+|++|..||...+....+..+..
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~ 319 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 55445556789999999988643 1234459999999999999999999988766655554443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=263.40 Aligned_cols=206 Identities=28% Similarity=0.483 Sum_probs=178.2
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc-cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCC
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (240)
.|+..+.||+|++|.||+|++..+|..||+|++...... .+.+.+|+..++.++||||+++++++..++..++||||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 488889999999999999999999999999998765433 3568899999999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCCCCc
Q 026299 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 179 (240)
Q Consensus 101 ~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~~~~ 179 (240)
+++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+....... ......
T Consensus 126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcccccccc
Confidence 9999998754 56899999999999999999999999999999999999987765 9999999986543322 234456
Q ss_pred CCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 180 ~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
+++.|+|||.+.+...+.+ +|+||||+++++|++|..||...+....+.++
T Consensus 203 gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~ 253 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 253 (321)
T ss_dssp SCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 8899999999987776555 99999999999999999999877655544433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=267.47 Aligned_cols=223 Identities=25% Similarity=0.336 Sum_probs=181.9
Q ss_pred CCCCCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEE--EEEEeecC--ccccHHHHHHHHHHHhc-CCCCeeee
Q 026299 8 VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELV--AVKYIERG--DKIDENVQREIINHRSL-RHPNIVRF 82 (240)
Q Consensus 8 ~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v--~iK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~ 82 (240)
.++....-.....++|++.+.||+|++|.||++++..++..+ ++|.+... ....+.+.+|+..++++ +||||+++
T Consensus 12 ~~~~~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 91 (327)
T 1fvr_A 12 NNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91 (327)
T ss_dssp ----CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCE
T ss_pred CCCCCcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhh
Confidence 344444444456799999999999999999999999888765 89988653 23345688999999999 89999999
Q ss_pred eEEEEcCCeEEEEEecCCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCC
Q 026299 83 KEVILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146 (240)
Q Consensus 83 ~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~ 146 (240)
++++.+.+..++|||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~ 171 (327)
T 1fvr_A 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 171 (327)
T ss_dssp EEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccc
Confidence 999999999999999999999999987653 6899999999999999999999999999999999
Q ss_pred CeEEcCCCCCcEEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCch
Q 026299 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (240)
Q Consensus 147 nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (240)
||+++.++. ++|+|||.+.............++..|+|||.+.+...+. ++|+||||+++++|++ |..||.+.+..
T Consensus 172 NIl~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 172 NILVGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp GEEECGGGC--EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred eEEEcCCCe--EEEcccCcCccccccccccCCCCCccccChhhhccccCCc-hhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence 999987665 9999999987544444444455678899999987766654 4999999999999998 99999887766
Q ss_pred hhhhhhhc
Q 026299 226 KNFRKTIH 233 (240)
Q Consensus 226 ~~~~~~~~ 233 (240)
....++..
T Consensus 249 ~~~~~~~~ 256 (327)
T 1fvr_A 249 ELYEKLPQ 256 (327)
T ss_dssp HHHHHGGG
T ss_pred HHHHHhhc
Confidence 65555443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=263.98 Aligned_cols=212 Identities=36% Similarity=0.608 Sum_probs=179.0
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
.++|++.+.||+|++|.||++++..+++.|++|.+..... ..+.+.+|+..++.++||||+++++++.++...++|||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 3689999999999999999999999999999999876533 335688999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC-CCCCcEEEecCCccccccccCCCCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKS 177 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~-~~~~~~~L~d~~~~~~~~~~~~~~~ 177 (240)
+++++|.+++...+.+++..++.++.|++.||++||+.|++|+||+|+||++.. +..+.++|+|||.+...... ....
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~ 166 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMST 166 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHH
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-cccc
Confidence 999999999988888999999999999999999999999999999999999932 22334999999987543221 2223
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
..+++.|+|||.+.+...+. ++|+||||+++++|++|..||...+....+.++.+
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 221 (304)
T 2jam_A 167 ACGTPGYVAPEVLAQKPYSK-AVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221 (304)
T ss_dssp HHSCCCBCCTTTBSSCSCCH-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred ccCCCCccChHHhccCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 35788999999998776644 49999999999999999999988776666555544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=270.64 Aligned_cols=209 Identities=28% Similarity=0.432 Sum_probs=171.0
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC------
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 90 (240)
.++|++++.||+|++|.||++.+..++..||+|++..... ....+.+|+..++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3799999999999999999999999999999999876422 2346789999999999999999999997654
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
..++|||++++ +|.+.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 178 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC-----
T ss_pred ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccc
Confidence 78999999976 6777774 45899999999999999999999999999999999999987765 9999999987554
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.........++..|+|||.+.+..++.+ +||||||+++++|++|..||.+.+..+.+.++++.
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 241 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 241 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-
T ss_pred cccccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 4444445678899999999988776555 99999999999999999999998888877777654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=259.75 Aligned_cols=202 Identities=38% Similarity=0.677 Sum_probs=177.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
++|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++++++.+++..++|+|+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 68999999999999999999999999999999987543 2336788999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc---CCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP 175 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~---~~~ 175 (240)
+++++|.+++.....+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+...... ...
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCB
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhcc
Confidence 999999999977778999999999999999999999999999999999999987665 999999998644322 222
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
....++..|+|||.+.+....+.++|+||||+++++|++|..||.....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 3456788999999998777656669999999999999999999987654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=274.88 Aligned_cols=206 Identities=30% Similarity=0.405 Sum_probs=171.3
Q ss_pred CCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 026299 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVIL 87 (240)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 87 (240)
+..+......++|++.+.||+|++|.||+|++..+++.||+|++.... .....+.+|+.+++.++||||+++++++.
T Consensus 16 ~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp TTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred hcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 334444555689999999999999999999999999999999987532 22356889999999999999999999998
Q ss_pred cC-----CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEec
Q 026299 88 TP-----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (240)
Q Consensus 88 ~~-----~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d 162 (240)
.. ...++|||++++ +|.+++.....+++..++.++.||+.||.|||+.||+||||+|+||+++.++. ++|+|
T Consensus 96 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~D 172 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCD 172 (432)
T ss_dssp CSCTTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECC
T ss_pred cCCCCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEcc
Confidence 76 568999999875 99999988888999999999999999999999999999999999999987766 99999
Q ss_pred CCccccccccCC-----------------------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 026299 163 FGYSKSSVLHSQ-----------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219 (240)
Q Consensus 163 ~~~~~~~~~~~~-----------------------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 219 (240)
||++........ .....++..|+|||.+......+.++|||||||++++|++|..||
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 999875433221 234567899999998765555566699999999999999854443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=279.27 Aligned_cols=209 Identities=25% Similarity=0.377 Sum_probs=175.4
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC--eEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT--HLA 93 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 93 (240)
...++|++.+.||+|++|.||+|++..++..||+|++..... ..+.+.+|+..++.++||||+++++++.... ..+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 345899999999999999999999999999999999876432 2356789999999999999999999998764 789
Q ss_pred EEEecCCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEc--CCCCCcEEEecCCcccc
Q 026299 94 IVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKS 168 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~---~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~--~~~~~~~~L~d~~~~~~ 168 (240)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+.||+|+||+|+||++. .+....++|+|||.+..
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999999986543 389999999999999999999999999999999999982 22333499999999976
Q ss_pred ccccCCCCCCcCCccccCccccccC-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 169 SVLHSQPKSTVGTPAYIAPEVLLKK-------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~pE~~~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
...........++..|+|||.+.+. ...+.++||||||+++|+|++|..||.......
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~ 230 (396)
T 4eut_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (396)
T ss_dssp CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT
T ss_pred ccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc
Confidence 6555555556789999999998652 222344999999999999999999997654433
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=269.98 Aligned_cols=209 Identities=26% Similarity=0.432 Sum_probs=173.9
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC-----
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 90 (240)
..++|++.+.||+|++|.||++.+..+|..||+|++..... ....+.+|+..++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 34789999999999999999999999999999999865322 2356789999999999999999999998653
Q ss_pred -eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 91 -~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
.+++|||++ +++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeeccccc
Confidence 469999999 7799988865 67899999999999999999999999999999999999987766 999999998754
Q ss_pred cccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 170 ~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.. ......++..|+|||.+.+....+.++|+|||||++++|++|..||.+.+..+.+.++++
T Consensus 179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 240 (367)
T 1cm8_A 179 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240 (367)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 32 234456789999999988754445569999999999999999999999888887777665
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=270.64 Aligned_cols=198 Identities=36% Similarity=0.574 Sum_probs=171.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
++|++.+.||+|+||.||++.+..++..||+|.+..... ...+|+..+.++ +||||+++++++.++...++||||+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 689999999999999999999999999999999876543 345688888777 7999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCC--CcEEEecCCcccccccc-CCCC
Q 026299 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLH-SQPK 176 (240)
Q Consensus 100 ~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~--~~~~L~d~~~~~~~~~~-~~~~ 176 (240)
+|++|.+.+...+.+++..+..++.|++.||+|||+.||+|+||+|+||++..+.. ..++|+|||++...... ....
T Consensus 99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 178 (342)
T 2qr7_A 99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178 (342)
T ss_dssp CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCcee
Confidence 99999999988888999999999999999999999999999999999999854322 34999999998754332 2233
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
...+++.|+|||.+.+..++. ++|+||||+++|+|++|..||...
T Consensus 179 ~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 179 TPCYTANFVAPEVLERQGYDA-ACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp CSSCCSSCCCHHHHHHHHHHH-HHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ccCCCccccCHHHhcCCCCCC-ccCeeeHhHHHHHHhcCCCCCCCC
Confidence 456789999999987766544 499999999999999999999763
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=270.76 Aligned_cols=214 Identities=32% Similarity=0.543 Sum_probs=177.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC------ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
++|++.+.||+|++|.||++.+..++..|++|++... ....+.+.+|+..++.++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 7899999999999999999999999999999998653 2334678899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHh
Q 026299 95 VMEYASGGELFERICN----------------------------------------AGRFSEDEARFFFQQLISGVSYCH 134 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~----------------------------------------~~~l~~~~~~~~~~~i~~~l~~LH 134 (240)
||||+++++|.+++.. ...+++..++.++.|++.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998742 112357788999999999999999
Q ss_pred hCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-----CCCCCcCCccccCccccccC-CCCCcccchHHHHHH
Q 026299 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVT 208 (240)
Q Consensus 135 ~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-----~~~~~~~~~~~~~pE~~~~~-~~~~~~~Di~slG~~ 208 (240)
+.|++|+||+|+||+++.++...++|+|||.+....... ......+++.|+|||.+.+. ...+.++||||||++
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 999999999999999987765569999999986443221 12345688999999998653 333455999999999
Q ss_pred HHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 209 LYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 209 l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
+++|++|..||...+..+.+.+++..
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~ 291 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNK 291 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhc
Confidence 99999999999988877776666543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=275.80 Aligned_cols=205 Identities=35% Similarity=0.572 Sum_probs=167.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---------cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
++|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.++++++||||+++++++.. ..
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 68999999999999999999999999999999987532 111347899999999999999999999754 55
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCCcccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV 170 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~~~~ 170 (240)
.++||||+++++|.+++.....+++..++.++.|++.||+|||+.||+|+||+|+||+++.++ ...++|+|||.+....
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~ 293 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence 789999999999999998888899999999999999999999999999999999999996533 2359999999997655
Q ss_pred ccCCCCCCcCCccccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
.........+++.|+|||.+.+ ....+.++|+||||+++|+|++|..||.......
T Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 351 (419)
T 3i6u_A 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351 (419)
T ss_dssp -----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence 4444455678999999999864 2333455999999999999999999998765443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=269.47 Aligned_cols=214 Identities=28% Similarity=0.454 Sum_probs=173.2
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC-------
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------- 90 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 90 (240)
...++|++.+.||+|+||.||++++..++..||+|++..+........+++..++.++||||+++++++....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 3447999999999999999999999999999999999877666677888899999999999999999986533
Q ss_pred eEEEEEecCCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHh--hCCceeecCCCCCeEEcC-CCCCcEEEecC
Q 026299 91 HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDG-SPAPRLKICDF 163 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l----~~~~~l~~~~~~~~~~~i~~~l~~LH--~~~ivh~~i~~~nili~~-~~~~~~~L~d~ 163 (240)
..++||||++++ +.+.+ .....+++..++.++.|++.||.||| +.||+|+||+|+||+++. ++ .++|+||
T Consensus 100 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--~~kl~Df 176 (360)
T 3e3p_A 100 YLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG--TLKLCDF 176 (360)
T ss_dssp EEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT--EEEECCC
T ss_pred eEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC--cEEEeeC
Confidence 378999999874 43333 34567899999999999999999999 999999999999999975 44 4999999
Q ss_pred CccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
|.+.............++..|+|||.+.+....+.++||||||+++++|++|..||...+....+.++++.
T Consensus 177 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 177 GSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp TTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 99986665555566678999999999977765566699999999999999999999998888887777653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=262.23 Aligned_cols=206 Identities=25% Similarity=0.348 Sum_probs=169.4
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
....++|++.+.||+|++|.||++++..++..|++|++...... .+.+.+|+..++.++||||+++++++..++..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 33458999999999999999999999999999999998764332 25678999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
++++|++++++|.+++....++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC-------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCcccccc
Confidence 999999999999999988888999999999999999999999999999999999999987765 999999998644332
Q ss_pred C--CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 173 S--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 173 ~--~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
. ......++..|+|||.+.+...+.+ +|+||||+++++|++|..||...+..
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~ 241 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLS 241 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHH
Confidence 2 2223457889999999987766555 99999999999999999999876543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=270.56 Aligned_cols=215 Identities=27% Similarity=0.427 Sum_probs=176.8
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc------ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (240)
+....++|++.+.||+|++|.||++++..++..|++|.+..... ....+.+|+..++.++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 33456899999999999999999999999999999999875321 134678999999999999999999999999
Q ss_pred CeEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 90 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
...++||||+++ +|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+..
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~ 161 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKS 161 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGST
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEeccccee
Confidence 999999999987 788777654 46899999999999999999999999999999999999987765 99999999875
Q ss_pred cccc-CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 169 SVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 169 ~~~~-~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.... .......+++.|+|||.+.+....+.++||||||+++++|++|..||.+.+..+.+.++++
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~ 227 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 227 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 4332 2233456789999999997766556669999999999999999999999888777777654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=258.61 Aligned_cols=213 Identities=26% Similarity=0.430 Sum_probs=182.7
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
+..++++|++.+.||+|++|.||++.+. ++..|++|.+.......+.+.+|+..++.++||||+++++++.+++..+++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 3456789999999999999999999997 677899999988766667899999999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc--
Q 026299 96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 172 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-- 172 (240)
||++++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEcccccccccccccc
Confidence 9999999999998764 46899999999999999999999999999999999999977665 999999998644321
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
.......++..|+|||.+.+...+. ++|+||||+++++|++ |..||...+......++.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~ 219 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred cccccccccccccChhhhcCCCccc-hhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh
Confidence 1223344567899999997776654 4999999999999999 899998877665555443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=261.81 Aligned_cols=212 Identities=23% Similarity=0.337 Sum_probs=182.5
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
....++|++.+.||+|++|.||++.+..++..|++|.+..+....+.+.+|+..++.++||||+++++++.++...++||
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34668999999999999999999999999999999999877666678999999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
|++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTY 166 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCCcc
Confidence 999999999999763 45899999999999999999999999999999999999977765 99999999864432221
Q ss_pred --CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 175 --PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 175 --~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
.....++..|+|||.+.+...+.+ +|+||||+++++|++ |..||...+.......+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~ 225 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred ccccCCccccCcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 122335668999999987776544 999999999999999 99999887665544433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=265.93 Aligned_cols=200 Identities=40% Similarity=0.657 Sum_probs=156.4
Q ss_pred CCeeEe---eeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELV---RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~---~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++. +.||+|+||.||++.+..++..|++|++... ......+|+..++.+. ||||+++++++.++...++||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 467776 7899999999999999999999999998654 3356789999999997 999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCCccccccccC-C
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHS-Q 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~~~~~~~-~ 174 (240)
||+++++|.+++...+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ ...++|+|||.+....... .
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999999999998888899999999999999999999999999999999999997654 2259999999986443322 2
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
.....++..|+|||.+.+..++.+ +||||||+++++|++|..||...+
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp ------------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC---
T ss_pred ccccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCc
Confidence 234457889999999977776544 999999999999999999998754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=272.90 Aligned_cols=208 Identities=30% Similarity=0.465 Sum_probs=175.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC------CeEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAI 94 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~l 94 (240)
.+|++.+.||+|+||.||++++..+++.||||++..+.. ...+|+.+++.++||||+++++++... .++++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 479999999999999999999999999999999876432 234799999999999999999988542 24679
Q ss_pred EEecCCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 95 VMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 95 v~~~~~~~~l~~~l~----~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
||||+++ ++.+.+. ....+++..++.++.||+.||.|||+.||+|+||+|+||+++.+.. .++|+|||++....
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLV 208 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECC
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhcc
Confidence 9999986 5555443 3467999999999999999999999999999999999999985532 38999999997665
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.........++..|+|||.+.+......++|||||||++|+|++|..||.+.+..+.+.++++
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 555555667899999999998765555669999999999999999999999888887777765
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=263.57 Aligned_cols=202 Identities=25% Similarity=0.459 Sum_probs=175.8
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC-CCCeeeeeEEEEc--CCeEE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHLA 93 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~ 93 (240)
..+.++|++.+.||+|++|.||++++..+++.|++|++.... .+.+.+|+.+++.++ ||||+++++++.+ ....+
T Consensus 32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 344588999999999999999999999999999999986533 467889999999997 9999999999987 56789
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
+|||++++++|.+++.. +++..++.++.|++.||+|||+.|++|+||+|+||+++.++. .++|+|||.+.......
T Consensus 110 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTC
T ss_pred EEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCC
Confidence 99999999999988743 799999999999999999999999999999999999986552 49999999997665555
Q ss_pred CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
......++..|+|||.+.+....+.++||||||+++++|++|..||.....
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 236 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 556667889999999998755556669999999999999999999955433
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=262.83 Aligned_cols=216 Identities=23% Similarity=0.355 Sum_probs=179.7
Q ss_pred CCcccCCCCCeeEeeeecCCCceeEEEEEec-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEE
Q 026299 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEV 85 (240)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~ 85 (240)
+-......++|++.+.||+|++|.||++.+. .++..|++|.+..... ..+.+.+|+..++.++||||++++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 3444556689999999999999999999984 4568899999876432 23567899999999999999999999
Q ss_pred EEcCCeEEEEEecCCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHhhCCceee
Q 026299 86 ILTPTHLAIVMEYASGGELFERICNAGR------------------------FSEDEARFFFQQLISGVSYCHSMQVCHR 141 (240)
Q Consensus 86 ~~~~~~~~lv~~~~~~~~l~~~l~~~~~------------------------l~~~~~~~~~~~i~~~l~~LH~~~ivh~ 141 (240)
+.+++..++||||+++++|.+++..... +++..++.++.|++.||.|||+.|++|+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999976433 8899999999999999999999999999
Q ss_pred cCCCCCeEEcCCCCCcEEEecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCC
Q 026299 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAY 217 (240)
Q Consensus 142 ~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~ 217 (240)
||+|+||+++.++. ++|+|||.+....... ......++..|+|||.+.+...+.. +||||||+++++|++ |..
T Consensus 175 dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 175 DLAARNILVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCSGGGEEEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCC
T ss_pred ccchheEEEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch-hhHHHHHHHHHHHHhCCCC
Confidence 99999999987665 9999999986443222 2223345678999999987766544 999999999999999 999
Q ss_pred CCCCCCchhhhhhh
Q 026299 218 PFEDPEEPKNFRKT 231 (240)
Q Consensus 218 pf~~~~~~~~~~~~ 231 (240)
||.+.+.......+
T Consensus 252 p~~~~~~~~~~~~~ 265 (314)
T 2ivs_A 252 PYPGIPPERLFNLL 265 (314)
T ss_dssp SSTTCCGGGHHHHH
T ss_pred CCCCCCHHHHHHHh
Confidence 99887665554443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=267.69 Aligned_cols=213 Identities=26% Similarity=0.385 Sum_probs=178.0
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecC-------CCcEEEEEEeecCccc--cHHHHHHHHHHHhc-CCCCeeeeeEEE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVI 86 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~ 86 (240)
....++|++.+.||+|+||.||+|++.. .+..|++|++...... ...+.+|+.+++.+ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 3455899999999999999999999753 3467999998765332 25688999999999 899999999999
Q ss_pred EcCCeEEEEEecCCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEE
Q 026299 87 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (240)
Q Consensus 87 ~~~~~~~lv~~~~~~~~l~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili 150 (240)
.+++..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||++
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 99999999999999999999997643 48999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchh
Q 026299 151 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (240)
Q Consensus 151 ~~~~~~~~~L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (240)
+.++. ++|+|||.+....... ......++..|+|||.+.+...+.+ +||||||+++++|++ |..||...+..+
T Consensus 225 ~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 225 TEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp CTTCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred cCCCc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 87765 9999999987543322 2223345678999999987766544 999999999999999 999998877665
Q ss_pred hhhhhh
Q 026299 227 NFRKTI 232 (240)
Q Consensus 227 ~~~~~~ 232 (240)
....+.
T Consensus 302 ~~~~~~ 307 (382)
T 3tt0_A 302 LFKLLK 307 (382)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 554443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=276.12 Aligned_cols=202 Identities=30% Similarity=0.428 Sum_probs=157.9
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC-----C
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-----T 90 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 90 (240)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3479999999999999999999999999999999986532 2235678999999999999999999998543 5
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
.+++|||+++ ++|.+++.....+++..++.++.||+.||+|||+.||+||||+|+||+++.++. ++|+|||++....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTT
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--Eeecccccchhcc
Confidence 6899999985 589998888888999999999999999999999999999999999999987776 9999999987543
Q ss_pred ccC----------------------------CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh--------
Q 026299 171 LHS----------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-------- 214 (240)
Q Consensus 171 ~~~----------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-------- 214 (240)
... ......+++.|+|||++.....++.++|||||||++|+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 221 11233568899999987655545566999999999999998
Q ss_pred ---CCCCCCCCC
Q 026299 215 ---GAYPFEDPE 223 (240)
Q Consensus 215 ---g~~pf~~~~ 223 (240)
|..+|.+.+
T Consensus 288 ~~~~~p~f~g~~ 299 (458)
T 3rp9_A 288 HADRGPLFPGSS 299 (458)
T ss_dssp GGGCCCSCC---
T ss_pred cccccccCCCCc
Confidence 677776654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=267.45 Aligned_cols=213 Identities=26% Similarity=0.396 Sum_probs=178.8
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (240)
....++|++.+.||+|+||.||++++.. ++..|++|.+..... ..+.+.+|+..++.++||||+++++++.++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 3455899999999999999999999973 458999999876432 235688999999999999999999999999
Q ss_pred CeEEEEEecCCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCC
Q 026299 90 THLAIVMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~------------------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~ 145 (240)
+..++||||+++++|.+++... .++++..++.++.|++.||.|||+.|++|+||+|
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 9999999999999999998763 5689999999999999999999999999999999
Q ss_pred CCeEEcCCCCCcEEEecCCcccccccc---CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 026299 146 ENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFED 221 (240)
Q Consensus 146 ~nili~~~~~~~~~L~d~~~~~~~~~~---~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~ 221 (240)
+||+++.++. ++|+|||.+...... .......++..|+|||.+.+...+. ++|+||||+++|+|++ |..||.+
T Consensus 203 ~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 203 RNCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp GGEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ceEEECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCc-ccccHHHHHHHHHHHhcCCCcCCC
Confidence 9999987765 999999998644322 2223345678899999988777654 4999999999999999 9999988
Q ss_pred CCchhhhhhhh
Q 026299 222 PEEPKNFRKTI 232 (240)
Q Consensus 222 ~~~~~~~~~~~ 232 (240)
.+.......+.
T Consensus 280 ~~~~~~~~~~~ 290 (343)
T 1luf_A 280 MAHEEVIYYVR 290 (343)
T ss_dssp SCHHHHHHHHH
T ss_pred CChHHHHHHHh
Confidence 77666555443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=268.55 Aligned_cols=206 Identities=31% Similarity=0.501 Sum_probs=178.9
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
...++|++.+.||+|++|.||++++..++..|++|++.... ...+.+.+|+..++.++||||+++++++.+++..++|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 44589999999999999999999999999999999987653 2235688999999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~-~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
|||+++++|.+++...+.+++..+..++.+++.||.|||+. |++|+||+|+||+++.++. ++|+|||.+..... ..
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~ 186 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SM 186 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HC
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCccccc-cc
Confidence 99999999999998888899999999999999999999986 9999999999999987766 99999999854322 22
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
.....++..|+|||.+.+...+.. +||||||+++++|++|..||...+....
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~ 238 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKEL 238 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCCHHHH
T ss_pred ccCCCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 334567899999999987766544 9999999999999999999987665543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=258.00 Aligned_cols=214 Identities=30% Similarity=0.512 Sum_probs=181.7
Q ss_pred CCCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 026299 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL 87 (240)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 87 (240)
|+.........+.|++.+.||+|++|.||++++..++..|++|.+.... ...+.+.+|+..++.++||||+++++++.
T Consensus 11 p~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 90 (303)
T 3a7i_A 11 PGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL 90 (303)
T ss_dssp --CTTCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CchhcCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 3333334444578999999999999999999999999999999987653 23367889999999999999999999999
Q ss_pred cCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
++...++||||+++++|.+++.. .+++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~ 167 (303)
T 3a7i_A 91 KDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAG 167 (303)
T ss_dssp ETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCE
T ss_pred cCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccce
Confidence 99999999999999999998854 57899999999999999999999999999999999999987765 9999999986
Q ss_pred cccccC-CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 168 SSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 168 ~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
...... ......++..|+|||.+.+...+.+ +|+||||+++++|++|..||........
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~ 227 (303)
T 3a7i_A 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKV 227 (303)
T ss_dssp ECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ecCccccccCccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHH
Confidence 543322 2344567889999999987776555 9999999999999999999987655443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=258.17 Aligned_cols=211 Identities=38% Similarity=0.621 Sum_probs=181.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++.+.||+|++|.||++++..++..|++|++.... ...+.+.+|+..+++++||||+++++++.+....++++|
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 68999999999999999999999999999999987643 234678899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCCccccccccCCCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
++++++|.+.+.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ ...++|+|||.+..........
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~ 181 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCS
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccc
Confidence 999999999988888899999999999999999999999999999999999997643 3359999999987554444444
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
...++..|+|||.+.+. . +.++|+||||+++++|++|..||...+..+...++..
T Consensus 182 ~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (287)
T 2wei_A 182 DRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236 (287)
T ss_dssp CHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 44577889999988654 4 4459999999999999999999988776665554443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=268.09 Aligned_cols=205 Identities=31% Similarity=0.552 Sum_probs=174.0
Q ss_pred CCCCeeEeeeecCCCceeEEEEEec---CCCcEEEEEEeecCc-----cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcC
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 89 (240)
..++|++.+.||+|+||.||++++. .++..|++|++.... ...+.+.+|+..++.+ +||||+++++++..+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 3479999999999999999999984 478999999986532 2335577899999999 699999999999999
Q ss_pred CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
...++||||+++++|.+++.....+++..++.++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++...
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~ 209 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEF 209 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEEC
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeec
Confidence 999999999999999999988888999999999999999999999999999999999999987765 999999998644
Q ss_pred ccc--CCCCCCcCCccccCccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 170 VLH--SQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 170 ~~~--~~~~~~~~~~~~~~pE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
... .......+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||......
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 268 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc
Confidence 322 2223346889999999997643 3345599999999999999999999765443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=270.57 Aligned_cols=211 Identities=27% Similarity=0.388 Sum_probs=182.8
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc------CCCCeeeeeEEEEcCCeEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL------RHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~ 93 (240)
..+|++++.||+|+||.||+|.+..++..||+|++.........+.+|+.+++.+ .|+||+++++++......+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 4689999999999999999999999999999999977655556777888888777 5679999999999999999
Q ss_pred EEEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
+|||++++ +|.+++.... .+++..++.++.|++.||+|||+.||+|+||+|+||+++.++...++|+|||++....
T Consensus 176 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~- 253 (429)
T 3kvw_A 176 MTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH- 253 (429)
T ss_dssp EEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT-
T ss_pred EEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC-
Confidence 99999975 8888886653 4899999999999999999999999999999999999987776569999999985432
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+..+.+..+++.
T Consensus 254 -~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~ 314 (429)
T 3kvw_A 254 -QRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314 (429)
T ss_dssp -CCCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred -CcccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 23344578899999999988777555 99999999999999999999999888877776653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=269.97 Aligned_cols=214 Identities=22% Similarity=0.331 Sum_probs=176.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEE-----ecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
..++|++.+.||+|+||.||+|+ +..++..|++|++.... .....+.+|+.+++.++||||+++++++.++..
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 34789999999999999999999 44567899999986532 223467899999999999999999999999999
Q ss_pred EEEEEecCCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecC
Q 026299 92 LAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDF 163 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~-------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~ 163 (240)
.++||||+++++|.+++.... .++...++.++.|++.||+|||+.||+||||+|+||+++.++ ...++|+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 999999999999999997643 489999999999999999999999999999999999997443 224999999
Q ss_pred Ccccccccc---CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 164 GYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 164 ~~~~~~~~~---~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
|.+...... .......+++.|+|||.+.+...+.+ +||||||+++++|++ |..||...+..+.+..+..
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 998643222 22234456789999999987776554 999999999999998 9999988877666555443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=263.76 Aligned_cols=214 Identities=30% Similarity=0.450 Sum_probs=159.2
Q ss_pred CCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC
Q 026299 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (240)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (240)
..+.....++|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++++++..++
T Consensus 7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 4566677899999999999999999999999899999999886542 23356789999999999999999999999999
Q ss_pred eEEEEEecCCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEec
Q 026299 91 HLAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~--------~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d 162 (240)
..++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~d 164 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIAD 164 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEe
Confidence 99999999999999998863 356899999999999999999999999999999999999987765 99999
Q ss_pred CCccccccccC------CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 163 FGYSKSSVLHS------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 163 ~~~~~~~~~~~------~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
||.+....... ......+++.|+|||.+.+....+.++|+||||+++++|++|..||.........
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 236 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL 236 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH
Confidence 99886433221 1223457889999999876443455599999999999999999999876554443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=269.05 Aligned_cols=200 Identities=36% Similarity=0.589 Sum_probs=163.3
Q ss_pred CCCeeEe-eeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHH-hcCCCCeeeeeEEEEc----CCeEE
Q 026299 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-SLRHPNIVRFKEVILT----PTHLA 93 (240)
Q Consensus 20 ~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~~~ 93 (240)
.++|.+. +.||.|+||.||++.+..+++.|++|++.. ...+.+|+..+. ..+||||+++++++.. ...++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 3678887 689999999999999999999999999853 245678888774 4589999999999875 56789
Q ss_pred EEEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCCcccccc
Q 026299 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV 170 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~~~~ 170 (240)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+.||+|+||+|+||+++.+. .+.++|+|||++....
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 9999999999999997643 599999999999999999999999999999999999998632 3459999999987555
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.........+++.|+|||++.+..++.. +||||||+++|+|++|..||...+.
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred CCCccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 4444455667899999999977766554 9999999999999999999976543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=262.49 Aligned_cols=196 Identities=27% Similarity=0.394 Sum_probs=165.4
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC--------
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 90 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 90 (240)
++|++.+.||+|++|.||+|++..++..||+|++.... ...+.+.+|+..+++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 57999999999999999999999999999999987543 23467899999999999999999999986542
Q ss_pred -------------------------------------------------eEEEEEecCCCCchHHHHHhcCC---CCHHH
Q 026299 91 -------------------------------------------------HLAIVMEYASGGELFERICNAGR---FSEDE 118 (240)
Q Consensus 91 -------------------------------------------------~~~lv~~~~~~~~l~~~l~~~~~---l~~~~ 118 (240)
..++||||+++++|.+++..... .+...
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 37999999999999999976543 55667
Q ss_pred HHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-------------CCCCCcCCcccc
Q 026299 119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------------QPKSTVGTPAYI 185 (240)
Q Consensus 119 ~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-------------~~~~~~~~~~~~ 185 (240)
++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+....... ......+++.|+
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 8999999999999999999999999999999987765 9999999986544331 223346889999
Q ss_pred CccccccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 026299 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219 (240)
Q Consensus 186 ~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 219 (240)
|||.+.+...+.+ +||||||+++++|++|..|+
T Consensus 244 aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 244 SPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp CHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCH
T ss_pred ChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCCh
Confidence 9999987776555 99999999999999987765
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=259.82 Aligned_cols=210 Identities=29% Similarity=0.476 Sum_probs=173.9
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEc------
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------ 88 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------ 88 (240)
.....++|++.+.||.|++|.||++++..++..|++|++.......+.+.+|+..++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 34456899999999999999999999999999999999987766678899999999998 79999999999987
Q ss_pred CCeEEEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 89 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
....++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~ 176 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVS 176 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTT
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCc
Confidence 46789999999999999998754 56899999999999999999999999999999999999987765 999999998
Q ss_pred cccccc-CCCCCCcCCccccCcccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 167 KSSVLH-SQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 167 ~~~~~~-~~~~~~~~~~~~~~pE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
...... .......++..|+|||.+.. ... +.++|+||||+++++|++|..||...+.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 243 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 644322 22334567889999999863 334 44599999999999999999999876654443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=260.11 Aligned_cols=216 Identities=25% Similarity=0.328 Sum_probs=174.0
Q ss_pred CCCCcccCCCCCeeEee-eecCCCceeEEEEEe--cCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeE
Q 026299 11 GMDMPIMHDSDRYELVR-DIGSGNFGVARLMRD--KKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKE 84 (240)
Q Consensus 11 ~~~~~~~~~~~~y~~~~-~l~~g~~g~v~~~~~--~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~ 84 (240)
..+-....+.++|++.+ .||+|++|.||++.+ ..++..|++|.+...... .+.+.+|+..++.++||||+++++
T Consensus 6 i~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 6 IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp -----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 33445556778999999 999999999999954 556789999998764322 356889999999999999999999
Q ss_pred EEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 85 ~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
++ ..+..++|||++++++|.+++.....+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 86 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg 162 (291)
T 1xbb_A 86 IC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFG 162 (291)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCT
T ss_pred EE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCC
Confidence 99 55678999999999999999988888999999999999999999999999999999999999987765 9999999
Q ss_pred ccccccccCC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 165 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 165 ~~~~~~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
.+........ .....++..|+|||.+.+...+. ++|+||||+++++|++ |..||...+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 232 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS-KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCCh-hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 9864432221 12223457899999997766644 4999999999999999 9999988766554433
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=268.21 Aligned_cols=208 Identities=26% Similarity=0.441 Sum_probs=162.6
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC------C
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 90 (240)
.++|++++.||+|++|.||+|.+..+|..|++|++.... .....+.+|+..++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 489999999999999999999999999999999986532 2235678999999999999999999998754 5
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
..+++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~ 183 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTA 183 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC--------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeecccccccc
Confidence 579999998 5689888754 67999999999999999999999999999999999999987766 9999999986433
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
. ......++..|+|||.+.+....+.++|||||||++++|++|..||.+.+..+.+.++++
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 244 (367)
T 2fst_X 184 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred c--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2 233456788999999988755455569999999999999999999999888877777665
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=258.93 Aligned_cols=203 Identities=32% Similarity=0.484 Sum_probs=170.4
Q ss_pred CCCeeEe-eeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEE
Q 026299 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 20 ~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
.+.|++. +.||+|++|.||++++..++..|++|++..... ..+.+.+|+..+.++ +||||+++++++.+++.+++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3789996 789999999999999999999999999876543 346788999999885 7999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCC-CcEEEecCCccccccccC--
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHS-- 173 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~-~~~~L~d~~~~~~~~~~~-- 173 (240)
||+++++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ..++|+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 99999999999988888999999999999999999999999999999999999976543 348999999986443211
Q ss_pred ------CCCCCcCCccccCcccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 174 ------QPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 174 ------~~~~~~~~~~~~~pE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
......++..|+|||.+.+ ...+ .++||||||+++++|++|..||....
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHT-TTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCC-cccccHhHHHHHHHHHHCCCCCcccc
Confidence 1123347889999999865 3343 44999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=272.70 Aligned_cols=212 Identities=27% Similarity=0.381 Sum_probs=177.9
Q ss_pred cccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
....+.++|++.+.||+|+||.||++++..++..||+|.+..... ..+.+.+|+.+++.++||||+++++++..++..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 345567899999999999999999999999999999998875422 224678999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
++||||+++++|.+++... ..++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEAD 265 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTT
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCC
Confidence 9999999999999998764 36899999999999999999999999999999999999987765 99999999864322
Q ss_pred cC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 026299 172 HS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (240)
Q Consensus 172 ~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (240)
.. ......++..|+|||.+.+...+.+ +||||||+++|+|++ |..||...+......
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~~~ 326 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTRE 326 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 11 1111224567999999987766544 999999999999998 999998776554433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=265.63 Aligned_cols=203 Identities=25% Similarity=0.320 Sum_probs=171.6
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC----e
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----H 91 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 91 (240)
+....++|++.+.||+|+||.||++++. +..||+|++...........+|+..+++++||||+++++++.... .
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3456689999999999999999999876 789999999776555556677899999999999999999998753 4
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC----------CceeecCCCCCeEEcCCCCCcEEEe
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM----------QVCHRDLKLENTLLDGSPAPRLKIC 161 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~----------~ivh~~i~~~nili~~~~~~~~~L~ 161 (240)
+++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. |++|+||+|+||+++.++. ++|+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~ 173 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIA 173 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEEC
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEc
Confidence 7999999999999999965 4589999999999999999999999 9999999999999987765 9999
Q ss_pred cCCccccccccCC---CCCCcCCccccCccccccCCC----CCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 162 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 162 d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
|||.+........ .....+++.|+|||.+.+... .+.++||||||+++|+|++|..||.+..
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 9999865433222 233468899999999876422 2334799999999999999999997654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=269.79 Aligned_cols=218 Identities=25% Similarity=0.396 Sum_probs=178.2
Q ss_pred CCCCCcccCCCCCeeEeeeecCCCceeEEEEE-----ecCCCcEEEEEEeecCccc--cHHHHHHHHHHHhc-CCCCeee
Q 026299 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVR 81 (240)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~ 81 (240)
|..........++|++.+.||+|+||.||+++ +..++..|++|++...... .+.+.+|+..++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 33334445567899999999999999999999 5567789999998764332 24688999999999 7899999
Q ss_pred eeEEEEcCC-eEEEEEecCCCCchHHHHHhcCC-----------------------------------------------
Q 026299 82 FKEVILTPT-HLAIVMEYASGGELFERICNAGR----------------------------------------------- 113 (240)
Q Consensus 82 ~~~~~~~~~-~~~lv~~~~~~~~l~~~l~~~~~----------------------------------------------- 113 (240)
+++++.+.+ ..++||||+++++|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998764 48999999999999999876432
Q ss_pred -------------------CCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-
Q 026299 114 -------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (240)
Q Consensus 114 -------------------l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~- 173 (240)
+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPD 248 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeeccccc
Confidence 899999999999999999999999999999999999987765 9999999986443222
Q ss_pred --CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 174 --~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
......++..|+|||.+.+...+. ++||||||+++|+|++ |..||........+.+
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 307 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred chhccccCCCceeEChhhhcCCCCCc-hhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH
Confidence 122344677899999998776654 4999999999999998 9999988765544433
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=269.24 Aligned_cols=208 Identities=27% Similarity=0.430 Sum_probs=174.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC------eEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLAI 94 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~l 94 (240)
.+|++.+.||+|+||.||+|++..++. +++|++...... ..+|+.+++.++||||+++++++.... ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 579999999999999999999987766 788877654322 236999999999999999999986543 3789
Q ss_pred EEecCCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEc-CCCCCcEEEecCCcccccc
Q 026299 95 VMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 95 v~~~~~~~~l~~~l---~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~-~~~~~~~~L~d~~~~~~~~ 170 (240)
||||++++.+.... .....+++..++.++.|++.||+|||+.||+||||+|+||+++ .++. ++|+|||.+....
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~--~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV--LKLIDFGSAKILI 193 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE--EEECCCTTCEECC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc--EEEeeCCCccccc
Confidence 99999875443322 2356799999999999999999999999999999999999997 4554 9999999997666
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.........+++.|+|||.+.+....+.++||||||+++|+|++|..||.+.+..+.+.++++.
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~ 257 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 6666666778999999999987765566699999999999999999999999888887777653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=262.52 Aligned_cols=204 Identities=29% Similarity=0.470 Sum_probs=173.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+.|++++.||+|+||.||++++..++..|++|++...... .+.+.+|+..++.++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4699999999999999999999999999999998764322 245789999999999999999999999999999999
Q ss_pred ecCCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~-~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
||+.| ++.+.+. ...++++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+..... .
T Consensus 134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~---~ 207 (348)
T 1u5q_A 134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---A 207 (348)
T ss_dssp ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---B
T ss_pred ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecCC---C
Confidence 99985 7777775 4567999999999999999999999999999999999999987665 99999999864432 2
Q ss_pred CCCcCCccccCccccc---cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
....+++.|+|||.+. +... +.++||||||+++++|++|..||...+....+.++
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 265 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 265 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 3456889999999985 3334 44599999999999999999999877665554443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=266.17 Aligned_cols=203 Identities=18% Similarity=0.240 Sum_probs=164.7
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCC-----CcEEEEEEeecCccc------------cHHHHHHHHHHHhcCCCCeee
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVR 81 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~ 81 (240)
..++|++.+.||+|+||.||++.+..+ +..|++|++...... ......|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 446999999999999999999998764 578999988664311 112334555666778999999
Q ss_pred eeEEEEcC----CeEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC
Q 026299 82 FKEVILTP----THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (240)
Q Consensus 82 ~~~~~~~~----~~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~ 156 (240)
+++++... ...++||||+ +++|.+++... ..+++..++.++.|++.||+|||+.||+|+||+|+||+++.+..+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998764 4589999999 88999998765 679999999999999999999999999999999999999844444
Q ss_pred cEEEecCCccccccccCCC--------CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 157 RLKICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 157 ~~~L~d~~~~~~~~~~~~~--------~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
.++|+|||++......... ....+++.|+|||.+.+...+ .++||||||+++|+|++|..||.+..
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCccccc
Confidence 5999999998644332221 233488999999999877764 44999999999999999999998643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=254.79 Aligned_cols=209 Identities=24% Similarity=0.404 Sum_probs=175.6
Q ss_pred CcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEc--
Q 026299 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT-- 88 (240)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 88 (240)
.....+...|++.+.||+|++|.||+|.+..++..|++|.+..... ..+.+.+|+..++.++||||+++++++..
T Consensus 19 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 19 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred hhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 3444556789999999999999999999999999999999876432 23467899999999999999999999875
Q ss_pred --CCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC--ceeecCCCCCeEEc-CCCCCcEEEecC
Q 026299 89 --PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLD-GSPAPRLKICDF 163 (240)
Q Consensus 89 --~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~--ivh~~i~~~nili~-~~~~~~~~L~d~ 163 (240)
...+++||||+++++|.+++.....++...++.++.|++.||.|||+.| ++|+||+|+||+++ .++. ++|+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Df 176 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDL 176 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCT
T ss_pred CCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeC
Confidence 3568999999999999999988888999999999999999999999999 99999999999997 4444 999999
Q ss_pred CccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
|.+..... .......+++.|+|||.+.+ .. +.++|+||||+++++|++|..||........
T Consensus 177 g~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 237 (290)
T 1t4h_A 177 GLATLKRA-SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQ 237 (290)
T ss_dssp TGGGGCCT-TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred CCcccccc-cccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHH
Confidence 99853322 22233457889999998764 34 4459999999999999999999988555443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=256.12 Aligned_cols=203 Identities=22% Similarity=0.266 Sum_probs=174.7
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
..++|++.+.||+|++|.||++++..++..|++|++.... ..+.+.+|+..++.+ +|++++++++++.++...++|||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 4579999999999999999999999999999999886543 345688999999999 79999999999999999999999
Q ss_pred cCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCC---CcEEEecCCccccccccC
Q 026299 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 98 ~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~---~~~~L~d~~~~~~~~~~~ 173 (240)
++ +++|.+++... .++++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ..++|+|||.+.......
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99 88999999764 46999999999999999999999999999999999999975432 249999999987544332
Q ss_pred C--------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 174 Q--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 174 ~--------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
. .....++..|+|||.+.+...+. ++||||||+++++|++|..||...+.
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSR-RDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCCh-HHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 2 23445889999999988777644 49999999999999999999988543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=263.41 Aligned_cols=215 Identities=23% Similarity=0.374 Sum_probs=164.0
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCc---EEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (240)
.....++|++.+.||+|++|.||++++..++. .|++|.+.... ...+.+.+|+..++.++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 33456899999999999999999999887765 89999987642 2335688999999999999999999999877
Q ss_pred CeE------EEEEecCCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCc
Q 026299 90 THL------AIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (240)
Q Consensus 90 ~~~------~lv~~~~~~~~l~~~l~~~~------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~ 157 (240)
... ++++||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~-- 175 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT-- 175 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC--
Confidence 654 89999999999999886432 5899999999999999999999999999999999999987765
Q ss_pred EEEecCCccccccccCCC---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 158 LKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 158 ~~L~d~~~~~~~~~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
++|+|||.+......... ....++..|+|||.+.+...+. ++||||||+++++|++ |..||.+.+.......+..
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTV-HSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCC-ccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 999999998644332221 2233567899999998776654 4999999999999999 9999998777666655543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=264.80 Aligned_cols=214 Identities=25% Similarity=0.385 Sum_probs=177.0
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEec-----CCCcEEEEEEeecC--ccccHHHHHHHHHHHhc-CCCCeeeeeEEEE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVIL 87 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (240)
.....++|++.+.||+|++|.||++.+. .++..|++|.+... ....+.+.+|+..++++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445689999999999999999999973 45778999998753 23346789999999999 8999999999999
Q ss_pred cCCeEEEEEecCCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCC
Q 026299 88 TPTHLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144 (240)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~l~~~~-----------------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~ 144 (240)
.++..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999999999999999999997543 27899999999999999999999999999999
Q ss_pred CCCeEEcCCCCCcEEEecCCccccccccCCC---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCC
Q 026299 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFE 220 (240)
Q Consensus 145 ~~nili~~~~~~~~~L~d~~~~~~~~~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~ 220 (240)
|+||+++.++. ++|+|||.+......... ....++..|+|||.+.+...+. ++||||||+++++|++ |..||.
T Consensus 200 p~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 200 ARNVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI-KSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp GGGEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTSCCSST
T ss_pred hhhEEEcCCCc--EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCCh-hHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999987765 999999998654433221 2233567899999988776654 4999999999999998 999998
Q ss_pred CCCchhhhhhhh
Q 026299 221 DPEEPKNFRKTI 232 (240)
Q Consensus 221 ~~~~~~~~~~~~ 232 (240)
+......+.+.+
T Consensus 277 ~~~~~~~~~~~~ 288 (344)
T 1rjb_A 277 GIPVDANFYKLI 288 (344)
T ss_dssp TCCCSHHHHHHH
T ss_pred cCCcHHHHHHHH
Confidence 877655554443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=256.43 Aligned_cols=203 Identities=29% Similarity=0.493 Sum_probs=173.2
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
.++|++.+.||.|++|.||++.+..++..|++|.+.... ..+.+.+|+..++.++||||+++++++..++..++||||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 478999999999999999999999999999999887643 3567899999999999999999999999999999999999
Q ss_pred CCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCC
Q 026299 100 SGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (240)
Q Consensus 100 ~~~~l~~~l~-~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~ 177 (240)
++++|.+++. ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...... .....
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~ 184 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRNT 184 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCBCC
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccccCc
Confidence 9999999986 4567999999999999999999999999999999999999987765 999999998654332 22334
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
..++..|+|||.+.+...+.. +|+||||+++++|++|..||...+...
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~ 232 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMR 232 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred cCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 567889999999987776555 999999999999999999998765433
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=266.65 Aligned_cols=202 Identities=22% Similarity=0.273 Sum_probs=165.9
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecC---CCcEEEEEEeecCcc------------ccHHHHHHHHHHHhcCCCCeeee
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDK------------IDENVQREIINHRSLRHPNIVRF 82 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~------------~~~~~~~e~~~l~~l~h~~i~~~ 82 (240)
...++|++.+.||+|++|.||+|.+.. ++..+++|....... ....+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345799999999999999999999987 788999998876432 12335677888889999999999
Q ss_pred eEEEEc----CCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcE
Q 026299 83 KEVILT----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (240)
Q Consensus 83 ~~~~~~----~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~ 158 (240)
++++.. ....++|||++ +++|.+++...+.+++..++.++.|++.||+|||+.|++|+||+|+||+++.++...+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999987 67899999999 8899999987778999999999999999999999999999999999999987774469
Q ss_pred EEecCCccccccccCCC--------CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 159 KICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 159 ~L~d~~~~~~~~~~~~~--------~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
+|+|||.+......... ....++..|+|||.+.+...+. ++||||||+++|+|++|..||..
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSR-RSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCccc
Confidence 99999998654332211 2345788999999988776644 49999999999999999999965
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=271.07 Aligned_cols=208 Identities=27% Similarity=0.415 Sum_probs=176.0
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC-eEEEE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIV 95 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 95 (240)
..+.++|++.+.||+|+||.||++.+. +..||+|.+.... ..+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 456689999999999999999999885 6789999987654 5577999999999999999999999987765 79999
Q ss_pred EecCCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 96 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~--l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
|||+++++|.+++...+. ++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST- 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccccc-
Confidence 999999999999976543 799999999999999999999999999999999999987765 999999998643322
Q ss_pred CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
.....++..|+|||.+.+...+.+ +||||||+++++|++ |..||...+..+...++.
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~ 400 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 122345678999999987776554 999999999999998 999998877666555443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=264.03 Aligned_cols=204 Identities=36% Similarity=0.577 Sum_probs=170.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---------cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
++|++.+.||+|++|.||++++..++..|++|.+.... .....+.+|+..++.++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 68999999999999999999999999999999986532 11235789999999999999999999987655
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCCcccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV 170 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~~~~ 170 (240)
.++||||+++++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ ...++|+|||.+....
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 899999999999999998888899999999999999999999999999999999999997544 2359999999986443
Q ss_pred ccCCCCCCcCCccccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
.........++..|+|||.+.. ....+.++||||||+++++|++|..||......
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (322)
T 2ycf_A 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225 (322)
T ss_dssp CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence 2222223457889999999742 333345599999999999999999999876544
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=266.09 Aligned_cols=211 Identities=25% Similarity=0.363 Sum_probs=169.3
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc------------cHHHHHHHHHHHhcCCCCeeeeeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVRFKEVI 86 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~~~~~~ 86 (240)
..++|++.+.||+|++|.||++.+.. +..|++|++...... .+.+.+|+..++.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 34899999999999999999999875 889999998653221 15688999999999999999999998
Q ss_pred Ec-----CCeEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEE
Q 026299 87 LT-----PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (240)
Q Consensus 87 ~~-----~~~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L 160 (240)
.. ....++|||++++ +|.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl 175 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITI 175 (362)
T ss_dssp EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEE
T ss_pred EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEE
Confidence 54 3468999999985 777777544 47999999999999999999999999999999999999987766 999
Q ss_pred ecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 161 ~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
+|||.+.............+++.|+|||.+.+....+.++|+||||+++++|++|..||.+.+..+.+.+++.
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999987555555555567888999999988755455669999999999999999999999887777666654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=263.14 Aligned_cols=215 Identities=22% Similarity=0.363 Sum_probs=171.2
Q ss_pred CCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcE----EEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeE
Q 026299 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKE 84 (240)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~----v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~ 84 (240)
..........++|++.+.||+|+||.||++++..++.. |++|.+.... .....+.+|+..+++++||||+++++
T Consensus 5 ~~~~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 84 (327)
T 3poz_A 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp -CCSSEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred hHHHHhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 34445556778999999999999999999998877665 4777765432 33467899999999999999999999
Q ss_pred EEEcCCeEEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecC
Q 026299 85 VILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (240)
Q Consensus 85 ~~~~~~~~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~ 163 (240)
++.++. .+++++++.+++|.+++.. ...++...++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+||
T Consensus 85 ~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Df 161 (327)
T 3poz_A 85 ICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDF 161 (327)
T ss_dssp EEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCT
T ss_pred EEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccC
Confidence 998765 7789999999999999876 457999999999999999999999999999999999999987765 999999
Q ss_pred CccccccccCCC---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 026299 164 GYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (240)
Q Consensus 164 ~~~~~~~~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (240)
|++......... ....++..|+|||.+.+...+.+ +||||||+++++|++ |..||...+......
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 230 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISS 230 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred cceeEccCCcccccccCCCccccccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccCCCHHHHHH
Confidence 998644332222 22334678999999987776554 999999999999999 999998776554433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=261.45 Aligned_cols=212 Identities=27% Similarity=0.507 Sum_probs=176.8
Q ss_pred CCeeEe-eeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEE
Q 026299 21 DRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 21 ~~y~~~-~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 95 (240)
++|.+. +.||+|++|.||++++..++..|++|++.... .....+.+|+..++.++ ||||+++++++.+....++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 578887 89999999999999999999999999987632 22357889999999985 69999999999999999999
Q ss_pred EecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCCcccccccc
Q 026299 96 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH 172 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~~~~~~ 172 (240)
|||+++++|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||+++... .+.++|+|||.+......
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 9999999999988543 5799999999999999999999999999999999999997621 335999999999766555
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.......+++.|+|||.+.+...+.+ +|+||||+++++|++|..||...+....+.++..
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 247 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh
Confidence 44455678999999999987776555 9999999999999999999988877666555443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=276.54 Aligned_cols=210 Identities=22% Similarity=0.344 Sum_probs=181.0
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
....+|++.+.||+|+||.||++.+..++..|++|.+.......+.+.+|+.++++++||||+++++++.....+++|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34578999999999999999999999889999999998776667889999999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc--C
Q 026299 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 173 (240)
Q Consensus 98 ~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~--~ 173 (240)
|+++++|.+++... ..++...+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||++...... .
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCEE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCcee
Confidence 99999999999753 45899999999999999999999999999999999999987665 999999998654322 1
Q ss_pred CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
......++..|+|||.+.+..++.+ +||||||+++++|++ |..||.+.+.......
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~ 431 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 431 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 1222334568999999987766554 999999999999999 9999988766554443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=260.37 Aligned_cols=214 Identities=24% Similarity=0.360 Sum_probs=179.1
Q ss_pred cccCCCCCeeEeeeecCCCceeEEEEEe-----cCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhc-CCCCeeeeeEEE
Q 026299 15 PIMHDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 86 (240)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 86 (240)
......++|++.+.||+|++|.||++.+ ..++..|++|.+..... ..+.+.+|+..++++ +||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 3444568999999999999999999985 45788999999876532 235688999999999 899999999999
Q ss_pred EcCCeEEEEEecCCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCe
Q 026299 87 LTPTHLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (240)
Q Consensus 87 ~~~~~~~lv~~~~~~~~l~~~l~~~~------------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~ni 148 (240)
.+++..++||||+++++|.+++.... ++++..++.++.|++.||.+||+.|++|+||+|+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 99999999999999999999987643 489999999999999999999999999999999999
Q ss_pred EEcCCCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCc
Q 026299 149 LLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE 224 (240)
Q Consensus 149 li~~~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 224 (240)
+++.++. ++|+|||.+........ .....++..|+|||.+.+...+. ++||||||+++++|++ |..||.....
T Consensus 177 l~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 177 LLTHGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EEETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EEcCCCC--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9987665 99999999865443322 12234567899999987776654 4999999999999998 9999988766
Q ss_pred hhhhhhh
Q 026299 225 PKNFRKT 231 (240)
Q Consensus 225 ~~~~~~~ 231 (240)
...+.+.
T Consensus 254 ~~~~~~~ 260 (313)
T 1t46_A 254 DSKFYKM 260 (313)
T ss_dssp SHHHHHH
T ss_pred hhHHHHH
Confidence 5544443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=255.54 Aligned_cols=212 Identities=23% Similarity=0.370 Sum_probs=178.2
Q ss_pred cccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
......++|++.+.||+|++|.||++.+. ++..|++|.+.......+.+.+|+..++.++||||+++++++.+ +..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 44456689999999999999999999976 56789999998776666789999999999999999999999864 55789
Q ss_pred EEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
|||++++++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDN 162 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCc
Confidence 999999999999986543 6899999999999999999999999999999999999987665 999999998644322
Q ss_pred C--CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 173 S--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 173 ~--~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
. ......++..|+|||.+.+...+.+ +|+||||+++++|++ |..||.+.+..+.+.++
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 223 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred ccccccCCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence 1 2223345678999999977666444 999999999999999 99999887766555444
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=272.48 Aligned_cols=212 Identities=23% Similarity=0.361 Sum_probs=179.5
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
.....++|++.+.||+|+||.||++.+. ++..||+|.+.......+.+.+|+.+++.++||||+++++++. ....++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 4455689999999999999999999987 4677999999887666788999999999999999999999986 5678999
Q ss_pred EecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-
Q 026299 96 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~- 172 (240)
|||+++++|.+++... ..++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNE 338 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCHH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCCc
Confidence 9999999999999743 36899999999999999999999999999999999999987765 999999998754321
Q ss_pred -CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 173 -~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
.......++..|+|||.+.....+. ++||||||+++++|++ |..||.+.+..+.+..+.
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~ 399 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTI-KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred eeccCCCcccccccCHHHhccCCCCc-HHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 1222334567899999997776654 4999999999999999 999998877666555443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=261.00 Aligned_cols=211 Identities=25% Similarity=0.396 Sum_probs=175.1
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEec-------CCCcEEEEEEeecCcc--ccHHHHHHHHHHHhc-CCCCeeeeeEEE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 86 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 86 (240)
....++|++.+.||+|+||.||++++. .++..|++|++..... ..+.+.+|+..++.+ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 345689999999999999999999976 3577899999876432 235678999999999 899999999999
Q ss_pred EcCCeEEEEEecCCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEE
Q 026299 87 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (240)
Q Consensus 87 ~~~~~~~lv~~~~~~~~l~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili 150 (240)
.+.+..++||||+++++|.+++.... .++...++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 99999999999999999999997643 38999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchh
Q 026299 151 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (240)
Q Consensus 151 ~~~~~~~~~L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (240)
+.++. ++|+|||.+....... ......++..|+|||.+.+...+.+ +||||||+++++|++ |..||.+.+..+
T Consensus 191 ~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 191 TENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp CTTCC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred cCCCC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH-HHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 87765 9999999986443221 1223345678999999877766544 999999999999999 999998876655
Q ss_pred hhhh
Q 026299 227 NFRK 230 (240)
Q Consensus 227 ~~~~ 230 (240)
....
T Consensus 268 ~~~~ 271 (334)
T 2pvf_A 268 LFKL 271 (334)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=260.53 Aligned_cols=211 Identities=23% Similarity=0.330 Sum_probs=172.8
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcE----EEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~----v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (240)
.....++|++.+.||+|+||.||++++..++.. |++|.+.... .....+.+|+..++.++||||+++++++. +
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 345668999999999999999999999877775 7777665432 22345778999999999999999999886 4
Q ss_pred CeEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 90 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
...++|++|+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+..
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~ 164 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADL 164 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGG
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCcccc
Confidence 6688999999999999998764 57899999999999999999999999999999999999987766 99999999875
Q ss_pred ccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 169 SVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 169 ~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
...... .....++..|+|||.+.+...+. ++||||||+++|+|++ |..||...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 229 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTH-QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL 229 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH
T ss_pred cCcccccccccCCCCcccccChHHhccCCCCh-hhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH
Confidence 433322 12334567899999998777654 4999999999999999 9999988765554443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=254.54 Aligned_cols=199 Identities=25% Similarity=0.360 Sum_probs=170.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|+..+..+ +||||+++++++.+++..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999987642 2335678899999988 8999999999999999999999
Q ss_pred ecCCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-----------------C
Q 026299 97 EYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-----------------A 155 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~----~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-----------------~ 155 (240)
||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 999999999998764 6689999999999999999999999999999999999997443 2
Q ss_pred CcEEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 156 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 156 ~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
..++|+|||.+..... .....++..|+|||.+.+....+.++||||||+++++|++|..|+...
T Consensus 171 ~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp CCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred eEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 2489999999864432 233458899999999987655555699999999999999998876544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=253.57 Aligned_cols=206 Identities=33% Similarity=0.443 Sum_probs=164.6
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-----ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
.+.++|++.+.||+|++|.||++.+. +..|++|++..... ..+.+.+|+..++.++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 45689999999999999999999975 78899999865432 225688999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC---ceeecCCCCCeEEcCC------CCCcEEEecC
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGS------PAPRLKICDF 163 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~---ivh~~i~~~nili~~~------~~~~~~L~d~ 163 (240)
++||||+++++|.+++. ..++++..++.++.|++.||.+||+.| ++|+||+|+||+++.+ ..+.++|+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999998884 567899999999999999999999999 8999999999999752 1335999999
Q ss_pred CccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhh
Q 026299 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (240)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (240)
|.+....... .....+++.|+|||.+.+...+. ++|+||||+++++|++|..||...+.....
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 223 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSK-GSDVWSYGVLLWELLTGEVPFRGIDGLAVA 223 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCCSH-HHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred Cccccccccc-ccCCCCccceeCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9986443322 22456788999999987776644 499999999999999999999886654443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=258.31 Aligned_cols=217 Identities=30% Similarity=0.420 Sum_probs=172.5
Q ss_pred CcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEE-----
Q 026299 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVIL----- 87 (240)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 87 (240)
+....-.++|++++.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++||||+++++++.
T Consensus 4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 4 IHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp --CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 344445689999999999999999999999999999999987643 23356889999999999999999999874
Q ss_pred ---------cCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcE
Q 026299 88 ---------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (240)
Q Consensus 88 ---------~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~ 158 (240)
+....++||||+++ +|.+++. .+++++..++.++.|++.||++||+.|++|+||+|+||+++.+. ..+
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~ 160 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYMET-DLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVL 160 (320)
T ss_dssp CCC----CCSCSEEEEEEECCSE-EHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEE
T ss_pred cccccccccccCceeEEeeccCC-CHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeE
Confidence 34678999999985 8998885 46789999999999999999999999999999999999997433 249
Q ss_pred EEecCCcccccccc----CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 159 KICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 159 ~L~d~~~~~~~~~~----~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
+|+|||.+...... .......++..|+|||.+.+....+.++|+||||+++++|++|..||...+......+++.
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999998754322 1223345678899999987655556669999999999999999999998887766665543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=267.64 Aligned_cols=212 Identities=25% Similarity=0.398 Sum_probs=168.4
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEec---CCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
...++|++.+.||+|+||.||++++. .++..|++|.+.... ...+.+.+|+.++++++||||+++++++.++...
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34578999999999999999999987 467789999987643 2335688999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
++||||+++++|.+++.... .++...++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLED 199 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC--------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCcccccccc
Confidence 99999999999999997653 6999999999999999999999999999999999999987765 99999999865433
Q ss_pred cCCC----CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 172 HSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 172 ~~~~----~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
.... ....++..|+|||.+.+...+.+ +||||||+++++|++ |..||...+..+....+.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~ 264 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 2211 11223567999999987776554 999999999999998 999998877665555443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=260.41 Aligned_cols=202 Identities=26% Similarity=0.337 Sum_probs=172.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
..++|++.+.||+|++|.||++++. ++..|++|.+..... ..+.+.+|+..++.++||||+++++++.+++..++|||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 4589999999999999999999975 688999998876432 33578899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 98 YASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~----~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
|+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTELD 193 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSSSS
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeeccccccccccc
Confidence 999999999886543 5899999999999999999999999999999999999987765 9999999986433221
Q ss_pred C---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 174 Q---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 174 ~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
. .....++..|+|||.+.+...+.+ +||||||+++++|++|..||.....
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred ccccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCc
Confidence 1 123346889999999987776555 9999999999999999999976543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=256.02 Aligned_cols=213 Identities=25% Similarity=0.369 Sum_probs=167.3
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCC---CcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (240)
.....++|++.+.||+|++|.||++.+..+ +..|++|.+.... ...+.+.+|+..++.++||||+++++++. ++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 344568999999999999999999998653 4579999876533 22356889999999999999999999984 46
Q ss_pred eEEEEEecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 91 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
..++||||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYM 166 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECcccccccc
Confidence 6789999999999999997554 6899999999999999999999999999999999999987665 999999998654
Q ss_pred cccCC--CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 170 VLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 170 ~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
..... .....+++.|+|||.+.+...+. ++|+||||+++++|++ |..||.+.+..+.+.++.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~ 231 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred CcccccccccCCCcccccChhhcccCCCCC-ccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH
Confidence 33221 12234567899999997766654 4999999999999996 999998877766655543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=255.35 Aligned_cols=202 Identities=25% Similarity=0.368 Sum_probs=157.4
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc---HHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
...++|++.+.||+|++|.||++++..+++.|++|++....... +.+.++...++.++||||+++++++.+++..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 35589999999999999999999999999999999987643222 223344455778899999999999999999999
Q ss_pred EEecCCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhC-CceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 95 VMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 95 v~~~~~~~~l~~~l~----~~~~l~~~~~~~~~~~i~~~l~~LH~~-~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
|||++++ +|.+++. ....+++..++.++.|++.||.|||+. |++|+||+|+||+++.++. ++|+|||.+...
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGYL 160 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCcccc
Confidence 9999986 7776664 356799999999999999999999998 9999999999999987665 999999998766
Q ss_pred cccCCCCCCcCCccccCccccc---cCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 170 VLHSQPKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 170 ~~~~~~~~~~~~~~~~~pE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
..........+++.|+|||.+. .....+.++|+||||+++++|++|..||...
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 5555555557889999999972 3333455599999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=259.81 Aligned_cols=204 Identities=28% Similarity=0.467 Sum_probs=168.5
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEE----ecCCCcEEEEEEeecCccc-cHHHHHHHHHHHhcCCCCeeeeeEEEEcC-
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTP- 89 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 89 (240)
.....++|++++.||+|++|.||+++ +..++..|++|++...... .+.+.+|+..++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 34566899999999999999999999 5678999999998764322 35688999999999999999999998654
Q ss_pred -CeEEEEEecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 90 -THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 90 -~~~~lv~~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
...++||||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+.
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~ 162 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTK 162 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccc
Confidence 56899999999999999997654 5899999999999999999999999999999999999987765 9999999987
Q ss_pred cccccCC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 168 SSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 168 ~~~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
....... .....++..|+|||.+.+...+.+ +||||||+++++|++|..||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChH-HHHHHHHHHHHHHHhcccccCCC
Confidence 5433221 122335567999999987776544 99999999999999999888653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=258.68 Aligned_cols=207 Identities=31% Similarity=0.437 Sum_probs=176.6
Q ss_pred CCCeeEeeeecCCCceeEEEEEe-cCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCC------CeeeeeEEEEcCCeE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRD-KKTEELVAVKYIERGDKIDENVQREIINHRSLRHP------NIVRFKEVILTPTHL 92 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~ 92 (240)
.++|++.+.||+|++|.||++.+ ..++..|++|++.......+.+.+|+..++.++|+ +++++++++.+.+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 37999999999999999999998 56789999999876655556788999999888654 599999999999999
Q ss_pred EEEEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC----------------
Q 026299 93 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---------------- 154 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~---------------- 154 (240)
++|||++ +++|.+++.... +++...++.++.|++.||+|||+.|++|+||+|+||+++.+.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 9999999 779999887654 689999999999999999999999999999999999997643
Q ss_pred -CCcEEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhh
Q 026299 155 -APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (240)
Q Consensus 155 -~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (240)
.+.++|+|||.+.... .......++..|+|||.+.+...+.+ +||||||+++++|++|..||...+..+....
T Consensus 172 ~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 172 INPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp SCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred cCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 3459999999986432 23345568899999999987776555 9999999999999999999988776655443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=262.63 Aligned_cols=207 Identities=23% Similarity=0.441 Sum_probs=177.7
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc------------------HHHHHHHHHHHhcCCCCeee
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID------------------ENVQREIINHRSLRHPNIVR 81 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------------------~~~~~e~~~l~~l~h~~i~~ 81 (240)
.++|++.+.||+|++|.||++.+ ++..|++|.+....... +.+.+|+..++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 37999999999999999999999 89999999987642211 77899999999999999999
Q ss_pred eeEEEEcCCeEEEEEecCCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcC
Q 026299 82 FKEVILTPTHLAIVMEYASGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDG 152 (240)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~~l~~~------l~~--~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~ 152 (240)
+++++.+.+..++||||+++++|.++ +.. ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 655 5679999999999999999999999 99999999999999987
Q ss_pred CCCCcEEEecCCccccccccCCCCCCcCCccccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCc-hhhhhh
Q 026299 153 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRK 230 (240)
Q Consensus 153 ~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~ 230 (240)
++. ++|+|||.+...... ......++..|+|||.+.+. ..+..++|+||||+++++|++|..||...+. ...+.+
T Consensus 188 ~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 188 NGR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp TSC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred CCc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 765 999999998654332 33445678899999999877 4444369999999999999999999988776 444444
Q ss_pred h
Q 026299 231 T 231 (240)
Q Consensus 231 ~ 231 (240)
+
T Consensus 265 i 265 (348)
T 2pml_X 265 I 265 (348)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=253.45 Aligned_cols=194 Identities=27% Similarity=0.388 Sum_probs=171.1
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEc------------
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT------------ 88 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------------ 88 (240)
.+|++++.||+|++|.||++++..+++.|++|.+.... +.+.+|+..++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 57999999999999999999999999999999987643 467789999999999999999998864
Q ss_pred ----CCeEEEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEec
Q 026299 89 ----PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (240)
Q Consensus 89 ----~~~~~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d 162 (240)
...+++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~D 165 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGD 165 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEECc
Confidence 34589999999999999999654 57999999999999999999999999999999999999987665 99999
Q ss_pred CCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026299 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (240)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (240)
||.+.............+++.|+|||.+.+...+.+ +|+||||+++++|++|..||.
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHH
T ss_pred chhheeccccccccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcch
Confidence 999876655555555678899999999987766554 999999999999999998874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=256.52 Aligned_cols=211 Identities=28% Similarity=0.437 Sum_probs=173.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
..++|++++.||+|++|.||++++..++..|++|.+.... ...+.+.+|+..++.++||||+++++++.+++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4479999999999999999999999999999999986643 334678899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cCCC
Q 026299 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~~~ 175 (240)
++++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..... ....
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 174 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQKR 174 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC-
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCcccccccccc
Confidence 9999999998865 456999999999999999999999999999999999999987765 99999998643221 2223
Q ss_pred CCCcCCccccCccccc----cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 176 KSTVGTPAYIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
....++..|+|||.+. .....+.++|+||||+++++|++|..||...+....+.++
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 234 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 234 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 3456788999999984 2333345599999999999999999999887665554443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=252.49 Aligned_cols=207 Identities=21% Similarity=0.313 Sum_probs=174.6
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--Ce
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 91 (240)
..+.++|++.+.||+|++|.||++++. +..|++|++..... ..+.+.+|+..++.++||||+++++++.+. ..
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 345689999999999999999999985 78899999876432 234688999999999999999999999887 77
Q ss_pred EEEEEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCC--ceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~--ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++. +++.|+++..
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~ 161 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKF 161 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCC
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEecccee
Confidence 899999999999999997655 4899999999999999999999999 999999999999987766 7888777654
Q ss_pred cccccCCCCCCcCCccccCccccccCCCCC--cccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~--~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
.. ......+++.|+|||.+.+..... .++||||||+++++|++|..||...+..+...++
T Consensus 162 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 223 (271)
T 3kmu_A 162 SF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223 (271)
T ss_dssp TT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH
T ss_pred ee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH
Confidence 32 223356788999999998765543 2599999999999999999999887666554443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=259.14 Aligned_cols=216 Identities=22% Similarity=0.358 Sum_probs=171.3
Q ss_pred CCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEE----EEEEeecC--ccccHHHHHHHHHHHhcCCCCeeeeeE
Q 026299 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELV----AVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKE 84 (240)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v----~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~ 84 (240)
...+......++|++++.||+|+||.||++++..++..+ ++|.+... ......+.+|+..++.++||||+++++
T Consensus 5 ~~~~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 84 (327)
T 3lzb_A 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp ---CCEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCE
T ss_pred chhhhcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence 344555667799999999999999999999998777755 66665443 233467899999999999999999999
Q ss_pred EEEcCCeEEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecC
Q 026299 85 VILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (240)
Q Consensus 85 ~~~~~~~~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~ 163 (240)
++..+. .+++++++.+++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+||
T Consensus 85 ~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~Df 161 (327)
T 3lzb_A 85 ICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDF 161 (327)
T ss_dssp EEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCT
T ss_pred EEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccC
Confidence 998765 7889999999999999876 457999999999999999999999999999999999999987665 999999
Q ss_pred CccccccccCCC---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 164 GYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 164 ~~~~~~~~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
|.+......... ....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...+.......
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 231 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 998654332222 22334668999999987776554 999999999999999 9999988766554433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=256.61 Aligned_cols=196 Identities=23% Similarity=0.309 Sum_probs=161.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc---HHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++.+.||+|++|.||+|++..++..||+|++....... .....|+..+..+ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999876543222 3345555555555 8999999999999999999999
Q ss_pred ecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
|++ +++|.+++... ..+++..++.++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||.+.........
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence 999 45888877654 46999999999999999999999999999999999999987766 999999998766555555
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
....+++.|+|||.+.+ .+ +.++||||||+++++|++|..||..
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred cccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCC
Confidence 55668999999998875 44 4459999999999999999766654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=257.46 Aligned_cols=203 Identities=17% Similarity=0.189 Sum_probs=169.8
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCC-------cEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTE-------ELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~-------~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (240)
...++|++.+.||+|++|.||++++..++ ..|++|.+.... ...+.+.+|+..++.++||||+++++++.++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 35689999999999999999999998776 479999886543 3346788999999999999999999999999
Q ss_pred CeEEEEEecCCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC------cEEEec
Q 026299 90 THLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICD 162 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~~~-l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~------~~~L~d 162 (240)
+..++||||+++++|.+++..... ++...++.++.|++.||.|||+.|++|+||+|+||+++.++.. .++|+|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999999999976554 8999999999999999999999999999999999999766542 289999
Q ss_pred CCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCC-CCCCCCC
Q 026299 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPE 223 (240)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~ 223 (240)
||.+...... ....++..|+|||.+.+....+.++||||||+++++|++|. .||...+
T Consensus 165 fg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 165 PGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp CCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 9987533221 12345678999999987454566699999999999999954 4544433
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=256.44 Aligned_cols=211 Identities=30% Similarity=0.455 Sum_probs=178.0
Q ss_pred CCCCeeEeeeecCCCceeEEEEEec-CCCcEEEEEEeecCc---cccHHHHHHHHHHHhc---CCCCeeeeeEEEE----
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVIL---- 87 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~-~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~---- 87 (240)
..++|++.+.||+|++|.||++++. .++..|++|++.... .....+.+|+..++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3479999999999999999999995 678999999987532 2234566777777666 8999999999987
Q ss_pred -cCCeEEEEEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 88 -TPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 88 -~~~~~~lv~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
.....++|+|++++ +|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 89 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg 165 (326)
T 1blx_A 89 DRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFG 165 (326)
T ss_dssp SSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCC
T ss_pred CCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCc
Confidence 45678999999985 9999887643 4899999999999999999999999999999999999987765 9999999
Q ss_pred ccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 165 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.+.............++..|+|||.+.+...+.+ +|+||||+++++|++|..||...+..+.+.++++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (326)
T 1blx_A 166 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233 (326)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccCCCCccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 9876554444455667899999999987776555 9999999999999999999999888777766654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=263.46 Aligned_cols=207 Identities=28% Similarity=0.445 Sum_probs=173.8
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE----
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHL---- 92 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---- 92 (240)
.++|++.+.||+|++|.||++.+..+++.||+|++...... ...+.+|+..++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 37999999999999999999999999999999998764322 35678999999999999999999999877654
Q ss_pred --EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 93 --AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 93 --~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
++|||++++ +|.+.+. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 121 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 121 DFYLVMPFMQT-DLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD 195 (371)
T ss_dssp CCEEEEECCCE-EHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC----
T ss_pred eEEEEEccccc-cHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCcccccc
Confidence 999999975 7877663 34899999999999999999999999999999999999987766 9999999986443
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
. ......+++.|+|||.+.+....+.++||||||+++++|++|..||.+.+..+.+.++++
T Consensus 196 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 256 (371)
T 4exu_A 196 A--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 256 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred c--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 2 233456788999999998754445559999999999999999999999888777776654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=258.98 Aligned_cols=203 Identities=26% Similarity=0.397 Sum_probs=167.9
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCC--CCeeeeeEEEEcCC
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRH--PNIVRFKEVILTPT 90 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~ 90 (240)
+....++|++++.||+|+||.||++.+. ++..||+|++...... .+.+.+|+..++.++| +||+++++++.++.
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 3446789999999999999999999986 6888999998764332 2567899999999976 99999999999999
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
..++|||+ .+++|.+++.....+++.++..++.|++.||.|||+.||+|+||+|+||+++. + .++|+|||++....
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~--~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCCC-
T ss_pred EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C--cEEEeecccccccC
Confidence 99999995 56799999988889999999999999999999999999999999999999963 3 49999999987543
Q ss_pred ccCC---CCCCcCCccccCcccccc----------CCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 171 LHSQ---PKSTVGTPAYIAPEVLLK----------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 171 ~~~~---~~~~~~~~~~~~pE~~~~----------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
.... .....+++.|+|||.+.+ ....+.++||||||+++++|++|..||....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 3222 234568999999999864 1333555999999999999999999997643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=254.93 Aligned_cols=200 Identities=29% Similarity=0.435 Sum_probs=168.7
Q ss_pred CCCCCeeEeeeecCCCceeEEEEE----ecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC--
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP-- 89 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 89 (240)
...+.|++.+.||+|++|.||+++ +..++..|++|.+.... ...+.+.+|+..++.++||||+++++++.+.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 344779999999999999999999 56789999999987543 2336788999999999999999999999876
Q ss_pred CeEEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 90 THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
...++||||+++++|.+++.. ...++...++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+..
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~ 175 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKA 175 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECccccccc
Confidence 668999999999999999954 457999999999999999999999999999999999999987765 99999999865
Q ss_pred ccccC----CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026299 169 SVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (240)
Q Consensus 169 ~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (240)
..... ......++..|+|||.+.+...+.+ +|+||||+++++|++|..|+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGG
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCc
Confidence 44332 2233456777999999987776544 999999999999999988753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=258.94 Aligned_cols=209 Identities=30% Similarity=0.427 Sum_probs=174.6
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcC-----Ce
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 91 (240)
..++|++.+.||+|++|.||++++..++..|++|.+..... ....+.+|+..++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 35899999999999999999999999999999999865332 234678999999999999999999998764 67
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
.++++|++++ +|.+++.. ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 89 ~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 89 VYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDE 164 (353)
T ss_dssp EEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC-
T ss_pred EEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEeccccccccc
Confidence 8999999975 88888755 56899999999999999999999999999999999999987765 99999999864432
Q ss_pred cCC-----------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 172 HSQ-----------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 172 ~~~-----------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
... .....++..|+|||.+.+....+.++|+||||+++++|++|..||.+.+..+.+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 235 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 211 122357889999998876555566699999999999999999999988766555443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=257.75 Aligned_cols=211 Identities=32% Similarity=0.531 Sum_probs=174.7
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEc--CCeEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLA 93 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 93 (240)
..++|++.+.||+|++|.||++++..+++.|++|.+..... ..+.+.+|+..+++++||||+++++++.+ +...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 45799999999999999999999999999999999876432 23567899999999999999999998754 57899
Q ss_pred EEEecCCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCC-----ceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 94 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~----~~l~~~~~~~~~~~i~~~l~~LH~~~-----ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
+||||+++++|.+++... ..+++..++.++.|++.||++||+.| ++|+||+|+||+++.++. ++|+|||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg 161 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFG 161 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCc
Confidence 999999999999998653 34899999999999999999999999 999999999999987765 9999999
Q ss_pred ccccccccCC-CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 165 YSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 165 ~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
.+........ .....++..|+|||.+.+...+. ++|+||||+++++|++|..||...+..+...++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~ 229 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNE-KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 229 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCc-hhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh
Confidence 9864332211 11235788999999998776654 4999999999999999999998877655544443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=271.92 Aligned_cols=206 Identities=13% Similarity=0.097 Sum_probs=162.0
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHH---HHHHhcCCCCeeeee-------E
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREI---INHRSLRHPNIVRFK-------E 84 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~ 84 (240)
..++|++.+.||+|+||.||+|++..++..||+|++... ....+.+.+|+ ..++.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 457899999999999999999999989999999998753 22335678999 455556899999988 6
Q ss_pred EEEcCC-----------------eEEEEEecCCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHhhCCcee
Q 026299 85 VILTPT-----------------HLAIVMEYASGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHSMQVCH 140 (240)
Q Consensus 85 ~~~~~~-----------------~~~lv~~~~~~~~l~~~l~~~~~l~~-------~~~~~~~~~i~~~l~~LH~~~ivh 140 (240)
++.+++ ..+++|||+ +++|.+++...+.+++ ..++.++.|++.||+|||+.||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 666553 278999999 5699999976544454 788889999999999999999999
Q ss_pred ecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcCCccccCccccccC-----------CCCCcccchHHHHHHH
Q 026299 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-----------EYDGKIADVWSCGVTL 209 (240)
Q Consensus 141 ~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-----------~~~~~~~Di~slG~~l 209 (240)
+||+|+||+++.++. ++|+|||++..... ......+ ..|+|||.+.+. .+ +.++||||||+++
T Consensus 230 rDikp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il 303 (377)
T 3byv_A 230 TYLRPVDIVLDQRGG--VFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI 303 (377)
T ss_dssp SCCCGGGEEECTTCC--EEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCC--EEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence 999999999987765 99999999874322 2223445 899999999877 44 4559999999999
Q ss_pred HHHHhCCCCCCCCCchhhhhhh
Q 026299 210 YVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 210 ~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
|+|++|..||...+.......+
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~ 325 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWI 325 (377)
T ss_dssp HHHHHSSCCC------CCSGGG
T ss_pred HHHHHCCCCCcccccccchhhh
Confidence 9999999999876655544443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=261.79 Aligned_cols=210 Identities=31% Similarity=0.423 Sum_probs=180.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC-CC-----CeeeeeEEEEcCCeEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HP-----NIVRFKEVILTPTHLAI 94 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~l 94 (240)
++|++.+.||+|++|.||+|++..+++.||+|++.........+.+|+..++.++ |+ +|+++.+++...+..++
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 7899999999999999999999999999999999766555566778888888774 44 49999999999999999
Q ss_pred EEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh--hCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH--~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
|||++++ +|.+++... ..++...+..++.|++.||.||| +.||+|+||+|+||+++.+....++|+|||.+....
T Consensus 134 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 134 VFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp EEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 9999976 999988765 46899999999999999999999 579999999999999976555569999999986543
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.......+++.|+|||.+.+..++.+ +||||||+++++|++|..||.+.+..+.+.++++.
T Consensus 213 --~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 273 (382)
T 2vx3_A 213 --QRIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273 (382)
T ss_dssp --CCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred --cccccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 23345678899999999988776555 99999999999999999999998888877776653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=268.52 Aligned_cols=212 Identities=24% Similarity=0.337 Sum_probs=175.1
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
.....++|++.+.||+|+||.||++.+.. +..||+|.+.......+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 33456889999999999999999999985 4669999998766666789999999999999999999999876 678999
Q ss_pred EecCCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 96 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
|||+++++|.+++.. ...++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNE 334 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC------
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCCc
Confidence 999999999999964 356899999999999999999999999999999999999987665 9999999986543221
Q ss_pred --CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 174 --~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
......++..|+|||.+.+...+.+ +||||||+++++|++ |..||.+....+.+.++.
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~ 395 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred eecccCCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 1122335678999999987766544 999999999999999 999998877666555443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=252.47 Aligned_cols=213 Identities=28% Similarity=0.428 Sum_probs=175.9
Q ss_pred ccCCCCCeeEee-eecCCCceeEEEEEec--CCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC
Q 026299 16 IMHDSDRYELVR-DIGSGNFGVARLMRDK--KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (240)
Q Consensus 16 ~~~~~~~y~~~~-~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (240)
+....++|.+.+ .||+|++|.||++.+. .++..|++|.+.... ...+.+.+|+..++.++||||+++++++ ..+
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 445668899988 9999999999999864 467889999987643 2335688999999999999999999999 456
Q ss_pred eEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
..++|||++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~ 160 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKAL 160 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceeee
Confidence 789999999999999988643 46999999999999999999999999999999999999987665 999999998654
Q ss_pred cccCC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 170 VLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 170 ~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
..... .....++..|+|||.+.+...+.. +|+||||+++++|++ |..||...+..+....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~ 227 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh
Confidence 32221 223345678999999977666544 999999999999998 999998877665554443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=257.54 Aligned_cols=213 Identities=23% Similarity=0.342 Sum_probs=172.1
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCC----cEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (240)
.+..++|++.+.||+|++|.||++.+..++ ..|++|.+..... ....+.+|+..++.++||||+++++++...+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 456689999999999999999999987543 4599999876432 2346789999999999999999999999999
Q ss_pred eEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
..++|||++++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVL 197 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC----
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCCcchhh
Confidence 999999999999999998754 57999999999999999999999999999999999999987665 999999998654
Q ss_pred cccCCC----CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 170 VLHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 170 ~~~~~~----~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
...... ....++..|+|||.+.+...+. ++||||||+++++|++ |..||...+..+....+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 264 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred ccccccccccCCCCccccccCchhcccCCCCc-hhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 332211 1223456899999997766654 4999999999999998 999998776665554443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=249.75 Aligned_cols=205 Identities=29% Similarity=0.475 Sum_probs=170.6
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc--------HHHHHHHHHHHhcCCCCeeeeeEEEEcC
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--------ENVQREIINHRSLRHPNIVRFKEVILTP 89 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (240)
...++|++.+.||+|++|.||++++..++..|++|.+....... +.+.+|+..++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 45689999999999999999999999999999999986543221 5678999999999999999999998766
Q ss_pred CeEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCC--ceeecCCCCCeEEcCCCC---CcEEEecC
Q 026299 90 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPA---PRLKICDF 163 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~--ivh~~i~~~nili~~~~~---~~~~L~d~ 163 (240)
. ++||||+++++|.+.+... .++++..++.++.|++.||+|||+.| ++|+||+|+||+++.++. ..++|+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 5999999999998887654 47999999999999999999999999 999999999999965442 23899999
Q ss_pred CccccccccCCCCCCcCCccccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
|.+..... ......+++.|+|||.+... ...+.++|+||||+++|+|++|..||.......
T Consensus 174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 235 (287)
T 4f0f_A 174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235 (287)
T ss_dssp TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence 99863322 22345678899999998432 223455999999999999999999998765433
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=264.59 Aligned_cols=201 Identities=26% Similarity=0.433 Sum_probs=170.3
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC--------CCCeeeeeEEEE----
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--------HPNIVRFKEVIL---- 87 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~---- 87 (240)
.++|++.+.||+|++|.||++++..++..||+|++.......+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 37899999999999999999999999999999999876555677889999999885 788999999987
Q ss_pred cCCeEEEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhC-CceeecCCCCCeEEcCCCC---------
Q 026299 88 TPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPA--------- 155 (240)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~-~ivh~~i~~~nili~~~~~--------- 155 (240)
....+++|||++.+ ++.+.+... ..+++..++.++.||+.||+|||+. ||+|+||+|+||+++.++.
T Consensus 116 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 55678999999955 555555443 4699999999999999999999998 9999999999999976531
Q ss_pred --------------------------------------CcEEEecCCccccccccCCCCCCcCCccccCccccccCCCCC
Q 026299 156 --------------------------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197 (240)
Q Consensus 156 --------------------------------------~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~ 197 (240)
..++|+|||.+..... ......++..|+|||.+.+..++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCT
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCc
Confidence 2499999999865432 234456889999999998877655
Q ss_pred cccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 198 KIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 198 ~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
+ +||||||+++|+|++|..||...+.
T Consensus 273 ~-~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 273 P-ADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred H-HHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 5 9999999999999999999987653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=253.37 Aligned_cols=207 Identities=27% Similarity=0.409 Sum_probs=168.4
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC-CeEEEE
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIV 95 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv 95 (240)
..+.++|++.+.||+|++|.||++++. +..|++|.+.... ..+.+.+|+..++.++||||+++++++... +..++|
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 446689999999999999999999875 7889999887543 456789999999999999999999997654 478999
Q ss_pred EecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST- 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeecccccccccc-
Confidence 99999999999987654 3899999999999999999999999999999999999987765 999999998643322
Q ss_pred CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
.....++..|+|||.+.+...+.+ +|+||||+++++|++ |..||...+..+...++
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 227 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred -ccCCCccccccCHHHhCCCCCCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 223356778999999877666544 999999999999998 99999887666555444
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=258.54 Aligned_cols=213 Identities=23% Similarity=0.350 Sum_probs=177.7
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCc-----EEEEEEeecCcc--ccHHHHHHHHHHHhc-CCCCeeeeeEEEE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (240)
.....++|++.+.||+|++|.||++.+..++. .|++|.+..... ..+.+.+|+..++.+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 44556899999999999999999999976654 799998876432 235688999999999 8999999999999
Q ss_pred cCCeEEEEEecCCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC
Q 026299 88 TPTHLAIVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (240)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~l~~~--------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~ 153 (240)
+++..++||||+++++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 999999999999999999988642 357999999999999999999999999999999999999876
Q ss_pred CCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 026299 154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (240)
Q Consensus 154 ~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (240)
+. ++|+|||.+........ .....++..|+|||.+.+...+. ++||||||+++++|++ |..||.+......+.
T Consensus 201 ~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 201 HV--AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV-QSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp GE--EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred Ce--EEECccccccccccccceeecCCCCCCccccCHHHhccCCCCh-HHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 65 99999999875433222 12234567899999988776654 4999999999999998 999998876655544
Q ss_pred hh
Q 026299 230 KT 231 (240)
Q Consensus 230 ~~ 231 (240)
++
T Consensus 278 ~~ 279 (333)
T 2i1m_A 278 KL 279 (333)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=255.29 Aligned_cols=214 Identities=24% Similarity=0.372 Sum_probs=167.7
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecC---CCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCC
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT 90 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (240)
....++|++.+.||+|++|.||++.+.. ++..|++|.+...... .+.+.+|+..+++++||||+++++++.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 3455899999999999999999998765 4568999998764322 246789999999999999999999998754
Q ss_pred -----eEEEEEecCCCCchHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEE
Q 026299 91 -----HLAIVMEYASGGELFERIC------NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (240)
Q Consensus 91 -----~~~lv~~~~~~~~l~~~l~------~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~ 159 (240)
..+++++++++++|.+++. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~k 187 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VC 187 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EE
Confidence 3599999999999999884 2356999999999999999999999999999999999999987765 99
Q ss_pred EecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 160 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 160 L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
|+|||.+....... ......++..|+|||.+.+...+.+ +|+||||+++++|++ |..||...+.......+..
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 99999986443322 1223345678999999977666544 999999999999999 9999988777665554443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=257.32 Aligned_cols=213 Identities=20% Similarity=0.333 Sum_probs=177.4
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEec-----CCCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcC
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTP 89 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (240)
....++|++.+.||+|++|.||++.+. .++..|++|.+...... ...+.+|+..++.++||||+++++++.++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 344579999999999999999999887 45788999998764332 24578999999999999999999999999
Q ss_pred CeEEEEEecCCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEE
Q 026299 90 THLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~ 159 (240)
+..++|||++++++|.+++... .+++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~k 178 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VK 178 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EE
Confidence 9999999999999999988642 35689999999999999999999999999999999999987765 99
Q ss_pred EecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 160 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 160 L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
|+|||.+........ .....+++.|+|||.+.+...+. ++||||||+++++|++ |..||...+.......+.
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCc-hhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 999999864432221 12234567899999987776654 4999999999999999 899998876665555443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=261.11 Aligned_cols=201 Identities=25% Similarity=0.398 Sum_probs=167.9
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcC--CCCeeeeeEEEEcCCeEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~ 93 (240)
..++|++.+.||+|+||.||++.+.. +..||+|++..... ..+.+.+|+.+++.++ ||||+++++++..++.++
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 34569999999999999999999875 88999999876432 2356789999999996 599999999999999999
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
+||| +.+++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++. + .++|+|||++.......
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~--~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S--CEEECCCSSSCCC----
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C--eEEEEecCccccccCCC
Confidence 9999 567799999988888999999999999999999999999999999999999953 3 49999999987543322
Q ss_pred ---CCCCCcCCccccCccccccC----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 174 ---QPKSTVGTPAYIAPEVLLKK----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 174 ---~~~~~~~~~~~~~pE~~~~~----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
......+++.|+|||.+.+. ...+.++||||||+++|+|++|..||.....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 272 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH
Confidence 12345689999999998652 2345559999999999999999999977543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=258.83 Aligned_cols=211 Identities=28% Similarity=0.445 Sum_probs=174.4
Q ss_pred CCCCCCcccCCCCCeeEeeeecCCCceeEEEEE----ecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeee
Q 026299 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFK 83 (240)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~ 83 (240)
.++....-..+.++|++.+.||+|++|.||+++ +..++..|++|.+..... ..+.+.+|+..+++++||||++++
T Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 11 LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp ------CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred HhhcChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 344555666788999999999999999999999 567899999999876532 235688999999999999999999
Q ss_pred EEEE--cCCeEEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEE
Q 026299 84 EVIL--TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (240)
Q Consensus 84 ~~~~--~~~~~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L 160 (240)
+++. +....++||||+++++|.+++.. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl 168 (327)
T 3lxl_A 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKI 168 (327)
T ss_dssp EEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEE
T ss_pred EEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEE
Confidence 9987 44678999999999999999976 356999999999999999999999999999999999999987765 999
Q ss_pred ecCCccccccccC----CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 161 CDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 161 ~d~~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
+|||.+....... ......++..|+|||.+.+...+.+ +||||||+++++|++|..||...
T Consensus 169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccceecccCCccceeeccCCccccccCHHHhccCCCChH-HhHHHHHHHHHHHHhCCCCCccc
Confidence 9999986443222 2223446777999999877766444 99999999999999999998654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=262.96 Aligned_cols=200 Identities=14% Similarity=0.151 Sum_probs=168.9
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecC--------CCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeee--------
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKK--------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-------- 81 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-------- 81 (240)
...++|++.+.||+|++|.||++++.. .+..||+|.+... +.+.+|+.++++++||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 345899999999999999999999987 4889999988654 45789999999999998887
Q ss_pred -------eeEEEEc-CCeEEEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEc
Q 026299 82 -------FKEVILT-PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (240)
Q Consensus 82 -------~~~~~~~-~~~~~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~ 151 (240)
+++++.. +...++||||+ +++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 6677765 67899999999 88999999875 6799999999999999999999999999999999999998
Q ss_pred CCCCCcEEEecCCccccccccCC--------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 152 GSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 152 ~~~~~~~~L~d~~~~~~~~~~~~--------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
.++...++|+|||.+........ .....+++.|+|||.+.+...+. ++||||||+++|+|++|..||....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR-RSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCcccCC
Confidence 77633599999999865443222 12346788999999998776644 4999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=258.32 Aligned_cols=217 Identities=25% Similarity=0.392 Sum_probs=177.5
Q ss_pred CCCCCcccCCCCCeeEeeeecCCCceeEEEEEe-----cCCCcEEEEEEeecCccc--cHHHHHHHHHHHhc-CCCCeee
Q 026299 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVR 81 (240)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~ 81 (240)
|..........++|++.+.||+|++|.||++++ ..++..|++|.+...... .+.+.+|+..++.+ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 333344456678999999999999999999985 356789999998765332 24678999999999 6899999
Q ss_pred eeEEEEcCC-eEEEEEecCCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHhhCCceeecCC
Q 026299 82 FKEVILTPT-HLAIVMEYASGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144 (240)
Q Consensus 82 ~~~~~~~~~-~~~lv~~~~~~~~l~~~l~~~~~----------------l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~ 144 (240)
+++++...+ .+++++||+++++|.+++..... ++...++.++.|++.||.+||+.|++|+||+
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dik 175 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 175 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCc
Confidence 999987754 58999999999999999976543 7899999999999999999999999999999
Q ss_pred CCCeEEcCCCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCC
Q 026299 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFE 220 (240)
Q Consensus 145 ~~nili~~~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~ 220 (240)
|+||+++.++. ++|+|||.+........ .....++..|+|||.+.+...+. ++||||||+++++|++ |..||.
T Consensus 176 p~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 176 ARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp GGGEEECGGGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSST
T ss_pred cceEEECCCCC--EEECCCccccccccCccceeccCCCcceeecCchhhccccccc-hhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999987665 99999999864433221 12234567899999998776654 4999999999999998 999998
Q ss_pred CCCchhhhh
Q 026299 221 DPEEPKNFR 229 (240)
Q Consensus 221 ~~~~~~~~~ 229 (240)
.......+.
T Consensus 253 ~~~~~~~~~ 261 (316)
T 2xir_A 253 GVKIDEEFC 261 (316)
T ss_dssp TCCCSHHHH
T ss_pred ccchhHHHH
Confidence 876554443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=256.39 Aligned_cols=209 Identities=26% Similarity=0.417 Sum_probs=171.4
Q ss_pred CCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEc-
Q 026299 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILT- 88 (240)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 88 (240)
.+.-.+....++|++.+.||+|++|.||++++..++..|++|++.... ...+.+.+|+..++.++||||+++++++..
T Consensus 19 ~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp EEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred ecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 333445567789999999999999999999999999999999886643 334568899999999999999999999873
Q ss_pred ---CCeEEEEEecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEe
Q 026299 89 ---PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (240)
Q Consensus 89 ---~~~~~lv~~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~ 161 (240)
....++|+||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~ 176 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLM 176 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEEC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEE
Confidence 3578999999999999998875 467999999999999999999999999999999999999987765 9999
Q ss_pred cCCccccccccCCC----------CCCcCCccccCccccccCCC--CCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 162 DFGYSKSSVLHSQP----------KSTVGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 162 d~~~~~~~~~~~~~----------~~~~~~~~~~~pE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
|||.+......... ....++..|+|||.+.+... ...++||||||+++++|++|..||..
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 99987543221111 12235888999999875542 24459999999999999999999953
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=255.92 Aligned_cols=201 Identities=30% Similarity=0.482 Sum_probs=174.4
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc-------cHHHHHHHHHHHhcC--CCCeeeeeEEEEcC
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------DENVQREIINHRSLR--HPNIVRFKEVILTP 89 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 89 (240)
..++|++.+.||+|++|.||++++..++..|++|.+...... ...+.+|+..+++++ |+||+++++++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 457999999999999999999999999999999998764322 245678999999996 59999999999999
Q ss_pred CeEEEEEecCCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEc-CCCCCcEEEecCCccc
Q 026299 90 THLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSK 167 (240)
Q Consensus 90 ~~~~lv~~~~~~-~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~-~~~~~~~~L~d~~~~~ 167 (240)
+..+++++++.+ ++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++ .++. ++|+|||.+.
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~--~kL~Dfg~~~ 198 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGA 198 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE--EEECCCTTCE
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC--EEEeeCcccc
Confidence 999999999975 89999998888899999999999999999999999999999999999997 4444 9999999986
Q ss_pred cccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
.... .......++..|+|||.+.+....+.++||||||+++++|++|..||...
T Consensus 199 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 199 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 5432 22334568889999999987777666689999999999999999999653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=252.54 Aligned_cols=201 Identities=28% Similarity=0.432 Sum_probs=162.4
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
..++|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|+..++.++||||+++++++..++..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3468999999999999999999999999999999987532 223567899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 95 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
|||++++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeeec
Confidence 9999999999998864 456899999999999999999999999999999999999987665 9999999986443
Q ss_pred ccC-CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 171 LHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 171 ~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
... ......++..|+|||.+.+...+. ++|+||||+++++|++|..||...
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCc-hhhHHHHHHHHHHHHhCCCCCccc
Confidence 322 223345788999999988776654 499999999999999999999754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=252.58 Aligned_cols=215 Identities=25% Similarity=0.364 Sum_probs=163.4
Q ss_pred CCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 026299 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVIL 87 (240)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~ 87 (240)
....+.-...++|++.+.||+|+||.||++++.. .+++|.+...... .+.+.+|+..++.++||||++++++.
T Consensus 14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp ----CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CCCCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 3344455567899999999999999999998754 4999988654322 35688999999999999999999965
Q ss_pred cCCeEEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 88 TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
.....++||||+++++|.+++.. ...++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~ 167 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLA 167 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC--
T ss_pred cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccceec
Confidence 45668999999999999998854 356899999999999999999999999999999999999987765 999999998
Q ss_pred ccccc---cCCCCCCcCCccccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 167 KSSVL---HSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 167 ~~~~~---~~~~~~~~~~~~~~~pE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
..... ........++..|+|||.+.. ....+.++||||||+++++|++|..||......+.+.+.
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 237 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence 64332 122233457899999999862 222344599999999999999999999887665544433
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=254.38 Aligned_cols=192 Identities=30% Similarity=0.465 Sum_probs=161.1
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEc------------
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT------------ 88 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------------ 88 (240)
++|++++.||+|++|.||++++..++..|++|.+.......+.+.+|+..++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 57999999999999999999999999999999997655555678899999999999999999998865
Q ss_pred -CCeEEEEEecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 89 -PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 89 -~~~~~lv~~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
....++|||++++++|.+++.... .+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~ 163 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLA 163 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcch
Confidence 356899999999999999997543 5788999999999999999999999999999999999987765 999999998
Q ss_pred cccccc---------------CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh
Q 026299 167 KSSVLH---------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214 (240)
Q Consensus 167 ~~~~~~---------------~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~ 214 (240)
...... .......++..|+|||.+.+....+.++|+||||+++++|++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 644321 112334578899999999866545556999999999999997
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=257.97 Aligned_cols=213 Identities=22% Similarity=0.325 Sum_probs=172.1
Q ss_pred CCCCCeeEeeeecCCCceeEEEEE-----ecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (240)
...++|++.+.||+|++|.||+++ +..++..|++|.+.... .....+.+|+..+++++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 455899999999999999999999 55678899999986532 22356889999999999999999999999999
Q ss_pred eEEEEEecCCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEec
Q 026299 91 HLAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICD 162 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~-------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d 162 (240)
..++||||+++++|.+++.... .++...++.++.|++.||.+||+.|++|+||+|+||+++.++ ...++|+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence 9999999999999999997653 489999999999999999999999999999999999997433 33499999
Q ss_pred CCcccccccc---CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 163 FGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 163 ~~~~~~~~~~---~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
||.+...... .......++..|+|||.+.+...+. ++||||||+++++|++ |..||...+.......+
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 9998643222 2223345678899999987776654 4999999999999998 99999887665554443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=253.46 Aligned_cols=208 Identities=32% Similarity=0.523 Sum_probs=171.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC-----ccccHHHHHHHHHHHhcCCCCeeeeeEEEE--cCCeEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DKIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHLA 93 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 93 (240)
++|++.+.||+|++|.||++.+..++..|++|.+... ....+.+.+|+..++.++||||+++++++. +....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 7899999999999999999999999999999998653 233467889999999999999999999984 446789
Q ss_pred EEEecCCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 94 IVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
+||||++++ +.+.+.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHP 161 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCT
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccCc
Confidence 999999875 6666654 356899999999999999999999999999999999999987765 99999999865432
Q ss_pred c---CCCCCCcCCccccCccccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 172 H---SQPKSTVGTPAYIAPEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 172 ~---~~~~~~~~~~~~~~pE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
. .......++..|+|||.+.+... .+.++|+||||+++++|++|..||.+.+....+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i 225 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH
Confidence 2 11234457889999999876432 344599999999999999999999887665555444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=258.54 Aligned_cols=199 Identities=27% Similarity=0.356 Sum_probs=170.5
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
...++|++.+.||+|++|.||++++. ++..|++|++..... ....+.+|+..++.++||||+++++++.++...++|
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 105 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEE
T ss_pred HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEE
Confidence 35589999999999999999999865 688899999876432 234688999999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 96 MEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~----~l~~~~~~~~~~~i~~~l~~LH~~---~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
|||+++++|.+++.... ++++..+..++.|++.||.|||+. |++|+||+|+||+++.++. ++|+|||.+..
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~ 183 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKL 183 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEE
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCccccc
Confidence 99999999999997543 489999999999999999999999 9999999999999987765 99999999865
Q ss_pred ccccCC--CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026299 169 SVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (240)
Q Consensus 169 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (240)
...... .....+++.|+|||.+.+...+.+ +||||||+++++|++|..||.
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCSSSSCEECCCCSCGGGCCHHHHHHSEECHH-HHHHHHHHHHHHHHHCCCSBC
T ss_pred cCcccccccccccCCcCccCHHHhccCCCCcc-ccchhHHHHHHHHHhCCCccc
Confidence 432222 223448899999999977776544 999999999999999999995
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=248.45 Aligned_cols=199 Identities=27% Similarity=0.291 Sum_probs=168.3
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEE-EcCCeEEEEEec
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVMEY 98 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~~~ 98 (240)
.++|++.+.||+|++|.||++++..+++.|++|++.... ..+.+.+|+..++.++|++++..+..+ ..+...++|||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 479999999999999999999999999999999886644 345688999999999987766555554 566788999999
Q ss_pred CCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEc---CCCCCcEEEecCCccccccccCC
Q 026299 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 99 ~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~---~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
+ +++|.+++.. ..++++..++.++.|++.||+|||+.|++|+||+|+||+++ .++. ++|+|||.+........
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe--EEEeeCCCccccccccc
Confidence 9 8899999873 45799999999999999999999999999999999999994 4444 99999999865443322
Q ss_pred --------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 175 --------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 175 --------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
.....++..|+|||.+.+...+. ++||||||+++++|++|..||....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccccccCChhhhcCCCCCc-chhhHHHHHHHHHHHhCCCCCCCcC
Confidence 23456888999999998777644 4999999999999999999998743
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=258.26 Aligned_cols=207 Identities=28% Similarity=0.444 Sum_probs=172.4
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe-----
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 91 (240)
.++|++.+.||+|++|.||++.+..+|..|++|.+...... ...+.+|+..++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 47899999999999999999999999999999998654322 3467899999999999999999999987653
Q ss_pred -EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 92 -LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 92 -~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
++++||++++ +|.+++. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 103 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 103 DFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD 177 (353)
T ss_dssp CCEEEEECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC--
T ss_pred eEEEEeccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCC
Confidence 4999999975 8877663 34899999999999999999999999999999999999987765 9999999986433
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
. ......++..|+|||.+.+....+.++|+||||+++++|++|..||.+.+..+.+.++++
T Consensus 178 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~ 238 (353)
T 3coi_A 178 A--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHH
T ss_pred C--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2 223446788999999988744445559999999999999999999998887766665543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=248.78 Aligned_cols=208 Identities=24% Similarity=0.304 Sum_probs=170.0
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecC---CCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
...++|++.+.||+|++|.||++.+.. ++..|++|.+.... ...+.+.+|+..++.++||||+++++++.++ ..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence 355899999999999999999999664 34569999887643 2335688999999999999999999998654 56
Q ss_pred EEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
++|||++++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIED 165 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC--
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCccccc
Confidence 8999999999999999765 45999999999999999999999999999999999999987665 99999999865433
Q ss_pred cCC--CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 026299 172 HSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (240)
Q Consensus 172 ~~~--~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (240)
... .....++..|+|||.+.+...+. ++|+||||+++++|++ |..||...+..+...
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~llt~g~~p~~~~~~~~~~~ 225 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTT-ASDVWMFAVCMWEILSFGKQPFFWLENKDVIG 225 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH
T ss_pred ccccccccCCCCcceeCchhhccCCCCc-hhccHHHHHHHHHHHhCCCCCcccCChHHHHH
Confidence 221 22334567899999997766654 4999999999999998 999997665554443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=270.53 Aligned_cols=211 Identities=24% Similarity=0.345 Sum_probs=178.4
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
+.+..++|++.+.||+|+||.||++.+.. +..|+||++.......+.+.+|+.+++.++|+||+++++++.+ ...++|
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 34456899999999999999999999985 5669999998776666789999999999999999999999876 678999
Q ss_pred EecCCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-
Q 026299 96 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~- 172 (240)
|||+++++|.+++.. ...++...++.++.||+.||+|||+.||+|+||+|+||+++.++. ++|+|||++......
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNE 417 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCc
Confidence 999999999999964 356899999999999999999999999999999999999987665 999999998644321
Q ss_pred -CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 173 -~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
.......++..|+|||.+.+..++.+ +||||||+++|+|++ |..||.+....+.+.++
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i 477 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH
T ss_pred eecccCCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 12223345678999999987766544 999999999999999 99999887766555444
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=255.67 Aligned_cols=208 Identities=26% Similarity=0.399 Sum_probs=173.8
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCC-cEEEEEEeecCccccHHHHHHHHHHHhcCCCC------eeeeeEEEEcCCeE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVILTPTHL 92 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~ 92 (240)
.++|++.+.||+|++|.||++.+..++ ..|++|++.......+.+.+|+..++.++|++ ++.+.+++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 489999999999999999999998766 78999998766555667888999999887654 89999999999999
Q ss_pred EEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC-----------------
Q 026299 93 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS----------------- 153 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~----------------- 153 (240)
++|||++.+ ++.+.+... .++++..++.++.|++.||+|||+.||+|+||+|+||++..+
T Consensus 98 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~ 176 (355)
T 2eu9_A 98 CIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176 (355)
T ss_dssp EEEEECCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred EEEEeccCC-ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccccc
Confidence 999999955 666666544 369999999999999999999999999999999999999432
Q ss_pred CCCcEEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 154 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 154 ~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
....++|+|||.+.... .......++..|+|||.+.+...+.+ +||||||+++|+|++|..||...+..+.+..+
T Consensus 177 ~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 177 KNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp SCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 23349999999986432 23344568899999999987776555 99999999999999999999887776655443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=248.38 Aligned_cols=200 Identities=27% Similarity=0.291 Sum_probs=165.2
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEE-EcCCeEEEEEec
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVMEY 98 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~~~ 98 (240)
.++|++.+.||+|++|.||++++..+++.|++|++.... ....+.+|+..++.++|++++..+..+ ..+...+++||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 378999999999999999999999999999999865543 334588999999999987766665555 667888999999
Q ss_pred CCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEE---cCCCCCcEEEecCCccccccccCC
Q 026299 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 99 ~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili---~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
+ +++|.+++.. ..++++..++.++.|++.||.|||+.|++|+||+|+||++ +.++. ++|+|||.+........
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe--EEEecCccceeccCccc
Confidence 9 8899998874 4579999999999999999999999999999999999999 55554 99999999875443322
Q ss_pred --------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 175 --------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 175 --------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.....++..|+|||.+.+...+. ++||||||+++++|++|..||...+.
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCc-hhHHHHHHHHHHHHhcCCCCCcccch
Confidence 23456789999999998777644 49999999999999999999987543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=253.82 Aligned_cols=205 Identities=27% Similarity=0.416 Sum_probs=153.0
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcC-CCCeeeeeEEEE--------
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLR-HPNIVRFKEVIL-------- 87 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-------- 87 (240)
....+|++.+.||+|++|.||++++..++..|++|++..... ..+.+.+|+..++++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 344699999999999999999999999999999998866532 2356789999999996 999999999984
Q ss_pred cCCeEEEEEecCCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCC--ceeecCCCCCeEEcCCCCCcEEEec
Q 026299 88 TPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICD 162 (240)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~l~~---~~~l~~~~~~~~~~~i~~~l~~LH~~~--ivh~~i~~~nili~~~~~~~~~L~d 162 (240)
....+++++|+++| +|.+++.. ..++++..++.++.|++.||.|||+.| ++|+||+|+||+++.++. ++|+|
T Consensus 105 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~D 181 (337)
T 3ll6_A 105 GQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCD 181 (337)
T ss_dssp SSEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCC
T ss_pred CCceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEec
Confidence 33458999999974 88887754 456999999999999999999999999 999999999999987765 99999
Q ss_pred CCccccccccCCC-------------CCCcCCccccCccccc--cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 163 FGYSKSSVLHSQP-------------KSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 163 ~~~~~~~~~~~~~-------------~~~~~~~~~~~pE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
||.+......... ....+++.|+|||.+. .....+.++||||||+++++|++|..||......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9998654332211 1334788899999983 2223344599999999999999999999765443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=255.23 Aligned_cols=199 Identities=31% Similarity=0.467 Sum_probs=165.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-------ccHHHHHHHHHHHhc----CCCCeeeeeEEEEc
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSL----RHPNIVRFKEVILT 88 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l----~h~~i~~~~~~~~~ 88 (240)
.++|++.+.||+|++|.||++++..++..|++|.+..... ....+.+|+..++++ +|+||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 3689999999999999999999999999999999866432 123456788888888 89999999999999
Q ss_pred CCeEEEEEec-CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEc-CCCCCcEEEecCCcc
Q 026299 89 PTHLAIVMEY-ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYS 166 (240)
Q Consensus 89 ~~~~~lv~~~-~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~-~~~~~~~~L~d~~~~ 166 (240)
.+..++++++ +.+++|.+++.+..++++..++.++.|++.||++||+.|++|+||+|+||+++ .++ .++|+|||.+
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~ 187 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSG 187 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSC
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchh
Confidence 8899999999 78899999998888899999999999999999999999999999999999997 454 4999999998
Q ss_pred ccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
..... .......++..|+|||.+.+......++|+||||+++++|++|..||..
T Consensus 188 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 188 ALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred hhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 65433 2233456788999999998777766569999999999999999999965
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=251.67 Aligned_cols=220 Identities=29% Similarity=0.438 Sum_probs=168.4
Q ss_pred CCCCCCcccCCCCCeeEeeeecCCCceeEEEEEecC-CC--cEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeee
Q 026299 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKK-TE--ELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVR 81 (240)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-~~--~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~ 81 (240)
+|..........++|++.+.||+|++|.||++++.. ++ ..|++|++.... ...+.+.+|+..++.++||||++
T Consensus 6 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 85 (291)
T 1u46_A 6 GPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85 (291)
T ss_dssp -----CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCccc
Confidence 444455566677899999999999999999998653 33 368999887542 22356789999999999999999
Q ss_pred eeEEEEcCCeEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEE
Q 026299 82 FKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (240)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L 160 (240)
+++++..+. .++|+|++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|
T Consensus 86 ~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl 162 (291)
T 1u46_A 86 LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKI 162 (291)
T ss_dssp EEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEE
T ss_pred EEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEE
Confidence 999998765 78999999999999988754 56899999999999999999999999999999999999987665 999
Q ss_pred ecCCccccccccCC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 161 CDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 161 ~d~~~~~~~~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
+|||.+........ .....++..|+|||.+.+...+. ++|+||||+++++|++ |..||...+....+.++.
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 238 (291)
T 1u46_A 163 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH-ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238 (291)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred ccccccccccccccchhhhccCCCCceeeCchhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH
Confidence 99999865433221 12334566899999987766644 4999999999999999 999998877666555443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=252.77 Aligned_cols=197 Identities=27% Similarity=0.364 Sum_probs=162.4
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHh--cCCCCeeeeeEEEEcC----CeE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTP----THL 92 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~~ 92 (240)
..++|++.+.||+|++|.||++++ ++..||+|++.... ...+.+|.+.+.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 347999999999999999999987 58899999986543 3445566666665 7899999999986543 458
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------hCCceeecCCCCCeEEcCCCCCcEEEecCC
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH--------~~~ivh~~i~~~nili~~~~~~~~~L~d~~ 164 (240)
++||||+++++|.+++. ...+++..++.++.|++.||+||| +.|++|+||+|+||+++.++. ++|+|||
T Consensus 82 ~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg 158 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLG 158 (301)
T ss_dssp EEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCT
T ss_pred EEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCC
Confidence 99999999999999984 457899999999999999999999 999999999999999987765 9999999
Q ss_pred ccccccccCC-----CCCCcCCccccCccccccCCCC-----CcccchHHHHHHHHHHHhC----------CCCCCCC
Q 026299 165 YSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKKEYD-----GKIADVWSCGVTLYVMLVG----------AYPFEDP 222 (240)
Q Consensus 165 ~~~~~~~~~~-----~~~~~~~~~~~~pE~~~~~~~~-----~~~~Di~slG~~l~~l~~g----------~~pf~~~ 222 (240)
.+........ .....+++.|+|||.+.+.... +.++||||||+++|+|++| ..||...
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9854332211 2334688999999999776322 2459999999999999999 8888654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=252.56 Aligned_cols=205 Identities=26% Similarity=0.378 Sum_probs=152.7
Q ss_pred cccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc--cHHHHHHHH-HHHhcCCCCeeeeeEEEEcCCe
Q 026299 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREII-NHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
......++|++.+.||+|++|.||++.+..+++.|++|.+...... ...+..|.. .++.++||||+++++++..++.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 3445668999999999999999999999999999999998764322 234455555 6677899999999999999999
Q ss_pred EEEEEecCCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhC-CceeecCCCCCeEEcCCCCCcEEEecCCc
Q 026299 92 LAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~LH~~-~ivh~~i~~~nili~~~~~~~~~L~d~~~ 165 (240)
.++|||++++ +|.+++.. ...+++..+..++.|++.||.+||+. |++|+||+|+||+++.++. ++|+|||.
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~ 172 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGI 172 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCC
Confidence 9999999986 77777653 56789999999999999999999998 9999999999999987765 99999999
Q ss_pred cccccccCCCCCCcCCccccCccccc----cCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 166 SKSSVLHSQPKSTVGTPAYIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~pE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
+.............++..|+|||.+. +... +.++|+||||+++++|++|..||....
T Consensus 173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp SCC------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ceecccccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 87554444444456888999999984 3334 445999999999999999999997643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=254.54 Aligned_cols=211 Identities=31% Similarity=0.464 Sum_probs=168.4
Q ss_pred CcCCCCCCCcccCCCCCeeEeeeecCCCceeEEEEE----ecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCe
Q 026299 6 MTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 79 (240)
Q Consensus 6 ~~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i 79 (240)
+...|+.+. .++.+.|++++.||+|++|.||++. +..++..|++|++.... ...+.+.+|+..++.++||||
T Consensus 18 ~~~~pg~~~--~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 95 (318)
T 3lxp_A 18 LFQGPGDPT--VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95 (318)
T ss_dssp ------CCC--BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred eecCCCCCc--eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcch
Confidence 334555543 3344455999999999999997775 44578999999987653 223568899999999999999
Q ss_pred eeeeEEEEcC--CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCc
Q 026299 80 VRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (240)
Q Consensus 80 ~~~~~~~~~~--~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~ 157 (240)
+++++++.+. ..+++||||+++++|.+++.+. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.
T Consensus 96 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~-- 172 (318)
T 3lxp_A 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL-- 172 (318)
T ss_dssp CCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--
T ss_pred hhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--
Confidence 9999999874 6789999999999999988654 4899999999999999999999999999999999999987765
Q ss_pred EEEecCCccccccccC----CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 158 LKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 158 ~~L~d~~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
++|+|||.+....... ......++..|+|||.+.+...+.+ +||||||+++++|++|..||...
T Consensus 173 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 173 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSH
T ss_pred EEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCccccc
Confidence 9999999986543322 1233446778999999987776544 99999999999999999998654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=247.72 Aligned_cols=210 Identities=27% Similarity=0.393 Sum_probs=169.1
Q ss_pred CcccCCCCCeeEeeeecCCCceeEEEEEecCCCc---EEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEc
Q 026299 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT 88 (240)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (240)
+.+......|++.+.||+|++|.||++.+..++. .+++|.+..... ..+.+.+|+..++.++||||+++++++.+
T Consensus 14 ~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 14 VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93 (298)
T ss_dssp GBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred eEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 3444444577888999999999999999765444 799998865432 23567899999999999999999999987
Q ss_pred CCeE-EEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 89 PTHL-AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 89 ~~~~-~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
.+.. +++++++.+++|.+++.. ...++...++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+
T Consensus 94 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~ 171 (298)
T 3pls_A 94 PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLA 171 (298)
T ss_dssp SSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSS
T ss_pred CCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCc
Confidence 6554 899999999999999876 456899999999999999999999999999999999999987765 999999998
Q ss_pred cccccc-----CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCC-CCCCCchh
Q 026299 167 KSSVLH-----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPK 226 (240)
Q Consensus 167 ~~~~~~-----~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~ 226 (240)
...... .......++..|+|||.+.+...+.+ +|+||||+++++|++|..| |...+..+
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~~~~ 236 (298)
T 3pls_A 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFD 236 (298)
T ss_dssp CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCGGG
T ss_pred ccccCCcccccccCcCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCCccCCHHH
Confidence 643221 22233446778999999987776544 9999999999999995555 54444433
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=248.06 Aligned_cols=203 Identities=33% Similarity=0.485 Sum_probs=168.8
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
.++|.....||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++++++.+.+..++|+|+
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 345555569999999999999999999999999987653 3346788999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC-CCCCcEEEecCCcccccccc-C
Q 026299 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLH-S 173 (240)
Q Consensus 99 ~~~~~l~~~l~~~---~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~-~~~~~~~L~d~~~~~~~~~~-~ 173 (240)
+++++|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||+++. ++. ++|+|||.+...... .
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGINP 178 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC--EEECCTTTCEESCC---
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC--EEEeecccccccCCCCC
Confidence 9999999998754 24678999999999999999999999999999999999976 444 999999998654332 2
Q ss_pred CCCCCcCCccccCccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 174 QPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 174 ~~~~~~~~~~~~~pE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
......++..|+|||.+.+.. ..+.++|+||||+++++|++|..||.....
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 233456788999999987653 234559999999999999999999976443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=260.42 Aligned_cols=202 Identities=29% Similarity=0.442 Sum_probs=154.9
Q ss_pred CCeeEe-eeecCCCceeEEEEEec--CCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEc--CCeEEEE
Q 026299 21 DRYELV-RDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIV 95 (240)
Q Consensus 21 ~~y~~~-~~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 95 (240)
+.|++. +.||+|+||.||+|++. .++..||+|.+... .....+.+|+.+++.++||||+++++++.. +...++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 457774 47999999999999965 56889999988654 334678899999999999999999999954 6789999
Q ss_pred EecCCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC--CCCCcEEEecCC
Q 026299 96 MEYASGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG--SPAPRLKICDFG 164 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~---------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~--~~~~~~~L~d~~ 164 (240)
|||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+||++.. +..+.++|+|||
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 999976 777766422 24899999999999999999999999999999999999932 223359999999
Q ss_pred cccccccc----CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 165 YSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 165 ~~~~~~~~----~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
++...... .......++..|+|||.+.+....+.++|||||||++|+|++|..||.....
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 98754332 2223356788999999998766556669999999999999999999976554
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=254.11 Aligned_cols=212 Identities=32% Similarity=0.480 Sum_probs=150.3
Q ss_pred CCCCCCcccCCCCCeeEee-eecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 026299 9 GPGMDMPIMHDSDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87 (240)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~-~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 87 (240)
.++.......-.++|++.+ .||+|++|.||++++..+++.||+|++..... ...+....++.++||||+++++++.
T Consensus 16 ~~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~~~ 92 (336)
T 3fhr_A 16 FQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDVYE 92 (336)
T ss_dssp ----CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHHHh
Confidence 3444444444558999966 59999999999999999999999999865432 2222334456779999999999987
Q ss_pred c----CCeEEEEEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEE
Q 026299 88 T----PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKI 160 (240)
Q Consensus 88 ~----~~~~~lv~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L 160 (240)
. +...++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ ...++|
T Consensus 93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred hccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEE
Confidence 6 456899999999999999997653 699999999999999999999999999999999999997533 345999
Q ss_pred ecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 161 ~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
+|||.+..... .......+++.|+|||.+.+...+.+ +||||||+++++|++|..||......
T Consensus 173 ~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 173 TDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp CCCTTCEEC-----------------------CHHHHH-HHHHHHHHHHHHHHHSSCCC------
T ss_pred eccccceeccc-cccccCCCCcCccChhhhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCccch
Confidence 99999864432 22334567889999999876666444 99999999999999999999765543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=251.69 Aligned_cols=195 Identities=26% Similarity=0.414 Sum_probs=160.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHH--hcCCCCeeeeeEEEEcC----CeEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRHPNIVRFKEVILTP----THLAI 94 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~--~l~h~~i~~~~~~~~~~----~~~~l 94 (240)
++|++.+.||+|++|.||++++. +..||+|++..... .....|.+.+. .++||||+++++++... ...++
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 68999999999999999999885 88999999866443 33444555444 44899999999999887 68999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--------CceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~--------~ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+. |++|+||+|+||+++.++. ++|+|||.+
T Consensus 113 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a 189 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLA 189 (337)
T ss_dssp EECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTC
T ss_pred EEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCCc
Confidence 9999999999999955 4689999999999999999999998 9999999999999987765 999999998
Q ss_pred ccccccCCC-----CCCcCCccccCccccccCCCCCc-----ccchHHHHHHHHHHHhC----------CCCCCCC
Q 026299 167 KSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYDGK-----IADVWSCGVTLYVMLVG----------AYPFEDP 222 (240)
Q Consensus 167 ~~~~~~~~~-----~~~~~~~~~~~pE~~~~~~~~~~-----~~Di~slG~~l~~l~~g----------~~pf~~~ 222 (240)
......... ....+++.|+|||.+.+...... ++||||||+++|+|++| ..||...
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 644332221 24568899999999977655443 38999999999999999 7777654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=248.96 Aligned_cols=213 Identities=25% Similarity=0.317 Sum_probs=169.7
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCC---CcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEE-cC
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL-TP 89 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~ 89 (240)
+.....+|++.+.||+|++|.||++.+..+ +..+++|.+..... ..+.+.+|+..+++++||||+++++++. .+
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 344457899999999999999999997643 34588998765332 2356889999999999999999999865 45
Q ss_pred CeEEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 90 THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
+..+++||++++++|.+++.. ...++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a~~ 177 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARD 177 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCGGGCC
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECccccccc
Confidence 678999999999999999975 346899999999999999999999999999999999999987765 99999999864
Q ss_pred ccccC-----CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 169 SVLHS-----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 169 ~~~~~-----~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
..... ......+++.|+|||.+.+...+.+ +|+||||+++++|++ +..||...+..+....+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 43222 1222345678999999977776544 999999999999999 66777766655444433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=256.29 Aligned_cols=202 Identities=26% Similarity=0.318 Sum_probs=159.2
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEc-----CCe
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-----PTH 91 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 91 (240)
..+.++|++.+.||+|+||.||++++ ++..||+|++............++..+..++||||+++++.+.. ...
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 34668999999999999999999976 57899999987654332233344444556899999999975542 236
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC---------CceeecCCCCCeEEcCCCCCcEEEec
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------QVCHRDLKLENTLLDGSPAPRLKICD 162 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~---------~ivh~~i~~~nili~~~~~~~~~L~d 162 (240)
+++||||+++++|.+++.... .+...++.++.|++.||.|||+. |++|+||+|+||+++.++. ++|+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECC
T ss_pred EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EEEee
Confidence 789999999999999996544 58999999999999999999999 9999999999999987765 99999
Q ss_pred CCcccccccc---------CCCCCCcCCccccCccccccC------CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 163 FGYSKSSVLH---------SQPKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 163 ~~~~~~~~~~---------~~~~~~~~~~~~~~pE~~~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
||.+...... .......++..|+|||.+.+. ...+.++||||||+++|+|++|..||....
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9998644321 112234588999999998763 122345899999999999999977764443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=247.87 Aligned_cols=201 Identities=28% Similarity=0.377 Sum_probs=168.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
..|...+.||+|++|.||++.+ ++..|++|.+.... ...+.+.+|+..++.++||||+++++++.+++..+++
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence 3455568999999999999987 57789999886532 2235688999999999999999999999999999999
Q ss_pred EecCCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 96 MEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~---~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
||++++++|.+++.. ..+++...++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASEKF 186 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSC
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeecccccccccc
Confidence 999999999998863 346899999999999999999999999999999999999987765 999999998644322
Q ss_pred CC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 173 SQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 173 ~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
.. .....+++.|+|||.+.+. . +.++|+||||+++++|++|..||........
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred cccccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 11 2334678999999988653 4 4459999999999999999999987665443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=248.27 Aligned_cols=197 Identities=34% Similarity=0.515 Sum_probs=162.4
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++.++|++.+.||+|++|.||++++. +..|++|.+... ...+.+.+|+..+++++||||+++++++.+ ..++|||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 46689999999999999999999875 678999988643 334678899999999999999999998874 4689999
Q ss_pred cCCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhh---CCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 98 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHS---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~---~l~~~~~~~~~~~i~~~l~~LH~---~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
|+++++|.+++.... .++...++.++.|++.||+|||+ .|++|+||+|+||+++.++. .++|+|||.+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQT 158 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEccccccccccc
Confidence 999999999997654 37899999999999999999999 89999999999999976553 379999999864332
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
. .....++..|+|||.+.+...+.+ +||||||+++++|++|..||....
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 159 H--MTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred c--cccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhC
Confidence 2 223457889999999987766555 999999999999999999997643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=270.03 Aligned_cols=208 Identities=25% Similarity=0.351 Sum_probs=170.0
Q ss_pred CCeeEee-eecCCCceeEEEEEec--CCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 21 DRYELVR-DIGSGNFGVARLMRDK--KTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 21 ~~y~~~~-~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
+.+.+.. .||+|+||.||++.+. .++..||||++..... ..+.+.+|+.+++.++||||+++++++.. +..++
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 4455543 7999999999999554 5678899999876432 23678999999999999999999999865 45789
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
||||+++++|.+++.....+++..++.++.||+.||+|||+.||+|+||+|+||+++.++. ++|+|||++........
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADEN 524 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC---
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCcc
Confidence 9999999999999988888999999999999999999999999999999999999987765 99999999864433221
Q ss_pred ----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 175 ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 175 ----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
.....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||.+.+..+....+.
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 586 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 122234578999999977776554 999999999999998 999998887766555443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=251.79 Aligned_cols=203 Identities=28% Similarity=0.456 Sum_probs=169.6
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEE----ecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (240)
.....++|++++.||+|++|.||+++ +..++..|++|.+..... ..+.+.+|+..++.++||||+++++++...+
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 34456789999999999999999999 466899999999876432 2356889999999999999999999987654
Q ss_pred --eEEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 91 --HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 91 --~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
..++|||++++++|.+++... ..++...++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTK 193 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCE
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchh
Confidence 689999999999999999765 45899999999999999999999999999999999999987665 9999999986
Q ss_pred cccccCC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 168 SSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 168 ~~~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
....... .....++..|+|||.+.+...+. ++||||||+++++|++|..||..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCc-hhhHHHHHHHHHHHHhcCCCCCC
Confidence 5433221 22234566799999988776644 49999999999999999988764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=259.66 Aligned_cols=197 Identities=18% Similarity=0.197 Sum_probs=148.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc----ccHHHHHHHHHHHhc--CCCCeeeee-------EEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL--RHPNIVRFK-------EVI 86 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~ 86 (240)
..+|++.+.||+|+||.||++++..++..||+|++..... ..+.+.+|+..++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3569999999999999999999999999999999987542 224556774444444 699987754 444
Q ss_pred EcC-----------------CeEEEEEecCCCCchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHhhCCceeec
Q 026299 87 LTP-----------------THLAIVMEYASGGELFERICNA-GRFSEDEA------RFFFQQLISGVSYCHSMQVCHRD 142 (240)
Q Consensus 87 ~~~-----------------~~~~lv~~~~~~~~l~~~l~~~-~~l~~~~~------~~~~~~i~~~l~~LH~~~ivh~~ 142 (240)
... ..+++||||++ ++|.+++... ..++.... ..++.|++.||+|||+.||+|+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 332 33799999998 6999999753 33455555 67779999999999999999999
Q ss_pred CCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcCCccccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026299 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (240)
Q Consensus 143 i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (240)
|+|+||+++.++. ++|+|||++....... ....+++.|+|||.+.+ ..+ +.++||||||+++|+|++|..||.
T Consensus 220 ikp~NIll~~~~~--~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFIMPDGR--LMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEECTTSC--EEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEECCCCC--EEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999987765 9999999986443221 13445699999999976 344 555999999999999999999998
Q ss_pred CC
Q 026299 221 DP 222 (240)
Q Consensus 221 ~~ 222 (240)
..
T Consensus 295 ~~ 296 (371)
T 3q60_A 295 LV 296 (371)
T ss_dssp BC
T ss_pred Cc
Confidence 76
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=259.54 Aligned_cols=200 Identities=27% Similarity=0.328 Sum_probs=169.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCC-CCeeeeeEEEEcCCeEEEEEec
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
.++|++.+.||+|+||.||++++..++..||||++.... ....+.+|+.+++.++| +++..+..++......++||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 378999999999999999999999999999999876543 33458899999999987 5666667777778889999999
Q ss_pred CCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEc---CCCCCcEEEecCCccccccccCC
Q 026299 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 99 ~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~---~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
+ +++|.+++.. ...+++..++.++.||+.||+|||+.||+|+||+|+||+++ .++. ++|+|||++........
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDTST 161 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTTT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe--EEEEeCCcceeccCCcc
Confidence 9 8899999874 56799999999999999999999999999999999999993 4444 99999999865443322
Q ss_pred --------CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 175 --------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 175 --------~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.....++..|+|||.+.+...+.+ +||||||+++|+|++|..||.+...
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccc
Confidence 224568899999999987776544 9999999999999999999988654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=255.66 Aligned_cols=201 Identities=26% Similarity=0.404 Sum_probs=169.3
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC-----------CCCeeeeeEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVIL 87 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~ 87 (240)
..++|++.+.||+|++|.||++++..++..|++|++.......+.+.+|+..+++++ |+||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 458999999999999999999999999999999998766555567889999988876 889999999988
Q ss_pred cCC----eEEEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhC-CceeecCCCCCeEEcCCC----CC
Q 026299 88 TPT----HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSP----AP 156 (240)
Q Consensus 88 ~~~----~~~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~-~ivh~~i~~~nili~~~~----~~ 156 (240)
..+ ..++++|++ +++|.+++... ..++...++.++.||+.||+|||+. ||+|+||+|+||+++.++ ..
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 654 789999999 77999988753 4599999999999999999999998 999999999999995432 22
Q ss_pred cEEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 157 ~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
.++|+|||.+..... ......+++.|+|||.+.+...+.. +||||||+++|+|++|..||...+
T Consensus 176 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC----
T ss_pred eEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCc
Confidence 599999999864432 2334567899999999988776555 999999999999999999998654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=255.16 Aligned_cols=210 Identities=24% Similarity=0.298 Sum_probs=163.3
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCC---CcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEc-CCe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PTH 91 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 91 (240)
.....|++.+.||+|+||.||++++..+ +..|++|.+.... ...+.+.+|+.++++++||||+++++++.. ++.
T Consensus 86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp STTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred hhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 3445789999999999999999997643 3468899876532 233568899999999999999999998754 467
Q ss_pred EEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
.++||||+++++|.+++... ..++...++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMY 243 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeecccccccc
Confidence 89999999999999999754 45899999999999999999999999999999999999987765 9999999986443
Q ss_pred ccCC-----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 026299 171 LHSQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (240)
Q Consensus 171 ~~~~-----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (240)
.... .....++..|+|||.+.+...+. ++||||||+++|+|++ |..||...+..+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~ 308 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCc-HHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH
Confidence 2211 12234567899999998776654 4999999999999999 7888877665544433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=266.88 Aligned_cols=213 Identities=28% Similarity=0.416 Sum_probs=172.7
Q ss_pred cCCCCCeeEee-eecCCCceeEEEEEec--CCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 17 MHDSDRYELVR-DIGSGNFGVARLMRDK--KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 17 ~~~~~~y~~~~-~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
....+++.+.+ .||+|+||.||++.+. .++..||||++.... ...+.+.+|+.+++.++||||+++++++.. +.
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 34456677777 8999999999999876 356679999987643 234678999999999999999999999976 56
Q ss_pred EEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
.++||||+++++|.+++... ..++...+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||++....
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~ 487 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALG 487 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCccccc
Confidence 89999999999999998654 46999999999999999999999999999999999999987765 9999999987543
Q ss_pred ccCCC----CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 171 LHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 171 ~~~~~----~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
..... ....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...+..+....+..
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~ 554 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence 22211 12224568999999977766554 999999999999998 9999998877666555443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=245.85 Aligned_cols=203 Identities=29% Similarity=0.397 Sum_probs=152.4
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc---HHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
...++|++++.||+|++|.||++++..++..|++|.+....... +.+.++...++.++||||+++++++.+++..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 35578999999999999999999999999999999987654322 223344456778899999999999999999999
Q ss_pred EEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhC-CceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~-~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
|||++ +..+..+... ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++. ++|+|||.+......
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDD 178 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC------
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCC
Confidence 99999 4455555543 46799999999999999999999995 9999999999999987765 999999998655444
Q ss_pred CCCCCCcCCccccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 173 SQPKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
.......+++.|+|||.+.. ....+.++||||||+++++|++|..||....
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC
Confidence 44445568899999999852 2233455999999999999999999998743
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=249.53 Aligned_cols=210 Identities=25% Similarity=0.383 Sum_probs=170.5
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
.....++|++.+.||+|++|.||++.+.. .+++|.+.... ...+.+.+|+..++.++||||+++++++.+....
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 34456899999999999999999998864 38999886532 2234577899999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
++++|++++++|.+++...+ .+++..++.++.|++.||++||+.|++|+||+|+||+++. + .++|+|||.+.....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~-~--~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-G--KVVITDFGLFSISGV 181 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC----
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC-C--CEEEeecCCcccccc
Confidence 99999999999999987654 6899999999999999999999999999999999999973 3 489999998753321
Q ss_pred c------CCCCCCcCCccccCccccccC--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 026299 172 H------SQPKSTVGTPAYIAPEVLLKK--------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 172 ~------~~~~~~~~~~~~~~pE~~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (240)
. .......++..|+|||.+.+. ...+.++||||||+++++|++|..||..........++
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 1 112223467889999998652 22355599999999999999999999887665554443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=241.29 Aligned_cols=176 Identities=17% Similarity=0.183 Sum_probs=153.6
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc----HHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
.++|++.+.||+|++|.||++++..+++.|++|++....... +.+.+|+..++.++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 378999999999999999999999999999999997754433 5688999999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
|||++|++|.+++.++ ....++..++.|++.||+|||+.||+|+||+|+||+++.++. ++|++++.
T Consensus 110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~~---------- 175 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPAT---------- 175 (286)
T ss_dssp EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCCC----------
T ss_pred EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEeccc----------
Confidence 9999999999998543 466788999999999999999999999999999999987776 88875432
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
++| .+.++||||||+++|+|++|..||.+.+...
T Consensus 176 ---------~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~ 209 (286)
T 3uqc_A 176 ---------MPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRS 209 (286)
T ss_dssp ---------CTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCC
T ss_pred ---------cCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcch
Confidence 222 2455999999999999999999998876544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=245.70 Aligned_cols=196 Identities=28% Similarity=0.354 Sum_probs=166.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHh--cCCCCeeeeeEEEEcCC----eEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTPT----HLAI 94 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~l 94 (240)
++|++.+.||+|++|.||++++ +++.|++|.+.... ...+.+|.+++.. ++||||+++++++.... ..++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l 117 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence 6899999999999999999988 48899999986543 3567788888877 78999999999998875 7899
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------hCCceeecCCCCCeEEcCCCCCcEEEecCCcc
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH--------~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~ 166 (240)
||||+++++|.+++.+ ..+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++. ++|+|||.+
T Consensus 118 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~ 194 (342)
T 1b6c_B 118 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLA 194 (342)
T ss_dssp EECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTTC
T ss_pred EEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCCc
Confidence 9999999999999965 46899999999999999999999 899999999999999987765 999999998
Q ss_pred ccccccC-----CCCCCcCCccccCccccccCCCCC-----cccchHHHHHHHHHHHhC----------CCCCCCCC
Q 026299 167 KSSVLHS-----QPKSTVGTPAYIAPEVLLKKEYDG-----KIADVWSCGVTLYVMLVG----------AYPFEDPE 223 (240)
Q Consensus 167 ~~~~~~~-----~~~~~~~~~~~~~pE~~~~~~~~~-----~~~Di~slG~~l~~l~~g----------~~pf~~~~ 223 (240)
....... ......++..|+|||.+.+..... .++||||||+++|+|++| ..||....
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 6544332 234456889999999987663321 459999999999999999 88987653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=269.27 Aligned_cols=204 Identities=31% Similarity=0.438 Sum_probs=174.2
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEc------CCe
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT------PTH 91 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~ 91 (240)
.++|++.+.||.|++|.||++.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 389999999999999999999999999999999886542 223568899999999999999999998765 567
Q ss_pred EEEEEecCCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCC-CcEEEecCCccc
Q 026299 92 LAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSK 167 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~---~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~-~~~~L~d~~~~~ 167 (240)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ..++|+|||.+.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999999999999997643 5899999999999999999999999999999999999986543 248999999997
Q ss_pred cccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
............++..|+|||.+.+..++.. +|+||||+++|+|++|..||.....
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~ 228 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQ 228 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred ccccccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccc
Confidence 6655555556678999999999987777665 9999999999999999999976533
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=244.36 Aligned_cols=201 Identities=25% Similarity=0.393 Sum_probs=165.7
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcC--CCCeeeeeEEEEcCCeE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPTHL 92 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~ 92 (240)
...++|++.+.||+|++|.||++.+. ++..|++|.+..... ..+.+.+|+..+++++ |+||+++++++.++...
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 35578999999999999999999987 588899999876432 2356789999999997 59999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
+++|| +.+++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||++++ +.++|+|||.+......
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCC----
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC---CeEEEeeccccccccCc
Confidence 99999 557799999988888999999999999999999999999999999999999964 34999999998654332
Q ss_pred CC---CCCCcCCccccCccccccC----------CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 173 SQ---PKSTVGTPAYIAPEVLLKK----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 173 ~~---~~~~~~~~~~~~pE~~~~~----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
.. .....++..|+|||.+.+. ...+.++||||||+++++|++|..||....
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 22 2234578999999998652 233455999999999999999999997653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=265.00 Aligned_cols=211 Identities=25% Similarity=0.373 Sum_probs=172.2
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCC---CcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
...++|++.+.||+|+||.||+|.+..+ +..|++|.+..... ..+.+.+|+..++.++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 3457899999999999999999998643 46799998765432 2356889999999999999999999985 4568
Q ss_pred EEEEecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
++||||+++++|.+++.... .++...++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMED 543 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCC
Confidence 99999999999999997544 6899999999999999999999999999999999999987765 99999999865433
Q ss_pred cCCC--CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 026299 172 HSQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 172 ~~~~--~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (240)
.... ....++..|+|||.+.+...+. ++||||||+++++|++ |..||.+.+..+.+.++.
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~ 606 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCc-hhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 2211 2233567899999997776654 4999999999999997 999998877766655543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=266.97 Aligned_cols=192 Identities=24% Similarity=0.337 Sum_probs=163.3
Q ss_pred CCCeeEeeeecCCCceeEEEEEecC-CCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe-----
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 91 (240)
.++|++.+.||+|+||.||++.+.. ++..|++|.+.... .....+.+|+.+++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3799999999999999999999986 78999999886532 223467899999999999999999999987654
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
.++||||++|++|.+++.. .+++..++.++.|++.+|+|||+.||+|+||+|+||+++.+ .++|+|||.+.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTC
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhccc
Confidence 7999999999999987754 68999999999999999999999999999999999999865 499999999864432
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
. ....+++.|+|||++.+.. +.++||||||+++++|++|..||..
T Consensus 234 ~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 234 F---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp C---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred C---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcc
Confidence 2 4456899999999987654 4559999999999999999988865
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=250.97 Aligned_cols=202 Identities=27% Similarity=0.327 Sum_probs=159.9
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
....+|++.+.||+|++|.|+. ....++..||||++..... ..+.+|+.+++.+ +||||+++++++.+....++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3446799999999999999764 4445788999999866432 3467899999999 7999999999999999999999
Q ss_pred ecCCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC---CCCCcEEEecCCcccccccc
Q 026299 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~---~~~~~~~L~d~~~~~~~~~~ 172 (240)
|++++ +|.+++.... ..+...++.++.|++.||.|||+.||+|+||+|+||+++. ++..+++|+|||++......
T Consensus 98 E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 99975 9999887553 4566677899999999999999999999999999999953 33335889999998654432
Q ss_pred C----CCCCCcCCccccCccccccC--CCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 026299 173 S----QPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 223 (240)
Q Consensus 173 ~----~~~~~~~~~~~~~pE~~~~~--~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 223 (240)
. ......+++.|+|||.+.+. ...+.++||||||+++++|++ |..||....
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 2 22345689999999998742 223445999999999999999 999996543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=235.13 Aligned_cols=185 Identities=35% Similarity=0.566 Sum_probs=153.4
Q ss_pred CcccCCCCCeeEe-eeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHH-HhcCCCCeeeeeEEEEc---
Q 026299 14 MPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT--- 88 (240)
Q Consensus 14 ~~~~~~~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~--- 88 (240)
+......++|.++ +.||+|++|.||++.+..++..||+|++.. .....+|+..+ +..+||||+++++++..
T Consensus 10 ~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 3333444789998 779999999999999999999999999854 34567888877 56689999999999876
Q ss_pred -CCeEEEEEecCCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCC
Q 026299 89 -PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFG 164 (240)
Q Consensus 89 -~~~~~lv~~~~~~~~l~~~l~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~ 164 (240)
....++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.+. ...++|+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 677899999999999999997654 699999999999999999999999999999999999998632 3459999999
Q ss_pred ccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 026299 165 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (240)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (240)
.+.... +..+ +.++|+||||+++|+|++|..||.....
T Consensus 166 ~a~~~~---------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 166 FAKETT---------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp TCEECT---------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred cccccc---------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 875321 1222 3449999999999999999999976543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=246.15 Aligned_cols=199 Identities=27% Similarity=0.319 Sum_probs=155.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
+.|.+.+.||+|++|+||.+. ..+|..||+|++.... .+.+.+|+..++.+ +||||+++++++.++...++|||++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 667778999999999998654 4578999999987643 35678899999876 8999999999999999999999999
Q ss_pred CCCchHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC-----------CCCcEEEe
Q 026299 100 SGGELFERICNAGRF-------SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-----------PAPRLKIC 161 (240)
Q Consensus 100 ~~~~l~~~l~~~~~l-------~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~-----------~~~~~~L~ 161 (240)
++ +|.+++...... ++..++.++.|++.||+|||+.||+|+||+|+||+++.+ ....++|+
T Consensus 92 ~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 92 NL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp SE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 65 999998765432 233457899999999999999999999999999999753 23469999
Q ss_pred cCCccccccccCC-----CCCCcCCccccCccccccC------CCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 026299 162 DFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 223 (240)
Q Consensus 162 d~~~~~~~~~~~~-----~~~~~~~~~~~~pE~~~~~------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 223 (240)
|||++........ .....+++.|+|||.+.+. ...+.++||||||+++++|++ |..||.+..
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 9999875443321 1234688999999998652 334555999999999999999 999997653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=251.39 Aligned_cols=196 Identities=20% Similarity=0.231 Sum_probs=160.1
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---------ccHHHHHHHHHHHhcC---------CCC
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLR---------HPN 78 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~---------h~~ 78 (240)
....++|++.+.||+|+||.||+|++ ++..||+|++..... ..+.+.+|+.+++.++ |||
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 16 CLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp HSCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred hcccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 34558999999999999999999998 679999999976532 1266889999888885 777
Q ss_pred eeeeeEEEE-----------------c-------------CCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHH
Q 026299 79 IVRFKEVIL-----------------T-------------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128 (240)
Q Consensus 79 i~~~~~~~~-----------------~-------------~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~ 128 (240)
|+++.+++. + +...++||||++++++.+.+.+ ..+++..++.++.|++.
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTA 172 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHH
Confidence 777766643 2 6789999999998877666643 56899999999999999
Q ss_pred HHHHHh-hCCceeecCCCCCeEEcCCCC------------------CcEEEecCCccccccccCCCCCCcCCccccCccc
Q 026299 129 GVSYCH-SMQVCHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189 (240)
Q Consensus 129 ~l~~LH-~~~ivh~~i~~~nili~~~~~------------------~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~ 189 (240)
||+||| +.||+||||||+||+++.++. ..++|+|||++..... ....+++.|+|||.
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGG
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhh
Confidence 999999 999999999999999987651 1599999999875432 23468899999999
Q ss_pred cccCCCCCcccchHHHHHH-HHHHHhCCCCCCC
Q 026299 190 LLKKEYDGKIADVWSCGVT-LYVMLVGAYPFED 221 (240)
Q Consensus 190 ~~~~~~~~~~~Di~slG~~-l~~l~~g~~pf~~ 221 (240)
+.+.. ..++|||||+++ .++++.|..||.+
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcc
Confidence 98766 455999998777 6678889999854
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=241.24 Aligned_cols=209 Identities=14% Similarity=0.093 Sum_probs=157.1
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHHhcCC-CCe---------eeeeE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH-PNI---------VRFKE 84 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h-~~i---------~~~~~ 84 (240)
....|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+..++.++| ++. +...+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456899999999999999999999999999999887322 224678899999999876 321 11111
Q ss_pred E------------EEc-----CCeEEEEEecCCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHhhCCcee
Q 026299 85 V------------ILT-----PTHLAIVMEYASGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHSMQVCH 140 (240)
Q Consensus 85 ~------------~~~-----~~~~~lv~~~~~~~~l~~~l~~-------~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh 140 (240)
. +.. ...++++|+.. +++|.+++.. ...+++..+..++.|++.||+|||+.||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1 111 12357788776 4588887741 234677889999999999999999999999
Q ss_pred ecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcCCccccCccccc---------cCCCCCcccchHHHHHHHHH
Q 026299 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---------KKEYDGKIADVWSCGVTLYV 211 (240)
Q Consensus 141 ~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~---------~~~~~~~~~Di~slG~~l~~ 211 (240)
|||||+||+++.++. ++|+|||++...... .....+ +.|+|||.+. .....+.++||||||+++|+
T Consensus 235 rDiKp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp SCCCGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 999999999987776 999999998644333 233456 8999999983 22223445999999999999
Q ss_pred HHhCCCCCCCCCchhhhhhhhc
Q 026299 212 MLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 212 l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
|++|..||...+.......++.
T Consensus 310 lltg~~Pf~~~~~~~~~~~~~~ 331 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWIFR 331 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGGGS
T ss_pred HHHCCCCCCCcchhhhHHHHHh
Confidence 9999999988766555554433
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=235.90 Aligned_cols=181 Identities=14% Similarity=0.059 Sum_probs=128.7
Q ss_pred eecCCCceeEEEEEecCCCcEEEEEEeecCc-----------cccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeEEEE
Q 026299 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 28 ~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 95 (240)
....|+.|....++....|+.+++|++.... ...+.+.+|+++|+++ .|+||+++++++.+++.+|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3456666666666777789999999987542 1224588999999999 699999999999999999999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CC
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~ 174 (240)
|||++|++|.+.+.+.++++... ++.||+.||+|+|+.|||||||||+|||++.++. +||+|||++...... ..
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~~---I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDREK---ILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHHH---HHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhCCCCCHHH---HHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCcc
Confidence 99999999999999888888764 7889999999999999999999999999987776 999999998644332 22
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhC
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g 215 (240)
.....+++.|+|||++.+.. ..++|+|++|++.+.+.++
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTT
T ss_pred ccCceechhhccHHHhCCCC--CCcccccccccchhhhccc
Confidence 23446889999999997653 3348999999987665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=202.67 Aligned_cols=181 Identities=20% Similarity=0.132 Sum_probs=136.5
Q ss_pred EeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---------ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
..+.||+|+||.||++.. .+..+++|....... ..+++.+|+.++++++||||+++..++...+..++|
T Consensus 340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 356899999999999943 467788887543211 123478999999999999999666666677777999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
|||+++++|.+++.. +..++.|++.+|+|||+.||+|+||||+||+++. .++|+|||++.........
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCcccc
Confidence 999999999998865 5689999999999999999999999999999986 4999999998755332211
Q ss_pred --------CCCcCCccccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026299 176 --------KSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (240)
Q Consensus 176 --------~~~~~~~~~~~pE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (240)
....+++.|+|||.+.. ..+.. ..|+|+..+-..+-+.++-+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~-~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKS-VYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHH-HCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHH-HHhHHHHHHHHHHHHHhccccC
Confidence 23457889999999876 33333 3799999888888777666653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=172.29 Aligned_cols=142 Identities=18% Similarity=0.160 Sum_probs=111.8
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-------------------ccHHHHHHHHHHHhcCCCCeeeee
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRFK 83 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~~i~~~~ 83 (240)
|++.+.||+|++|.||++.+ .++..||+|.+..... ....+.+|+.++++++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 34449999999999999999 7899999999864321 1345789999999998 4 5666
Q ss_pred EEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecC
Q 026299 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (240)
Q Consensus 84 ~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~ 163 (240)
+++.. +..++||||++|++|.+ +. ......++.|++.|+.+||+.|++|+||+|+||+++ ++ .++|+||
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~--~vkl~DF 236 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE--GIWIIDF 236 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT--EEEECCC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC--cEEEEEC
Confidence 65543 45689999999999987 41 133457999999999999999999999999999998 44 4999999
Q ss_pred CccccccccCCCCCCcCCccccCccccc
Q 026299 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLL 191 (240)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~ 191 (240)
|.+... ..+.|||.+.
T Consensus 237 G~a~~~------------~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVEV------------GEEGWREILE 252 (282)
T ss_dssp TTCEET------------TSTTHHHHHH
T ss_pred CCCeEC------------CCCCHHHHHH
Confidence 998532 2356777764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-21 Score=152.32 Aligned_cols=137 Identities=15% Similarity=0.097 Sum_probs=106.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcE--EEEEEeecCccc-------------------------cHHHHHHHHHHHh
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGDKI-------------------------DENVQREIINHRS 73 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~--v~iK~~~~~~~~-------------------------~~~~~~e~~~l~~ 73 (240)
.-|++.+.||+|++|.||+|.+..+|.. ||+|++...... ...+.+|+..++.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3578999999999999999999778888 999986543111 1257889999999
Q ss_pred cCCCCe--eeeeEEEEcCCeEEEEEecCCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hCCceeecCCC
Q 026299 74 LRHPNI--VRFKEVILTPTHLAIVMEYASG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKL 145 (240)
Q Consensus 74 l~h~~i--~~~~~~~~~~~~~~lv~~~~~~-~----~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH-~~~ivh~~i~~ 145 (240)
++|+++ +.++.. ...++||||+.+ + +|.+.... .++..+..++.|++.++.+|| +.|++|+||+|
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 988764 333332 245799999942 3 56655432 235567889999999999999 99999999999
Q ss_pred CCeEEcCCCCCcEEEecCCcccc
Q 026299 146 ENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 146 ~nili~~~~~~~~~L~d~~~~~~ 168 (240)
.||+++. .++|+|||++..
T Consensus 200 ~NILl~~----~~~liDFG~a~~ 218 (258)
T 1zth_A 200 YNIMYID----KVYFIDMGQAVT 218 (258)
T ss_dssp TSEEESS----SEEECCCTTCEE
T ss_pred HHEEEcC----cEEEEECccccc
Confidence 9999976 499999999853
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.9e-19 Score=144.39 Aligned_cols=139 Identities=16% Similarity=0.128 Sum_probs=101.0
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---------------cH--------HHHHHHHHHHhcCCC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------------DE--------NVQREIINHRSLRHP 77 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---------------~~--------~~~~e~~~l~~l~h~ 77 (240)
.-|++..+||.|++|.||.|.+. +|..||||++...... .. ....|+..+.++.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34899999999999999999986 6889999987542110 00 123566777777555
Q ss_pred CeeeeeEEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC-
Q 026299 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP- 156 (240)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~- 156 (240)
++....-+.... .++||||++|.+|..+.. ......++.|++.++.+||+.|+|||||||.|||++.++.+
T Consensus 174 gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 174 GFPVPEPIAQSR--HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp TCSCCCEEEEET--TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCCCeeeeccC--ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 543222222222 269999999988865431 22345688999999999999999999999999999766532
Q ss_pred -------cEEEecCCcccc
Q 026299 157 -------RLKICDFGYSKS 168 (240)
Q Consensus 157 -------~~~L~d~~~~~~ 168 (240)
.+.++||+.+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 389999998753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=1.7e-13 Score=107.03 Aligned_cols=138 Identities=17% Similarity=0.123 Sum_probs=108.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
..|++...++.|+.+.||++... +..+++|...... .....+.+|...++.+. +..++++++++.+.+..++||++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 46999999999999999999754 5789999876532 22356889999999885 56788899999888899999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS------------------------------------------- 135 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~------------------------------------------- 135 (240)
++|.++.+... +......++.++.+++..||+
T Consensus 92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 99998876531 222334678889999999998
Q ss_pred ----------------CCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 136 ----------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 136 ----------------~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
..++|||++|.||+++++. .+.++||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK--VSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE--EEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc--EEEEEEchhcc
Confidence 4489999999999997543 25699999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.37 E-value=5.4e-12 Score=98.06 Aligned_cols=135 Identities=13% Similarity=0.103 Sum_probs=97.4
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCC--eeeeeEEEEcCCeEEEEEe
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~~ 97 (240)
...|.+....+.|..+.||++... +|..+++|..... ....+.+|...++.+++.+ +.+++.+...++..++||+
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 356776555556667899999654 5677999986554 2355788999888886444 5568888888788999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ---------------------------------------- 137 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~---------------------------------------- 137 (240)
+++|.++. .. ..+. ..++.++...+..||+..
T Consensus 96 ~i~G~~l~--~~---~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 96 EVPGQDLL--SS---HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CCSSEETT--TS---CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred ecCCcccC--cC---cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 99998874 21 1122 245667777777777643
Q ss_pred ------------------ceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 138 ------------------VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 138 ------------------ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
++|||++|.||+++++. .+.++||+.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~liD~~~a~ 213 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGR--FSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc--EEEEEcchhcc
Confidence 99999999999997543 25699999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.31 E-value=2.1e-11 Score=99.41 Aligned_cols=141 Identities=14% Similarity=0.206 Sum_probs=105.5
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEee--cCc--cccHHHHHHHHHHHhcCC--CCeeeeeEEEEcC---CeEE
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGD--KIDENVQREIINHRSLRH--PNIVRFKEVILTP---THLA 93 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~--~~~--~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~ 93 (240)
..-++.++.|..+.+|++... +..+++|+.. ... .....+.+|+..++.+.. ..+++++.++.+. +..+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 345778899999999999875 3578999776 432 223568889999998874 4577888888766 4578
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------- 135 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~-------------------------------------- 135 (240)
+|||+++|.++.+.. ...++......++.++.++|..||+
T Consensus 118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999998775421 2336788888999999999999997
Q ss_pred --------------------CCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 136 --------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 136 --------------------~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
..++|||+++.||+++.+....+.++||+.+.
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 35899999999999986653335899999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.06 E-value=1.5e-10 Score=92.16 Aligned_cols=187 Identities=16% Similarity=0.093 Sum_probs=116.6
Q ss_pred eeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC-CCC--eeeeeEEEEcCC---eEEEEEecC
Q 026299 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN--IVRFKEVILTPT---HLAIVMEYA 99 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~~~~ 99 (240)
++.++.|..+.+|.+. ..+++|+... ......+.+|...++.+. +.. +..++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS-HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC-cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4558889999998874 3589997543 233466889999998873 333 344444433333 347899999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------------
Q 026299 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------- 135 (240)
Q Consensus 100 ~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~-------------------------------------------- 135 (240)
+|.++.+... ..++.++...++.++...+..||+
T Consensus 99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9988865332 236777777888888888888875
Q ss_pred --------------CCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCcCCccccCcccc----ccCCCCC
Q 026299 136 --------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL----LKKEYDG 197 (240)
Q Consensus 136 --------------~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~----~~~~~~~ 197 (240)
..++|||++|.||+++.+....+.++||+.+.................-..|+.. .......
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 1369999999999998742223789999987533211000000000000112111 1111001
Q ss_pred ---------cccchHHHHHHHHHHHhCCCCCC
Q 026299 198 ---------KIADVWSCGVTLYVMLVGAYPFE 220 (240)
Q Consensus 198 ---------~~~Di~slG~~l~~l~~g~~pf~ 220 (240)
-..+.|+++.+++.+.+|..+|.
T Consensus 257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 01589999999999999987763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=7e-08 Score=75.25 Aligned_cols=130 Identities=19% Similarity=0.216 Sum_probs=91.7
Q ss_pred cCCCce-eEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEEEecCCCCchHHH
Q 026299 30 GSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFER 107 (240)
Q Consensus 30 ~~g~~g-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~ 107 (240)
..|..+ .||......++..+++|+..... ...+.+|...++.+. +--+.+++.++.+.+..++||++++|.++.+.
T Consensus 33 ~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~--~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 33 NVGQSGATIYRLYGKPNAPELFLKHGKGSV--ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp ECSSSSCEEEEEECCTTCCCEEEEEEETHH--HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred cCCCcCCeEEEEEecCCCeEEEEEECCCCC--HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 334444 68998888788889999765432 356778988888775 22367788888888999999999999887765
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHhhC---------------------------------------------------
Q 026299 108 ICNAGRFSEDEARFFFQQLISGVSYCHSM--------------------------------------------------- 136 (240)
Q Consensus 108 l~~~~~l~~~~~~~~~~~i~~~l~~LH~~--------------------------------------------------- 136 (240)
.... ......+..++...|..||+.
T Consensus 111 ~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 186 (272)
T 4gkh_A 111 LEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKL 186 (272)
T ss_dssp HHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTT
T ss_pred ccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhc
Confidence 4331 122234455555555555531
Q ss_pred -------CceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 137 -------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 137 -------~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
.++|||+.+.||+++++.. +-++||+.+.
T Consensus 187 ~~~~~~~~l~HGDl~~~Nil~~~~~~--~~viDwe~a~ 222 (272)
T 4gkh_A 187 LPFSPDSVVTHGDFSLDNLIFDEGKL--IGCIDVGRVG 222 (272)
T ss_dssp CCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred ccccCCcEEEcCCCCCCeEEEECCeE--EEEEECcccc
Confidence 1589999999999975542 5699999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=1.3e-07 Score=75.32 Aligned_cols=134 Identities=19% Similarity=0.154 Sum_probs=88.7
Q ss_pred eeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCC---CeeeeeEEEE-cCCeEEEEEecCCC
Q 026299 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVIL-TPTHLAIVMEYASG 101 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~~~~~~ 101 (240)
++.++.|....+|.+ +..+++|+. ........+.+|...++.+.+. .+..++.+.. ..+..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~-~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFP-KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEE-SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEec-CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 455788888899988 456899974 3223345788999999998642 3566666664 34567899999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh----------------------------------------------
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHS---------------------------------------------- 135 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~---------------------------------------------- 135 (240)
.++.+... ..++......++.++.+.|..||+
T Consensus 98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 88865321 123444444444444444444443
Q ss_pred --------------CCceeecCCCCCeEEcCC--CCCcEEEecCCccc
Q 026299 136 --------------MQVCHRDLKLENTLLDGS--PAPRLKICDFGYSK 167 (240)
Q Consensus 136 --------------~~ivh~~i~~~nili~~~--~~~~~~L~d~~~~~ 167 (240)
..++|||+.+.||+++.+ ....+.++||+.+.
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 245999999999999761 11224799999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.3e-06 Score=71.99 Aligned_cols=76 Identities=17% Similarity=0.114 Sum_probs=49.4
Q ss_pred EeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--------cccHHHHHHHHHHHhcCC--CC-eeeeeEEEEcCCeEE
Q 026299 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------KIDENVQREIINHRSLRH--PN-IVRFKEVILTPTHLA 93 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~e~~~l~~l~h--~~-i~~~~~~~~~~~~~~ 93 (240)
-.+.+|.|..+.||++....++..+++|...+.. ...+++..|...++.+.. +. +++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 4678999999999999876667889999754321 123456788888887742 33 3445543 334457
Q ss_pred EEEecCCCC
Q 026299 94 IVMEYASGG 102 (240)
Q Consensus 94 lv~~~~~~~ 102 (240)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999773
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=8.6e-07 Score=71.92 Aligned_cols=83 Identities=8% Similarity=0.090 Sum_probs=56.5
Q ss_pred eeEeeee-cCCCceeEEEEEec--C----CCcEEEEEEeecCc---c-ccHHHHHHHHHHHhcCC---CCeeeeeEEEEc
Q 026299 23 YELVRDI-GSGNFGVARLMRDK--K----TEELVAVKYIERGD---K-IDENVQREIINHRSLRH---PNIVRFKEVILT 88 (240)
Q Consensus 23 y~~~~~l-~~g~~g~v~~~~~~--~----~~~~v~iK~~~~~~---~-~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~ 88 (240)
-...+.| +.|..+.+|.+... . ++..+++|...... . ....+.+|...++.+.. ..+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445777 88888999988754 1 25679999765433 1 23567788888887742 346677777665
Q ss_pred C---CeEEEEEecCCCCchH
Q 026299 89 P---THLAIVMEYASGGELF 105 (240)
Q Consensus 89 ~---~~~~lv~~~~~~~~l~ 105 (240)
. +..++||++++|.++.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3568999999986653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.18 E-value=2.6e-05 Score=62.49 Aligned_cols=74 Identities=15% Similarity=0.197 Sum_probs=41.0
Q ss_pred eeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC--CCCeeeeeE------EEEcCCeEEEEEe
Q 026299 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--HPNIVRFKE------VILTPTHLAIVME 97 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~------~~~~~~~~~lv~~ 97 (240)
++.++.|..+.+|++... ++ .+++|+..... .....|...++.+. .-.+++++. +....+..+++++
T Consensus 37 ~~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD-SG-AVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEET-TE-EEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeC-CC-CEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 445666778899998764 33 48999876532 33344555554442 112333332 1234567889999
Q ss_pred cCCCCch
Q 026299 98 YASGGEL 104 (240)
Q Consensus 98 ~~~~~~l 104 (240)
|++|.++
T Consensus 112 ~i~G~~~ 118 (346)
T 2q83_A 112 WIEGRPF 118 (346)
T ss_dssp CCCCBCC
T ss_pred eecCccC
Confidence 9998654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.16 E-value=1.3e-05 Score=63.46 Aligned_cols=71 Identities=13% Similarity=0.095 Sum_probs=45.1
Q ss_pred eeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCe-eeeeEEEEcCCeEEEEEecC-CCCc
Q 026299 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA-SGGE 103 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~-~~~~ 103 (240)
++.++.|....+|++ ..+++|+............+|...++.+...++ .+++... .+.-+++++|+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 788888999999999 458999876543222234567777776643333 4455443 33346899999 7755
Q ss_pred h
Q 026299 104 L 104 (240)
Q Consensus 104 l 104 (240)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.92 E-value=0.0001 Score=61.14 Aligned_cols=73 Identities=15% Similarity=0.182 Sum_probs=43.6
Q ss_pred EeeeecCCCceeEEEEEecCCCcEEEEEEeecC-----cc---ccHHHHHHHHHHHhc---CCCCeeeeeEEEEcCCeEE
Q 026299 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DK---IDENVQREIINHRSL---RHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~ 93 (240)
-++.++.|..+.+|++.. ++..+++|...+. .. .......|.+.+..+ ....+++++.+. ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 467789999999999964 4667999943221 11 112222233333222 234556666654 45668
Q ss_pred EEEecC-CC
Q 026299 94 IVMEYA-SG 101 (240)
Q Consensus 94 lv~~~~-~~ 101 (240)
+|||++ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=0.00011 Score=60.04 Aligned_cols=138 Identities=16% Similarity=0.135 Sum_probs=79.5
Q ss_pred eeeecCCCceeEEEEEecC-------CCcEEEEEEeecCccccHHHHHHHHHHHhcCCCC-eeeeeEEEEcCCeEEEEEe
Q 026299 26 VRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~~ 97 (240)
++.+..|-...+|++.... ++..+++|+............+|...++.+...+ ..++++.+.+ .+|++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 4567778888899988742 3578999986443333456678998888775333 3555555433 28999
Q ss_pred cCCCCchHH--------------HH---Hhc-----CCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 026299 98 YASGGELFE--------------RI---CNA-----GRFS--EDEARFFFQQLIS-------------------GVSY-- 132 (240)
Q Consensus 98 ~~~~~~l~~--------------~l---~~~-----~~l~--~~~~~~~~~~i~~-------------------~l~~-- 132 (240)
|++|.++.. .+ ... ++.. ...+..+..++.. .++.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999865431 11 111 1111 2445555544321 1222
Q ss_pred --Hhh----CCceeecCCCCCeEEcCC--CCCcEEEecCCccc
Q 026299 133 --CHS----MQVCHRDLKLENTLLDGS--PAPRLKICDFGYSK 167 (240)
Q Consensus 133 --LH~----~~ivh~~i~~~nili~~~--~~~~~~L~d~~~~~ 167 (240)
|.. ..++|+|+.+.||+++.+ ..+.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 222 258999999999999865 12348999999874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00037 Score=55.52 Aligned_cols=75 Identities=9% Similarity=0.048 Sum_probs=47.6
Q ss_pred eeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCC--eeeeeEE-----EEcCCeEEEEEecC
Q 026299 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV-----ILTPTHLAIVMEYA 99 (240)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-----~~~~~~~~lv~~~~ 99 (240)
+.++ |....+|++... +|..+++|...+.....+.+..|...++.+.... +++++.. ...++..+.+++++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4455 777889988664 4567999988654334456677877777664222 3333332 12245668899999
Q ss_pred CCCc
Q 026299 100 SGGE 103 (240)
Q Consensus 100 ~~~~ 103 (240)
+|.+
T Consensus 110 ~G~~ 113 (328)
T 1zyl_A 110 GGRQ 113 (328)
T ss_dssp CCEE
T ss_pred CCCC
Confidence 8854
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00021 Score=59.45 Aligned_cols=75 Identities=13% Similarity=0.135 Sum_probs=49.9
Q ss_pred EeeeecCCCceeEEEEEecC-------CCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCe-eeeeEEEEcCCeEEEEE
Q 026299 25 LVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVM 96 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 96 (240)
-++.++.|....+|++.... .+..+++|+.... ...+.+.+|...++.+...++ +++++.+. + .+|+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 35677888889999998653 2568999977432 221556688888888754333 55665543 2 2899
Q ss_pred ecCCCCch
Q 026299 97 EYASGGEL 104 (240)
Q Consensus 97 ~~~~~~~l 104 (240)
+|++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00074 Score=52.85 Aligned_cols=78 Identities=12% Similarity=0.055 Sum_probs=54.1
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCC---CeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHP---NIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~lv~ 96 (240)
.+..-++.+|.|..+.||++... +|+.|++|+...+.. ....+..|...|+.+... -+++++.+ .. -+++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEE
Confidence 34566788999999999999876 678899997654432 234577899988888432 23444443 22 26889
Q ss_pred ecCCCCc
Q 026299 97 EYASGGE 103 (240)
Q Consensus 97 ~~~~~~~ 103 (240)
|++++..
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.0002 Score=56.96 Aligned_cols=139 Identities=14% Similarity=0.108 Sum_probs=74.9
Q ss_pred eEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCC--eeeeeEE------EEcCCeEEEE
Q 026299 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAIV 95 (240)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv 95 (240)
.-++.++.|....+|.+... ++ .+++|..... ...+.+..|...+..+...+ +.+++.. ....+..+.+
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 34567777888899998765 33 6899987653 12344566777666553212 2222211 1223567899
Q ss_pred EecCCCCchHH-----------H---HHhc-C----C----CCHHHHHHH---------------HHHHHHHHHHHh---
Q 026299 96 MEYASGGELFE-----------R---ICNA-G----R----FSEDEARFF---------------FQQLISGVSYCH--- 134 (240)
Q Consensus 96 ~~~~~~~~l~~-----------~---l~~~-~----~----l~~~~~~~~---------------~~~i~~~l~~LH--- 134 (240)
++|++|.++.. . ++.. . + ......... ...+...++.+.
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 99999865311 1 1110 0 0 111110000 011233444444
Q ss_pred ----hCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 135 ----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 135 ----~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
..+++|+|+.+.||+++.+.. +.++||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~--~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEeCCce--EEEecchhcc
Confidence 246999999999999976532 4799998874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00043 Score=56.28 Aligned_cols=75 Identities=15% Similarity=0.048 Sum_probs=44.4
Q ss_pred eeeecCCCceeEEEEEecCC--------CcEEEEEEeecCccccHHHHHHHHHHHhcCCCC-eeeeeEEEEcCCeEEEEE
Q 026299 26 VRDIGSGNFGVARLMRDKKT--------EELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 96 (240)
++.++.|....+|++..... +..+++|+.........+...|...++.+...+ ..++++.. .+ ++++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 55677788889999986531 367899977554322223457777777775333 34555443 22 5899
Q ss_pred ecCCCCch
Q 026299 97 EYASGGEL 104 (240)
Q Consensus 97 ~~~~~~~l 104 (240)
+|++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99988543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.0011 Score=52.87 Aligned_cols=32 Identities=31% Similarity=0.414 Sum_probs=25.6
Q ss_pred CCceeecCCCCCeEEcCCC--CCcEEEecCCccc
Q 026299 136 MQVCHRDLKLENTLLDGSP--APRLKICDFGYSK 167 (240)
Q Consensus 136 ~~ivh~~i~~~nili~~~~--~~~~~L~d~~~~~ 167 (240)
..++|||+.+.||+++.+. ...+.++||+.+.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 4699999999999997541 1348999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0043 Score=51.98 Aligned_cols=76 Identities=16% Similarity=0.089 Sum_probs=49.2
Q ss_pred EeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCe-eeeeEEEEcCCeEEEEEecCCCCc
Q 026299 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGE 103 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~~~~~ 103 (240)
-++.|+.|-...+|++.....+..+++|+........-+..+|...++.+...++ +++++.+. +. .|++|++|.+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~ 187 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYA 187 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCcc
Confidence 3567788888999999876545789999875432222223578888888865555 45666652 32 5999998854
Q ss_pred h
Q 026299 104 L 104 (240)
Q Consensus 104 l 104 (240)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0032 Score=49.96 Aligned_cols=94 Identities=17% Similarity=0.114 Sum_probs=70.8
Q ss_pred EeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC---CCCeeeeeEEEEcCCeEEEEEecCCC
Q 026299 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYASG 101 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (240)
-++.++.|....+|++.. ++..+++|+.... ....+..|...++.+. ...+++++.+....+..++||+|++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 467789999999999986 3667899976543 2456788888888774 35677888888877889999999998
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 026299 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136 (240)
Q Consensus 102 ~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~ 136 (240)
.++.. ..+.++.++|..||+.
T Consensus 116 ~~~~~--------------~~~~~lG~~LA~LH~~ 136 (312)
T 3jr1_A 116 SKNKQ--------------SSFTIFAEKIAQLHQI 136 (312)
T ss_dssp CCCCT--------------THHHHHHHHHHHHHHC
T ss_pred CCCCc--------------hhHHHHHHHHHHHHcC
Confidence 75421 2356777888889964
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.26 E-value=0.01 Score=47.54 Aligned_cols=30 Identities=23% Similarity=0.475 Sum_probs=25.1
Q ss_pred CCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 136 ~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
..++|||+.+.||+++.++. +.++||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~--~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEES--IYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGC--EEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCe--EEEEECCCCe
Confidence 46899999999999975544 8999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0028 Score=52.49 Aligned_cols=76 Identities=16% Similarity=0.076 Sum_probs=48.9
Q ss_pred EeeeecCCCceeEEEEEecCC-------CcEEEEEEeecCccccHHHHHHHHHHHhcCCCC-eeeeeEEEEcCCeEEEEE
Q 026299 25 LVRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 96 (240)
-++.+..|-...+|++..... +..+++++........-+..+|...++.+...+ ..++++.+ .+ +.|+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 355677788889999987631 577999986554322233467888887775333 34455433 22 6899
Q ss_pred ecCCCCch
Q 026299 97 EYASGGEL 104 (240)
Q Consensus 97 ~~~~~~~l 104 (240)
+|++|.++
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0069 Score=45.17 Aligned_cols=101 Identities=16% Similarity=0.052 Sum_probs=62.4
Q ss_pred CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHh-hCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCc
Q 026299 102 GELFERICN-AGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179 (240)
Q Consensus 102 ~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH-~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~ 179 (240)
.||.++|.. ..+++++++|+++.|.+..|..+- .+.-...-+.|..|++..++. +.+.+ ..+ ..
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s-----------~~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AAD-----------DA 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-ccc-----------cc
Confidence 478888864 568999999999999999987762 122223444568888887776 55542 110 01
Q ss_pred CCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCC
Q 026299 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218 (240)
Q Consensus 180 ~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 218 (240)
....+.+||... .....+.=|||||+++|.-+.-..|
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 123456777653 1223336899999999998875544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.32 E-value=0.024 Score=46.50 Aligned_cols=30 Identities=40% Similarity=0.606 Sum_probs=24.0
Q ss_pred ceeecCCCCCeEEcC----CCCCcEEEecCCccc
Q 026299 138 VCHRDLKLENTLLDG----SPAPRLKICDFGYSK 167 (240)
Q Consensus 138 ivh~~i~~~nili~~----~~~~~~~L~d~~~~~ 167 (240)
++|+|+.+.||++.+ +....+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 689999999999953 223359999999974
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.66 E-value=2 Score=31.79 Aligned_cols=83 Identities=10% Similarity=0.048 Sum_probs=60.0
Q ss_pred cCCCCeeeeeEEEEcCCeEEEEEecCC-CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC
Q 026299 74 LRHPNIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (240)
Q Consensus 74 l~h~~i~~~~~~~~~~~~~~lv~~~~~-~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~ 152 (240)
..+|++++. .+-.+++.+.+.++.-+ +-++.. + ...+..+.++++..|+...++++. -.|--++|+|++++.
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTR 114 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECT
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcC
Confidence 368999977 57677777777777654 334443 2 236899999999999987744433 367889999999988
Q ss_pred CCCCcEEEecCCc
Q 026299 153 SPAPRLKICDFGY 165 (240)
Q Consensus 153 ~~~~~~~L~d~~~ 165 (240)
+.. +++.--|+
T Consensus 115 ~~~--p~i~~RGi 125 (215)
T 4ann_A 115 DGL--PIAKTRGL 125 (215)
T ss_dssp TSC--EEESCCEE
T ss_pred CCC--EEEEEccC
Confidence 876 77775554
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.15 E-value=5.5 Score=29.51 Aligned_cols=82 Identities=13% Similarity=0.051 Sum_probs=59.3
Q ss_pred cCCCCeeeeeEEEEcCCeEEEEEecCCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHhhCCceeecCCCCCeEEc
Q 026299 74 LRHPNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVS-YCHSMQVCHRDLKLENTLLD 151 (240)
Q Consensus 74 l~h~~i~~~~~~~~~~~~~~lv~~~~~~-~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~-~LH~~~ivh~~i~~~nili~ 151 (240)
..||++ -..+-.+++.+.+.++.-++ -++.. + ...+..+.++++..|+.... ++ ..-.|--++|+|++++
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 368888 45555777888887776533 34443 3 23689999999999988655 33 3457888999999998
Q ss_pred CCCCCcEEEecCCc
Q 026299 152 GSPAPRLKICDFGY 165 (240)
Q Consensus 152 ~~~~~~~~L~d~~~ 165 (240)
.+.. +++.--|+
T Consensus 119 ~~~~--p~i~hRGi 130 (219)
T 4ano_A 119 RALE--PFFLHVGV 130 (219)
T ss_dssp TTCC--EEESCCEE
T ss_pred CCCc--EEEEEcCC
Confidence 7777 88876665
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=87.51 E-value=9.4 Score=30.31 Aligned_cols=138 Identities=12% Similarity=0.077 Sum_probs=75.4
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEE-----------------
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV----------------- 85 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~----------------- 85 (240)
...++....|..|..+... ++..|+||.. .....+.+-.++...-.++.|...-+..-
T Consensus 71 v~~I~~s~~Gstgvff~~t---d~~~~VVK~s--~~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~~~~~ 145 (342)
T 1cja_A 71 FKGIERSEKGTEGLFFVET---ESGVFIVKRS--TNIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAIDKS 145 (342)
T ss_dssp EEEEEECCSTTSCEEEEEE---SSCEEEEECC--TTHHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHHCSS
T ss_pred eeEEEeccCCCCCeEEEEe---CCCEEEEeCc--HHHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHHhhhh
Confidence 7777888888766655554 4667999943 22222334444444455566664332211
Q ss_pred -----EEcCCeEEEEEecCCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCC-----ceeecCCCCCeEEcCC
Q 026299 86 -----ILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGS 153 (240)
Q Consensus 86 -----~~~~~~~~lv~~~~~~~~l~~~l~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~-----ivh~~i~~~nili~~~ 153 (240)
....+.++++|+|.+|..|.+.-.. ...+..+....+.+ +-+++.+..++ +.++.=+++||+++.+
T Consensus 146 ~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG~--Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~ 223 (342)
T 1cja_A 146 FRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLGS--LMALDVIVNNSDRLPIAWTNEGNLDNIMLSER 223 (342)
T ss_dssp SCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHHH--HHHHHHHHTCCSSSCSSSCSCCCGGGEEEESB
T ss_pred hHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhch--hheehhhhcCCccCcccccCCCChhheEEeCC
Confidence 0012357799999988666432110 01123333332211 22445555432 2333468999999875
Q ss_pred CCCcEEEecCCcccc
Q 026299 154 PAPRLKICDFGYSKS 168 (240)
Q Consensus 154 ~~~~~~L~d~~~~~~ 168 (240)
.. ++.++|-+.+..
T Consensus 224 n~-~~~~IDhn~af~ 237 (342)
T 1cja_A 224 GA-TVVPIDSKIIPL 237 (342)
T ss_dssp TT-CEEECSCCCCCC
T ss_pred CC-eEEEEcCCcccc
Confidence 53 689999988753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 240 | ||||
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-67 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-67 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-66 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-65 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-63 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-63 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-61 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-60 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-58 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-57 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-56 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-54 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-54 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-53 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-53 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-51 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-50 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-50 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-50 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-50 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-50 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-49 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-47 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-45 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-42 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-34 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-15 |
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 212 bits (542), Expect = 1e-68
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 3/218 (1%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 79
D Y+++ ++GSG FGV +K T + K+I +D V+ EI L HP +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
+ + + +++E+ SGGELF+RI + SE E + +Q G+ + H +
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
H D+K EN + + A +KI DFG + K T T + APE++ ++
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-F 207
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
D+W+ GV YV+L G PF ++ + + +
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 245
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-67
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 7/207 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
D +E + ++G+GN GV + K + ++A K I E I + RE+ P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ- 137
IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEE 224
+ +D+WS G++L M VG YP P+
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPDA 208
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 208 bits (530), Expect = 7e-67
Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 3/227 (1%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIIN 70
+++ H D Y++ ++G+G FGV + ++ T A K++ + D E V++EI
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISG 129
LRHP +V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + H H DLK EN + + LK+ DFG + K T GT + APEV
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
K D+WS GV Y++L G PF + + R +
Sbjct: 197 AEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 242
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-66
Identities = 78/218 (35%), Positives = 121/218 (55%), Gaps = 7/218 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ ++LV+ +G G +G +L ++ TEE VAVK + +R EN+++EI ++ L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+F + +EY SGGELF+RI E +A+ FF QL++GV Y H + +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKKEY 195
HRD+K EN LLD LKI DFG + +++ + GT Y+APE+L ++E+
Sbjct: 125 THRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+ DVWSCG+ L ML G P++ P +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 220
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 1e-66
Identities = 71/220 (32%), Positives = 117/220 (53%), Gaps = 8/220 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLRH 76
+ +E+ R +G G FG L R+K+++ ++A+K + + V +RE+ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R T + +++EYA G ++ + +F E + +L + +SYCHS
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN LL + LKI DFG+S + S+ + GT Y+ PE++ + +D
Sbjct: 126 RVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
K D+WS GV Y LVG PFE + +++ V +
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 221
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 8e-65
Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 2/217 (0%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++Y + D+G G FG+ + +++ K+++ V++EI RH NI+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
E + L ++ E+ SG ++FERI +A +E E + Q+ + + HS +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
D+WS G +YV+L G PF + ++ Y
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (512), Expect = 1e-64
Identities = 79/220 (35%), Positives = 118/220 (53%), Gaps = 4/220 (1%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
D Y+ +G+G F L DK+T++LVA+K I + + + +++ EI ++HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV ++ + HL ++M+ SGGELF+RI G ++E +A Q++ V Y H +
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 138 VCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK EN L ++ I DFG SK S + GTP Y+APEVL +K Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
D WS GV Y++L G PF D + K F + + Y
Sbjct: 188 KA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY 226
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-63
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 9/228 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D +E++ ++G G FG ++K+T L A K I+ + + E+ EI S HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV+ + +L I++E+ +GG + + R +E + + +Q + ++Y H +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
+ HRDLK N L +K+ DFG S + Q + + +GTP ++APEV++ +
Sbjct: 131 IIHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 197 GKI----ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCTFS 240
+ ADVWS G+TL M P + + K T +
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 9e-63
Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 10/223 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
+ ++ + +G G+F L R+ T A+K +E+ I EN + L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 193
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L +K
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
+D+W+ G +Y ++ G PF E F+K I + Y
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY 227
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-62
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 6/223 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
+Y IG G G D T + VA++ + + E + EI+ R ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + L L +VMEY +GG L + + E + ++ + + + HS QV
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
HRD+K +N LL +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 138 IHRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCTFS 240
K D+WS G+ M+ G P+ + +
Sbjct: 196 K-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (491), Expect = 2e-61
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 13/221 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR 75
+ +R+IG G+FG RD + E+VA+K + K +++ +E+ + LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HPN ++++ L +VMEY G + E E + G++Y HS
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---K 192
+ HRD+K N LL +K+ DFG + + + S VGTP ++APEV+L +
Sbjct: 134 HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDE 188
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+YDGK DVWS G+T + P +
Sbjct: 189 GQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 188 bits (479), Expect = 4e-60
Identities = 71/232 (30%), Positives = 107/232 (46%), Gaps = 18/232 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREIIN 70
+ YE +G G V R K T + AVK I E ++ E +E+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 71 HRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
R + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
+ D GK D+WS GV +Y +L G+ PF ++ R + Y
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-59
Identities = 76/226 (33%), Positives = 122/226 (53%), Gaps = 10/226 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y+ ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS+Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
+ AD+WS GV Y++L GA PF + + V Y
Sbjct: 189 NYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 184 bits (467), Expect = 2e-58
Identities = 60/226 (26%), Positives = 91/226 (40%), Gaps = 11/226 (4%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRS 73
H SDRYEL +G G L RD + VAVK + R +RE N +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 74 LRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
L HP IV + T IVMEY G L + + G + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAP 187
+++ H + HRD+K N ++ + A ++ + S +Q + +GT Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
E D + +DV+S G LY +L G PF + +
Sbjct: 184 EQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 4e-58
Identities = 68/225 (30%), Positives = 106/225 (47%), Gaps = 18/225 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
+ YE++ IG+G++G + +R K +++ K ++ G + Q E+ R L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 78 NIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
NIVR+ + I+ T T L IVMEY GG+L I + E+ QL +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 132 YCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG-TPAYI 185
CH V HRDLK N LDG +K+ DFG ++ + TP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+PE + + Y+ K +D+WS G LY + PF + + K
Sbjct: 182 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGK 225
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-57
Identities = 73/215 (33%), Positives = 114/215 (53%), Gaps = 9/215 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DKIDENVQREIINHRSLR 75
+ + L + +G G+FG L KKT + A+K +++ D ++ + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HP + T +L VMEY +GG+L I + +F A F+ ++I G+ + HS
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 194
+ +RDLKL+N LLD +KI DFG K ++L +T GTP YIAPE+LL ++
Sbjct: 122 KGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
Y+ D WS GV LY ML+G PF +E + F
Sbjct: 180 YNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 7e-57
Identities = 75/223 (33%), Positives = 116/223 (52%), Gaps = 14/223 (6%)
Query: 11 GMDMPIMHDSDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI- 68
G+ + D Y++ +G G G + +K+T+E A+K ++ K +RE+
Sbjct: 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVE 56
Query: 69 INHRSLRHPNIVRFKEVILTP----THLAIVMEYASGGELFERICNAG--RFSEDEARFF 122
++ R+ + P+IVR +V L IVME GGELF RI + G F+E EA
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
+ + + Y HS+ + HRD+K EN L P LK+ DFG++K + H+ + T
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
P Y+APEVL ++YD D+WS GV +Y++L G PF
Sbjct: 177 PYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHG 218
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 9e-56
Identities = 54/227 (23%), Positives = 101/227 (44%), Gaps = 13/227 (5%)
Query: 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHR 72
+ +D + +IG G+F D +T VA ++ + + E +
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 73 SLRHPNIVRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
L+HPNIVRF + + + +V E + G L + R + +Q++
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123
Query: 129 GVSYCHSM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
G+ + H+ + HRDLK +N + G P +KI D G + S K+ +GTP ++A
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMA 181
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
PE+ +++YD DV++ G+ + M YP+ + + + +
Sbjct: 182 PEM-YEEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 226
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-55
Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 12/222 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-------VQREIINHRS 73
+Y++ +GSG FG VA+K++E+ D V E++ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 74 LR--HPNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGV 130
+ ++R + P +++E +LF+ I G E+ AR FF Q++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+CH+ V HRD+K EN L+D + LK+ DFG + + GT Y PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
Y G+ A VWS G+ LY M+ G PFE EE +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 223
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 176 bits (447), Expect = 3e-54
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 11/224 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-------S 73
+ + + R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
H+ V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL K
Sbjct: 124 HNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKG 180
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYC 237
AD +S G L+ +L G PF + K+ + +
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLT 223
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 7e-54
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 15/224 (6%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLR 75
+ + + IGSG+FG + VAVK + + +Q E+ R R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 134
H NI+ F T LAIV ++ G L+ + +F + +Q G+ Y H
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
+ + HRDLK N L +KI DFG + Q + G+ ++APEV+
Sbjct: 122 AKSIIHRDLKSNNIFLHED--LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 192 KKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
++ + +DV++ G+ LY ++ G P+ + +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 171 bits (435), Expect = 5e-53
Identities = 68/217 (31%), Positives = 112/217 (51%), Gaps = 9/217 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
++++R +G+G+FG L+R + A+K +++ + E+ E + + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P I+R + ++M+Y GGELF + + RF A+F+ ++ + Y HS
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ +RDLK EN LLD + +KI DFG++K + + GTP YIAPEV+ K Y+
Sbjct: 124 DIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
D WS G+ +Y ML G PF D K + K ++
Sbjct: 180 KS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-53
Identities = 67/238 (28%), Positives = 99/238 (41%), Gaps = 16/238 (6%)
Query: 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
T G G D P Y + IG+G+FGV + + ELVA+K + + R
Sbjct: 9 TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNR 62
Query: 67 EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGG---ELFERICNAGRFSED 117
E+ R L H NIVR + + +L +V++Y
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ + QL ++Y HS +CHRD+K +N LLD A K+CDFG +K V S
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVS 181
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235
+ + Y APE++ DVWS G L +L+G F + I V+
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-52
Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 9/220 (4%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHP 77
E + +G G F RDK T ++VA+K I+ G D I+ REI + L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NI+ + +++++V ++ N+ + + + + G+ Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK N LLD + LK+ DFG +KS + V T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
G D+W+ G L +L+ + + +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 218
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-51
Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 11/217 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 61
Query: 79 IVRFKEVIL-TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + + + GR D F + + Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRDL N L+ K+ DFG +K S + + APE L +K++
Sbjct: 122 NNFVHRDLAARNVLVSED--NVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKF 177
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
K +DVWS G+ L+ + K+ +
Sbjct: 178 STK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 213
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-50
Identities = 55/241 (22%), Positives = 97/241 (40%), Gaps = 18/241 (7%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREI 68
++ P + +YE + IG G FG R +KT + VA+K + + REI
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60
Query: 69 INHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAGRFSEDEAR 120
+ L+H N+V E+ T + +V ++ +F+ E +
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQP 175
Q L++G+ Y H ++ HRD+K N L+ LK+ DFG ++ + ++
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRY 178
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235
+ V T Y PE+LL + G D+W G + M + + E +
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 236 Y 236
Sbjct: 239 G 239
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-50
Identities = 73/218 (33%), Positives = 112/218 (51%), Gaps = 8/218 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRH 76
+ ++ ++ +G G FG L+R+K T A+K + + I ++ E ++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y HS
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 195
V +RD+KLEN +LD +KI DFG K + K+ GTP Y+APEVL +Y
Sbjct: 125 DVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
D W GV +Y M+ G PF + + + F +
Sbjct: 183 GRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 164 bits (416), Expect = 3e-50
Identities = 53/215 (24%), Positives = 100/215 (46%), Gaps = 9/215 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 79
D Y+LVR +G G + + E V VK ++ K + ++REI +LR PNI
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92
Query: 80 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ +++ P A+V E+ + + + ++ + RF+ +++ + YCHSM
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K N ++D +L++ D+G ++ + V + + PE+L+ +
Sbjct: 150 IMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
D+WS G L M+ PF + + I
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 4e-50
Identities = 63/226 (27%), Positives = 94/226 (41%), Gaps = 13/226 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
RY + IG G +G+ D + VA+K I + REI RH N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 79 IVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
I+ ++I PT ++ + G +L++ + S D +F Q++ G+ Y H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 190
S V HRDLK N LL+ + LKICDFG ++ V T Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
L + K D+WS G L ML F + ++
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (416), Expect = 6e-50
Identities = 65/220 (29%), Positives = 119/220 (54%), Gaps = 9/220 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
D+++ ++ +G+G+FG L++ K++ A+K +++ + E+ E +++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ +RDLK EN L+D +++ DFG++K + + GTP +APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
D W+ GV +Y M G PF + + + K +
Sbjct: 217 KA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-50
Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 8/216 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D ++++G+G FGV + + + + VA+K I+ G ++ E +L H
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ 137
+V+ V + I+ EY + G L + RF + + + + Y S Q
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 195
HRDL N L++ +K+ DFG S+ + S + PEVL+ ++
Sbjct: 121 FLHRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 196 DGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
K +D+W+ GV ++ + +G P+E +
Sbjct: 179 SSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 213
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-49
Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 15/225 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
Y ++ +GSG +G D +T VA+K + R + + RE+ + +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 78 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V T +VM + G ++ + ED +F Q++ G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y H+ + HRDLK N ++ LKI DFG ++ S+ V T Y APEV+L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
+ D+WS G + M+ G F+ + ++ + V
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 8e-49
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 7/221 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+ ++ V IG G +GV R+K T E+VA+K I + + REI + L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
NIV+ +VI T L +V E+ + F + + QL+ G+++CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
+V HRDLK +N L++ +K+ DFG +++ + + + V T Y APE+LL +Y
Sbjct: 122 RVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
D+WS G M+ F E + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-48
Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 7/217 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D V++IGSG FG+ L ++ VA+K I G +E+ E L HP
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPK 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+V+ V L + +V E+ G L + G F+ + + G++Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
V HRDL N L+ + +K+ DFG ++ ++ T + +PEV Y
Sbjct: 122 VIHRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
K +DVWS GV ++ + + + I
Sbjct: 180 SSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (401), Expect = 2e-48
Identities = 47/218 (21%), Positives = 85/218 (38%), Gaps = 7/218 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + + R S + Q+ S + Y
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL N L+ + +K+ DFG S+ + ++ + APE L +
Sbjct: 135 NFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+ K +DVW+ GV L+ + + + +
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 4e-48
Identities = 57/239 (23%), Positives = 95/239 (39%), Gaps = 15/239 (6%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
M++ + +RY L R IGSG+FG L D E VA+K +E + E +
Sbjct: 1 MELRV---GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIY 56
Query: 72 RSLRHPN-IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ ++ I + + +VME + +FS Q+IS +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 131 SYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGT 181
Y HS HRD+K +N L+ G + I DFG +K + + + K+ GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCTFS 240
Y + L E + D+ S G L +G+ P++ + +K + S
Sbjct: 177 ARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 157 bits (397), Expect = 8e-48
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 7/221 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
++Y + IG G +GV ++ E A+K I + + I REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV+ +VI T L +V E+ G A+ F QL++G++YCH +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+ +
Sbjct: 121 VLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYC 237
D+WS G M+ G F E + ++
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 156 bits (396), Expect = 1e-47
Identities = 44/228 (19%), Positives = 87/228 (38%), Gaps = 14/228 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
Y++ R IG G+FGV + + VA+K+ R ++ E ++ L I
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
H +V++ +FS +Q+++ V H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 140 HRDLKLENTLLDGSPAP---RLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 188
+RD+K +N L+ + + + DFG K + + + K+ GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
L +E + D+ + G L G+ P++ + N +K +
Sbjct: 184 THLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-47
Identities = 50/218 (22%), Positives = 85/218 (38%), Gaps = 9/218 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 73
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L + + + Q+ SG++Y M
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ ++ + + APE L
Sbjct: 133 NYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+ K +DVWS G+ L + + +
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 227
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-47
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 6/224 (2%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHP 77
+YE + IG G +G ++++T E+VA+K + D + + REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIVR +V+ + L +V E+ G + + F QL+ G+ +CHS
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLKKEYD 196
V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL +
Sbjct: 122 VLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMYCTFS 240
D+WS G + P + + K I + T +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (391), Expect = 1e-46
Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 16/225 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D ++ + IG+G FG L K E VA+K ++ G +K + E
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSY 132
HPN++ + V+ T + I+ E+ G L N G+F+ + + + +G+ Y
Sbjct: 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIA 186
M HRDL N L++ + K+ DFG S+ S ++ + A
Sbjct: 144 LADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
PE + +++ +DVWS G+ ++ ++ G P+ D
Sbjct: 202 PEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-46
Identities = 46/219 (21%), Positives = 87/219 (39%), Gaps = 9/219 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +LV +G+G FG + + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR V+ T + I+ EY G L + + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 194
HRDL+ N L+ KI DFG ++ + + APE +
Sbjct: 129 NYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+ K +DVWS G+ L ++ + +
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 1e-46
Identities = 64/229 (27%), Positives = 96/229 (41%), Gaps = 16/229 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYI---ERGDKIDENVQREIINHRSL-- 74
+YE V +IG G +G RD K VA+K + + + + RE+ R L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 75 -RHPNIVRFKEVILTP-----THLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLI 127
HPN+VR +V T L +V E+ + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
EVLL+ Y D+WS G M F + K + V+
Sbjct: 185 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 7e-46
Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 17/230 (7%)
Query: 14 MPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKID----ENVQR 66
+ + L+ +G G+FGV VAVK ++ ++ R
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 67 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQ 125
E+ SL H N++R V+LTP + +V E A G L +R+ + G F + Q
Sbjct: 61 EVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGT 181
+ G+ Y S + HRDL N LL +KI DFG + + + +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230
A+ APE L + + +D W GVTL+ M G P+ + K
Sbjct: 178 FAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-45
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 12/223 (5%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+R EL R IG G FG M + VA+K + D + E +E + R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSY 132
HP+IV+ VI T + I+ME + GEL + + QL + ++Y
Sbjct: 65 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
S + HRD+ N L+ + +K+ DFG S+ + K++ ++APE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+ + +DVW GV ++ +L+ + + I
Sbjct: 182 NFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 223
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-45
Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 21 DRYELV-RDIGSGNFGVARL--MRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLR 75
D + ++G GNFG R R +K + VA+K +++G + E + RE L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 134
+P IVR V L +VME A GG L + + Q+ G+ Y
Sbjct: 68 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 126
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 190
HRDL N LL + I DFG SK ++ + + APE +
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 191 LKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
+++ + +DVWS GVT++ L G P++ + P+
Sbjct: 185 NFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 224
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 4e-45
Identities = 55/250 (22%), Positives = 90/250 (36%), Gaps = 38/250 (15%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL-----VAVKYI--ERGDKIDENVQREIINH 71
+ E + +GSG FG + VAVK + + E + E+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---------------------- 108
L H NIV + ++ EY G+L +
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 109 -CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+ + ++ F Q+ G+ + HRDL N L+ +KICDFG ++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLAR 212
Query: 168 ---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPE 223
S + + ++APE L + Y K +DVWS G+ L+ + +G P+
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 224 EPKNFRKTIH 233
NF K I
Sbjct: 272 VDANFYKLIQ 281
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-45
Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 13/225 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRH 76
+RY+ + +GSG +G D KT VAVK + R + + RE+ + ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 77 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V L ++ + G I + ++D +F Q++ G+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y HS + HRDLK N ++ LKI DFG ++ + V T Y APE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIML 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
+ + D+WS G + +L G F + + + ++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 6e-45
Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 17/223 (7%)
Query: 21 DRYELV---RDIGSGNFGVARL--MRDKKTEELVAVKYIERG---DKIDENVQREIINHR 72
DR L +++GSGNFG + + KK + VAVK ++ + + + E +
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
L +P IVR + + + +VME A G L + + + Q+ G+ Y
Sbjct: 64 QLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPE 188
HRDL N LL KI DFG SK+ + + APE
Sbjct: 123 LEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 189 VLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
+ ++ K +DVWS GV ++ G P+ + +
Sbjct: 181 CINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 222
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 8e-44
Identities = 46/229 (20%), Positives = 88/229 (38%), Gaps = 13/229 (5%)
Query: 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI------ERGDKIDENVQRE 67
+ I+ +++ ++ ++ +GSG FG E V + K ++ + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
S+ +P++ R + LT T I G L + + Q+
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAY 184
G++Y ++ HRDL N L+ +KI DFG +K + + +
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+A E +L + Y + +DVWS GVT++ ++ D +
Sbjct: 180 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-43
Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 10/226 (4%)
Query: 21 DRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHR 72
+ +EL++ +G+G +G R + T +L A+K +++ K E+ + E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 73 SLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+R P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
+ H + + +RD+KLEN LLD + L + + GT Y+AP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 192 -KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
K D WS GV +Y +L GA PF E + + +
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-43
Identities = 57/234 (24%), Positives = 88/234 (37%), Gaps = 25/234 (10%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGDKID--ENVQREIINHRSL 74
D + + IG GNFG R KK A+K ++ D + E+ L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 75 -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSED 117
HPNI+ +L + +EYA G L + + A S
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ F + G+ Y Q HRDL N L+ + KI DFG S+ ++ +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTM 185
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230
++A E L Y +DVWS GV L+ ++ G P+ + + K
Sbjct: 186 GRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-42
Identities = 58/230 (25%), Positives = 90/230 (39%), Gaps = 27/230 (11%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ L IG G FG + + E VAVK ++ + EI LRH NI
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 80 VRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+ F T T L +V +Y G LF+ + N + + SG+++ H
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 136 --------MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTP 182
+ HRDLK +N L+ + I D G S + + P VGT
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 183 AYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227
Y+APEVL +K K AD+++ G+ + + E+ +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (360), Expect = 4e-42
Identities = 55/246 (22%), Positives = 93/246 (37%), Gaps = 37/246 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYI--ERGDKIDENVQREIINHRS 73
+ E VRDIG G FG R + +VAVK + E + + QRE
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 113
+PNIV+ V + ++ EY + G+L E + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 114 ----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 167
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
S+ + + ++ PE + Y + +DVW+ GV L+ + +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 227 NFRKTI 232
+
Sbjct: 250 EVIYYV 255
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 8e-42
Identities = 54/225 (24%), Positives = 90/225 (40%), Gaps = 15/225 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
RY+ ++ IGSG G+ D + VA+K + R + RE++ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 78 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
NI+ V + +VME + + Q++ G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
+ HS + HRDLK N ++ LKI DFG ++++ V T Y APEV+L
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236
Y + D+WS G + M+ F + + K I +
Sbjct: 192 GMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-41
Identities = 51/232 (21%), Positives = 87/232 (37%), Gaps = 15/232 (6%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDE--NVQRE 67
+ I S IG G+FG L+ + + AVK + R I E E
Sbjct: 19 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 68 IINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQ 125
I + HPN++ + L + +V+ Y G+L + + F Q
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 180
+ G+ + S + HRDL N +LD +K+ DFG ++
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
++A E L +++ K +DVWS GV L+ ++ P + +
Sbjct: 197 PVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 5e-41
Identities = 51/225 (22%), Positives = 87/225 (38%), Gaps = 14/225 (6%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERG--DKIDENVQREIINHR 72
+ IG+G FG K + E VA+K ++ G +K + E
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVS 131
H NI+R + VI + I+ EY G L + + G FS + + + +G+
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAP 187
Y +M HRDL N L++ + K+ DFG S+ + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
E + +++ +DVWS G+ ++ ++ K I
Sbjct: 183 EAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 226
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 8e-40
Identities = 49/238 (20%), Positives = 81/238 (34%), Gaps = 32/238 (13%)
Query: 19 DSDRYELVRDIGSGNFGV-----ARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
+R + +G+G FG A + VAVK ++ + E + E+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC------------------NAG 112
L H NIV ++ EY G+L + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172
++ F Q+ G+++ S HRDL N LL KICDFG ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKND 198
Query: 173 SQPKST---VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227
S ++APE + Y + +DVWS G+ L+ + +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS 255
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-38
Identities = 51/240 (21%), Positives = 91/240 (37%), Gaps = 29/240 (12%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE-------LVAVKYI--ERGDKIDENVQREII 69
DR L + +G G FG L ++ VAVK + + +K ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70
Query: 70 NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAG 112
+ + +H NI+ L +++EYAS G L E +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVL 171
+ S + Q+ G+ Y S + HRDL N L+ ++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
+ + + ++APE L + Y + +DVWS GV L+ + +G P+ + F+
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 6e-37
Identities = 43/234 (18%), Positives = 90/234 (38%), Gaps = 23/234 (9%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKIDE--NVQREIINH 71
++ + R++G G+FG+ K + E VA+K + + E E
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF----------SEDEARF 121
+ ++VR V+ ++ME + G+L + + S +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 178
++ G++Y ++ + HRDL N ++ +KI DFG ++ + + +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+ +++PE L + DVWS GV L+ + A + + +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-35
Identities = 52/244 (21%), Positives = 93/244 (38%), Gaps = 32/244 (13%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL-----VAVKYIERGDKIDEN---VQREIIN 70
DR +L + +G G FG ++ VAVK ++ G E+ + I
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 71 HRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGR---------------- 113
H N+V P L +++E+ G L + +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 114 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 170
+ + + Q+ G+ + S + HRDL N LL +KICDFG ++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 188
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFR 229
+ + ++APE + + Y + +DVWS GV L+ + A P+ + + F
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 230 KTIH 233
+ +
Sbjct: 248 RRLK 251
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 125 bits (313), Expect = 1e-34
Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 20/233 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 81
RY LVR +G G+F L +D VA+K + E + EI + + + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 82 ---------------FKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQ 125
F H+ +V E L + + +Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 126 LISGVSYCHSMQ-VCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
L+ G+ Y H + H D+K EN L++ SP ++I + +++ T
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235
Y +PEVLL + AD+WS ++ ++ G + FE E + H+
Sbjct: 194 EYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 69.0 bits (168), Expect = 4e-15
Identities = 29/202 (14%), Positives = 57/202 (28%), Gaps = 39/202 (19%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----------DKIDENVQREIINH 71
+ + +G G +K E VK+ + G D D + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 72 RSLRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
+ + + + + + A++ME R + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMIL 113
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
V+ + + H DL N L+ + I DF SV + +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFP---QSVEVGEEGW----REILER 163
Query: 188 EVL-----LKKEYDGKIADVWS 204
+V + Y D+ S
Sbjct: 164 DVRNIITYFSRTY-RTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 240 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.77 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.57 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.81 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.68 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.06 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=316.40 Aligned_cols=211 Identities=33% Similarity=0.613 Sum_probs=187.2
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
.++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999999999999999999998653 23346688999999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
|||+++++|.+++.+.+++++..++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||++..... ...
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~-~~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRR 161 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCC-CCC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCC-Ccc
Confidence 999999999999988889999999999999999999999999999999999999987766 99999999864432 223
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
....|++.|+|||++.+...+.+ +|||||||++|+|++|..||.+.+....+.++.+.
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 219 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred cccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 34568999999999988776555 99999999999999999999988887777776554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=319.45 Aligned_cols=204 Identities=38% Similarity=0.669 Sum_probs=179.7
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
.++|++++.||+|+||+||+|++..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 368999999999999999999999999999999987643 223568999999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc---CC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQ 174 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~---~~ 174 (240)
|+++++|.+++.....+++..++.++.|++.||+|||+.||+||||+|+||+++.++. +||+|||++...... ..
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCcccc
Confidence 9999999999988888999999999999999999999999999999999999987765 999999999754322 22
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCch
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (240)
.....|++.|+|||++.+...++.++||||||+++|+|++|..||......
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 344578999999999988887766699999999999999999999776543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=320.22 Aligned_cols=214 Identities=31% Similarity=0.496 Sum_probs=187.5
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
++++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.++++++||||+++++++.+++.+++
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 457899999999999999999999999999999998753 2333568899999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~- 173 (240)
||||++|++|.+++...+.+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++.......
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESK 163 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC----
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCc
Confidence 9999999999999988899999999999999999999999999999999999999987776 9999999987543322
Q ss_pred --CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 174 --~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
......|++.|+|||++.+..++. ++|||||||++|+|++|..||.+.+....+.++++.-
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~-~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 226 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred ccccccccCCccccCceeeccCCCCc-ccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC
Confidence 223456899999999998777654 5999999999999999999999988888888777643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=315.35 Aligned_cols=210 Identities=29% Similarity=0.485 Sum_probs=184.5
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
.++|++++.||+|+||.||+|++..+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 368999999999999999999999999999999987643 3346789999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~ 177 (240)
++|++|.+++.+ ..+++..++.++.||+.||+|||++||+||||+|+||+++.++. ++|+|||++...... .....
T Consensus 99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCC
T ss_pred cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeeccccccccc
Confidence 999999987754 56999999999999999999999999999999999999987765 999999999755433 33345
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
..|++.|+|||.+.+..++.+ +||||||+++|+|++|..||.+.+..+.+.++..
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 230 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred cccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh
Confidence 568999999999988777555 9999999999999999999998877666655543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-50 Score=319.35 Aligned_cols=214 Identities=36% Similarity=0.633 Sum_probs=173.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
+.|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 67999999999999999999999999999999987643 2235578999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcC-CCCCcEEEecCCccccccccCCCCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKS 177 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~-~~~~~~~L~d~~~~~~~~~~~~~~~ 177 (240)
++|++|.+++.+.+.+++..+..++.||+.||+|||+.||+|+||+|+||++.. +..+.++|+|||++...........
T Consensus 89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 168 (307)
T d1a06a_ 89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST 168 (307)
T ss_dssp CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeee
Confidence 999999999988889999999999999999999999999999999999999964 2334599999999976655555556
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
..|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+......++++.-
T Consensus 169 ~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 225 (307)
T d1a06a_ 169 ACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 225 (307)
T ss_dssp ----CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC
T ss_pred eeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC
Confidence 779999999999988776555 999999999999999999999988887777776543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-50 Score=320.64 Aligned_cols=204 Identities=31% Similarity=0.514 Sum_probs=180.7
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
..++|++++.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4679999999999999999999999999999999987643 33457889999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~-~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
||++|++|.+++.+.+.+++..++.++.|++.||+|||++ ||+||||||+||+++.++. +||+|||+|..... ...
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~-~~~ 160 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 160 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HTC
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCC-Ccc
Confidence 9999999999998888999999999999999999999974 9999999999999987766 99999999875433 233
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
....|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+...
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKE 210 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred ccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 45679999999999998877665 999999999999999999998876543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-49 Score=322.36 Aligned_cols=214 Identities=31% Similarity=0.542 Sum_probs=189.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
++|++++.||+|+||.||+|++..+|..||+|++..... ..+.+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 689999999999999999999999999999999876432 2356789999999999999999999999999999999999
Q ss_pred CCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCC
Q 026299 100 SGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (240)
Q Consensus 100 ~~~~l~~~l~-~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~ 178 (240)
+|++|.+++. ..+++++..+..++.||+.||+|||+.||+||||+|+||+++.+..+.++|+|||++............
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 185 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEE
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccccee
Confidence 9999999885 445799999999999999999999999999999999999997655556999999998766555555556
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
.+++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+.+.++.+.-
T Consensus 186 ~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 241 (350)
T d1koaa2 186 TGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 241 (350)
T ss_dssp CSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 78999999999988777544 999999999999999999999988888777776543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=311.43 Aligned_cols=214 Identities=34% Similarity=0.611 Sum_probs=190.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-------cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
++|++.+.||+|+||.||+|++..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 67999999999999999999999999999999987532 12356889999999999999999999999999999
Q ss_pred EEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCC--CcEEEecCCccccccc
Q 026299 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVL 171 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~--~~~~L~d~~~~~~~~~ 171 (240)
+||||+++++|.+++.+.+.+++..++.++.|++.||+|||+.||+|+||+|+||+++.++. ..++|+|||++.....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 99999999999999988889999999999999999999999999999999999999976553 2599999999976666
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
........+++.|+|||.+.+...+.+ +||||||+++|+|++|..||.+.+..+.+.++.+..
T Consensus 170 ~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 232 (293)
T d1jksa_ 170 GNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232 (293)
T ss_dssp SCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred CccccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence 666666778999999999987777555 999999999999999999999988887777766543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=315.82 Aligned_cols=212 Identities=34% Similarity=0.590 Sum_probs=189.8
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
.++|++++.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46899999999999999999999999999999998753 22346688999999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc-cCC
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~-~~~ 174 (240)
|||++|++|.+++.+.+.+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++..... ...
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCcc
Confidence 999999999999998899999999999999999999999999999999999999987765 99999999975443 333
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.....|++.|+|||++.+..++.. +|+|||||++|+|++|..||.+.+....++++...
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~ 220 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC
Confidence 445678999999999988887655 99999999999999999999999888877776654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=312.02 Aligned_cols=212 Identities=29% Similarity=0.437 Sum_probs=183.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
+.|++++.||+|+||.||+|++..++..||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56999999999999999999999999999999987643 33467899999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCC
Q 026299 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (240)
Q Consensus 100 ~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~ 177 (240)
++++|.+++.+ .+++++..+..++.||+.||+|||++||+||||+|+||+++.++. +||+|||++...... .....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcccccc
Confidence 99999998765 457999999999999999999999999999999999999987776 999999998643322 22335
Q ss_pred CcCCccccCccccccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 178 TVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
..|++.|+|||++... ..++.++|||||||++|+|++|..||.+.+..+.+.++.+.
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~ 230 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 6789999999998532 23355599999999999999999999998887777766543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.3e-49 Score=313.39 Aligned_cols=211 Identities=33% Similarity=0.584 Sum_probs=188.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
++|++++.||+|+||+||+|++..+|+.||+|++... ....+.+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 6799999999999999999999999999999998753 233467889999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
||++|+++..++.....+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++..... ...
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~--~~~ 159 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VTY 159 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CBC
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEecc--ccc
Confidence 99999999999988888999999999999999999999999999999999999987765 99999999875433 234
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceec
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (240)
...|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....+.++++.-.
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~ 218 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 218 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC
T ss_pred cccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC
Confidence 5678999999999988777655 9999999999999999999999988888888776543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=317.68 Aligned_cols=214 Identities=24% Similarity=0.447 Sum_probs=191.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecCC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (240)
++|++.+.||+|+||.||+|++..+++.||+|.+.........+.+|+.+++.++||||+++++++.+++.+++||||++
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 78999999999999999999999999999999998766555678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCCc
Q 026299 101 GGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179 (240)
Q Consensus 101 ~~~l~~~l~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~~ 179 (240)
|++|.+++...+ ++++.+++.++.||+.||+|||+.||+||||+|+||+++.+....++|+|||.+.............
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~ 164 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEE
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccc
Confidence 999999997654 7999999999999999999999999999999999999987766679999999987655444444556
Q ss_pred CCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 180 ~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
+++.|+|||.+.+...+. ++|||||||++|+|++|..||.+.+..+.+.++++..
T Consensus 165 ~t~~y~ape~~~~~~~~~-~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~ 219 (321)
T d1tkia_ 165 TAPEYYAPEVHQHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219 (321)
T ss_dssp SCGGGSCHHHHTTCEECH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred cccccccchhccCCCCCc-hhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 889999999988777655 4999999999999999999999999888888877644
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.2e-49 Score=319.50 Aligned_cols=214 Identities=28% Similarity=0.489 Sum_probs=189.0
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc-ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (240)
++|++++.||+|+||.||+|++..+|+.||+|++..... ....+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 679999999999999999999999999999999876542 2356789999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCCCC
Q 026299 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (240)
Q Consensus 100 ~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~~~ 178 (240)
+|++|.+.+... .++++.+++.++.||+.||+|||+.||+||||+|+|||++....+.++|+|||++............
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~ 188 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 188 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeec
Confidence 999998877554 4699999999999999999999999999999999999998655556999999999766555555556
Q ss_pred cCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 179 ~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
.+++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....+.++.+.-
T Consensus 189 ~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 244 (352)
T d1koba_ 189 TATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 244 (352)
T ss_dssp CSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC
T ss_pred cCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 78999999999988777555 999999999999999999999988888877776543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-48 Score=310.41 Aligned_cols=209 Identities=28% Similarity=0.422 Sum_probs=182.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcccc----HHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (240)
+.|+.++.||+|+||.||+|++..++..||||++....... +.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999999999999999987654222 45789999999999999999999999999999999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCCC
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~~ 176 (240)
||++++++..++....++++..++.++.||+.||+|||+.||+||||+|+||+++.++. ++|+|||++..... ..
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~~ 169 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---AN 169 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BC
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---CC
Confidence 99999999877777788999999999999999999999999999999999999987765 99999999874432 34
Q ss_pred CCcCCccccCccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 177 STVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
...|++.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+.+++..
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~ 229 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 56799999999998643 22345599999999999999999999988877776666543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=308.48 Aligned_cols=213 Identities=32% Similarity=0.517 Sum_probs=173.0
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEc--CCeEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI 94 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 94 (240)
.++|++++.||+|+||.||+|++..+|+.||+|.+...... .+.+.+|+.++++++||||+++++++.+ ++.+++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 47899999999999999999999999999999998765322 2457899999999999999999999875 356899
Q ss_pred EEecCCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCC-----ceeecCCCCCeEEcCCCCCcEEEecCCc
Q 026299 95 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGY 165 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~-----ivh~~i~~~nili~~~~~~~~~L~d~~~ 165 (240)
||||+++++|.+++.+ ...+++..++.++.|++.||+|||+.| |+||||+|+||+++.++. ++|+|||+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~ 160 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL 160 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccc
Confidence 9999999999998853 357999999999999999999999876 999999999999987766 99999999
Q ss_pred cccccccC-CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 166 SKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 166 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
+....... ......+++.|+|||.+.+..++. ++||||||+++|+|++|..||.+.+..+.+.++.+.-
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~-~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~ 230 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNE-KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 230 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCCh-HHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 87554332 234467899999999997777654 5999999999999999999999988887777766543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-48 Score=309.22 Aligned_cols=215 Identities=21% Similarity=0.279 Sum_probs=183.7
Q ss_pred cccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
.+.++.++|++.+.||+|+||.||+|++..++..||+|++..+....+.+.+|+.++++++||||+++++++.+++.+++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 44556789999999999999999999999999999999998877667889999999999999999999999999999999
Q ss_pred EEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
||||+++++|.+++.+. ..+++..+..++.|++.||+|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGD 168 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCC
Confidence 99999999999998654 56899999999999999999999999999999999999987776 999999998744332
Q ss_pred CCC--CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 173 SQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 173 ~~~--~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
... ....++..|+|||.+.+..++. ++||||||+++|+|++|..||........+.+++
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~-k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i 229 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CceeeccccccccccChHHHcCCCCCc-hhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH
Confidence 211 2234678899999998877654 5999999999999999777765555544444433
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8e-48 Score=302.53 Aligned_cols=213 Identities=32% Similarity=0.470 Sum_probs=188.3
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----------cHHHHHHHHHHHhcC-CCCeeeeeEEEEcC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DENVQREIINHRSLR-HPNIVRFKEVILTP 89 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----------~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 89 (240)
++|++.+.||+|+||+||+|++..+++.||+|++...... .+.+.+|+..+++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 7899999999999999999999999999999998764321 135789999999997 99999999999999
Q ss_pred CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
+..++||||+++++|.+++..++++++..+..++.||+.||+|||+.||+||||+|+||+++.++. ++|+|||++...
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQL 160 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEEC
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeEc
Confidence 999999999999999999998889999999999999999999999999999999999999987776 999999999766
Q ss_pred cccCCCCCCcCCccccCccccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 170 VLHSQPKSTVGTPAYIAPEVLLKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 170 ~~~~~~~~~~~~~~~~~pE~~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
..........++..|+|||.+.+. ...+.++||||+|+++|+|++|..||.+.+......++++.-
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~ 231 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence 555555667789999999998643 223456999999999999999999999998887777776543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-48 Score=313.80 Aligned_cols=212 Identities=31% Similarity=0.547 Sum_probs=189.1
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC----ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
.++|++++.||+|+||.||+|++..+|+.||+|++... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 37899999999999999999999999999999998753 23335688999999999999999999999999999999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
++++.+++|.+.+.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++..... ..
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~--~~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--RT 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--CB
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeeccc--cc
Confidence 999999999999988889999999999999999999999999999999999999987765 99999999875432 23
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceec
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (240)
....|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....+.++.....
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~ 255 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred ccccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC
Confidence 45678999999999988777655 9999999999999999999999888877777765543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=300.29 Aligned_cols=204 Identities=25% Similarity=0.436 Sum_probs=173.2
Q ss_pred CCe-eEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEc----CCeE
Q 026299 21 DRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 92 (240)
Q Consensus 21 ~~y-~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 92 (240)
.+| ++.+.||+|+||+||+|++..++..||+|.+..... ..+.+.+|++++++++||||+++++++.+ +..+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 445 788899999999999999999999999999876432 23467899999999999999999999865 3568
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC--ceeecCCCCCeEEcC-CCCCcEEEecCCccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 169 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~--ivh~~i~~~nili~~-~~~~~~~L~d~~~~~~~ 169 (240)
++||||+++++|.+++.+...+++..+..++.||+.||+|||+++ |+||||||+||+++. ++. +||+|||++...
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLK 165 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGC
T ss_pred EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCcceec
Confidence 999999999999999988889999999999999999999999998 999999999999964 444 999999998643
Q ss_pred cccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 026299 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (240)
Q Consensus 170 ~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (240)
. ........|++.|+|||.+.+ .. +.++|||||||++|+|++|..||.+......+.
T Consensus 166 ~-~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~ 222 (270)
T d1t4ha_ 166 R-ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222 (270)
T ss_dssp C-TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred c-CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH
Confidence 2 222334578999999998865 34 455999999999999999999998766554443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=300.66 Aligned_cols=212 Identities=26% Similarity=0.431 Sum_probs=174.3
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
+++++|++.+.||+|+||.||+|++. ++..||||++..+....+++.+|+..+++++||||+++++++.+++..++|||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 46789999999999999999999987 56789999998877777889999999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC--
Q 026299 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (240)
Q Consensus 98 ~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~-- 174 (240)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+|+||||+|+||+++.++. +||+|||++........
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCcee
Confidence 99999999988654 56889999999999999999999999999999999999987776 99999999865433222
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
.....++..|+|||.+.+..++. ++||||||+++|+|++ |..||...+....+.++..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~-k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~ 217 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 217 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCH-HHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCCc-hhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh
Confidence 22345788999999998877654 5999999999999999 5666666666555555433
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=304.36 Aligned_cols=210 Identities=35% Similarity=0.568 Sum_probs=184.2
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHHHHHHH-hcCCCCeeeeeEEEEcCCeEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHR-SLRHPNIVRFKEVILTPTHLAIV 95 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 95 (240)
++|++.+.||+|+||+||+|++..+++.||+|++..+. ...+.+..|...+. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999999999999999997532 22345666766654 68999999999999999999999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CC
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~ 174 (240)
|||+++++|.+++.....+++..+..++.||+.||+|||+.||+||||+|+||+++.++. ++|+|||.+...... ..
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhccccccc
Confidence 999999999999998889999999999999999999999999999999999999987765 999999999755433 33
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.....|++.|+|||.+.+..++.+ +|||||||++|+|++|..||.+.+....+.++..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~ 217 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 217 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 334578999999999998887654 9999999999999999999999888877777654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=297.15 Aligned_cols=212 Identities=23% Similarity=0.408 Sum_probs=186.1
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
++++|++.+.||+|+||+||+++++ ++..||||.+.......+.+++|+..+++++||||+++++++.+++.+++||||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 5789999999999999999999986 778899999998877778999999999999999999999999999999999999
Q ss_pred CCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC--C
Q 026299 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (240)
Q Consensus 99 ~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~--~ 175 (240)
++++++.+++.. ...+++..++.++.|+++||+|||+.||+|+||+|+||+++.++. +||+|||++........ .
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceee
Confidence 999999888654 457899999999999999999999999999999999999987766 99999999864433222 2
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhce
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 234 (240)
....+++.|+|||.+.+..++. ++||||||+++|+|++ |..||...+..+...++.+.
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~-ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~ 217 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSS-KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 217 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred cccCCCCCcCCcHHhcCCCCCc-ceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 2345788999999998877755 4999999999999998 89999998887777766553
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.8e-47 Score=307.92 Aligned_cols=204 Identities=30% Similarity=0.461 Sum_probs=175.8
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc----cccHHHHHH---HHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQRE---IINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... .....+.+| +.+++.++||||+++++++.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 478999999999999999999999999999999986532 112233444 5666777899999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
++||||++|++|.+++.+...+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||++.....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~- 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK- 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSS-
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCC-
Confidence 999999999999999988889999999999999999999999999999999999999987766 99999999875433
Q ss_pred CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 173 ~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
.......|++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+
T Consensus 160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 213 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC
T ss_pred CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH
Confidence 334456799999999999776655666999999999999999999998765443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.6e-47 Score=298.44 Aligned_cols=211 Identities=28% Similarity=0.404 Sum_probs=176.9
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc----cHHHHHHHHHHHhcCCCCeeeeeEEEEcCC----eE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPT----HL 92 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~ 92 (240)
++|++.+.||+|+||.||+|++..+++.||+|++...... ...+.+|+..++.++||||+++++++...+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 6899999999999999999999999999999998764322 246789999999999999999999987643 47
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
++||||++|++|.+++...+++++.++..++.|++.||+|||+.||+||||||+||+++.++. .+++|||.+......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC--
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhccc
Confidence 899999999999999988889999999999999999999999999999999999999987776 899999987543322
Q ss_pred C----CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 173 S----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 173 ~----~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
. ......|++.|+|||++.+...+. ++||||||+++|+|++|..||.+.+..+.+.++++.
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~-~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~ 229 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDA-RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229 (277)
T ss_dssp --------------TTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred cccccccccccCcccccCHHHHcCCCCCc-ceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc
Confidence 2 223446899999999998776654 499999999999999999999988877777666543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=294.93 Aligned_cols=218 Identities=22% Similarity=0.334 Sum_probs=179.1
Q ss_pred CCCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC
Q 026299 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (240)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (240)
|.-+..+.++.++|++.+.||+|+||.||+|++. ++..||||++.......+.+.+|+.++++++||||+++++++.+
T Consensus 2 p~~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 2 PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp CTTTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCCCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 3333344446689999999999999999999987 57789999998877667789999999999999999999998765
Q ss_pred CeEEEEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 90 THLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
+..++||||+++++|.+++... .++++..+..++.||++||.|||+.+|+||||+|+||+++.++. +||+|||++.
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~ 157 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLAR 157 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCE
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceE
Confidence 5678999999999999876433 36899999999999999999999999999999999999987776 9999999997
Q ss_pred ccccc--CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhC-CCCCCCCCchhhhhhhh
Q 026299 168 SSVLH--SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 168 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~ 232 (240)
..... .......+++.|+|||.+.+...+. ++||||||+++|+|++| ..||...+..+.+.++.
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~-~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~ 224 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTI-KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred EccCCccccccccCCcccccChHHHhCCCCCc-hhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 54332 2223445788999999998777654 49999999999999995 45555555555544443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=301.85 Aligned_cols=208 Identities=26% Similarity=0.391 Sum_probs=179.6
Q ss_pred EeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc------ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEec
Q 026299 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
.++.||+|+||+||+|++..+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 57899999999999999999999999999865322 234688999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCCC
Q 026299 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (240)
Q Consensus 99 ~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~~ 177 (240)
+.++++..+...+..+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||.+...... .....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCcccccc
Confidence 999888777766778999999999999999999999999999999999999987766 999999998654433 23344
Q ss_pred CcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 178 ~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
..+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+.+.++.+.
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~ 216 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHh
Confidence 568999999999987776677799999999999999999999999888887777653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=295.64 Aligned_cols=209 Identities=26% Similarity=0.374 Sum_probs=171.5
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
++.++|++.+.||+|+||+||+|+... .||||++.... ...+.+.+|+.++++++||||+++++++.+ ..+++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 467899999999999999999998653 49999986542 223578899999999999999999998754 56789
Q ss_pred EEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC
Q 026299 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~ 173 (240)
||||+++++|.+++... .++++..+..++.|++.||+|||+.||+||||+|+||+++.++. +||+|||++.......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC-----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccC
Confidence 99999999999998654 56999999999999999999999999999999999999987776 9999999986443222
Q ss_pred ---CCCCCcCCccccCccccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 026299 174 ---QPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (240)
Q Consensus 174 ---~~~~~~~~~~~~~pE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (240)
......+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||.+.+....+...+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~ 222 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 223456889999999986543 23556999999999999999999999877665554443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-47 Score=299.93 Aligned_cols=213 Identities=23% Similarity=0.372 Sum_probs=170.6
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCc---EEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
.+.++|++.+.||+|+||+||+|++..++. .|++|.+..... ..+.+.+|+.++++++||||+++++++.+++.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 445889999999999999999999876654 588888765432 235689999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
++||||+++++|.+++... +.+++.++..++.|++.||+|||+.|++||||+|+||+++.++. +||+|||++.....
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLED 180 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC--------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccC
Confidence 9999999999999988764 56999999999999999999999999999999999999987776 99999999865433
Q ss_pred cCCC------CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 172 HSQP------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 172 ~~~~------~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
.... ....+++.|+|||.+.+...+.+ +||||||+++|+|++ |..||.+....+.+.++.+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~ 248 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 2221 12346788999999987766554 999999999999998 8999998887776665544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=303.09 Aligned_cols=203 Identities=35% Similarity=0.554 Sum_probs=174.7
Q ss_pred CCCeeEee-eecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHh-cCCCCeeeeeEEEEc----CCeEE
Q 026299 20 SDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-LRHPNIVRFKEVILT----PTHLA 93 (240)
Q Consensus 20 ~~~y~~~~-~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~~ 93 (240)
.++|+++. .||+|+||.||+|++..+++.||||++.. ...+.+|+.++.+ .+||||+++++++.+ +..++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 47899986 59999999999999999999999999854 3557789988654 589999999999875 46789
Q ss_pred EEEecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCC-CCcEEEecCCcccccc
Q 026299 94 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV 170 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~-~~~~~L~d~~~~~~~~ 170 (240)
+||||++|++|.+++.+. ..+++.+++.++.||+.||+|||+.||+||||+|+||+++.+. .+.++|+|||++....
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence 999999999999999764 4699999999999999999999999999999999999997533 3459999999998766
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
.........+++.|+|||.+.+..++.+ +|||||||++|+|++|..||.+.+....
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~ 221 (335)
T d2ozaa1 166 SHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAI 221 (335)
T ss_dssp CCCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred CCCccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHH
Confidence 6666667789999999999987776554 9999999999999999999987665443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=296.29 Aligned_cols=211 Identities=30% Similarity=0.448 Sum_probs=180.4
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++++.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999999999999999986543 234678899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCC
Q 026299 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~ 175 (240)
+++++.+...... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++. ++|+|||.+...... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcccc
Confidence 9977544433333 456999999999999999999999999999999999999987765 999999998755432 334
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
....+++.|+|||.+......+.++|+||||+++|+|++|..||.+.+..+.+.++.+
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~ 217 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHH
Confidence 4557899999999988887777779999999999999999999998887776666554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=299.09 Aligned_cols=214 Identities=26% Similarity=0.405 Sum_probs=178.6
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCc-----EEEEEEeecC--ccccHHHHHHHHHHHhc-CCCCeeeeeEEEEc
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILT 88 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~-----~v~iK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 88 (240)
.++.++|++.+.||+|+||+||+|++...++ .|++|.+... ......+.+|+..++++ +||||+++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3456799999999999999999999875543 6899987653 33346788999999988 89999999999999
Q ss_pred CCeEEEEEecCCCCchHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCC
Q 026299 89 PTHLAIVMEYASGGELFERICNA-----------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145 (240)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~l~~~-----------------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~ 145 (240)
.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+.||+||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 99999999999999999998653 2488999999999999999999999999999999
Q ss_pred CCeEEcCCCCCcEEEecCCccccccccCCC---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 026299 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFED 221 (240)
Q Consensus 146 ~nili~~~~~~~~~L~d~~~~~~~~~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~ 221 (240)
+||+++.++. +||+|||++......... ....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.+
T Consensus 193 ~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 193 RNVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp GGEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hccccccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-eeccchhHHHHHHHhCCCCCCCC
Confidence 9999987765 999999998654433322 23446889999999987777554 999999999999997 8999998
Q ss_pred CCchhhhhhhhc
Q 026299 222 PEEPKNFRKTIH 233 (240)
Q Consensus 222 ~~~~~~~~~~~~ 233 (240)
.+....+.++++
T Consensus 270 ~~~~~~~~~~~~ 281 (325)
T d1rjba_ 270 IPVDANFYKLIQ 281 (325)
T ss_dssp CCCSHHHHHHHH
T ss_pred CCHHHHHHHHHh
Confidence 877776666654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=289.90 Aligned_cols=213 Identities=28% Similarity=0.407 Sum_probs=176.7
Q ss_pred cCCCCCeeEeee-ecCCCceeEEEEEecC--CCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 17 MHDSDRYELVRD-IGSGNFGVARLMRDKK--TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 17 ~~~~~~y~~~~~-l~~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
.++.++|.+.+. ||+|+||.||+|.+.. ++..||||++..... ..+.+.+|+.++++++||||+++++++.+ +.
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 345578999884 9999999999998764 455799999876432 23578999999999999999999999875 46
Q ss_pred EEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 92 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
+++||||+++++|.+++.. ...+++..+..++.|++.||+|||++|++||||+|+||+++.++. +||+|||++....
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALG 160 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECT
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhccc
Confidence 7899999999999998754 457999999999999999999999999999999999999987765 9999999987543
Q ss_pred ccC----CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 171 ~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
... ......+++.|+|||.+.+...+.+ +||||||+++|+|++ |..||.+.+..+....+.+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~ 227 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred ccccccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 322 2223457789999999987776554 999999999999998 9999998877766655543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-45 Score=291.27 Aligned_cols=211 Identities=29% Similarity=0.452 Sum_probs=181.6
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc---cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++++.||+|+||.||+|++. +++.||+|++.... .....+.+|+.++++++||||+++++++.+++..+++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 68999999999999999999997 78899999986643 234678999999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc-CCCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~-~~~~ 176 (240)
++.++.+..+....+.+++..++.++.||+.||+|||+.||+|+||||+||+++.++. ++|+|||.+...... ....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccccc
Confidence 9988777777777788999999999999999999999999999999999999987766 999999998654432 2234
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
...+++.|+|||.+.+....+.++|+||||+++++|++|..||.+.+..+.+.++...
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~ 216 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 4467889999999988777667799999999999999999999998888877776543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=289.98 Aligned_cols=201 Identities=30% Similarity=0.489 Sum_probs=174.1
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc-------cHHHHHHHHHHHhcC--CCCeeeeeEEEEcCC
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------DENVQREIINHRSLR--HPNIVRFKEVILTPT 90 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 90 (240)
.++|++.+.||+|+||.||+|++..++..||+|++...... ...+.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36899999999999999999999999999999998753211 234678999999986 899999999999999
Q ss_pred eEEEEEecCCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccc
Q 026299 91 HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (240)
Q Consensus 91 ~~~lv~~~~~~-~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~ 169 (240)
..++|||++.+ +++.+++.+...+++.+++.++.|++.||+|||+.||+||||+|+||+++.+. +.++|+|||.+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEEC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceec
Confidence 99999999975 57788888888899999999999999999999999999999999999997543 24999999998643
Q ss_pred cccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026299 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (240)
Q Consensus 170 ~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (240)
. ........|++.|+|||.+.+...++.++|||||||++|+|++|..||...
T Consensus 162 ~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 162 K-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp C-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred c-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 3 233345678999999999988877767689999999999999999999763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=288.34 Aligned_cols=209 Identities=25% Similarity=0.347 Sum_probs=170.7
Q ss_pred CCeeEe-eeecCCCceeEEEEEecC--CCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEE
Q 026299 21 DRYELV-RDIGSGNFGVARLMRDKK--TEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (240)
Q Consensus 21 ~~y~~~-~~l~~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (240)
+.+++. +.||+|+||.||+|.++. ++..||+|++..... ..+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 334444 369999999999998653 457899999865432 23568999999999999999999999865 45789
Q ss_pred EEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-
Q 026299 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (240)
Q Consensus 95 v~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~- 173 (240)
||||+++++|.+++.+..++++..+..++.||+.||+|||+.||+||||+|+||+++.++. ++|+|||++.......
T Consensus 85 vmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADEN 162 (277)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCS
T ss_pred EEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhcccccc
Confidence 9999999999999988889999999999999999999999999999999999999987765 9999999986443221
Q ss_pred ---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 174 ---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 174 ---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
......+++.|+|||.+.+...+.+ +||||||+++|+|++ |..||.+.+..+....+.+
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~ 225 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred ccccccccCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc
Confidence 2223457889999999987776554 999999999999998 8999998877666555443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=285.21 Aligned_cols=216 Identities=23% Similarity=0.294 Sum_probs=173.7
Q ss_pred CCCCCcccCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC
Q 026299 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (240)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (240)
++.++++ +.++|++.+.||+|+||.||+|++..+ ..||||++.......+.+.+|+.++++++||||+++++++.+
T Consensus 8 ~~~~~~i--~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 8 AKDAWEI--PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp STTCSBC--CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCcceEc--CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 3444444 568999999999999999999999854 569999998777667789999999999999999999999855
Q ss_pred CeEEEEEecCCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 90 THLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
+..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++.
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~ 161 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLAR 161 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhh
Confidence 567899999999999888753 356999999999999999999999999999999999999987766 9999999987
Q ss_pred cccccC--CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCC-CCCCchhhhhhhh
Q 026299 168 SSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRKTI 232 (240)
Q Consensus 168 ~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~ 232 (240)
...... ......+++.|+|||.+.+...+. ++||||||+++|+|++|..|| ......+.+..+.
T Consensus 162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~ 228 (285)
T d1fmka3 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred hccCCCceeeccccccccccChHHHhCCCCCc-HHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 543322 222345788999999998877755 499999999999999965554 4444444444443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=285.39 Aligned_cols=210 Identities=22% Similarity=0.309 Sum_probs=167.5
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCC----cEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
+.+++|+..+.||+|+||.||+|.+..++ ..||||.+...... ...+.+|+.++++++||||+++++++.+++.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 35689999999999999999999987654 47999998664322 3468899999999999999999999999999
Q ss_pred EEEEEecCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
.++|+|++.++++.+.+... ..+++..+..++.|++.|++|||+.+|+||||+|+||+++.++. +||+|||++....
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhccc
Confidence 99999999999998877654 57999999999999999999999999999999999999987776 9999999986543
Q ss_pred ccCC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCC-CCCCchhhhhh
Q 026299 171 LHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRK 230 (240)
Q Consensus 171 ~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~ 230 (240)
.... .....+++.|+|||.+.+...+.+ +||||||+++|+|+++..|| ......+.++.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~ 225 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 225 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHHHHHH
Confidence 3221 122346789999999987776554 99999999999999965554 44444444333
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=288.03 Aligned_cols=213 Identities=30% Similarity=0.429 Sum_probs=178.7
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCC-CcEEEEEEeecCc---cccHHHHHHHHHHHhc---CCCCeeeeeEEEEc---
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILT--- 88 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~--- 88 (240)
..++|++++.||+|+||+||+|++..+ ++.||||++.... .....+.+|+..++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 457999999999999999999999655 6779999986532 2234566777777665 79999999999863
Q ss_pred --CCeEEEEEecCCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCc
Q 026299 89 --PTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (240)
Q Consensus 89 --~~~~~lv~~~~~~~~l~~~l~-~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~ 165 (240)
....++++|+++++.+..... ....+++..++.++.|++.||+|||+.||+||||||+|||++.++. ++|+|||.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~ 162 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGL 162 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCS
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhh
Confidence 246899999999876654443 3456899999999999999999999999999999999999987766 99999999
Q ss_pred cccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
+.............|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+.+.++++.
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 230 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred hhhhcccccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 876666666667789999999999988877655 99999999999999999999999888887776653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=291.55 Aligned_cols=209 Identities=30% Similarity=0.438 Sum_probs=178.7
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC------CeEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAI 94 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~l 94 (240)
.+|+.++.||+|+||+||+|++..+|+.||||++..+.. ...+|+.++++++||||+++++++... .++++
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 479999999999999999999999999999999976543 234799999999999999999998542 35789
Q ss_pred EEecCCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 95 VMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 95 v~~~~~~~~l~~~l---~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
||||++++.+..+. .....+++..++.++.|++.||+|||+.||+||||||+||+++.++. .++|+|||++.....
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccC
Confidence 99999876443332 34557999999999999999999999999999999999999986652 389999999987666
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
........++..|+|||.+.+...+..++|||||||++|+|++|..||...+..+.+.++++
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~ 237 (350)
T d1q5ka_ 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237 (350)
T ss_dssp TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHH
Confidence 66666778999999999988776666669999999999999999999999888887777654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-44 Score=286.08 Aligned_cols=216 Identities=25% Similarity=0.364 Sum_probs=179.7
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecC---ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC----
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP---- 89 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 89 (240)
+...++|++++.||+|+||+||+|++..+|+.||||++... .....++.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 44568999999999999999999999999999999998653 23346788999999999999999999998653
Q ss_pred ----CeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCc
Q 026299 90 ----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (240)
Q Consensus 90 ----~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~ 165 (240)
+..+++||++.++.+.........+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++++|||+
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~ 163 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGL 163 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTT
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecce
Confidence 457899999988777666556677999999999999999999999999999999999999987776 99999999
Q ss_pred cccccc-----cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 166 SKSSVL-----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 166 ~~~~~~-----~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
+..... ........+++.|+|||.+.+...++.++||||||+++++|++|..||.+.+....+..+.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 864332 122233468999999999987765566699999999999999999999988777766665543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=282.53 Aligned_cols=212 Identities=25% Similarity=0.377 Sum_probs=168.8
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCC---CcEEEEEEeecCc--cccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (240)
..++|++.+.||+|+||.||+|++..+ +..|++|.+.... ...+.+.+|+..+++++||||+++++++.+ +.++
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEE
Confidence 457999999999999999999998754 3468888876533 223568899999999999999999999864 6789
Q ss_pred EEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 94 lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
+||||++++++.+++.. ..++++..+..++.||+.||.|||+.|++||||+|+||+++.++. +||+|||++......
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC----------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCC
Confidence 99999999999987754 457999999999999999999999999999999999999987776 999999998754332
Q ss_pred C--CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhce
Q 026299 173 S--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 173 ~--~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 234 (240)
. ......+++.|+|||.+.+...+. ++||||||+++|+|++ |..||.+.+..+.+.++...
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~-~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~ 225 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 225 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred cceeccceecCcccchhhHhccCCCCC-ccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 2 223345678999999998777655 4999999999999998 89999998888777766543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=280.33 Aligned_cols=209 Identities=27% Similarity=0.465 Sum_probs=180.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc---ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeEEEEEe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (240)
++|++++.||+|+||+||+|++..+++.||||++..... ....+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 689999999999999999999999999999999876432 23578899999999999999999999999999999999
Q ss_pred cCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccC-CCC
Q 026299 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (240)
Q Consensus 98 ~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~-~~~ 176 (240)
++.++++..++...+.+++..++.++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccce
Confidence 9999999888888889999999999999999999999999999999999999987765 9999999997654433 333
Q ss_pred CCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC-Cchhhhhhh
Q 026299 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKT 231 (240)
Q Consensus 177 ~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~ 231 (240)
...++..|.|||.+.+....+.++|||||||++++|++|..||... +..+.+.++
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~ 215 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 4456788999999887776666699999999999999999986544 444444443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=280.02 Aligned_cols=208 Identities=26% Similarity=0.386 Sum_probs=171.0
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcC-CeEEEEE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIVM 96 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 96 (240)
++.++|++.+.||+|+||.||+|++. |..||+|+++.+ ...+.+.+|+..+++++||||+++++++.++ +.+++||
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 45678999999999999999999984 678999998654 3457799999999999999999999998654 5689999
Q ss_pred ecCCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCC
Q 026299 97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~ 174 (240)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++. ++++|||.+..... .
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~--~ 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS--T 156 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC---------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecCC--C
Confidence 999999999998654 35899999999999999999999999999999999999987776 99999999864432 2
Q ss_pred CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 026299 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 175 ~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (240)
.....++..|+|||.+.+...+. ++||||||+++|+|++ |..||...+..+.+.++..
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~-~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~ 215 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT
T ss_pred CccccccccCCChHHHhCCCCCh-HHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence 23345678999999998877654 4999999999999998 7888988877777666544
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-44 Score=285.10 Aligned_cols=213 Identities=25% Similarity=0.338 Sum_probs=179.2
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCcE--EEEEEeecC--ccccHHHHHHHHHHHhc-CCCCeeeeeEEEEcCCeE
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~--v~iK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 92 (240)
++.++|++.+.||+|+||.||+|++..++.. |+||.+... ....+.+.+|+..++++ +||||+++++++.+++..
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 3668999999999999999999999888764 667776543 22345789999999998 799999999999999999
Q ss_pred EEEEecCCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCC
Q 026299 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~ 156 (240)
++||||+++++|.+++... ..+++..+..++.|++.|+.|||+.|++||||+|+||+++.++.
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~- 165 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV- 165 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc-
Confidence 9999999999999998643 46899999999999999999999999999999999999987776
Q ss_pred cEEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCC-CCCCCCCchhhhhhhhc
Q 026299 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 157 ~~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~~~~~~~~~~ 233 (240)
+||+|||++.............++..|+|||.+.+..++.+ +||||||+++|+|++|. .||.+.+..+...++.+
T Consensus 166 -~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 166 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp -EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred -eEEccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 99999999976665555556678899999999988777554 99999999999999965 67888777777666654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-43 Score=285.38 Aligned_cols=202 Identities=25% Similarity=0.471 Sum_probs=176.7
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC-CCCeeeeeEEEEcC--CeEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIV 95 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv 95 (240)
+.++|++++.||+|+||+||+|++..+++.||+|++.... .+++.+|+.+++.++ ||||+++++++... ...++|
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 4578999999999999999999999999999999987543 467889999999995 99999999999754 568999
Q ss_pred EecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC
Q 026299 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (240)
Q Consensus 96 ~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~ 175 (240)
|||+++++|.... +.+++..++.++.||+.||+|||+.||+|+||+|+|||++.++. .++|+|||.+.........
T Consensus 111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCC
T ss_pred EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcc
Confidence 9999999987653 45899999999999999999999999999999999999975543 4899999999866666666
Q ss_pred CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 176 ~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
....++..|+|||.+.+....+.++|+||||+++++|++|..||.......
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~ 237 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH
Confidence 677789999999998887766666999999999999999999998765543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=285.43 Aligned_cols=210 Identities=30% Similarity=0.459 Sum_probs=173.9
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCcc--ccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC-----eE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT-----HL 92 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 92 (240)
.++|++++.||+|+||+||+|++..+|+.||||++..... ..+.+.+|+.+++.++||||+++++++.... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4689999999999999999999999999999999875432 2356789999999999999999999987643 34
Q ss_pred EEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccccc
Q 026299 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~ 172 (240)
++++ ++.+++|.+++.. ..+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||.+......
T Consensus 87 ~l~~-~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVT-HLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPD 162 (345)
T ss_dssp EEEE-ECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGG
T ss_pred EEEE-eecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCC
Confidence 5554 5668899999864 46899999999999999999999999999999999999987765 999999998654333
Q ss_pred CC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 173 ~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
.. .....+++.|+|||.+.....++.++||||+|+++++|++|..||.+.+..+.....+.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~ 227 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhh
Confidence 22 34456888999999987777667779999999999999999999998887776665543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=283.60 Aligned_cols=210 Identities=22% Similarity=0.356 Sum_probs=169.5
Q ss_pred CCCCCeeEeeeecCCCceeEEEEEecCCCc----EEEEEEeecC--ccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCCe
Q 026299 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (240)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (240)
.+.++|++++.||+|+||+||+|.+..+|+ +||+|.+... ....+.+.+|+.++++++||||+++++++.++ .
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 345789999999999999999999987765 5888887653 23346789999999999999999999999875 4
Q ss_pred EEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 92 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
.+++++++.+++|.+.+.. ...+++..+..++.|++.||+|||+.||+||||+|+||+++.++. +||+|||++....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~ 162 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLG 162 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceecc
Confidence 5677888888888887765 457999999999999999999999999999999999999987775 9999999987543
Q ss_pred ccCCC---CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 026299 171 LHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (240)
Q Consensus 171 ~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (240)
..... ....++..|+|||.+.+..++. ++||||||+++|+|++ |..||.+.+.......+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~-~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i 226 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH
T ss_pred cccccccccccccCccccChHHHhcCCCCh-hhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 32222 2234788999999998877654 4999999999999998 89999877665554443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=287.95 Aligned_cols=209 Identities=27% Similarity=0.447 Sum_probs=173.6
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcCC------
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 90 (240)
.++|++++.||+|+||.||+|++..+|+.||||++...... .+.+.+|+.+++.++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 58999999999999999999999999999999998754322 346789999999999999999999998654
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
.+++||||+ +.+|..+. ....+++..++.++.|++.||+|||+.||+|+||+|+||+++.++. ++++|||.+....
T Consensus 97 ~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQAD 172 (346)
T ss_dssp CCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred eEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceeccC
Confidence 479999999 55676655 4567999999999999999999999999999999999999987776 9999999986443
Q ss_pred ccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhce
Q 026299 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 171 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (240)
.......+++.|+|||.+.+....+.++|||||||++++|++|..||.+.+..+.+.++...
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~ 234 (346)
T d1cm8a_ 173 --SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234 (346)
T ss_dssp --SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred --CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhc
Confidence 33345678999999999987766666699999999999999999999998877776655543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=281.14 Aligned_cols=214 Identities=29% Similarity=0.430 Sum_probs=169.0
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecCC---CcEEEEEEeecCc----cccHHHHHHHHHHHhcCCCCeeeeeEEEEcC
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (240)
.++.++|++.+.||+|+||.||+|+.... ...||||++.... ...+.+.+|+.++++++||||+++++++.++
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~ 83 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 83 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec
Confidence 34568899999999999999999986533 3468999887542 2235689999999999999999999999764
Q ss_pred CeEEEEEecCCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 90 THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
..++||||++++++.+.+.. ..+++...+..++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||++..
T Consensus 84 -~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~ 160 (273)
T d1u46a_ 84 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRA 160 (273)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEE
T ss_pred -chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhh
Confidence 66899999999999887654 457999999999999999999999999999999999999988775 99999999875
Q ss_pred ccccCC----CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCchhhhhhhhce
Q 026299 169 SVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHV 234 (240)
Q Consensus 169 ~~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 234 (240)
...... .....++..|+|||.+.+...+.. +||||||+++|+|++ |..||.+.+..+.+.++.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~ 230 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC
Confidence 432222 222345678999999988776544 999999999999998 89999998888877776543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=279.09 Aligned_cols=215 Identities=26% Similarity=0.385 Sum_probs=175.4
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecCCC-------cEEEEEEeecCccc--cHHHHHHHHHHHhc-CCCCeeeeeEE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTE-------ELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEV 85 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~-------~~v~iK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~ 85 (240)
+.+..++|++.+.||+|+||.||+|++..++ ..||||++..+... ...+.+|...+.++ +||||++++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 4456689999999999999999999976543 47999998765432 35678888888888 79999999999
Q ss_pred EEcCCeEEEEEecCCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeE
Q 026299 86 ILTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (240)
Q Consensus 86 ~~~~~~~~lv~~~~~~~~l~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nil 149 (240)
+.++...++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+|+||||+|+||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 99999999999999999999998644 24899999999999999999999999999999999999
Q ss_pred EcCCCCCcEEEecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCch
Q 026299 150 LDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (240)
Q Consensus 150 i~~~~~~~~~L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (240)
++.++. ++|+|||.+....... ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.+.+..
T Consensus 168 l~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 168 VTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp ECTTCC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ecCCCC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 987776 9999999987554332 2234567889999999988776554 999999999999998 79999887777
Q ss_pred hhhhhhhc
Q 026299 226 KNFRKTIH 233 (240)
Q Consensus 226 ~~~~~~~~ 233 (240)
..++.+.+
T Consensus 245 ~~~~~i~~ 252 (299)
T d1fgka_ 245 ELFKLLKE 252 (299)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHc
Confidence 66555433
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=283.64 Aligned_cols=212 Identities=30% Similarity=0.536 Sum_probs=181.0
Q ss_pred CCCeeEeeeecCCCceeEEEEEec---CCCcEEEEEEeecC-----ccccHHHHHHHHHHHhcCC-CCeeeeeEEEEcCC
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERG-----DKIDENVQREIINHRSLRH-PNIVRFKEVILTPT 90 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 90 (240)
.++|++++.||+|+||.||+|++. .+|+.||+|.+... ....+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 378999999999999999999874 46899999998543 2234567899999999976 89999999999999
Q ss_pred eEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCcccccc
Q 026299 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (240)
Q Consensus 91 ~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~ 170 (240)
..++++|++.+++|.+++...+.+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECC
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhc
Confidence 99999999999999999998888999999999999999999999999999999999999987765 9999999986443
Q ss_pred c--cCCCCCCcCCccccCccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 026299 171 L--HSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 171 ~--~~~~~~~~~~~~~~~pE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (240)
. ........+++.|++||.+.+.. ..+.++|||||||++|+|++|..||.+....+...++.+
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~ 246 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 246 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2 23334567899999999997654 345559999999999999999999988877666555544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-43 Score=280.03 Aligned_cols=211 Identities=26% Similarity=0.395 Sum_probs=177.2
Q ss_pred CCCeeEeeeecCCCceeEEEEEec-----CCCcEEEEEEeecCccc--cHHHHHHHHHHHhcCCCCeeeeeEEEEcCCeE
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (240)
.++|++.+.||+|+||+||+|++. .++..||||++...... .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 468999999999999999999975 35678999998764332 35689999999999999999999999999999
Q ss_pred EEEEecCCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCe
Q 026299 93 AIVMEYASGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (240)
Q Consensus 93 ~lv~~~~~~~~l~~~l~~~~------------------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~ni 148 (240)
++++|++++++|.+++.... .++...+..++.|++.||+|||+.+++||||+|+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 99999999999999885422 378899999999999999999999999999999999
Q ss_pred EEcCCCCCcEEEecCCcccccccc---CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCC-CCCCCCCc
Q 026299 149 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEE 224 (240)
Q Consensus 149 li~~~~~~~~~L~d~~~~~~~~~~---~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~ 224 (240)
+++.++. +||+|||++...... .......+++.|+|||.+.+..++. ++||||||+++|+|++|. .||.+.+.
T Consensus 172 Lld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~-ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 172 LVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp EECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred EECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCCh-hhhhccchhhHHHHHccCCCCCCCCCH
Confidence 9987766 999999998644332 2223345778999999998877755 499999999999999985 67888877
Q ss_pred hhhhhhhhc
Q 026299 225 PKNFRKTIH 233 (240)
Q Consensus 225 ~~~~~~~~~ 233 (240)
.+...++.+
T Consensus 249 ~e~~~~v~~ 257 (301)
T d1lufa_ 249 EEVIYYVRD 257 (301)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHc
Confidence 776666544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-43 Score=284.40 Aligned_cols=210 Identities=26% Similarity=0.385 Sum_probs=169.8
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEc------CCe
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT------PTH 91 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~ 91 (240)
++|++++.||+|+||+||+|++..+|..||||++...... ..++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6899999999999999999999999999999999765322 2457899999999999999999999964 367
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
+|+||||+.++.+. .+ ...+++..++.++.|++.||+|||+.||+|+||||+||+++.++. ++++|||.+.....
T Consensus 97 ~~iv~Ey~~~~l~~-~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT 171 (355)
T ss_dssp EEEEEECCSEEHHH-HH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC------
T ss_pred eEEEEeccchHHHH-hh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhcccc
Confidence 89999999875444 34 345899999999999999999999999999999999999987766 99999999876666
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhceec
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVMY 236 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (240)
........++..|+|||.+.+..++.+ +||||+||++++|++|..||.+.+......++++...
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~ 235 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhcc
Confidence 666666678999999999988777665 9999999999999999999999988888777766544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-43 Score=277.56 Aligned_cols=214 Identities=24% Similarity=0.381 Sum_probs=165.6
Q ss_pred ccCCCCCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHHhc-CCCCeeeeeEEEE
Q 026299 16 IMHDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (240)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (240)
+.++.++|++.+.||+|+||.||+|.+.. +++.||+|++..... ..+.+.+|...+.++ +|+||+.+++++.
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 33556899999999999999999999754 356899999875432 234567777777776 6899999999887
Q ss_pred cC-CeEEEEEecCCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEE
Q 026299 88 TP-THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (240)
Q Consensus 88 ~~-~~~~lv~~~~~~~~l~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili 150 (240)
.. ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 64 5689999999999999998643 248899999999999999999999999999999999999
Q ss_pred cCCCCCcEEEecCCccccccccC---CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhC-CCCCCCCCchh
Q 026299 151 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPK 226 (240)
Q Consensus 151 ~~~~~~~~~L~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~ 226 (240)
+.++. +||+|||++....... ......+++.|+|||.+.+...+. ++||||||+++|+|+++ ..||...+...
T Consensus 168 ~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~-~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 168 SEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp CGGGC--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCCc--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCc-ccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 87776 9999999986443322 223346788999999998877654 49999999999999986 56888777666
Q ss_pred hhhhhh
Q 026299 227 NFRKTI 232 (240)
Q Consensus 227 ~~~~~~ 232 (240)
.+.+.+
T Consensus 245 ~~~~~~ 250 (299)
T d1ywna1 245 EFCRRL 250 (299)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 555443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7e-42 Score=271.06 Aligned_cols=204 Identities=22% Similarity=0.286 Sum_probs=172.6
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCC-CCeeeeeEEEEcCCeEEEEEec
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+|++.++.++| +|++.+++++..+...++|||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 378999999999999999999999999999999876543 34567889999999975 8999999999999999999999
Q ss_pred CCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC---CCCcEEEecCCcccccccc--
Q 026299 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVLH-- 172 (240)
Q Consensus 99 ~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~---~~~~~~L~d~~~~~~~~~~-- 172 (240)
+ +++|.+++... ..++...+..++.|++.||++||+.||+||||||+||+++.+ ..+.++|+|||++......
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 8 56888888654 479999999999999999999999999999999999999642 2345999999999644322
Q ss_pred ------CCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchh
Q 026299 173 ------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (240)
Q Consensus 173 ------~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (240)
.......|++.|+|||.+.+...+.+ +||||||+++|+|++|..||.......
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~~~ 220 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAAT 220 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccchh
Confidence 12234568999999999988776544 999999999999999999998665443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=275.66 Aligned_cols=216 Identities=25% Similarity=0.366 Sum_probs=179.7
Q ss_pred cccCCCCCeeEeeeecCCCceeEEEEEec-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHHhc-CCCCeeeeeEEE
Q 026299 15 PIMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 86 (240)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 86 (240)
.+.+..++|++.+.||+|+||.||+|++. .++..||||++..... ....+.+|+..++.+ +||||+++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 34456689999999999999999999863 4677999999976533 234678999999999 699999999999
Q ss_pred EcCCeEEEEEecCCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCe
Q 026299 87 LTPTHLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (240)
Q Consensus 87 ~~~~~~~lv~~~~~~~~l~~~l~~~~------------------~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~ni 148 (240)
.++...+++|||+++++|.+++.+.. .+++..+..++.||+.|++|||+.|++||||+|+||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 99999999999999999999986543 589999999999999999999999999999999999
Q ss_pred EEcCCCCCcEEEecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCc
Q 026299 149 LLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE 224 (240)
Q Consensus 149 li~~~~~~~~~L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 224 (240)
+++.++. ++++|||.+........ .....+++.|+|||.+.+...+.+ +||||||+++|+|++ |..||...+.
T Consensus 177 l~~~~~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 177 LLTHGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp EEETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cccccCc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc-ccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9987765 99999999874433222 123457889999999987776554 999999999999998 6677777776
Q ss_pred hhhhhhhhc
Q 026299 225 PKNFRKTIH 233 (240)
Q Consensus 225 ~~~~~~~~~ 233 (240)
...+.++++
T Consensus 254 ~~~~~~~i~ 262 (311)
T d1t46a_ 254 DSKFYKMIK 262 (311)
T ss_dssp SHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 666666553
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=281.84 Aligned_cols=211 Identities=26% Similarity=0.432 Sum_probs=176.4
Q ss_pred CCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc---cHHHHHHHHHHHhcCCCCeeeeeEEEEcC-----Ce
Q 026299 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (240)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 91 (240)
+++|++++.||+|+||+||+|++..+|+.||||++...... .+.+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999999999999999998764322 24678999999999999999999998643 23
Q ss_pred EEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccc
Q 026299 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (240)
Q Consensus 92 ~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~ 171 (240)
.+++++++.+++|.+++. .+.+++..++.++.||+.||+|||++||+||||||+||+++.++. ++++|||.+....
T Consensus 97 ~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT-
T ss_pred eEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC-
Confidence 456666777889999884 457999999999999999999999999999999999999987766 9999999986433
Q ss_pred cCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhhhhhhhcee
Q 026299 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVM 235 (240)
Q Consensus 172 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (240)
.......++..|+|||.+.+....+.++||||||+++|+|++|..||.+.+......++++..
T Consensus 173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~ 235 (348)
T d2gfsa1 173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235 (348)
T ss_dssp -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 233445678899999998887766666999999999999999999999998888877776553
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=273.79 Aligned_cols=214 Identities=20% Similarity=0.319 Sum_probs=180.2
Q ss_pred cCCCCCeeEeeeecCCCceeEEEEEecC-----CCcEEEEEEeecCcccc--HHHHHHHHHHHhcCCCCeeeeeEEEEcC
Q 026299 17 MHDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVILTP 89 (240)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (240)
.+.+++|++.+.||+|+||.||+|.+.. ++..||||++....... ..+.+|+.++++++||||+++++++..+
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 3456899999999999999999998853 35789999987643322 3578999999999999999999999999
Q ss_pred CeEEEEEecCCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEE
Q 026299 90 THLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (240)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~ 159 (240)
...++||||+++++|.+++... ..++...+..++.|++.||.|||+.+|+||||+|+||+++.+.. +|
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~K 173 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VK 173 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EE
Confidence 9999999999999999987532 24788999999999999999999999999999999999987776 99
Q ss_pred EecCCccccccccCC---CCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhC-CCCCCCCCchhhhhhhhc
Q 026299 160 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIH 233 (240)
Q Consensus 160 L~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~ 233 (240)
|+|||++........ .....+++.|+|||.+.+...+.+ +||||||+++++|++| ..||.+.+....+..+.+
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999864433222 233457899999999988877554 9999999999999997 588888887777766654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-41 Score=269.82 Aligned_cols=204 Identities=26% Similarity=0.286 Sum_probs=165.5
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCC-eeeeeEEEEcCCeEEEEEecC
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYA 99 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~~~~ 99 (240)
++|++.+.||+|+||.||+|++..+|+.||||++.... ....+..|+++++.++|++ |+.+..++.+++..++|||++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 57999999999999999999999999999999877643 3456889999999998765 555566667788899999999
Q ss_pred CCCchHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCC-CCCcEEEecCCccccccccC----
Q 026299 100 SGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS---- 173 (240)
Q Consensus 100 ~~~~l~~~l-~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~-~~~~~~L~d~~~~~~~~~~~---- 173 (240)
++ ++.+.+ .....+++..+..++.|++.||+|||+.||+||||+|+||+++.. ....++|+|||++.......
T Consensus 86 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 86 GP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp CC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred CC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 66 555544 445679999999999999999999999999999999999998532 23359999999997543322
Q ss_pred ----CCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCchhh
Q 026299 174 ----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (240)
Q Consensus 174 ----~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (240)
......+++.|+|||.+.+...+. ++||||||+++++|++|..||........
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~~l~el~tg~~P~~~~~~~~~ 221 (299)
T d1ckia_ 165 IPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATK 221 (299)
T ss_dssp CCCCBCCSCCCCSSSCCHHHHTTBCCCH-HHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred eeccccCCcCCCccccCHHHHhCCCCCC-hhhEEecCHHHHHHHhCCCcccccchHHH
Confidence 223446899999999998777654 49999999999999999999987655443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-42 Score=272.07 Aligned_cols=196 Identities=27% Similarity=0.301 Sum_probs=160.0
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCeeeeeEEEEcCC----eEEEEE
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM 96 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~ 96 (240)
.+|.+.+.||+|+||.||+|+. +|..||||++..+.........|+..++.++||||+++++++.+++ .+++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5799999999999999999986 5789999998765443333445556667789999999999998653 589999
Q ss_pred ecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------CCceeecCCCCCeEEcCCCCCcEEEecCCcccc
Q 026299 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (240)
Q Consensus 97 ~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~--------~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~ 168 (240)
||+++++|.+++.+. +++......++.+++.|++|||+ .||+||||+|+||+++.++. +||+|||++..
T Consensus 81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCcccc
Confidence 999999999999654 68999999999999999999996 59999999999999987766 99999999864
Q ss_pred ccccC-----CCCCCcCCccccCccccccCCC-----CCcccchHHHHHHHHHHHhCCCCCCC
Q 026299 169 SVLHS-----QPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFED 221 (240)
Q Consensus 169 ~~~~~-----~~~~~~~~~~~~~pE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (240)
..... ......+++.|+|||.+.+... .+.++||||||+++|+|++|..||..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 43322 2334568999999999876532 23458999999999999999887743
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-41 Score=268.08 Aligned_cols=197 Identities=24% Similarity=0.309 Sum_probs=161.8
Q ss_pred eEeeeecCCCceeEEEEEecCCC---cEEEEEEeecC--ccccHHHHHHHHHHHhcCCCCeeeeeEEEEc-CCeEEEEEe
Q 026299 24 ELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME 97 (240)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~~~~---~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~~ 97 (240)
.+.+.||+|+||+||+|++..++ ..||||.+... ....+++.+|++++++++||||+++++++.. +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 44678999999999999987543 36899998653 2233678999999999999999999999875 468899999
Q ss_pred cCCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecCCccccccccCCC-
Q 026299 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (240)
Q Consensus 98 ~~~~~~l~~~l~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~~~~~~~~~- 175 (240)
|+++++|.+++... ..++...+..++.|++.||.|||+.+|+||||+|+||+++.++. ++|+|||++.........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhcccccccc
Confidence 99999999988744 45778899999999999999999999999999999999987766 999999998754332222
Q ss_pred ----CCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 176 ----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 176 ----~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
....++..|+|||.+.+...+.+ +||||||+++|+|++|..||....
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC--
T ss_pred ceecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCC
Confidence 22346789999999987776544 999999999999999877776543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-35 Score=242.07 Aligned_cols=202 Identities=26% Similarity=0.430 Sum_probs=160.0
Q ss_pred CCCCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC-----------CCCeeeeeEEEE
Q 026299 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVIL 87 (240)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~ 87 (240)
.+++|++++.||+|+||+||+|++..+|+.||||++..+....+.+.+|+.+++.++ |+||+++++++.
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 346799999999999999999999999999999999877655667788998888774 578999998876
Q ss_pred cC--CeEEEEEecCCCC-chHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceeecCCCCCeEEcCCCCC----c
Q 026299 88 TP--THLAIVMEYASGG-ELFERI--CNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAP----R 157 (240)
Q Consensus 88 ~~--~~~~lv~~~~~~~-~l~~~l--~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~ivh~~i~~~nili~~~~~~----~ 157 (240)
.. ...++++.+.... ...... .....+++..++.++.|++.||+|||+ .||+||||||+||+++.++.. .
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 53 4555555555433 222222 234568999999999999999999997 899999999999999755432 4
Q ss_pred EEEecCCccccccccCCCCCCcCCccccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026299 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (240)
Q Consensus 158 ~~L~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (240)
++++|||.+... ........+++.|+|||.+.+..++.+ +|+||+|+++++|++|..||....
T Consensus 171 ~kl~dfg~s~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 171 IKIADLGNACWY--DEHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEECCCTTCEET--TBCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC----
T ss_pred eeEeeccccccc--ccccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCc
Confidence 899999997633 334455678999999999988777654 999999999999999999997544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.3e-24 Score=160.75 Aligned_cols=132 Identities=17% Similarity=0.152 Sum_probs=103.7
Q ss_pred eeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccc-------------------cHHHHHHHHHHHhcCCCCeeeee
Q 026299 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------------------DENVQREIINHRSLRHPNIVRFK 83 (240)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-------------------~~~~~~e~~~l~~l~h~~i~~~~ 83 (240)
+.+.+.||+|+||+||+|++. +|+.||||++..+... ......|+..+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999986 6889999986532110 11234678888899999998877
Q ss_pred EEEEcCCeEEEEEecCCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceeecCCCCCeEEcCCCCCcEEEecC
Q 026299 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (240)
Q Consensus 84 ~~~~~~~~~~lv~~~~~~~~l~~~l~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ivh~~i~~~nili~~~~~~~~~L~d~ 163 (240)
+... .+++|+++++..+.+ ++......++.|++.++.+||+.||+|+||+|+||++++++ ++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence 6532 269999998865533 34555678899999999999999999999999999998543 899999
Q ss_pred Cccccc
Q 026299 164 GYSKSS 169 (240)
Q Consensus 164 ~~~~~~ 169 (240)
|.+...
T Consensus 147 G~a~~~ 152 (191)
T d1zara2 147 PQSVEV 152 (191)
T ss_dssp TTCEET
T ss_pred CCcccC
Confidence 987543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.77 E-value=9e-08 Score=72.38 Aligned_cols=85 Identities=15% Similarity=0.062 Sum_probs=60.4
Q ss_pred CCeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCc-cccHHHHHHHHHHHhcC-CCCeeeeeEEEEcCCeEEEEEec
Q 026299 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY 98 (240)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~ 98 (240)
..|+.++..+.++.+.||.+.. ++..+++|+..... .....+.+|...+..+. +--+.+++.+..+++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 5778887766566678998853 45567888776543 22345778888887764 33356777888888889999999
Q ss_pred CCCCchHHH
Q 026299 99 ASGGELFER 107 (240)
Q Consensus 99 ~~~~~l~~~ 107 (240)
++|.++.+.
T Consensus 92 l~G~~~~~~ 100 (263)
T d1j7la_ 92 ADGVLCSEE 100 (263)
T ss_dssp CSSEEHHHH
T ss_pred ccccccccc
Confidence 999777543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.57 E-value=4.3e-07 Score=72.85 Aligned_cols=77 Identities=18% Similarity=0.139 Sum_probs=49.3
Q ss_pred eeeecCCCceeEEEEEecCCCcEEEEEEeecC--------ccccHHHHHHHHHHHhcC-C-C-CeeeeeEEEEcCCeEEE
Q 026299 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG--------DKIDENVQREIINHRSLR-H-P-NIVRFKEVILTPTHLAI 94 (240)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~e~~~l~~l~-h-~-~i~~~~~~~~~~~~~~l 94 (240)
.+.+|.|....||++.+..++..+++|.-.+. +...++...|.+.++.+. + | .+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56789999999999999888889999975431 112245567888777663 2 3 34555544 4445578
Q ss_pred EEecCCCCch
Q 026299 95 VMEYASGGEL 104 (240)
Q Consensus 95 v~~~~~~~~l 104 (240)
+||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.41 E-value=2.6e-06 Score=63.73 Aligned_cols=74 Identities=14% Similarity=0.065 Sum_probs=51.5
Q ss_pred eecCCCc-eeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCC--CCeeeeeEEEEcCCeEEEEEecCCCCch
Q 026299 28 DIGSGNF-GVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 28 ~l~~g~~-g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (240)
.+..|.. +.||.+... ++..+++|...... ...+..|...++.+.. --+.+++.+..+++..+++|++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3344443 578888765 56778999765543 2446778887776643 2356678888888889999999998665
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.81 E-value=4.7e-05 Score=59.05 Aligned_cols=131 Identities=11% Similarity=0.062 Sum_probs=77.7
Q ss_pred CCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCee--eee-----EEEEcCCeEEEEEecCCCCch
Q 026299 32 GNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV--RFK-----EVILTPTHLAIVMEYASGGEL 104 (240)
Q Consensus 32 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~--~~~-----~~~~~~~~~~lv~~~~~~~~l 104 (240)
+-...||+++.. +|..|++|+..++....+.+..|...+..+....+. ... ..+..++..+.++++++|..+
T Consensus 33 s~EN~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cccceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 334689999886 678899998877666667788888888777422221 111 122334567889999887443
Q ss_pred H-----H------HH---Hh---c------CCCCHH----------------------HHHHHHHHHHHHHHHHh----h
Q 026299 105 F-----E------RI---CN---A------GRFSED----------------------EARFFFQQLISGVSYCH----S 135 (240)
Q Consensus 105 ~-----~------~l---~~---~------~~l~~~----------------------~~~~~~~~i~~~l~~LH----~ 135 (240)
. . .+ .. . ..++.. .....+.++...++..- .
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 1 0 11 00 0 011111 12223333433333322 1
Q ss_pred CCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 136 ~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
.+++|||+.+.||+++++ ..++||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~~----~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG----PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS----EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeCC----ceEEechhcc
Confidence 468999999999999633 4689999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.68 E-value=0.00015 Score=57.68 Aligned_cols=77 Identities=13% Similarity=0.150 Sum_probs=51.0
Q ss_pred CeeEeeeecCCCceeEEEEEecC-------CCcEEEEEEeecCccccHHHHHHHHHHHhcCCCCe-eeeeEEEEcCCeEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLA 93 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~ 93 (240)
..+ ++.|+.|-...+|++.... ....|++++.. +....-+..+|..+++.+.-.++ +++++++.+ +
T Consensus 44 ~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 44 HLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp GEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred ceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 344 4577888889999998763 24567777665 33333456688888887753344 466666542 5
Q ss_pred EEEecCCCCch
Q 026299 94 IVMEYASGGEL 104 (240)
Q Consensus 94 lv~~~~~~~~l 104 (240)
.|++|++|.++
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.06 E-value=0.0012 Score=50.38 Aligned_cols=141 Identities=15% Similarity=0.075 Sum_probs=71.0
Q ss_pred CeeEeeeecCCCceeEEEEEecCCCcEEEEEEeecCccccHHHHHHHHHHHhcC-----CCCeeee-eE--EEEcCCeEE
Q 026299 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRF-KE--VILTPTHLA 93 (240)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~-~~--~~~~~~~~~ 93 (240)
+.+-.+.+..|-..+.|.+.... | .+++|++.... ..+....|+..+..+. .|..+.. .| +........
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~ 95 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 95 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred CceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence 34445566777778899988763 3 48999876542 3344555666665553 2222211 00 111234455
Q ss_pred EEEecCCCCchHH-----------H---HHh---c---C---C------------------CCHHHHHHHHHHHHHHHHH
Q 026299 94 IVMEYASGGELFE-----------R---ICN---A---G---R------------------FSEDEARFFFQQLISGVSY 132 (240)
Q Consensus 94 lv~~~~~~~~l~~-----------~---l~~---~---~---~------------------l~~~~~~~~~~~i~~~l~~ 132 (240)
.++.+..+..... . +.. . . . .........+......+..
T Consensus 96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (316)
T d2ppqa1 96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 175 (316)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence 6666665532210 0 000 0 0 0 0001112222233333333
Q ss_pred Hh----hCCceeecCCCCCeEEcCCCCCcEEEecCCccc
Q 026299 133 CH----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (240)
Q Consensus 133 LH----~~~ivh~~i~~~nili~~~~~~~~~L~d~~~~~ 167 (240)
.. ..|++|+|+.++|++++.+.. .-++||+.+.
T Consensus 176 ~~~~~L~~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~ 212 (316)
T d2ppqa1 176 HWPKDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 212 (316)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred cCccccccccccCCcchhhhhcccccc--eeEecccccc
Confidence 33 257999999999999986653 5899999975
|